Citrus Sinensis ID: 005450
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 696 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.472 | 0.464 | 0.430 | 5e-72 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.433 | 0.396 | 0.449 | 8e-72 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.416 | 0.389 | 0.452 | 8e-72 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.436 | 0.466 | 0.445 | 4e-71 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.410 | 0.397 | 0.448 | 3e-70 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.403 | 0.391 | 0.442 | 2e-69 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.439 | 0.426 | 0.439 | 4e-69 | |
| Q8RXC8 | 460 | Receptor-like cytosolic s | no | no | 0.439 | 0.665 | 0.44 | 5e-69 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.412 | 0.404 | 0.440 | 8e-69 | |
| Q5XF57 | 579 | Probable receptor-like se | no | no | 0.418 | 0.502 | 0.438 | 9e-69 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 272 bits (696), Expect = 5e-72, Method: Compositional matrix adjust.
Identities = 149/346 (43%), Positives = 211/346 (60%), Gaps = 17/346 (4%)
Query: 337 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEIE 395
LF+Y++L+ AT+ F ENL+G+GG VYKG LPDG+ +AVK LK +EF E+E
Sbjct: 364 LFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVE 423
Query: 396 IITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 455
++ +HH++++S++G C + LL+YD++S L +LHG K + W+ R K+A G
Sbjct: 424 TLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEK---SVLDWATRVKIAAG 480
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 515
A L YLH R+IHRD+KSSNILL D+F+ ++SDFGLA+ A ++HIT T V GT
Sbjct: 481 AARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHIT-TRVIGT 539
Query: 516 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 575
FGY+APEY GK+ +K DV++FGVVLLEL+TGRKP+ P G ESLV WA+P++S
Sbjct: 540 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAI 599
Query: 576 VTQ----LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA--DVTK 629
T+ L DP LG NY +M RM+ A+ C+R RP+M +++ A D+T
Sbjct: 600 ETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESLAAEDLTN 659
Query: 630 WARLQVNASEESEMLDD-ESCPRSNLQSHLNLALLDVEDDSFSMSS 674
RL ESE+ + + L + + D FS SS
Sbjct: 660 GMRLG-----ESEVFNSAQQSAEIRLFRRMAFGSQNYSTDFFSHSS 700
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 272 bits (695), Expect = 8e-72, Method: Compositional matrix adjust.
Identities = 142/316 (44%), Positives = 203/316 (64%), Gaps = 14/316 (4%)
Query: 337 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEIE 395
LF+Y++L+ AT+ F ENL+G+GG +VYKG LPD + +AVK LK +EF E++
Sbjct: 417 LFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFKAEVD 476
Query: 396 IITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 455
I+ +HH+N++S++G+C +N LL+YD++ +L +LH W+ R K+A G
Sbjct: 477 TISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGT--PGLDWATRVKIAAG 534
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 515
A L YLH R+IHRD+KSSNILL ++F +SDFGLAK A ++HIT T V GT
Sbjct: 535 AARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHIT-TRVMGT 593
Query: 516 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG- 574
FGY+APEY GK+ +K DV++FGVVLLEL+TGRKP+ P G ESLV WA+P+LS+
Sbjct: 594 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSNAT 653
Query: 575 ---KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR--GDADVTK 629
+ T L DP LG NY +M RM+ A+ CIR RP+MS +++ + D+T
Sbjct: 654 ETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSLAEEDLTN 713
Query: 630 WARLQ----VNASEES 641
RL +N++++S
Sbjct: 714 GMRLGESEIINSAQQS 729
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 272 bits (695), Expect = 8e-72, Method: Compositional matrix adjust.
Identities = 138/305 (45%), Positives = 201/305 (65%), Gaps = 15/305 (4%)
Query: 333 ATCRL----FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KPSEDVI 387
ATC L F +L AT F A+ ++G+GG +VY+G + DG E+AVK+L + +++
Sbjct: 328 ATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRD 387
Query: 388 KEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWS 447
+EF+ E+E+++ LHH+N++ L+G C E L+Y+ + GS+E +LH D W
Sbjct: 388 REFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEGTLD-----WD 442
Query: 448 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507
R K+A+G A L YLH S RVIHRD K+SN+LL DDF P++SDFGLA+ A+ S HI
Sbjct: 443 ARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 502
Query: 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 567
+ T V GTFGY+APEY M G + K DVY++GVVLLELLTGR+P+ P G+E+LV WA
Sbjct: 503 S-TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWA 561
Query: 568 KPILSSGK-VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLV---LKLLRG 623
+P+L++ + + QL+DPAL Y++D M ++ + +C+ ++ RP M V LKL+
Sbjct: 562 RPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLIYN 621
Query: 624 DADVT 628
DAD T
Sbjct: 622 DADET 626
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 270 bits (689), Expect = 4e-71, Method: Compositional matrix adjust.
Identities = 140/314 (44%), Positives = 204/314 (64%), Gaps = 10/314 (3%)
Query: 320 LPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKI 379
LP GL +S + F Y++L AT+ F NL+G+GG V+KG LP GKE+AVK
Sbjct: 252 LPPPSPGLVLGFSKST--FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQ 309
Query: 380 LKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK 438
LK S +EF E+EII+ +HH++++SL+G+C LLVY+F+ +LE +LHG
Sbjct: 310 LKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG-- 367
Query: 439 KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498
K WS R K+A+G A+ L YLH ++IHRD+K+SNIL+ FE +++DFGLAK
Sbjct: 368 KGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK 427
Query: 499 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 558
AS +++H++ T V GTFGYLAPEY GK+ +K DV++FGVVLLEL+TGR+P+ ++
Sbjct: 428 IASDTNTHVS-TRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVY 486
Query: 559 GQESLVMWAKPILS----SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQM 614
+SLV WA+P+L+ G L D +GN YD ++M RMV + C+R R RP+M
Sbjct: 487 VDDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRM 546
Query: 615 SLVLKLLRGDADVT 628
S +++ L G+ ++
Sbjct: 547 SQIVRALEGNVSLS 560
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 266 bits (681), Expect = 3e-70, Method: Compositional matrix adjust.
Identities = 132/294 (44%), Positives = 197/294 (67%), Gaps = 8/294 (2%)
Query: 338 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP-SEDVIKEFVLEIEI 396
F+Y++L T F +N++G+GG VYKG L DGK +AVK LK S +EF E+EI
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418
Query: 397 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 456
I+ +HH++++SL+G+C D + LL+Y+++S +LE +LHG K WS+R ++A+G
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHG--KGLPVLEWSKRVRIAIGS 476
Query: 457 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 516
A+ L YLH ++IHRD+KS+NILL D++E Q++DFGLA+ T+ +H++ T V GTF
Sbjct: 477 AKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVS-TRVMGTF 535
Query: 517 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL----S 572
GYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ESLV WA+P+L
Sbjct: 536 GYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIE 595
Query: 573 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 626
+G +++L+D L Y ++ RM+ + C+R RP+M V++ L D D
Sbjct: 596 TGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGD 649
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 264 bits (674), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 128/289 (44%), Positives = 192/289 (66%), Gaps = 8/289 (2%)
Query: 338 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP-SEDVIKEFVLEIEI 396
F Y++L T F ++G+GG VYKG L +GK +A+K LK S + +EF E+EI
Sbjct: 358 FTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEI 417
Query: 397 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 456
I+ +HH++++SL+G+C + + L+Y+F+ +L+ +LHG K+ WS R ++A+G
Sbjct: 418 ISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHG--KNLPVLEWSRRVRIAIGA 475
Query: 457 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 516
A+ L YLH ++IHRD+KSSNILL D+FE Q++DFGLA+ T+ SHI+ T V GTF
Sbjct: 476 AKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHIS-TRVMGTF 534
Query: 517 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL----S 572
GYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ESLV WA+P L
Sbjct: 535 GYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIEAIE 594
Query: 573 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621
G +++++DP L N+Y ++ +M+ + C+R RP+M V++ L
Sbjct: 595 KGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL 643
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 263 bits (672), Expect = 4e-69, Method: Compositional matrix adjust.
Identities = 138/314 (43%), Positives = 199/314 (63%), Gaps = 8/314 (2%)
Query: 316 DSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKEL 375
D + LP GL FNY++L AT+ F NL+G+GG V+KG L +GKE+
Sbjct: 320 DQSVLPPPSPGLALGLGIYQGTFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEV 379
Query: 376 AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL 434
AVK LK S +EF E+ II+ +HH+++++L+G+C D LLVY+F+ +LE +L
Sbjct: 380 AVKQLKEGSSQGEREFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHL 439
Query: 435 HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 494
HG K WS R K+A+G A+ L YLH ++IHRD+K+SNIL+ FE +++DF
Sbjct: 440 HG--KGRPTMEWSSRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADF 497
Query: 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 554
GLAK AS +++H++ T V GTFGYLAPEY GK+ +K DV++FGVVLLEL+TGR+PI
Sbjct: 498 GLAKIASDTNTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDV 556
Query: 555 DHPKGQESLVMWAKPILSS----GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA 610
++ SLV WA+P+L+ G ++D L N YD ++M RMV + C+R
Sbjct: 557 NNVHADNSLVDWARPLLNQVSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPR 616
Query: 611 RPQMSLVLKLLRGD 624
RP+M V ++L G+
Sbjct: 617 RPRMDQVARVLEGN 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RXC8|RBK2_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK2 OS=Arabidopsis thaliana GN=RBK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 263 bits (671), Expect = 5e-69, Method: Compositional matrix adjust.
Identities = 143/325 (44%), Positives = 197/325 (60%), Gaps = 19/325 (5%)
Query: 327 LHEKYSATCRLFNYQ--DLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK--- 381
LH+ Y L N+ D+ AT NF EN+IG+GG + VY+G LP+GK +AVK L
Sbjct: 118 LHDIYDFQSSLQNFSISDIEIATDNFSPENIIGRGGYADVYQGILPEGKLIAVKRLTKGT 177
Query: 382 PSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP 441
P E EF+ E+ II + H N +G C E + LV+ GSL LHG K
Sbjct: 178 PDEQT-AEFLSELGIIAHVDHPNTAKFIGCCIE-GGMHLVFRLSPLGSLGSLLHGPSK-- 233
Query: 442 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501
WS RY VA+G A+ L YLH G +R+IHRD+K+ NILL++DF+PQ+ DFGLAKW
Sbjct: 234 YKLTWSRRYNVALGTADGLVYLHEGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLP 293
Query: 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 561
+H + GTFGY APEYFM+G V++K DV+AFGV+LLEL+TG + + Q+
Sbjct: 294 KQLTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVFAFGVLLLELITGHPALD----ESQQ 349
Query: 562 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621
SLV+WAKP+L + +L+DP+LG+ Y+ +++ R+ + LCI + RP+MS V++LL
Sbjct: 350 SLVLWAKPLLERKAIKELVDPSLGDEYNREELIRLTSTASLCIDQSSLLRPRMSQVVELL 409
Query: 622 RGDADVTKWAR------LQVNASEE 640
G DV R +Q SEE
Sbjct: 410 LGHEDVVMTPREAKIKMMQRTYSEE 434
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (669), Expect = 8e-69, Method: Compositional matrix adjust.
Identities = 130/295 (44%), Positives = 195/295 (66%), Gaps = 8/295 (2%)
Query: 338 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEIEI 396
F Y++L T F N++G+GG VYKG L DGK +AVK LK S +EF E+EI
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400
Query: 397 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 456
I+ +HH++++SL+G+C D+ LL+Y+++ +LE +LHG K W+ R ++A+G
Sbjct: 401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHG--KGRPVLEWARRVRIAIGS 458
Query: 457 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 516
A+ L YLH ++IHRD+KS+NILL D+FE Q++DFGLAK ++ +H++ T V GTF
Sbjct: 459 AKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVS-TRVMGTF 517
Query: 517 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL----S 572
GYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ESLV WA+P+L
Sbjct: 518 GYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIE 577
Query: 573 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADV 627
+G ++L+D L +Y +++ RM+ + C+R RP+M V++ L + D+
Sbjct: 578 TGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDM 632
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5XF57|Y5576_ARATH Probable receptor-like serine/threonine-protein kinase At5g57670 OS=Arabidopsis thaliana GN=At5g57670 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (669), Expect = 9e-69, Method: Compositional matrix adjust.
Identities = 133/303 (43%), Positives = 195/303 (64%), Gaps = 12/303 (3%)
Query: 336 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KPSEDVIKE--FVL 392
+ F Y ++ AT++F N++G GG S+VY+G L DG+ +AVK L K S D+ KE F+
Sbjct: 253 QCFTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESGDMNKEKEFLT 312
Query: 393 EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 452
E+ II+ + H N LLG C E L LV+ F G+L LH N+ + W RYK+
Sbjct: 313 ELGIISHVSHPNTALLLGCCVE-KGLYLVFRFSENGTLYSALHENEN--GSLDWPVRYKI 369
Query: 453 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 512
A+GVA L YLH R+IHRD+KSSN+LL D+EPQ++DFGLAKW +H V
Sbjct: 370 AVGVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPV 429
Query: 513 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 572
GTFGYLAPE M G +++K D+YAFG++LLE++TGR+P++ Q+ +++WAKP +
Sbjct: 430 EGTFGYLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVN----PTQKHILLWAKPAME 485
Query: 573 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR--GDADVTKW 630
+G ++L+DP L + YD QM ++VL + C+++ P RP M+ VL+LL +A++ K
Sbjct: 486 TGNTSELVDPKLQDKYDDQQMNKLVLTASHCVQQSPILRPTMTQVLELLTNGNEAEIAKS 545
Query: 631 ARL 633
R+
Sbjct: 546 WRM 548
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 696 | ||||||
| 255558560 | 758 | ATP binding protein, putative [Ricinus c | 0.989 | 0.908 | 0.673 | 0.0 | |
| 224082346 | 697 | predicted protein [Populus trichocarpa] | 0.969 | 0.968 | 0.711 | 0.0 | |
| 356547275 | 736 | PREDICTED: uncharacterized protein LOC10 | 0.962 | 0.910 | 0.623 | 0.0 | |
| 449523137 | 756 | PREDICTED: uncharacterized LOC101203034 | 0.959 | 0.883 | 0.636 | 0.0 | |
| 449463428 | 756 | PREDICTED: uncharacterized protein LOC10 | 0.959 | 0.883 | 0.636 | 0.0 | |
| 224066793 | 738 | predicted protein [Populus trichocarpa] | 0.952 | 0.898 | 0.659 | 0.0 | |
| 302141759 | 732 | unnamed protein product [Vitis vinifera] | 0.958 | 0.911 | 0.655 | 0.0 | |
| 356515943 | 743 | PREDICTED: probable receptor-like serine | 0.962 | 0.901 | 0.624 | 0.0 | |
| 351727927 | 649 | protein kinase family protein [Glycine m | 0.918 | 0.984 | 0.647 | 0.0 | |
| 224096079 | 720 | predicted protein [Populus trichocarpa] | 0.969 | 0.937 | 0.586 | 0.0 |
| >gi|255558560|ref|XP_002520305.1| ATP binding protein, putative [Ricinus communis] gi|223540524|gb|EEF42091.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 979 bits (2532), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 515/765 (67%), Positives = 585/765 (76%), Gaps = 76/765 (9%)
Query: 1 MKMVQQEGDVISSGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVD 60
MKM+Q SG RTV+VGVKLD+ SRELLTWA+VKVAQPGDTVIALHVL NN IVD
Sbjct: 1 MKMIQHAEKKGGSGC-RTVMVGVKLDSESRELLTWAMVKVAQPGDTVIALHVLGNNEIVD 59
Query: 61 RDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGT-------EDHRRNSLLDVI- 112
R+GKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRG+ + + S ++I
Sbjct: 60 REGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGSSIRKILVREAKSYSATNIIV 119
Query: 113 -----HRSI----SMSKITGQKNSK------------VVTDDGS---------------- 135
H +I S++K +K SK V +GS
Sbjct: 120 GAARTHHTIRSPTSVAKYCAKKLSKDCLVLAVHNGKVVFQKEGSTAKTGDSHGSEDDQRK 179
Query: 136 ------------SITSKPVDDLG-----------GSVMNLEQALVKARSDCSGSAAKRNC 172
S SK + + G G+ QALVKAR + GS K+NC
Sbjct: 180 GFVNIFHRSISLSKNSKVISESGINEAPKYVVGEGNEQTFHQALVKARPNSLGSIMKQNC 239
Query: 173 SICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPG 232
++CG V N D SC+QS E+S D G ++SLA+VPV VE S+S L+ Q+PE +PG
Sbjct: 240 TVCGAVGNSLDESCNQSAEKSSGDNGGDNKSLALVPVSKVEGRSSSFRSLIAQVPELKPG 299
Query: 233 WPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQ-PSYLANSDVKQITYDPGDNESIN 291
WPLLRRAI P +A DRSSLR+ISVVQWA+RLP+RQ S ++N D KQ G+ + +
Sbjct: 300 WPLLRRAILPGGQASDRSSLRQISVVQWAMRLPSRQLSSSISNLDHKQ----NGEGQP-S 354
Query: 292 LNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFL 351
L+G+SGAIV VG + ++ P S DH++ +LP ELEG HEKYSATCRLF YQ+LLSATSNFL
Sbjct: 355 LDGESGAIVAVGTDALTIPPSPDHNA-KLPIELEGFHEKYSATCRLFQYQELLSATSNFL 413
Query: 352 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
AE L+GKGGSSQVYKGCLPDGKELAVKILKPSEDV+KEFVLEIEIITTL+HKNIISLLGF
Sbjct: 414 AEYLVGKGGSSQVYKGCLPDGKELAVKILKPSEDVLKEFVLEIEIITTLNHKNIISLLGF 473
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
CFE N LLLVYDFLSRGSLEENLHGN+KDP AF W ERYKVA+GVAEAL YLH+G+AQ V
Sbjct: 474 CFEYNKLLLVYDFLSRGSLEENLHGNRKDPLAFNWYERYKVAVGVAEALNYLHTGTAQPV 533
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 531
IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI CTDVAGTFGYLAPEYFMYGKVN+
Sbjct: 534 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIICTDVAGTFGYLAPEYFMYGKVNE 593
Query: 532 KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 591
KIDVYAFGVVLLELL+GRKPISND PKGQESLVMWAKPIL GK QLLDP+LG++YD D
Sbjct: 594 KIDVYAFGVVLLELLSGRKPISNDLPKGQESLVMWAKPILDDGKFCQLLDPSLGDDYDQD 653
Query: 592 QMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPR 651
QMERMVLA+ LC++R PRARPQMSLVLKLL GDA+VTKWARLQVN EES+MLDDE+CPR
Sbjct: 654 QMERMVLAATLCVKRSPRARPQMSLVLKLLHGDAEVTKWARLQVNKVEESDMLDDETCPR 713
Query: 652 SNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 696
SN+QSHLNLA LDVEDDS S+SSIEQ+VSLEDYL GR SRSSSFD
Sbjct: 714 SNIQSHLNLAFLDVEDDSLSISSIEQTVSLEDYLQGRCSRSSSFD 758
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224082346|ref|XP_002306655.1| predicted protein [Populus trichocarpa] gi|222856104|gb|EEE93651.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 947 bits (2449), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 494/694 (71%), Positives = 563/694 (81%), Gaps = 19/694 (2%)
Query: 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSV 77
TV+VGVKLD SRELLTWALVKVAQPGDTVIALH+L NN IVDR+GKSSLLSLVKAFD+V
Sbjct: 8 TVIVGVKLDPASRELLTWALVKVAQPGDTVIALHILDNNEIVDREGKSSLLSLVKAFDNV 67
Query: 78 LAVYEGFCNLKQVDLKLKICRGTEDHRRNSLLDVIHRSISMSK-ITGQKNSKVVTDDGSS 136
LAVYEGFCNLKQVDLKLKICRG+ R +L +S + +K I G + + +S
Sbjct: 68 LAVYEGFCNLKQVDLKLKICRGSSIRR---ILVREAKSYTATKVIVGATRNHLSIWPSTS 124
Query: 137 ITSKPVDDL--GGSVMNLEQALVKARSD----------CS-GSAAKRNCSICGPVRNLPD 183
+ L SV+ V + + CS S K NCS+CG V D
Sbjct: 125 VAKYCAKKLPKDCSVLAFNNGKVVFQRERTPNNTGNFSCSLASIMKENCSVCGSVMKPAD 184
Query: 184 GSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPD 243
SC+QS E S D D+SLA+VPV VE ++S++ L+ Q+PE +PGWPLLR ++ P+
Sbjct: 185 DSCNQSAEASCGDRDGDDKSLALVPVPRVEEPTSSVSTLIGQVPELKPGWPLLRSSVLPN 244
Query: 244 RRAPDRSSLRKISVVQWALRLPTRQPSY-LANSDVKQITYDPGDNESINLNGDSGAIVPV 302
R+ +RS +R+ISVVQWA+RLP+RQ S NSD KQ D G+ E +NL+G+SGAIV V
Sbjct: 245 RKTSNRSLVRQISVVQWAMRLPSRQLSLSTVNSDHKQDVSDKGE-EQLNLDGESGAIVAV 303
Query: 303 GNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSS 362
G E ++PLS DH+S LPKELEGLHEKYSATCRLF Q+LLSATSNFLAENLIGKGGSS
Sbjct: 304 GMETATAPLSPDHNSRSLPKELEGLHEKYSATCRLFQCQELLSATSNFLAENLIGKGGSS 363
Query: 363 QVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422
QVYKGCLPDGKELAVKILKPSEDV+KEFV EIEIITTL HKNIISLLGFCFE NLLLVY
Sbjct: 364 QVYKGCLPDGKELAVKILKPSEDVLKEFVQEIEIITTLSHKNIISLLGFCFEGKNLLLVY 423
Query: 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 482
DFLSRGSLEENLHGNKKDP AFGW+ERYKVA+G+AEAL+YLHS SAQ VIHRDVKSSNIL
Sbjct: 424 DFLSRGSLEENLHGNKKDPRAFGWNERYKVALGIAEALDYLHSCSAQPVIHRDVKSSNIL 483
Query: 483 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 542
LSDDFEPQLSDFGLAKWA TSSSHI C DVAGTFGYLAPEYFMYGKVN+KIDVYAFGVVL
Sbjct: 484 LSDDFEPQLSDFGLAKWAPTSSSHIICNDVAGTFGYLAPEYFMYGKVNNKIDVYAFGVVL 543
Query: 543 LELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL 602
LELL+G+KPISND PKGQESLVMWAKPIL+ GKV+QLLDP LG++ D DQMERMVLA+ L
Sbjct: 544 LELLSGKKPISNDLPKGQESLVMWAKPILNGGKVSQLLDPILGDSCDRDQMERMVLAATL 603
Query: 603 CIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNLQSHLNLAL 662
C+RR PRARPQMSLV+KLL+GDA+VT+WARLQVNA EES++LDDE+CPRSNLQSHLNLAL
Sbjct: 604 CVRRAPRARPQMSLVVKLLQGDAEVTRWARLQVNAVEESDVLDDEACPRSNLQSHLNLAL 663
Query: 663 LDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 696
LDVE+DS S SS+EQS+SL+DYL GRWSRSSS D
Sbjct: 664 LDVENDSLSSSSLEQSISLQDYLQGRWSRSSSLD 697
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547275|ref|XP_003542041.1| PREDICTED: uncharacterized protein LOC100797280 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 892 bits (2306), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 475/762 (62%), Positives = 548/762 (71%), Gaps = 92/762 (12%)
Query: 1 MKMVQ--QEGDVISSGAG-RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNA 57
MKM+ G SGAG RTVVVG+K+D+HS ELLTWAL KVAQPGD V+ALHVL N+
Sbjct: 1 MKMLPPPTAGGASHSGAGDRTVVVGMKMDSHSTELLTWALFKVAQPGDVVLALHVLGNDE 60
Query: 58 IVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTEDHR------------- 104
IV+R+GKSSL SLVKAFDS+LAVYEGFCNLKQVDLK KICRG+ R
Sbjct: 61 IVNREGKSSLFSLVKAFDSILAVYEGFCNLKQVDLKFKICRGSSVRRILVREANAYSATH 120
Query: 105 ----RNSLLDVIHRSISMSKITGQK-----------NSKVVTD-DGSSIT---------- 138
+ L +I IS+++ +K N K+V +GS T
Sbjct: 121 IIVGSSQGLHIIRPCISVARYCAKKLPKDCWVLAVDNGKIVFKREGSPATRAELKGLDQD 180
Query: 139 ----------------SKPVDDLGGSVMNL--------EQALVKARSDCSGSAAKRNCSI 174
SK +DD G + + +L KA D K+ CSI
Sbjct: 181 HKTRLLGSIHRTISKGSKVLDDDGTGIHEKGCGNGEYSDHSLAKAFLDSKEFVEKKRCSI 240
Query: 175 CGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWP 234
C SEEES D + LAIVPVQ +AA S+PGWP
Sbjct: 241 CA------------SEEESCGDASDENNPLAIVPVQTNDAA-------------SKPGWP 275
Query: 235 LLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNG 294
LLR+ I D++ ++S LR+ISVVQWA++LP+R SY A+ D K D ++ + L+
Sbjct: 276 LLRKTIASDKKCSEKSLLRQISVVQWAMQLPSRDLSYAAHQDHKANNCDQNKDQFLALDS 335
Query: 295 DSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAEN 354
SGA+VPV EI ++ S + +S +PKELEGLHEKYS+TCRLF YQ+L+ ATSNFL EN
Sbjct: 336 KSGALVPVDAEIGTAS-SPERNSRSIPKELEGLHEKYSSTCRLFEYQELVLATSNFLPEN 394
Query: 355 LIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 414
LIGKGGSSQVY+GCLPDGKELAVKILKPS+DV+KEFVLEIEIITTL+HKNIISLLGFCFE
Sbjct: 395 LIGKGGSSQVYRGCLPDGKELAVKILKPSDDVLKEFVLEIEIITTLNHKNIISLLGFCFE 454
Query: 415 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 474
D NLLLVYDFLSRGSLEENLHGNKK+P FGW+ERYKVAMGVAEALEYLH+ Q VIHR
Sbjct: 455 DGNLLLVYDFLSRGSLEENLHGNKKNPLVFGWTERYKVAMGVAEALEYLHNNEGQSVIHR 514
Query: 475 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKID 534
DVKSSN+LLS+DFEPQLSDFGLAKWASTSSSHI CTDVAGTFGY+APEYFMYGKVNDKID
Sbjct: 515 DVKSSNVLLSEDFEPQLSDFGLAKWASTSSSHIICTDVAGTFGYMAPEYFMYGKVNDKID 574
Query: 535 VYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQME 594
VYAFGVVLLELL+GRKPIS D+PKGQESLVMWA PIL+SGKV Q+LDP+LG NYD+++ME
Sbjct: 575 VYAFGVVLLELLSGRKPISGDYPKGQESLVMWASPILNSGKVLQMLDPSLGENYDHEEME 634
Query: 595 RMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNL 654
RMVLA+ LCIRR PRARP MSL+ KLL GD DV KWARL+ NA E EMLD E+CP SNL
Sbjct: 635 RMVLAATLCIRRAPRARPLMSLISKLLGGDPDVIKWARLEANALEAPEMLDGEACPPSNL 694
Query: 655 QSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 696
QSHLNLALLDVEDDS SM S+EQ+VSLEDYL GRWSRSSSFD
Sbjct: 695 QSHLNLALLDVEDDSLSMCSVEQNVSLEDYLRGRWSRSSSFD 736
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449523137|ref|XP_004168581.1| PREDICTED: uncharacterized LOC101203034 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 891 bits (2302), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 480/754 (63%), Positives = 564/754 (74%), Gaps = 86/754 (11%)
Query: 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF 74
+ RTV+VG+KLD+HSRELLTWALVKVAQPGD VIALHVL N+ IV++DGKSSLLSLVKAF
Sbjct: 17 SARTVLVGMKLDSHSRELLTWALVKVAQPGDLVIALHVLGNHEIVNQDGKSSLLSLVKAF 76
Query: 75 DSVLAVYEGFCNLKQVDLKLKICRG----------TEDHRRNSLL-------DVIHRSIS 117
D+VLAVYEGFCNLKQVDLKLKICRG + +R +L+ I S S
Sbjct: 77 DTVLAVYEGFCNLKQVDLKLKICRGESARKILVREAKSYRATNLIVGTARKHHKIRSSTS 136
Query: 118 MSKITGQK-----------NSKVV---------TDD-----------------GSSITSK 140
++K +K N KV+ T D GS+ +S
Sbjct: 137 VAKYCAKKLPKDFWVLAVHNGKVIFEREGCPVATGDCHGNEEQRHSNLLAAVYGSAGSSP 196
Query: 141 PV--------------DDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSC 186
V D+LG N +Q KA S K+NCSICG + +
Sbjct: 197 KVQSGESFGSLLARDRDNLGIG-KNSDQEFEKA---LSVGTDKQNCSICGSESSFVE--- 249
Query: 187 SQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLR---RAIFPD 243
QS E S SDG DESLA+VPVQ VE AS+SIT L++QLPE +PGWPLLR ++
Sbjct: 250 -QSAEISSSDGEKHDESLALVPVQIVEVASSSITKLIKQLPEVKPGWPLLRHVDQSCESG 308
Query: 244 RRA-PDRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPV 302
R+A DRS ++ISVVQWA++LP+R P Y A D K T D +S+ L+G++GA+V V
Sbjct: 309 RQASSDRSLAKQISVVQWAMKLPSRSPLYPAALDYKSNTSD----QSLGLDGENGAMVLV 364
Query: 303 GNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSS 362
G+E V SPLS+D D+ LPKELEG HEKYS+TCRLFNY +LL+ATSNFL ENLIGKGGSS
Sbjct: 365 GSEPVPSPLSSDSDTETLPKELEGFHEKYSSTCRLFNYHELLTATSNFLPENLIGKGGSS 424
Query: 363 QVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422
QV++GCLPDGKE+AVKILK SEDV+KEFV+E+EIIT+L HKNIISLLGFCFE++ LLVY
Sbjct: 425 QVFRGCLPDGKEVAVKILKTSEDVLKEFVMEVEIITSLSHKNIISLLGFCFENSKFLLVY 484
Query: 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 482
DFLSRG LEE LHGN+K+P FGWSERYKVA+GVAEAL+YLH AQ VIHRDVKSSNIL
Sbjct: 485 DFLSRGCLEEILHGNRKNPNTFGWSERYKVAVGVAEALDYLHL-DAQHVIHRDVKSSNIL 543
Query: 483 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 542
LSDDFEPQLSDFGLAK S++SSH+TCTDVAGTFGYLAPEYFMYGKVNDKIDVYA+GVVL
Sbjct: 544 LSDDFEPQLSDFGLAK-RSSNSSHVTCTDVAGTFGYLAPEYFMYGKVNDKIDVYAYGVVL 602
Query: 543 LELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL 602
LEL++GRKPIS ++PKGQESLVMWA+PIL GKV++LLDP LG NY+ D+MER+VLA+ L
Sbjct: 603 LELISGRKPISTEYPKGQESLVMWARPILIDGKVSRLLDPTLGGNYNQDEMERVVLAASL 662
Query: 603 CIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNLQSHLNLAL 662
CIRR PRARP MSLVLKLL+GDADVTKWAR Q+NA +S LDDE CPRS++QSHLNLAL
Sbjct: 663 CIRRAPRARPPMSLVLKLLQGDADVTKWARQQINALGDSNTLDDEVCPRSDIQSHLNLAL 722
Query: 663 LDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 696
LDV+DDS S+SSIE S+SLEDYL GRWSRSSSFD
Sbjct: 723 LDVDDDSLSLSSIEHSISLEDYLQGRWSRSSSFD 756
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463428|ref|XP_004149436.1| PREDICTED: uncharacterized protein LOC101203034 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 890 bits (2301), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 480/754 (63%), Positives = 563/754 (74%), Gaps = 86/754 (11%)
Query: 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF 74
+ RTV+VG+KLD+HSRELLTWALVKVAQPGD VIALHVL N+ IV++DGKSSLLSLVKAF
Sbjct: 17 SARTVLVGMKLDSHSRELLTWALVKVAQPGDLVIALHVLGNHEIVNQDGKSSLLSLVKAF 76
Query: 75 DSVLAVYEGFCNLKQVDLKLKICRG----------TEDHRRNSLL-------DVIHRSIS 117
D+VLAVYEGFCNLKQVDLKLKICRG + +R +L+ I S S
Sbjct: 77 DTVLAVYEGFCNLKQVDLKLKICRGESARKILVREAKSYRATNLIVGTARKHHKIRSSTS 136
Query: 118 MSKITGQK-----------NSKVV---------TDD-----------------GSSITSK 140
++K +K N KV+ T D GS+ +S
Sbjct: 137 VAKYCAKKLPKDFWVLAVHNGKVIFEREGCPVATGDCHGNEEQRHSNLLAAVYGSAGSSP 196
Query: 141 PV--------------DDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSC 186
V D+LG N +Q KA S K+NCSICG + +
Sbjct: 197 KVQSGESFGSLLARDRDNLGIG-KNSDQEFEKA---LSVGTDKQNCSICGSESSFVE--- 249
Query: 187 SQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLR---RAIFPD 243
QS E S SDG DESLA+VPVQ VE AS+SIT L++QLPE +PGWPLLR ++
Sbjct: 250 -QSAEISSSDGEKHDESLALVPVQIVEVASSSITKLIKQLPEVKPGWPLLRHVDQSCESG 308
Query: 244 RRA-PDRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPV 302
R+A DRS ++ISVVQWA++LP+R P Y A D K T D +S+ L+G++GA+V V
Sbjct: 309 RQASSDRSLAKQISVVQWAMKLPSRSPLYPAALDYKSNTSD----QSLGLDGENGAMVLV 364
Query: 303 GNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSS 362
G+E V SPLS+D D+ LPKELEG HEKYS+TCRLFNY +LL+ATSNFL ENLIGKGGSS
Sbjct: 365 GSEPVPSPLSSDSDTETLPKELEGFHEKYSSTCRLFNYHELLTATSNFLPENLIGKGGSS 424
Query: 363 QVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422
QV++GCLPDGKE+AVKILK SEDV+KEFV+E+EIIT+L HKNIISLLGFCFE++ LLVY
Sbjct: 425 QVFRGCLPDGKEVAVKILKTSEDVLKEFVMEVEIITSLSHKNIISLLGFCFENSKFLLVY 484
Query: 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 482
DFLSRG LEE LHGN+K+P FGWSERYKVA+GVAEAL+YLH AQ VIHRDVKSSNIL
Sbjct: 485 DFLSRGCLEEILHGNRKNPNTFGWSERYKVAVGVAEALDYLHL-DAQHVIHRDVKSSNIL 543
Query: 483 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 542
LSDDFEPQLSDFGLAK S++SSH+TCTDVAGTFGYLAPEYFMYGKVNDKIDVYA+GVVL
Sbjct: 544 LSDDFEPQLSDFGLAK-RSSNSSHVTCTDVAGTFGYLAPEYFMYGKVNDKIDVYAYGVVL 602
Query: 543 LELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL 602
LEL++GRKPIS +PKGQESLVMWA+PIL GKV++LLDP LG NY+ D+MER+VLA+ L
Sbjct: 603 LELISGRKPISTKYPKGQESLVMWARPILIDGKVSRLLDPTLGGNYNQDEMERVVLAASL 662
Query: 603 CIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNLQSHLNLAL 662
CIRR PRARP MSLVLKLL+GDADVTKWAR Q+NA +S LDDE CPRS++QSHLNLAL
Sbjct: 663 CIRRAPRARPPMSLVLKLLQGDADVTKWARQQINALGDSNTLDDEVCPRSDIQSHLNLAL 722
Query: 663 LDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 696
LDV+DDS S+SSIE S+SLEDYL GRWSRSSSFD
Sbjct: 723 LDVDDDSLSLSSIEHSISLEDYLQGRWSRSSSFD 756
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224066793|ref|XP_002302218.1| predicted protein [Populus trichocarpa] gi|222843944|gb|EEE81491.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 888 bits (2294), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/732 (65%), Positives = 555/732 (75%), Gaps = 69/732 (9%)
Query: 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSV 77
TV+VGVKLD+ SRELLTWALVKVAQPGDTVIALHVL +N IVDR+GKSSLLSLVKAFDSV
Sbjct: 8 TVIVGVKLDSMSRELLTWALVKVAQPGDTVIALHVLGSNEIVDREGKSSLLSLVKAFDSV 67
Query: 78 LAVYEGFCNLKQVDLKLKICRGTEDH-------RRNSLLDVI------HRSI----SMSK 120
LAVYEGFCNLKQVDLKLKICRG+ + + VI H SI S++K
Sbjct: 68 LAVYEGFCNLKQVDLKLKICRGSSTRKILVREVKSYAATKVIVGAAKNHPSIWSSTSVAK 127
Query: 121 ITGQK-----------NSKVVTDDGSSITSKPVDDLGGSVMNL----------------- 152
+K N KVV S + D S++++
Sbjct: 128 YCAKKLPKDCSVLAVNNGKVVFQRERSPNTSGTKDHSKSLLSVVHRTISSEKKSRELNES 187
Query: 153 ------------EQALVKA----RSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESPSD 196
+Q L KA RS+ S K NCS+CG D S ++S E S SD
Sbjct: 188 SANGGSKDDQDSDQILEKALMKARSNSLESIMKENCSVCGSATIFADDSSNESAEASSSD 247
Query: 197 GGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKIS 256
G D+SLA+VPV +E ++S++ L+RQ+PE +PGWPLL RA+ PD++ + S +R++
Sbjct: 248 NGGDDKSLALVPVPRLEEPTSSVSTLIRQVPELKPGWPLLCRAVLPDKKESNISLVRQVC 307
Query: 257 VVQW-ALRLPTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDH 315
VVQW L L T NSD KQ D G+++ NL+G+SGAIV VG E ++P + H
Sbjct: 308 VVQWEQLSLST------VNSDHKQDGSDKGEDK-FNLDGESGAIVAVGMETATAPHTPHH 360
Query: 316 DSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKEL 375
+S PKELEGLHEKYSATCRLF YQ+LLSATSNFLAENLIGKGGSSQVYKGCL DGKEL
Sbjct: 361 NSRSPPKELEGLHEKYSATCRLFQYQELLSATSNFLAENLIGKGGSSQVYKGCLSDGKEL 420
Query: 376 AVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLH 435
AVKILKPSEDV+KEFVLEIEIITTLHHKNIISLLGFCFED NLLLVYDFL RGSLE+NL+
Sbjct: 421 AVKILKPSEDVLKEFVLEIEIITTLHHKNIISLLGFCFEDKNLLLVYDFLPRGSLEDNLY 480
Query: 436 GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 495
GNKKDP FGW+ERYKVA+GVAEAL+YLHS SAQ VIHRDVKSSNILLSDDFEPQLSDFG
Sbjct: 481 GNKKDPLTFGWNERYKVALGVAEALDYLHSCSAQPVIHRDVKSSNILLSDDFEPQLSDFG 540
Query: 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 555
LAKWA TSSSHI CTDVAGTFGYLAPEYFMYGKVN KIDVYAFGVVLLELL+G+KPISND
Sbjct: 541 LAKWAPTSSSHIICTDVAGTFGYLAPEYFMYGKVNKKIDVYAFGVVLLELLSGKKPISND 600
Query: 556 HPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMS 615
PKGQESLVMWAKPIL+ GKV+QLLD +LG++YD DQMERMVLA+ LC++R PRARPQMS
Sbjct: 601 LPKGQESLVMWAKPILNGGKVSQLLDSSLGDSYDLDQMERMVLAANLCVKRAPRARPQMS 660
Query: 616 LVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSI 675
LV+KLL+GDA+ TKWARLQVNA+EES++LDDE+CPRSNL SHLNLALLDVEDD S+SSI
Sbjct: 661 LVVKLLQGDAEATKWARLQVNAAEESDVLDDEACPRSNLLSHLNLALLDVEDDLLSLSSI 720
Query: 676 EQSVSLEDYLLG 687
E S+SLEDYL G
Sbjct: 721 EHSISLEDYLAG 732
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302141759|emb|CBI18962.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 868 bits (2243), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/714 (65%), Positives = 548/714 (76%), Gaps = 47/714 (6%)
Query: 24 KLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEG 83
KLD+ SRELLTWALVKVAQPGD VIALHVL +N + S +V +F AVYEG
Sbjct: 25 KLDSQSRELLTWALVKVAQPGDRVIALHVLGHNEMGVCRNCGSRWEIVASF----AVYEG 80
Query: 84 FCNLKQVDLKLKICRGTEDHR-------------------RNSLLDVIHRSISMSKITGQ 124
FCNLKQVDLKLKICRG+ + RN I S +++K +
Sbjct: 81 FCNLKQVDLKLKICRGSSIGKILVREVKSYVASKVIVGTARNH--HAIRSSAAVAKYCAK 138
Query: 125 K-----------NSKVVTDDGSSITS------KPVDDLGGSVMNLEQALVK-ARSDCSGS 166
K N KVV +S+ + K G + ++Q++ K +++ G
Sbjct: 139 KLPKDCSVLAVNNGKVVFQREASMRTTVDSQEKEEHRRNGLLGGIQQSVSKKSKALNHGK 198
Query: 167 AAKRNCSICGP--VRNLPDG--SCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITML 222
+ +IC P ++L G SCSQS E S D D+SLAIVPVQ +EA+S+SI++L
Sbjct: 199 VNEEPSTICDPSACQSLELGLNSCSQSIEGSSGDSHHEDDSLAIVPVQKLEASSSSISLL 258
Query: 223 VRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQPSYLANSDVKQITY 282
+R+LPE RPGWPLLRRAI PDR+ +SS+R+ISVVQWA+RLP+R A+ D + +
Sbjct: 259 IRELPELRPGWPLLRRAILPDRQTSTKSSVRQISVVQWAMRLPSRNFPSAASLDNIESSC 318
Query: 283 DPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQD 342
D ++ S NL+G+SGAIVPVG S+P S ST+L KELEGLHEKYSATCRLF +Q+
Sbjct: 319 DGDEDLSTNLDGESGAIVPVGTVNASAPPSPSRSSTKLAKELEGLHEKYSATCRLFKFQE 378
Query: 343 LLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH 402
L SATSNF+ ENLIGKGGSS+VY+GCL DGKELAVKILK S+D++KEF+LEIEII+TLHH
Sbjct: 379 LFSATSNFMPENLIGKGGSSRVYRGCLSDGKELAVKILKQSDDILKEFLLEIEIISTLHH 438
Query: 403 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 462
KNIISLLGFCFE+NNLLLVYDFLSRGSLEENL+GNKKD AFGWSERYKVA+GVAEAL+Y
Sbjct: 439 KNIISLLGFCFENNNLLLVYDFLSRGSLEENLYGNKKDLFAFGWSERYKVAVGVAEALDY 498
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
LH GSAQ VIH DVKSSNILL+DDFEPQLSDFGLAKWASTSSSHITC+DVAGTFGY+APE
Sbjct: 499 LHCGSAQAVIHGDVKSSNILLADDFEPQLSDFGLAKWASTSSSHITCSDVAGTFGYMAPE 558
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582
YFMYGKVN+KIDVYAFGVVLLELL+GRKPIS+D+PKGQESLVMWAKPIL GKV++LLDP
Sbjct: 559 YFMYGKVNEKIDVYAFGVVLLELLSGRKPISSDYPKGQESLVMWAKPILYGGKVSELLDP 618
Query: 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESE 642
+LG+NYD QMERMV A+ILCIRR PRARPQMSLVLKLL+GDA+ TKWARLQVNA E S+
Sbjct: 619 SLGSNYDSSQMERMVWAAILCIRRAPRARPQMSLVLKLLQGDAEATKWARLQVNACEGSD 678
Query: 643 MLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 696
DDE+ P SNLQSHLNLALLDVE+DS SMSSIEQSVSLEDYL GRWSRSSSFD
Sbjct: 679 TPDDEAFPHSNLQSHLNLALLDVEEDSLSMSSIEQSVSLEDYLQGRWSRSSSFD 732
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356515943|ref|XP_003526656.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 861 bits (2225), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/746 (62%), Positives = 543/746 (72%), Gaps = 76/746 (10%)
Query: 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF 74
GRTV+VGVK+D+ S+ELLTWALVKVA PGDTV+ALHVL NN V+ DGKSSLLSLVKAF
Sbjct: 10 GGRTVLVGVKMDSPSKELLTWALVKVAHPGDTVVALHVLGNNETVNGDGKSSLLSLVKAF 69
Query: 75 DSVLAVYEGFCNLKQVDLKLKICRGTEDHR-------------------------RNSLL 109
DSVLA Y+GFCNLKQVDLKLKICRG+ + R+S +
Sbjct: 70 DSVLAAYKGFCNLKQVDLKLKICRGSSVKKTLVREANGYSATHVVVGTTHGLHKIRSSTV 129
Query: 110 DVIHRSISMSK---ITGQKNSKVVTDDGSSITS----KPVD--DLGGSVMNLEQALVKAR 160
H + +SK + N KVV SS S + VD + G + ++ L K R
Sbjct: 130 VAKHCAKKLSKDCCVLAVNNGKVVFKRDSSPPSVAELQGVDRHNRNGLLGSIHWTLGKNR 189
Query: 161 S----DCSG--------------SAAK---------RN--CSICGPVRNLPDGSCSQSEE 191
D SG S AK RN CSICG LPD S QS E
Sbjct: 190 KVLSDDSSGMDADEKKTGPISDHSLAKFFLESKETVRNPSCSICGTTLALPDPSFYQSAE 249
Query: 192 ESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSS 251
D G + SLA+VPVQ AA T E +PGWPLL I DR++ RS
Sbjct: 250 GVSGDEGR-ENSLAMVPVQPTVAAKT----------ELKPGWPLLDGRILSDRQSAGRSL 298
Query: 252 LR-KISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSP 310
+ISVVQWA+RLP+R SY + D K D G ++ L+ +SGA+V V E+ ++
Sbjct: 299 FHLQISVVQWAMRLPSRNLSYAVDRDEKSKICDQGQDQPAALDSESGALVLVDAELGTAS 358
Query: 311 LSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP 370
S +++S +PKELEGLHEKYS+TCRLF YQ+L+SATSNFL ENLIGKGGSSQVY+GCLP
Sbjct: 359 -SPENNSGNIPKELEGLHEKYSSTCRLFEYQELVSATSNFLHENLIGKGGSSQVYRGCLP 417
Query: 371 DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 430
DGKELAVKIL PS+DV+ EF+LEIEIITTLHHKNIISLLGFCFE+ LLLVYDFLSRGSL
Sbjct: 418 DGKELAVKILNPSDDVLSEFLLEIEIITTLHHKNIISLLGFCFENGKLLLVYDFLSRGSL 477
Query: 431 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 490
EENLHGNKK+ FGWSERYKVA+GVAEAL+YLHS Q VIHRDVKSSN+LLS++FEPQ
Sbjct: 478 EENLHGNKKNSLVFGWSERYKVAVGVAEALDYLHSKDDQPVIHRDVKSSNVLLSENFEPQ 537
Query: 491 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRK 550
LSDFGLAKWAST SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL+GRK
Sbjct: 538 LSDFGLAKWASTLSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLSGRK 597
Query: 551 PISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA 610
PIS D+PKGQESLVMWA PIL+SGKV QLLDP+LG+NYD+++ME++VLA+ LCI+R PRA
Sbjct: 598 PISRDYPKGQESLVMWASPILNSGKVLQLLDPSLGDNYDHEEMEKIVLAATLCIKRAPRA 657
Query: 611 RPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSF 670
RPQM+L+ KLL+GDA+ KWARLQVNA + EMLDDE+CP SNLQSH+NLALLDVEDD
Sbjct: 658 RPQMNLISKLLQGDAEAIKWARLQVNALDPPEMLDDEACPPSNLQSHINLALLDVEDDLL 717
Query: 671 SMSSIEQSVSLEDYLLGRWSRSSSFD 696
SM S+EQ ++LEDYL GRWSR+SSFD
Sbjct: 718 SMCSVEQGLTLEDYLRGRWSRASSFD 743
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727927|ref|NP_001238713.1| protein kinase family protein [Glycine max] gi|223452363|gb|ACM89509.1| protein kinase family protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 845 bits (2183), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/692 (64%), Positives = 517/692 (74%), Gaps = 53/692 (7%)
Query: 8 GDVISSGAG-RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS 66
GD AG R VVVG+K+D+HS ELLTWAL KVAQPGD V+ALHVL N+ IV+R+GKSS
Sbjct: 8 GDAGHGSAGDRIVVVGMKMDSHSTELLTWALFKVAQPGDVVLALHVLGNDEIVNREGKSS 67
Query: 67 LLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTEDHRRNSLLDVIHRSISMSKITGQKN 126
L SLVKAFDS+LAVYEGFCNLKQVDLK KICRG+ R L+ + + I G
Sbjct: 68 LFSLVKAFDSILAVYEGFCNLKQVDLKFKICRGSSVTR--ILVREANAYSATHIIVGSSQ 125
Query: 127 SKVVTDDGSSITSKPVDDLGGS--VMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDG 184
+T S+ L V ++ + + + GSAA R+ + +
Sbjct: 126 GLHITRPCISVARYCAKKLPKDCWVFAVDNGKIVFKRE--GSAATRS-DLKEFIEKKRCS 182
Query: 185 SCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDR 244
+ + EEES +D LAIVPVQ +AAS +PGWPLLR+ I DR
Sbjct: 183 TSASEEEESCADACDEMNPLAIVPVQTNDAAS-------------KPGWPLLRKTIVSDR 229
Query: 245 RAPDRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGN 304
+ RS L +ISVVQWA+ SGA+VPV
Sbjct: 230 KCSQRSLLCQISVVQWAMH-------------------------------KSGALVPVDA 258
Query: 305 EIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQV 364
EI ++P ST+H+S +PKELEGLHEKYS+TCRLF YQ+L+ ATSNFL ENLIGKGGSSQV
Sbjct: 259 EIGTAP-STEHNSRSIPKELEGLHEKYSSTCRLFKYQELVLATSNFLPENLIGKGGSSQV 317
Query: 365 YKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424
Y+GCLPDGKELAVKILKPS+DV+KEFVLEIEIITTL+HK++ISLLGFCFED NLLLVYDF
Sbjct: 318 YRGCLPDGKELAVKILKPSDDVLKEFVLEIEIITTLNHKSLISLLGFCFEDGNLLLVYDF 377
Query: 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 484
LSRGSLEENLHGNKK+P FGW+ERYKVA+GVAEALEYLH+ Q VIHRDVKSSN+LLS
Sbjct: 378 LSRGSLEENLHGNKKNPLMFGWTERYKVAIGVAEALEYLHNNDGQSVIHRDVKSSNVLLS 437
Query: 485 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLE 544
+DFEPQLSDFGLAKWAST+SSHI CTDVAGTFGY+APEYFMYGKVNDKIDVYAFGVVLLE
Sbjct: 438 EDFEPQLSDFGLAKWASTTSSHIICTDVAGTFGYMAPEYFMYGKVNDKIDVYAFGVVLLE 497
Query: 545 LLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCI 604
LL+GRKPIS D+PKGQESLVMWA PIL+SGKV QLLDP+LG+NY++++MERMVLA+ LC
Sbjct: 498 LLSGRKPISGDYPKGQESLVMWASPILNSGKVLQLLDPSLGDNYNHEEMERMVLAATLCT 557
Query: 605 RRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNLQSHLNLALLD 664
RR PRARPQMSL+ KLL GD DV KWARL+VNA E EMLDDE+CP SNLQSHLNLALLD
Sbjct: 558 RRAPRARPQMSLISKLLGGDPDVIKWARLEVNALEAPEMLDDEACPPSNLQSHLNLALLD 617
Query: 665 VEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 696
VEDDS SM S+EQ+VSLEDYL GRWSRSSSFD
Sbjct: 618 VEDDSLSMCSVEQNVSLEDYLRGRWSRSSSFD 649
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224096079|ref|XP_002310531.1| predicted protein [Populus trichocarpa] gi|222853434|gb|EEE90981.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 800 bits (2067), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/726 (58%), Positives = 518/726 (71%), Gaps = 51/726 (7%)
Query: 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFD 75
G VVVGVK D S+ELLTW+L+K+AQPGD VIA+HVL ++A G +SLLSLVK FD
Sbjct: 1 GEVVVVGVKFDGPSKELLTWSLMKMAQPGDHVIAVHVL-DSATECMAGTASLLSLVKTFD 59
Query: 76 SVLAVYEGFCNLKQVDLKLKICRG-------TEDHRRNSLLDVI----------HRSISM 118
S+LAVYEGFCNLKQVDLKLK+CRG + + NS +I + S S
Sbjct: 60 SLLAVYEGFCNLKQVDLKLKVCRGESVRKILVREAKANSAAKLIVGTSKKHQKLYSSTST 119
Query: 119 SKITGQK-----------NSKVVTDDGSSITSKPVDDLGG-----------------SVM 150
+K +K N K+V +S+ + +D L G +
Sbjct: 120 AKYCAKKLSKGFSVYAVRNGKLVFQREASVPN--IDTLQGFSSLLFWVSSRKIITDATYF 177
Query: 151 NLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQ 210
+ L + +CS + +N C P L D S + EES DG GD SLA+VP+Q
Sbjct: 178 VVADKLNQESRNCSQKSQIKNSINCTPRLLLLDESGAHELEESCRDGN-GDNSLALVPIQ 236
Query: 211 NVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQPS 270
+ S S + + L ES+ GW LRR F ++ +++ ++KISVV+W RLPTR S
Sbjct: 237 TNKPLSNSDSDVSEGLVESKQGWSFLRRVFFHKQQHTEKAHIKKISVVKWVCRLPTRNSS 296
Query: 271 YLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEK 330
+ D KQ T ++++ N + AIVPVG E+ +P+S H +P+EL+ LHEK
Sbjct: 297 SVVYPDQKQNTSHVDEDQNSNSERKNYAIVPVGPEVAWTPISPCHGLNGIPEELKDLHEK 356
Query: 331 YSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEF 390
YS++CRLF+Y++L+ ATSNF+ EN++GKGGSS VYKGCLPDGKELAVKILKPSEDVIKEF
Sbjct: 357 YSSSCRLFSYEELVMATSNFIPENMVGKGGSSHVYKGCLPDGKELAVKILKPSEDVIKEF 416
Query: 391 VLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 450
V EIEIITTLHHKNIISL GFCFE N LLLVYDFLSRGSLEENLHGNKKD A GW ERY
Sbjct: 417 VAEIEIITTLHHKNIISLFGFCFEHNKLLLVYDFLSRGSLEENLHGNKKDWNAVGWQERY 476
Query: 451 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 510
KVA+GVAEAL+YLH+ Q VIH+DVKSSNILLSDDFEPQLSDFGLA WASTS + TCT
Sbjct: 477 KVAVGVAEALDYLHNCCDQPVIHKDVKSSNILLSDDFEPQLSDFGLASWASTSCN-ATCT 535
Query: 511 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 570
DVAGTFGYLAPEYFM+GKV+DK+DV+AFGVVLLELL+GR PI+++HPKGQESLVMWAKPI
Sbjct: 536 DVAGTFGYLAPEYFMHGKVSDKVDVFAFGVVLLELLSGRMPINSEHPKGQESLVMWAKPI 595
Query: 571 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKW 630
L GKV+QLLDP LG+ YD D +ERMVLA+ LCIRR PR RPQMSL+LKLL+GD +V W
Sbjct: 596 LEGGKVSQLLDPHLGSEYDDDHIERMVLAATLCIRRSPRCRPQMSLILKLLQGDEEVKNW 655
Query: 631 ARLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWS 690
AR QV ASEE + +D E+ P +N+QSHLNLALLD+EDDS S+SS EQ VS+EDYL GRWS
Sbjct: 656 ARHQVCASEELDAVDGEAFP-TNIQSHLNLALLDLEDDSLSISSTEQGVSVEDYLQGRWS 714
Query: 691 RSSSFD 696
R+SSFD
Sbjct: 715 RTSSFD 720
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 696 | ||||||
| TAIR|locus:2195975 | 794 | AT1G77280 [Arabidopsis thalian | 0.794 | 0.696 | 0.616 | 2.7e-213 | |
| TAIR|locus:2026957 | 756 | AT1G21590 [Arabidopsis thalian | 0.834 | 0.768 | 0.559 | 9.6e-198 | |
| TAIR|locus:2160801 | 705 | AT5G63940 [Arabidopsis thalian | 0.949 | 0.937 | 0.516 | 2.7e-171 | |
| TAIR|locus:2059919 | 617 | AT2G16750 [Arabidopsis thalian | 0.482 | 0.544 | 0.556 | 7.3e-117 | |
| TAIR|locus:2156050 | 552 | AT5G37790 [Arabidopsis thalian | 0.620 | 0.782 | 0.399 | 1.9e-74 | |
| TAIR|locus:2165041 | 669 | AT5G56790 [Arabidopsis thalian | 0.419 | 0.436 | 0.447 | 2.1e-74 | |
| TAIR|locus:2172555 | 579 | AT5G57670 [Arabidopsis thalian | 0.436 | 0.525 | 0.432 | 5.9e-74 | |
| TAIR|locus:2091511 | 753 | AT3G13690 [Arabidopsis thalian | 0.410 | 0.379 | 0.446 | 2.9e-72 | |
| TAIR|locus:2044420 | 392 | AT2G18890 [Arabidopsis thalian | 0.482 | 0.857 | 0.433 | 2.3e-71 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.543 | 0.526 | 0.387 | 4.7e-70 |
| TAIR|locus:2195975 AT1G77280 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1730 (614.0 bits), Expect = 2.7e-213, Sum P(2) = 2.7e-213
Identities = 356/577 (61%), Positives = 429/577 (74%)
Query: 129 VVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICG-----PVRNLPD 183
V + + + S +D +QA + +A NCS+CG P
Sbjct: 233 VTLNKTTKVVSHSEEDSNSKEEEEDQACGQNLRQVLAAARLENCSVCGFDSLSPNDTTTP 292
Query: 184 GSCS-QSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFP 242
G S S+ + D ++++ IVPV E + S+TMLVR+LPE RPGWPLLRRA+
Sbjct: 293 GKLSGASDFDRSEDDDECNKAMEIVPVNGSEDSGGSVTMLVRKLPEPRPGWPLLRRAV-- 350
Query: 243 DRRAPDRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPV 302
+ KI VVQWAL+LP R D KQ+ YD ++ LN A+VP
Sbjct: 351 -STLGQSVTPHKIPVVQWALKLPPR--------DTKQLGYDSSEDNLSTLN----ALVPF 397
Query: 303 GNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSS 362
G +++ D+ +LP+ELEGL+E++S+TCR F Y++L+S TSNF A+N IGKGGSS
Sbjct: 398 GINSITNKSIPDNSPRKLPEELEGLYERFSSTCRFFKYKELVSVTSNFSADNFIGKGGSS 457
Query: 363 QVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422
+V++GCL +G+ +AVKILK +EDV+ +FV EIEIITTLHHKNIISLLGFCFED+NLLLVY
Sbjct: 458 RVFRGCLSNGRVVAVKILKQTEDVLNDFVAEIEIITTLHHKNIISLLGFCFEDHNLLLVY 517
Query: 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 482
++LSRGSLEENLHGNKKDP AF WSERYKVA+GVAEAL+YLH+ ++Q VIHRDVKSSNIL
Sbjct: 518 NYLSRGSLEENLHGNKKDPLAFCWSERYKVAVGVAEALDYLHNTASQPVIHRDVKSSNIL 577
Query: 483 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 542
LSDDFEPQLSDFGLA+WAS S++HI C+DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL
Sbjct: 578 LSDDFEPQLSDFGLARWASISTTHIICSDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 637
Query: 543 LELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL--GNNYDYDQMERMVLAS 600
LELL+GRKPIS+ PKGQESLVMWAKPIL GK +QLLDP+L NN + DQM+RM LA+
Sbjct: 638 LELLSGRKPISSGCPKGQESLVMWAKPILDDGKYSQLLDPSLRDNNNNNDDQMQRMALAA 697
Query: 601 ILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNAS-EESEMLDDESCPRSNLQSHLN 659
LCIRR P+ARP+MS+VLKLL+GD D +WA QVN+S EESEML DE C RSNLQSHLN
Sbjct: 698 TLCIRRSPQARPKMSIVLKLLKGDEDTLEWAMQQVNSSSEESEMLKDEQCQRSNLQSHLN 757
Query: 660 LALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 696
LALLDVEDDS SM SIEQ VS+EDYL GR SRSSSFD
Sbjct: 758 LALLDVEDDSISMGSIEQGVSVEDYLKGRTSRSSSFD 794
|
|
| TAIR|locus:2026957 AT1G21590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1631 (579.2 bits), Expect = 9.6e-198, Sum P(2) = 9.6e-198
Identities = 341/609 (55%), Positives = 442/609 (72%)
Query: 98 RGTEDHRRNSLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALV 157
+G D RRN+L S +T +KN+KVV S + + ++ + +L ++LV
Sbjct: 166 KGKSDARRNTL-----SSFFQMPVTLRKNTKVVNH--SEVEEEEAEEDHSNGQSLRRSLV 218
Query: 158 KARSDCSGSAAKRNCSICGPVRNLPD-GSCSQSEE-ESPSDGGAG-DESLAIVPVQNVEA 214
A C G NCS+ + +LP G+ S+S D A +++A+VP + E
Sbjct: 219 YA---CLG-----NCSV-RDMNSLPTPGNLSRSSSCNGDQDDNADLHKAMALVPAKFPED 269
Query: 215 ASTSITMLVRQLPESRPGWPLLRRAIFPD--RRAPDRSSLRKISVVQWALRLPTRQPSYL 272
+ ITMLV++LPE RPGWPLL R D AP SS RKI VVQW L+LP R S +
Sbjct: 270 LTPFITMLVKELPEFRPGWPLLCRVASSDVLASAPRSSSFRKIPVVQWVLKLPARTNSVV 329
Query: 273 ANSDVKQITYDPGDNES----INLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLH 328
+SD KQI +D ++E + N + AIVP + IV L DH S P+ +EGL
Sbjct: 330 GSSDTKQIGFDSSESEENDKLSSSNVERQAIVPDESMIVKCSL--DHSSGRFPENVEGLQ 387
Query: 329 EKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIK 388
+ S +C+ F Y++L+S TSNF A+N IGKGGSS+V++G LP+G+E+AVKILK +E V+K
Sbjct: 388 ARISTSCQFFTYKELVSVTSNFCADNFIGKGGSSRVFRGYLPNGREVAVKILKRTECVLK 447
Query: 389 EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE 448
+FV EI+IITTLHHKN+ISLLG+CFE+NNLLLVY++LSRGSLEENLHGNKKD AF W+E
Sbjct: 448 DFVAEIDIITTLHHKNVISLLGYCFENNNLLLVYNYLSRGSLEENLHGNKKDLVAFRWNE 507
Query: 449 RYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 508
RYKVA+G+AEAL+YLH+ + Q VIHRDVKSSNILLSDDFEPQLSDFGLAKWAS S++ I
Sbjct: 508 RYKVAVGIAEALDYLHNDAPQPVIHRDVKSSNILLSDDFEPQLSDFGLAKWASESTTQII 567
Query: 509 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 568
C+DVAGTFGYLAPEYFMYGK+N+KIDVYA+GVVLLELL+GRKP++++ PK Q+SLVMWAK
Sbjct: 568 CSDVAGTFGYLAPEYFMYGKMNNKIDVYAYGVVLLELLSGRKPVNSESPKAQDSLVMWAK 627
Query: 569 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVT 628
PIL + +QLLD +L ++ + DQME+M LA+ LCIR +P+ RP M +VL+LL+GD ++
Sbjct: 628 PILDDKEYSQLLDSSLQDDNNSDQMEKMALAATLCIRHNPQTRPTMGMVLELLKGDVEML 687
Query: 629 KWARLQV-NASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLG 687
KWA+LQV N E+S +L DE RSNLQSHLNLA LD+EDDS SM S+EQ +S+E+YL G
Sbjct: 688 KWAKLQVSNPLEDSMLLKDEKLRRSNLQSHLNLAFLDMEDDSLSMGSMEQGISVEEYLKG 747
Query: 688 RWSRSSSFD 696
R SRSSSF+
Sbjct: 748 RTSRSSSFN 756
|
|
| TAIR|locus:2160801 AT5G63940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1665 (591.2 bits), Expect = 2.7e-171, P = 2.7e-171
Identities = 369/714 (51%), Positives = 484/714 (67%)
Query: 11 ISSGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSL 70
++ G+ ++VGVK D SRE+LTW+LV VA+PGD ++ALHVL + +G +SL+SL
Sbjct: 15 VAEGSA-LLIVGVKPDEWSREVLTWSLVNVARPGDRIVALHVLDYSL----EGSTSLISL 69
Query: 71 VKAFDSVLAVYEGFCNLKQVDLKLKICRGTEDHR----------RNSLL-------DVIH 113
V+ FD++L VYE FCNLKQVDLKLK+ RG + SL+ I
Sbjct: 70 VRNFDTMLGVYESFCNLKQVDLKLKVFRGKSARKVLVQEVKSCGATSLIVGSSRKHHTIR 129
Query: 114 RSISMSKITGQ---KNSKVVTDDGSSITSKPVDDLGGS---VMNLEQALVKARSDCSGSA 167
S S++K + K+ V I + V + G+ MN+ +LV D + A
Sbjct: 130 SSASLAKYCARNLAKDVSVFAVKSGKIMFRRVPNTNGADGPQMNIP-SLVCGSPDIAIEA 188
Query: 168 AKRNCSICGPVRNLPDGS-CSQSEE-ESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQ 225
AK S P R + S+S +SP G D LA+VPVQ E S S+
Sbjct: 189 AKIGNSF-SPARTSSRWTRTSRSSSLQSPDSLGV-DNLLALVPVQTNETDSGSL------ 240
Query: 226 LPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPG 285
ES PGW LR +R++ + S +K +V+QW RL R + D K+ D G
Sbjct: 241 --ESGPGWHFLRGLYGNNRKSWTKVSAKK-AVLQWVSRLRGRHSETVIYLDRKRS--DSG 295
Query: 286 DNE--SINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDL 343
+E S +++G+ +I G+E++ SPLS S +P+ELEGLHEKYS+TCRLF Y+++
Sbjct: 296 CDEDCSSSIDGEDVSISRFGSELMQSPLSPFIGSNNIPEELEGLHEKYSSTCRLFTYEEV 355
Query: 344 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK 403
LS TSNF +ENL+G+GG+S VY+G LPDG+ELAVKILKP DV+KEF+LEIE+IT++HHK
Sbjct: 356 LSITSNFASENLVGEGGNSYVYRGDLPDGRELAVKILKPCLDVLKEFILEIEVITSVHHK 415
Query: 404 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 463
NI+SL GFCFE+NNL+LVYD+L RGSLEENLHGN+KD FGW ERYKVA+GVAEAL+YL
Sbjct: 416 NIVSLFGFCFENNNLMLVYDYLPRGSLEENLHGNRKDAKKFGWMERYKVAVGVAEALDYL 475
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523
H+ VIHRDVKSSN+LL+DDFEPQLSDFG A AS++S H+ D+AGTFGYLAPEY
Sbjct: 476 HNTHDPEVIHRDVKSSNVLLADDFEPQLSDFGFASLASSTSQHVAGGDIAGTFGYLAPEY 535
Query: 524 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583
FM+GKV DKIDVYAFGVVLLEL++GRKPI D KGQESLV+WA PIL SGK QLLDP+
Sbjct: 536 FMHGKVTDKIDVYAFGVVLLELISGRKPICVDQSKGQESLVLWANPILDSGKFAQLLDPS 595
Query: 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEM 643
L N+ D +E+++LA+ LCI+R P RPQ+ LVLK+L+G+ + T+W + QV ASE
Sbjct: 596 LENDNSNDLIEKLLLAATLCIKRTPHDRPQIGLVLKILQGEEEATEWGKQQVRASE---- 651
Query: 644 LDDESCPRSNLQSHLNLALLDVEDDSFSMSSIE-QSVSLEDYLLGRWSRSSSFD 696
D S +N++SH+NLALLD+EDD+ S SS E S+S+E+YL GRWSR++SF+
Sbjct: 652 --DVSAYLTNIESHINLALLDLEDDAASDSSPEASSISVEEYLKGRWSRTASFN 703
|
|
| TAIR|locus:2059919 AT2G16750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 973 (347.6 bits), Expect = 7.3e-117, Sum P(3) = 7.3e-117
Identities = 192/345 (55%), Positives = 250/345 (72%)
Query: 336 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS-EDVIKEFVLEI 394
R F+Y L +ATS+F ENLIGKGG ++VYKG L DGK +AVKILKPS ++ +KEFV E+
Sbjct: 263 RWFSYDVLKTATSDFSLENLIGKGGCNEVYKGFLEDGKGVAVKILKPSVKEAVKEFVHEV 322
Query: 395 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 454
I+++L H NI L+G C N+L+ VY+ S+GSLEE L G W ER K+A+
Sbjct: 323 SIVSSLSHSNISPLIGVCVHYNDLISVYNLSSKGSLEETLQGKH----VLRWEERLKIAI 378
Query: 455 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 514
G+ EAL+YLH+ + VIHRDVKSSN+LLSD+FEPQLSDFGL+ W S S + DV G
Sbjct: 379 GLGEALDYLHNQCSNPVIHRDVKSSNVLLSDEFEPQLSDFGLSMWGSKSCRYTIQRDVVG 438
Query: 515 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 574
TFGYLAPEYFMYGKV+DK+DVYAFGVVLLEL++GR IS+D P+GQESLVMWAKP++ G
Sbjct: 439 TFGYLAPEYFMYGKVSDKVDVYAFGVVLLELISGRTSISSDSPRGQESLVMWAKPMIEKG 498
Query: 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQ 634
+LLDP + +D DQ +MVLA+ C+ R RP + +LKLLRG+ DV+KW +++
Sbjct: 499 NAKELLDPNIAGTFDEDQFHKMVLAATHCLTRAATYRPNIKEILKLLRGEDDVSKWVKIE 558
Query: 635 VNASEESEMLDDESCPRSNLQSHLNLALLDVED-DSFSMSSIEQS 678
++ + DDE P SN + HL+LA++DVED DS S SS+E+S
Sbjct: 559 ---EDDEDGFDDEVYPNSNTELHLSLAMVDVEDNDSVSNSSLERS 600
|
|
| TAIR|locus:2156050 AT5G37790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 751 (269.4 bits), Expect = 1.9e-74, P = 1.9e-74
Identities = 185/463 (39%), Positives = 260/463 (56%)
Query: 228 ESRPGWPLLRRAIFPDRRAPD----RSSLRKISVVQWAL-RLPTRQPSYLANSDVKQITY 282
E+ W L A P+ PD SS R Q L ++ +PS A+S + ++
Sbjct: 93 ENNKAWLLAETA--PENMNPDPHSVHSSFRFSLCSQIELEKMKGEEPSLSASSSCRNLSV 150
Query: 283 DPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQD 342
G + +N ++G GN +TD + LE + T F+Y +
Sbjct: 151 SGGSTTVLMVNLENGVKETTGN-------ATDDLRWTRARSLEKSISPVANTLVRFSYGE 203
Query: 343 LLSATSNFLAENLIGKGGSSQVYKGCLPDGKE-LAVKIL-KPSEDVIKEFVLEIEIITTL 400
+++AT NF ++G+G S V++G + + LA+K L K ++ K F E+ I ++L
Sbjct: 204 IVAATRNFSKGRVLGRGACSYVFRGKIGMWRTALAIKRLDKEDKESPKSFCRELMIASSL 263
Query: 401 HHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDP---AAFG--WSERYKVAM 454
H NI+ LLGFC + + L LVY ++S GSLE LH KK AAFG WS RYKVA+
Sbjct: 264 HSSNIVPLLGFCIDPEEGLFLVYKYVSGGSLEHYLHDKKKKKGVKAAFGLPWSARYKVAL 323
Query: 455 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 514
G+A+A+ YLH+G+ Q V+HRD+K SNILLS P+L DFGLA W + S C V G
Sbjct: 324 GIADAIAYLHNGTEQCVVHRDIKPSNILLSSKKIPKLCDFGLATWTAAPSVPFLCKTVKG 383
Query: 515 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 574
TFGYLAPEYF +GK++DK DVYAFGVVLLEL+TGRKPI GQE+LV+WAKP+L G
Sbjct: 384 TFGYLAPEYFQHGKISDKTDVYAFGVVLLELITGRKPIEARRASGQENLVVWAKPLLDRG 443
Query: 575 --KVTQLLDPALG-NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADV---T 628
+ +LLDP L + QMERM+ A+ C+ + RP M ++ +L+G+ V T
Sbjct: 444 IEAIVELLDPRLKCTRKNSVQMERMIRAAAACVINEESRRPGMEEIVSILKGEEGVEPET 503
Query: 629 KWARLQVNASEESEMLDDESCPRSNLQSHLNLALLDV---EDD 668
+R N S + +S ++ HL+LA+L V EDD
Sbjct: 504 HSSRKTTNISGMIDSYTQLQQTKSEMKCHLDLAMLGVTEFEDD 546
|
|
| TAIR|locus:2165041 AT5G56790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 679 (244.1 bits), Expect = 2.1e-74, Sum P(3) = 2.1e-74
Identities = 133/297 (44%), Positives = 188/297 (63%)
Query: 330 KYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIK 388
K+ R F Y +L +AT F + + +GG V+ G LPDG+ +AVK K S +
Sbjct: 370 KFGNPPRWFTYSELETATKGFSKGSFLAEGGFGSVHLGTLPDGQIIAVKQYKIASTQGDR 429
Query: 389 EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE 448
EF E+E+++ H+N++ L+G C ED LLVY+++ GSL +L+G ++P GWS
Sbjct: 430 EFCSEVEVLSCAQHRNVVMLIGLCVEDGKRLLVYEYICNGSLHSHLYGMGREP--LGWSA 487
Query: 449 RYKVAMGVAEALEYLHSGSAQR-VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507
R K+A+G A L YLH ++HRD++ +NILL+ DFEP + DFGLA+W +
Sbjct: 488 RQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPEGDKGV 547
Query: 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 567
T V GTFGYLAPEY G++ +K DVY+FGVVL+EL+TGRK + PKGQ+ L WA
Sbjct: 548 E-TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELITGRKAMDIKRPKGQQCLTEWA 606
Query: 568 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624
+P+L + +LLDP L N Y ++ M L + LCIRRDP +RP+MS VL++L GD
Sbjct: 607 RPLLQKQAINELLDPRLMNCYCEQEVYCMALCAYLCIRRDPNSRPRMSQVLRMLEGD 663
|
|
| TAIR|locus:2172555 AT5G57670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 663 (238.4 bits), Expect = 5.9e-74, Sum P(2) = 5.9e-74
Identities = 138/319 (43%), Positives = 202/319 (63%)
Query: 338 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KPSEDVIKE--FVLEI 394
F Y ++ AT++F N++G GG S+VY+G L DG+ +AVK L K S D+ KE F+ E+
Sbjct: 255 FTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESGDMNKEKEFLTEL 314
Query: 395 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 454
II+ + H N LLG C E L LV+ F G+L LH N+ + W RYK+A+
Sbjct: 315 GIISHVSHPNTALLLGCCVE-KGLYLVFRFSENGTLYSALHENEN--GSLDWPVRYKIAV 371
Query: 455 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 514
GVA L YLH R+IHRD+KSSN+LL D+EPQ++DFGLAKW +H V G
Sbjct: 372 GVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPVEG 431
Query: 515 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 574
TFGYLAPE M G +++K D+YAFG++LLE++TGR+P++ P Q+ +++WAKP + +G
Sbjct: 432 TFGYLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVN---PT-QKHILLWAKPAMETG 487
Query: 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG--DADVTKWAR 632
++L+DP L + YD QM ++VL + C+++ P RP M+ VL+LL +A++ K R
Sbjct: 488 NTSELVDPKLQDKYDDQQMNKLVLTASHCVQQSPILRPTMTQVLELLTNGNEAEIAKSWR 547
Query: 633 L---QVNASEESEMLDDES 648
+ N +++ DD S
Sbjct: 548 MPKDMTNDDDDNNEWDDYS 566
|
|
| TAIR|locus:2091511 AT3G13690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 666 (239.5 bits), Expect = 2.9e-72, Sum P(2) = 2.9e-72
Identities = 130/291 (44%), Positives = 187/291 (64%)
Query: 336 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEI 394
RLF Y +L AT F N + +GG V++G LP+G+ +AVK K S EF E+
Sbjct: 397 RLFTYAELELATGGFSQANFLAEGGYGSVHRGVLPEGQVVAVKQHKLASSQGDVEFCSEV 456
Query: 395 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 454
E+++ H+N++ L+GFC ED+ LLVY+++ GSL+ +L+G +K+ W R K+A+
Sbjct: 457 EVLSCAQHRNVVMLIGFCIEDSRRLLVYEYICNGSLDSHLYGRQKE--TLEWPARQKIAV 514
Query: 455 GVAEALEYLHSGSAQR-VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 513
G A L YLH ++HRD++ +NIL++ D EP + DFGLA+W + T V
Sbjct: 515 GAARGLRYLHEECRVGCIVHRDMRPNNILITHDNEPLVGDFGLARWQPDGEMGVD-TRVI 573
Query: 514 GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 573
GTFGYLAPEY G++ +K DVY+FGVVL+EL+TGRK I PKGQ+ L WA+P+L
Sbjct: 574 GTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAIDITRPKGQQCLTEWARPLLEE 633
Query: 574 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624
+ +L+DP LGN + ++ M+ A+ LCIRRDP RP+MS VL++L GD
Sbjct: 634 YAIDELIDPRLGNRFVESEVICMLHAASLCIRRDPHLRPRMSQVLRILEGD 684
|
|
| TAIR|locus:2044420 AT2G18890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 722 (259.2 bits), Expect = 2.3e-71, P = 2.3e-71
Identities = 154/355 (43%), Positives = 222/355 (62%)
Query: 308 SSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG 367
SSPL+ ST+ + + + + F++Q++ AT+ F +ENL+G+GG ++VYKG
Sbjct: 28 SSPLAAS--STKCVEGFQETDQFQRPKWKCFSFQEIYDATNGFSSENLVGRGGFAEVYKG 85
Query: 368 CL-PDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422
L +G+E+AVK + + E KEF++EI I + H N++SLLG C DN L LV+
Sbjct: 86 ILGKNGEEIAVKRITRGGRDDERREKEFLMEIGTIGHVSHPNVLSLLGCCI-DNGLYLVF 144
Query: 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 482
F SRGSL LH + P W RYK+A+G A+ L YLH G +R+IHRD+KSSN+L
Sbjct: 145 IFSSRGSLASLLHDLNQAPLE--WETRYKIAIGTAKGLHYLHKGCQRRIIHRDIKSSNVL 202
Query: 483 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 542
L+ DFEPQ+SDFGLAKW + SH + + GTFG+LAPEY+ +G V++K DV+AFGV L
Sbjct: 203 LNQDFEPQISDFGLAKWLPSQWSHHSIAPIEGTFGHLAPEYYTHGIVDEKTDVFAFGVFL 262
Query: 543 LELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL 602
LEL++G+KP+ H +SL WAK I+ G++ +L+DP +G +D Q+ R+ A+ L
Sbjct: 263 LELISGKKPVDASH----QSLHSWAKLIIKDGEIEKLVDPRIGEEFDLQQLHRIAFAASL 318
Query: 603 CIRRDPRARPQMSLVLKLLRG-DADVTKWARLQVNASEES----EMLDDESCPRS 652
CIR RP M VL++L+G D + KW + +E E L+D C S
Sbjct: 319 CIRSSSLCRPSMIEVLEVLQGEDIEKEKWKMEEEEEVKEEFWGYEDLEDCECDSS 373
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 686 (246.5 bits), Expect = 4.7e-70, Sum P(2) = 4.7e-70
Identities = 152/392 (38%), Positives = 233/392 (59%)
Query: 267 RQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLST-DHDSTELPKELE 325
R+ +S + Y P N S+N G GN S+ S+ D +S PK
Sbjct: 284 RRKQKKGSSSPRSNQYLPPANVSVNTEGFIHYRQKPGNGNSSAQNSSPDTNSLGNPKHGR 343
Query: 326 GLHEK-YSATCRL-FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP- 382
G + T ++ F Y++L T F ++G+GG VYKG L +GK +A+K LK
Sbjct: 344 GTPDSAVIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSV 403
Query: 383 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 442
S + +EF E+EII+ +HH++++SL+G+C + + L+Y+F+ +L+ +LHG K+
Sbjct: 404 SAEGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHG--KNLP 461
Query: 443 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502
WS R ++A+G A+ L YLH ++IHRD+KSSNILL D+FE Q++DFGLA+ T
Sbjct: 462 VLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDT 521
Query: 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 562
+ SHI+ T V GTFGYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ES
Sbjct: 522 AQSHIS-TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEES 580
Query: 563 LVMWAKPIL----SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 618
LV WA+P L G +++++DP L N+Y ++ +M+ + C+R RP+M V+
Sbjct: 581 LVEWARPRLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVV 640
Query: 619 KLL--RGD-ADVTKWARLQVNASEESEMLDDE 647
+ L R D +D+T ++ + +S +E
Sbjct: 641 RALDTRDDLSDLTNGVKVGQSRVYDSGQYSNE 672
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_Genewise1_v1.C_LG_V0045 | hypothetical protein (697 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 696 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-39 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-27 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-24 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-16 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-14 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-04 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 4e-51
Identities = 87/268 (32%), Positives = 127/268 (47%), Gaps = 36/268 (13%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL---EIEIITTLHHKNIISLLGF 411
+G G VYK GK +AVKILK + K+ EI I+ L H NI+ L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
+ ++L LV ++ G L + L E K+A+ + LEYLHS +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGP----LSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE----YFMYG 527
IHRD+K NILL ++ +++DFGLAK SSS T GT Y+APE YG
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS--LTTFVGTPWYMAPEVLLGGNGYG 177
Query: 528 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL---VMWAKPILSSGKVTQLLDPAL 584
K+DV++ GV+L ELLTG+ P S ++ Q L ++ K + + A
Sbjct: 178 P---KVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK 234
Query: 585 GNNYDYDQMERMVLASILCIRRDPRARP 612
D +++ C+ +DP RP
Sbjct: 235 ------DLIKK-------CLNKDPSKRP 249
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 4e-48
Identities = 72/195 (36%), Positives = 114/195 (58%), Gaps = 13/195 (6%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
+G+GG VY GK++A+KI+K S +++E + EIEI+ L+H NI+ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 472
++N+L LV ++ GSL++ L N+ E ++ + + E LEYLHS +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHS---NGII 114
Query: 473 HRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVN 530
HRD+K NILL SD+ + +L+DFGL+K +S + GT Y+APE + G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSK--LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 531 DKIDVYAFGVVLLEL 545
+K D+++ GV+L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 4e-47
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 354 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDV--IKEFVLEIEIITTLHHKNIISLLG 410
+G+G +VY GK +A+K++K + + + EI+I+ L H NI+ L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 411 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEALEYLHSGS 467
+++ L LV ++ G L + L + A F + + ALEYLHS
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ-------ILSALEYLHS-- 115
Query: 468 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 527
+ ++HRD+K NILL +D +L+DFGLA+ T GT Y+APE +
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGK 171
Query: 528 KVNDKIDVYAFGVVLLELLTGRKPISNDH 556
+D+++ GV+L ELLTG+ P D
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGDD 200
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 88/277 (31%), Positives = 131/277 (47%), Gaps = 36/277 (12%)
Query: 356 IGKGGSSQVYKGCL---PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 408
+G+G +VYKG L DGKE+ AVK LK SE I+EF+ E I+ L H NI+ L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 468
LG C E+ L++V +++ G L + L K P S+ A+ +A +EYL S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLES--- 121
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 528
+ IHRD+ + N L+ ++ ++SDFGL++ + ++APE GK
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 529 VNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584
K DV++FGV+L E+ T G +P +SN L G L P
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE----------VLEYLKKGYR--LPKPPN 228
Query: 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621
Y M + C DP RP S ++++L
Sbjct: 229 CPPELYKLMLQ-------CWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 8e-44
Identities = 71/206 (34%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 413
IGKGG +VYK GKE+A+K++K KE ++ EI+I+ H NI+ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 414 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 471
+ + L +V +F S GSL++ L + +E V + + LEYLHS +
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQ-----TLTESQIAYVCKELLKGLEYLHS---NGI 119
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 531
IHRD+K++NILL+ D E +L DFGL+ S + + T + GT ++APE +
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAPEVINGKPYDY 176
Query: 532 KIDVYAFGVVLLELLTGRKPISNDHP 557
K D+++ G+ +EL G+ P S P
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPP 202
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 7e-43
Identities = 84/278 (30%), Positives = 128/278 (46%), Gaps = 39/278 (14%)
Query: 356 IGKGGSSQVYKGCL----PDGKEL-AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 408
+G+G +VYKG L K AVK LK SE I+EF+ E I+ L H N++ L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 468
LG C E+ L +V +++ G L L N+ S+ A+ +A +EYL S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLES--- 120
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYG 527
+ IHRD+ + N L+ ++ ++SDFGL++ + ++APE G
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEG 178
Query: 528 KVNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583
K K DV++FGV+L E+ T G +P +SN+ L +G L P
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE----------VLEYLKNGYR--LPQPP 226
Query: 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621
YD M + C DP RP S ++++L
Sbjct: 227 NCPPELYDLMLQ-------CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 4e-40
Identities = 79/272 (29%), Positives = 124/272 (45%), Gaps = 41/272 (15%)
Query: 354 NLIGKGGSSQVYKGCLPD-GKELAVK---ILKPSEDVIKEFVLEIEIITTLHHKNIISLL 409
L+G+G VY D G+ +AVK + SE+ ++ EI I+++L H NI+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 410 GFCF--EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE----RYKVAMGVAEALEYL 463
G E N L + +++S GSL L K P E +Y + E L YL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP------EPVIRKY-TRQ-ILEGLAYL 117
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523
HS ++HRD+K +NIL+ D +L+DFG AK + V GT ++APE
Sbjct: 118 HS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 524 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL---L 580
+ D+++ G ++E+ TG+ P S G ++ I SSG+ ++ L
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWSE---LGNPMAALYK--IGSSGEPPEIPEHL 229
Query: 581 DPALGNNYDYDQMERMVLASILCIRRDPRARP 612
D + + C+RRDP+ RP
Sbjct: 230 SEEA-----KDFLRK-------CLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 7e-40
Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 37/284 (13%)
Query: 354 NLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 407
+G+G +VYKG L DGK AVK LK SE+ K+F+ E ++ L H N++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 408 LLGFCFEDNNLLLVYDFLSRGSL-----EENLHGNKKDPAAFGWSERYKVAMGVAEALEY 462
LLG C E+ L LV +++ G L + + + + A+ +A+ +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
L S ++ +HRD+ + N L+ +D ++SDFGL++ + T ++APE
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAKPILSSGKVTQ 578
G K DV++FGV+L E+ T G P +SN+ V+ L G +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VL---EYLRKGY--R 225
Query: 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
L P + Y+ M C + DP RP S +++ L
Sbjct: 226 LPKPEYCPDELYELMLS-------CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 7e-39
Identities = 67/216 (31%), Positives = 110/216 (50%), Gaps = 38/216 (17%)
Query: 356 IGKGGSSQVYKGCL---PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 408
+G+G +VYKG L +G E AVK LK SE+ +EF+ E I+ L H NI+ L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 468
LG C + L +V +++ G L + L + + + ++A+ +A+ +EYL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLES--- 120
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY---------- 518
+ +HRD+ + N L++++ ++SDFGL++ D+ Y
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR------------DIYEDDYYRKRGGGKLPI 168
Query: 519 --LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
+APE GK K DV++FGV+L E+ T G +P
Sbjct: 169 KWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (329), Expect = 4e-33
Identities = 80/286 (27%), Positives = 127/286 (44%), Gaps = 27/286 (9%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHK 403
++ +G+G +VY D K +A+K+L ++ F+ EI+I+ +L H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 404 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 463
NI+ L F ++ +L LV +++ GSLE+ L SE + + ALEYL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117
Query: 464 HSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSH----ITCTDVAGTFGY 518
HS + +IHRD+K NILL D +L DFGLAK S + GT GY
Sbjct: 118 HS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 519 LAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 575
+APE + + D+++ G+ L ELLTG P + S + I+
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL---KIILELP 231
Query: 576 VTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLK 619
L P + ++ + +L + +DP+ R S L
Sbjct: 232 TPSLASP---LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 67/200 (33%), Positives = 108/200 (54%), Gaps = 16/200 (8%)
Query: 355 LIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 414
IGKG V G G+++AVK LK + F+ E ++TTL H N++ LLG +
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 415 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 474
N L +V +++++GSL + L + A +++ A+ V E +EYL + +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEE---KNFVHR 126
Query: 475 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYGKVNDK 532
D+ + N+L+S+D ++SDFGLAK AS +G + APE K + K
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQD-------SGKLPVKWTAPEALREKKFSTK 179
Query: 533 IDVYAFGVVLLELLT-GRKP 551
DV++FG++L E+ + GR P
Sbjct: 180 SDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 73/276 (26%), Positives = 129/276 (46%), Gaps = 25/276 (9%)
Query: 349 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN 404
+ IGKG +VY DGK +K + SE ++ + E++I+ L+H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
II E L +V ++ G L + + KK+ F + + + AL+YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 524
S ++++HRD+K NI L+ + +L DFG++K S++ V GT YL+PE
Sbjct: 121 S---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL--AKTVVGTPYYLSPELC 175
Query: 525 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584
N K D+++ G VL EL T + P ++ L + K+ + P +
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELAL---------KILKGQYPPI 223
Query: 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620
+ Y + + +V + +++DP RP ++ +L+
Sbjct: 224 PSQYSSE-LRNLVSS---LLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 414
IG+G S +VYK GKE+A+K ++ + + + EI I+ H NI+ +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD-SYL 85
Query: 415 DNNLL-LVYDFLSRGSLEENLHGNKKD----PAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
+ L +V +++ GSL + + N A+ V V + LEYLHS Q
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-------VCREVLQGLEYLHS---Q 135
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 529
VIHRD+KS NILLS D +L+DFG A A + V GT ++APE
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFA--AQLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 530 NDKIDVYAFGVVLLELLTGRKPISNDHP 557
K+D+++ G++ +E+ G P + P
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEPPYLREPP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 349 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKN 404
N+ +LIG+G VYKG L G +A+K + E+ +K + EI+++ L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
I+ +G ++L ++ ++ GSL + + F S V + L YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP----FPESLVAVYVYQVLQGLAYLH 116
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 524
Q VIHRD+K++NIL + D +L+DFG+A + V GT ++APE
Sbjct: 117 E---QGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVI 171
Query: 525 MYGKVNDKIDVYAFGVVLLELLTGRKP-------------ISNDHP 557
+ D+++ G ++ELLTG P + +DHP
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP 217
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 37/278 (13%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
IG G ++ VY CLP+ +++A+K + K V E E++ ++ +H N++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNHPNVVKYYTS 67
Query: 412 CFEDNNLLLVYDFLSRGSLEENL-HGNKKDPAAFGWSERYKVAM--GVAEALEYLHSGSA 468
+ L LV +LS GSL + + + G E + V + LEYLHS
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRG----GLDEAIIATVLKEVLKGLEYLHS--- 120
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS--SSHITCTDVAGTFGYLAPEYFMY 526
IHRD+K+ NILL +D +++DFG++ + + GT ++APE
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 527 GK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585
+ K D+++FG+ +EL TG P S P + L++ L + P+L
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAPYSKYPP--MKVLML----TLQNDP------PSLE 228
Query: 586 NNYDYDQ----MERMVLASILCIRRDPRARPQMSLVLK 619
DY + +M+ LC+++DP RP +LK
Sbjct: 229 TGADYKKYSKSFRKMI---SLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 83/292 (28%), Positives = 128/292 (43%), Gaps = 42/292 (14%)
Query: 354 NLIGKGGSSQVYKGCLP-----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNII 406
+G+G +V G+++AVK L S E +F EIEI+ TL H+NI+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 407 SLLGFCFED--NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
G C + +L L+ ++L GSL + L ++ + + + ++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLG 126
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT--FGYLAPE 522
S QR IHRD+ + NIL+ + ++SDFGLAK + + + F Y APE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581
K + DV++FGV L EL T G + P E L M VT+LL+
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDP---SQSPP-AEFLRMIG-IAQGQMIVTRLLE 237
Query: 582 ----------PALGNNYDYDQMERMVLASILCIRRDPRARPQMS-LVLKLLR 622
P + YD M+ C +P+ RP + L+L + R
Sbjct: 238 LLKEGERLPRPPSCPDEVYDLMKL-------CWEAEPQDRPSFADLILIVDR 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 9e-29
Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 36/222 (16%)
Query: 356 IGKGGSSQVYKG-----CLPDGKEL-AVKILK--PSEDVIKEFVLEIEIITTLHHKNIIS 407
+G+G +V+ G + KEL AVK LK S D K+F E E++T H+NI+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENL--HG--------NKKDPAAFGWSERYKVAMGVA 457
G C E + ++V++++ G L + L HG S+ ++A+ +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 458 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD---VAG 514
+ YL ++Q +HRD+ + N L+ D ++ DFG+ S + TD V G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGM-------SRDVYTTDYYRVGG 182
Query: 515 T----FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
++ PE MY K + DV++FGVVL E+ T G++P
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 77/276 (27%), Positives = 127/276 (46%), Gaps = 31/276 (11%)
Query: 354 NLIGKGGSSQVYKGC-LPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLL 409
N IG G +VY L G+ +AVK ++ IKE E++++ L H N++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 410 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
G + + ++ S G+LEE L + Y + + E L YLHS
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV--IRVYTLQL--LEGLAYLHS---H 118
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKW--ASTSSSHITCTDVAGTFGYLAPEYFMYG 527
++HRD+K +NI L + +L DFG A +T++ +AGT Y+APE G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 528 KVNDK---IDVYAFGVVLLELLTGRKPISN-DHPKGQESLVMWAKPILSSGKVTQLLDPA 583
K D+++ G V+LE+ TG++P S D+ E +M+ + +G + D
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----EFQIMFH---VGAGHKPPIPDSL 231
Query: 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
+ D ++R C+ DP+ RP S +L+
Sbjct: 232 QLSPEGKDFLDR-------CLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 15/212 (7%)
Query: 350 FLAENLIGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNII 406
F IGKG +VYK + +A+K+ L+ +ED I++ EI+ ++ I
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
G + + L ++ ++ GS + L K D + R V LEYLH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILRE-----VLLGLEYLHE- 116
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEYFM 525
+ IHRD+K++NILLS++ + +L+DFG++ + ST S T GT ++APE
Sbjct: 117 --EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT---FVGTPFWMAPEVIK 171
Query: 526 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557
++K D+++ G+ +EL G P+S+ HP
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSDLHP 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 71/232 (30%), Positives = 107/232 (46%), Gaps = 39/232 (16%)
Query: 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKE----FVL-EIEIITTL- 400
+F +IG+G S V KE A+KIL + +IKE +V E E++T L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ-LIKEKKVKYVKIEKEVLTRLN 59
Query: 401 HHKNIISLLGFCFEDN-NLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVA 457
H II L + F+D NL V ++ G L + +G+ + R+ A +
Sbjct: 60 GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT-----RFYAAE-IL 112
Query: 458 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA---- 513
ALEYLHS + +IHRD+K NILL D +++DFG AK +SS + A
Sbjct: 113 LALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 514 --------------GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
GT Y++PE D++A G ++ ++LTG+ P
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 71/211 (33%), Positives = 104/211 (49%), Gaps = 34/211 (16%)
Query: 356 IGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIKEFVL----EIEIITTLHHKNIIS 407
+GKG +V K GK A+K+LK + + ++ V E I++ ++H I+
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 408 LLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEYL 463
L + F+ L LV ++ G L +L + + Y AE ALEYL
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE--ERARFY-----AAEIVLALEYL 109
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523
HS +I+RD+K NILL D +L+DFGLAK S+ S GT YLAPE
Sbjct: 110 HS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEV 164
Query: 524 FM---YGKVNDKIDVYAFGVVLLELLTGRKP 551
+ YGK +D ++ GV+L E+LTG+ P
Sbjct: 165 LLGKGYGKA---VDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 12/210 (5%)
Query: 350 FLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISL 408
F +G+G VYK G+ +A+K++ P E+ ++E + EI I+ I+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 468
G F++ +L +V ++ GS+ + + K E + + LEYLHS
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLHS--- 117
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEYFMYG 527
+ IHRD+K+ NILL+++ + +L+DFG++ + T + T V GT ++APE
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT---VIGTPFWMAPEVIQEI 174
Query: 528 KVNDKIDVYAFGVVLLELLTGRKPISNDHP 557
N+K D+++ G+ +E+ G+ P S+ HP
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHP 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 83/283 (29%), Positives = 136/283 (48%), Gaps = 35/283 (12%)
Query: 347 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL--------KPSEDVIKEFVLEIEII 397
NF E IGKG S VYK CL DG+ +A+K + K +D +KE I+++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKE----IDLL 56
Query: 398 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA 457
L H N+I L E+N L +V + G L + KK +K + +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 458 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTDVAGT 515
ALE++HS +R++HRD+K +N+ ++ +L D GL ++ S T+++H + GT
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGT 169
Query: 516 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 575
Y++PE N K D+++ G +L E+ + P D + +L K K
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLCK------K 219
Query: 576 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 618
+ + P L ++ Y + R +++ CI DP RP +S VL
Sbjct: 220 IEKCDYPPLPADH-YSEELRDLVS--RCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNI 405
F E +G G +V++G + +A+KILK S+D++K +F E++ + L HK++
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILK-SDDLLKQQDFQKEVQALKRLRHKHL 64
Query: 406 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 465
ISL C + ++ + + +GSL L + + +A VAE + YL
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK-----WASTSSSHITCTDVAGTFGYLA 520
Q IHRD+ + NIL+ +D +++DFGLA+ +S I + + A
Sbjct: 123 ---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-------PYKWTA 172
Query: 521 PEYFMYGKVNDKIDVYAFGVVLLELLT 547
PE +G + K DV++FG++L E+ T
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 80/284 (28%), Positives = 139/284 (48%), Gaps = 35/284 (12%)
Query: 348 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL--------KPSEDVIKEFVLEIEIIT 398
+NF E IG+G S+VY+ CL D K +A+K + K +D +KE I+++
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKE----IDLLK 57
Query: 399 TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 458
L+H N+I L EDN L +V + G L + + KK +K + +
Sbjct: 58 QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 459 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTDVAGTF 516
A+E++HS +RV+HRD+K +N+ ++ +L D GL ++ S T+++H + GT
Sbjct: 118 AVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTP 170
Query: 517 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576
Y++PE N K D+++ G +L E+ + P D + +L + K+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLFSLCQ------KI 220
Query: 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620
Q P L + Y + R +++ +CI DP RP + V ++
Sbjct: 221 EQCDYPPLPTEH-YSEKLRELVS--MCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-25
Identities = 82/296 (27%), Positives = 137/296 (46%), Gaps = 30/296 (10%)
Query: 332 SATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEF 390
S + D+LS+ EN+I +G YKG + +G + VK + +
Sbjct: 677 SKVSKSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE 733
Query: 391 VLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 450
+ ++ L H NI+ L+G C + L+++++ +L E L W R
Sbjct: 734 IADMG---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRR 783
Query: 451 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 510
K+A+G+A+AL +LH + V+ ++ I++ EP L S + CT
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---------LSLPGLLCT 834
Query: 511 DVAGTF--GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 568
D Y+APE + +K D+Y FG++L+ELLTG+ P ++ S+V WA+
Sbjct: 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP-ADAEFGVHGSIVEWAR 893
Query: 569 PILSSGKVTQLLDPALGNNYDYDQ---MERMVLASILCIRRDPRARPQMSLVLKLL 621
S + +DP++ + +Q +E M LA + C DP ARP + VLK L
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLA-LHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 62/274 (22%), Positives = 118/274 (43%), Gaps = 51/274 (18%)
Query: 356 IGKGGSSQVYKGCL-PDGKELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
+G+G S VYK P GK A+K + E+ K+ + E++ + + ++ G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 470
+++ + +V +++ GSL + L KK E +A + + L+YLH+
Sbjct: 69 YKEGEISIVLEYMDGGSLADLL---KKVG---KIPEPVLAYIARQILKGLDYLHTKR--H 120
Query: 471 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV-----AGTFGYLAPEYF- 524
+IHRD+K SN+L++ E +++DFG+ S + T GT Y++PE
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGI-------SKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 525 --MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ----ESLVMWAKPILSSGKVTQ 578
Y D+++ G+ LLE G+ P +++ P L + + +
Sbjct: 174 GESYSY---AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSP 230
Query: 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARP 612
+ + C+++DP+ RP
Sbjct: 231 -------------EFRDFI---SACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 78/272 (28%), Positives = 126/272 (46%), Gaps = 46/272 (16%)
Query: 356 IGKGGSSQVYKGCL--PDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
+G G S V K L P GK +AVK L+ +E + K+ + E++I+ + I+ G
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGW-SERY--KVAMGVAEALEYLHSGSA 468
+ + ++ + +++ GSL++ L G ER K+A+ V + L YLH
Sbjct: 68 FYNNGDISICMEYMDGGSLDKIL------KEVQGRIPERILGKIAVAVLKGLTYLHE--K 119
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 528
++IHRDVK SNIL++ + +L DFG++ S + T V GT Y+APE
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFV-GTSSYMAPERIQGND 175
Query: 529 VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD------- 581
+ K D+++ G+ L+EL TGR P + + +LL
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFP--------------YPPENDPPDGIFELLQYIVNEPP 221
Query: 582 PALGN-NYDYDQMERMVLASILCIRRDPRARP 612
P L + + D LC+ +DPR RP
Sbjct: 222 PRLPSGKFSPD----FQDFVNLCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 85/278 (30%), Positives = 128/278 (46%), Gaps = 34/278 (12%)
Query: 356 IGKGGSSQVYKGC--LPDGKEL--AVKILKPSEDVI--KEFVLEIEIITTLHHKNIISLL 409
+G G V KG + GKE+ AVK LK KEF+ E ++ L H I+ L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 410 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
G C + L+LV + G L + L ++ P S+ ++A VA + YL S +
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPV----SDLKELAHQVAMGMAYLES---K 114
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYG 527
+HRD+ + N+LL + + ++SDFG+++ S + T AG + + APE YG
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT-AGRWPLKWYAPECINYG 173
Query: 528 KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586
K + K DV+++GV L E + G KP KG E + M L SG+ +L P
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGE--MKGAEVIAM-----LESGE--RLPRPEECP 224
Query: 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624
Y M C + P RP S + R D
Sbjct: 225 QEIYSIMLS-------CWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 81/286 (28%), Positives = 139/286 (48%), Gaps = 35/286 (12%)
Query: 348 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL--------KPSEDVIKEFVLEIEIIT 398
+NF E IG+G S+VY+ CL DG +A+K + K D IKE I+++
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKE----IDLLK 57
Query: 399 TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 458
L+H N+I EDN L +V + G L + KK +K + +
Sbjct: 58 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 459 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTDVAGTF 516
ALE++HS +RV+HRD+K +N+ ++ +L D GL ++ S T+++H + GT
Sbjct: 118 ALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTP 170
Query: 517 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576
Y++PE N K D+++ G +L E+ + P D + +L K K+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLCK------KI 220
Query: 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
Q P L +++ +++ ++V +CI DP RP ++ V + +
Sbjct: 221 EQCDYPPLPSDHYSEELRQLV---NMCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 82/276 (29%), Positives = 132/276 (47%), Gaps = 39/276 (14%)
Query: 356 IGKGGSSQVYKGCLPDGKEL-AVKILK-PSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 413
+G G +VYK + A KI++ SE+ +++F++EI+I++ H NI+ L F
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 414 EDNNLLLVYDFLSRGSL----EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
+N L ++ +F G+L E G + + V + EAL +LHS
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-------VCRQMLEALNFLHS---H 122
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 528
+VIHRD+K+ NILL+ D + +L+DFG+ AK ST T GT ++APE
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVACET 179
Query: 529 VND-----KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583
D K D+++ G+ L+EL P +P V+ IL S T L P+
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNP----MRVLLK--ILKSEPPT-LDQPS 232
Query: 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
++ D ++ C+ +DP RP + +LK
Sbjct: 233 KWSSSFNDFLKS-------CLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 71/270 (26%), Positives = 131/270 (48%), Gaps = 30/270 (11%)
Query: 356 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 415
IG G V+ G + +++A+K ++ ++F+ E +++ L H ++ L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 475
+ + LV++F+ G L + L + F + + V E + YL S + VIHRD
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 476 VKSSNILLSDDFEPQLSDFGLAKWA---STSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 532
+ + N L+ ++ ++SDFG+ ++ +SS T V + +PE F + K + K
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK----WSSPEVFSFSKYSSK 181
Query: 533 IDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 591
DV++FGV++ E+ + G+ P N + +V +++G +L P L + Y+
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYEN---RSNSEVV----ETINAG--FRLYKPRLASQSVYE 232
Query: 592 QMERMVLASILCIRRDPRARPQMSLVLKLL 621
M+ C + P RP SL+L L
Sbjct: 233 LMQH-------CWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 7e-23
Identities = 68/182 (37%), Positives = 101/182 (55%), Gaps = 13/182 (7%)
Query: 372 GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVYDFLSR 427
G+++AVK LKP + I + EIEI+ L+H+NI+ G C ED N + L+ +FL
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 487
GSL+E L NK ++ K A+ + + ++YL GS Q V HRD+ + N+L+ +
Sbjct: 93 GSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYL--GSRQYV-HRDLAARNVLVESEH 146
Query: 488 EPQLSDFGLAKWASTSSSHITCTD--VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 545
+ ++ DFGL K T + T D + F Y APE + K DV++FGV L EL
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYEL 205
Query: 546 LT 547
LT
Sbjct: 206 LT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 8e-23
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSE----DVIKEFVLEIEIITTLHHK 403
+F +IGKG +V D K++ A+K + + ++ + E I+ L+H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 404 NIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEA 459
+++L + F+D N+ LV D L G L +L K + F E + A
Sbjct: 61 FLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICE-------IVLA 112
Query: 460 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 519
LEYLHS + +IHRD+K NILL + ++DF +A + + T +GT GY+
Sbjct: 113 LEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYM 166
Query: 520 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
APE + +D ++ GV E L G++P
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 9e-23
Identities = 67/223 (30%), Positives = 117/223 (52%), Gaps = 26/223 (11%)
Query: 350 FLAENLIGKGGSSQVYKGCL--PDGKE----LAVKILKPSE--DVIKEFVLEIEIITTLH 401
FL E +G+G +VYKG L P+ + +A+K LK + V +EF E E+++ L
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66
Query: 402 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYK-------- 451
H NI+ LLG C ++ +++++L+ G L E L + D A E K
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 452 --VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 509
+A+ +A +EYL S+ +HRD+ + N L+ + ++SDFGL++ ++ +
Sbjct: 127 LHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 510 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
+ ++ PE +YGK + D+++FGVVL E+ + G +P
Sbjct: 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-22
Identities = 70/205 (34%), Positives = 115/205 (56%), Gaps = 20/205 (9%)
Query: 356 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKE-FVLEIEIITTLHHKNIISLLGFCFE 414
IG+G V +G G+++AVK +K DV + F+ E ++T LHHKN++ LLG
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 415 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 474
N L +V + +S+G+L L + A + + ++ VAE +EYL S ++++HR
Sbjct: 71 -NGLYIVMELMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLES---KKLVHR 124
Query: 475 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKID 534
D+ + NIL+S+D ++SDFGLA+ + + V T APE + K + K D
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVKWT----APEALKHKKFSSKSD 179
Query: 535 VYAFGVVLLELLT-GRKPISNDHPK 558
V+++GV+L E+ + GR P +PK
Sbjct: 180 VWSYGVLLWEVFSYGRAP----YPK 200
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 50/290 (17%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHH---KNIIS 407
LIG+G VY+G +P G+ +A+KI+ P +DV + E+ +++ L NI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV-SDIQREVALLSQLRQSQPPNITK 66
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK--VAMGVAEALEYLHS 465
G + L ++ ++ GS+ + E+Y + V AL+Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIA-------EKYISVIIREVLVALKYIHK 119
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYF 524
VIHRD+K++NIL+++ +L DFG+ A SS T GT ++APE
Sbjct: 120 VG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST---FVGTPYWMAPEVI 173
Query: 525 MYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583
GK D K D+++ G+ + E+ TG P S+ L+ +KP P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP------------PR 221
Query: 584 L-GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWAR 632
L N Y E + C+ +P+ R +LK +KW +
Sbjct: 222 LEDNGYSKLLREFVA----ACLDEEPKERLSAEELLK--------SKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 32/212 (15%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKE-----FVLEIEIITTLHHKNIISLL 409
IG+G QVYK G+ +A+K ++ + KE + EI+++ L H NI+ L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENE--KEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 410 GFCFED--NNLLLVYDFLS---RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
++ +V++++ G L+ K F S+ + E L+YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLD---SPEVK----FTESQIKCYMKQLLEGLQYLH 117
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 524
S ++HRD+K SNIL+++D +L+DFGLA+ T + T+ T Y PE
Sbjct: 118 S---NGILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITLWYRPPELL 173
Query: 525 M----YGKVNDKIDVYAFGVVLLELLTGRKPI 552
+ YG ++D+++ G +L EL G KPI
Sbjct: 174 LGATRYGP---EVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 37/275 (13%)
Query: 355 LIGKGGSSQVYKGC-LPDGKELAVKIL------KPSEDVIKEFVLEIEIITTLHHKNIIS 407
L+G G VY+G L DG AVK + + ++ +K+ EI +++ L H NI+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHS 465
LG E++NL + + + GSL + L +G+ +P ++ + + LEYLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ------ILLGLEYLHD 120
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 525
+ +HRD+K +NIL+ + +L+DFG+AK S G+ ++APE
Sbjct: 121 ---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIA 174
Query: 526 -YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584
G D+++ G +LE+ TG+ P S ++ I S ++ P +
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA----AVFK--IGRSKEL-----PPI 223
Query: 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
++ D+ + +L C++RDP RP + +L+
Sbjct: 224 PDHLS-DEAKDFIL---KCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 56/180 (31%), Positives = 88/180 (48%), Gaps = 10/180 (5%)
Query: 376 AVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEEN 433
AVK LK D++ +F+ E I+ +L H+N+I L G + L++V + GSL +
Sbjct: 27 AVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-THPLMMVTELAPLGSLLDR 85
Query: 434 LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 493
L + Y A+ +A + YL S +R IHRD+ + NILL+ D + ++ D
Sbjct: 86 LRKDALGHFLISTLCDY--AVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGD 140
Query: 494 FGLAKWASTSSSHITCT-DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
FGL + + H + F + APE + DV+ FGV L E+ T G +P
Sbjct: 141 FGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 4e-22
Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 15/213 (7%)
Query: 351 LAENLIGKGGSSQVYKGCLPDGKEL-AVKILK-PSEDVIKEFVLEIEIITTLHHKNIISL 408
L E GK ++ Y C K L AVK LK S++ K+F E E++T L H++I+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD---------PAAFGWSERYKVAMGVAEA 459
G C E + L++V++++ G L + L + D PA S+ +A +A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 460 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 519
+ YL S Q +HRD+ + N L+ ++ ++ DFG+++ ++ + ++
Sbjct: 133 MVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 520 APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
PE MY K + DV++ GVVL E+ T G++P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 32/223 (14%)
Query: 355 LIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFC 412
+IG+G +VYK G+ +A+KI+ ED +E E I+ +H NI + G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG-A 71
Query: 413 F-------EDNNLLLVYDFLSRGS---LEENLH--GNKKDPAAFGWSERYKVAMGVAEAL 460
F D+ L LV + GS L + L G + + R L
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR-----ETLRGL 126
Query: 461 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYL 519
YLH +VIHRD+K NILL+ + E +L DFG+ A+ ST T GT ++
Sbjct: 127 AYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GTPYWM 180
Query: 520 APEYFMYGKVND-----KIDVYAFGVVLLELLTGRKPISNDHP 557
APE + D + DV++ G+ +EL G+ P+ + HP
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 356 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 415
+G G +V++G + +AVK LKP K+F+ E +I+ L H +I L C +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 475
+ +V + + GSL E L G A + +A VA + YL AQ IHRD
Sbjct: 74 EPIYIVTELMKYGSLLEYLQGGAG--RALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128
Query: 476 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYGKVNDKI 533
+ + N+L+ ++ +++DFGLA+ I F + APE +Y + + K
Sbjct: 129 LAARNVLVGENNICKVADFGLAR---VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 534 DVYAFGVVLLELLT-GRKP 551
DV++FG++L E++T GR P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 5e-22
Identities = 78/267 (29%), Positives = 125/267 (46%), Gaps = 29/267 (10%)
Query: 356 IGKGGSSQVYKGCLPDGKEL-AVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
IGKG +VYKG KE+ A+KI L+ +ED I++ EI +++ I G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 472
+ L ++ ++L GS + L P + + + + L+YLHS +R I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHS---ERKI 123
Query: 473 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 532
HRD+K++N+LLS+ + +L+DFG+A + + I GT ++APE + K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 533 IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQ 592
D+++ G+ +EL G P S+ HP L+ P P L Y
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP------------PTLEGQYS-KP 228
Query: 593 MERMVLASILCIRRDPRARPQMSLVLK 619
+ V A C+ +DPR RP +LK
Sbjct: 229 FKEFVEA---CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 5e-22
Identities = 65/199 (32%), Positives = 109/199 (54%), Gaps = 16/199 (8%)
Query: 356 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 415
IGKG V G G ++AVK +K ++ + F+ E ++T L H N++ LLG E+
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 416 N-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 474
L +V +++++GSL + L + + G K ++ V EA+EYL + + +HR
Sbjct: 72 KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 475 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG-TFGYLAPEYFMYGKVNDKI 533
D+ + N+L+S+D ++SDFGL K AS++ D + APE K + K
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTKS 180
Query: 534 DVYAFGVVLLELLT-GRKP 551
DV++FG++L E+ + GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-22
Identities = 72/280 (25%), Positives = 124/280 (44%), Gaps = 35/280 (12%)
Query: 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVK---ILKPSEDVIKEFVLEIEIITTLHHKN 404
+F N IGKG V+K D + A+K + K + +E + E ++ L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER--YKVAMGVAEALEY 462
II + L +V ++ G L + L + P E ++ + + L +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPL----PEDQVWRFFIQILLGLAH 116
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
LHS ++++HRD+KS N+ L ++ D G+AK S ++ + GT YL+PE
Sbjct: 117 LHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPE 171
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582
N+K DV+A GVVL E TG+ P ++ Q +L++ K+ + + P
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALIL---------KIIRGVFP 219
Query: 583 ALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKL 620
+ Y LA ++ C+ +D R RP +L+
Sbjct: 220 PVSQMYSQQ------LAQLIDQCLTKDYRQRPDTFQLLRN 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 355 LIGKGGSSQVYKGC--LPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLL 409
++G+G V K C G+ +A+K K SED +K+ L E++++ L H+NI++L
Sbjct: 8 VVGEGAYGVVLK-CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 410 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
L LV++++ R LE + P + +A+ Y HS
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLEL----LEASPGGLPPDAVRSYIWQLLQAIAYCHS---H 119
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE----YFM 525
+IHRD+K NIL+S+ +L DFG A+ A + TD T Y APE
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFAR-ALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 526 YGKVNDKIDVYAFGVVLLELLTGR 549
YGK +DV+A G ++ ELL G
Sbjct: 179 YGK---PVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 8e-22
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCF 413
IG G VYK + G+ +A+K++K D + EI ++ H NI++ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 414 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL---EYLHSGSAQR 470
+ L +V ++ GSL++ + G ++A E L YLH
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTR------GPLSELQIAYVCRETLKGLAYLHE---TG 121
Query: 471 VIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYF---MY 526
IHRD+K +NILL++D + +L+DFG+ A+ +T + + GT ++APE
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS---FIGTPYWMAPEVAAVERK 178
Query: 527 GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557
G + K D++A G+ +EL + P+ + HP
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPMFDLHP 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 9e-22
Identities = 76/286 (26%), Positives = 129/286 (45%), Gaps = 43/286 (15%)
Query: 354 NLIGKGGSSQVYKGCLPDGKELAVK--ILKPS-----EDVIKEFVLEIEIITTLHHKNII 406
++GKG VY G G+ +AVK L S E ++ E++++ +L H NI+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 464
LG C +DN + + +F+ GS+ L N+ P +Y ++ GVA YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVA----YLH 119
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK---WASTSSSHIT-CTDVAGTFGYLA 520
+ V+HRD+K +N++L + +L DFG A+ W +H + GT ++A
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 521 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK--VTQ 578
PE K D+++ G + E+ TG+ P+++ + A + + + + +
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-------LAAMFYIGAHRGLMPR 229
Query: 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624
L D D+ C+ RD RP L+LLR D
Sbjct: 230 LPDSFSAAAIDFVTS---------CLTRDQHERPS---ALQLLRHD 263
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 75/267 (28%), Positives = 127/267 (47%), Gaps = 29/267 (10%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
IGKG +V+KG K +A+KI L+ +ED I++ EI +++ + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 472
+D L ++ ++L GS + L +P ++ + + + L+YLHS ++ I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS---EKKI 123
Query: 473 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 532
HRD+K++N+LLS+ E +L+DFG+A + + I GT ++APE + K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 533 IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQ 592
D+++ G+ +EL G P S HP L+ P P L NY
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP------------PTLEGNYS-KP 228
Query: 593 MERMVLASILCIRRDPRARPQMSLVLK 619
++ V A C+ ++P RP +LK
Sbjct: 229 LKEFVEA---CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII 406
++ ++ +G G +VY+G +AVK LK ++EF+ E ++ + H N++
Sbjct: 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 65
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYL 463
LLG C + ++ +F++ G+L + L + + +A ++ A+EYL
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL 120
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT---FGYLA 520
+ IHRD+ + N L+ ++ +++DFGL++ + T T AG + A
Sbjct: 121 EKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTA 173
Query: 521 PEYFMYGKVNDKIDVYAFGVVLLELLT 547
PE Y K + K DV+AFGV+L E+ T
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 35/278 (12%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKIL--KPSEDVIKEFVLEIEIITTLHHKNI 405
+ + +G+G V K L + + A+K + P+ D+ K+ + E+EI + I
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 406 ISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 463
+ G + +++ + ++ GSL+ KK G K+A V + L YL
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG----YL 519
HS +++IHRD+K SNILL+ + +L DFG++ S +AGTF Y+
Sbjct: 122 HS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--------LAGTFTGTSFYM 170
Query: 520 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI-----LSSG 574
APE + DV++ G+ LLE+ R P P+G+ L PI + +
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLG----PIELLSYIVNM 223
Query: 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 612
+L D GN + + + + C+ +DP RP
Sbjct: 224 PNPELKD-EPGNGIKWSEEFKDFIKQ--CLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 27/232 (11%)
Query: 393 EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 452
EI I++ L H NII+ +DN LL+ ++ + G+L + + ++ F E +
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI--VRQKGQLF--EEEMVL 104
Query: 453 AM--GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 510
+ A+ Y+H ++HRD+K+ NI L+ +L DFG++K + S
Sbjct: 105 WYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM--AE 159
Query: 511 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 570
V GT Y++PE K N K D++A G VL ELLT ++ +P
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----------LN 208
Query: 571 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
L V P + Y ++ S +++DP RP VL
Sbjct: 209 LVVKIVQGNYTPVVSV---YSSELISLVHS--LLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 355 LIGKGGSSQVYKGC---LPD--GKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISL 408
+GKG V L D G+ +AVK L+ S + +++F EIEI+ +L H NI+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 409 LGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
G C+ NL LV ++L GSL + L ++ + A + + +EYL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYL--- 124
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT--FGYLAPEYF 524
++R +HRD+ + NIL+ + ++ DFGL K + + + F Y APE
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESL 183
Query: 525 MYGKVNDKIDVYAFGVVLLELLT 547
K + DV++FGVVL EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 77/290 (26%), Positives = 123/290 (42%), Gaps = 60/290 (20%)
Query: 350 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNII 406
FL E +G G V+ G ++A+K+++ SED +F+ E +++ L H N++
Sbjct: 8 FLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLV 62
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
L G C + + +V ++++ G L L K G + V EA+EYL S
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN 119
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA----STSSSHITCTDVAGT---FGYL 519
IHRD+ + N L+ +D ++SDFGLA++ TSS GT +
Sbjct: 120 G---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ--------GTKFPVKWA 168
Query: 520 APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT- 577
PE F Y + + K DV++FGV++ E+ + G+ P S+ +V
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER----------------FSNSEVVE 212
Query: 578 ------QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621
+L P L Y M C P RP +L L
Sbjct: 213 SVSAGYRLYRPKLAPTEVYTIMY-------SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 74/286 (25%), Positives = 132/286 (46%), Gaps = 34/286 (11%)
Query: 351 LAENLIGKGGSSQVYKGCLPDGKEL-AVKILK-PSEDVIKEFVLEIEIITTLHHKNIISL 408
L E GK ++ Y K L AVK LK P+ K+F E E++T L H++I+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP------------AAFGWSERYKVAMGV 456
G C + + L++V++++ G L + L + D G S+ +A +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 457 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 516
A + YL S Q +HRD+ + N L+ + ++ DFG+++ ++ +
Sbjct: 133 ASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 517 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGK 575
++ PE MY K + DV++FGV+L E+ T G++P + V+ ++ G+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN----TEVI---ECITQGR 242
Query: 576 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621
V L P + YD M + C +R+P+ R + + K+L
Sbjct: 243 V--LERPRVCPKEVYDIM-------LGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILKPSE--DVIKEFVL-EIEIITTLHHKNIISLLGF 411
IG+G VYK G+ +A+K +K + I + L EI+++ L+H NII LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVAEALEYLHSGSA 468
+L LV++F+ + +L+ KD G E + + + + L + HS
Sbjct: 67 FRHKGDLYLVFEFM-----DTDLYKLIKD-RQRGLPESLIKSYLYQ-LLQGLAFCHS--- 116
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF---- 524
++HRD+K N+L++ + +L+DFGLA+ S S T T Y APE
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLAR--SFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 525 MYGKVNDKIDVYAFGVVLLELLTGR 549
Y +D+++ G + ELL+ R
Sbjct: 175 GYST---PVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 413
IG+G S VY + G+E+A+K + + KE ++ EI ++ H NI++ L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 414 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 473
+ L +V ++L+ GSL + + D V +ALE+LHS +VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHS---NQVIH 138
Query: 474 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 533
RD+KS NILL D +L+DFG A + + + GT ++APE K+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 534 DVYAFGVVLLELLTGRKPISNDHP 557
D+++ G++ +E++ G P N++P
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 356 IGKGGSSQVYKGC-LPDGK----ELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISL 408
+G G VYKG +P+G+ +A+K+L+ KE + E ++ ++ H +++ L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA---FGWSERYKVAMGVAEALEYLHS 465
LG C + L+ + G L + + +K + + W + +A+ + YL
Sbjct: 75 LGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL-- 125
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 525
+R++HRD+ + N+L+ +++DFGLAK ++A E +
Sbjct: 126 -EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 526 YGKVNDKIDVYAFGVVLLELLT-GRKP 551
+ K DV+++GV + EL+T G KP
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 356 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 415
+G G +V+ G ++AVK LKP + F+ E +I+ L H ++ L C E+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 475
+ +V +++S+GSL + L + + +A +AE + YL S + IHRD
Sbjct: 74 EPIYIVTEYMSKGSLLDFLK--SGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRD 128
Query: 476 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYGKVNDKI 533
+ + NIL+ ++ +++DFGLA+ F + APE YG+ K
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDD---EYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 534 DVYAFGVVLLELLT-GRKP 551
DV++FG++L E++T GR P
Sbjct: 186 DVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 26/216 (12%)
Query: 349 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE-----DVIKEFVL-EIEIITTLH 401
+ +G+G + VYK G+ +A+K +K E D I L EI+++ L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 402 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA-EAL 460
H NII LL +N+ LV++F+ LE+ + KD + K M + L
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVI----KDKSIVLTPADIKSYMLMTLRGL 115
Query: 461 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 520
EYLHS ++HRD+K +N+L++ D +L+DFGLA+ + + +T V T Y A
Sbjct: 116 EYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRA 170
Query: 521 PEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 552
PE YG +D+++ G + ELL R P
Sbjct: 171 PELLFGARHYGV---GVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 78/291 (26%), Positives = 132/291 (45%), Gaps = 42/291 (14%)
Query: 355 LIGKGGSSQVYKGCL--PDGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLL 409
L+G+G V K C G+ +A+K SED V K + EI ++ L H+N+++L+
Sbjct: 8 LVGEGSYGMVMK-CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 410 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
L LV++F+ L++ +K P S K + +E+ HS
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDL----EKYPNGLDESRVRKYLFQILRGIEFCHS---H 119
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---- 525
+IHRD+K NIL+S +L DFG A+ + ++ TD T Y APE +
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 526 YGKVNDKIDVYAFGVVLLELLTGR----------------KPISNDHPKGQESLVMWAKP 569
YG+ +D++A G ++ E+LTG K + N P+ QE + P
Sbjct: 178 YGR---AVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE--IFQKNP 232
Query: 570 ILSSGKVTQLLDPALGNNYDYDQMERMVLASI-LCIRRDPRARPQMSLVLK 619
+ + ++ ++ + + ++ +VL C+R DP RP S +L
Sbjct: 233 LFAGMRLPEVKEIE-PLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 355 LIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
IGKG VYKG L E+AVK + P + K F+ E EI+ H NI+ L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGV 60
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
C + + +V + + GSL L K + ++++ A +EYL S +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLES---KNC 114
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAK----WASTSSSHITCTDVAGTFGYLAPEYFMYG 527
IHRD+ + N L+ ++ ++SDFG+++ T S + + T APE YG
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT----APEALNYG 170
Query: 528 KVNDKIDVYAFGVVLLELLT-GRKPISN 554
+ + DV+++G++L E + G P
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 355 LIGKGGSSQVYKGC-LPDGKELAVK-------ILKPSEDVIKEFV----LEIEIITTLHH 402
LIGKG +VY + G+ +AVK I + K+ V EIE + L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 403 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 462
NI+ LGF + L + +++ GS+ L + F V E L Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
LHS + ++HRD+K+ N+L+ D ++SDFG++K + + + G+ ++APE
Sbjct: 124 LHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 523 YF-MYGK-VNDKIDVYAFGVVLLELLTGRKPISND 555
Y + + K+D+++ G V+LE+ GR+P S++
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 16/216 (7%)
Query: 372 GKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSR 427
G+ +AVK LK + + EI I+ TL+H+NI+ G C E L L+ +++
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 487
GSL + L +K ++ A + E + YLHS Q IHRD+ + N+LL +D
Sbjct: 93 GSLRDYLPKHK-----LNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDR 144
Query: 488 EPQLSDFGLAKWASTSSSHITCTDVAGT--FGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 545
++ DFGLAK + + + F Y A E K + DV++FGV L EL
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKENKFSYASDVWSFGVTLYEL 203
Query: 546 LTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581
LT PK E ++ + ++ ++ +LL+
Sbjct: 204 LTHCDS-KQSPPKKFEEMIGPKQGQMTVVRLIELLE 238
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 9e-20
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 25/216 (11%)
Query: 355 LIGKGGSSQVYKGC--LPDGKELAVKIL------KPSEDVIKEFVLEIEIITTLHHKNII 406
L+G+G +VY C + G+ELAVK + ++ + EI+++ L H+ I+
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 407 SLLGFCFEDNNLLLVY-DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 465
G C D+ L ++ +++ GS+++ L K A + K + E +EYLHS
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT-CTDVAGTFGYLAPEYF 524
++HRD+K +NIL +L DFG +K T S T V GT +++PE
Sbjct: 123 ---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 525 M---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557
YG+ K DV++ G ++E+LT + P +
Sbjct: 180 SGEGYGR---KADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 57/188 (30%), Positives = 99/188 (52%), Gaps = 26/188 (13%)
Query: 374 ELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 430
++A+K++K SED EF+ E +++ L H+ ++ L G C + + +V +++S G L
Sbjct: 30 DVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86
Query: 431 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 490
L + K S+ ++ V E + YL S ++ IHRD+ + N L+ D +
Sbjct: 87 LNYLREHGKRFQP---SQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVK 140
Query: 491 LSDFGLAKWA----STSSSHITCTDVAGTF--GYLAPEYFMYGKVNDKIDVYAFGVVLLE 544
+SDFGL+++ TSS V F + PE +Y K + K DV+AFGV++ E
Sbjct: 141 VSDFGLSRYVLDDEYTSS-------VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWE 193
Query: 545 LLT-GRKP 551
+ + G+ P
Sbjct: 194 VYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 28/206 (13%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILK--PSEDVIKEFVL-EIEIITTLHHKNIISLLGF 411
+G+G VYK G+ +A+K ++ E+ I L EI ++ L H NI+ LL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHG--NKKDPAAFGWSERY-KVAMG-VAEALEYLHSGS 467
+ L LV+++ + +L +K+ S K M + L Y HS
Sbjct: 67 IHTERKLYLVFEYC-----DMDLKKYLDKRPGPL---SPNLIKSIMYQLLRGLAYCHS-- 116
Query: 468 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 525
R++HRD+K NIL++ D +L+DFGLA+ A T T T Y APE +
Sbjct: 117 -HRILHRDLKPQNILINRDGVLKLADFGLAR-AFGIPLR-TYTHEVVTLWYRAPEILLGS 173
Query: 526 --YGKVNDKIDVYAFGVVLLELLTGR 549
Y +D+++ G + E++TG+
Sbjct: 174 KHYST---AVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 25/212 (11%)
Query: 353 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 406
E +IG G +V +G L P KE+ A+K LK S+ +F+ E I+ H NII
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
L G + ++++ +++ GSL++ L N F + + G+A ++YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYL--- 122
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------YLA 520
S +HRD+ + NIL++ + ++SDFGL++ S + T T G + A
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT------TKGGKIPIRWTA 176
Query: 521 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
PE Y K DV++FG+V+ E+++ G +P
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 73/265 (27%), Positives = 110/265 (41%), Gaps = 26/265 (9%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKNIISLLGF 411
IGKG V K DGK L K + KE V E+ I+ L H NI+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 412 CFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA- 468
+ +N L +V ++ G L + + KK+ +++ + AL H+ S
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 469 -QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 527
V+HRD+K +NI L + +L DFGLAK SS GT Y++PE +
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHM 185
Query: 528 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587
++K D+++ G ++ EL P + Q L K GK ++ P
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPF---TARNQLQLASKIK----EGKFRRI--P----- 231
Query: 588 YDYDQMERMVLASILCIRRDPRARP 612
Y Y V+ S + DP RP
Sbjct: 232 YRYSSELNEVIKS--MLNVDPDKRP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 72/253 (28%), Positives = 126/253 (49%), Gaps = 28/253 (11%)
Query: 371 DGKELAVK---ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427
DGK+ +K I K S +E E+ +++ + H NI+ E+ NL +V D+
Sbjct: 24 DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83
Query: 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 487
G L + + N + F + + + AL+++H ++++HRD+KS NI L+ D
Sbjct: 84 GDLYKKI--NAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDG 138
Query: 488 EPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 546
+L DFG+A+ ST TC GT YL+PE N+K D++A G VL E+
Sbjct: 139 TIKLGDFGIARVLNSTVELARTCI---GTPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195
Query: 547 TGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRR 606
T + + K +LV+ K+ + P + ++Y YD R +++ + +R
Sbjct: 196 TLKHAFEAGNMK---NLVL---------KIIRGSYPPVSSHYSYDL--RNLVSQLF--KR 239
Query: 607 DPRARPQMSLVLK 619
+PR RP ++ +L+
Sbjct: 240 NPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 61/204 (29%), Positives = 106/204 (51%), Gaps = 12/204 (5%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 413
IG+G S V+ + G+E+A+K + + KE ++ EI ++ L + NI++ L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 414 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 473
+ L +V ++L+ GSL + + D A V +ALE+LH A +VIH
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIA-----AVCRECLQALEFLH---ANQVIH 138
Query: 474 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 533
RD+KS N+LL D +L+DFG A + + + GT ++APE K+
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 534 DVYAFGVVLLELLTGRKPISNDHP 557
D+++ G++ +E++ G P N++P
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 36/222 (16%)
Query: 356 IGKGGSSQVY----KGCLPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISL 408
+G+G +V+ LP+ ++ AVK LK SE ++F E E++T L H++I+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD-----------PAAFGWSERYKVAMGVA 457
G C E LL+V++++ G L L + D P + +A +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 458 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 517
+ YL S +HRD+ + N L+ ++ DFG+ S I TD G
Sbjct: 133 SGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGM-------SRDIYSTDYYRVGG 182
Query: 518 -------YLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
++ PE +Y K + D+++FGVVL E+ T G++P
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-19
Identities = 60/208 (28%), Positives = 111/208 (53%), Gaps = 16/208 (7%)
Query: 353 ENLIGKGGSSQVYKGCL--PDGKE--LAVKILKP--SEDVIKEFVLEIEIITTLHHKNII 406
+ +IG G +V++G L P KE +A+K LKP +E ++F+ E I+ H NII
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
L G + +++ +++ G+L++ L + + +++ + + G+A ++YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY---QLVGMLRGIAAGMKYL--- 123
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG--YLAPEYF 524
S +HRD+ + NIL++ + E ++SDFGL++ T T G + APE
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSR-VLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 525 MYGKVNDKIDVYAFGVVLLELLT-GRKP 551
Y K DV++FG+V+ E+++ G +P
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 8e-19
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 413
IG+G S VY + G+E+A++ + + KE ++ EI ++ + NI++ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 414 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 473
+ L +V ++L+ GSL + + D V +ALE+LHS +VIH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHS---NQVIH 139
Query: 474 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 533
RD+KS NILL D +L+DFG A + + + GT ++APE K+
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 534 DVYAFGVVLLELLTGRKPISNDHP 557
D+++ G++ +E++ G P N++P
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 356 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 415
+G+G +V+ G +A+K LKP + F+ E +++ L H+ ++ L E+
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 416 NNLLLVYDFLSRGSLEENLHGNK----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
+ +V +++S+GSL + L G + P + + M E + Y
Sbjct: 74 P-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY--------- 123
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 531
+HRD++++NIL+ ++ +++DFGLA+ + + + APE +YG+
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 532 KIDVYAFGVVLLELLT-GRKP 551
K DV++FG++L EL T GR P
Sbjct: 183 KSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 355 LIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
L+GKG +V+KG L D +AVK K P E IK F+ E I+ H NI+ L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGV 60
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
C + + +V + + G L K + + K A+ A + YL S +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLES---KNC 114
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWAST---SSSHITCTDVAGTFGYLAPEYFMYGK 528
IHRD+ + N L+ ++ ++SDFG+++ SSS + + T APE YG+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT----APEALNYGR 170
Query: 529 VNDKIDVYAFGVVLLELLT 547
+ + DV+++G++L E +
Sbjct: 171 YSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 40/222 (18%)
Query: 355 LIGKGGSSQVYKG------CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNI 405
+G+G QV K + +AVK+LK E + + V E+E++ + HKNI
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 406 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK--------------------KDPAAFG 445
I+LLG C ++ L +V ++ + G+L + L + KD +F
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 446 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505
+ VA +E+L S ++ IHRD+ + N+L+++D +++DFGLA+
Sbjct: 139 YQ--------VARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187
Query: 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 547
+ T+ ++APE + DV++FGV+L E+ T
Sbjct: 188 YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 71/270 (26%), Positives = 128/270 (47%), Gaps = 35/270 (12%)
Query: 356 IGKGGSSQVYKGCLPDGKEL-AVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
IGKG +V+KG +++ A+KI L+ +ED I++ EI +++ + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEYLHSGSAQ 469
+ L ++ ++L GS + L D +++A + E L+YLHS +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFD--------EFQIATMLKEILKGLDYLHS---E 120
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 529
+ IHRD+K++N+LLS+ + +L+DFG+A + + I GT ++APE
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 530 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 589
+ K D+++ G+ +EL G P S+ HP L+ P +G+ ++
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSK----------- 227
Query: 590 YDQMERMVLASILCIRRDPRARPQMSLVLK 619
+ + A C+ +DP RP +LK
Sbjct: 228 --PFKEFIDA---CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 22/236 (9%)
Query: 328 HEKYSATCRLF-NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKP 382
HE++ A +L + D +F+ IG+G + V C+ GK++AVK +
Sbjct: 4 HEQFRAALQLVVSPGDPREYLDSFIK---IGEGSTGIV---CIATEKHTGKQVAVKKMDL 57
Query: 383 SEDVIKEFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP 441
+ +E + E+ I+ HH+N++ + + L +V +FL G+L + + + +
Sbjct: 58 RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE 117
Query: 442 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501
V + V AL YLH+ Q VIHRD+KS +ILL+ D +LSDFG A
Sbjct: 118 EQIA-----TVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQ 167
Query: 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557
S + GT ++APE ++D+++ G++++E++ G P N+ P
Sbjct: 168 VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 56/197 (28%), Positives = 104/197 (52%), Gaps = 8/197 (4%)
Query: 356 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 415
+G+G +V+ G ++A+K LKP + + F+ E +I+ L H ++ L E+
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 475
+ +V +F+ +GSL + L + D + +A +A+ + Y+ IHRD
Sbjct: 74 P-IYIVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRD 127
Query: 476 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 535
++++NIL+ D+ +++DFGLA+ + + + APE +YG+ K DV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 536 YAFGVVLLELLT-GRKP 551
++FG++L EL+T GR P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 354 NLIGKGGSSQVYKGCL--PDGKEL--AVKILKPSEDV--IKEFVLEIEIITTLHHKNIIS 407
+IGKG VY G L DG+++ AVK L D+ +++F+ E I+ H N++S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 408 LLGFCFEDNNL-LLVYDFLSRGSLEENLHGNKKDPA-----AFGWSERYKVAMGVAEALE 461
LLG C L+V ++ G L + +P FG + VA+ +E
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG--------LQVAKGME 112
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK--WASTSSSHITCTDVAGTFGYL 519
YL S ++ +HRD+ + N +L + F +++DFGLA+ + S T ++
Sbjct: 113 YLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169
Query: 520 APEYFMYGKVNDKIDVYAFGVVLLELLT 547
A E K K DV++FGV+L EL+T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 72/248 (29%), Positives = 117/248 (47%), Gaps = 27/248 (10%)
Query: 327 LHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYK-GCLPDGKELAVKILKPSED 385
L+ + + + L T + IGKG +VYK DG AVKIL P D
Sbjct: 1 LYGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD 60
Query: 386 VIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN-----LLLVYDFLSRGSLEENLHG--- 436
V +E E I+ +L +H N++ G ++ + L LV + + GS+ E + G
Sbjct: 61 VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI 120
Query: 437 --NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 494
+ D A + + G L++LH+ R+IHRDVK +NILL+ + +L DF
Sbjct: 121 CGQRLDEAMISY-----ILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDF 172
Query: 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND-----KIDVYAFGVVLLELLTGR 549
G++ A +S+ + GT ++APE + D + DV++ G+ +EL G
Sbjct: 173 GVS--AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230
Query: 550 KPISNDHP 557
P+ + HP
Sbjct: 231 PPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 413
IG+G S VY + G+E+A+K + + KE ++ EI ++ + NI++ L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 414 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 473
+ L +V ++L+ GSL + + D V +AL++LHS +VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALDFLHS---NQVIH 138
Query: 474 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 533
RD+KS NILL D +L+DFG A + + + GT ++APE K+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 534 DVYAFGVVLLELLTGRKPISNDHP 557
D+++ G++ +E++ G P N++P
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 29/204 (14%)
Query: 356 IGKGGSSQVYK------GCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 409
+G G +VYK G L K + K SE+ ++++++EIEI+ T +H I+ LL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 410 GFCFEDNNLLLVYDFLSRGSLEE---NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
G + D L ++ +F G+++ L +P + + + EAL+YLHS
Sbjct: 76 GAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP------QIQVICRQMLEALQYLHS- 128
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 526
++IHRD+K+ N+LL+ D + +L+DFG++ A + GT ++APE M
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 527 GKVND-----KIDVYAFGVVLLEL 545
+ D K D+++ G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 353 ENLIGKGGSSQVYKGCL--PDGKE--LAVKILKP--SEDVIKEFVLEIEIITTLHHKNII 406
E +IG G +V +G L P +E +A+K LK +E ++F+ E I+ H NII
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
L G + ++++ +F+ G+L+ L N F + + G+A ++YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYL--- 122
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG---TFGYLAPEY 523
S +HRD+ + NIL++ + ++SDFGL+++ +S T T G + APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 524 FMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
Y K DV+++G+V+ E+++ G +P
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 8/197 (4%)
Query: 356 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 415
+G G +V+ G ++AVK LKP + F+ E +I+ L H ++ L E+
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 475
+ +V +++S+GSL + L + A +A VA + Y+ IHRD
Sbjct: 74 P-IYIVTEYMSKGSLLDFL--KDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 127
Query: 476 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 535
++S+NIL+ D +++DFGLA+ + + + APE +YG+ K DV
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 536 YAFGVVLLELLT-GRKP 551
++FG++L EL+T GR P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 70/274 (25%), Positives = 124/274 (45%), Gaps = 27/274 (9%)
Query: 349 NFLAENLIGKGGSSQVYK-GCLPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKN 404
+F +GKG VYK L D + A+K + KE V EI I+ +++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
IIS + N L +V ++ G L + + KK E +++ + + L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 524
Q+++HRD+KS+NILL + ++ D G++K ++ T + GT Y+APE +
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI-GTPHYMAPEVW 173
Query: 525 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584
+ K D+++ G +L E+ T P + + L KV + P +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEA---RSMQDL---------RYKVQRGKYPPI 221
Query: 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 618
Y D ++ + + ++ P+ RP +L
Sbjct: 222 PPIYSQD-LQNFIRS---MLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 9e-18
Identities = 67/194 (34%), Positives = 103/194 (53%), Gaps = 24/194 (12%)
Query: 372 GKELAVKILKPSEDVIK----EFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426
GK A+KIL ++K E VL E I+ ++ H +++L G +D+NL LV +++
Sbjct: 26 GKYYALKILS-KAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVP 84
Query: 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 486
G L +L + + P + Y A V ALEYLHS +++RD+K N+LL D
Sbjct: 85 GGELFSHLRKSGRFPE--PVARFY--AAQVVLALEYLHS---LDIVYRDLKPENLLLDSD 137
Query: 487 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLL 543
+++DFG AK T T + GT YLAPE + YGK +D +A G+++
Sbjct: 138 GYIKITDFGFAKRVKGR----TYT-LCGTPEYLAPEIILSKGYGK---AVDWWALGILIY 189
Query: 544 ELLTGRKPISNDHP 557
E+L G P +D+P
Sbjct: 190 EMLAGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 351 LAENLIGKGGSSQVYKGCLPDGKELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISL 408
L E GK +Y + + +A+K LK + EF E ++ LHH NI+ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENL-----H---GNKKD-----PAAFGWSERYKVAMG 455
LG ++ + +++++L++G L E L H G D ++ + +A+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 515
+A +EYL S+ +H+D+ + NIL+ + ++SD GL++ ++ +
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 516 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
++ PE MYGK + D+++FGVVL E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 70/268 (26%), Positives = 124/268 (46%), Gaps = 35/268 (13%)
Query: 375 LAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 432
+AVKIL+P +++ +F+ E++I++ L NII LLG C +++ L ++ +++ G L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 433 NL----------HGNKKDPAA-----FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 477
L +GN P A +S VA+ +A ++YL S+ +HRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 478 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYA 537
+ N L+ ++ +++DFG+++ + ++A E + GK DV+A
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 538 FGVVLLELLTGRKPISNDHPKGQ---ESLVMWAKPIL-SSGKVTQLLDPALGNNYDYDQM 593
FGV L E+L + + P G+ E ++ A G+ L P Y+ M
Sbjct: 226 FGVTLWEILM----LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELM 281
Query: 594 ERMVLASILCIRRDPRARPQMSLVLKLL 621
+ C RD R RP S + L
Sbjct: 282 LQ-------CWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 71/288 (24%), Positives = 126/288 (43%), Gaps = 42/288 (14%)
Query: 349 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILK-------PSEDVIKEFVLEIEIITTL 400
+L +G G S Y+ + G +AVK + E+V++ EI ++ L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 401 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 460
+H +II +LG ED++ L ++++ GS+ L AF + + L
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGL 116
Query: 461 EYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTD-----VAG 514
YLH ++IHRDVK +N+L+ S +++DFG A+ ++ T + G
Sbjct: 117 SYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGA---AARLAAKGTGAGEFQGQLLG 170
Query: 515 TFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 571
T ++APE YG+ DV++ G V++E+ T + P + + +L+
Sbjct: 171 TIAFMAPEVLRGEQYGR---SCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227
Query: 572 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
++ + + L P L R V + C+ P RP +LK
Sbjct: 228 TAPSIPEHLSPGL----------RDVT--LRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 83/297 (27%), Positives = 129/297 (43%), Gaps = 50/297 (16%)
Query: 357 GKGGSSQVYKGCLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 414
G GGS K +P G +A K+ + V K+ + E++I+ I+S G
Sbjct: 16 GNGGSVSKVKH-IPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74
Query: 415 DNNLLLVYDFLSRGSLEENLH-GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 473
+NN+ + +F+ GSL+ G G K+A+ V E L YL++ R++H
Sbjct: 75 ENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYN--VHRIMH 127
Query: 474 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 533
RD+K SNIL++ + +L DFG++ S I T V GT Y++PE GK K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFV-GTSTYMSPERIQGGKYTVKS 183
Query: 534 DVYAFGVVLLELLTGRKPI--SNDHPKGQES----------LVMWAKPILSSGKVTQLLD 581
DV++ G+ ++EL G+ P SN GQ+ +V P L S +
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPED-- 241
Query: 582 PALGNNYDYDQMERMVLASILCIRRDP--RARPQ-----MSLVLKLLRGDADVTKWA 631
+ V A C+ +DP R PQ + L + D+ WA
Sbjct: 242 -----------LRDFVDA---CLLKDPTERPTPQQLCAMPPFIQALRASNVDLQAWA 284
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 36/222 (16%)
Query: 356 IGKGGSSQVY---KGCLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISL 408
I KG +V+ K G A+K++K + ++ + + + E +I++ ++ L
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 409 LGFCFE-DNNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
+ F+ NL LV ++L G SL EN+ +D A +E + ALEYLH
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAE-------IVLALEYLH 110
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT------CTDVAGTFGY 518
S +IHRD+K NIL+ + +L+DFGL+K + GT Y
Sbjct: 111 S---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 519 LAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557
+APE + + K +D ++ G +L E L G P + P
Sbjct: 168 IAPEVILGQGHSK---TVDWWSLGCILYEFLVGIPPFHGETP 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 58/218 (26%), Positives = 113/218 (51%), Gaps = 21/218 (9%)
Query: 356 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 415
+G G +V+ G + ++AVK LKP ++ F+ E ++ TL H ++ L ++
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 416 NNLLLVYDFLSRGSLEENLHGNKKD----PAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
+ ++ +++++GSL + L ++ P +S + +AE + Y+ +
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIER---KNY 124
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG-TFGYLAPEYFMYGKVN 530
IHRD++++N+L+S+ +++DFGLA+ + T + A + APE +G
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 531 DKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 567
K DV++FG++L E++T G+ P +P S VM A
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIP----YPGMSNSDVMSA 216
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 66/273 (24%), Positives = 119/273 (43%), Gaps = 26/273 (9%)
Query: 350 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 409
F+ E +G G V+ G ++A+K + ++F+ E +++ L H ++ L
Sbjct: 8 FMKE--LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLY 65
Query: 410 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
G C + L +V +F+ G L L+ ++ + V E +EYL S
Sbjct: 66 GVCTQQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS-- 120
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 529
IHRD+ + N L+S ++SDFG+ ++ + + + + PE F + K
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 530 NDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 588
+ K DV++FGV++ E+ T G+ P E + M +S G +L P L +
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFEKK--SNYEVVEM-----ISRGF--RLYRPKLASMT 229
Query: 589 DYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621
Y+ M C P RP + +L+ +
Sbjct: 230 VYEVMYS-------CWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 69/222 (31%), Positives = 112/222 (50%), Gaps = 32/222 (14%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFC 412
++G G QVYKG + G+ A+K++ +ED +E LEI ++ HH+NI + G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 413 FE------DNNLLLVYDFLSRGS---LEENLHGN--KKDPAAFGWSERYKVAMGVAEALE 461
+ D+ L LV +F GS L +N GN K+D A+ + + L
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-------ICREILRGLA 135
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLA 520
+LH A +VIHRD+K N+LL+++ E +L DFG+ A+ T T GT ++A
Sbjct: 136 HLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWMA 189
Query: 521 PEYFMYGKVND-----KIDVYAFGVVLLELLTGRKPISNDHP 557
PE + D + D+++ G+ +E+ G P+ + HP
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 348 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK--PSEDVIKEFVL-EIEIITTLHHK 403
+ F N IG+G VY+ G+ +A+K ++ D I L EI ++ L H
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 404 NIISLLGFCFED--NNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 459
NI+ L +++ LV ++ + SL +N+ P F S+ + + +
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM------PTPFSESQVKCLMLQLLRG 120
Query: 460 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 519
L+YLH +IHRD+K SN+LL+D +++DFGLA+ + +T V T Y
Sbjct: 121 LQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYR 175
Query: 520 APEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPI 552
APE + ID++A G +L ELL KP+
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAH-KPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 30/223 (13%)
Query: 356 IGKGGSSQVYK----GCLPDGKEL--AVKILK--PSEDVIKEFVLEIEIITTLHHKNIIS 407
IG+G +V++ G LP AVK+LK S D+ +F E ++ H NI+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNK------------------KDPAAFGWSER 449
LLG C + L++++++ G L E L +P +E+
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 450 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 509
+A VA + YL S ++ +HRD+ + N L+ ++ +++DFGL++ ++ +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 510 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
+ A ++ PE Y + + DV+A+GVVL E+ + G +P
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 76/295 (25%), Positives = 134/295 (45%), Gaps = 30/295 (10%)
Query: 328 HEKYSATCRLF-NYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSED 385
HE++ A ++ + D + NF+ IG+G + V + GK +AVK + +
Sbjct: 2 HEQFRAALQMVVDPGDPRTYLDNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ 58
Query: 386 VIKEFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAF 444
+E + E+ I+ H+N++ + + L +V +FL G+L + + + +
Sbjct: 59 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI 118
Query: 445 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504
V + V +AL LH AQ VIHRD+KS +ILL+ D +LSDFG A S
Sbjct: 119 A-----AVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK 168
Query: 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 564
+ GT ++APE ++D+++ G++++E++ G P N+
Sbjct: 169 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--------- 219
Query: 565 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
P+ + + L P L N + + L +L RDP R + +LK
Sbjct: 220 ---PPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV--RDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 354 NLIGKGGSSQVYKGC----LPDGKE---LAVKILK--PSEDVIKEFVLEIEIITTLHHKN 404
N +G G +VY+G L G +AVK L+ ++ KEF+ E +++ +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD---PAAFGWSERYKVAMGVAEALE 461
I+ LLG C + ++ + + G L L + + P E + + VA+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 462 YLHSGSAQRVIHRDVKSSNILLSD-----DFEPQLSDFGLAKWASTSSSHITCTDVAGTF 516
YL IHRD+ + N L+S+ D ++ DFGLA+ S + +
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 517 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
++APE + GK + DV++FGV++ E+LT G++P
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 55/189 (29%), Positives = 101/189 (53%), Gaps = 18/189 (9%)
Query: 374 ELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSL 430
++AVK+LK +E + + + E+E++ + HKNII+LLG C +D L ++ ++ S+G+L
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 431 EENLHGNKKDPAAFGWS------------ERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 478
E L + + ++ + A VA +EYL S ++ IHRD+ +
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAA 168
Query: 479 SNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAF 538
N+L+++D +++DFGLA+ + T+ ++APE + DV++F
Sbjct: 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228
Query: 539 GVVLLELLT 547
GV+L E+ T
Sbjct: 229 GVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-17
Identities = 64/218 (29%), Positives = 112/218 (51%), Gaps = 34/218 (15%)
Query: 353 ENLIGKGGSSQVYKGCLP-DGKEL--AVKILK--PSEDVIKEFVLEIEIITTL-HHKNII 406
E++IG+G QV + + DG ++ A+K+LK SE+ ++F E+E++ L HH NII
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPA---------AFGWSERYKVAM 454
+LLG C L + ++ G+L + L ++ DPA + + A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 455 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 514
VA ++YL S ++ IHRD+ + N+L+ ++ +++DFGL++ V
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY--------VKK 175
Query: 515 TFG-----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT 547
T G ++A E Y K DV++FGV+L E+++
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 65/205 (31%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 356 IGKGGSSQVYKGC--LPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLLG 410
IG+G V+K C G+ +A+K SED VIK+ L EI ++ L H N+++L+
Sbjct: 9 IGEGSYGVVFK-CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 411 FCFEDNNLLLVYDFLSR---GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 467
L LV+++ LE+N G + K+ +A+ + H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-------KIIWQTLQAVNFCH--- 117
Query: 468 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 525
IHRDVK NIL++ + +L DFG A+ + TD T Y APE +
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPELLVGD 175
Query: 526 --YGKVNDKIDVYAFGVVLLELLTG 548
YG +DV+A G V ELLTG
Sbjct: 176 TQYGP---PVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 356 IGKGGSSQVYKGCLP----DGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLG 410
IG+G + V C+ G+++AVK + + +E + E+ I+ H NI+ +
Sbjct: 27 IGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 411 FCFEDNNLLLVYDFLSRGSLEENL-HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
+ L +V +FL G+L + + H + V + V +AL +LH+ Q
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI------ATVCLAVLKALSFLHA---Q 134
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 529
VIHRD+KS +ILL+ D +LSDFG A S + GT ++APE
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192
Query: 530 NDKIDVYAFGVVLLELLTGRKPISNDHP 557
++D+++ G++++E++ G P N+ P
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 58/190 (30%), Positives = 100/190 (52%), Gaps = 22/190 (11%)
Query: 375 LAVKILK--PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 431
+AVK+LK ++ + + V E+E++ + HKNII+LLG C +D L ++ ++ S+G+L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 432 ENLHGNKKDPAAFGWS--------------ERYKVAMGVAEALEYLHSGSAQRVIHRDVK 477
E L + P +S + A VA +EYL S Q+ IHRD+
Sbjct: 107 EYLRARR--PPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLA 161
Query: 478 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYA 537
+ N+L+++D +++DFGLA+ + T+ ++APE + DV++
Sbjct: 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 221
Query: 538 FGVVLLELLT 547
FGV+L E+ T
Sbjct: 222 FGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 57/197 (28%), Positives = 103/197 (52%), Gaps = 15/197 (7%)
Query: 356 IGKGGSSQVYKGCLPDGKELAVK--ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 413
+G G +VYK + LA I SE+ ++++++EI+I+ + H NI+ LL +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 414 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 473
+NNL ++ +F + G+++ + ++ + V EAL YLH ++IH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHE---NKIIH 126
Query: 474 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND-- 531
RD+K+ NIL + D + +L+DFG++ A + + GT ++APE M D
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 532 ---KIDVYAFGVVLLEL 545
K DV++ G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 22/228 (9%)
Query: 354 NLIGKGGSSQVYKGCL----PDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNI 405
+G G +VY+G D EL V + SE +F++E I++ +H+NI
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 406 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEY 462
+ L+G FE ++ + ++ G L+ L N+ + P++ + A VA+ +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGY 518
L IHRD+ + N LL+ P ++DFG+A+ +S + +
Sbjct: 132 LEE---NHFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 519 LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 565
+ PE F+ G K DV++FGV+L E+ + G P QE +
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT--NQEVMEF 233
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 24/208 (11%)
Query: 356 IGKGGSSQVYKGCLPDGK---ELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLG 410
+G G V KG K ++A+K+LK + V E + E EI+ L + I+ ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 411 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE-RYKVAMGVAEALEYLHSGSAQ 469
C E L+LV + S G L + L G K + E ++V+MG ++YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG----MKYLEG---K 114
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-----YLAPEYF 524
+HRD+ + N+LL + ++SDFGL+K S+ A + G + APE
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK----ARSAGKWPLKWYAPECI 170
Query: 525 MYGKVNDKIDVYAFGVVLLELLT-GRKP 551
+ K + + DV+++G+ + E + G+KP
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 50/272 (18%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
+G G VYK L + LAVK+ L + ++ K+ + E+EI+ II G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 472
F +N + + +F+ GSL+ ++ + G ++A+ V + L YL S +++
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPEHV-LG-----RIAVAVVKGLTYLWS---LKIL 117
Query: 473 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 532
HRDVK SN+L++ + +L DFG+ ST + GT Y+APE +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGV----STQLVNSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 533 IDVYAFGVVLLELLTGRKPISNDHPKGQ------------ESLVMWAKPILSSGKVTQLL 580
DV++ G+ +EL GR P +P+ Q + +V P+L G+ +
Sbjct: 174 SDVWSLGISFMELALGRFP----YPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFS--- 226
Query: 581 DPALGNNYDYDQMERMVLASILCIRRDPRARP 612
E+ V C+R+ P+ RP
Sbjct: 227 -------------EKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 26/270 (9%)
Query: 356 IGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFC 412
IG+G +V+ G L D +AVK + + D+ +F+ E I+ H NI+ L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 472
+ + +V + + G L + + E ++ A +EYL S + I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL---RTEGPRLKVKELIQMVENAAAGMEYLES---KHCI 116
Query: 473 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 532
HRD+ + N L+++ ++SDFG+++ T + APE YG+ + +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 533 IDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 591
DV++FG++L E + G P +N + + + +L P L + Y
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE---------QGVRLPCPELCPDAVYR 227
Query: 592 QMERMVLASILCIRRDPRARPQMSLVLKLL 621
MER C DP RP S V + L
Sbjct: 228 LMER-------CWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 2e-16
Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFC 412
L+G G QVYKG + G+ A+K++ + D +E EI ++ HH+NI + G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 413 FE------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
+ D+ L LV +F GS+ + + K + W + + L +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQ- 129
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFM 525
+VIHRD+K N+LL+++ E +L DFG+ A+ T T GT ++APE
Sbjct: 130 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWMAPEVIA 184
Query: 526 YGKVND-----KIDVYAFGVVLLELLTGRKPISNDHP 557
+ D K D+++ G+ +E+ G P+ + HP
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 51/188 (27%), Positives = 98/188 (52%), Gaps = 18/188 (9%)
Query: 375 LAVKILK--PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 431
+AVK+LK ++ + + + E+E++ + HKNII+LLG C ++ L ++ ++ ++G+L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 432 ENLH------------GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 479
E L K + + A VA +EYL S +R IHRD+ +
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAAR 163
Query: 480 NILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFG 539
N+L+++D +++DFGLA+ + ++ ++APE + DV++FG
Sbjct: 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 540 VVLLELLT 547
+++ E+ T
Sbjct: 224 ILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 356 IGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKE----FVLEIEIITTLHHKNIISLL 409
+GKGG +V C GK A K L ++ + E +I+ + + I+SL
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL- 58
Query: 410 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 468
+ FE ++L LV ++ G L+ H F + A + LE+LH
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLK--YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ--- 113
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 528
+R+++RD+K N+LL D ++SD GLA AGT GY+APE
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEV 170
Query: 529 VNDKIDVYAFGVVLLELLTGRKP 551
+ +D +A G L E++ GR P
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 57/192 (29%), Positives = 102/192 (53%), Gaps = 26/192 (13%)
Query: 375 LAVKILK--PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 431
+AVK+LK +E + + V E+E++ + HKNII+LLG C +D L ++ ++ S+G+L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 432 ENLHGNKKDPAAFGW----------------SERYKVAMGVAEALEYLHSGSAQRVIHRD 475
E L + + + S Y+VA G +EYL S Q+ IHRD
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARG----MEYLAS---QKCIHRD 162
Query: 476 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 535
+ + N+L++++ +++DFGLA+ + + T+ ++APE + DV
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222
Query: 536 YAFGVVLLELLT 547
++FGV++ E+ T
Sbjct: 223 WSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-16
Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 19/229 (8%)
Query: 375 LAVKILKPSEDVIKEFVL------------EIEIITTLHHKNIISLLGFCFEDNNLLLVY 422
+A + P E V+ +FV+ E+ + H I+ D+ LLL+
Sbjct: 85 VATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144
Query: 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 482
++ S G L + + K+ F E + + AL+ +HS ++++HRD+KS+NI
Sbjct: 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIF 201
Query: 483 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 542
L +L DFG +K S S S + GT YLAPE + + + K D+++ GV+L
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVIL 261
Query: 543 LELLTGRKPISNDHPKGQESLVMWAK----PILSSGKVTQLLDPALGNN 587
ELLT +P + V++ K P S + LLDP L N
Sbjct: 262 YELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKN 310
|
Length = 478 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 34/217 (15%)
Query: 354 NLIGKGGSSQVYKGCLP-DGKEL--AVKILK--PSEDVIKEFVLEIEIITTL-HHKNIIS 407
++IG+G QV K + DG + A+K +K S+D ++F E+E++ L HH NII+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPA-------AFGWSER--YKVAMG 455
LLG C L L ++ G+L + L ++ DPA A S + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 515
VA ++YL S ++ IHRD+ + NIL+ +++ +++DFGL++ V T
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--------VKKT 169
Query: 516 FG-----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT 547
G ++A E Y DV+++GV+L E+++
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 64/293 (21%), Positives = 121/293 (41%), Gaps = 58/293 (19%)
Query: 356 IGKGGSSQVYKGCLPD------GKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 407
+G+G VY+G +A+K + S EF+ E ++ + +++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 408 LLGFCFEDNNLLLVYDFLSRGSL--------EENLHGNKKDPAAFGWSERYKVAMGVAEA 459
LLG L+V + +++G L E + P + ++A +A+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP--TLQKFIQMAAEIADG 131
Query: 460 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-- 517
+ YL A++ +HRD+ + N ++++D ++ DFG+ + I TD G
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-------DIYETDYYRKGGKG 181
Query: 518 -----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAK 568
++APE G K DV++FGVVL E+ T +P +SN+ V+ K
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VL--K 232
Query: 569 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621
++ G + P + + M C + +P+ RP ++ L
Sbjct: 233 FVIDGGHLDL---PENCPDKLLELMRM-------CWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 51/290 (17%)
Query: 353 ENLIGKGGSSQVYKGCL-PDGKEL--AVKILK--PSEDVIKEFVLEIEIITTL-HHKNII 406
+++IG+G QV K + DG + A+K +K S+D ++F E+E++ L HH NII
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPA---------AFGWSERYKVAM 454
+LLG C L L ++ G+L + L ++ DPA + A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 455 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 514
VA ++YL S ++ IHRD+ + NIL+ +++ +++DFGL++ V
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--------VKK 180
Query: 515 TFG-----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 568
T G ++A E Y DV+++GV+L E+++ G P G ++ K
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-----GMTCAELYEK 235
Query: 569 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 618
L G +L P ++ YD M + C R P RP + +L
Sbjct: 236 --LPQG--YRLEKPLNCDDEVYDLMRQ-------CWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 66/236 (27%), Positives = 104/236 (44%), Gaps = 21/236 (8%)
Query: 378 KILKPSEDVIKEFVLEIEIIT-TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 436
K + + I + V E+ II L H NI+ E++ L +V D + L E+ +
Sbjct: 43 KDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNS 102
Query: 437 NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496
K+ F + + + + AL YLH +R++HRD+ +NI+L +D + ++DFGL
Sbjct: 103 LKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGL 160
Query: 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 556
AK S T V GT Y PE +K DV+AFG +L ++ T + P +
Sbjct: 161 AKQKQPESK---LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF---Y 214
Query: 557 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 612
SL V + +P Y + V+ S C+ D ARP
Sbjct: 215 STNMLSLATKI--------VEAVYEPL--PEGMYSEDVTDVITS--CLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 23/217 (10%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCF 413
IGKG +V+K +G + AVKIL P D+ +E E I+ L H N++ G +
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 414 EDN-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK---VAMGVAEALEYLHS 465
+ + L LV + + GS+ + + G K ER + +A + EAL L
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR------GERMEEPIIAYILHEALMGLQH 139
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF- 524
+ IHRDVK +NILL+ + +L DFG++ A +S+ + GT ++APE
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAPEVIA 197
Query: 525 ----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557
+ + + DV++ G+ +EL G P+++ HP
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 355 LIGKGGSSQVYKGCLPDGK----ELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISL 408
IG+G VY+G + +AVK K S V ++F+ E I+ H +I+ L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 468
+G +N + +V + G L L NK + + + ++ AL YL S
Sbjct: 73 IGVI-TENPVWIVMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLES--- 125
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 528
+R +HRD+ + N+L+S +L DFGL+++ S+ + ++APE + +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFRR 184
Query: 529 VNDKIDVYAFGVVLLELLT-GRKP 551
DV+ FGV + E+L G KP
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 22/236 (9%)
Query: 328 HEKYSATCRLFNYQ-DLLSATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKP 382
HE++ A R+ Q D S N++ IG+G + V C+ G+++AVK++
Sbjct: 3 HEQFKAALRMVVDQGDPRSLLENYIK---IGEGSTGIV---CIAREKHSGRQVAVKMMDL 56
Query: 383 SEDVIKEFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP 441
+ +E + E+ I+ H+N++ + L ++ +FL G+L + + + +
Sbjct: 57 RKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNE 116
Query: 442 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501
V V +AL YLHS Q VIHRD+KS +ILL+ D +LSDFG A
Sbjct: 117 EQIA-----TVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFC--AQ 166
Query: 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557
S + GT ++APE ++D+++ G++++E++ G P +D P
Sbjct: 167 ISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 78/279 (27%), Positives = 123/279 (44%), Gaps = 40/279 (14%)
Query: 356 IGKGGSSQVYKG---CLPDGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLL 409
+G G V KG K +AVKILK + + E + E ++ L + I+ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 410 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
G C E + +LV + G L + L NK ++V+MG ++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKYLEETN-- 115
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-----YLAPEYF 524
+HRD+ + N+LL ++SDFGL+K ++ A T G + APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK----AKTHGKWPVKWYAPECM 170
Query: 525 MYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583
Y K + K DV++FGV++ E + G+KP KG E M + SG+ ++ P
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG--MKGNEVTQM-----IESGE--RMECPQ 221
Query: 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
YD M+ LC RP ++V LR
Sbjct: 222 RCPPEMYDLMK-------LCWTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 78/283 (27%), Positives = 130/283 (45%), Gaps = 39/283 (13%)
Query: 350 FLAENLIGKGGSSQVYKGCLPDGKEL-AVKIL----KPSEDVIKEFVLEIEIITTLHHKN 404
F+ + IG G VY E+ AVK + K + + ++ + E++ + L H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
I G +++ LV ++ GS + L +KK E + G + L YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEY-CLGSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLH 138
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 524
S +IHRD+K+ NILL++ + +L+DFG A +S ++S + GT ++APE
Sbjct: 139 S---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVI 189
Query: 525 MY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581
+ G+ + K+DV++ G+ +EL + P+ N M A L + Q
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFN----------MNAMSALY--HIAQNDS 237
Query: 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624
P L +N D V C+++ P+ RP +LLR D
Sbjct: 238 PTLQSNEWTDSFRGFV---DYCLQKIPQERPAS---AELLRHD 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 74/283 (26%), Positives = 126/283 (44%), Gaps = 50/283 (17%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHH-KNIISLLG 410
IG G QVYK G +AVK ++ + ++ K +++++++ H I+ G
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 411 FCFEDNNLLLVYDFLS----------RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 460
+ D+++ + + +S +G + E++ G K+ + + +AL
Sbjct: 82 YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG--------------KMTVAIVKAL 127
Query: 461 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 520
YL VIHRDVK SNILL +L DFG++ S + T AG Y+A
Sbjct: 128 HYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMA 182
Query: 521 PEYFMYGKVNDKI----DVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576
PE N K DV++ G+ L+EL TG+ P N + + +L+ K+
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE---------VLT--KI 231
Query: 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
Q P+L N + + LC+ +D R RP+ +L+
Sbjct: 232 LQEEPPSLPPNEGFSPDFCSFV--DLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 67/217 (30%), Positives = 110/217 (50%), Gaps = 33/217 (15%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 407
NFL ++GKG +V EL A+KILK +DVI + + ++ T+ K +++
Sbjct: 3 NFLM--VLGKGSFGKVMLAERKGTDELYAIKILK--KDVI---IQDDDVECTMVEKRVLA 55
Query: 408 LLG---------FCFED-NNLLLVYDFLSRGSLEENLH--GNKKDP-AAFGWSERYKVAM 454
L G CF+ + L V ++++ G L ++ G K+P A F +E
Sbjct: 56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAE------ 109
Query: 455 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 514
+A L +LHS + +I+RD+K N++L + +++DFG+ K + T T G
Sbjct: 110 -IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRT-FCG 163
Query: 515 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
T Y+APE Y +D +AFGV+L E+L G+ P
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLG 410
IG G VY + + +A+K + K S + ++ + E+ + L H N I G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 411 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 470
++ LV ++ GS + L +KK E + G + L YLHS
Sbjct: 83 CYLREHTAWLVMEY-CLGSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHS---HE 135
Query: 471 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY---G 527
IHRD+K+ NILL++ +L+DFG A S ++S + GT ++APE + G
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDEG 189
Query: 528 KVNDKIDVYAFGVVLLELLTGRKPISN 554
+ + K+DV++ G+ +EL + P+ N
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 65/262 (24%), Positives = 119/262 (45%), Gaps = 28/262 (10%)
Query: 375 LAVKILKPSEDVIK----EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 430
+AVK+L+ DV K +F+ EI+I++ L + NII LLG C D+ L ++ +++ G L
Sbjct: 47 VAVKMLRA--DVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 431 EENL----------HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 480
+ L H N + + + +A+ +A ++YL S +HRD+ + N
Sbjct: 105 NQFLSQREIESTFTHAN--NIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159
Query: 481 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGV 540
L+ + + +++DFG+++ + + ++A E + GK DV+AFGV
Sbjct: 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 541 VLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLAS 600
L E+ T K ++ + + + G+ L L + + M R
Sbjct: 220 TLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMR----- 274
Query: 601 ILCIRRDPRARPQMSLVLKLLR 622
C RD + RP + + LR
Sbjct: 275 --CWSRDIKDRPTFNKIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 29/221 (13%)
Query: 348 SNFLAENLIGKGGSSQV----YKGCLPDGKELAVKILKPSEDV----IKEFVLEIEIITT 399
S+F +G G +V +KG G+ A+K LK E + ++ E I+
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILME 74
Query: 400 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGV 456
L H I++++ ++N + + +F+ G L +L + P A F +E +
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE-------L 127
Query: 457 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 516
A EYLHS + +I+RD+K N+LL + +++DFG AK + C GT
Sbjct: 128 VLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFTLC----GTP 179
Query: 517 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557
YLAPE +D + GV+L E + G P +D P
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220
|
Length = 329 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 74/272 (27%), Positives = 128/272 (47%), Gaps = 32/272 (11%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILK--PSED--VIKEFVLEIEIITTLHHKNIISLLG 410
IG G VYK + G+ A+K++K P ED V+++ EI ++ H NI++ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHSNIVAYFG 73
Query: 411 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 470
+ L + +F GSL++ H S+ V+ + L YLHS
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSKGK-- 127
Query: 471 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY---G 527
+HRD+K +NILL+D+ +L+DFG++ A +++ GT ++APE G
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 528 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587
N D++A G+ +EL + P+ + HP +L + K S+ + +L D +N
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHP--MRALFLMTK---SNFQPPKLKDKMKWSN 239
Query: 588 YDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
+ +M L ++P+ RP +L+
Sbjct: 240 -SFHHFVKMALT------KNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 37/214 (17%)
Query: 354 NLIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLG 410
N IG G VYK P G+ A+K++ + V ++ EIEI+ ++H N++
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 411 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSA 468
+ + ++ +F+ GSLE E++ VA + + YLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLE----------GTHIADEQFLADVARQILSGIAYLHR--- 186
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYG 527
+ ++HRD+K SN+L++ +++DFG+++ A T C GT Y++PE
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPE----- 238
Query: 528 KVNDKI----------DVYAFGVVLLELLTGRKP 551
++N + D+++ GV +LE GR P
Sbjct: 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 66/254 (25%), Positives = 120/254 (47%), Gaps = 28/254 (11%)
Query: 374 ELAVKILKPSEDVIKEFVL--EIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSL 430
++AVK+LKP+ + L E++I++ L +H+NI++LLG C +L++ ++ G L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 431 EENLHGNKKDPAAFG--WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 488
L ++ S Y+VA G + +L S + IHRD+ + N+LL+
Sbjct: 127 LNFLRRKRESFLTLEDLLSFSYQVAKG----MAFLASKNC---IHRDLAARNVLLTHGKI 179
Query: 489 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT- 547
++ DFGLA+ S+++ + ++APE + DV+++G++L E+ +
Sbjct: 180 VKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 239
Query: 548 GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRD 607
G P +P G + K I ++ Q P YD M+ C D
Sbjct: 240 GSNP----YP-GMPVDSKFYKLIKEGYRMAQ---PEHAPAEIYDIMKT-------CWDAD 284
Query: 608 PRARPQMSLVLKLL 621
P RP +++L+
Sbjct: 285 PLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 22/203 (10%)
Query: 372 GKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLS 426
GK A+KILK ++D + + E ++ H + SL + F+ + L V ++++
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVN 78
Query: 427 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 483
G L +L + +D F +E + AL+YLHSG ++++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFSEDRTRFYGAE-------IVSALDYLHSG---KIVYRDLKLENLML 128
Query: 484 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 543
D +++DFGL K T ++ T GT YLAPE +D + GVV+
Sbjct: 129 DKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186
Query: 544 ELLTGRKPISN-DHPKGQESLVM 565
E++ GR P N DH K E ++M
Sbjct: 187 EMMCGRLPFYNQDHEKLFELILM 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 54/204 (26%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
E +G G +V+ ++AVK +KP ++ F+ E ++ TL H ++ L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 413 FEDNNLLLVYDFLSRGSLEENL---HGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSA 468
++ + ++ +F+++GSL + L G+K+ P +S + +AE + ++
Sbjct: 71 TKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQ--- 120
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 528
+ IHRD++++NIL+S +++DFGLA+ + + + APE +G
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGS 179
Query: 529 VNDKIDVYAFGVVLLELLT-GRKP 551
K DV++FG++L+E++T GR P
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 4e-15
Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 355 LIGKGGSSQVYKGC-LPDGKEL----AVKILK----PSEDVIKEFVLEIEIITTLHHKNI 405
++G G VYKG +P+G+ + A+KIL P +V EF+ E I+ ++ H ++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPHL 71
Query: 406 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 465
+ LLG C + LV + G L + +H +K + G + +A+ + YL
Sbjct: 72 VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDN---IGSQLLLNWCVQIAKGMMYLEE 127
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 525
+R++HRD+ + N+L+ +++DFGLA+ ++A E
Sbjct: 128 ---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 526 YGKVNDKIDVYAFGVVLLELLT-GRKP 551
Y K + DV+++GV + EL+T G KP
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 64/249 (25%), Positives = 114/249 (45%), Gaps = 23/249 (9%)
Query: 375 LAVKILKPSEDVIK----EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 430
+AVK+L+ ED K +F+ EI+I++ L NII LL C + L ++ +++ G L
Sbjct: 49 VAVKMLR--EDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 431 EENL-------HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 483
+ L K D +S +A +A ++YL S+ +HRD+ + N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLV 163
Query: 484 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 543
++ +++DFG+++ + + +++ E + GK DV+AFGV L
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223
Query: 544 ELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILC 603
E+LT K ++ + + G+ L PAL + Y M + C
Sbjct: 224 EILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLM-------LSC 276
Query: 604 IRRDPRARP 612
RR+ + RP
Sbjct: 277 WRRNAKERP 285
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 355 LIGKGGSSQVY----KGCLPDGKEL--AVKIL--KPSEDVIKEFVLEIEIITTLHHKNII 406
+G+G +V+ KG +G E VK L E++ EF E+++ L HKN++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-----DPAAFGWSERYKVAMGVAEALE 461
LLG C E ++ ++ G L++ L K P ++ + +A ++
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 521
+L S R +HRD+ + N L+S E ++S L+K S + + +LAP
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAP 187
Query: 522 EYFMYGKVNDKIDVYAFGVVLLELLT 547
E + K DV++FGV++ E+ T
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 356 IGKGGSSQVYKGCLPDGKEL-AVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLG 410
+G+GG QV+ D E+ A+K +K S + ++ + E +I+TT + ++ LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 411 FCFED-NNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
+ F+D L L +++ G +L NL +D A F Y M EA++ LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-----YMAEM--FEAVDALHEL 120
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 526
IHRD+K N L+ +L+DFGL+K + ++ V G+ Y+APE
Sbjct: 121 G---YIHRDLKPENFLIDASGHIKLTDFGLSK-GIVTYAN----SVVGSPDYMAPEVLRG 172
Query: 527 GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557
+ +D ++ G +L E L G P S P
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 33/271 (12%)
Query: 355 LIGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL----EIEIITTLHHKNIISL 408
++G+G V+ C D K + +K + P E + K+ L E +++ L H NII
Sbjct: 7 VVGRGAFGIVHL-CRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 468
ED L++V ++ G+L E + K+ + + + AL ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVH---T 119
Query: 469 QRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 527
+ ++HRD+K+ NILL ++ DFG++K S+ S T V GT Y++PE
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCEGK 176
Query: 528 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587
N K D++A G VL EL + ++ + +LV+ K+ + +
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAAN---LPALVL---------KIMSGTFAPISDR 224
Query: 588 YDYDQMERMVLASILCIRRDPRARPQMSLVL 618
Y D R ++ S+L DP RPQ+S ++
Sbjct: 225 YSPDL--RQLILSML--NLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 355 LIGKGGSSQVYKGCLPDGKE-LAVKILKPSEDVIK----EFVL-EIEIITTLHHKNIISL 408
+G G +V+ + A+K++ +VI+ + V E ++ + H II L
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIP-EVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 468
+ L ++ +++ G L L + + F S A + ALEYLHS
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR----FSNSTGLFYASEIVCALEYLHS--- 119
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 528
+ +++RD+K NILL + +L+DFG AK T T + GT YLAPE
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWT-LCGTPEYLAPEVIQSKG 174
Query: 529 VNDKIDVYAFGVVLLELLTGRKPISNDHPKG 559
N +D +A G+++ E+L G P +D+P G
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 54/214 (25%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 355 LIGKGGSSQVYKGC-LPDGKEL----AVKIL--KPSEDVIKEFVLEIEIITTLHHKNIIS 407
L+G G V+KG +P+G + A+K + + +E + + +L H I+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK--DPAAF-GWSERYKVAMGVAEALEYLH 464
LLG C +L LV GSL +++ ++ DP W + +A+ + YL
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLE 126
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 524
R++HR++ + NILL D Q++DFG+A ++ ++A E
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 525 MYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 557
++G+ + DV+++GV + E+++ G +P + P
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 31/215 (14%)
Query: 355 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIISL----- 408
++GKG +V L EL AVK+LK +DVI + + ++ T+ K +++L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLK--KDVI---LQDDDVECTMTEKRVLALAGKHP 56
Query: 409 ----LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEAL 460
L CF+ + L V ++++ G L ++ + + A F Y A + L
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-----Y--AAEIVLGL 109
Query: 461 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 520
++LH + +I+RD+K N+LL + +++DFG+ K +T + GT Y+A
Sbjct: 110 QFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIA 164
Query: 521 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 555
PE Y +D +A GV+L E+L G+ P D
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-15
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 372 GKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 426
G+ A+KIL+ ++D + V E ++ H ++ L + F+ ++ L V ++ +
Sbjct: 20 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP-FLTALKYAFQTHDRLCFVMEYAN 78
Query: 427 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 483
G L +L + ++ A F +E + ALEYLHS + V++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFTEERARFYGAE-------IVSALEYLHS---RDVVYRDIKLENLML 128
Query: 484 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 543
D +++DFGL K + + T GT YLAPE +D + GVV+
Sbjct: 129 DKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186
Query: 544 ELLTGRKPISN-DHPKGQESLVM 565
E++ GR P N DH + E ++M
Sbjct: 187 EMMCGRLPFYNQDHERLFELILM 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 37/216 (17%)
Query: 356 IGKGGSSQVYKGCL-PDGKELAVKILKPSEDV---IKEFV-LEIEIITTLHHKNIISLLG 410
+G GG +V + + A+K +K V +E + E EI+ +H I+ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 411 FCFEDNN---LLL-------VYDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 459
F+D +L+ ++ L RG +E ++ R+ +A V A
Sbjct: 61 -TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE-------------YTARFYIAC-VVLA 105
Query: 460 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 519
EYLH+ + +I+RD+K N+LL + +L DFG AK S T T GT Y+
Sbjct: 106 FEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAK--KLKSGQKTWTFC-GTPEYV 159
Query: 520 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 555
APE + + +D ++ G++L ELLTGR P D
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 70/240 (29%), Positives = 115/240 (47%), Gaps = 37/240 (15%)
Query: 355 LIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLG--- 410
++GKG +V+ L + A+K LK +DV+ +++ ++ T+ K ++SL
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALK--KDVV---LMDDDVECTMVEKRVLSLAWEHP 56
Query: 411 -----FC-FE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 463
+C F+ NL V ++L+ G L ++ K F A + L++L
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK----FDLPRATFYAAEIICGLQFL 112
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523
HS + +++RD+K NILL D +++DFG+ K + TCT GT Y+APE
Sbjct: 113 HS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCT-FCGTPDYIAPEI 167
Query: 524 FMYGKVNDKIDVYAFGVVLLELLTGRKP------------ISNDHPKGQESLVMWAKPIL 571
+ K N +D ++FGV+L E+L G+ P I D+P L AK IL
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDIL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 356 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 415
+G G +V+ G ++A+K LK + F+ E ++ L H ++ L ++
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG--VAEALEYLHSGSAQRVIH 473
+ ++ +++ GSL + L K P + + M +AE + ++ + IH
Sbjct: 74 P-IYIITEYMENGSLVDFL----KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125
Query: 474 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG-TFGYLAPEYFMYGKVNDK 532
RD++++NIL+S+ +++DFGLA+ + T + A + APE YG K
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 533 IDVYAFGVVLLELLT-GRKP 551
DV++FG++L E++T GR P
Sbjct: 184 SDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 72/222 (32%), Positives = 105/222 (47%), Gaps = 40/222 (18%)
Query: 354 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKE-----FVLEIEIITTLHHKNIISL 408
IG+G QVYK D EL V + K D KE + EI+I+ L+H+NI++L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGEL-VALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 409 ----------LGFCFEDNNLLLVYDFLSR---GSLEENL-HGNKKDPAAFGWSERYKVAM 454
L F + LV++++ G LE L H ++ +F K +
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF-----MKQLL 126
Query: 455 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 514
E L Y H + +HRD+K SNILL++ + +L+DFGLA+ ++ S V
Sbjct: 127 ---EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI- 179
Query: 515 TFGYLAPEYF----MYGKVNDKIDVYAFGVVLLELLTGRKPI 552
T Y PE YG IDV++ G +L EL T +KPI
Sbjct: 180 TLWYRPPELLLGEERYGPA---IDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 355 LIGKGGSSQVYKGC-LPDGKELAVK---ILKPSED-------VIKEFVLEIEIITTLHHK 403
LIG G VY G G+ +AVK + S ++ EI ++ L H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 404 NIISLLGFCFEDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALE 461
NI+ LG + ++L + +++ GS+ N +G ++ + + + + L
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------ILKGLN 120
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT----DVAGTFG 517
YLH+ + +IHRD+K +NIL+ + ++SDFG++K +S + G+
Sbjct: 121 YLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 518 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 554
++APE K D+++ G +++E+LTG+ P +
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 355 LIGKGGSSQVYKGCLPDGKEL----AVKILKPSEDVIKE-----FVLEIEIITTLHHKNI 405
++GKGG +V++ G + A+K+LK + V + E I+ + H I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 406 ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALE 461
+ L+ + F+ L L+ ++LS G L +L +D A F SE ++ ALE
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE-------ISLALE 114
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 521
+LH Q +I+RD+K NILL +L+DFGL K S +T T GT Y+AP
Sbjct: 115 HLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHT-FCGTIEYMAP 169
Query: 522 EYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 558
E M +D ++ G ++ ++LTG P + ++ K
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK 206
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 349 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKN 404
NF IG+G VYK G+ +A+K ++ +E V + EI ++ L+H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD--PAAFGWSERYKVAMGVAEALEY 462
I+ LL +N L LV++FL + L++ + + P S +++ G+A +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----F 115
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
HS RV+HRD+K N+L++ + +L+DFGLA+ T T T Y APE
Sbjct: 116 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPE 170
Query: 523 YFMYGKV-NDKIDVYAFGVVLLELLTGR 549
+ K + +D+++ G + E++T R
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 69/274 (25%), Positives = 126/274 (45%), Gaps = 38/274 (13%)
Query: 356 IGKGGSSQVY--------KGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 407
IG+G ++Y + C+ +L +K E KE +L + + H NI++
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVIL----LAKMKHPNIVT 63
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 467
E+ L +V ++ G L + + N++ F + + ++ L+++H
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRI--NRQRGVLFSEDQILSWFVQISLGLKHIHD-- 119
Query: 468 AQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWASTSSSHI-TCTDVAGTFGYLAPEYFM 525
++++HRD+KS NI LS + +L DFG+A+ + S TC GT YL+PE
Sbjct: 120 -RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC---VGTPYYLSPEICQ 175
Query: 526 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585
N+K D+++ G VL EL T + P ++ LV+ K+ Q +
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNN---LHQLVL---------KICQGYFAPIS 223
Query: 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
N+ D R +++ + + PR RP ++ +LK
Sbjct: 224 PNFSRDL--RSLISQLF--KVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 57/227 (25%), Positives = 108/227 (47%), Gaps = 26/227 (11%)
Query: 346 ATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSEDVI--KEFVLEIEII 397
+T F+ E +G+ +VYKG L + +A+K LK + +EF E +
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 398 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL------------HGNKKDPAAFG 445
+ L H NI+ LLG ++ L +++ + S L E L +K +
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 446 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505
++ + +A +E+L S+ V+H+D+ + N+L+ D ++SD GL + +
Sbjct: 123 PADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
+ + +++PE MYGK + D++++GVVL E+ + G +P
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 71/269 (26%), Positives = 110/269 (40%), Gaps = 65/269 (24%)
Query: 356 IGKGGSSQVYKGCL---PDGKELAVKILKPSEDVIKEF----VLEIEIITTLHHKNIISL 408
IG+G +VYK DGKE A+K K ++ EI ++ L H+N++SL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 409 LGFCFEDNN--LLLVYDFLSRGSLEENL---------HGNKKDPAAFGWSERYKVAMGVA 457
+ E + + L++D+ E +L P + S +++ GV
Sbjct: 68 VEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 458 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLA-KWASTSSSHITCTDV 512
YLHS V+HRD+K +NIL+ + + + D GLA + + V
Sbjct: 123 ----YLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 513 AGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 568
T Y APE + Y K ID++A G + ELLT PI KG+E+
Sbjct: 176 VVTIWYRAPELLLGARHYTKA---IDIWAIGCIFAELLTLE-PIF----KGREA------ 221
Query: 569 PILSSGKVTQLLDPALGNNYDYDQMERMV 597
N + DQ+ER+
Sbjct: 222 ------------KIKKSNPFQRDQLERIF 238
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILK--PSED--VIKEFVLEIEIITTLHHKNIISLLG 410
+G G VYK L G+ AVKI+K P +D +I++ EI ++ H NI++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHCNIVAYFG 73
Query: 411 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE---YLHSGS 467
L + ++ GSL++ H G ++A E L+ YLHS
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYH-------VTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 468 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY- 526
+HRD+K +NILL+D+ + +L+DFG+A A +++ GT ++APE
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 527 --GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557
G N D++A G+ +EL + P+ + HP
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 370 PDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425
P G +A K++ KP+ + + + E++++ + I+ G + D + + + +
Sbjct: 28 PSGLIMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85
Query: 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 485
GSL++ L K+ P KV++ V L YL +++HRDVK SNIL++
Sbjct: 86 DGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNS 139
Query: 486 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 545
E +L DFG++ S ++ GT Y++PE + + D+++ G+ L+EL
Sbjct: 140 RGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
Query: 546 LTGRKPISNDHPKGQESLVMWAKPILSSG 574
GR PI P +E ++ +P++
Sbjct: 196 AIGRYPIPP--PDAKELEAIFGRPVVDGE 222
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 50/193 (25%), Positives = 84/193 (43%), Gaps = 20/193 (10%)
Query: 372 GKELAVKILKPSEDV----IKEFVLEIEIITTLHHKNIISLLGFCFED-NNLLLVYDFLS 426
G A+K+LK S+ + + E I+ ++ L + F+ + L LV ++L+
Sbjct: 21 GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80
Query: 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-VIHRDVKSSNILLSD 485
G + W+++Y V +E LH QR +IHRD+K N+L+
Sbjct: 81 GGDCASLI--KTLGGLPEDWAKQY--IAEVVLGVEDLH----QRGIIHRDIKPENLLIDQ 132
Query: 486 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 545
+L+DFGL++ + GT YLAPE + + D ++ G V+ E
Sbjct: 133 TGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEF 186
Query: 546 LTGRKPISNDHPK 558
L G P + P
Sbjct: 187 LFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 29/193 (15%)
Query: 451 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 510
K+A+ + +ALEYLHS VIHRDVK SN+L++ + + +L DFG++ + S + T
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKT 161
Query: 511 DVAGTFGYLAPEYF---MYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMW 566
AG Y+APE + K D K DV++ G+ ++EL TGR P + W
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS-----------W 210
Query: 567 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP------QMSLVLKL 620
P +V + P L + + V C++++ + RP Q
Sbjct: 211 KTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNK---CLKKNYKERPNYPELLQHPFFELH 267
Query: 621 LRGDADVTKWARL 633
L + DV + L
Sbjct: 268 LSKNTDVASFVSL 280
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 71/249 (28%), Positives = 111/249 (44%), Gaps = 46/249 (18%)
Query: 349 NFLAENLIGKGGSSQVY----KGCLPDGKELAVKILKP--------------SEDVIKEF 390
NF ++G G +V+ G GK A+K+LK +E + E
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 391 VLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 449
V + TLH + F+ D L L+ D+++ G L +L+ + F SE
Sbjct: 61 VRRCPFLVTLH---------YAFQTDTKLHLILDYVNGGELFTHLYQREH----FTESE- 106
Query: 450 YKVAMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506
V + +AE AL++LH +I+RD+K NILL + L+DFGL+K
Sbjct: 107 --VRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
Query: 507 ITCTDVAGTFGYLAPEYFMYGKV--NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 564
GT Y+APE G + +D ++ GV+ ELLTG P + D + +S +
Sbjct: 162 RA-YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220
Query: 565 MWAKPILSS 573
++ IL S
Sbjct: 221 --SRRILKS 227
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 68/239 (28%), Positives = 110/239 (46%), Gaps = 35/239 (14%)
Query: 384 EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA 443
+D+IKE + + L H N I G ++ LV ++ GS + L +KK
Sbjct: 60 QDIIKE----VRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQE 114
Query: 444 FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503
E V G + L YLHS +IHRDVK+ NILLS+ +L DFG A + +
Sbjct: 115 V---EIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168
Query: 504 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 560
+ + GT ++APE + G+ + K+DV++ G+ +EL + P+ N
Sbjct: 169 NXFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN------ 216
Query: 561 ESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
M A L + Q PAL + + + V + C+++ P+ RP ++LK
Sbjct: 217 ----MNAMSALY--HIAQNESPALQSGHWSEYFRNFVDS---CLQKIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 14/212 (6%)
Query: 348 SNFLAENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLH 401
S E +IG G +V G L P +E+ A+K LK +E ++F+ E I+
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 402 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 461
H NII L G + +++V +++ GSL+ L +K F + + G+A ++
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLRGIASGMK 120
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLA 520
YL S +HRD+ + NIL++ + ++SDFGL++ + T + A
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 177
Query: 521 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
PE Y K DV+++G+V+ E+++ G +P
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 67/227 (29%), Positives = 116/227 (51%), Gaps = 28/227 (12%)
Query: 355 LIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFV---LEIEIITTLHHKNIIS 407
++G+G +V+ K PD +L A+K+LK + +++ V +E +I+ ++H I+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 408 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGN---KKDPAAFGWSERYKVAMGVAEALEYL 463
L + F+ + L L+ DFL G L L ++ F +E +A AL++L
Sbjct: 63 L-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-------LALALDHL 114
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA--STSSSHITCTDVAGTFGYLAP 521
HS +I+RD+K NILL ++ +L+DFGL+K + ++ C GT Y+AP
Sbjct: 115 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC----GTVEYMAP 167
Query: 522 EYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 568
E D ++FGV++ E+LTG P K ++++ AK
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 31/242 (12%)
Query: 381 KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD 440
K S + ++ + E++ + + H N I G ++ LV ++ GS + L +KK
Sbjct: 63 KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGSASDLLEVHKKP 121
Query: 441 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500
E + G + L YLHS +IHRD+K+ NILL++ + +L+DFG A A
Sbjct: 122 LQEV---EIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175
Query: 501 STSSSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557
S ++S + GT ++APE + G+ + K+DV++ G+ +EL + P+ N
Sbjct: 176 SPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--- 226
Query: 558 KGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLV 617
M A L + Q P L +N D V + C+++ P+ RP +
Sbjct: 227 -------MNAMSALY--HIAQNESPTLQSNEWSDYFRNFVDS---CLQKIPQDRPTSEEL 274
Query: 618 LK 619
LK
Sbjct: 275 LK 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 6e-14
Identities = 70/235 (29%), Positives = 92/235 (39%), Gaps = 52/235 (22%)
Query: 344 LSATSNFLAE-------NLI-GKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIE 395
LS FL LI GK G V K P K KI+K K F IE
Sbjct: 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKH-KPTQKLFVQKIIKA-----KNFN-AIE 58
Query: 396 I-ITTL--HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 452
+ L + N I L +L+ D++ G L + L K +E K+
Sbjct: 59 PMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK----LSEAEVKKI 114
Query: 453 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCT 510
+ EAL LH +IH D+K N+L D + + L D+GL K T S +
Sbjct: 115 IRQLVEALNDLHK---HNIIHNDIKLENVLY-DRAKDRIYLCDYGLCKIIGTPSCY---- 166
Query: 511 DVAGTFGYLAPEYFMYGKVNDKI---------DVYAFGVVLLELLTGRKPISNDH 556
D GT Y +PE KI D +A GV+ ELLTG+ P D
Sbjct: 167 D--GTLDYFSPE---------KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 69/213 (32%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 356 IGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI--------- 405
IGKG QVY+ D + A+K+L KE V + E+ T+ +NI
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK-----KEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 406 --ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 462
I L F F+ D++L LV D++S G L +L + ++ +A V ALE+
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED---RAKFYIAELVL-ALEH 111
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
LH +++RD+K NILL L DFGL+K A+ + + T T GT YLAPE
Sbjct: 112 LHK---YDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNT-FCGTTEYLAPE 166
Query: 523 YFM----YGKVNDKIDVYAFGVVLLELLTGRKP 551
+ Y K +D ++ GV++ E+ G P
Sbjct: 167 VLLDEKGYTK---HVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 355 LIGKGGSSQVYKGCL--PDGKEL--AVKILKP---SEDVIKEFVLEIEIITTLHHKNIIS 407
++G+G V +G L DG +L AVK +K + I+EF+ E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 408 LLGFCFEDNNL------LLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEA 459
L+G CFE ++L +++ F+ G L L ++ P K + +A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 460 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS----SHITCTDVAGT 515
+EYL S + IHRD+ + N +L +D ++DFGL+K + I V
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 180
Query: 516 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
++A E K DV+AFGV + E+ T G+ P
Sbjct: 181 --WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 31/220 (14%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 407
NFL ++GKG +V EL A+KILK +DV+ + + ++ T+ K +++
Sbjct: 3 NFLM--VLGKGSFGKVMLAERKGTDELYAIKILK--KDVV---IQDDDVECTMVEKRVLA 55
Query: 408 LLG---------FCFED-NNLLLVYDFLSRGSLEENLH--GNKKDPAAFGWSERYKVAMG 455
L G CF+ + L V ++++ G L + G K+P A + A
Sbjct: 56 LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY------AAE 109
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 515
+A L +LHS + +I+RD+K N++L + +++DFG+ K +T GT
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGT 164
Query: 516 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 555
Y+APE Y +D +AFGV+L E+L G+ P +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSED--VIKEFVLEIEIITTLHHKNIISLLGF 411
IG+G VYKG G+ +A+K I SE+ V + EI ++ L H NI+ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 412 CFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 468
+++ L L+++FLS L+ ++L + A S Y++ G+ + HS
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGIL----FCHS--- 119
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG- 527
+RV+HRD+K N+L+ + +L+DFGLA+ T V T Y APE +
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLLGSP 177
Query: 528 KVNDKIDVYAFGVVLLELLTGRKPI 552
+ + +D+++ G + E+ T +KP+
Sbjct: 178 RYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 54/229 (23%), Positives = 108/229 (47%), Gaps = 35/229 (15%)
Query: 349 NFLAENLIGKGGSSQVYKGC------LPDGKELAVKILK----PSEDVIKEFVLEIEIIT 398
N + +G+G +V K +AVK+LK SE +++ + E ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE--LRDLLSEFNLLK 58
Query: 399 TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYK------ 451
++H ++I L G C +D LLL+ ++ GSL L ++K P+ G
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 452 -----VAMG--------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498
+ MG ++ ++YL + +++HRD+ + N+L+++ + ++SDFGL++
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 499 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 547
S++ + ++A E + DV++FGV+L E++T
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 76/298 (25%), Positives = 122/298 (40%), Gaps = 60/298 (20%)
Query: 350 FLAENL-----IGKGGSSQVYKGCLPD-GKELAVKILKPSED--VIKEFVLEIEIITTLH 401
F AE+L IG+G V K G +AVK ++ + D K +++++++
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 402 H-KNIISLLG---------FCFE------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFG 445
I+ G C E D VY+ L + + E + G
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-KSVIPEEILG--------- 110
Query: 446 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505
K+A+ +AL YL ++IHRDVK SNILL + +L DFG++ S
Sbjct: 111 -----KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS-- 161
Query: 506 HITCTDVAGTFGYLAPEY---FMYGKVNDKIDVYAFGVVLLELLTGRKPISN-DHPKGQE 561
I T AG Y+APE + + DV++ G+ L E+ TG+ P + Q
Sbjct: 162 -IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
Query: 562 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
+ V+ P P L N+ + + V LC+ +D RP+ +L+
Sbjct: 221 TQVVKGDP------------PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 356 IGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIE-----IITTLHHKNIISLL 409
IGKG +V DGK AVK+L+ + K+ I ++ + H ++ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 410 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEALEYLHS 465
+ F+ + L V D+++ G L +L + P A F +E +A AL YLHS
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE-------IASALGYLHS 114
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 525
+I+RD+K NILL L+DFGL K S T + GT YLAPE
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLR 169
Query: 526 YGKVNDKIDVYAFGVVLLELLTGRKPI-SNDH 556
+ +D + G VL E+L G P S D
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT 201
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 66/239 (27%), Positives = 116/239 (48%), Gaps = 35/239 (14%)
Query: 384 EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK----K 439
ED KE VL + + H NI++ D +L +V ++ G L + + +
Sbjct: 43 EDSRKEAVL----LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFP 98
Query: 440 DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499
+ W ++ +GV +++H +RV+HRD+KS NI L+ + + +L DFG A+
Sbjct: 99 EDTILQWF--VQMCLGV----QHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149
Query: 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 559
++ ++ CT V GT Y+ PE + N+K D+++ G +L EL T + P +
Sbjct: 150 LTSPGAY-ACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--- 204
Query: 560 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 618
W IL KV Q L ++Y Y+ R ++ + +R+PR+RP + +L
Sbjct: 205 ------WKNLIL---KVCQGSYKPLPSHYSYEL--RSLIKQMF--KRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 21/206 (10%)
Query: 355 LIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLL 409
++GKG +V L G+ AVK+LK +D ++ + E I++ + ++ L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 410 GFCFED-NNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHS 465
CF+ + L V +F++ G L ++ +++ A F +E + AL +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE-------ITSALMFLHD 114
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 525
+ +I+RD+K N+LL + +L+DFG+ K + T + GT Y+APE
Sbjct: 115 ---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQ 169
Query: 526 YGKVNDKIDVYAFGVVLLELLTGRKP 551
+D +A GV+L E+L G P
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 347 TSNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKP----SEDVIKEFVLEIEIITTLH 401
NFL ++GKG +V EL A+KILK +D ++ ++E ++
Sbjct: 1 DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 402 HKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLH--GNKKDPAAFGWSERYKVAMGVAE 458
++ L CF+ + L V ++++ G L ++ G K+P A + A ++
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISV 112
Query: 459 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 518
L +LH + +I+RD+K N++L + +++DFG+ K +T GT Y
Sbjct: 113 GLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDY 167
Query: 519 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 555
+APE Y +D +A+GV+L E+L G+ P +
Sbjct: 168 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 47/133 (35%), Positives = 75/133 (56%), Gaps = 5/133 (3%)
Query: 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 479
LV D+ + G L + + K F E + + V A+ ++HS + +IHRD+KS+
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSA 172
Query: 480 NILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAF 538
NILL + +L DFG +K +A+T S + T GT Y+APE + + K D+++
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTPYYVAPEIWRRKPYSKKADMFSL 231
Query: 539 GVVLLELLTGRKP 551
GV+L ELLT ++P
Sbjct: 232 GVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 356 IGKGGSSQVY------KGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 409
+GKGG +V G L K+L K LK + V E I+ +H + I+SL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV-EKRILAKVHSRFIVSL- 58
Query: 410 GFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 468
+ F+ +L LV ++ G L +++ ++ F + LE+LH
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--- 115
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 528
+R+I+RD+K N+LL +D ++SD GLA AGT G++APE +
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 529 VNDKIDVYAFGVVLLELLTGRKP 551
+ +D +A GV L E++ R P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 2e-13
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 49/206 (23%)
Query: 372 GKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLLGF-------CFEDNNLLLV 421
G+++A+K I +D+I K + EI+++ L H+NII LL F D + +V
Sbjct: 25 GRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND--VYIV 82
Query: 422 YDFL---------SRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLHSGSAQRV 471
+ + S L + + + + + L+YLHS + V
Sbjct: 83 TELMETDLHKVIKSPQPLTD---------------DHIQYFLYQILRGLKYLHSAN---V 124
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC-TDVAGTFGYLAPEYFM----Y 526
IHRD+K SNIL++ + + ++ DFGLA+ T+ T Y APE + Y
Sbjct: 125 IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRY 184
Query: 527 GKVNDKIDVYAFGVVLLELLTGRKPI 552
K ID+++ G + ELLT RKP+
Sbjct: 185 TK---AIDIWSVGCIFAELLT-RKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 355 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEII-TTLHHKNIISLLG-- 410
++GKG +V L E A+K LK K+ VLE + + T+ + +++L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALK------KDVVLEDDDVECTMVERRVLALAWEH 55
Query: 411 ------FC-FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 462
FC F+ +L V ++L+ G L ++ + + F + A + L++
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR----FDEARARFYAAEIICGLQF 111
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
LH + +I+RD+K N+LL D +++DFG+ K + GT Y+APE
Sbjct: 112 LHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIAPE 166
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 555
K N+ +D ++FGV+L E+L G+ P +
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 53/165 (32%), Positives = 86/165 (52%), Gaps = 35/165 (21%)
Query: 401 HHKNIISLLGFCFEDNN--LLLVYDFLS-------RGSLEENLHGNKKDPAAFGWSERYK 451
H NI+ LL +N+ + LV++++ R ++ E++H +RY
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH------------KRY- 111
Query: 452 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST---SSSHIT 508
+ + +AL+Y+HSG VIHRD+K SNILL+ D +L+DFGLA+ S + +
Sbjct: 112 IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 509 CTDVAGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 549
TD T Y APE + Y K +D+++ G +L E+L G+
Sbjct: 169 LTDYVATRWYRAPEILLGSTRYTK---GVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 354 NLIGKGGSSQVYKGC-LPDGKELAVK-ILKP-SEDVIKEFVL-EIEI---ITTLHHKNII 406
IG+G VYK L G+ +A+K + P SE+ I L EI + + + H NI+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 407 SLLGFC-----FEDNNLLLVYDFLSRGSLEENLHGN-KKDPAAFGWSERYKVAMG-VAEA 459
LL C + L LV++ + +++L K P E K M +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 460 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 519
+++LHS R++HRD+K NIL++ D + +++DFGLA+ S + T V T Y
Sbjct: 120 VDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVTLWYR 173
Query: 520 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 552
APE + +D+++ G + EL R+P+
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAELFR-RRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 355 LIGKGGSSQVYKGC--LPDGKELAVKILK---PSEDVIKE---FVLEIEIITTLHHKNII 406
L+G+G +VY C + G+ELA K ++ S + KE EI+++ L H+ I+
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 407 SLLGFCFEDN---NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 463
G C D L + +++ GS+++ L K A S K + E + YL
Sbjct: 68 QYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEGMSYL 122
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST-SSSHITCTDVAGTFGYLAPE 522
HS ++HRD+K +NIL +L DFG +K T S V GT +++PE
Sbjct: 123 HS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
K DV++ G ++E+LT + P
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 38/211 (18%)
Query: 356 IGKGGSSQVYKGCLPDGKEL-AVKILK---PS-EDVIKEFVLEIEIITTL-HHKNIISLL 409
+G G VY + EL A+K +K S E+ + + E++ + L H NI+ L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNEHPNIVKLK 64
Query: 410 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYL 463
E++ L V++++ E NL+ KD +SE Y++ G L ++
Sbjct: 65 EVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQG----LAHI 115
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC----TDVAGTFGYL 519
H HRD+K N+L+S +++DFGLA+ I TD T Y
Sbjct: 116 HK---HGFFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRWYR 165
Query: 520 APEYFMY-GKVNDKIDVYAFGVVLLELLTGR 549
APE + + +D++A G ++ EL T R
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 28/206 (13%)
Query: 372 GKELAVKILKPSEDVIKEFV----LEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 426
GK A+KILK + K+ V E ++ H + +L + F+ ++ L V ++ +
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYAN 78
Query: 427 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 483
G L +L + +D A F +E + AL YLHS V++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFSEDRARFYGAE-------IVSALGYLHS---CDVVYRDLKLENLML 128
Query: 484 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGV 540
D +++DFGL K + + T GT YLAPE YG+ +D + GV
Sbjct: 129 DKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRA---VDWWGLGV 183
Query: 541 VLLELLTGRKPISN-DHPKGQESLVM 565
V+ E++ GR P N DH K E ++M
Sbjct: 184 VMYEMMCGRLPFYNQDHEKLFELILM 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 356 IGKGGSSQVYK-GCLPDGKELAVK--ILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGF 411
IG+G V+K G+ +A+K L+ E I L EI+ + H ++ LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
+ +LV +++ L E L +++ P + Y + + + Y+H A +
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLR-DEERPLPEAQVKSY--MRMLLKGVAYMH---ANGI 120
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG--KV 529
+HRD+K +N+L+S D +++DFGLA+ S + VA T Y APE +YG K
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPE-LLYGARKY 178
Query: 530 NDKIDVYAFGVVLLELLTGR 549
+ +D++A G + ELL G
Sbjct: 179 DPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 65/250 (26%), Positives = 102/250 (40%), Gaps = 55/250 (22%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKE-----FVLEIEIITTLH 401
+F +IG+G +V+ D ++ A+K+L+ S D+IK E +I+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKS-DMIKRNQIAHVRAERDILADAD 59
Query: 402 HKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE-- 458
I+ L + F+D +L LV +++ G L L +KD + Y +AE
Sbjct: 60 SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEETARFY-----IAELV 111
Query: 459 -ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK------------------- 498
AL+ +H IHRD+K NIL+ D +L+DFGL K
Sbjct: 112 LALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 499 --------WASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLT 547
+ GT Y+APE YG + D ++ GV+L E+L
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGL---ECDWWSLGVILYEMLY 225
Query: 548 GRKPISNDHP 557
G P +D
Sbjct: 226 GFPPFYSDTL 235
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 372 GKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 426
G+ A+KILK ++D + + E ++ H ++ L + F+ ++ L V ++ +
Sbjct: 20 GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP-FLTALKYSFQTHDRLCFVMEYAN 78
Query: 427 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 483
G L +L + +D A F +E + AL+YLHS + V++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFSEDRARFYGAE-------IVSALDYLHS--EKNVVYRDLKLENLML 129
Query: 484 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 543
D +++DFGL K + T GT YLAPE +D + GVV+
Sbjct: 130 DKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 187
Query: 544 ELLTGRKPISN-DHPKGQESLVM 565
E++ GR P N DH K E ++M
Sbjct: 188 EMMCGRLPFYNQDHEKLFELILM 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 17/214 (7%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILK---PSEDVIKE---FVLEIEIITTL 400
+N+ L+G+G +VY D G+ELAVK ++ S + KE EI+++ L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 401 HHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 458
H+ I+ G + + L + + + GS+++ L K A + K + E
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILE 117
Query: 459 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS-SHITCTDVAGTFG 517
+ YLHS ++HRD+K +NIL +L DFG +K T S V GT
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174
Query: 518 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
+++PE K D+++ G ++E+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 355 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIISL----- 408
++GKG +V L E+ A+K+LK +DVI + + ++ T+ K I++L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLK--KDVI---LQDDDVDCTMTEKRILALAAKHP 56
Query: 409 ----LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 463
L CF+ + L V ++++ G L + ++K F A V AL +L
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK----FDEPRSRFYAAEVTLALMFL 112
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523
H VI+RD+K NILL + +L+DFG+ K + +T T GT Y+APE
Sbjct: 113 HRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEI 167
Query: 524 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 556
+ +D +A GV++ E++ G+ P D+
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 372 GKELAVKILKPSEDVI---KEFVLEIEIITTLHHKNIISLL------GFCFEDNNLLLVY 422
GK++A+K + + DV K + E++I+ H NII++ G F+D + +V
Sbjct: 30 GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD--VYVVM 87
Query: 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 482
D L L +H ++ Y++ G L+Y+HS + VIHRD+K SN+L
Sbjct: 88 D-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRG----LKYIHSAN---VIHRDLKPSNLL 139
Query: 483 LSDDFEPQLSDFGLAKWASTSSSHIT--CTDVAGTFGYLAPE-YFMYGKVNDKIDVYAFG 539
+++D E ++ DFG+A+ S+S + T+ T Y APE + ID+++ G
Sbjct: 140 VNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVG 199
Query: 540 VVLLELLTGRKPI-SNDHPKGQESLVM 565
+ E+L GR+ + + Q L++
Sbjct: 200 CIFAEML-GRRQLFPGKNYVHQLKLIL 225
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVK-ILKPSED--VIKEFVLEIEIITTLHHKNIISLLGF 411
IG+G VYK G+ +A+K I +ED V + EI ++ L+H NI+ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
+N L LV++FL L+ + + + + + Y HS RV
Sbjct: 67 VHSENKLYLVFEFLD---LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRV 120
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK-VN 530
+HRD+K N+L+ + +L+DFGLA+ T V T Y APE + + +
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGSRQYS 178
Query: 531 DKIDVYAFGVVLLELLTGRKPI 552
+D+++ G + E++ R+P+
Sbjct: 179 TPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 372 GKELAVKILKPSEDVIKEFV-----LEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFL 425
GK A+K+LK + V K E +++ + + L + F+ D L L+ D++
Sbjct: 28 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYI 87
Query: 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 485
+ G L +L ++ F E + + ALE+LH +I+RD+K NILL
Sbjct: 88 NGGELFTHLSQRER----FKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDS 140
Query: 486 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDK-IDVYAFGVVLL 543
+ L+DFGL+K GT Y+AP+ G +DK +D ++ GV++
Sbjct: 141 NGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMY 199
Query: 544 ELLTGRKPISNDHPKGQES 562
ELLTG P + D K ++
Sbjct: 200 ELLTGASPFTVDGEKNSQA 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILK---PSEDVIKE---FVLEIEIITTLH 401
N+ L+G+G +VY D G+ELAVK + S++ KE EI+++ L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 402 HKNIISLLGFCFED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 458
H I+ G C D L + +++ GS+++ L K A + + + +
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQ 117
Query: 459 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST-SSSHITCTDVAGTFG 517
+ YLHS ++HRD+K +NIL +L DFG +K T S V GT
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 518 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
+++PE K DV++ ++E+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 39/106 (36%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 515
+ E L YLH AQR+IHRDVK+ NI ++D + + D G A++ + + + +AGT
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL---GLAGT 219
Query: 516 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 561
APE K N K D+++ G+VL E+L I D P E
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265
|
Length = 357 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 26/203 (12%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFV--LEIEIITTL-HHKNIISLLGF 411
IG+G S+V K GK A+K +K +++ EI+ + L H NI+ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 412 CFE--DNNLLLVYDFLSRGSLEENLH---GNKKDPAAFGWSERYKVAM-GVAEALEYLHS 465
F+ L LV++ + + NL+ +K P +R K M + ++L+++H
Sbjct: 67 LFDRKTGRLALVFELM-----DMNLYELIKGRKRPLP---EKRVKSYMYQLLKSLDHMH- 117
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 525
+ HRD+K NIL+ DD +L+DFG + S T+ T Y APE +
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCR---GIYSKPPYTEYISTRWYRAPECLL 171
Query: 526 Y-GKVNDKIDVYAFGVVLLELLT 547
G K+D++A G V E+L+
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 355 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKN---II 406
+IG+GG +VY GC GK A+K L +K+ L I+ +L I
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 407 SLLGFCFED-NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYL 463
+ + F + L + D ++ G L +L HG F E A + LE++
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHM 113
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523
H+ + V++RD+K +NILL + ++SD GLA S H + GT GY+APE
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 524 FMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESL 563
G D D ++ G +L +LL G P K + +
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 67/237 (28%), Positives = 99/237 (41%), Gaps = 53/237 (22%)
Query: 355 LIGKGGSSQVY----KGCLPDGKELAVKILKPSEDV----IKEFVLEIEIITTLHHKNII 406
L+GKG +V+ KG GK A+K+L E + +K + E EI+ TL H +
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLH---GN--KKDPAAFGWSERYKVAMGVAEALE 461
+L + L LV D+ G L L G ++ A F +E V ALE
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAE-------VLLALE 117
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA---------------STSSSH 506
YLH +++RD+K NILL + LSDF L+K + SS +
Sbjct: 118 YLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 507 ITCTDVA------------GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
++ GT Y+APE +D + G++L E+L G P
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 37/219 (16%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKE-FVL----EIEIITTLHHKNIISL 408
IG+G +V+K + +A+K +L +E KE F + EI+I+ L H+N+++L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNL 76
Query: 409 LGFCFED----NN----LLLVYDFLSRGSLEENLHGNKKDPAA-FGWSERYKVAMGVAEA 459
+ C N LV++F E +L G + F SE KV +
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFC-----EHDLAGLLSNKNVKFTLSEIKKVMKMLLNG 131
Query: 460 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS-SSHITC-TDVAGTFG 517
L Y+H +++HRD+K++NIL++ D +L+DFGLA+ S S +S T+ T
Sbjct: 132 LYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 518 YLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 552
Y PE + YG ID++ G ++ E+ T R PI
Sbjct: 189 YRPPELLLGERDYGP---PIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 57/220 (25%), Positives = 107/220 (48%), Gaps = 19/220 (8%)
Query: 356 IGKGGSSQVYK-GCLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLG 410
+G G V+K P G +A K++ KP+ + + + E++++ + I+ G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYG 70
Query: 411 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 470
+ D + + + + GSL++ L + P KV++ V + L YL +
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE--KHK 124
Query: 471 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 530
++HRDVK SNIL++ E +L DFG++ S ++ GT Y++PE +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYS 180
Query: 531 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 570
+ D+++ G+ L+E+ GR PI P +E +M+ P+
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFGCPV 218
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 50/230 (21%)
Query: 349 NFLAENLIGKGGSSQV----YKGCLPDGKELAVKILKPSEDVIKEFVLE----------- 393
LA ++G+G +V YK G+ A+K LK K ++
Sbjct: 2 RCLA--VLGRGHFGKVLLAEYK---KTGELYAIKALK------KGDIIARDEVESLMCEK 50
Query: 394 --IEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 450
E + H +++L CF+ ++++ V ++ + G L ++H + +SE
Sbjct: 51 RIFETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDV-------FSEPR 102
Query: 451 KV--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK---WASTSSS 505
V A V L+YLH ++++RD+K N+LL + +++DFGL K +S
Sbjct: 103 AVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159
Query: 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 555
C GT +LAPE +D + GV++ E+L G P D
Sbjct: 160 TF-C----GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 67/246 (27%), Positives = 106/246 (43%), Gaps = 29/246 (11%)
Query: 355 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKN---II 406
+IG+GG +VY GC GK A+K L +K+ L I+ +L I
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 407 SLLGFCFED-NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYL 463
+ + F + L + D ++ G L +L HG F +E A + LE++
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHM 113
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523
H+ + V++RD+K +NILL + ++SD GLA S H + GT GY+APE
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 524 FMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQ---ESLVMWAKPILSSGKVTQL 579
G D D ++ G +L +LL G P K + + + + L +L
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 226
Query: 580 LDPALG 585
G
Sbjct: 227 RSLLEG 232
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 355 LIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
++GKG VY L +A+K + + S V + EI + + L H+NI+ LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV-QPLHEEIALHSYLKHRNIVQYLGS 73
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
E+ + + + GSL L +K P + E L+YLH ++
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQI 129
Query: 472 IHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDV-AGTFGYLAPEYF----- 524
+HRD+K N+L++ ++SDFG +K + + CT+ GT Y+APE
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP---CTETFTGTLQYMAPEVIDKGPR 186
Query: 525 MYGKVNDKIDVYAFGVVLLELLTGRKP 551
YG D+++ G ++E+ TG+ P
Sbjct: 187 GYGA---PADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 459 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 518
L+Y+HS +IHRD+K SNI +++D E ++ DFGLA+ T T Y
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 181
Query: 519 LAPE-YFMYGKVNDKIDVYAFGVVLLELLTGR 549
APE + N +D+++ G ++ ELLTG+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 25/205 (12%)
Query: 356 IGKGGSSQVYKGCLPDGKEL-AVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
+G+G + VYKG E+ A+K L E + EI ++ L H+NI+ L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 413 FEDNNLLLVYDFLSRGSLEE--NLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
+N L+LV++++ L++ + HG + S Y++ G+A + H
Sbjct: 68 HTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA----FCHE---N 119
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKW----ASTSSSHITCTDVAGTFGYLAPEYFM 525
RV+HRD+K N+L++ E +L+DFGLA+ +T S+ + T Y AP+ +
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV------TLWYRAPDVLL 173
Query: 526 YGKV-NDKIDVYAFGVVLLELLTGR 549
+ + ID+++ G ++ E++TGR
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 72/280 (25%), Positives = 126/280 (45%), Gaps = 44/280 (15%)
Query: 349 NFLAENLIGKGGSSQVY---KGCLPD-GKELAVKILKPSEDVIKEFVLE-----IEIITT 399
NF ++G G +V+ K D GK A+K+L+ + V K +E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 400 LHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGN---KKDPAAFGWSERYKVAMG 455
+ + L + F+ + L L+ D++S G + +L+ +D F E
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGE------- 113
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 515
+ ALE+LH +++RD+K NILL + L+DFGL+K + T + GT
Sbjct: 114 IILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGT 169
Query: 516 FGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 571
Y+APE +GK +D ++ G+++ ELLTG P + + + +S V ++ IL
Sbjct: 170 IEYMAPEIIRGKGGHGKA---VDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRIL 224
Query: 572 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRAR 611
K +G + +L +L +DP+ R
Sbjct: 225 ---KCDPPFPSFIG------PEAQDLLHKLLR--KDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 65/206 (31%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 355 LIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVI------KEFVLEIEII-TTLHHKNII 406
+IGKG +V DGK AVK+L+ + ++ K + E ++ + H ++
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQ--KKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 407 SLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 465
L + F+ L V DF++ G L +L + P R+ A +A AL YLHS
Sbjct: 60 GL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAAE-IASALGYLHS 114
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 525
+++RD+K NILL L+DFGL K S T T GT YLAPE
Sbjct: 115 ---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIR 169
Query: 526 YGKVNDKIDVYAFGVVLLELLTGRKP 551
++ +D + G VL E+L G P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 44/227 (19%)
Query: 348 SNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL----EIEIITTLHH 402
+ + IG+G V P G ++A+K + P E F EI+I+ H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT--FCQRTLREIKILRRFKH 62
Query: 403 KNIISLLGF----CFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER-------- 449
+NII +L FE N++ +V + + E +L+ K ++
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIK-------TQHLSNDHIQY 110
Query: 450 --YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH- 506
Y++ G L+Y+HS + V+HRD+K SN+LL+ + + ++ DFGLA+ A H
Sbjct: 111 FLYQILRG----LKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163
Query: 507 ITCTDVAGTFGYLAPEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPI 552
T+ T Y APE + K K ID+++ G +L E+L+ R P+
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 51/191 (26%), Positives = 93/191 (48%), Gaps = 26/191 (13%)
Query: 380 LKPSEDVIKEFVLEIEIITTLHHKN---IISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 436
+KP+ + + + E+++ LH N I+ G + D + + + + GSL++ L
Sbjct: 38 IKPA--IRNQIIRELKV---LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 92
Query: 437 NKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 494
+ P E K+++ V L YL +++HRDVK SNIL++ E +L DF
Sbjct: 93 AGRIP------ENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDF 144
Query: 495 GLAKWA--STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 552
G++ S ++S + GT Y++PE + D+++ G+ L+E+ GR PI
Sbjct: 145 GVSGQLIDSMANSFV------GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
Query: 553 SNDHPKGQESL 563
K E++
Sbjct: 199 PPPDAKELEAM 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-11
Identities = 58/192 (30%), Positives = 92/192 (47%), Gaps = 22/192 (11%)
Query: 372 GKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL--GFCFEDNNLLLVYDFL 425
G E+A+K+L+ E F E + L+H NI++LL G L V++++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS- 484
+L E L + PA E ++ + V +AL H Q ++HRD+K NI++S
Sbjct: 62 PGRTLREVLAADGALPAG----ETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQ 114
Query: 485 DDFEP--QLSDFGLAKWAS----TSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYA 537
P ++ DFG+ + +T T+V GT Y APE V D+YA
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 538 FGVVLLELLTGR 549
+G++ LE LTG+
Sbjct: 175 WGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 350 FLAENLIGKGGSSQVYKGCLPDGK-----ELAVKILK--PSEDVIKEFVLEIEIITTLHH 402
+L+ +G +++ G L D K E+ VK +K SE + + E ++ L H
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67
Query: 403 KNIISLLGFCFEDNNLLLV-YDFLSRGSLEENL----HGNKKDPAAFGWSERYKVAMG-- 455
+NI+ +L C ED V Y +++ G+L+ L G +P A S + V M
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL--STQQLVHMAIQ 125
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 515
+A + YLH + VIH+D+ + N ++ ++ + +++D L++ H +
Sbjct: 126 IACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 516 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 547
++A E + + + DV++FGV+L EL+T
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 70/296 (23%), Positives = 128/296 (43%), Gaps = 45/296 (15%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNIISLLGFC 412
+GKG VYK P G +A+K ++ D K + ++E++I+ I+ G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 472
F + + + +++ GSL++ L+ ++ V + L++L +I
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNII 125
Query: 473 HRDVKSSNILLSDDFEPQLSDFGLAK--WASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 530
HRDVK +N+L++ + + +L DFG++ AS + ++I C Y+APE G N
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS------YMAPERIKSGGPN 179
Query: 531 DKI------DVYAFGVVLLELLTGRKPI---SNDHPKGQESLVMWAKPILSSGKVTQLLD 581
DV++ G+ +LE+ GR P + + Q S ++ P
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------------ 227
Query: 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL------KLLRGDADVTKWA 631
P L + Y D + + C+ + P RP + +L K D D+ +W
Sbjct: 228 PTLPSGYSDDAQDFVA----KCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWV 279
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEF--VLEIEIITTLHHKNIISLLGFC 412
+G+G + VYKG +GK +A+K+++ E+ F + E ++ L H NI+ L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 472
L LV++++ + K P + L Y+H + ++
Sbjct: 73 HTKETLTLVFEYVHTDLCQYM----DKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYIL 125
Query: 473 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVND 531
HRD+K N+L+SD E +L+DFGLA+ A + SH +V T Y P+ + + +
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 532 KIDVYAFGVVLLELLTG 548
+D++ G + +E++ G
Sbjct: 184 CLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 31/213 (14%)
Query: 356 IGKGGSSQVY----KGCLPDGKE--LAVKILKPSEDVIK--EFVLEIEIITTLHHKNIIS 407
+G+G VY KG + D E +A+K + + + + EF+ E ++ + +++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP------AAFGWSERYKVAMGVAEALE 461
LLG + L++ + ++RG L+ L + + A + ++A +A+ +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG---- 517
YL +A + +HRD+ + N ++++DF ++ DFG+ + I TD G
Sbjct: 134 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------DIYETDYYRKGGKGLL 183
Query: 518 ---YLAPEYFMYGKVNDKIDVYAFGVVLLELLT 547
+++PE G DV++FGVVL E+ T
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 49/206 (23%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 353 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 406
E ++G G ++ +GCL P +EL A+ L+ S+ + F+ E + H NI+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
L G N +++V +++S G+L+ L +K + + G+A ++YL
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYL--- 123
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 526
S +H+ + + +L++ D ++S F + + + + T + + + APE Y
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-WAAPEAIQY 182
Query: 527 GKVNDKIDVYAFGVVLLELLT-GRKP 551
+ DV++FG+V+ E+++ G +P
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 31/215 (14%)
Query: 355 LIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISL----- 408
++GKG +V L G+ AVK LK +DV+ +++ ++ T+ K +++L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALK--KDVV---LIDDDVECTMVEKRVLALAWENP 56
Query: 409 ----LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---AL 460
L F+ +L V +FL+ G L ++ +D F + Y+ AE L
Sbjct: 57 FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI----QDKGRF---DLYRATFYAAEIVCGL 109
Query: 461 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 520
++LHS + +I+RD+K N++L D +++DFG+ K + + GT Y+A
Sbjct: 110 QFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIA 164
Query: 521 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 555
PE K +D ++FGV+L E+L G+ P D
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 355 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSE--DVIKEFVL-EIEIITTLHHKNIISLLG 410
++G+G V K + KE+ A+K K SE + +KE L E++++ TL +NI+ L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 411 FCFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 467
L LV++++ + LE E +G + KV + + ++ +H
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE----------KVRSYIYQLIKAIHWCH 117
Query: 468 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 527
++HRD+K N+L+S + +L DFG A+ S S+ T+ T Y +PE +
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGA 176
Query: 528 KVNDKIDVYAFGVVLLELLTGR 549
+D+++ G +L EL G+
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 52/212 (24%), Positives = 102/212 (48%), Gaps = 15/212 (7%)
Query: 348 SNFLAENLIGKGGSSQVYKGC-LPDGKEL----AVKILK--PSEDVIKEFVLEIEIITTL 400
+ F ++G G VYKG +P+G+++ A+K L+ S KE + E ++ ++
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 401 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 460
+ ++ LLG C + + L+ + G L + + +K + G + +A+ +
Sbjct: 67 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGM 122
Query: 461 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 520
YL +R++HRD+ + N+L+ +++DFGLAK ++A
Sbjct: 123 NYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 521 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
E ++ + DV+++GV + EL+T G KP
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 355 LIGKGGSSQVYKGC-LPDGKEL----AVKILK--PSEDVIKEFVLEIEIITTLHHKNIIS 407
++G G VYKG +PDG+ + A+K+L+ S KE + E ++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 467
LLG C + + LV + G L + + NK G + + +A+ + YL
Sbjct: 74 LLGICLT-STVQLVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEE-- 127
Query: 468 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 527
R++HRD+ + N+L+ +++DFGLA+ + ++A E ++
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 528 KVNDKIDVYAFGVVLLELLT-GRKP 551
+ + DV+++GV + EL+T G KP
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 54/187 (28%), Positives = 91/187 (48%), Gaps = 24/187 (12%)
Query: 376 AVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEEN 433
AVK+L+P ++F+ E++I++ L NI LLG C D L ++ +++ G L +
Sbjct: 50 AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQF 109
Query: 434 LHGNKKDPAAFGWSERYK-------VAMGV--AEALEYLHSGSAQRVIHRDVKSSNILLS 484
L K G + K + M A + YL S +HRD+ + N L+
Sbjct: 110 LQ--KHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVG 164
Query: 485 DDFEPQLSDFGLAKWASTSSSHITCTDVAGT----FGYLAPEYFMYGKVNDKIDVYAFGV 540
++ +++DFG+++ +S + V G ++A E + GK K DV+AFGV
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYY----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220
Query: 541 VLLELLT 547
L E+LT
Sbjct: 221 TLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 37/222 (16%)
Query: 355 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLE---IEIITTLHH-----KNI 405
+IG+G ++V L + + A+K++K KE V + I+ + T H N
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIK------KELVNDDEDIDWVQTEKHVFETASNH 55
Query: 406 ISLLGF--CFE-DNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEA 459
L+G CF+ ++ L V +F+S G L ++ +K P A F +E ++ A
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAE-------ISLA 108
Query: 460 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 519
L +LH +I+RD+K N+LL + +L+D+G+ K T + GT Y+
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYI 163
Query: 520 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI----SNDHP 557
APE +D +A GV++ E++ GR P +D+P
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 76/307 (24%), Positives = 121/307 (39%), Gaps = 61/307 (19%)
Query: 355 LIGK----GGSSQVYKGCLPDGKELAVKILKPSEDVIKEFV-LEIEIITT--LHHKNIIS 407
LIGK + K P +AVK + ++ L+ EIIT+ L H NI+
Sbjct: 5 LIGKCFEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 408 LLGFCF-EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVAEALEYL 463
+ F D+ L +V ++ GS E+ L + + G E + + V AL+Y+
Sbjct: 64 YV-TSFIVDSELYVVSPLMAYGSCEDLLKTHFPE----GLPELAIAF-ILKDVLNALDYI 117
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-----Y 518
HS + IHR VK+S+ILLS D + LS + +
Sbjct: 118 HS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174
Query: 519 LAPEYF---MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 575
L+PE + G N+K D+Y+ G+ EL G P + M + + G
Sbjct: 175 LSPEVLQQNLQG-YNEKSDIYSVGITACELANGHVPFKDMPA-----TQMLLEKV--RGT 226
Query: 576 VTQLLD---------------PALGNNYDYDQMERMVLASI---------LCIRRDPRAR 611
V LLD + + + D ++ + LC++RDP +R
Sbjct: 227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESR 286
Query: 612 PQMSLVL 618
P S +L
Sbjct: 287 PSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 16/166 (9%)
Query: 412 CFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 470
CF+ + L LV ++++ G L ++ +K P R+ A + AL +LH +
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHA---RFYAAE-ICIALNFLHE---RG 116
Query: 471 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 530
+I+RD+K N+LL D +L+D+G+ K T + GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYG 174
Query: 531 DKIDVYAFGVVLLELLTGRKP--ISNDHP--KGQESL--VMWAKPI 570
+D +A GV++ E++ GR P I D+P ++ L V+ KPI
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 59/192 (30%), Positives = 99/192 (51%), Gaps = 22/192 (11%)
Query: 372 GKELAVK-ILKP-SEDVI-KEFVLEIEIITTLHHKNIISLLG-FCFEDNNLLLVYDFLSR 427
G+ +A+K I+KP S V+ K E++++ L H+NIISL F ++ V + L
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT 94
Query: 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 487
L L + F Y++ G L+Y+HS V+HRD+K SNIL++++
Sbjct: 95 -DLHRLLTSRPLEKQ-FIQYFLYQILRG----LKYVHSAG---VVHRDLKPSNILINENC 145
Query: 488 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELL 546
+ ++ DFGLA+ + T T Y APE + + K + ++D+++ G + E+L
Sbjct: 146 DLKICDFGLAR---IQDPQM--TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
Query: 547 TGRKPI--SNDH 556
G KP+ DH
Sbjct: 201 EG-KPLFPGKDH 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 42/201 (20%)
Query: 372 GKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLLGFC-------FEDNNLLLV 421
+++A+K I ++ I K + EI+++ L H+N+I++ F D + +V
Sbjct: 30 NEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND--VYIV 87
Query: 422 YDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQRVIHRD 475
Y+ + + +LH + S+ Y++ G L+Y+HS + V+HRD
Sbjct: 88 YELM-----DTDLHQIIRSSQTL--SDDHCQYFLYQLLRG----LKYIHSAN---VLHRD 133
Query: 476 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM----YGKVND 531
+K SN+LL+ + + ++ DFGLA+ +TS T+ T Y APE + Y
Sbjct: 134 LKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTA-- 189
Query: 532 KIDVYAFGVVLLELLTGRKPI 552
IDV++ G + ELL GRKP+
Sbjct: 190 -IDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 14/151 (9%)
Query: 412 CFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 470
CF+ ++ L V ++++ G L ++ +K P R+ A ++ AL YLH +
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA---RFYSAE-ISLALNYLHE---RG 116
Query: 471 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 530
+I+RD+K N+LL + +L+D+G+ K T + GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYG 174
Query: 531 DKIDVYAFGVVLLELLTGRKPI----SNDHP 557
+D +A GV++ E++ GR P S+D+P
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 54/200 (27%), Positives = 101/200 (50%), Gaps = 17/200 (8%)
Query: 356 IGKGGSSQVYKG--CLPDGKELAVKI-LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
+G+G + VYKG L D +I L+ E + E+ ++ L H NI++L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 413 FEDNNLLLVYDFLSRGSLEENLH--GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 470
+ +L LV+++L + L++ L GN + + V + + + L L+ ++
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDCGNSIN--------MHNVKLFLFQLLRGLNYCHRRK 124
Query: 471 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKV 529
V+HRD+K N+L+++ E +L+DFGLA+ S + T ++ T Y P+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDY 182
Query: 530 NDKIDVYAFGVVLLELLTGR 549
+ +ID++ G + E+ TGR
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 393 EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 452
E +I+ ++H ++L G +++ L LV +F+ G L NK+ P G ++
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140
Query: 453 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 512
+ EYL S +++RD+K N+LL D +++DFG AK T ++ C
Sbjct: 141 VL----IFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTYTLC--- 189
Query: 513 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557
GT Y+APE + D + G+ + E+L G P + P
Sbjct: 190 -GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 356 IGKGGSSQV------YKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 409
+GKGG +V G + K+L K LK K +LE EI+ ++ I++L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGE-KMALLEKEILEKVNSPFIVNL- 58
Query: 410 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 468
+ FE +L LV ++ G L+ H + + + +LHS
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLHS--- 113
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 528
+++RD+K N+LL D +LSD GLA T T AGT GY+APE
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEP 170
Query: 529 VNDKIDVYAFGVVLLELLTGRKPISNDHPK 558
+ +D +A G + E++ GR P + K
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 66/272 (24%), Positives = 119/272 (43%), Gaps = 44/272 (16%)
Query: 356 IGKGGSSQVYKGCL---PD------GKELAV--KILKPSEDVIKEFVLEIEIITTLHHKN 404
+G+G + +YKG L D G+E++V K+L F +++ L HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
++ L G C D N ++V +++ G L+ LH K + + W + VA +A AL YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSL-HW--KLDVAKQLASALHYLE 118
Query: 465 SGSAQRVIHRDVKSSNILL---SDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFG 517
++++H +V NIL+ + LSD G+ + +
Sbjct: 119 D---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE------RIP 169
Query: 518 YLAPEYFMYGKVNDKI--DVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK----PI 570
++APE G+ + I D ++FG LLE+ + G +P+S E + P+
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKERFYQDQHRLPM 227
Query: 571 LSSGKVTQLLDPALGNNYDYDQMERMVLASIL 602
++ L++ + YD +R +IL
Sbjct: 228 PDCAELANLIN----QCWTYDPTKRPSFRAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 64/252 (25%), Positives = 103/252 (40%), Gaps = 50/252 (19%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVL----EIEIITTLHH 402
+F + +IG+G +V D G A+K L+ SE + KE V E +I+ +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 403 KNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 461
++ L + F+D N L L+ ++L G + L KKD + Y +AE +
Sbjct: 61 PWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFY-----IAETIL 112
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL----------------AKWASTSSS 505
+ S IHRD+K N+LL +LSDFGL + ++
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 506 HITCT--------------------DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 545
GT Y+APE F+ N + D ++ GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 546 LTGRKPISNDHP 557
L G P +D+P
Sbjct: 233 LVGYPPFCSDNP 244
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 54/189 (28%), Positives = 89/189 (47%), Gaps = 26/189 (13%)
Query: 372 GKELAVKIL-KPSEDVI--KEFVLEIEIITTLHHKNIISLLGF-----CFEDNNLLLVYD 423
G +AVK L +P + +I K E+ ++ + H+N+I LL E+ N + +
Sbjct: 42 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101
Query: 424 FLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 481
L L + K D F + + L+Y+HS +IHRD+K SN+
Sbjct: 102 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSAD---IIHRDLKPSNL 151
Query: 482 LLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGV 540
+++D E ++ DFGLA+ T T Y APE + + N +D+++ G
Sbjct: 152 AVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 206
Query: 541 VLLELLTGR 549
++ ELLTGR
Sbjct: 207 IMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 35/94 (37%), Positives = 55/94 (58%), Gaps = 6/94 (6%)
Query: 459 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA-STSSSHITCTDVAGTFG 517
AL+Y+H+ + V HRD+K NIL + D + ++ DFGLA+ A + + + I TD T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 518 YLAPEY--FMYGKVNDKIDVYAFGVVLLELLTGR 549
Y APE + K ID+++ G + E+LTG+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 53/169 (31%), Positives = 75/169 (44%), Gaps = 22/169 (13%)
Query: 406 ISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
I L + F+D+ L +V +++ G L NL N P W+ Y V AL+ +H
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLV-NLMSNYDIPEK--WARFY--TAEVVLALDAIH 159
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEY 523
S IHRDVK N+LL +L+DFG K + C GT Y++PE
Sbjct: 160 S---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR--CDTAVGTPDYISPEV 214
Query: 524 FM-------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 565
YG+ + D ++ GV L E+L G P D G S +M
Sbjct: 215 LKSQGGDGYYGR---ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 28/223 (12%)
Query: 349 NFLAENLIGKG--GSSQVYKGCLPDGKELAVKILKPSEDVIKEFVL----EIEIITTLHH 402
+F ++L+G+G G QV + G A+K++K S + +E V E +I++ +
Sbjct: 2 DFDVKSLVGRGHFGEVQVVRE-KATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 403 KNIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 461
I L + F+D NL LV ++ G L +L +D ++ Y +AE +
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLL-SLLNRYEDQFDEDMAQFY-----LAELVL 113
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 521
+HS +HRD+K N+L+ +L+DFG A T++ + GT Y+AP
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAP 172
Query: 522 EYF---------MYGKVNDKIDVYAFGVVLLELLTGRKPISND 555
E YG + D ++ GV+ E++ GR P
Sbjct: 173 EVLTTMNGDGKGTYGV---ECDWWSLGVIAYEMIYGRSPFHEG 212
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 3e-10
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 36/207 (17%)
Query: 373 KELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN--LLLVYDFLSRGSL 430
K ++ + LK E + V+E+ ++ L HKNI+ + N L ++ +F G L
Sbjct: 44 KAISYRGLKEREK--SQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDL 101
Query: 431 EENLHGNKKDPAAFGWSERY---KVAMGVAEALEYLHS----GSAQRVIHRDVKSSNILL 483
N+ K FG E + + + AL Y H+ + +RV+HRD+K NI L
Sbjct: 102 SRNIQKCYK---MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158
Query: 484 SDDFE-----------------PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 526
S ++ DFGL+K S +C GT Y +PE ++
Sbjct: 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCV---GTPYYWSPELLLH 215
Query: 527 --GKVNDKIDVYAFGVVLLELLTGRKP 551
+DK D++A G ++ EL +G+ P
Sbjct: 216 ETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 356 IGKGGSSQVYKGCLPDGKEL-AVK--ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
+G+G + V+KG + L A+K L+ E + E+ ++ L H NI++L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLHSGSAQRV 471
D +L LV+++L +++L D K+ + + L Y H ++V
Sbjct: 74 HTDKSLTLVFEYL-----DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKV 125
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVN 530
+HRD+K N+L+++ E +L+DFGLA+ S + T ++ T Y P+ + + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 531 DKIDVYAFGVVLLELLTGR 549
+ID++ G + E+ +GR
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 10/167 (5%)
Query: 393 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 451
E +I+ ++ + ++SL + +E + L LV ++ G L+ H A F
Sbjct: 50 EKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEGRAVF 106
Query: 452 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 511
A + LE LH +R+++RD+K NILL D ++SD GLA T
Sbjct: 107 YAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKG 160
Query: 512 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 558
GT GY+APE + D +A G +L E++ G+ P K
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 37/99 (37%), Positives = 58/99 (58%), Gaps = 11/99 (11%)
Query: 459 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS----SSHITCTDVAG 514
L+Y+HS + V+HRD+K N+L++ D E ++ DFGLA+ S + + + T+
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM--TEYVA 171
Query: 515 TFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPI 552
T Y APE + + IDV++ G +L ELL GRKP+
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 44/124 (35%), Positives = 62/124 (50%), Gaps = 25/124 (20%)
Query: 454 MGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----- 505
M AE ALEYLH+ ++HRD+K N+L++ +L+DFGL+K S +
Sbjct: 105 MYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE 161
Query: 506 -HITC-------TDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISN 554
HI V GT Y+APE + YGK +D +A G++L E L G P
Sbjct: 162 GHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYEFLVGCVPFFG 218
Query: 555 DHPK 558
D P+
Sbjct: 219 DTPE 222
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 5e-10
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 356 IGKGGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISL--LGF 411
+G+G VYK DGK+ LK E + EI ++ L H N+I+L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 412 CFEDNNLLLVYDFLSRG-----SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
D + L++D+ NKK P S + + + + YLH
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKK-PMQLPRSMVKSLLYQILDGIHYLH-- 125
Query: 467 SAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAP 521
A V+HRD+K +NIL+ + +++D G A+ ++ + D V TF Y AP
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 522 EYFMYGKVNDK-IDVYAFGVVLLELLTGRKPI 552
E + + K ID++A G + ELLT +PI
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 356 IGKGGSSQVYKGCLPDGKELA----VKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
IG+G V+K + E+ V++ E V + EI ++ L HKNI+ L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 412 CFEDNNLLLVYDFLSRG--SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
D L LV+++ + ++ +G DP S +++ G+A + HS
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNG-DIDPEIVK-SFMFQLLKGLA----FCHS---H 118
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 529
V+HRD+K N+L++ + E +L+DFGLA+ + V T Y P+ K+
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKL 176
Query: 530 ND-KIDVYAFGVVLLELLTGRKPI 552
ID+++ G + EL +P+
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 356 IGKGGSSQVYKGCLPD-GKELA---VKILKPSEDVIKEFVLEIEIITTLH---HKNIISL 408
IG G VYK P G +A V++ + + V E+ ++ L H NI+ L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 409 LGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEY 462
+ C + + LV++ + + L L K P +E K M L++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYL---DKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
LH A ++HRD+K NIL++ + +L+DFGLA+ S + T V T Y APE
Sbjct: 124 LH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLWYRAPE 177
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLTGRKPI 552
+ +D+++ G + E+ RKP+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 42/230 (18%)
Query: 354 NLIGKGGSSQVYKGC-LPDGKELAVKILKPSE---DVIKE----------FVL--EIEII 397
+G+G +V K GK +A+K +K E DV K+ F E++I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 398 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK--VAMG 455
+ H+NI+ L+ E + + LV D ++ L++ + + +E + +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR------LTESQVKCILLQ 127
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG- 514
+ L LH +HRD+ +NI ++ +++DFGLA+ T +
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 515 -----------TFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPI 552
T Y APE M K + +D+++ G + ELLTG KP+
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233
|
Length = 335 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 356 IGKGGSSQVYKG--CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
+G+G + VYKG L G+ +A+K L+ E + E ++ L H NI++L
Sbjct: 13 LGEGSYATVYKGRSKL-TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 412 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPA---AFGWSERYKVAMGVAEALEYLHSG 466
L LV+++L L++ + G F +++ G L Y H
Sbjct: 72 IHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLF----LFQLLRG----LAYCHQ- 121
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 526
+RV+HRD+K N+L+S+ E +L+DFGLA+ A + S +V T Y P+ +
Sbjct: 122 --RRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVV-TLWYRPPDVLL- 176
Query: 527 GKVN--DKIDVYAFGVVLLELLTGR 549
G +D++ G + E+ TGR
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 27/253 (10%)
Query: 371 DGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLL-GFCFEDNNLLLVYDFLS 426
DGK+ +K L S K E ++++ L H NI++ + ED L +V F
Sbjct: 24 DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83
Query: 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 486
G L L K ++ + + +A AL+YLH + ++HRD+K+ N+ L+
Sbjct: 84 GGDLYHKLKEQKGK--LLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRT 138
Query: 487 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 546
++ D G+A+ + + + GT Y++PE F N K DV+A G + E+
Sbjct: 139 NIIKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMA 196
Query: 547 TGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRR 606
T + + K SLV + GK+ + P DY ++A++L +
Sbjct: 197 TLKHAFN---AKDMNSLVYR----IIEGKLPPM--PK-----DYSPELGELIATMLS--K 240
Query: 607 DPRARPQMSLVLK 619
P RP + +L+
Sbjct: 241 RPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 355 LIGKGGSSQVY---KGCLPDGKELAVKILKPSEDVIKEFVLEIE-----IITTLHHKNII 406
+IGKG +V + DG AVK+L+ + K+ I ++ L H ++
Sbjct: 2 VIGKGSFGKVLLAKRKS--DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 407 SLLGFCFED-NNLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYL 463
L + F+ L V D+++ G L +L + +P A R+ A VA A+ YL
Sbjct: 60 GL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRA-----RFYAAE-VASAIGYL 112
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523
HS +I+RD+K NILL L+DFGL K T + GT YLAPE
Sbjct: 113 HS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEV 167
Query: 524 FMYGKVNDKIDVYAFGVVLLELLTGRKP 551
+ +D + G VL E+L G P
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 42/161 (26%), Positives = 80/161 (49%), Gaps = 12/161 (7%)
Query: 391 VLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 450
+ E+ ++ L H NI++L + L LV+++L + +L +
Sbjct: 51 IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-----DSDLKQYLDNCGNLMSMHNV 105
Query: 451 KVAM-GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 509
K+ M + L Y H ++++HRD+K N+L+++ E +L+DFGLA+ S + T
Sbjct: 106 KIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TY 160
Query: 510 TDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGR 549
++ T Y P+ + + + ID++ G +L E+ TGR
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 9e-10
Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 17/213 (7%)
Query: 356 IGKGGSSQVYKGCLPDGKELA---VKILKPSEDVIKE--FVLEIEIITTLHHKNIISLLG 410
IG G +V G G A VK L+ S ++ F+ E++ L+H N++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 411 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE-RYKVAMGVAEALEYLHSGSAQ 469
C E LLV +F G L+ L N+ A + ++A VA L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY------ 523
IH D+ N L+ D ++ D+GLA +IT A +LAPE
Sbjct: 121 -FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 524 -FMYGKVNDKIDVYAFGVVLLELLT-GRKPISN 554
+ K ++++ GV + EL T +P +
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 20/212 (9%)
Query: 356 IGKGGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISL--LGF 411
+G+G VYK DGK+ LK E + EI ++ L H N+ISL +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 412 CFEDNNLLLVYDFLSRG-----SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
D + L++D+ NKK P + + + + YLH
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKK-PVQLPRGMVKSLLYQILDGIHYLH-- 125
Query: 467 SAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAP 521
A V+HRD+K +NIL+ + +++D G A+ ++ + D V TF Y AP
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 522 EYFMYGKVNDK-IDVYAFGVVLLELLTGRKPI 552
E + + K ID++A G + ELLT +PI
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 356 IGKGGSSQVYKGC-LPDGKELA----VKILKPSEDVIKEFVLEIEII---TTLHHKNIIS 407
IG+G +V+K L +G V++ E + + E+ ++ T H N++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 408 LLGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALE 461
L C + L LV++ + + L L K P +E K M + L+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL---DKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 521
+LHS RV+HRD+K NIL++ + +L+DFGLA+ S + T V T Y AP
Sbjct: 125 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAP 178
Query: 522 EYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 552
E + +D+++ G + E+ RKP+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 64/291 (21%), Positives = 125/291 (42%), Gaps = 48/291 (16%)
Query: 356 IGKGGSSQVYKGCLPD------GKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNIIS 407
+G+G VY+G D +AVK + S + + EF+ E ++ +++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA------AFGWSERYKVAMGVAEALE 461
LLG + L+V + ++ G L+ L + + E ++A +A+ +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG---- 517
YL +A++ +HRD+ + N +++ DF ++ DFG+ + I TD G
Sbjct: 134 YL---NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-------DIYETDYYRKGGKGLL 183
Query: 518 ---YLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSS 573
++APE G D+++FGVVL E+ + +P LS+
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG----------------LSN 227
Query: 574 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624
+V + + + + ER+ +C + +P+ RP ++ LL+ D
Sbjct: 228 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 40/173 (23%), Positives = 82/173 (47%), Gaps = 8/173 (4%)
Query: 373 KELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 432
KE+ V L P+E V + E ++++ L H I+ E + ++ ++ L+
Sbjct: 34 KEIPVGELNPNETV--QANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDC 91
Query: 433 NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 492
L K ++ + + + + Y+H +R++HRD+K+ NI L ++ ++
Sbjct: 92 KLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIG 147
Query: 493 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 545
DFG+++ S T GT Y++PE + + K D+++ G +L E+
Sbjct: 148 DFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKI--LKPSEDVIKEFVLEIEIITTLHH 402
A +++L +G+G + VYKG +G+ +A+K+ +K E V + E ++ L H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 403 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 462
NI+ L L V++++ L + + + P + L Y
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYM-HTDLAQYM---IQHPGGLHPYNVRLFMFQLLRGLAY 118
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
+H Q ++HRD+K N+L+S E +L+DFGLA+ S S + V T Y P+
Sbjct: 119 IHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD 173
Query: 523 YFMYG-KVNDKIDVYAFGVVLLELLTGR 549
+ + +D++ G + +E+L G+
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 71/264 (26%), Positives = 111/264 (42%), Gaps = 28/264 (10%)
Query: 322 KELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKG--GSSQVYKGCLPDGKELAVKI 379
K ++ +Y T + +DL ++ +IG+G G Q+ + K A+K+
Sbjct: 19 KNIDNFLNRYKDT--INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR-KVYAMKL 75
Query: 380 LKPSEDVIKE---FVLEIEIITTLHHKNIISLLGFCFEDNNLL-LVYDFLSRGSLEENLH 435
L E + + F E I + + L + F+D+ L +V +++ G L NL
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLM 134
Query: 436 GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 495
N P W+ Y V AL+ +HS IHRDVK N+LL +L+DFG
Sbjct: 135 SNYDVPEK--WARFYTAE--VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG 187
Query: 496 LAKWASTSSSHITCTDVAGTFGYLAPEYF-------MYGKVNDKIDVYAFGVVLLELLTG 548
+ C GT Y++PE YG+ + D ++ GV L E+L G
Sbjct: 188 TCM-KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR---ECDWWSVGVFLYEMLVG 243
Query: 549 RKPISNDHPKGQESLVMWAKPILS 572
P D G S +M K L+
Sbjct: 244 DTPFYADSLVGTYSKIMNHKNSLT 267
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 393 EIEIITTLHHKNIISLLGFCFEDN--NLLLVYDFLSRGSLEENLHG---NKKDPAAFGWS 447
EI I+ L H NI+++ N + +V +++ E +L K P F S
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV-----EHDLKSLMETMKQP--FLQS 106
Query: 448 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507
E + + + + +LH ++HRD+K+SN+LL++ ++ DFGLA+ +
Sbjct: 107 EVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163
Query: 508 TCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPI 552
T V T Y APE + K + ID+++ G + ELLT +KP+
Sbjct: 164 TQLVV--TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 355 LIGKGGSSQVYKGCLP----DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNII 406
++GKG V + L +++AVK+LK S D I+EF+ E + H N+I
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVI 64
Query: 407 SLLGFCFEDNNL------LLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAE 458
L+G +++ F+ G L L ++ ++P + + +A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 459 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 518
+EYL S++ IHRD+ + N +L+++ ++DFGL+K + + +
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 519 LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
LA E DV+AFGV + E++T G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 45/232 (19%)
Query: 355 LIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVI------KEFVLEIEIITTLHHKNIIS 407
LIGKGG +VY P + +A+K K ED+ K F+ E +I L H I+
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALK--KIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENL------------HGNKKDPAAFGWSERYKVAMG 455
+ C + + + ++ +L+ L K AF S +K+
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF-LSIFHKICAT 125
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW---------------- 499
+ EY+HS + V+HRD+K NILL E + D+G A +
Sbjct: 126 I----EYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
SS + GT Y+APE + ++ D+YA GV+L ++LT P
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 63/211 (29%), Positives = 91/211 (43%), Gaps = 34/211 (16%)
Query: 356 IGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNI--------I 406
IGKG +V + D + + A+K ++ + V + E+ TL + + I
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRS-----EVTHTLAERTVLAQVNCPFI 55
Query: 407 SLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEY 462
L F F+ L LV F++ G L +L G + + AE ALE
Sbjct: 56 VPLKFSFQSPEKLYLVLAFINGGELFHHLQRE-------GRFDLSRARFYTAELLCALEN 108
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK--WASTSSSHITCTDVAGTFGYLA 520
LH + VI+RD+K NILL L DFGL K ++ C GT YLA
Sbjct: 109 LHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC----GTPEYLA 161
Query: 521 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
PE + +D + GV+L E+LTG P
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 49/146 (33%), Positives = 70/146 (47%), Gaps = 14/146 (9%)
Query: 409 LGFCFED-NNLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHS 465
L F F+ + L V D+++ G L +L + +P A R+ A +A AL YLHS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-----RFYAAE-IASALGYLHS 114
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 525
+++RD+K NILL L+DFGL K + T + GT YLAPE
Sbjct: 115 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLH 169
Query: 526 YGKVNDKIDVYAFGVVLLELLTGRKP 551
+ +D + G VL E+L G P
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 54/242 (22%)
Query: 345 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKE-FVL----EIEII 397
S ++ +G+G +VYK + G+ +A+K IL +E K+ F + EI+I+
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE---KDGFPITALREIKIL 61
Query: 398 TTLHHKNIISLLGFCFE-----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 452
L H N++ L+ E VY ++ +L G ++P K+
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP--YMDHDLSGLLENP-------SVKL 112
Query: 453 AMG--------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA------- 497
+ E + YLH ++HRD+K++NIL+ + +++DFGLA
Sbjct: 113 TESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169
Query: 498 ---KWASTSSSHITCTDVAGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRK 550
K + T++ T Y PE + Y +D++ G V E+ T R+
Sbjct: 170 PNPKGGGGGGTR-KYTNLVVTRWYRPPELLLGERRYTT---AVDIWGIGCVFAEMFT-RR 224
Query: 551 PI 552
PI
Sbjct: 225 PI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 69/256 (26%), Positives = 109/256 (42%), Gaps = 47/256 (18%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFV----LEIEIITTLHHK 403
+F + +IG+G +V D G A+KIL+ ++ + KE V E +I+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 404 NIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 462
++ + + F+D NL L+ +FL G + L KKD ++ Y +AE +
Sbjct: 62 WVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFY-----IAETVLA 113
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTSS-----SHITCTD--- 511
+ S IHRD+K N+LL +LSDFGL K A + +H +D
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 512 ----------------------VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 549
GT Y+APE FM N D ++ GV++ E+L G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 550 KPISNDHPKGQESLVM 565
P ++ P+ VM
Sbjct: 234 PPFCSETPQETYKKVM 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 49/174 (28%), Positives = 83/174 (47%), Gaps = 35/174 (20%)
Query: 388 KEFVLEIEIITTLHHKNIISLLGFCF-------EDNNLLLVYDFLSRGSLEENLHGNKKD 440
+E VL + ++HKNII LL F E ++ LV + + +L + + +
Sbjct: 64 RELVL----MKLVNHKNIIGLLN-VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLD- 116
Query: 441 PAAFGWSER-----YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 495
ER Y++ G+ ++LHS +IHRD+K SNI++ D ++ DFG
Sbjct: 117 ------HERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163
Query: 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 549
LA+ A TS T T Y APE + + +D+++ G ++ E++ G
Sbjct: 164 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 356 IGKGGSSQVYKGCLPD-----------GKELAV--KILKPSE-DVIKEFVLEIEIITTLH 401
+G+G +Q+Y G L KE+ V K+L PS D+ F ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 402 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 461
HK+I+ L G C D ++V +F+ G L+ +H K D W ++KVA +A AL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSDVLTTPW--KFKVAKQLASALS 119
Query: 462 YLHSGSAQRVIHRDVKSSNILLS-----DDFEP--QLSDFGLAKWASTSSSHITCTDVAG 514
YL + ++H +V + NILL+ + P +LSD G+ T S C +
Sbjct: 120 YLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI---PITVLSRQECVE--- 170
Query: 515 TFGYLAPEYFMYGKV-NDKIDVYAFGVVLLEL-LTGRKPISN 554
++APE K + D ++FG L E+ G P+ +
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 68/256 (26%), Positives = 111/256 (43%), Gaps = 47/256 (18%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEI----EIITTLHHK 403
+F + +IG+G +V D G A+KIL+ ++ + KE V I +I+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 404 NIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 462
++ + + F+D NL L+ +FL G + L KKD + ++ Y +AE +
Sbjct: 62 WVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFY-----IAETVLA 113
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTSS-----SHITCTDVA- 513
+ + IHRD+K N+LL +LSDFGL K A + +H +D +
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 514 ------------------------GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 549
GT Y+APE FM N D ++ GV++ E+L G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 550 KPISNDHPKGQESLVM 565
P ++ P+ VM
Sbjct: 234 PPFCSETPQETYRKVM 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 54/165 (32%), Positives = 76/165 (46%), Gaps = 23/165 (13%)
Query: 411 FC-FEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 468
FC F+D+ L +V +++ G L NL N P W++ Y V AL+ +HS
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEK--WAKFYTAE--VVLALDAIHS--- 160
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEYF--- 524
+IHRDVK N+LL +L+DFG K T C GT Y++PE
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR--CDTAVGTPDYISPEVLKSQ 218
Query: 525 ----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 565
YG+ + D ++ GV L E+L G P D G S +M
Sbjct: 219 GGDGYYGR---ECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 58/239 (24%), Positives = 104/239 (43%), Gaps = 70/239 (29%)
Query: 373 KELAVKILK----PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN-LLLVYDFLS 426
+ +AVK+LK SE K + E++I+ + HH N+++LLG C + L+++ ++
Sbjct: 38 RTVAVKMLKEGATASEY--KALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCK 95
Query: 427 RGSLEENLHGNK--------------------------------KDPAAFGW-------- 446
G+L L + + A+ G+
Sbjct: 96 FGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD 155
Query: 447 -------SERYKV----------AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 489
E YK + VA +E+L S ++ IHRD+ + NILLS++
Sbjct: 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVV 212
Query: 490 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLT 547
++ DFGLA+ ++ D ++APE ++ KV + DV++FGV+L E+ +
Sbjct: 213 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPES-IFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 29/167 (17%)
Query: 393 EIEIITTLHHKNIISLLGF------CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGW 446
E+ ++ ++HKNIISLL E ++ LV + + +L + +H
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELD------- 121
Query: 447 SER-----YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501
ER Y++ G+ ++LHS +IHRD+K SNI++ D ++ DFGLA+
Sbjct: 122 HERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--- 171
Query: 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 548
T+ ++ T T Y APE + + +D+++ G ++ EL+ G
Sbjct: 172 TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 22/166 (13%)
Query: 393 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 451
E +I+ ++ + ++SL + +E + L LV ++ G L+ +++ N +P G+ E
Sbjct: 50 EKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY-NMGNP---GFDEERA 104
Query: 452 V--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI-- 507
V A + LE LH +R+++RD+K NILL D ++SD GLA I
Sbjct: 105 VFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLA-------VEIPE 154
Query: 508 --TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
T GT GY+APE + D + G ++ E++ G+ P
Sbjct: 155 GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 79/352 (22%), Positives = 144/352 (40%), Gaps = 46/352 (13%)
Query: 356 IGKGGSSQVYKGCLPD-GKELAVKILKPSEDV-IKEFVLEIEIITTLHHKNII------- 406
+G G + V+ D K +AVK + ++ +K + EI+II L H NI+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 407 -------SLLGFCFEDNNLLLVYDFLS---RGSLEENLHGNKKDPAAFGWSERYKVAMGV 456
+G E N++ +V +++ LE+ + Y++ G
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFM-----YQLLRG- 126
Query: 457 AEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSH---ITCTDV 512
L+Y+HS + V+HRD+K +N+ ++ +D ++ DFGLA+ SH ++ V
Sbjct: 127 ---LKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 513 AGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 571
T Y +P + ID++A G + E+LTG+ + H Q L++ + P++
Sbjct: 181 --TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238
Query: 572 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWA 631
+LL+ + R L +L +P A + + ++L +
Sbjct: 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLP-GVNPEA---LDFLEQILTFN----PMD 290
Query: 632 RLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLED 683
RL + + SCP S + D DD M+ I + D
Sbjct: 291 RLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELDDILLMTEIHSIIYNWD 342
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 69/265 (26%), Positives = 117/265 (44%), Gaps = 27/265 (10%)
Query: 372 GKELAVKIL-KP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 428
G ++A+K L +P SE K E+ ++ + H+N+I LL D +L +DF
Sbjct: 40 GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99
Query: 429 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 488
G + + + L+Y+H+ +IHRD+K N+ +++D E
Sbjct: 100 PFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCE 156
Query: 489 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLT 547
++ DFGLA+ + T T Y APE + + +D+++ G ++ E+LT
Sbjct: 157 LKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211
Query: 548 GRKPI--SNDH-PKGQESLVMWAKPILSSGKVTQLLDPALGNNY--DYDQMERMVLASIL 602
G KP+ +DH + E + + P S + Q L NY + + S+L
Sbjct: 212 G-KPLFKGHDHLDQLMEIMKVTGTP---SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLL 267
Query: 603 CIRRDPRARPQMSLVL-KLLRGDAD 626
P A P VL K+L DA+
Sbjct: 268 -----PNANPLAVNVLEKMLVLDAE 287
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 26/192 (13%)
Query: 371 DGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLLGF-------CFEDNNLLL 420
DGK +A+K + K E++++ H N++S L FE+ + +
Sbjct: 24 DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE--IYV 81
Query: 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLHSGSAQRVIHRDVKSS 479
V + + + +LH P S+ KV + + L+YLHS ++HRD+K
Sbjct: 82 VTELM-----QSDLHKIIVSPQPLS-SDHVKVFLYQILRGLKYLHSA---GILHRDIKPG 132
Query: 480 NILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYA 537
N+L++ + ++ DFGLA S H+T V T Y APE M + +D+++
Sbjct: 133 NLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV--TQYYRAPEILMGSRHYTSAVDIWS 190
Query: 538 FGVVLLELLTGR 549
G + ELL R
Sbjct: 191 VGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 44/162 (27%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 393 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 451
E +I+ ++ + +++L + +E + L LV ++ G L+ +++ N +P G+ E
Sbjct: 50 EKQILEKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIY-NMGNP---GFEEERA 104
Query: 452 V--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 509
+ A + LE LH + ++RD+K NILL D ++SD GLA S
Sbjct: 105 LFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---I 158
Query: 510 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
GT GY+APE + D + G ++ E++ G+ P
Sbjct: 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 9/91 (9%)
Query: 460 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 519
L+Y+HS +IHRD+K SN+ +++D E ++ DFGLA+ A T T Y
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYR 182
Query: 520 APEYFM-YGKVNDKIDVYAFGVVLLELLTGR 549
APE + + N +D+++ G ++ ELL G+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 393 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 451
E I+ ++ + ++SL + +E + L LV ++ G L+ +++ N +P G+ E+
Sbjct: 50 EKRILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIY-NMGNP---GFDEQRA 104
Query: 452 V--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 509
+ A + LE L +R+++RD+K NILL D ++SD GLA T
Sbjct: 105 IFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TV 158
Query: 510 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
GT GY+APE K D + G ++ E++ G+ P
Sbjct: 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 27/209 (12%)
Query: 356 IGKGGSSQVYKGCLPDGKE-LAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
IG+G VYK E +A+K ++ E V + EI ++ + H NI+ L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHS 465
+ L LV+++ L+ +L + F + R Y++ G+A Y HS
Sbjct: 70 VHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----YCHS 120
Query: 466 GSAQRVIHRDVKSSNILLSDDFEP-QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 524
RV+HRD+K N+L+ +L+DFGLA+ T V T Y APE
Sbjct: 121 ---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEIL 175
Query: 525 MYGK-VNDKIDVYAFGVVLLELLTGRKPI 552
+ + + +D+++ G + E++ +KP+
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203
|
Length = 294 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 356 IGKGGSSQVYKGCLPDGK---ELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 409
+G+G V +G L ++AVK +K + +++F+ E + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 410 GFCFEDN------NLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALE 461
G C + + +++ F+ G L L ++ P K +A +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 521
YL S++ IHRD+ + N +L+++ ++DFGL+K + ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 522 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
E K DV++FGV + E+ T G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 66/272 (24%), Positives = 108/272 (39%), Gaps = 62/272 (22%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFV----LEIEIITTLHH 402
S F+ IG G +V D L A+K L+ ++ +++ E +I+ +
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN 60
Query: 403 KNIISLLGFCFED-NNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAE 458
+ ++ L + F+D +NL V D++ G SL L ++D A F +E +
Sbjct: 61 EWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAE-------LTC 112
Query: 459 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA--------------------- 497
A+E +H IHRD+K NIL+ D +L+DFGL
Sbjct: 113 AIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169
Query: 498 ------KWASTSSS------------HITCT--DVAGTFGYLAPEYFMYGKVNDKIDVYA 537
+W+ H C + GT Y+APE + D ++
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229
Query: 538 FGVVLLELLTGRKPISNDHPKG-QESLVMWAK 568
GV+L E+L G+ P D P Q ++ W
Sbjct: 230 VGVILYEMLVGQPPFLADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 22/161 (13%)
Query: 397 ITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 455
ITTLH + F+D N L LV D+ G L L +D + Y
Sbjct: 63 ITTLH---------YAFQDENYLYLVMDYYVGGDLL-TLLSKFEDRLPEDMARFY----- 107
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 515
+AE + +HS +HRD+K N+LL + +L+DFG + + + GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGT 166
Query: 516 FGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKP 551
Y++PE GK + D ++ GV + E+L G P
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 42/165 (25%), Positives = 70/165 (42%), Gaps = 18/165 (10%)
Query: 393 EIEIITTLHHKNIISLLGFCFEDNNLLLV-----YDFLSRGSLEENLHGNKKDPAAFGWS 447
EI+I+ T+ H+ II+L+ + + +V D + + ++ P
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFT--------YVDRSGPLPL--E 185
Query: 448 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507
+ + + EAL YLH + +IHRDVK+ NI L + L DFG A
Sbjct: 186 QAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242
Query: 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 552
C +GT +PE K D+++ G+VL E+ +
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 55/186 (29%), Positives = 92/186 (49%), Gaps = 21/186 (11%)
Query: 372 GKELAVKIL-KP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF-LSR 427
G+++A+K L +P SE K E+ ++ + H+N+I LL + DF L
Sbjct: 40 GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99
Query: 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLS 484
++ +L P SE KV V + L+Y+HS +IHRD+K N+ ++
Sbjct: 100 PYMQTDLQKIMGHP----LSED-KVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVN 151
Query: 485 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLL 543
+D E ++ DFGLA+ A T T Y APE + + N +D+++ G ++
Sbjct: 152 EDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMA 206
Query: 544 ELLTGR 549
E+LTG+
Sbjct: 207 EMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 356 IGKGGSSQVYKGCLPDG---KELAVKILKPSEDVIKE--FVLEIEIITTLHHKNIISLLG 410
IG G +V G + G ++ VK L+ S V ++ F+ E + +L H N++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 411 FCFEDNNLLLVYDFLSRGSLEENLHGNKK------DPAAFGWSERYKVAMGVAEALEYLH 464
C E LLV +F G L+ L +K DP ++A +A L +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTL-----QRMACEIALGLLHLH 117
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 524
+ IH D+ N LL+ D ++ D+GL+ ++T + ++APE
Sbjct: 118 KNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 525 --MYGK--VNDKI---DVYAFGVVLLELLT-GRKP 551
++G V D+ +V++ GV + EL G +P
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 515
VA+ +E+L S ++ IHRD+ + NILLS++ ++ DFGLA+ ++ D
Sbjct: 188 VAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 516 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
++APE + DV++FGV+L E+ + G P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 19/167 (11%)
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 515
VA +E+L S ++ IHRD+ + NILLS++ ++ DFGLA+ ++
Sbjct: 183 VARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 516 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSG 574
++APE + DV++FGV+L E+ + G P +P Q + + L G
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP----YPGVQINEEFCQR--LKDG 293
Query: 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621
T++ P ++ R++LA C + DP+ RP S ++++L
Sbjct: 294 --TRMRAP----ENATPEIYRIMLA---CWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 17/163 (10%)
Query: 391 VLEIEIITTLHHKNIISLLG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 449
E I+ ++H +II L G F + L++ + + L L + +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAAKRNIAIC----DI 184
Query: 450 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 509
+ V A++YLH R+IHRD+K+ NI ++ + L DFG A+ I
Sbjct: 185 LAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFG----AACFPVDINA 237
Query: 510 TDV---AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 549
AGT APE +D+++ G+VL E+ T
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 15/158 (9%)
Query: 393 EIEIITTLHHKNIISLLGFCFEDNNLLLVYD-FLSRGSLEENLHG---NKKDPAAFGWSE 448
E+ ++ ++HKNIISLL +L D +L ++ NL + D +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL- 124
Query: 449 RYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 508
Y++ G+ ++LHS +IHRD+K SNI++ D ++ DFGLA+ A TS
Sbjct: 125 LYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FM 174
Query: 509 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 546
T T Y APE + + +D+++ G ++ E++
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 8e-07
Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 22/153 (14%)
Query: 356 IGKGGSSQVY---KGCLPDGKELAVKILKPSEDVIKEFV----LEIEIITTLHHKNIISL 408
I +G +VY K + K AVK++K ++ + K V E + + I+ L
Sbjct: 12 ISRGAFGKVYLGRKKN--NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL 69
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENLH--GNKKDPAAFGW-SERYKVAMGVAEALEYLHS 465
NN+ LV ++L G ++ LH G + A + SE VA AL+YLH
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISE-------VALALDYLHR 122
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498
+IHRD+K N+L+S++ +L+DFGL+K
Sbjct: 123 HG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 28/97 (28%), Positives = 56/97 (57%), Gaps = 4/97 (4%)
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 515
VA+ +++L +++ IHRDV + N+LL+D ++ DFGLA+ S+++ +
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 516 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
++APE + DV+++G++L E+ + G+ P
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 459 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 518
+++LHS +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYY 191
Query: 519 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 549
APE + + +D+++ G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 31/216 (14%)
Query: 357 GKGGSSQVYKGCLPDGKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNIISLLGFCFE 414
GK S++Y + VK LK + + EF+ + + L H NI+ LG C E
Sbjct: 9 GKVLLSEIYTD--TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE 66
Query: 415 DNNLLLVYDFLSRGSL------EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 468
LLV+++ G L E+ N + ++A +A + ++H
Sbjct: 67 AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQL------LLLQRMACEIAAGVTHMHK--- 117
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 528
+H D+ N L+ D ++ D+G+ T D +LAPE + G+
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE--LVGE 175
Query: 529 VNDKI---------DVYAFGVVLLELL-TGRKPISN 554
+ + +V+A GV L EL +P S+
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 13/156 (8%)
Query: 404 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 463
N++ L + ++++ LV G L ++ P +R+ M VA L+ L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPE--ECVKRWAAEMVVA--LDAL 101
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523
H + ++ RD+ +NILL D QL+ F +W+ S C A Y APE
Sbjct: 102 HR---EGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDS---CDGEAVENMYCAPEV 153
Query: 524 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 559
+ + D ++ G +L ELLTG K + HP G
Sbjct: 154 GGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 46/210 (21%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 355 LIGKGGSSQVYKGCLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLG 410
LI + + +YKG + KE+ ++ K + +I EI+ + + NI+ + G
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85
Query: 411 FCFEDNNLL----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
F + + L L+ ++ +RG L E L K + + +A+ + L L+
Sbjct: 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKY 141
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF-- 524
+ + ++++ S + L++++++ ++ GL K S+ +V Y + +
Sbjct: 142 TNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK----NV-NFMVYFSYKMLND 194
Query: 525 MYGKVNDKIDVYAFGVVLLELLTGRKPISN 554
++ + K D+Y+ GVVL E+ TG+ P N
Sbjct: 195 IFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224
|
Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 19/214 (8%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPDG-KELAVKILKPSEDVIKE----FVLEIEIITTLHHK 403
+F +IG+G +V L + K A+KIL E + + F E +++ ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 404 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA-EALEY 462
I +L ++NNL LV D+ G L L +D + Y M +A +++
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLL-TLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
LH +HRD+K NIL+ + +L+DFG + + + GT Y++PE
Sbjct: 121 LH------YVHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPE 173
Query: 523 YFMY-----GKVNDKIDVYAFGVVLLELLTGRKP 551
GK + D ++ GV + E+L G P
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 49/169 (28%), Positives = 73/169 (43%), Gaps = 38/169 (22%)
Query: 397 ITTLHHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 455
IT LH + F+D NNL LV D+ G L L + F +R M
Sbjct: 63 ITNLH---------YAFQDENNLYLVMDYYVGGDLLTLL-------SKFE--DRLPEDMA 104
Query: 456 ---VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG----LAKWASTSSSHIT 508
+AE + + S +HRD+K N+LL + +L+DFG L + S+
Sbjct: 105 RFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN--- 161
Query: 509 CTDVA-GTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKP 551
VA GT Y++PE G+ + D ++ GV + E+L G P
Sbjct: 162 ---VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 3/93 (3%)
Query: 452 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 511
VA + A++Y+H + +IHRD+K+ N+L++ + L DFG A +A S S
Sbjct: 265 VARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 512 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLE 544
+AGT APE +D+++ G+V+ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 66/271 (24%), Positives = 108/271 (39%), Gaps = 60/271 (22%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSE----DVIKEFVLEIEIITTLHH 402
S F+ +G G +V C D L A+K L+ + + + E +I+ +
Sbjct: 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN 60
Query: 403 KNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 461
+ ++ L + F+D +NL V D++ G + L + P R+ +A + A+E
Sbjct: 61 EWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA---RFYIAE-LTLAIE 115
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTSS-----SHI------ 507
+H IHRD+K NIL+ D +L+DFGL +W S SHI
Sbjct: 116 SVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172
Query: 508 -----------TCTD--------------------VAGTFGYLAPEYFMYGKVNDKIDVY 536
C D + GT Y+APE + D +
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232
Query: 537 AFGVVLLELLTGRKPISNDHP-KGQESLVMW 566
+ GV+L E+L G+ P P + Q ++ W
Sbjct: 233 SVGVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 515
VA+ + +L S + IHRD+ + NILL+ ++ DFGLA+ S+++ +
Sbjct: 223 VAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 516 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
++APE + DV+++G++L E+ + G P
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 27/92 (29%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 515
VA +E+L S + +HRD+ + N+L+ + ++ DFGLA+ S++I+
Sbjct: 248 VANGMEFLAS---KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 516 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 547
++APE DV++FG++L E+ T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 52/208 (25%), Positives = 81/208 (38%), Gaps = 60/208 (28%)
Query: 409 LGFCFED-NNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
L + F+D +NL V D++ G SL + +D A F +E + A+E +H
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAE-------LTCAVESVH 118
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTS------------------ 503
IHRD+K NIL+ D +L+DFGL +W S
Sbjct: 119 K---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 504 ----SSHITCTD--------------------VAGTFGYLAPEYFMYGKVNDKIDVYAFG 539
++ C D + GT Y+APE + D ++ G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235
Query: 540 VVLLELLTGRKPISNDHP-KGQESLVMW 566
V+L E+L G+ P P + Q ++ W
Sbjct: 236 VILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 38/140 (27%), Positives = 70/140 (50%), Gaps = 16/140 (11%)
Query: 353 ENLIGKGGSSQVYKGC---LPDGKEL-----AVKILKPSEDVIKEFVLE-IEIITTLHHK 403
E+L G+G ++++KG + D EL +K+L S E E +++ L HK
Sbjct: 1 ESL-GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHK 59
Query: 404 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 463
+++ G C + ++V +++ GSL+ L KK+ S + +VA +A AL +L
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYL---KKNKNLINISWKLEVAKQLAWALHFL 116
Query: 464 HSGSAQRVIHRDVKSSNILL 483
+ + H +V + N+LL
Sbjct: 117 ED---KGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 50/189 (26%), Positives = 81/189 (42%), Gaps = 21/189 (11%)
Query: 383 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 442
+ +++ E+ + +H NI+ DN L +V F++ GS ++ + + D
Sbjct: 39 TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD-- 96
Query: 443 AFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500
G SE + GV +AL+Y+H +HR VK+S+IL+S D + LS GL
Sbjct: 97 --GMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLS--GLRSNL 149
Query: 501 STSSS-------HITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKP 551
S + H +L+PE + K D+Y+ G+ EL G P
Sbjct: 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
Query: 552 ISNDHPKGQ 560
D P Q
Sbjct: 210 F-KDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 9e-05
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVK--ILKPSEDVIKEFVL-EIEIITTLHHKN-IISLLG 410
IG+G +VYK GK +A+K L+ E+ I L EI ++ L I+ LL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 411 FCFEDNN-----LLLVYDFLSRGSLEENLHGNKKD-----PAAFGWSERYKVAMGVAEAL 460
+ L LV+++L L++ + N + PA S Y++ GVA
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA--- 124
Query: 461 EYLHSGSAQRVIHRDVKSSNILLSDDFEP-QLSDFGLAKWASTSSSHITCTDVAGTFGYL 519
+ H V+HRD+K N+L+ +++D GL + S T V T Y
Sbjct: 125 -HCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWYR 178
Query: 520 APEYFMYGK-VNDKIDVYAFGVVLLELLTG 548
APE + + +D+++ G + E+
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 33/148 (22%), Positives = 57/148 (38%), Gaps = 15/148 (10%)
Query: 355 LIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS--LLGFC 412
L+ G +++VY D +KI E E+ I+ L K + +L
Sbjct: 5 LLKGGLTNRVYLLGTKDED-YVLKINPSREKGAD-REREVAILQLLARKGLPVPKVLASG 62
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 472
D L+ +++ +L+E K+D +A +AE L LH +
Sbjct: 63 ESDGWSYLLMEWIEGETLDEVSEEEKED-----------IAEQLAELLAKLHQLPLLVLC 111
Query: 473 HRDVKSSNILLSDDFEPQLSDFGLAKWA 500
H D+ NIL+ D + D+ A +
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 55/204 (26%), Positives = 82/204 (40%), Gaps = 22/204 (10%)
Query: 370 PDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426
P G + V+I +E+ +K E+ + H NI++ + L ++ F++
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 427 RGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 484
GS L K G SE + G L YLH IHR++K+S+IL+S
Sbjct: 83 YGSANSLL----KTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILIS 135
Query: 485 DDFEPQLSDFG-LAKWASTSSSHITCTDV----AGTFGYLAPEYF---MYGKVNDKIDVY 536
D LS L D +L+PE +YG N K D+Y
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIY 194
Query: 537 AFGVVLLELLTGRKPISNDHPKGQ 560
+ G+ EL TGR P D + Q
Sbjct: 195 SVGITACELATGRVPFQ-DMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 67/265 (25%), Positives = 101/265 (38%), Gaps = 69/265 (26%)
Query: 349 NFLAENLIGKGGSSQV---YKGCLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLH 401
+F +IGKG +V K GK A+K L SE D + E +++
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD 59
Query: 402 HKNIISLLGFCFEDNNLL-LVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVA 457
++SL + F+D L L+ +FL G L L K D +SE R+ +A V
Sbjct: 60 SPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTML--IKYDT----FSEDVTRFYMAECVL 112
Query: 458 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK------------------- 498
A+E +H IHRD+K NIL+ +LSDFGL+
Sbjct: 113 -AIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168
Query: 499 ----------------WASTSSSHITCT----------DVAGTFGYLAPEYFMYGKVNDK 532
+ SS T GT Y+APE F+ +
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228
Query: 533 IDVYAFGVVLLELLTGRKPISNDHP 557
D ++ G ++ E L G P +++
Sbjct: 229 CDWWSLGAIMFECLIGWPPFCSENS 253
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 25/92 (27%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 515
VA +E+L S + +HRD+ + N+LL+ ++ DFGLA+ S++++
Sbjct: 246 VARGMEFLAS---KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 516 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 547
++APE DV+++G++L E+ +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 49/189 (25%), Positives = 82/189 (43%), Gaps = 26/189 (13%)
Query: 370 PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC-FEDNNLLLV--YDFLS 426
P + L K +K + EI + L+H+NI+ + E N ++ YDF
Sbjct: 190 PKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-- 247
Query: 427 RGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 480
+L+ D AF W +R + + A+EY+H +++IHRD+K N
Sbjct: 248 ------DLYSFMYD-EAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLEN 297
Query: 481 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA--GTFGYLAPEYFMYGKVNDKIDVYAF 538
I L+ D + L DFG A D GT +PE + D+++
Sbjct: 298 IFLNCDGKIVLGDFGT---AMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSC 354
Query: 539 GVVLLELLT 547
G++LL++L+
Sbjct: 355 GLILLDMLS 363
|
Length = 501 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 696 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.43 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.98 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.98 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.85 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.76 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.69 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.65 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.55 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.53 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.52 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.4 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.34 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.3 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.28 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.28 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.24 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.13 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.12 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.04 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.01 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.92 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.84 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.84 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.84 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.74 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.71 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.66 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.65 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.62 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.53 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.44 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.35 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.27 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.23 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.09 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.03 | |
| PLN02236 | 344 | choline kinase | 96.91 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.73 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 96.57 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.48 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.45 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.45 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.3 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.26 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.24 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.22 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.15 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.0 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.98 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.93 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.37 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.84 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 94.78 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.73 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.56 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.41 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 93.85 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-55 Score=480.81 Aligned_cols=288 Identities=49% Similarity=0.879 Sum_probs=260.0
Q ss_pred cccccChHHHHHhhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhH-HHHHHHHHHHHHhcCCcceeEEeeEE
Q 005450 334 TCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV-IKEFVLEIEIITTLHHKNIISLLGFC 412 (696)
Q Consensus 334 ~~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~-~~~~~~Ei~iL~~L~HpnIV~l~g~~ 412 (696)
..+.|++.++..+|++|...+.||+|+||.||+|.+++|..||||.+...... .++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56889999999999999999999999999999999999999999998875544 66799999999999999999999999
Q ss_pred EecC-ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEE
Q 005450 413 FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 491 (696)
Q Consensus 413 ~~~~-~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL 491 (696)
.+.+ +.+||||||++|+|.++|+..... .++|..|++|+.++|+||+|||+.+...||||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998 499999999999999999976543 7899999999999999999999988779999999999999999999999
Q ss_pred eecCccccccC-CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccc
Q 005450 492 SDFGLAKWAST-SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 570 (696)
Q Consensus 492 ~DFGlA~~~~~-~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 570 (696)
+|||+|+.... ....... ..||.+|+||||+..+..+.|+|||||||+|+||+||++|.....+.....++.|..+.
T Consensus 219 sDFGLa~~~~~~~~~~~~~--~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTT--VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred cCccCcccCCccccceeee--cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 99999976665 2222111 17999999999999999999999999999999999999999876666677799999999
Q ss_pred cccCccccccCcccC-CCCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 571 LSSGKVTQLLDPALG-NNYDY-DQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 571 ~~~g~l~~llD~~L~-~~~~~-~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
+..+++.+++|+.+. ..+.. .++.+++.+|..|++.+|.+||+|.+|+++|+...
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 999999999999997 56654 78999999999999999999999999999995443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=377.75 Aligned_cols=248 Identities=26% Similarity=0.418 Sum_probs=204.8
Q ss_pred ceeeeeeeccCceEEEEEEeC-CCCEEEEEEec--CChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc-eEEEEeec
Q 005450 350 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFL 425 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~-~~LV~Ey~ 425 (696)
....+.||+|..|+||++.++ +++.+|+|.+. .+....+++.+|++++...+|||||.+||.|..... ..|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 345688999999999999965 78899999994 456778899999999999999999999999999885 99999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++|+|++++...+ .+++...-+|+.++++||.|||+ .++||||||||+|||++..|++||||||.++.+..+
T Consensus 161 DgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred CCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 9999999998654 58899999999999999999995 288999999999999999999999999999987665
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCc--cchhhHHhhhccccccCccccccCcc
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP--KGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~--~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
.+.+++||..|||||.+.+..|+.++||||||++++|+.+|+.||....+ .....+..+.- .-..|.
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv---------~~ppP~ 301 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV---------DEPPPR 301 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh---------cCCCCC
Confidence 34568999999999999999999999999999999999999999987522 12222222211 011133
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
++...-.++ +..++..||++||.+||++.++++
T Consensus 302 lP~~~fS~e---f~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 302 LPEGEFSPE---FRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCcccCCHH---HHHHHHHHhcCCcccCCCHHHHhc
Confidence 333222233 344455599999999999999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=387.88 Aligned_cols=251 Identities=32% Similarity=0.514 Sum_probs=205.0
Q ss_pred eeeeeeccCceEEEEEEeCCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecC-ceEEEEeecCC
Q 005450 352 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-NLLLVYDFLSR 427 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~-~~~LV~Ey~~g 427 (696)
..+.||.|+||+||+|.+.....||||++.... ...+.|.+|+.+|.+++|||||+++|+|.+.. .++|||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345599999999999998665559999998643 22678999999999999999999999999887 79999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCc-eEeecccccceeeCCCC-ceEEeecCccccccCCCC
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-VIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~g-IIHrDLKpsNILLd~~~-~vKL~DFGlA~~~~~~~~ 505 (696)
|+|.++++.. ....+++..++.++.+||+||.|||+ ++ ||||||||+|||++.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 9999999874 23479999999999999999999999 66 99999999999999998 99999999998776543
Q ss_pred CcccccccccCCCCCcceec--cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 506 HITCTDVAGTFGYLAPEYFM--YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~--~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
...+...||+.|||||++. ...|+.|+||||||++||||+||+.||....+......+.... . -+.
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~------~-----Rp~ 266 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGG------L-----RPP 266 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC------C-----CCC
Confidence 1223367999999999999 5689999999999999999999999998877622222111111 0 011
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
+ +......+..++..||+.||..||++.+++..|+..
T Consensus 267 ~----p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 267 I----PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred C----CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 1 111233455566669999999999999999999754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=381.17 Aligned_cols=251 Identities=27% Similarity=0.407 Sum_probs=202.2
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh--------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecC
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 416 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~--------~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~ 416 (696)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||+++... .......+|++||++|+|||||+++++|....
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345688999999999999999984 689999999998632 12234569999999999999999999999999
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC---CceEEee
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSD 493 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~---~~vKL~D 493 (696)
..||||||++||+|.+.+-.++. +.+..-..++.|++.|+.|||+ +||+||||||+||||..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999977653 6666778899999999999999 999999999999999766 7899999
Q ss_pred cCccccccCCCCCcccccccccCCCCCcceeccCC---CCCcccchhhHHHHHHHHhCCCCCCCCCccc-hhhHHhhhcc
Q 005450 494 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPISNDHPKG-QESLVMWAKP 569 (696)
Q Consensus 494 FGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~---~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~-~~~lv~~~~~ 569 (696)
||+|+...... .+.+.+|||.|.|||++.... +..++||||+|||||-+|+|.+||.+..... ....+..
T Consensus 323 FGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~--- 396 (475)
T KOG0615|consen 323 FGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK--- 396 (475)
T ss_pred cchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc---
Confidence 99999887543 345689999999999998664 3347899999999999999999998765432 2222211
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 570 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 570 ~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
|+... -|. ....-.++...++.+||..||++|||+.|+|+
T Consensus 397 ----G~y~f--~p~----~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 ----GRYAF--GPL----QWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ----Ccccc--cCh----hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 11110 000 11122355666788899999999999999986
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=390.19 Aligned_cols=246 Identities=28% Similarity=0.443 Sum_probs=209.0
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecC----ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~----~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
..|...++||+|||++||.+.. .+|..||+|++.+ .....+...+||+|.++|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4588899999999999999997 8899999999986 4566788999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
|+|.+++|.+++...+ .+++.+++.+..||+.||.|||+ ++|||||||..||||+++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999998544 69999999999999999999999 9999999999999999999999999999998875
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
..... .+.+|||.|+|||++.....+..+||||+|||||.||.|++||+...-.+....+......++ .
T Consensus 171 ~~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P-----~---- 239 (592)
T KOG0575|consen 171 DGERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMP-----S---- 239 (592)
T ss_pred ccccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccc-----c----
Confidence 43322 348999999999999999999999999999999999999999987654443333322211111 1
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.-..+..+ ++..+|+.||.+|||+++|+.
T Consensus 240 -----~ls~~A~d---LI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 240 -----HLSAEAKD---LIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -----ccCHHHHH---HHHHHhcCCcccCCCHHHHhc
Confidence 11233344 444589999999999999996
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=372.69 Aligned_cols=206 Identities=30% Similarity=0.518 Sum_probs=184.8
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
..+|...+.||+|+||+||+|.++ ++..||||.+... ....+.+..|+.||+.++|||||.+++++...+.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888889999999999999964 6899999998653 466778899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC------CceEEeecCc
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD------FEPQLSDFGL 496 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~------~~vKL~DFGl 496 (696)
|||.||+|.++|+..+ .+++.+++.++.||+.||++||+ ++||||||||.||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999998775 58999999999999999999999 999999999999999865 4589999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhh
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 562 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~ 562 (696)
|+.+..... ..+.+|+|.|||||+++.++|+.|+|+||+|+|||+|++|+.||....+.+...
T Consensus 162 AR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 162 ARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred hhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 999885432 345899999999999999999999999999999999999999998776654433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=366.64 Aligned_cols=241 Identities=29% Similarity=0.425 Sum_probs=200.2
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.++||+|+||.||.++. ++++.||+|++++.. ...+....|..||.+++||+||+++-.|++..++|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46799999999999999999985 468899999998743 3466788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
+||+.||.|...|++.+ .|++..+..++.+|+.||.|||+ ++||||||||+|||||.+|+++|+|||+++..-
T Consensus 104 ld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999998765 48999999999999999999999 999999999999999999999999999998544
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
.... ...+++||+.|||||++....|+..+|+||||+++|||++|.+||...+.......+...+.
T Consensus 177 ~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~------------ 242 (357)
T KOG0598|consen 177 KDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL------------ 242 (357)
T ss_pred cCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC------------
Confidence 4322 22348999999999999999999999999999999999999999988765443333222110
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCC
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARP 612 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RP 612 (696)
.....+-..+... +....+.+||++|-
T Consensus 243 -~~~p~~ls~~ard---ll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 -PLPPGYLSEEARD---LLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCCccCCHHHHH---HHHHHhccCHHHhc
Confidence 0111112233333 34458899999996
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=365.34 Aligned_cols=259 Identities=27% Similarity=0.390 Sum_probs=212.0
Q ss_pred cCceeeeeeeccCceEEEEEE-eCCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEee-EEEecCc-eEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLG-FCFEDNN-LLLV 421 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~-~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g-~~~~~~~-~~LV 421 (696)
.+|.+.+.||+|.||+||++. +.+|..+|.|.++-. ......+..|+.+|++|+|||||++++ .|.+++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457888999999999999997 679999999998743 355678899999999999999999999 4555555 8999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCC-CceEeecccccceeeCCCCceEEeecCccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA-QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~-~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
|||+.+|+|...++..+.....+++.++|+++.|++.||.++|+.-. .-|+||||||.||+|+.+|.+||+|||+++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999998888777889999999999999999999998432 23899999999999999999999999999999
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
....+.. ...+|||.||+||.+...+|+.|+||||+||++|||+.-++||.+++-...... +..++.+.+.
T Consensus 179 ~s~~tfA--~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~K-------I~qgd~~~~p 249 (375)
T KOG0591|consen 179 SSKTTFA--HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKK-------IEQGDYPPLP 249 (375)
T ss_pred cchhHHH--HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHH-------HHcCCCCCCc
Confidence 8765443 347899999999999999999999999999999999999999988732221111 1222222221
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
+ .-....+..++..|+..||+.||+...++..+..
T Consensus 250 ~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 D--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred H--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1 2234456666677999999999996655554443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=368.60 Aligned_cols=251 Identities=27% Similarity=0.457 Sum_probs=207.5
Q ss_pred eeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCCh
Q 005450 351 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 430 (696)
Q Consensus 351 ~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL 430 (696)
...+.||+|-||.||.|.++....||+|.++......+.|.+|+.+|++|+|+|||+++++|..+..++||||||+.|+|
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 45688999999999999998888999999998777778899999999999999999999999998899999999999999
Q ss_pred hhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccc
Q 005450 431 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 510 (696)
Q Consensus 431 ~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~ 510 (696)
.++|... ....+...+.+.++.|||+|++||++ +++|||||-..|||++++..+||+|||||+...++... ...
T Consensus 289 l~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~-~~~ 362 (468)
T KOG0197|consen 289 LDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT-ASE 362 (468)
T ss_pred HHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCcee-ecC
Confidence 9999862 23468889999999999999999999 99999999999999999999999999999954443322 212
Q ss_pred cccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCC
Q 005450 511 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 589 (696)
Q Consensus 511 ~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~ 589 (696)
...-..-|.|||.+..++++.|||||||||+||||+| |+.|+......+....+........ |.. -
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~---------P~~----C 429 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR---------PEG----C 429 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---------CCC----C
Confidence 2233557999999999999999999999999999999 9999987665444433332221111 111 2
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 590 YDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 590 ~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
++ .+..++..||+.+|++|||+..+...|+.
T Consensus 430 P~---~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 430 PD---EVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred CH---HHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 22 34556677999999999999988877754
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.29 Aligned_cols=259 Identities=24% Similarity=0.428 Sum_probs=202.1
Q ss_pred hcCceeeeeeeccCceEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec-C
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-N 416 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~-~ 416 (696)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.. ......+.+|+.++..+ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46799999999999999999973 23568999999753 23456789999999999 899999999998764 4
Q ss_pred ceEEEEeecCCCChhhhhhcCCCC--------------------------------------------------------
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKD-------------------------------------------------------- 440 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~-------------------------------------------------------- 440 (696)
.+++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 589999999999999998753210
Q ss_pred --CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccccccccCCC
Q 005450 441 --PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 518 (696)
Q Consensus 441 --~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y 518 (696)
...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 1347888999999999999999999 89999999999999999999999999999866443322222334567899
Q ss_pred CCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHH
Q 005450 519 LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMV 597 (696)
Q Consensus 519 lAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~ 597 (696)
+|||++.+..++.++|||||||+||||++ |..||......... ... +..+... .... .....+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~--~~~----~~~~~~~-----~~~~----~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF--CQR----LKDGTRM-----RAPE----NATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH--HHH----HhcCCCC-----CCCC----CCCHHHH
Confidence 99999998899999999999999999997 99999765432211 110 0111100 0111 1123455
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 598 LASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 598 ~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.++..||+.||.+|||+.++++.|+.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHH
Confidence 67777999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=346.93 Aligned_cols=261 Identities=26% Similarity=0.359 Sum_probs=208.0
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChh---HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~---~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
.|.....+|+|+||.||+++.+ +|+.||||.+..+++ ..+-.++||++|++++|+|+|.|+++|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4677789999999999999965 699999999987543 356678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
++. ++.+-|.... ..++...+.+++.|++.|+.|+|+ +++|||||||+||||+.++.+||||||+|+.+....
T Consensus 83 ~dh-TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 83 CDH-TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred cch-HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 988 4444444333 368889999999999999999999 889999999999999999999999999999887522
Q ss_pred CCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhc--------cccc-cC
Q 005450 505 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK--------PILS-SG 574 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~--------~~~~-~g 574 (696)
..+++.+.|.+|.|||.+.+ .+|...+||||+||++.||++|.+.|.+..+.++..++.... .++. ++
T Consensus 156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 34567889999999999886 689999999999999999999999999988877765554321 1111 11
Q ss_pred -----ccccccCcc-cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 575 -----KVTQLLDPA-LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 575 -----~l~~llD~~-L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+.+.-++. +...+ +....-++.++..|++.||.+|++-++++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 122221111 11111 112235566777899999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=362.77 Aligned_cols=252 Identities=27% Similarity=0.375 Sum_probs=207.0
Q ss_pred HhhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCce
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~ 418 (696)
...++|...+.||.|+|++||+|.. ..++.||||++.+. +...+-...|-++|.+| .||.|++|+-.|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3456889999999999999999985 57999999999753 23345567899999999 799999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
|+|+||+++|+|.++|++.+ .|++.-.+.++.+|+.||+|||+ +|||||||||+|||||.|+++||+|||-|+
T Consensus 150 YFvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccc
Confidence 99999999999999999876 48899999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCC---------cc--cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhh
Q 005450 499 WASTSSSH---------IT--CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 567 (696)
Q Consensus 499 ~~~~~~~~---------~~--~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~ 567 (696)
.+...... .. ...++||..|.+||++..+..+..+|||+||||||+|+.|.+||.+.++--....++-.
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l 302 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL 302 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence 88653222 11 24489999999999999999999999999999999999999999886643222222211
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 568 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 568 ~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
+-.+...++ +.+. .++...|..||.+|++..+|-++
T Consensus 303 -------------~y~fp~~fp-~~a~---dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 303 -------------DYEFPEGFP-EDAR---DLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -------------cccCCCCCC-HHHH---HHHHHHHccCccccccHHHHhhC
Confidence 112222222 2333 34445788999999999888764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=349.63 Aligned_cols=261 Identities=28% Similarity=0.428 Sum_probs=207.6
Q ss_pred hcCceeeeeeeccCceEEEEEE-eCCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 347 TSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~-~~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.++|.+.+.||.|..++||+|. .+.+..||||++..++ ...+.+.+|+..++.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4678999999999999999997 5778999999998643 446889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
||.+|++.+++...-. ..+.+..+..|+.++++||.|||. +|.||||||+.||||+.+|.+||+|||.+..+-..
T Consensus 105 fMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999986543 358999999999999999999999 89999999999999999999999999998766553
Q ss_pred CCC-ccc-ccccccCCCCCcceecc--CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 504 SSH-ITC-TDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 504 ~~~-~~~-~~~~GT~~YlAPE~l~~--~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
... ... .+++||+.|||||+++. ..|+.|+||||||++.+||.+|..||....+.....+.....+... . ...
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~--~-t~~ 256 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTL--L-TSG 256 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCc--c-ccc
Confidence 321 111 45799999999999653 3799999999999999999999999988766443222211111100 0 111
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
++..-...+ -..+-.++-.||++||.+|||++++++
T Consensus 257 ~~~d~~k~~----~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 257 LDKDEDKKF----SKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CChHHhhhh----cHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111111111 123334455699999999999999986
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=342.50 Aligned_cols=263 Identities=25% Similarity=0.403 Sum_probs=202.7
Q ss_pred cCceeeeeeeccCceEEEEEEeCC-----------------CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPD-----------------GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISL 408 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~-----------------g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l 408 (696)
++|.+.+.||+|+||.||++..++ +..||+|+++.. ......|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999997532 346999999763 3456789999999999999999999
Q ss_pred eeEEEecCceEEEEeecCCCChhhhhhcCCC---------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEe
Q 005450 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 473 (696)
Q Consensus 409 ~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~---------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIH 473 (696)
++++.+.+..++||||+++|+|.+++..... ....++|..++.++.||+.||.|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 9999999999999999999999998864321 11347888999999999999999999 89999
Q ss_pred ecccccceeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh--CCCC
Q 005450 474 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKP 551 (696)
Q Consensus 474 rDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt--G~~P 551 (696)
|||||+|||++.++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986644333222233456889999999998899999999999999999987 5667
Q ss_pred CCCCCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 552 ISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 552 f~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
|........ .......+..... ... .. .+......+..++.+||+.+|.+|||+.+|.+.|+
T Consensus 242 ~~~~~~~~~---~~~~~~~~~~~~~-~~~-~~----~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQV---IENAGEFFRDQGR-QVY-LF----RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHHH---HHHHHHHhhhccc-ccc-cc----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 765433221 1111111111000 000 00 01111235666778899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=333.47 Aligned_cols=201 Identities=29% Similarity=0.434 Sum_probs=183.4
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|...+.||.|+||+|.+++.+ +|..||+|++...+ ...+...+|..+|+.+.||+++++++.|.+.+.+||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46889999999999999999864 68899999998754 34566778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||++||.|..+|+..+ +|++..++.++.||+.||+|||+ ++|++|||||+|||||.+|++||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999998765 58999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccch
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 560 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~ 560 (696)
. +-+.+|||.|+|||++....|+.++|.|||||++|||+.|.+||..+.+...
T Consensus 197 r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i 249 (355)
T KOG0616|consen 197 R-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI 249 (355)
T ss_pred c-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH
Confidence 3 2348899999999999999999999999999999999999999998877433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.65 Aligned_cols=263 Identities=26% Similarity=0.344 Sum_probs=208.9
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLV 421 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~--~~~~LV 421 (696)
+.|..++.||+|.||.||+|+. .+|+.||+|.++.. ........+||.||++|.||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4577788999999999999984 68999999998753 34566778999999999999999999998876 689999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
+|||+. +|.-++.... ..|+..++..++.||+.||+|+|. +||+|||||.+|||||++|.+||+|||||+++.
T Consensus 197 FeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999987 8998887543 369999999999999999999999 999999999999999999999999999999887
Q ss_pred CCCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc--c
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT--Q 578 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~--~ 578 (696)
...... ++..+-|.+|.|||.+.+. .|+.++|+||.||||.||+.|++.|.+.....|...+-..-.-..+..+. .
T Consensus 270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 755442 5567899999999998865 79999999999999999999999999988777766553322111111111 1
Q ss_pred c-----c------CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 579 L-----L------DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 579 l-----l------D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+ + ...+.+.+ .......+.++-.+|..||.+|.|+.++|+
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~-~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETF-KDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHHh-ccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1 1 11111110 001123344455588899999999999986
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.42 Aligned_cols=263 Identities=22% Similarity=0.306 Sum_probs=212.1
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHH--HHHHHHHHhcC-CcceeEEeeEEEecC-ceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEF--VLEIEIITTLH-HKNIISLLGFCFEDN-NLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~--~~Ei~iL~~L~-HpnIV~l~g~~~~~~-~~~LV 421 (696)
-++|.+.+.||.|.||.||+|.. .+|..||||.++..-...++. ++|+..|++|+ |||||+|++++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 46788999999999999999984 578999999998754444443 47999999999 999999999999887 99999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
||||+. +|++++..+. ..|++..++.|+.||++||+|+|. +|+.|||+||+|||+..+..+||+|||+|+...
T Consensus 89 fE~Md~-NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhhh-hHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence 999976 9999998763 379999999999999999999999 999999999999999988899999999999766
Q ss_pred CCCCCcccccccccCCCCCcceec-cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC------
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG------ 574 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~-~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g------ 574 (696)
... .++..+.|.+|.|||++. .+.|+.+.|+|++|||++|+.+-++.|.+.+..++...+..........
T Consensus 162 Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 543 345678999999999765 6789999999999999999999999999888777665544322111111
Q ss_pred ccccccCc--------ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 575 KVTQLLDP--------ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 575 ~l~~llD~--------~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.+...++= .+..-+ .......+.++..|+..||.+|||+.+.+++
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111111 111111 1244567777778999999999999999985
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=335.95 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=198.9
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.|...+.||+|+||.||++.. .+|+.||+|.+.... .....+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 478889999999999999985 579999999987532 233467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+++|+|..++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999999988864322 258899999999999999999999 89999999999999999999999999999875433
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... ..... ..
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~~~~~------~~ 223 (285)
T cd05631 156 ET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR---VKEDQ------EE 223 (285)
T ss_pred Ce---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH---hhccc------cc
Confidence 22 22357999999999999999999999999999999999999999865432221111100 00000 00
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLK 619 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPS-----m~eVL~ 619 (696)
+...+ ...+..++..||+.||.+||+ ++++++
T Consensus 224 ~~~~~----s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 224 YSEKF----SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CCccC----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11111 234555667799999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=352.08 Aligned_cols=250 Identities=25% Similarity=0.332 Sum_probs=204.0
Q ss_pred HhhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----h--hHHHHHHHHHHHHHhcC-CcceeEEeeEEEecC
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----E--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDN 416 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~--~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~ 416 (696)
...+.|.+.+.||+|+||+|++|.. .+|..||+|++... . ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3467899999999999999999975 57899999987653 1 23456778999999999 999999999999999
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC-CceEEeecC
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFG 495 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~-~~vKL~DFG 495 (696)
..++||||+.||+|.+++...+ .+.+..+.+++.|++.|++|+|+ +||+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999998733 57889999999999999999999 999999999999999999 999999999
Q ss_pred ccccccCCCCCcccccccccCCCCCcceeccCC-CC-CcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccccc
Q 005450 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK-VN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 573 (696)
Q Consensus 496 lA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~-~s-~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 573 (696)
++..... ......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+.........+....
T Consensus 167 ~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~----- 239 (370)
T KOG0583|consen 167 LSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE----- 239 (370)
T ss_pred cccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC-----
Confidence 9997741 122334588999999999999877 76 68999999999999999999998754332222211110
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 574 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 574 g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
-.+...++ ...+..++..|+..+|.+|+++.++++
T Consensus 240 ~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 240 FKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 01111111 234455666799999999999999984
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.28 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=198.5
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecC--ceEEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLLLVY 422 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~--~~~LV~ 422 (696)
..+|...+.||+|+||+||++... +|...|||.+.... ...+.+.+|+.+|.+++|||||+++|...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345777899999999999999965 49999999987542 22567899999999999999999999855444 699999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC-CCceEEeecCcccccc
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWAS 501 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~-~~~vKL~DFGlA~~~~ 501 (696)
||+++|+|.+++...+. .+++..+..+..||++||.|||+ +|||||||||+||||+. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999987653 48999999999999999999999 99999999999999999 7999999999998776
Q ss_pred CCC-CCcccccccccCCCCCcceeccCC-CCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 502 TSS-SHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 502 ~~~-~~~~~~~~~GT~~YlAPE~l~~~~-~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
... .........||+.|||||++..+. ...++|||||||+++||+||+.||.... .....+ ..+...+...
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~--~~~~~~---~~ig~~~~~P-- 242 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF--EEAEAL---LLIGREDSLP-- 242 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc--chHHHH---HHHhccCCCC--
Confidence 411 112223478999999999999643 3359999999999999999999997641 111111 1111111111
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
.+... -.++...+ ...|+..+|++|||+.++|+..-
T Consensus 243 ---~ip~~-ls~~a~~F---l~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 243 ---EIPDS-LSDEAKDF---LRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ---CCCcc-cCHHHHHH---HHHHhhcCcccCcCHHHHhhChh
Confidence 12111 12333443 44599999999999999998643
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=328.04 Aligned_cols=251 Identities=23% Similarity=0.422 Sum_probs=204.2
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
++|.+.+.||+|+||.||++..+++..+|+|.++........+.+|+++++.++||||++++++|...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 46888999999999999999988888999999886655567889999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
|+|.++++... ..+++..+..++.+++.||.|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 84 GCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 99999987543 258899999999999999999999 89999999999999999999999999999865432211
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~ 586 (696)
......++..|+|||++.+..++.++||||||+++|||++ |+.||...........+ .. +. ....+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i---~~----~~--~~~~~~--- 224 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI---SR----GF--RLYRPK--- 224 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HC----CC--CCCCCC---
Confidence 1112345678999999998899999999999999999999 99999765432221111 11 00 000111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005450 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621 (696)
Q Consensus 587 ~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L 621 (696)
.. ...+..++..||+.+|.+||++.++++.|
T Consensus 225 -~~---~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 -LA---SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -CC---CHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11 23466777789999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=344.17 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=203.1
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||.||+|... +++.||+|+++... .....+.+|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47899999999999999999975 58999999997532 34567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999997543 47889999999999999999999 8999999999999999999999999999986544
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHH-hhhccccccCccccccC
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV-MWAKPILSSGKVTQLLD 581 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv-~~~~~~~~~g~l~~llD 581 (696)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ .|... +.. ....+
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~---~~~~~ 224 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET-LQR---PVYDD 224 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-ccC---CCCCc
Confidence 123367999999999999889999999999999999999999999876543322211 12111 100 00000
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
+. ......+..++..||..+|.+||++.++++.
T Consensus 225 ~~------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 PR------FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cc------cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 1112334456667999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.53 Aligned_cols=255 Identities=22% Similarity=0.417 Sum_probs=208.0
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
.++|.+.+.||+|+||.||+|...++..||+|.+.......+.+.+|+.+++.++|+||+++++++...+..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 35789999999999999999998888999999988766667889999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+++|.+++.... ...+++..++.++.+++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 85 KGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999997543 2357889999999999999999999 89999999999999999999999999999876543221
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
......++..|+|||++..+.++.++|||||||++|+|++ |+.||......... ........ . +..
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~~~~~---~-----~~~- 226 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM---SALQRGYR---M-----PRM- 226 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH---HHHHcCCC---C-----CCC-
Confidence 1122446778999999998899999999999999999998 99999765432211 11111000 0 000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.. ....+..++..|+..+|++||++.++.+.|+.
T Consensus 227 ~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 EN----CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11 11345667778999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=351.34 Aligned_cols=248 Identities=24% Similarity=0.339 Sum_probs=202.4
Q ss_pred HHhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 005450 344 LSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 344 ~~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~ 418 (696)
....++|.+++.||+|+||.||++..+ +|..+|+|++++++ ..++....|-.||....+|+||+|+..|++...+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 446788999999999999999999854 69999999999864 4456778899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
||||||++||++..+|.... .|++..+..++.+++.|++-||+ +|+|||||||+|+|||..|++||+||||+.
T Consensus 217 YLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccc
Confidence 99999999999999997654 58999999999999999999999 999999999999999999999999999985
Q ss_pred cccC-----------------------CCC-----Ccc-----------------cccccccCCCCCcceeccCCCCCcc
Q 005450 499 WAST-----------------------SSS-----HIT-----------------CTDVAGTFGYLAPEYFMYGKVNDKI 533 (696)
Q Consensus 499 ~~~~-----------------------~~~-----~~~-----------------~~~~~GT~~YlAPE~l~~~~~s~ks 533 (696)
-+.. ... ... ....+|||.|+|||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 3211 000 000 0115699999999999999999999
Q ss_pred cchhhHHHHHHHHhCCCCCCCCCccchh-hHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC
Q 005450 534 DVYAFGVVLLELLTGRKPISNDHPKGQE-SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 612 (696)
Q Consensus 534 DVwSLGvvL~ELltG~~Pf~~~~~~~~~-~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RP 612 (696)
|+||||||+||||.|.+||..+.+.... .++.|...+....... ..++... ++..|+. ||++|-
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~-----------~s~eA~D---LI~rll~-d~~~RL 434 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVD-----------LSDEAKD---LITRLLC-DPENRL 434 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCc-----------ccHHHHH---HHHHHhc-CHHHhc
Confidence 9999999999999999999998886644 4555654332211110 1133333 4445666 999998
Q ss_pred C
Q 005450 613 Q 613 (696)
Q Consensus 613 S 613 (696)
-
T Consensus 435 G 435 (550)
T KOG0605|consen 435 G 435 (550)
T ss_pred C
Confidence 7
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=335.82 Aligned_cols=264 Identities=22% Similarity=0.289 Sum_probs=201.3
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
++|.+.+.||+|+||.||++..+ +++.||+|+++.. ....+.+.+|+.++..++||||++++++|...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999975 6788999998753 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|++++.|..+.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99997776554322 258899999999999999999999 89999999999999999999999999999876443
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhc-cc--------cccC
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-PI--------LSSG 574 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~-~~--------~~~g 574 (696)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... +. ....
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred ccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 221 2233579999999999998899999999999999999999999998754332221111110 00 0000
Q ss_pred ccccccCcccCCCCC------hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 575 KVTQLLDPALGNNYD------YDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 575 ~l~~llD~~L~~~~~------~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.......+....... ......+..++..||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000011100000 001234667777899999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.96 Aligned_cols=256 Identities=26% Similarity=0.400 Sum_probs=208.0
Q ss_pred hhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
..++|.+.+.||+|++|.||+|..++++.||+|.++......+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 34678999999999999999999888889999999876655678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++++|.+++.... ...+++..+..++.+++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999997543 2358999999999999999999999 8999999999999999999999999999987763322
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
.. .....++..|+|||++.+..++.++||||||+++|||++ |+.||...........+. . ....
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---~---~~~~-------- 223 (261)
T cd05068 159 EA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD---Q---GYRM-------- 223 (261)
T ss_pred cc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---c---CCCC--------
Confidence 11 111223467999999998899999999999999999999 999997654322111111 0 0000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.........+..++.+|++.+|.+||++.++++.|+.
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0011122456677788999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.50 Aligned_cols=244 Identities=23% Similarity=0.342 Sum_probs=195.2
Q ss_pred eeeeeccCceEEEEEEeCCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEe----cCceEEEEee
Q 005450 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLVYDF 424 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~----~~~~~LV~Ey 424 (696)
...||+|++|.||+|.. +|+.||||.++... ...+.+.+|+.+|.+++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 78899999997543 225678899999999999999999999977 3468999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++|+|.+++.... .+++.....++.+++.||.|||+. .+++||||||+|||++.++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 99999999997543 588999999999999999999972 378899999999999999999999999998664422
Q ss_pred CCcccccccccCCCCCcceecc--CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~--~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+... ... +
T Consensus 178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~-----~~~------~ 241 (283)
T PHA02988 178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK-----NNS------L 241 (283)
T ss_pred -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-----CCC------C
Confidence 12468999999999975 68999999999999999999999999865433221111100 000 0
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.+ +......+..++..||+.||++|||+.++++.|+.
T Consensus 242 ~~----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 242 KL----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred CC----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 01 11112345556677999999999999999998863
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=324.86 Aligned_cols=263 Identities=26% Similarity=0.362 Sum_probs=214.4
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.+|...+.||+|.||.||+|++ .+|+.||||.++..+ .......+||+.|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677889999999999999985 689999999998643 234578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
||+. +|+..+..... .++...+..++.++++||+|||. +.|+||||||.|+||+.+|.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIkd~~i---~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNI---ILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhccccc---ccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9977 99999976543 68889999999999999999999 88999999999999999999999999999988775
Q ss_pred CCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCc---cccc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK---VTQL 579 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~---l~~l 579 (696)
..... ..+-|.+|.|||.+.+. .|+..+|+||.|||+.||+-|.+-|.++.+.+|...+-.+........ +..+
T Consensus 155 ~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 155 NRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred Ccccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 54433 34789999999988755 699999999999999999999999998888777666543332222211 1111
Q ss_pred cC---------cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 580 LD---------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 580 lD---------~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.| +.+.. .-.......+.+...++..||.+|++++|++++
T Consensus 233 pdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 22211 223344555777778999999999999999874
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=351.82 Aligned_cols=258 Identities=24% Similarity=0.385 Sum_probs=202.1
Q ss_pred cCceeeeeeeccCceEEEEEEe------CCCCEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCce
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~------~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~ 418 (696)
++|.+.+.||+|+||.||+|.. .++..||||+++... ...+.+.+|+.++..+ +||||++++++|..++..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4578889999999999999863 346689999997543 3456788999999999 899999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCC-----------------------------------------------------------
Q 005450 419 LLVYDFLSRGSLEENLHGNKK----------------------------------------------------------- 439 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~----------------------------------------------------------- 439 (696)
++||||+++|+|.+++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999999864321
Q ss_pred ------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 440 ------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 440 ------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 01247889999999999999999999 899999999999999999999999999998665433222
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~ 586 (696)
......++..|+|||++....++.++|||||||++|||++ |..||....... ....+.. .+.. +.. .
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~----~~~~-----~~~-~ 339 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIK----EGYR-----MLS-P 339 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHH----hCcc-----CCC-C
Confidence 2222345678999999999999999999999999999998 899986543221 1111111 1100 000 0
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 587 ~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.... ..+..++..||+.||++||++.+|++.|+.
T Consensus 340 ~~~~---~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 340 ECAP---SEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1112 245566677999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.32 Aligned_cols=263 Identities=21% Similarity=0.327 Sum_probs=200.0
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
++|.+.+.||.|+||.||+|... +++.||+|+++... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999864 68899999987532 2345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++ +|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 985 8998886443 247889999999999999999999 899999999999999999999999999997654322
Q ss_pred CCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC---------
Q 005450 505 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG--------- 574 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g--------- 574 (696)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..........
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred c--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 1 1223568999999998865 468999999999999999999999998765443322221111100000
Q ss_pred ccccccCcccCCCC----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 575 KVTQLLDPALGNNY----DYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 575 ~l~~llD~~L~~~~----~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+...+.+...... ..........++..||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11111111100000 0011234556777899999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=337.99 Aligned_cols=244 Identities=25% Similarity=0.297 Sum_probs=199.5
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||.||++... +|+.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999865 68999999987532 34566889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999997543 47889999999999999999999 8999999999999999999999999999986643
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
.. ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+... ..
T Consensus 154 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------~~------ 215 (291)
T cd05612 154 RT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-------KL------ 215 (291)
T ss_pred Cc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------Cc------
Confidence 21 2356999999999999888999999999999999999999999775443222111111 00
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 620 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPS-----m~eVL~~ 620 (696)
.+...+ ...+..++..||+.||.+||+ +.++++.
T Consensus 216 ~~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 EFPRHL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCccC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011111 123445666799999999995 7777753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.73 Aligned_cols=257 Identities=28% Similarity=0.482 Sum_probs=205.5
Q ss_pred cCceeeeeeeccCceEEEEEEeCC------CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~------g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
++|.+.+.||+|+||.||+|.... ...||+|.++.. ......+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 367888999999999999998533 257999998753 344567899999999999999999999999989999
Q ss_pred EEEeecCCCChhhhhhcCCCC------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC
Q 005450 420 LVYDFLSRGSLEENLHGNKKD------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 487 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~------------~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~ 487 (696)
++|||+++++|.+++...... ...+++..++.++.|++.||.|||+ ++++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 999999999999999754211 1357889999999999999999999 8999999999999999999
Q ss_pred ceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhh
Q 005450 488 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 566 (696)
Q Consensus 488 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~ 566 (696)
.++|+|||+++...............+++.|+|||++..+.++.++|||||||++|||++ |..||.+.........+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~- 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR- 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 999999999986544332222233567889999999998899999999999999999998 999997655432222111
Q ss_pred hccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 567 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 567 ~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.+.... .+......+..++..||+.+|.+||++.+|++.|+.
T Consensus 241 ------~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 241 ------SRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ------cCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111 011122456667778999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.21 Aligned_cols=240 Identities=25% Similarity=0.361 Sum_probs=194.3
Q ss_pred eeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCC
Q 005450 354 NLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 428 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gG 428 (696)
+.||+|+||.||++.. .+|+.||+|+++.. ......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 47899999999753 234466788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcc
Q 005450 429 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 508 (696)
Q Consensus 429 sL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~ 508 (696)
+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~ 151 (323)
T cd05571 81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--T 151 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--c
Confidence 9999987543 57899999999999999999999 8999999999999999999999999999975432211 1
Q ss_pred cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCC
Q 005450 509 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 588 (696)
Q Consensus 509 ~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~ 588 (696)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. +. ..+...+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~-------~~------~~~p~~~ 218 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------EE------IRFPRTL 218 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc-------CC------CCCCCCC
Confidence 2346799999999999988999999999999999999999999976543222111110 00 0111111
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005450 589 DYDQMERMVLASILCIRRDPRARP-----QMSLVLK 619 (696)
Q Consensus 589 ~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~ 619 (696)
...+..++..||+.||++|| ++.++++
T Consensus 219 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 219 ----SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ----CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 22345566679999999999 7888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=327.97 Aligned_cols=254 Identities=20% Similarity=0.368 Sum_probs=201.7
Q ss_pred hcCceeeeeeeccCceEEEEEEeC----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
.++|.+.+.||+|+||.||+|..+ .+..||+|.++.. ......+.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356899999999999999999753 4568999999864 2445678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+|||++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999997543 258899999999999999999999 89999999999999999999999999987654
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
...... ......++..|+|||++.++.++.++|||||||++|||++ |+.||...........+. .+..
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-------~~~~--- 226 (266)
T cd05064 158 KSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-------DGFR--- 226 (266)
T ss_pred cccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-------CCCC---
Confidence 322111 1112345678999999999999999999999999999775 999997654332211111 1100
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
..... .....+..++..||+.+|.+||++.++++.|..
T Consensus 227 --~~~~~----~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 --LPAPR----NCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred --CCCCC----CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 00111 112345566777999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=354.15 Aligned_cols=246 Identities=26% Similarity=0.424 Sum_probs=205.0
Q ss_pred CceeeeeeeccCceEEEEEE-eCCCCEEEEEEecCChhH-HHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 349 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDV-IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~-~~~g~~vAVK~l~~~~~~-~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
.|.....||+|+.|.||.+. ..+++.||||++...... .+-+.+|+.+|+..+|+|||++++.|..++++++|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 46667889999999999998 457899999999876544 4457799999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
||+|.+.+... .+++.++..|+.+++.||+|||. ++|||||||.+|||++.+|.+||+|||++..+.....
T Consensus 354 ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 354 GGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 99999998754 38899999999999999999999 9999999999999999999999999999988776544
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhc-cccccCccccccCcccC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-PILSSGKVTQLLDPALG 585 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~-~~~~~g~l~~llD~~L~ 585 (696)
.....+|||.|||||++....|++|.||||||++++||+.|.+||..+.+.....++.-.. +.+ +..+.+
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~l---k~~~kl----- 495 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKL---KNPEKL----- 495 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCc---CCcccc-----
Confidence 3345789999999999999999999999999999999999999998876654443332211 100 111111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..+++ .+..+||+.||++||++.|+|+
T Consensus 496 ----S~~~k---dFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 496 ----SPELK---DFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ----CHHHH---HHHHHHhhcchhcCCCHHHHhc
Confidence 12223 3444699999999999999997
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.04 Aligned_cols=244 Identities=26% Similarity=0.371 Sum_probs=199.3
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||.||+|... +++.||+|+++... ...+.+.+|+.++.+++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57899999999999999999865 68999999997532 34567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999997543 47888999999999999999999 8999999999999999999999999999986644
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
.. ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+. .+.+
T Consensus 171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~-------~~~~------ 232 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL-------AGRL------ 232 (329)
T ss_pred Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh-------cCCc------
Confidence 22 23579999999999998899999999999999999999999997654322111111 1110
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 620 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPS-----m~eVL~~ 620 (696)
.+...++ ..+..++..||+.||.+||+ +.++++.
T Consensus 233 ~~p~~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 KFPNWFD----GRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCCCC----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0111111 23455667799999999997 5666653
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=349.91 Aligned_cols=258 Identities=25% Similarity=0.422 Sum_probs=201.7
Q ss_pred cCceeeeeeeccCceEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCce
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~ 418 (696)
++|.+.+.||+|+||.||++.. .++..||+|+++.. ......+.+|+++++.+ +||||++++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 3688899999999999999873 23467999999753 34456788999999999 899999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCC-----------------------------------------------------------
Q 005450 419 LLVYDFLSRGSLEENLHGNKK----------------------------------------------------------- 439 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~----------------------------------------------------------- 439 (696)
++||||+++|+|.+++.....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999998854211
Q ss_pred -------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccccc
Q 005450 440 -------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 512 (696)
Q Consensus 440 -------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 512 (696)
....+++..+++|+.||+.||.|||+ ++|+||||||+|||+++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 11247888999999999999999999 89999999999999999999999999999866543322222233
Q ss_pred cccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCChH
Q 005450 513 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 591 (696)
Q Consensus 513 ~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~ 591 (696)
.+++.|+|||++....++.++|||||||++|||++ |+.||............. . .+ ..+..... .
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~--~----~~-----~~~~~~~~-~-- 340 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV--K----RG-----YQMSRPDF-A-- 340 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH--H----cc-----cCccCCCC-C--
Confidence 45678999999998899999999999999999997 999997654322111110 0 00 00000011 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 592 QMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 592 e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
...+..++..||+.+|.+||++.+|+++|+.
T Consensus 341 -~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 341 -PPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred -CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1345556667999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=352.87 Aligned_cols=262 Identities=28% Similarity=0.455 Sum_probs=206.3
Q ss_pred HHhhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 344 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 344 ~~~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
..-.+++.+...||+|.||+||+|.+.. .||||+++. +.+..+.|.+|+..+++-+|.||+-+.|||..... .|
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 3344566788999999999999999743 599999985 45678899999999999999999999999988766 99
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
|+.+|+|-+|+.+||-.. ..|...+.+.|+.||++|+.|||. ++|||||||+.||||.+++.|||+||||+..-
T Consensus 465 iTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeee
Confidence 999999999999999655 468999999999999999999999 99999999999999999999999999999754
Q ss_pred cCCCCCcccccccccCCCCCcceecc---CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~---~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
..-..........|...|||||+++. ..|+..+||||||+|+|||++|..||..... ++ +.|.. |+-.
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-dq---IifmV-----GrG~ 609 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-DQ---IIFMV-----GRGY 609 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-hh---eEEEe-----cccc
Confidence 43333333344668899999999873 3699999999999999999999999984332 22 11111 1111
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCcc
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 626 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~~ 626 (696)
-..|.......-..++++ +...||..++++||.+.+|+..|+....
T Consensus 610 l~pd~s~~~s~~pk~mk~---Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 610 LMPDLSKIRSNCPKAMKR---LLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cCccchhhhccCHHHHHH---HHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 111221111122334444 4555999999999999999997765543
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=328.32 Aligned_cols=257 Identities=26% Similarity=0.453 Sum_probs=205.0
Q ss_pred hcCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~ 418 (696)
..+|.+.+.||+|+||.||+|... +++.||||+++... ...+.+.+|++++..++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 346788899999999999999863 34789999997643 3467899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCC----------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc
Q 005450 419 LLVYDFLSRGSLEENLHGNKK----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 488 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~----------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~ 488 (696)
++||||+++++|.+++..... ....+++..+..++.+++.||.|||+ ++++||||||+|||++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 999999999999999975431 22457899999999999999999999 89999999999999999999
Q ss_pred eEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhh
Q 005450 489 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 567 (696)
Q Consensus 489 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~ 567 (696)
+||+|||++................+++.|+|||++.++.++.++|||||||++|||++ |+.||........ +...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH
Confidence 99999999976543322222223456788999999999999999999999999999998 9999976543222 1111
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 568 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 568 ~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
. .+..... +......+..++..||+.+|.+||++.||++.|+
T Consensus 238 ~----~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T----QGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H----cCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 1111110 0111234556677799999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=328.10 Aligned_cols=258 Identities=21% Similarity=0.396 Sum_probs=203.4
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 417 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~ 417 (696)
.+++|.+.+.||+|+||.||+|... .+..||+|.+.... ....++.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999998743 35679999986532 345678899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCCC------CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEE
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKD------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 491 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~------~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL 491 (696)
.++||||+++++|.+++...... ...+++..+..++.|++.||.|||+ .+++||||||+|||+++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998653321 2346788999999999999999999 89999999999999999999999
Q ss_pred eecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccc
Q 005450 492 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPI 570 (696)
Q Consensus 492 ~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~ 570 (696)
+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||...........+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~----- 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM----- 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----
Confidence 99999986544332222222456788999999998899999999999999999999 788987654322211111
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 571 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 571 ~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
.+.... +... ....+..++.+|++.+|++|||+.++++.|+
T Consensus 236 --~~~~~~-----~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 --EGGLLD-----KPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred --cCCcCC-----CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 011100 0111 1134566777899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=336.36 Aligned_cols=201 Identities=26% Similarity=0.418 Sum_probs=177.1
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.++|.+.+.||+|+||.||++... +|..+|+|++... ....+.+.+|++++.+++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999865 6889999998753 3455789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+++++|.+++.... .+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999997543 478899999999999999999971 36999999999999999999999999999765432
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~ 557 (696)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 158 ~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 207 (331)
T cd06649 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA 207 (331)
T ss_pred c----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2 1235699999999999988999999999999999999999999975443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=355.54 Aligned_cols=242 Identities=23% Similarity=0.373 Sum_probs=201.6
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~ 419 (696)
..++|...++||+|.||+|+++..+ +++.||||++++. ++.++..+.|.+|+.... ||++++|+.+|+..+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4578999999999999999999965 6789999999974 467888899999998886 999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+||||+.||++..+.+.. .|++..+..++.+|+.||+|||+ ++|||||||.+|||||.+|++||+|||+++.
T Consensus 446 fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence 999999999955444322 58999999999999999999999 9999999999999999999999999999985
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
.-.... ...+++|||.|||||++.+..|+..+|+|||||+|||||.|..||.+++.++.-.-+...
T Consensus 518 ~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d------------ 583 (694)
T KOG0694|consen 518 GMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND------------ 583 (694)
T ss_pred cCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------
Confidence 542222 345699999999999999999999999999999999999999999987765443222211
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQM 614 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm 614 (696)
|+.. +.......+.++...|.++|++|.-+
T Consensus 584 -~~~y----P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 -EVRY----PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCCC----CCcccHHHHHHHHHHhccCcccccCC
Confidence 1111 22223344555566899999999987
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=355.71 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=201.4
Q ss_pred ceeeeeeeccCceEEEEEEeC-C-CCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 350 FLAENLIGKGGSSQVYKGCLP-D-GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~-~-g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
|.+.+.||+|+||.||+|... + +..||+|.+.... .....+.+|+.++..++||||++++++|..++.++|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 889999999999999999854 3 6778888775433 444567889999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+|+|.+++.........+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 999999886543334468899999999999999999999 89999999999999999999999999999876554332
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~ 586 (696)
......+||++|+|||++.+..++.++|||||||++|||++|+.||...........+.. +... + +..
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~-------~~~~----~-~~~ 293 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY-------GKYD----P-FPC 293 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCCC----C-CCc
Confidence 223346799999999999989999999999999999999999999976543221111111 1110 0 001
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 587 ~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. ....+..++..||+.+|.+||++.+++.
T Consensus 294 ~----~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 294 P----VSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred c----CCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1 1124555667799999999999999875
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=337.92 Aligned_cols=262 Identities=23% Similarity=0.354 Sum_probs=195.6
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-----CceE
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NNLL 419 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~-----~~~~ 419 (696)
+|.+.+.||+|+||.||+|... +|..||||+++.. ......+.+|+++++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4888999999999999999864 7899999998742 23445788999999999999999999988643 2489
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+||||+. ++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 68998886543 48899999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCC-CcccccccccCCCCCcceecc--CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccc-----
Q 005450 500 ASTSSS-HITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL----- 571 (696)
Q Consensus 500 ~~~~~~-~~~~~~~~GT~~YlAPE~l~~--~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~----- 571 (696)
...... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||...........+.......
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 533221 122234679999999999875 678999999999999999999999997654332221111000000
Q ss_pred ---ccCccccccC---cc----cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 572 ---SSGKVTQLLD---PA----LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 572 ---~~g~l~~llD---~~----L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
........++ +. +...+ ......+..++..||+.+|++|||+.++++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000000 00 00000 001123456777899999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=341.19 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=202.1
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||+||+|... +|+.||||+++... .....+..|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999965 78999999997532 44567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999997652 58899999999999999999999 9999999999999999999999999999986654
Q ss_pred CC---------------------------CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCC
Q 005450 503 SS---------------------------SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 555 (696)
Q Consensus 503 ~~---------------------------~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~ 555 (696)
.. .........||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 33 001123357999999999999999999999999999999999999999876
Q ss_pred CccchhhHH-hhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 005450 556 HPKGQESLV-MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLKL 620 (696)
Q Consensus 556 ~~~~~~~lv-~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPS-m~eVL~~ 620 (696)
........+ .|.... .+.. . .. ....+..++..|++ +|.+||+ +.++++.
T Consensus 234 ~~~~~~~~i~~~~~~~----~~p~-----~-~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWKESL----RFPP-----D-PP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccCCcc----cCCC-----C-CC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 533222111 111110 0000 0 00 11234445556887 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=333.81 Aligned_cols=254 Identities=22% Similarity=0.400 Sum_probs=201.6
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCC----EEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~----~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
.+|...+.||+|+||.||+|.+. ++. .||+|.++.. ....+++.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56899999999999999999853 343 4899998753 34567889999999999999999999999764 6789
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999997543 257889999999999999999999 89999999999999999999999999999977
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
.............++..|+|||++....++.++|||||||++|||++ |+.||.+.............. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~------~~--- 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------RL--- 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC------CC---
Confidence 65433322222345778999999999999999999999999999998 999997654322211111000 00
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
..+ .. ....+..++..||+.+|.+||++.+++..|...
T Consensus 231 ~~~---~~----~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 231 PQP---PI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred CCC---CC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 01 112455677789999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=323.22 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=205.4
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
.+|.+.+.||+|+||.||+|... +++.+|+|++.........+.+|++++..++||||+++++++..++..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 46888999999999999999864 58899999998776667789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+++|.+++..... ..+++..++.++.|++.||.|||+ ++++||||||+|||+++++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 86 YGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999875432 358899999999999999999999 89999999999999999999999999999876543221
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
. .....++..|+|||++.+..++.++|||||||++|||++ |..||...........+. .. ..+...
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~---~~---------~~~~~~ 227 (263)
T cd05052 161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---KG---------YRMERP 227 (263)
T ss_pred c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---CC---------CCCCCC
Confidence 1 112334678999999998899999999999999999998 999997654322111111 00 000111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.. ....+..++.+||+.+|.+||++.++++.|+.
T Consensus 228 ~~----~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 228 EG----CPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CC----CCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 11 12345556677999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=328.99 Aligned_cols=263 Identities=22% Similarity=0.336 Sum_probs=195.2
Q ss_pred cCceeeeeeeccCceEEEEEEe--CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhc---CCcceeEEeeEEEe-----
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSE---DVIKEFVLEIEIITTL---HHKNIISLLGFCFE----- 414 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~--~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L---~HpnIV~l~g~~~~----- 414 (696)
.+|.+.+.||+|+||.||+|.. .+++.||+|+++... .....+.+|+.++..+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688999999999999999986 346889999987432 2234566787777766 69999999999852
Q ss_pred cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeec
Q 005450 415 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 494 (696)
Q Consensus 415 ~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DF 494 (696)
...+++||||+. ++|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 599998875432 247899999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC
Q 005450 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 495 GlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
|+++...... ......||+.|+|||++....++.++|||||||++|||++|++||...........+..........
T Consensus 155 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 9998665432 1233569999999999988899999999999999999999999998765433322221111000000
Q ss_pred cccc---ccCcccCC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 575 KVTQ---LLDPALGN-------NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 575 ~l~~---llD~~L~~-------~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.... +....+.. ....+....+..++..||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 1000 00000000 000111234456777899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=340.56 Aligned_cols=204 Identities=26% Similarity=0.395 Sum_probs=177.2
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||+||++... +++.||+|+++.. ......+.+|+.++..++||||+++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999864 6899999999753 233456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999997543 58899999999999999999999 8999999999999999999999999999975432
Q ss_pred CCCC---------------------------------cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCC
Q 005450 503 SSSH---------------------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 549 (696)
Q Consensus 503 ~~~~---------------------------------~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~ 549 (696)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0012357999999999999899999999999999999999999
Q ss_pred CCCCCCCcc
Q 005450 550 KPISNDHPK 558 (696)
Q Consensus 550 ~Pf~~~~~~ 558 (696)
.||......
T Consensus 234 ~Pf~~~~~~ 242 (363)
T cd05628 234 PPFCSETPQ 242 (363)
T ss_pred CCCCCCCHH
Confidence 999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.39 Aligned_cols=255 Identities=25% Similarity=0.435 Sum_probs=204.6
Q ss_pred hcCceeeeeeeccCceEEEEEEeCC----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
.++|.+.+.||+|+||.||+|.... ...||||.++.. ......|.+|+.++..++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4578999999999999999998642 457999998753 3445678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++++|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||+++++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999975432 68999999999999999999999 89999999999999999999999999999977
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
.............+++.|+|||++.+..++.++||||||+++|+|++ |..||........ ....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~~~~---~~~--- 227 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---IKAVEDG---YRL--- 227 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---HHHHHcC---CCC---
Confidence 53222222222345678999999998899999999999999999998 9999965432221 1111100 000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
+. .......+..++..|++.+|++||++.+|++.|..
T Consensus 228 --~~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 228 --PP-----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred --CC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 00 11112345677778999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=323.02 Aligned_cols=252 Identities=24% Similarity=0.402 Sum_probs=203.6
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
++|.+.+.||+|+||.||++...++..+|+|.++........+.+|+.++.+++||||++++++|......++||||+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 46888999999999999999887777899999886655567899999999999999999999999998899999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
|+|.+++..... .+++..++.++.+++.||.|||+ .+++|+||||+|||++.++.+||+|||+++........
T Consensus 84 ~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 84 GCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 999999875432 58999999999999999999999 89999999999999999999999999999865443221
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~ 586 (696)
......++..|+|||++.+..++.++||||||+++|+|++ |+.||...........+.. +... ....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-------~~~~-----~~~~ 224 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-------GLRL-----YRPH 224 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc-------CCCC-----CCCC
Confidence 1112345678999999998889999999999999999998 9999975443221111110 0000 0000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 587 ~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
.....+..++..||+.+|.+||++.++++.|+
T Consensus 225 ----~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 ----LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ----CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11245566777899999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=356.85 Aligned_cols=257 Identities=26% Similarity=0.378 Sum_probs=205.4
Q ss_pred HhhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC----
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN---- 416 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~---- 416 (696)
...++|.+.+.||+|+||+||++.. .+|+.||||++... ......+.+|+.++..++|+||++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457899999999999999999985 57999999998653 345667889999999999999999988775432
Q ss_pred ----ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEe
Q 005450 417 ----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 492 (696)
Q Consensus 417 ----~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~ 492 (696)
.+++||||+++|+|.+++.........+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEE
Confidence 3689999999999999997654444568999999999999999999999 899999999999999999999999
Q ss_pred ecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccc
Q 005450 493 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 572 (696)
Q Consensus 493 DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~ 572 (696)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~------- 258 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL------- 258 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-------
Confidence 9999987654333333334679999999999999899999999999999999999999997654322111110
Q ss_pred cCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 573 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 573 ~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.+.. ++ +... ....+..++..||+.+|.+||++.++++.
T Consensus 259 ~~~~----~~-~~~~----~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRY----DP-LPPS----ISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCC----CC-CCCC----CCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0111 11 1111 12345566677999999999999998863
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=335.73 Aligned_cols=238 Identities=26% Similarity=0.336 Sum_probs=190.7
Q ss_pred eeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCCh
Q 005450 356 IGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 430 (696)
Q Consensus 356 LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL 430 (696)
||+|+||.||++... +++.||+|+++.. ......+.+|+.++.+++||||++++++|...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999865 6889999998752 34456788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccc
Q 005450 431 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 510 (696)
Q Consensus 431 ~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~ 510 (696)
.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 151 (312)
T cd05585 81 FHHLQREG----RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTN 151 (312)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccc
Confidence 99997543 48899999999999999999999 8999999999999999999999999999985433221 123
Q ss_pred cccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCCh
Q 005450 511 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 590 (696)
Q Consensus 511 ~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~ 590 (696)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+ .. +. ..+...++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~------~~-~~------~~~~~~~~- 217 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI------LQ-EP------LRFPDGFD- 217 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH------Hc-CC------CCCCCcCC-
Confidence 467999999999999889999999999999999999999999765432211111 10 00 01111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 005450 591 DQMERMVLASILCIRRDPRARPQ---MSLVLK 619 (696)
Q Consensus 591 ~e~~~l~~la~~Cl~~dP~~RPS---m~eVL~ 619 (696)
..+..++..||+.||.+||+ +.++++
T Consensus 218 ---~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 218 ---RDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred ---HHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 23445566799999999986 455554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=319.58 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=196.1
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCCh
Q 005450 354 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 430 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL 430 (696)
+.||+|+||.||+|... +++.+|+|.+... .+....+.+|+++++.++||||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999864 7899999987643 34567899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccc
Q 005450 431 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 510 (696)
Q Consensus 431 ~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~ 510 (696)
.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.............
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99996433 257899999999999999999999 899999999999999999999999999987654322111111
Q ss_pred cccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCC
Q 005450 511 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 589 (696)
Q Consensus 511 ~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~ 589 (696)
...++..|+|||++..+.++.++||||||+++|||++ |..||...........+....+ ... +
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~------------~~~----~ 218 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR------------LPC----P 218 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC------------CCC----c
Confidence 1233567999999998999999999999999999998 8889865443222111111000 000 1
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 590 YDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 590 ~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
......+..++..|++.+|++||++.++++.|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111234566777899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=337.49 Aligned_cols=241 Identities=26% Similarity=0.367 Sum_probs=194.9
Q ss_pred eeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCC
Q 005450 354 NLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 428 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gG 428 (696)
+.||+|+||.||++.. .+|+.||+|++... ......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999986 46899999999753 244567889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcc
Q 005450 429 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 508 (696)
Q Consensus 429 sL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~ 508 (696)
+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 151 (328)
T cd05593 81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--T 151 (328)
T ss_pred CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--c
Confidence 9999886543 48899999999999999999999 8999999999999999999999999999875433221 1
Q ss_pred cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCC
Q 005450 509 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 588 (696)
Q Consensus 509 ~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~ 588 (696)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+... . ..+...+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-------~------~~~p~~~ 218 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-------D------IKFPRTL 218 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-------C------ccCCCCC
Confidence 23367999999999999889999999999999999999999999765432221111100 0 0111111
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005450 589 DYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 620 (696)
Q Consensus 589 ~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~~ 620 (696)
...+..++..||+.||.+|| ++.++++.
T Consensus 219 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 ----SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 12345566679999999997 88888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.63 Aligned_cols=259 Identities=26% Similarity=0.464 Sum_probs=206.4
Q ss_pred hcCceeeeeeeccCceEEEEEEe------CCCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~------~~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
..+|.+.+.||+|+||.||++.. .++..+|+|.+... ....+.+.+|+.++.+++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 35788999999999999999974 23456899998754 345678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCC---------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceE
Q 005450 420 LVYDFLSRGSLEENLHGNKK---------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 490 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~---------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vK 490 (696)
+||||+++++|.+++..... ....+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 99999999999999875431 22358999999999999999999999 8999999999999999999999
Q ss_pred EeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhcc
Q 005450 491 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKP 569 (696)
Q Consensus 491 L~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~ 569 (696)
|+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~---- 236 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT---- 236 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----
Confidence 999999986654332222233456789999999998899999999999999999998 999987654322111111
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 570 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 570 ~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.+.... .....+ ..+..++..||+.+|.+|||+.++++.|+..
T Consensus 237 ---~~~~~~-----~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 237 ---QGRVLQ-----RPRTCP----KEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred ---cCCcCC-----CCCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111111 111112 3466677789999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.23 Aligned_cols=257 Identities=25% Similarity=0.438 Sum_probs=202.9
Q ss_pred cCceeeeeeeccCceEEEEEEe-----CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-----~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
++|++.+.||+|+||.||+|.. .++..+++|.++.. ......+.+|+++++.++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999974 35678999999753 2445678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCC-------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC
Q 005450 421 VYDFLSRGSLEENLHGNKK-------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 487 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~-------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~ 487 (696)
||||+++++|.+++..... ....+++..+..++.+++.||.|||+ ++|+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 9999999999999853321 12347888999999999999999999 8999999999999999999
Q ss_pred ceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhh
Q 005450 488 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 566 (696)
Q Consensus 488 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~ 566 (696)
.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||...........+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~- 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR- 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 999999999986644322222233456788999999988889999999999999999998 999997654322111111
Q ss_pred hccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 567 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 567 ~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
. ..... ..... ...+..++..|++.+|.+||++.+|+++|++
T Consensus 241 --~----~~~~~-----~~~~~----~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 --K----RQLLP-----CSEDC----PPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --c----CCcCC-----CCCCC----CHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0 00000 11111 1345556677999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=321.94 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=202.4
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
.+|.+.+.||+|+||.||++..+++..+|+|++.........+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 35778899999999999999987788899999876554556788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
++|.+++..... .+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 84 GCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999999975432 58999999999999999999999 899999999999999999999999999998654322111
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~ 586 (696)
.....++..|+|||++.+..++.++||||||+++|+|++ |+.||...........+. .. .....
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---~~---------~~~~~-- 222 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS---AG---------YRLYR-- 222 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH---cC---------CcCCC--
Confidence 111234567999999998899999999999999999999 899997644322111111 00 00001
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005450 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621 (696)
Q Consensus 587 ~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L 621 (696)
+......+..++..||+.+|++|||+.++++.|
T Consensus 223 --~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 --PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111233566777889999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=336.52 Aligned_cols=241 Identities=26% Similarity=0.374 Sum_probs=194.0
Q ss_pred eeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCC
Q 005450 354 NLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 428 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gG 428 (696)
+.||+|+||.||++.. .+|+.||+|+++.. ......+.+|+.++..++||||++++++|...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999986 47899999999753 234566788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcc
Q 005450 429 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 508 (696)
Q Consensus 429 sL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~ 508 (696)
+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 151 (323)
T cd05595 81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--T 151 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--c
Confidence 9999886543 48899999999999999999999 8999999999999999999999999999875322211 1
Q ss_pred cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCC
Q 005450 509 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 588 (696)
Q Consensus 509 ~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~ 588 (696)
.....||+.|+|||++.++.++.++|||||||++|||++|+.||...........+... . ..+...+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-------~------~~~p~~~ 218 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------E------IRFPRTL 218 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------C------CCCCCCC
Confidence 22367999999999999899999999999999999999999999765433221111110 0 0111111
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005450 589 DYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 620 (696)
Q Consensus 589 ~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~~ 620 (696)
+ ..+..++..||+.||.+|| ++.++++.
T Consensus 219 ~----~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 219 S----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred C----HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1 2344566679999999998 78888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=344.66 Aligned_cols=246 Identities=28% Similarity=0.459 Sum_probs=206.3
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
.|.....||+|.||.||+|.+ ..++.||+|++... ++..+++.+|+.+|.+++++||.++|+.+..+..++++|||+
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 466668899999999999986 47889999999864 466788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
.||++.+.|.... .+.+..+..|+.+++.||.|||. .+.+|||||+.|||+..+|.+||+|||++..+.....
T Consensus 94 ~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred cCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999997543 34667777899999999999999 8899999999999999999999999999988877554
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
.. .+++|||.|||||+++...|+.|+||||||++.+||++|.+|+...++.....++. .-..|.+.
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp------------k~~PP~L~ 232 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP------------KSAPPRLD 232 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc------------CCCCCccc
Confidence 43 56899999999999998899999999999999999999999998887743332222 11223343
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+.+. ..++. ++-.||++||+.||++.++++
T Consensus 233 ~~~S-~~~kE---FV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 233 GDFS-PPFKE---FVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccC-HHHHH---HHHHHhhcCcccCcCHHHHhh
Confidence 3222 22333 344499999999999999997
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.69 Aligned_cols=201 Identities=24% Similarity=0.428 Sum_probs=172.2
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 578999999999999999999965 78999999987533 233467789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+. ++|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 58888776433 257889999999999999999999 89999999999999999999999999999754332
Q ss_pred CCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCC
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDH 556 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~ 556 (696)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 157 SH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred Cc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 21 2233568999999998865 458889999999999999999999997653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=340.00 Aligned_cols=254 Identities=22% Similarity=0.350 Sum_probs=197.0
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
+.|...+.||+|+||+||+|.. .+++.||+|++... ......+.+|++++..++||||+++++++.+.+.+++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 3688999999999999999985 46889999999753 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 81 DYIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred ecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 9999999999997543 47888999999999999999999 8999999999999999999999999999864321
Q ss_pred CCC---------------------------------------------CcccccccccCCCCCcceeccCCCCCcccchh
Q 005450 503 SSS---------------------------------------------HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYA 537 (696)
Q Consensus 503 ~~~---------------------------------------------~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwS 537 (696)
... ........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 000 00012357999999999999889999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCccchh-hHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005450 538 FGVVLLELLTGRKPISNDHPKGQE-SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSL 616 (696)
Q Consensus 538 LGvvL~ELltG~~Pf~~~~~~~~~-~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~e 616 (696)
|||++|||++|+.||......... ..+.|..... +. +. ..++ .+...++.. +.|+..+|..||++.+
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~----~~--~~~s-~~~~dli~~-ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWENTLH----IP----PQ--VKLS-PEAVDLITK-LCCSAEERLGRNGADD 301 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccC----CC----CC--CCCC-HHHHHHHHH-HccCcccccCCCCHHH
Confidence 999999999999999875543221 1222211100 00 00 0112 223333222 2377778888999999
Q ss_pred HHHH
Q 005450 617 VLKL 620 (696)
Q Consensus 617 VL~~ 620 (696)
+++.
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=340.07 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=197.3
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||+||++... +|+.||||+++.. ......+.+|+.++..++||||++++++|.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999864 6899999999753 234456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999997543 48899999999999999999999 8999999999999999999999999999976532
Q ss_pred CCCCc------------------------------------ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHH
Q 005450 503 SSSHI------------------------------------TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 546 (696)
Q Consensus 503 ~~~~~------------------------------------~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELl 546 (696)
..... .....+||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 21100 011246999999999999899999999999999999999
Q ss_pred hCCCCCCCCCccchhh-HHhhhccccccCccccccCcccCCC-CChHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 005450 547 TGRKPISNDHPKGQES-LVMWAKPILSSGKVTQLLDPALGNN-YDYDQMERMVLASILCIRRDPRARPQ---MSLVLKL 620 (696)
Q Consensus 547 tG~~Pf~~~~~~~~~~-lv~~~~~~~~~g~l~~llD~~L~~~-~~~~e~~~l~~la~~Cl~~dP~~RPS---m~eVL~~ 620 (696)
+|+.||.......... +..|..... +... .-.+.+.. ++..|+. +|.+|++ +.++++.
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~~~~~------------~~~~~~~s~~~~~---li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWKETLQ------------FPDEVPLSPEAKD---LIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCccC------------CCCCCCCCHHHHH---HHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999998765432211 111211100 0000 01223333 3344775 9999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=324.25 Aligned_cols=250 Identities=34% Similarity=0.544 Sum_probs=193.1
Q ss_pred eeeeeeeccCceEEEEEEeC-----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 351 LAENLIGKGGSSQVYKGCLP-----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 351 ~~~~~LG~G~fG~Vyka~~~-----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
...+.||.|.||.||+|... .+..|+||.++.. ....+.|.+|++++.+++||||++++|+|...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35688999999999999976 3567999999753 3457899999999999999999999999998888999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+++|+|.++|.... ...+++..+..|+.||+.||.|||+ ++++|+||+++|||++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 999999999998762 2358999999999999999999999 88999999999999999999999999999877333
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
..........+...|+|||.+....++.++||||||+++|||++ |+.||...........+... .....
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~-------~~~~~--- 226 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG-------QRLPI--- 226 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT-------EETTS---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------cccee---
Confidence 22222233457788999999998899999999999999999999 78998665332211111111 11000
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L 621 (696)
+......+..++..||..+|++||++.++++.|
T Consensus 227 ------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 ------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111123355667779999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.20 Aligned_cols=260 Identities=26% Similarity=0.405 Sum_probs=206.3
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecC
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 416 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~ 416 (696)
..++|...+.||+|+||.||++... ....+|+|.+... ......+.+|++++.++ +||||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3467889999999999999999853 2367999998753 34456788999999999 7999999999999999
Q ss_pred ceEEEEeecCCCChhhhhhcCC------------CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC
Q 005450 417 NLLLVYDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 484 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~------------~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd 484 (696)
..+++|||+++|+|..+++... .....+++..++.++.|++.||.|||+ ++|+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 9999999999999999996532 223468899999999999999999999 8999999999999999
Q ss_pred CCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhH
Q 005450 485 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 563 (696)
Q Consensus 485 ~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~l 563 (696)
.++.+||+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||...........
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 999999999999987655332222222345678999999988899999999999999999998 9999976543222111
Q ss_pred HhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 564 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 564 v~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.. .+.. ...+......+..++..|++.+|.+|||+.++++.|+..
T Consensus 247 ~~-------~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 247 LK-------EGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HH-------cCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11 0000 001112234566677889999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=321.66 Aligned_cols=257 Identities=21% Similarity=0.393 Sum_probs=205.3
Q ss_pred hcCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~ 418 (696)
.++|.+.+.||+|+||.||+|... .+..||+|.+.... .....+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 457899999999999999999864 24689999987543 4456788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCC------CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEe
Q 005450 419 LLVYDFLSRGSLEENLHGNKKD------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 492 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~------~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~ 492 (696)
++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence 9999999999999999754321 1247889999999999999999999 899999999999999999999999
Q ss_pred ecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhcccc
Q 005450 493 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPIL 571 (696)
Q Consensus 493 DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~ 571 (696)
|||+++...............+|..|+|||.+..+.++.++|||||||++|||++ |..||...........+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~------ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI------ 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh------
Confidence 9999986554332222233457889999999998899999999999999999998 999997654332221111
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 572 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 572 ~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
.+.... ..... ...+..++..||+.+|.+|||+.++++.|+
T Consensus 236 -~~~~~~-----~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -DGGHLD-----LPENC----PDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -cCCCCC-----CCCCC----CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111 11111 245666777899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=337.07 Aligned_cols=251 Identities=21% Similarity=0.260 Sum_probs=198.8
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||+||++... +|+.||+|+++... ...+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999864 78999999998542 34567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999997652 258899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCcccccccccCCCCCcceec------cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFM------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~------~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...........+.... ..
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~------~~ 227 (330)
T cd05601 155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ------RF 227 (330)
T ss_pred CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC------Cc
Confidence 3322 222357999999999986 4568899999999999999999999997655432211111100 00
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..+ ... ......+..++..|++ +|.+||++.++++
T Consensus 228 ~~~-----~~~--~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 LKF-----PED--PKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cCC-----CCC--CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 000 000 0111233445556887 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=338.31 Aligned_cols=244 Identities=23% Similarity=0.316 Sum_probs=198.5
Q ss_pred cCceeeeeeeccCceEEEEEEeCC--CCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPD--GKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~--g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
++|.+.+.||+|+||.||+|...+ +..||+|++... ......+.+|+.++..++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468999999999999999998543 368999998643 23456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 110 ~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999997553 48899999999999999999999 899999999999999999999999999998664
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....+......+. .+..
T Consensus 183 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~-------~~~~----- 245 (340)
T PTZ00426 183 TRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL-------EGII----- 245 (340)
T ss_pred CCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh-------cCCC-----
Confidence 321 23579999999999998889999999999999999999999998654432211111 0100
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 620 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~~ 620 (696)
.+....+ ..+..++..|++.+|.+|+ ++.++++.
T Consensus 246 -~~p~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -YFPKFLD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -CCCCCCC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0111111 2244566679999999995 88888764
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.36 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=195.7
Q ss_pred CceeeeeeeccCceEEEEEEe----CCCCEEEEEEecCC-----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCce
Q 005450 349 NFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPS-----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~----~~g~~vAVK~l~~~-----~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~ 418 (696)
+|.+.+.||+|+||.||++.. .+++.||+|++... ....+.+..|+.++..+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999875 36889999998742 23345678899999999 499999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999987543 48899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 499 WASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 499 ~~~~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
......... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.. ....
T Consensus 154 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~--~~~~----- 225 (332)
T cd05614 154 EFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR--RILK----- 225 (332)
T ss_pred cccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH--HHhc-----
Confidence 654332221 1236799999999998765 478899999999999999999999975433222111110 0000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 620 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~~ 620 (696)
.++.+...++ ..+..++..||+.||.+|| ++.++++.
T Consensus 226 --~~~~~~~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 --CDPPFPSFIG----PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --CCCCCCCCCC----HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0111111111 2334456679999999999 66777753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.34 Aligned_cols=266 Identities=26% Similarity=0.376 Sum_probs=201.2
Q ss_pred ceeeeeeeccCceEEEEEEe-----CCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceEE
Q 005450 350 FLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLL 420 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~-----~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~--~~~~L 420 (696)
|...+.||+|+||+||++.. .++..||+|+++... .....+.+|+++++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988652 467899999997643 3557788999999999999999999998753 35899
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++++|.+++... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++...
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999999653 48999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcc-cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 501 STSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 501 ~~~~~~~~-~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
........ .....++..|+|||++....++.++||||||+++|||++|+.||........ ....+.........+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhh
Confidence 54322111 1123456779999999888999999999999999999999999865432111 111111111111111112
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
++.......+......+..++..||+.+|++|||+.++++.|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 221111111222234566677789999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.49 Aligned_cols=258 Identities=24% Similarity=0.437 Sum_probs=206.3
Q ss_pred cCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
.+|.+.+.||+|+||.||++... ++..+++|.+.... ...+.+.+|++++.+++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888999999999999999742 45678999987644 345678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc
Q 005450 421 VYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 488 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~ 488 (696)
||||+++++|.+++..... ....+++..++.++.+|+.||.|||+ ++|+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 9999999999999975431 12358999999999999999999999 89999999999999999999
Q ss_pred eEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhh
Q 005450 489 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 567 (696)
Q Consensus 489 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~ 567 (696)
++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |+.||......... ...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~~~ 238 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI---ECI 238 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH
Confidence 99999999986654332222233557889999999998899999999999999999999 99998765443221 111
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 568 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 568 ~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
..+..... .. .....+..++.+||+.+|.+||++.+|+++|+..
T Consensus 239 ----~~~~~~~~-----~~----~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 239 ----TQGRVLER-----PR----VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred ----hCCCCCCC-----Cc----cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11111111 00 1123456677789999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=337.91 Aligned_cols=258 Identities=24% Similarity=0.426 Sum_probs=202.0
Q ss_pred cCceeeeeeeccCceEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEe-cCc
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFE-DNN 417 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~-~~~ 417 (696)
++|.+.+.||+|+||.||+|.. .+++.||+|+++.. ....+.+.+|+.++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 4788999999999999999963 23578999998753 23456788899999999 79999999998864 457
Q ss_pred eEEEEeecCCCChhhhhhcCCCC---------------------------------------------------------
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKD--------------------------------------------------------- 440 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~--------------------------------------------------------- 440 (696)
++++|||+++++|.+++......
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 89999999999999998643210
Q ss_pred CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccccccccCCCCC
Q 005450 441 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 520 (696)
Q Consensus 441 ~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlA 520 (696)
...++|..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++..+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1257899999999999999999999 8999999999999999999999999999987654333333333556788999
Q ss_pred cceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHH
Q 005450 521 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLA 599 (696)
Q Consensus 521 PE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~l 599 (696)
||++.+..++.++|||||||+||||++ |..||........ +.... ..+... .. +......+..+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~~----~~~~~~-----~~----~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRRL----KEGTRM-----RA----PEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHHH----hccCCC-----CC----CccCCHHHHHH
Confidence 999999999999999999999999998 9999976433221 11100 111000 00 11112346677
Q ss_pred HHHhcccCCCCCCCHHHHHHHhhC
Q 005450 600 SILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 600 a~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
+..||+.+|++||++.+++++|+.
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHH
Confidence 788999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=320.95 Aligned_cols=254 Identities=25% Similarity=0.419 Sum_probs=207.4
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChh-HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~-~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
..+|.+.+.||.|+||.||+|...++..+++|++..... ....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 456888999999999999999988899999999986553 5678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++++|.+++..... ..+++..++.++.+++.||.|||+ ++|+||||||+|||+++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999975432 358999999999999999999999 8999999999999999999999999999986644322
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
.. ....++..|+|||++....++.++||||||+++|+|++ |+.||...........+. ... . .
T Consensus 160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~~~---~------~-- 223 (261)
T cd05148 160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT---AGY---R------M-- 223 (261)
T ss_pred cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH---hCC---c------C--
Confidence 11 12346778999999988899999999999999999998 899997654322111111 000 0 0
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.........+..++.+|++.+|.+|||+.++++.|+.
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 --PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0011112345677788999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=332.99 Aligned_cols=241 Identities=27% Similarity=0.387 Sum_probs=192.9
Q ss_pred eeeeccCceEEEEEEe----CCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 354 NLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+.||+|+||.||++.. .+++.||+|+++... .....+.+|+++++.++||||++++++|..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 367899999997532 2345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++.... .+.+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999987543 47788899999999999999999 899999999999999999999999999987543322
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. +.. .+
T Consensus 155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~-------~~~------~~ 219 (323)
T cd05584 155 T--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK-------GKL------NL 219 (323)
T ss_pred C--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc-------CCC------CC
Confidence 2 12235799999999999988899999999999999999999999976543222111110 110 01
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 620 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~~ 620 (696)
.... ...+..++..||+.+|++|| ++.++++.
T Consensus 220 ~~~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 PPYL----TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCC----CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1111 12345566779999999999 78887763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=318.89 Aligned_cols=252 Identities=26% Similarity=0.434 Sum_probs=202.9
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
++|.+.+.||+|+||.||++..+++..+|+|.+.........+.+|+.++++++|+|++++++++. ....+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 468889999999999999999888889999999876555677999999999999999999999885 4568999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
++|.+++..... ..+++..++.++.+++.||.|||+ ++|+||||||+||++++++.++|+|||++..........
T Consensus 85 ~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 85 GSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999975432 357899999999999999999999 889999999999999999999999999998765432211
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~ 586 (696)
.....++..|+|||++....++.++||||||+++|+|++ |..||.......... ..... ...
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~---~~~~~---~~~---------- 222 (260)
T cd05070 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE---QVERG---YRM---------- 222 (260)
T ss_pred -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHHcC---CCC----------
Confidence 112345678999999988889999999999999999999 899997654322111 11100 000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 587 ~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
..+.+....+..++.+|++.+|.+|||+.++++.|+
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 258 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 001111234666777899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=317.58 Aligned_cols=259 Identities=28% Similarity=0.428 Sum_probs=206.8
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecC----ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~----~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||.||+|... +++.||||.++. .......+.+|+++++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999864 789999998754 2344567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++++|.+++.........+++..+..++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886543333457889999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
... ......|++.|+|||++.+..++.++||||||+++|||++|+.||........ ........ ... +
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~----~~~-----~ 226 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-SLCQKIEQ----CDY-----P 226 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-HHHHHHhc----CCC-----C
Confidence 322 11235688999999999988899999999999999999999999965432211 11111110 000 1
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
... .......+..++.+||+.+|.+||++.+|++.|+..
T Consensus 227 ~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 PLP---TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCC---hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 110 111224456667789999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=316.42 Aligned_cols=259 Identities=28% Similarity=0.414 Sum_probs=208.1
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||.||+|... +|+.||+|.++.. ......+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67999999999999999999976 8999999988642 234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++++|.+++.........+++..++.++.+++.||.|||+ .+|+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999987544444568999999999999999999999 8999999999999999999999999999886654
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
.... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||......... +... +..+....
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~----~~~~~~~~---- 227 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCKK----IEKCDYPP---- 227 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH-HHhh----hhcCCCCC----
Confidence 3221 12356899999999999888999999999999999999999999654321111 1110 00111111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.. .......+..++..||..+|.+||++.+|+++|+..
T Consensus 228 -~~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 -LP---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -CC---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 00 011223455667779999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=324.29 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=202.9
Q ss_pred CceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
+|++.+.||+|+||.||+|... ....+++|.+.... .....+.+|+.++..++||||+++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999852 23578999887543 345678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCC--------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccc
Q 005450 421 VYDFLSRGSLEENLHGNKK--------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 480 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~--------------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsN 480 (696)
||||+.+++|.+++..... ....+++..++.++.|++.||.|||+ ++|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 9999999999999864321 12357899999999999999999999 899999999999
Q ss_pred eeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccc
Q 005450 481 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKG 559 (696)
Q Consensus 481 ILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~ 559 (696)
||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986544332222222456778999999988889999999999999999998 999997654332
Q ss_pred hhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 560 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 560 ~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
... +..... .... +......+..++..|++.+|.+||++.++++.|+..
T Consensus 238 ~~~---~~~~~~---------~~~~----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 238 LFN---LLKTGY---------RMER----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred HHH---HHhCCC---------CCCC----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 211 111100 0000 111123566777889999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.22 Aligned_cols=253 Identities=23% Similarity=0.390 Sum_probs=204.7
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
.++|.+.+.||+|+||.||+|..++++.||+|.+.........+.+|+.+++.++||||+++++++. .+..+++|||+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 4578899999999999999999989999999999876666678999999999999999999999874 467899999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+++|.+++..... ..+++..++.++.+++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 84 NGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999865432 358899999999999999999999 89999999999999999999999999999876532221
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
......++..|+|||++..+.++.++||||||+++|||++ |+.||.......... ...... . ....
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~~~~---~------~~~~ 225 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ---NLERGY---R------MPRP 225 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH---HHHcCC---C------CCCC
Confidence 1122446788999999998899999999999999999999 999997654322111 111000 0 0001
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
.. ....+..++.+|++.+|++||+++++++.|+
T Consensus 226 ~~----~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 226 DN----CPEELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred CC----CCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 11 1134666777899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=347.00 Aligned_cols=245 Identities=29% Similarity=0.415 Sum_probs=204.2
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+. +...+.+.+|++|++.++||||+.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999865 6788999998764 3556778899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+.| +|..+|...+ .++++.++.|+.+++.||.|||+ ++|+|||+||.||||+.++.+|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9988 9999998665 58999999999999999999999 99999999999999999999999999999988875
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
.... +.+.|||.|||||.+.++.|+..+|.||||||||||.+|++||...... .++. .+..+ +.
T Consensus 154 t~vl--tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~---~Lv~---~I~~d--------~v 217 (808)
T KOG0597|consen 154 TSVL--TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT---QLVK---SILKD--------PV 217 (808)
T ss_pred ceee--eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH---HHHH---HHhcC--------CC
Confidence 4433 3478999999999999999999999999999999999999999754321 2221 11111 11
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. .+......+..+..-.+.+||..|.+-.+++.
T Consensus 218 ~---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 K---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred C---CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 0 11122334445555588999999999888775
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=318.17 Aligned_cols=255 Identities=22% Similarity=0.361 Sum_probs=197.3
Q ss_pred ceeeeeeeccCceEEEEEEeCCC-C--EEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec------Cc
Q 005450 350 FLAENLIGKGGSSQVYKGCLPDG-K--ELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NN 417 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~~g-~--~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~------~~ 417 (696)
|.+.+.||+|+||.||+|...+. . .+|+|.++.. ....+.+.+|+.++..++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 34678899999999999986543 3 5899998753 45567889999999999999999999987542 25
Q ss_pred eEEEEeecCCCChhhhhhcCC--CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecC
Q 005450 418 LLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 495 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~--~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFG 495 (696)
.+++|||+++|+|.+++.... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 789999999999999874322 223458999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccC
Q 005450 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 496 lA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
+++...............+++.|+|||++....++.++||||||+++|||++ |+.||...........+ ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-------~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL-------RQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HcC
Confidence 9987654332212222346778999999998899999999999999999999 89999764332211111 111
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 575 ~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.... . .......+..++..||+.+|++|||+.++++.|+.
T Consensus 231 ~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRLK-----Q----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1100 0 11112345667778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=319.33 Aligned_cols=254 Identities=24% Similarity=0.427 Sum_probs=204.5
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
.++|.+.+.||+|+||.||+|...++..||+|+++......+.+.+|+.++..++||||+++++++. ....++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 3568999999999999999998877778999999875555578899999999999999999999875 456899999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+|+|.+++.... ...+++..+..++.+++.||.|||+ .+|+||||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 84 KGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999997542 2357899999999999999999999 89999999999999999999999999999866543322
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
. .....++..|+|||+..+..++.++||||||+++|+|++ |..||...........+.... .. .
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~------~~------~-- 223 (262)
T cd05071 159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------RM------P-- 223 (262)
T ss_pred c-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC------CC------C--
Confidence 1 122446778999999988899999999999999999999 888987654332211111000 00 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
........+..++..|++.+|.+||++.++++.|+.
T Consensus 224 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 224 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred --CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 011223456677888999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=361.19 Aligned_cols=258 Identities=27% Similarity=0.484 Sum_probs=211.1
Q ss_pred hcCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~ 418 (696)
+.+....+.||+|+||.||+|... +...||||.++... +...+|.+|++++..++|||||+|+|.|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 455667889999999999999843 34679999998744 4678999999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCC---------C-CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc
Q 005450 419 LLVYDFLSRGSLEENLHGNKK---------D-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 488 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~---------~-~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~ 488 (696)
++|+|||..|+|.++|..... . +..++..+.+.|+.|||.|++||-+ +.+|||||-..|.||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceE
Confidence 999999999999999964331 1 3448899999999999999999999 88999999999999999999
Q ss_pred eEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhh
Q 005450 489 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 567 (696)
Q Consensus 489 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~ 567 (696)
|||+|||+++-.-..+.+.......-...|||||.|++++||.+||||||||+|||+++ |+.|+.+....+....+.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~-- 719 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR-- 719 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH--
Confidence 99999999986554443332222334578999999999999999999999999999999 999998766544433332
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 568 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 568 ~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.|++-+- +..-...+..++..||+.+|.+||++++|-..|+.
T Consensus 720 -----~g~lL~~---------Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 720 -----AGQLLSC---------PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred -----cCCcccC---------CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 2332111 11223456667778999999999999999999874
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=321.44 Aligned_cols=258 Identities=25% Similarity=0.427 Sum_probs=202.4
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 417 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~ 417 (696)
.+++|.+.+.||+|+||.||+|... .+..|++|.+... ......+.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3567999999999999999999864 3567899988743 3345678999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCC---CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC---ceEE
Q 005450 418 LLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQL 491 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~---~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~---~vKL 491 (696)
.++||||+++++|.+++..... ....+++..+..++.||+.||.|||+ ++++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999975432 22358999999999999999999999 8899999999999998654 5899
Q ss_pred eecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccc
Q 005450 492 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPI 570 (696)
Q Consensus 492 ~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~ 570 (696)
+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||...........+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~----- 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT----- 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----
Confidence 99999987643222111112334568999999998899999999999999999997 999997654432221111
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 571 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 571 ~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
...... ..... ...+..++..|++.+|++||++.+|++.|+
T Consensus 236 -~~~~~~------~~~~~----~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 -GGGRLD------PPKGC----PGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -cCCcCC------CCCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 000100 01111 234556667799999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=331.02 Aligned_cols=243 Identities=23% Similarity=0.362 Sum_probs=192.5
Q ss_pred ceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHH---HhcCCcceeEEeeEEEecCceEEE
Q 005450 350 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEII---TTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL---~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
|.+.+.||+|+||.||++... +|+.||||+++... ...+.+.+|++++ ..++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999864 68999999997532 3345666776665 466799999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++++|...+... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999888642 48999999999999999999999 899999999999999999999999999987543
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....
T Consensus 153 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~------------ 218 (324)
T cd05589 153 GFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV------------ 218 (324)
T ss_pred CCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------
Confidence 2221 12346799999999999988999999999999999999999999976544322211111100
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLK 619 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPS-----m~eVL~ 619 (696)
.....+ ...+..++..||+.||.+||+ +.++++
T Consensus 219 -~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 -RYPRFL----SREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -CCCCCC----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 011111 133455677799999999994 566654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=335.80 Aligned_cols=245 Identities=24% Similarity=0.399 Sum_probs=190.5
Q ss_pred ceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 350 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
|...+.||+|+||.||++... +|+.||||++... ......+.+|+++++.++|+||+++++++...+.+++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 455688999999999999864 7899999998653 3445778999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+|+|.... ...+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 156 ~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 156 GGSLEGTH--------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCcccccc--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 99986532 24567788999999999999999 8999999999999999999999999999987654322
Q ss_pred cccccccccCCCCCcceecc-----CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 507 ITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~-----~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
......||..|+|||++.. ...+.++|||||||++|||++|+.||..........+...... .. .
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----~~-----~ 293 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM----SQ-----P 293 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc----cC-----C
Confidence 1223579999999998743 2345689999999999999999999974433222222111100 00 0
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
+.. .......+..++..||+.||++||++.|+++.
T Consensus 294 ~~~----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 PEA----PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCC----CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001 11112345566677999999999999999873
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=338.24 Aligned_cols=203 Identities=27% Similarity=0.378 Sum_probs=174.9
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||.||++.. .+++.||||++.... ...+.+.+|++++..++||||++++++|.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4789999999999999999985 478999999986532 34567888999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999997543 47889999999999999999999 8999999999999999999999999999963321
Q ss_pred CCCC---------------------------------------------cccccccccCCCCCcceeccCCCCCcccchh
Q 005450 503 SSSH---------------------------------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYA 537 (696)
Q Consensus 503 ~~~~---------------------------------------------~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwS 537 (696)
.... ......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 1000 0001246999999999999889999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCc
Q 005450 538 FGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 538 LGvvL~ELltG~~Pf~~~~~ 557 (696)
|||++|||++|+.||.....
T Consensus 234 lGvil~elltG~~Pf~~~~~ 253 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENS 253 (377)
T ss_pred cchhhhhhhcCCCCCCCCCH
Confidence 99999999999999976554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=317.03 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=199.7
Q ss_pred ceeeeeeeccCceEEEEEEeCC----CCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc-----
Q 005450 350 FLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 417 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~~----g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~----- 417 (696)
|.+.+.||+|+||.||+|.... +..||+|.++.. ......+.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998642 367999998753 2445688999999999999999999999876554
Q ss_pred -eEEEEeecCCCChhhhhhcCC--CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeec
Q 005450 418 -LLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 494 (696)
Q Consensus 418 -~~LV~Ey~~gGsL~~~L~~~~--~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DF 494 (696)
.++||||+++|+|..++.... .....+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 799999999999999985432 223468999999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhcccccc
Q 005450 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSS 573 (696)
Q Consensus 495 GlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~ 573 (696)
|+++...............++..|+|||++....++.++|||||||++|||++ |..||....... +..+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~~~---- 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLRH---- 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----
Confidence 99987654433222222345678999999988889999999999999999999 899986644322 1111110
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 574 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 574 g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
+... .. +......+..++..||+.||.+||++.++++.|+.
T Consensus 231 ~~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 231 GNRL-----KQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CCCC-----CC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 1000 01 11122356667777999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=343.32 Aligned_cols=259 Identities=23% Similarity=0.384 Sum_probs=203.5
Q ss_pred hcCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCc
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNN 417 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~ 417 (696)
.++|.+.+.||+|+||.||+|... .+..||||+++... ...+.+.+|++++..+. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457889999999999999999742 23579999997532 34567899999999996 9999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCC----------------------------------------------------------
Q 005450 418 LLLVYDFLSRGSLEENLHGNKK---------------------------------------------------------- 439 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~---------------------------------------------------------- 439 (696)
.+|||||+++|+|.++|+....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998865321
Q ss_pred ----------------------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC
Q 005450 440 ----------------------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 485 (696)
Q Consensus 440 ----------------------------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~ 485 (696)
....+++..+..++.|++.||.|||+ .+|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 01247888899999999999999999 89999999999999999
Q ss_pred CCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHH
Q 005450 486 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLV 564 (696)
Q Consensus 486 ~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv 564 (696)
++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......... .
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--Y 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--H
Confidence 99999999999986654333222333557889999999998899999999999999999997 99999754322111 1
Q ss_pred hhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 565 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 565 ~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
... ..+. .... +......+..++..||+.+|++||++.+|.++|+.
T Consensus 351 ~~~----~~~~-----~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 351 NKI----KSGY-----RMAK----PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred HHH----hcCC-----CCCC----CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 000 0110 0000 11112345667778999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=323.71 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=201.6
Q ss_pred cCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
.+|.+.+.||+|+||.||+|... ++..||+|+++... .....+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34677889999999999999853 35789999997543 34567889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCC------------CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC
Q 005450 420 LVYDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 487 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~------------~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~ 487 (696)
+++||+.+++|.+++.... .....+++..+..++.|++.||.|||+ ++|+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 9999999999999985321 112357888999999999999999999 8999999999999999999
Q ss_pred ceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhh
Q 005450 488 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 566 (696)
Q Consensus 488 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~ 566 (696)
.+||+|||+++...............+++.|+|||++..+.++.++|||||||++|||++ |..||.+.........+..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999886644332222233456789999999988899999999999999999998 8889876543222111111
Q ss_pred hccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 567 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 567 ~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
+.... ... +....+..++..||+.+|.+||++.+|+..|+
T Consensus 242 -------~~~~~-----~~~----~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 242 -------RQVLP-----CPD----DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred -------CCcCC-----CCC----CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 11100 011 11233556677799999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=331.29 Aligned_cols=201 Identities=25% Similarity=0.429 Sum_probs=176.4
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.++|.+.+.||+|+||.||++... ++..+|+|++... ......+.+|++++..++||||++++++|..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999865 6888999988753 3445678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+++++|.+++.... .+++..+..++.+++.||.|||+ ..+|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999997543 47888999999999999999997 146999999999999999999999999999765432
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~ 557 (696)
. .....||..|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 158 ~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred c----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 1 1235689999999999988899999999999999999999999976543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=322.36 Aligned_cols=264 Identities=24% Similarity=0.387 Sum_probs=205.4
Q ss_pred hcCceeeeeeeccCceEEEEEEeCC-----------------CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPD-----------------GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIIS 407 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~-----------------g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~ 407 (696)
..+|.+.+.||+|+||.||++...+ +..||+|.+... ....+.+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578899999999999999987542 246899998764 345678899999999999999999
Q ss_pred EeeEEEecCceEEEEeecCCCChhhhhhcCCC-------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccc
Q 005450 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 480 (696)
Q Consensus 408 l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~-------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsN 480 (696)
++++|..+...++||||+++++|.+++..... ....+++..++.++.|++.||.|||+ ++|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 99999999999999999999999999976541 12258999999999999999999999 899999999999
Q ss_pred eeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh--CCCCCCCCCcc
Q 005450 481 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPK 558 (696)
Q Consensus 481 ILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt--G~~Pf~~~~~~ 558 (696)
|+++.++.++|+|||++................+++.|+|||++..+.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986544332222233557889999999998899999999999999999998 77787654321
Q ss_pred chhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 559 GQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 559 ~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
. ................... .+......+..++..|++.+|.+|||+.+|++.|+
T Consensus 241 ~---~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 Q---VIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H---HHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 1111111111111111000 01111245677788899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=330.10 Aligned_cols=240 Identities=23% Similarity=0.330 Sum_probs=192.4
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCc-ceeEEeeEEEecCceEEEE
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHK-NIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~Hp-nIV~l~g~~~~~~~~~LV~ 422 (696)
+|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+..|++++..+.|+ +|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999865 5789999999753 24456788899999999764 6888999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999987543 47899999999999999999999 8999999999999999999999999999874322
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+... . .
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------~------~ 218 (324)
T cd05587 154 GGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------N------V 218 (324)
T ss_pred CCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------C------C
Confidence 111 122367999999999999889999999999999999999999999765433222111100 0 0
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQM 614 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm 614 (696)
.+.... ...+..++..||+.+|.+||+.
T Consensus 219 ~~~~~~----~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 SYPKSL----SKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCC----CHHHHHHHHHHhhcCHHHcCCC
Confidence 111111 2244556677999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=337.43 Aligned_cols=202 Identities=24% Similarity=0.351 Sum_probs=174.4
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.|...+.||+|+||+||+|.. .+++.||+|++.... .....+.+|++++++++||||+++++.|.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 688999999999999999986 468899999997532 345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999987543 47888899999999999999999 89999999999999999999999999997532110
Q ss_pred C---------------------------------------------CCcccccccccCCCCCcceeccCCCCCcccchhh
Q 005450 504 S---------------------------------------------SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAF 538 (696)
Q Consensus 504 ~---------------------------------------------~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSL 538 (696)
. .........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0000112579999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCc
Q 005450 539 GVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 539 GvvL~ELltG~~Pf~~~~~ 557 (696)
||+||||++|+.||....+
T Consensus 235 Gvil~elltG~~Pf~~~~~ 253 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTP 253 (382)
T ss_pred hHHHHHHHhCCCCCCCCCH
Confidence 9999999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=315.66 Aligned_cols=253 Identities=25% Similarity=0.433 Sum_probs=203.0
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
++|.+.+.||+|++|.||++..+++..+|+|.+.......+.+.+|+++++.++|||++++++++. .+..++||||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 468899999999999999999877778999998876655677899999999999999999999875 4578999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
++|.+++.... ...+++..+..++.+++.||.|||+ .+++||||||+||++++++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 85 GSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999997543 2357899999999999999999999 89999999999999999999999999999866443221
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~ 586 (696)
......++..|+|||++.+..++.++||||||+++|+|++ |+.||......... .+..... . +..
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~~~~---~------~~~-- 224 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL---EQVERGY---R------MPC-- 224 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCC---C------CCC--
Confidence 1122346788999999988899999999999999999999 99999765432221 1111000 0 000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 587 ~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
+......+..++.+||+.+|.+||++.+|++.|+.
T Consensus 225 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 --PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11112345566677999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.63 Aligned_cols=242 Identities=25% Similarity=0.364 Sum_probs=194.4
Q ss_pred eeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCC
Q 005450 354 NLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 428 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gG 428 (696)
+.||+|+||.||++.. .+|+.||+|+++.. ......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 47899999999753 234567788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcc
Q 005450 429 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 508 (696)
Q Consensus 429 sL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~ 508 (696)
+|..++.... .+++..+..++.||+.||.|||+ ..+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (325)
T cd05594 81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T 152 (325)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence 9999886543 48899999999999999999995 15899999999999999999999999999875432221 1
Q ss_pred cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCC
Q 005450 509 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 588 (696)
Q Consensus 509 ~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~ 588 (696)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.... ..+...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~-------------~~~p~~~ 219 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-------------IRFPRTL 219 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-------------CCCCCCC
Confidence 223579999999999998899999999999999999999999997654432222221110 0011111
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005450 589 DYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 620 (696)
Q Consensus 589 ~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~~ 620 (696)
+ ..+..++..||+.||.+|+ ++.++++.
T Consensus 220 ~----~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 220 S----PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C----HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1 2344566679999999996 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=321.39 Aligned_cols=270 Identities=26% Similarity=0.349 Sum_probs=199.6
Q ss_pred cCceeeeeeeccCceEEEEEEe-----CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCceE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLL 419 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-----~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~--~~~~~ 419 (696)
.+|.+.+.||+|+||.||++.. .++..||+|.+.... ...+.+.+|++++..++||||+++++++.. ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4788899999999999999874 368899999987643 456788999999999999999999998754 34689
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999997543 258899999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCccc-ccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 500 ASTSSSHITC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 500 ~~~~~~~~~~-~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
.......... ....++..|+|||++.+..++.++|||||||++|||++|..|+......-................+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 6543322111 112244569999999988999999999999999999999887643321100000000000000000000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.+...............+..++..||+.+|++|||+.+|++.|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 111000000111222456677778999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.34 Aligned_cols=204 Identities=25% Similarity=0.352 Sum_probs=175.3
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||.||++.. .+++.||||++.... .....+.+|++++..++||||+++++.|.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 4789999999999999999985 468999999997532 23456888999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|..+..
T Consensus 81 E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 9999999999997543 47888899999999999999999 8999999999999999999999999999853211
Q ss_pred CC-----------------------------------------CCcccccccccCCCCCcceeccCCCCCcccchhhHHH
Q 005450 503 SS-----------------------------------------SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVV 541 (696)
Q Consensus 503 ~~-----------------------------------------~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvv 541 (696)
.. .........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0000113579999999999998899999999999999
Q ss_pred HHHHHhCCCCCCCCCcc
Q 005450 542 LLELLTGRKPISNDHPK 558 (696)
Q Consensus 542 L~ELltG~~Pf~~~~~~ 558 (696)
+|||++|+.||....+.
T Consensus 234 lyell~G~~Pf~~~~~~ 250 (376)
T cd05598 234 LYEMLVGQPPFLADTPA 250 (376)
T ss_pred eeehhhCCCCCCCCCHH
Confidence 99999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=321.53 Aligned_cols=253 Identities=23% Similarity=0.422 Sum_probs=200.0
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCC----EEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~----~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
.+|.+.+.||+|+||.||+|... ++. .+++|.+... .....++..|+.++..+.||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46788899999999999999853 444 4788887643 234567888999999999999999999885 456789
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
++||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++++||||||+|||+++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 999999999999997543 258999999999999999999999 88999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
.............++..|+|||++.++.++.++|||||||++|||++ |+.||.+........++. .+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~-- 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-------KGERL-- 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCCcC--
Confidence 54433333334567889999999998899999999999999999998 999997654433222221 11100
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
..+.. .. ..+..++..|+..+|.+|||+.++++.|..
T Consensus 231 ~~~~~---~~----~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 231 AQPQI---CT----IDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred CCCCC---CC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 01111 11 234556678999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=322.09 Aligned_cols=246 Identities=26% Similarity=0.353 Sum_probs=193.4
Q ss_pred eeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCCh
Q 005450 356 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 430 (696)
Q Consensus 356 LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL 430 (696)
||+|+||+||++... +|+.||+|.+.... ...+.+..|+++++.++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 78999999987532 2345678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccc
Q 005450 431 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 510 (696)
Q Consensus 431 ~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~ 510 (696)
..++.........+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++......... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 98886543333468999999999999999999999 89999999999999999999999999999866543222 22
Q ss_pred cccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCCh
Q 005450 511 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 590 (696)
Q Consensus 511 ~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~ 590 (696)
...||+.|+|||++.+..++.++|||||||++|||++|+.||............ ...... +.. .++.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~-~~~----------~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQRILN-DSV----------TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH--HHhhcc-cCC----------CCcc
Confidence 357999999999999999999999999999999999999999764432111111 001110 000 0111
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005450 591 DQMERMVLASILCIRRDPRARP-----QMSLVLK 619 (696)
Q Consensus 591 ~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~ 619 (696)
.....+..++..||+.||.+|| ++.++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 1123345566679999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=329.32 Aligned_cols=240 Identities=24% Similarity=0.337 Sum_probs=192.9
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEE
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
+|.+.+.||+|+||.||+|... +++.||+|+++.. ......+..|..++..+ +|++|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999865 5789999998753 23345567788888877 5899999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++|+|.+.+.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999987543 47899999999999999999999 8999999999999999999999999999975432
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... ..
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-------~~------ 218 (323)
T cd05616 154 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-------NV------ 218 (323)
T ss_pred CCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------CC------
Confidence 221 223467999999999999999999999999999999999999999875543222211110 00
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQM 614 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm 614 (696)
.+... ....+..++..|++.+|.+|++.
T Consensus 219 ~~p~~----~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AYPKS----MSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCc----CCHHHHHHHHHHcccCHHhcCCC
Confidence 01111 12345566677999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=315.19 Aligned_cols=255 Identities=26% Similarity=0.453 Sum_probs=207.1
Q ss_pred hhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
..++|.+.+.||+|+||.||++..++++.+|||.+.......+.+.+|+.++++++||||+++++++......++||||+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 34689999999999999999999888889999999876666678999999999999999999999999889999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++++|.+++..... ..+++..+..++.+++.||.|||+ ++++|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 84 SKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred CCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999976432 358999999999999999999999 8899999999999999999999999999986654211
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+ .... . ...
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~---~~~~---~------~~~ 225 (261)
T cd05034 159 T-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV---ERGY---R------MPR 225 (261)
T ss_pred h-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcCC---C------CCC
Confidence 1 1112335678999999998889999999999999999998 99999765432211111 1000 0 000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
+......+..++.+|++.+|.+||++.++.+.|+
T Consensus 226 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 226 ----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred ----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 0011234566777899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=319.41 Aligned_cols=259 Identities=23% Similarity=0.405 Sum_probs=206.5
Q ss_pred hhcCceeeeeeeccCceEEEEEEeCC-----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe-cCc
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLPD-----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNN 417 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~~-----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~-~~~ 417 (696)
..++|.+.+.||+|+||.||+|...+ +..|++|+++.. ....+.+.+|+.+++.++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999999755 788999998754 3456778899999999999999999999876 567
Q ss_pred eEEEEeecCCCChhhhhhcCCCC----CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEee
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKD----PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 493 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~----~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~D 493 (696)
.+++++|+++++|.+++...... ...+++..++.++.+++.||+|||+ ++++||||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998754322 1468999999999999999999999 8999999999999999999999999
Q ss_pred cCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccc
Q 005450 494 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILS 572 (696)
Q Consensus 494 FGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~ 572 (696)
||+++.+.............++..|+|||++....++.++||||||+++|||++ |+.||....+.. +..+....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~-- 235 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLKDG-- 235 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHHcC--
Confidence 999986644333222223456778999999988889999999999999999999 999997654322 22211110
Q ss_pred cCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 573 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 573 ~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
..+. ..... ...+..++.+||+.+|++|||+.++++.|+.
T Consensus 236 -~~~~------~~~~~----~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 236 -YRLA------QPINC----PDELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred -CCCC------CCCcC----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0000 00111 1245667778999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=347.10 Aligned_cols=264 Identities=20% Similarity=0.284 Sum_probs=194.5
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--------C
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED--------N 416 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~--------~ 416 (696)
...+|.+.+.||+|+||.||+|.. .+++.||||.+..... ...+|+.+++.++||||+++++++... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 356799999999999999999986 4688999998865432 334799999999999999999987532 2
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC-ceEEeecC
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFG 495 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~-~vKL~DFG 495 (696)
.+++||||+++ +|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46799999975 7877775433334468999999999999999999999 8999999999999998664 69999999
Q ss_pred ccccccCCCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccccc-
Q 005450 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS- 573 (696)
Q Consensus 496 lA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~- 573 (696)
+|+........ ....||+.|+|||++.+. .++.++|||||||+||||++|++||.+.........+.........
T Consensus 217 la~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99876543222 235689999999988654 6999999999999999999999999876543322211111000000
Q ss_pred ------C-----ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 574 ------G-----KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 574 ------g-----~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. .+.......+...++......+..++..||+.+|.+|||+.++++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0 000000000111111111234566777899999999999999885
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=321.94 Aligned_cols=251 Identities=24% Similarity=0.306 Sum_probs=199.3
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
+|...+.||+|+||+||++.. .+++.||+|++.... .....+.+|+.+++.++||||+++++++..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478899999999999999986 468999999987532 223457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999988865332 358999999999999999999999 89999999999999999999999999999876433
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+... +....
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~---~~~~~-------- 221 (285)
T cd05605 156 ET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR---VKEDQ-------- 221 (285)
T ss_pred Cc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH---hhhcc--------
Confidence 22 12357899999999999889999999999999999999999999865432221111100 00000
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 620 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~~ 620 (696)
..+.......+..++..||+.||.+|| ++.++++.
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 --EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 001111223455667779999999999 78787654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=324.17 Aligned_cols=262 Identities=23% Similarity=0.378 Sum_probs=200.8
Q ss_pred cCceeeeeeeccCceEEEEEEeCC---------------CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEee
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPD---------------GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLG 410 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~---------------g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g 410 (696)
++|.+.+.||+|+||.||++.... ...||+|.++.. ......+.+|++++.+++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578899999999999999987532 235899998763 344567899999999999999999999
Q ss_pred EEEecCceEEEEeecCCCChhhhhhcCCC--------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccccee
Q 005450 411 FCFEDNNLLLVYDFLSRGSLEENLHGNKK--------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 482 (696)
Q Consensus 411 ~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~--------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNIL 482 (696)
++...+..++||||+++++|.+++..... ....+++..++.++.+++.||.|||+ ++++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 99999999999999999999999864321 11246889999999999999999999 89999999999999
Q ss_pred eCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh--CCCCCCCCCccch
Q 005450 483 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPKGQ 560 (696)
Q Consensus 483 Ld~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt--G~~Pf~~~~~~~~ 560 (696)
++.++.+||+|||++................++..|+|||++..+.++.++|||||||++|+|++ |..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999986544322222223446788999999998899999999999999999998 6677765433221
Q ss_pred hhHHhhhcccccc-CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 561 ESLVMWAKPILSS-GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 561 ~~lv~~~~~~~~~-g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
...+ ...... +....... +......+..++..|++.+|++||++.+|++.|+
T Consensus 242 ~~~~---~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 IENT---GEFFRNQGRQIYLSQ-------TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHH---HHhhhhccccccCCC-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111 000000 00000000 0011235777788899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=311.99 Aligned_cols=246 Identities=26% Similarity=0.426 Sum_probs=197.6
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCChh
Q 005450 354 NLIGKGGSSQVYKGCLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 431 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL~ 431 (696)
++||+|+||.||+|...++..+|+|.++.. ......+.+|++++..++||||++++++|...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888999999998753 334457889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCccccc
Q 005450 432 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 511 (696)
Q Consensus 432 ~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~ 511 (696)
+++.... ..+.+..+..++.+++.||.|||+ ++++||||||+||+++.++.+||+|||++.......... ...
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~ 153 (250)
T cd05085 81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGL 153 (250)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc-CCC
Confidence 9986543 247899999999999999999999 899999999999999999999999999997544322111 112
Q ss_pred ccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCCh
Q 005450 512 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 590 (696)
Q Consensus 512 ~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~ 590 (696)
..+++.|+|||++..+.++.++||||||+++|+|++ |..||...........+. . +. .... ..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~---~----~~-----~~~~----~~ 217 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE---K----GY-----RMSC----PQ 217 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH---c----CC-----CCCC----CC
Confidence 345678999999998899999999999999999998 999997654322111111 0 00 0000 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 591 DQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 591 ~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
.....+..++..|++.+|++||++.++++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 12245666777899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=313.40 Aligned_cols=253 Identities=26% Similarity=0.506 Sum_probs=204.4
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
..+|.+.+.||+|+||.||++...++..+|+|++.........+.+|++++++++||||+++++++......++||||++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35688899999999999999998778899999998665555678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+++|.+++.... ..+++..++.++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 999999987543 247899999999999999999999 88999999999999999999999999998765432211
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
......++.+|+|||++.++.++.++||||||+++|||++ |+.||............. .+ .....+..
T Consensus 157 -~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~--~~~~~~~~- 225 (256)
T cd05112 157 -SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-------AG--FRLYKPRL- 225 (256)
T ss_pred -ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-------CC--CCCCCCCC-
Confidence 1112335678999999998899999999999999999998 999997654322111110 00 00111111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
. ...+..++.+||+.+|.+||++.++++.|.
T Consensus 226 ---~---~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ---A---SQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---C---CHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1 245667788899999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=316.91 Aligned_cols=258 Identities=28% Similarity=0.429 Sum_probs=205.9
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||.||++.. .+++.+|||.+... .....++.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999985 58899999987642 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++++|.+++.........+++..++.++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999987543334468999999999999999999999 8999999999999999999999999999886654
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
.... .....|+..|+|||++....++.++||||||+++|+|++|..||......... ..... .....+
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~---------~~~~~~ 226 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCKKI---------EQCDYP 226 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH-Hhhhh---------hcCCCC
Confidence 3321 12356899999999998888999999999999999999999999754332111 11100 000111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.+... .....+..++..|++.+|++||||.+|++.++.
T Consensus 227 ~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 227 PLPSD---HYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCCcc---cccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 11111 122345556667999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=311.59 Aligned_cols=250 Identities=28% Similarity=0.470 Sum_probs=202.3
Q ss_pred eeeeccCceEEEEEEeCC----CCEEEEEEecCChh--HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKGGSSQVYKGCLPD----GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~----g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
+.||+|+||.||++.... +..|++|+++.... ..+.+.+|++++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998653 78899999987543 367889999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCC-----CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 428 GSLEENLHGNKKD-----PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 428 GsL~~~L~~~~~~-----~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
++|.+++...... ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999865221 2468999999999999999999999 8999999999999999999999999999987765
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
...........+++.|+|||.+....++.++||||||+++|+|++ |..||...........+ .. +..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~~----~~~----- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL---RK----GYR----- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---Hc----CCC-----
Confidence 432222334568899999999998899999999999999999999 69999776432211111 10 000
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
... .......+..++..|++.+|.+||++.++++.|+
T Consensus 226 ~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 LPK----PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCC----CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000 1111235566777799999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=338.07 Aligned_cols=254 Identities=22% Similarity=0.265 Sum_probs=199.5
Q ss_pred HhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
...++|.+.+.||+|+||.||++... +++.||+|++.... .....+.+|+.++..++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45678999999999999999999864 68899999997432 33455778999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+||||+++|+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 999999999999998643 36788888999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCCCCcceeccC----CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 575 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~----~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 575 (696)
....... ......||+.|+|||++... .++.++|||||||++|||++|+.||...........+..... .
T Consensus 192 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-----~ 265 (370)
T cd05596 192 MDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN-----S 265 (370)
T ss_pred ccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-----c
Confidence 6443221 22346799999999998643 488899999999999999999999987654322211111000 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005450 576 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA--RPQMSLVLKL 620 (696)
Q Consensus 576 l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~--RPSm~eVL~~ 620 (696)
+ .+.... .....+..++..||+.+|.+ ||++.++++.
T Consensus 266 ~------~~~~~~--~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 L------TFPDDI--EISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred C------CCCCcC--CCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 001100 11123444556699999987 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=324.36 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=201.9
Q ss_pred cCceeeeeeeccCceEEEEEEeC--------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecC
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 416 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~--------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~ 416 (696)
++|.+.+.||+|+||.||++... ++..+|+|.++.. .....++.+|++++..+ +||||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 57899999999999999998742 2357999999864 34456788999999999 7999999999999999
Q ss_pred ceEEEEeecCCCChhhhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 484 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd 484 (696)
..++||||+++|+|.+++..... ....+++.++..++.|++.||+|||+ ++++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 99999999999999999975432 11358899999999999999999999 8999999999999999
Q ss_pred CCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhH
Q 005450 485 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 563 (696)
Q Consensus 485 ~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~l 563 (696)
.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 999999999999976643222111112234578999999998889999999999999999998 8899865443221111
Q ss_pred HhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 564 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 564 v~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
+.. +.... .+......+..++..|++.+|.+||++.+|++.|...
T Consensus 255 ~~~-------~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 255 LKE-------GHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred HHc-------CCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 110 10000 0111123445567779999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=328.46 Aligned_cols=241 Identities=24% Similarity=0.351 Sum_probs=192.8
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
+.||+|+||.||+|... +++.||+|+++.. ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999865 5789999999753 23456677899998876 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
|+|...+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-- 151 (321)
T cd05591 81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-- 151 (321)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--
Confidence 99999887543 47899999999999999999999 8999999999999999999999999999875433221
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~ 587 (696)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.. +.. .....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~-------~~~------~~p~~ 218 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH-------DDV------LYPVW 218 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc-------CCC------CCCCC
Confidence 12346799999999999988999999999999999999999999987654322211110 000 00011
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 005450 588 YDYDQMERMVLASILCIRRDPRARP-------QMSLVLKL 620 (696)
Q Consensus 588 ~~~~e~~~l~~la~~Cl~~dP~~RP-------Sm~eVL~~ 620 (696)
.+ ..+..++..||+.+|.+|| ++.++++.
T Consensus 219 ~~----~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 LS----KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CC----HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11 2345566679999999999 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=319.47 Aligned_cols=257 Identities=23% Similarity=0.417 Sum_probs=202.7
Q ss_pred cCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
.+|...+.||+|+||.||++... ++..+|+|.++.. ......+.+|++++..++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46778899999999999999632 4567899988754 3456789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCC-----------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCce
Q 005450 421 VYDFLSRGSLEENLHGNKK-----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 489 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~-----------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~v 489 (696)
+|||+++++|.+++..... ....+++..++.++.|++.||+|||+ ++++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999875431 11357899999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhc
Q 005450 490 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 568 (696)
Q Consensus 490 KL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~ 568 (696)
||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |+.||...........+....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence 9999999976544322222223446788999999998899999999999999999998 999996544322221111110
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 569 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 569 ~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
+. ......+ ..+..++..||+.+|.+||++.+|++.|++
T Consensus 242 ~~------------~~~~~~~----~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 242 EL------------ERPRTCP----PEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred cC------------CCCCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 00 0001111 234566677999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=321.54 Aligned_cols=263 Identities=22% Similarity=0.369 Sum_probs=201.5
Q ss_pred cCceeeeeeeccCceEEEEEEeC-----------------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-----------------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISL 408 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-----------------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l 408 (696)
++|.+.+.||+|+||.||++... ++..+|+|+++.. ......+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56899999999999999998532 2446899999753 3455789999999999999999999
Q ss_pred eeEEEecCceEEEEeecCCCChhhhhhcCCCC-------CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccce
Q 005450 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD-------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 481 (696)
Q Consensus 409 ~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~-------~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNI 481 (696)
++++...+..++||||+++++|.+++...... ...+++..++.++.|++.||+|||+ ++++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 99999999999999999999999998754321 1247788999999999999999999 8999999999999
Q ss_pred eeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh--CCCCCCCCCccc
Q 005450 482 LLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPKG 559 (696)
Q Consensus 482 LLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt--G~~Pf~~~~~~~ 559 (696)
|++.++.++|+|||++................+++.|+|||+...+.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986644332222222345678999999888899999999999999999998 778886543322
Q ss_pred hhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 560 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 560 ~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
.... ......... .....+. +......+..++.+||+.||.+||++.+|++.|+
T Consensus 242 ~~~~---~~~~~~~~~-~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VIEN---TGEFFRDQG-RQVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHH---HHHHHhhcc-ccccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1111 100000000 0000000 0111245566777899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=336.05 Aligned_cols=207 Identities=25% Similarity=0.335 Sum_probs=178.2
Q ss_pred HHHHhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC
Q 005450 342 DLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 416 (696)
Q Consensus 342 el~~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~ 416 (696)
.+....++|.+.+.||+|+||.||++... +++.+|+|++... ......+.+|+.++..++||||+++++++..++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999865 6889999998642 233456788999999999999999999999999
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCc
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGl 496 (696)
..++||||+++|+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEeccc
Confidence 999999999999999998643 36888899999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceeccC----CCCCcccchhhHHHHHHHHhCCCCCCCCCc
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~----~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~ 557 (696)
+........ .......||+.|+|||++... .++.++|||||||+||||++|+.||.....
T Consensus 189 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~ 252 (370)
T cd05621 189 CMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252 (370)
T ss_pred ceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence 987643322 122346799999999998753 378899999999999999999999987654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=328.21 Aligned_cols=240 Identities=24% Similarity=0.371 Sum_probs=189.0
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
+.||+|+||.||+|... +++.||+|+++... ...+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 57899999997532 3345566677777654 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~-- 151 (316)
T cd05592 81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-- 151 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--
Confidence 99999987543 48889999999999999999999 8999999999999999999999999999986533221
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~ 587 (696)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... +.+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------------~~~~~~ 218 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR-------------PHFPRW 218 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------CCCCCC
Confidence 2234679999999999998899999999999999999999999998654322211111000 011111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 005450 588 YDYDQMERMVLASILCIRRDPRARPQMS-LVLK 619 (696)
Q Consensus 588 ~~~~e~~~l~~la~~Cl~~dP~~RPSm~-eVL~ 619 (696)
+ ...+..++..||+.+|.+||++. ++++
T Consensus 219 ~----~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 219 I----SKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred C----CHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1 12344556679999999999975 4443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.02 Aligned_cols=237 Identities=26% Similarity=0.362 Sum_probs=190.6
Q ss_pred eeeeccCceEEEEEEe----CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 354 NLIGKGGSSQVYKGCL----PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~----~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
+.||+|+||.||++.. .+|+.||+|+++... .....+.+|++++.+++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 368899999997532 234567789999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 999999986543 48899999999999999999999 89999999999999999999999999999865443221
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~ 586 (696)
.....||+.|+|||++....++.++|||||||++|||++|+.||...........+.. ... .+..
T Consensus 155 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~-------~~~------~~p~ 219 (318)
T cd05582 155 --AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK-------AKL------GMPQ 219 (318)
T ss_pred --eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc-------CCC------CCCC
Confidence 2236799999999999988899999999999999999999999976543222111110 000 0111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005450 587 NYDYDQMERMVLASILCIRRDPRARPQMSL 616 (696)
Q Consensus 587 ~~~~~e~~~l~~la~~Cl~~dP~~RPSm~e 616 (696)
.+ ...+..++..||+.||.+||++.+
T Consensus 220 ~~----~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FL----SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CC----CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11 123445666799999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=338.98 Aligned_cols=195 Identities=22% Similarity=0.321 Sum_probs=169.6
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
..+|.+.+.||+|+||.||++.. .+++.||+|.... ..+.+|++++++++||||++++++|......++|||++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 46799999999999999999986 4688999997542 35678999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
. ++|..++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 166 ~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 166 K-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred C-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 5 68888886543 47899999999999999999999 8999999999999999999999999999975433221
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCC
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 555 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~ 555 (696)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 238 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 238 N-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred c-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 1 223367999999999999889999999999999999999999887543
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.74 Aligned_cols=255 Identities=25% Similarity=0.445 Sum_probs=202.6
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CC---CEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DG---KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g---~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
+++|...+.||+|+||.||+|... ++ ..+++|.++.. ....+.+..|++++..++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888999999999999999864 33 36999998754 3445678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++++|.+++.... ..+++..+..++.+++.||+|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999987533 258999999999999999999999 89999999999999999999999999999866
Q ss_pred cCCCCCccc-ccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 501 STSSSHITC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 501 ~~~~~~~~~-~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
......... .....++.|+|||++....++.++|||||||++|||++ |+.||...........+. .. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~---~~---~~~~~ 231 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN---DG---FRLPA 231 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh---cC---CCCCC
Confidence 543222111 11223567999999998899999999999999999997 999997654322211111 00 00000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
..+....+..++.+|++.+|++||++.+|++.|+.
T Consensus 232 ----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 232 ----------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred ----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 01112345677788999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=319.18 Aligned_cols=257 Identities=25% Similarity=0.478 Sum_probs=203.6
Q ss_pred hcCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~ 418 (696)
.++|.+.+.||+|+||.||++..+ ++..||+|++... ......+.+|+.++..++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999853 4678999998754 24456789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCC------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKK------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 480 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~------------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsN 480 (696)
++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+ ++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 999999999999999964321 12347888999999999999999999 899999999999
Q ss_pred eeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccc
Q 005450 481 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKG 559 (696)
Q Consensus 481 ILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~ 559 (696)
||++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876543322211222345678999999998899999999999999999998 888986544322
Q ss_pred hhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 560 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 560 ~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
...... .+.... ... .....+..++.+|++.+|.+|||+.|+++.|+
T Consensus 241 ---~~~~~~----~~~~~~-----~~~----~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 241 ---VIYYVR----DGNVLS-----CPD----NCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred ---HHHHHh----cCCCCC-----CCC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 111111 111110 001 11235666778899999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=320.14 Aligned_cols=260 Identities=22% Similarity=0.387 Sum_probs=203.4
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 417 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~ 417 (696)
.+++|.+.+.||+|+||.||+|... .+..||+|.++... .....+.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999998743 24579999987543 334567889999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCCC------CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEE
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKD------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 491 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~------~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL 491 (696)
.++||||+++|+|.+++...... ...+.+..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999753211 1345677889999999999999999 89999999999999999999999
Q ss_pred eecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccc
Q 005450 492 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPI 570 (696)
Q Consensus 492 ~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~ 570 (696)
+|||+++...............++..|+|||++..+.++.++|||||||++|||++ |..||...........+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~----- 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM----- 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----
Confidence 99999986544332222222346778999999998899999999999999999998 788986543322111110
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 571 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 571 ~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
. +.... . +......+..++..|++.+|++||++.++++.|+..
T Consensus 236 -~-~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 236 -D-GGYLD-----Q----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -c-CCCCC-----C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 0 10000 0 011123566677789999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.65 Aligned_cols=249 Identities=26% Similarity=0.390 Sum_probs=203.0
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+|.+.+.||+|++|.||++... +++.|++|.+... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 5788899999999999999864 6899999998643 35567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++.... ...+++..++.++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999997642 2358899999999999999999999 899999999999999999999999999998665432
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
.. .....|++.|+|||++....++.++||||||+++|+|++|+.||....... ...... .+.... +
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----~~~~~~-----~ 221 (256)
T cd08529 156 NF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILKII----RGVFPP-----V 221 (256)
T ss_pred ch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----cCCCCC-----C
Confidence 22 123568999999999998899999999999999999999999997654221 111111 011110 1
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.......+..++..||+.+|++||++.++++.
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 ----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11122345667778999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=315.05 Aligned_cols=251 Identities=33% Similarity=0.489 Sum_probs=199.1
Q ss_pred ceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHH---HHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 350 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIK---EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~---~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
|++.+.||+|+||+||++... +++.||+|++........ ...+|+.++.+++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678899999999999999975 466899999987653322 3456999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
.+++|.+++.... .+++..+..++.|+++||.|||+ .+|+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-- 151 (260)
T PF00069_consen 81 PGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-- 151 (260)
T ss_dssp TTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--
T ss_pred ccccccccccccc----ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--
Confidence 9999999998332 57999999999999999999999 89999999999999999999999999999765221
Q ss_pred CcccccccccCCCCCcceec-cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 506 HITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~-~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
........+|..|+|||++. ...++.++||||||+++|+|++|..||.................. . +....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~-------~-~~~~~ 223 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR-------P-LPSSS 223 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT-------H-HHHHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc-------c-ccccc
Confidence 22333467899999999998 888999999999999999999999999876222222211111000 0 00000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. ........+..++..||+.||++||++.++++
T Consensus 224 ~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 Q--QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp T--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred c--ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00001156667777899999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=325.02 Aligned_cols=263 Identities=19% Similarity=0.327 Sum_probs=198.3
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
++|.+.+.||+|+||.||+|... +++.||+|.++... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57899999999999999999865 67889999987532 3345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++ +|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 8888876543 247889999999999999999999 899999999999999999999999999997654322
Q ss_pred CCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc----
Q 005450 505 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL---- 579 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l---- 579 (696)
. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..............+
T Consensus 159 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 K--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred c--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 2 1223568999999998864 46899999999999999999999999876544333222211110000000000
Q ss_pred --cCcccCCC-------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 580 --LDPALGNN-------YDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 580 --lD~~L~~~-------~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+...... ........+..++..|++.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000 00001123455667799999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.98 Aligned_cols=255 Identities=23% Similarity=0.417 Sum_probs=200.6
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCC----EEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~----~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
.++|...+.||+|+||+||+|.. .+|+ .||+|+++.. ......+.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 46788999999999999999984 4554 4899998753 3456778899999999999999999999975 4578
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
++|||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceee
Confidence 9999999999999997543 258999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
..............+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+ .. +....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~---~~----~~~~~ 231 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL---EK----GERLP 231 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HC----CCcCC
Confidence 754333222222345678999999998899999999999999999998 99998754432221111 11 10000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
... .....+..++..||+.||++||++.++++.|...
T Consensus 232 -----~~~----~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 232 -----QPP----ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred -----CCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 000 1123455667779999999999999999888643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=322.31 Aligned_cols=260 Identities=26% Similarity=0.413 Sum_probs=204.2
Q ss_pred hcCceeeeeeeccCceEEEEEEe--------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL--------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 415 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~--------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~ 415 (696)
..+|.+.+.||+|+||.||++.. .++..||+|.+... ......+.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 45688899999999999999963 13457999998753 34457789999999999 799999999999999
Q ss_pred CceEEEEeecCCCChhhhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee
Q 005450 416 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 483 (696)
Q Consensus 416 ~~~~LV~Ey~~gGsL~~~L~~~~~------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL 483 (696)
...++||||+++|+|.+++..... ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 999999999999999999975422 12357889999999999999999999 899999999999999
Q ss_pred CCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhh
Q 005450 484 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 562 (696)
Q Consensus 484 d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~ 562 (696)
+.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||..........
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 250 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 9999999999999987654333222223456788999999988889999999999999999998 888886543322211
Q ss_pred HHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 563 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 563 lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
.+. .+.... . +......+..++..||+.+|.+||++.++++.|+...
T Consensus 251 ~~~-------~~~~~~-----~----~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 251 LLK-------EGHRMD-----K----PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HHH-------cCCcCC-----C----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 111 000000 0 1111234555667799999999999999999996543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=311.70 Aligned_cols=254 Identities=22% Similarity=0.419 Sum_probs=205.1
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
.++|.+.+.||+|+||.||++...++..+|+|.+.........+.+|+.+++.++|+||+++++++.. ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 46789999999999999999998888889999998766666789999999999999999999999887 78899999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+++|.+++.... ...+++..+..++.+++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 84 KGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999997543 2357889999999999999999999 89999999999999999999999999999766443221
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
......++..|+|||++..+.++.++|||||||++|+|++ |+.||...........+ . .+.... .
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~---~----~~~~~~-----~- 224 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---E----RGYRMP-----R- 224 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---h----CCCCCC-----C-
Confidence 1122346678999999998889999999999999999999 99999765432221111 1 000000 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.......+..++.+|++.+|++||++.++++.|+.
T Consensus 225 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 ---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112345566778999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=328.38 Aligned_cols=235 Identities=25% Similarity=0.379 Sum_probs=188.9
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
+.||+|+||.||++..+ +++.||||+++.. ......+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 6889999999753 23456677899998877 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-- 151 (320)
T cd05590 81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-- 151 (320)
T ss_pred chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--
Confidence 99999887543 48899999999999999999999 8999999999999999999999999999875432211
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~ 587 (696)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+. .+.. .+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~-------~~~~------~~~~~ 218 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL-------NDEV------VYPTW 218 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh-------cCCC------CCCCC
Confidence 1233679999999999998899999999999999999999999997655332211111 0000 00111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCH
Q 005450 588 YDYDQMERMVLASILCIRRDPRARPQM 614 (696)
Q Consensus 588 ~~~~e~~~l~~la~~Cl~~dP~~RPSm 614 (696)
. ...+..++..||+.||.+||++
T Consensus 219 ~----~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 L----SQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred C----CHHHHHHHHHHcccCHHHCCCC
Confidence 1 1234456667999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=327.88 Aligned_cols=261 Identities=24% Similarity=0.292 Sum_probs=203.7
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC-----ceEEEE
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLLLVY 422 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~-----~~~LV~ 422 (696)
.|...+++|.|+||.||+|.. .+++.||||....+... -.+|+.+|+.+.|||||+|+-+|.... .+.|||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 467789999999999999985 45799999998765532 236999999999999999999887532 356899
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC-CceEEeecCcccccc
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWAS 501 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~-~~vKL~DFGlA~~~~ 501 (696)
|||+. +|.+.++........++...+.-+..||++||.|||+ .+|+||||||.|||+|.+ |.+||||||.|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99987 9999998654444567888888999999999999999 999999999999999976 899999999999988
Q ss_pred CCCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC------
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG------ 574 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g------ 574 (696)
.+..... ...|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+++...+..++..........
T Consensus 178 ~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 178 KGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred cCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 7766543 5689999999988754 79999999999999999999999999988777665553332221111
Q ss_pred ------ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 575 ------KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 575 ------~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+..++....+..-+........+.+...+++.+|.+|.++.|++.
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 111111111111111222345566777799999999999999885
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=327.76 Aligned_cols=240 Identities=24% Similarity=0.382 Sum_probs=190.5
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
+.||+|+||.||+|... +++.||||+++.. ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 5789999999764 23445667788888764 899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05619 81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-- 151 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence 99999987543 47889999999999999999999 8999999999999999999999999999875432221
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~ 587 (696)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... +.+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-------------~~~~~~ 218 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-------------PCYPRW 218 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------CCCCcc
Confidence 1223679999999999998899999999999999999999999997654332221111111 111111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 005450 588 YDYDQMERMVLASILCIRRDPRARPQMS-LVLK 619 (696)
Q Consensus 588 ~~~~e~~~l~~la~~Cl~~dP~~RPSm~-eVL~ 619 (696)
. ...+..++..||+.+|.+||++. ++++
T Consensus 219 ~----~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 219 L----TREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred C----CHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1 12344556679999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.53 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=200.3
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~------~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
++|...+.||+|++|.||++.. .+++.+|+|.+.... .....+.+|++++++++||||+++++++..+...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999986 468999999986432 234568889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++++|.+++.... .+++..+..++.+++.||.|||+ .+|+||||+|+||+++.++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999987543 47888999999999999999999 89999999999999999999999999999865
Q ss_pred cCCCCCcc-cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 501 STSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 501 ~~~~~~~~-~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
........ .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.......... .... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~---~~~---- 224 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF---KIAT---QPT---- 224 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH---HHhc---cCC----
Confidence 43221111 123568899999999998889999999999999999999999997643322111 1100 000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.+.+... ....+..++..||..+|.+|||+.++++.
T Consensus 225 -~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 -NPQLPSH----VSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCCcc----CCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0111111 12234556677999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=339.45 Aligned_cols=250 Identities=25% Similarity=0.352 Sum_probs=210.4
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc-eEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~-~~LV~ 422 (696)
++|...+.||+|+||.+++...+ +++.|++|.+.-. +.......+|+.++++++|||||.+++.|.+++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999998754 6789999998753 3445578899999999999999999999999888 99999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
+|++||+|.+.|...+ ...|+++.+.+++.|++.|+.|||+ ..|+|||||+.|||++.++.+||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998765 3478999999999999999999998 8899999999999999999999999999999887
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
.... ...++||+.|+.||.+.+..|+.|+|||||||++|||++-+++|...+.......+... .++|
T Consensus 159 ~~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~-----------~~~P 225 (426)
T KOG0589|consen 159 EDSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG-----------LYSP 225 (426)
T ss_pred chhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc-----------cCCC
Confidence 6532 23478999999999999999999999999999999999999999887654433222111 1111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.+......+..++..|++.+|+.||++.++|..
T Consensus 226 -----lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 -----LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 122233445556667999999999999999875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=339.71 Aligned_cols=239 Identities=31% Similarity=0.510 Sum_probs=198.2
Q ss_pred eeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCChhh
Q 005450 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 432 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL~~ 432 (696)
.+-||.|+.|-||+|.+ .++.||||.++.-+ ..+|+.|++|+||||+.+.|+|.....++||||||..|-|.+
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 46689999999999998 45789999876422 347889999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccccc
Q 005450 433 NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 512 (696)
Q Consensus 433 ~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 512 (696)
.|.... .+.......+..+||.|+.|||. +.|||||||+-||||+.+..+||+|||-++......+. ..+
T Consensus 202 VLka~~----~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk---MSF 271 (904)
T KOG4721|consen 202 VLKAGR----PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK---MSF 271 (904)
T ss_pred HHhccC----ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhhhh---hhh
Confidence 997654 46777888999999999999999 89999999999999999999999999999877664322 248
Q ss_pred cccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCChHH
Q 005450 513 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQ 592 (696)
Q Consensus 513 ~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e 592 (696)
+||..|||||++.....++|+|||||||||||||||..||.+-+. ..+.|.-. .+.+. + ..+...
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwGVG---sNsL~-L-------pvPstc 336 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWGVG---SNSLH-L-------PVPSTC 336 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEecc---CCccc-c-------cCcccC
Confidence 899999999999999999999999999999999999999976432 22333211 11111 1 112233
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 593 MERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 593 ~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
...+.+++.+||+..|.+||++.+++.+|.-
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 4567778888999999999999999988864
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=329.18 Aligned_cols=247 Identities=21% Similarity=0.335 Sum_probs=191.3
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
+.||+|+||.||++... +++.||+|+++.. ......+..|+.++..+ +||||++++++|...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 6889999999753 23456688899999998 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-- 151 (329)
T cd05588 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-- 151 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--
Confidence 99999886543 58999999999999999999999 8999999999999999999999999999874322111
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccc--hhhHHhhhccccccCccccccCcccC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG--QESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~--~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......+.......... .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p 225 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIP 225 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCC
Confidence 2234679999999999999999999999999999999999999996422111 00000111000111100 111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQ------MSLVLK 619 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPS------m~eVL~ 619 (696)
..+ ...+..++..||+.||.+||+ +.++++
T Consensus 226 ~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 226 RSL----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCC----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 111 223455667799999999998 566664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.52 Aligned_cols=254 Identities=26% Similarity=0.455 Sum_probs=200.8
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CC---CEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DG---KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g---~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
++|.+.+.||+|+||.||+|... ++ ..||||.+... ......|..|+.+++.++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45788999999999999999864 33 36999998753 44567899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 99999999999987543 258899999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCccccc-cc--ccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 502 TSSSHITCTD-VA--GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 502 ~~~~~~~~~~-~~--GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
.......... .. .+..|+|||++.+..++.++|||||||++|||++ |..||........ ..+..... .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~~i~~~~---~~~ 231 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---INAIEQDY---RLP 231 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HHHHHcCC---cCC
Confidence 4332211111 11 2457999999998999999999999999999886 9999976543221 11111100 000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
. ..+....+..++..||+.+|.+||++.+++..|+.
T Consensus 232 ------~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 232 ------P----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ------C----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0 01112234566677999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=328.01 Aligned_cols=240 Identities=25% Similarity=0.346 Sum_probs=189.9
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
+.||+|+||.||++... +|+.||+|+++.. ......+..|..++..+ +||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999865 6889999999753 23445667788888764 899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
|+|..++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05620 81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-- 151 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--
Confidence 99999987543 47889999999999999999999 8999999999999999999999999999874322111
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~ 587 (696)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... .+.+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-------------~~~~~~~ 218 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-------------TPHYPRW 218 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------CCCCCCC
Confidence 223467999999999999999999999999999999999999999765432221111100 0111111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 005450 588 YDYDQMERMVLASILCIRRDPRARPQMS-LVLK 619 (696)
Q Consensus 588 ~~~~e~~~l~~la~~Cl~~dP~~RPSm~-eVL~ 619 (696)
. ...+..++..||+.||.+||++. ++++
T Consensus 219 ~----~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 219 I----TKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred C----CHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1 12344566679999999999974 5553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.65 Aligned_cols=255 Identities=26% Similarity=0.421 Sum_probs=198.8
Q ss_pred cCceeeeeeeccCceEEEEEEeCC-CC--EEEEEEecC--ChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPD-GK--ELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~-g~--~vAVK~l~~--~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV 421 (696)
++|.+.+.||+|+||.||+|...+ +. .+++|.++. .....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999998653 33 478888874 234557789999999999 799999999999999999999
Q ss_pred EeecCCCChhhhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCce
Q 005450 422 YDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 489 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~v 489 (696)
|||+++++|.+++..... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 999999999999975431 11358899999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhc
Q 005450 490 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 568 (696)
Q Consensus 490 KL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~ 568 (696)
||+|||++........ ......+..|+|||++....++.++|||||||++|||++ |..||...........+ .
T Consensus 159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~---~ 232 (297)
T cd05089 159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL---P 232 (297)
T ss_pred EECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---h
Confidence 9999999864322111 111223567999999988889999999999999999997 99999765432211111 0
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 569 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 569 ~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
. + ........ ....+..++..|++.+|.+||++.++++.|...
T Consensus 233 ~----~-----~~~~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 233 Q----G-----YRMEKPRN----CDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred c----C-----CCCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0 00001111 113455677789999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=318.25 Aligned_cols=265 Identities=25% Similarity=0.386 Sum_probs=205.7
Q ss_pred cChHHHHHhhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEE--
Q 005450 338 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCF-- 413 (696)
Q Consensus 338 f~~~el~~~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~-- 413 (696)
+.++.+..+.++|.+.+.||+|+||.||++.. .+++.+|+|++.........+..|+.++..+ +||||++++++|.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34455666788999999999999999999986 4688999999876555556788899999999 6999999999884
Q ss_pred ---ecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceE
Q 005450 414 ---EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 490 (696)
Q Consensus 414 ---~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vK 490 (696)
.++..++||||+++++|.+++.........+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEE
Confidence 3456899999999999999886433333468899999999999999999999 8999999999999999999999
Q ss_pred EeecCccccccCCCCCcccccccccCCCCCcceecc-----CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHh
Q 005450 491 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 565 (696)
Q Consensus 491 L~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~-----~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~ 565 (696)
|+|||++........ ......|++.|+|||++.. ..++.++|||||||++|||++|+.||....+.... ..
T Consensus 165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~~ 240 (286)
T cd06638 165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--FK 240 (286)
T ss_pred EccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--hh
Confidence 999999986644221 1223569999999998853 45788999999999999999999999765432211 11
Q ss_pred hhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005450 566 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621 (696)
Q Consensus 566 ~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L 621 (696)
.. ......+.++. . ....+..++..||+.+|++||++.++++.+
T Consensus 241 ~~-----~~~~~~~~~~~---~----~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 IP-----RNPPPTLHQPE---L----WSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cc-----ccCCCcccCCC---C----cCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 00001111111 0 112455667779999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=328.40 Aligned_cols=247 Identities=20% Similarity=0.337 Sum_probs=190.2
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
+.||+|+||.||++... +++.||+|+++.. ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 6789999999753 23455678899988877 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
|+|..++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-- 151 (329)
T cd05618 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-- 151 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--
Confidence 99998886543 48899999999999999999999 8999999999999999999999999999975432211
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccc--hhhHHhhhccccccCccccccCcccC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG--QESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~--~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......+.......... .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~- 224 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI- 224 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CC-
Confidence 1234679999999999999999999999999999999999999995321110 00000011000000000 11
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQ------MSLVLK 619 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPS------m~eVL~ 619 (696)
+......+..++..||+.||.+||+ +.++++
T Consensus 225 ---p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 225 ---PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred ---CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 1111234456667799999999998 456654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=343.23 Aligned_cols=268 Identities=18% Similarity=0.226 Sum_probs=197.9
Q ss_pred hHHHHHhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCC------cceeEEeeEE
Q 005450 340 YQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHH------KNIISLLGFC 412 (696)
Q Consensus 340 ~~el~~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~H------pnIV~l~g~~ 412 (696)
.+++...+++|.+.+.||+|+||+||+|... +++.||||+++........+..|+.++..++| +++++++++|
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3444556789999999999999999999864 67889999997655555566778888887755 4588999988
Q ss_pred Eec-CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC----
Q 005450 413 FED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---- 487 (696)
Q Consensus 413 ~~~-~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~---- 487 (696)
... .++++|||++ +++|.+++.... .+++..+..|+.||+.||+|||+. .+||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccc
Confidence 764 4789999988 678988886543 588999999999999999999961 4899999999999998765
Q ss_pred ------------ceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCC
Q 005450 488 ------------EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 555 (696)
Q Consensus 488 ------------~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~ 555 (696)
.+||+|||++...... .....||+.|+|||++.+..|+.++|||||||+||||++|+.||...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4999999988643221 23467999999999999999999999999999999999999999876
Q ss_pred CccchhhHHhhhcccccc------------------CccccccCcc-----cCCC--CChHHHHHHHHHHHHhcccCCCC
Q 005450 556 HPKGQESLVMWAKPILSS------------------GKVTQLLDPA-----LGNN--YDYDQMERMVLASILCIRRDPRA 610 (696)
Q Consensus 556 ~~~~~~~lv~~~~~~~~~------------------g~l~~llD~~-----L~~~--~~~~e~~~l~~la~~Cl~~dP~~ 610 (696)
.......++......+.. +.+....++. .... ........+..++..||+.||.+
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 543333222211100000 0000000000 0000 00001234557788899999999
Q ss_pred CCCHHHHHH
Q 005450 611 RPQMSLVLK 619 (696)
Q Consensus 611 RPSm~eVL~ 619 (696)
|||+.|+++
T Consensus 429 R~ta~e~L~ 437 (467)
T PTZ00284 429 RLNARQMTT 437 (467)
T ss_pred CCCHHHHhc
Confidence 999999986
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=336.09 Aligned_cols=263 Identities=22% Similarity=0.307 Sum_probs=198.6
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC-----ceE
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLL 419 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~-----~~~ 419 (696)
+|.+.+.||+|+||.||++.. .+|+.||||.+... ....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999986 47899999998643 234567889999999999999999999998776 789
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+||||+. ++|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 57888775432 58899999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc-
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT- 577 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~- 577 (696)
....... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||....+..+...+...........+.
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 6443222 22335689999999998764 57899999999999999999999998765543322221110000000000
Q ss_pred -------ccc----C-cccCC--CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 578 -------QLL----D-PALGN--NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 578 -------~ll----D-~~L~~--~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.+. . +.... .........+..++..||+.||.+|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000 0 00000 0011112345567778999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=310.34 Aligned_cols=250 Identities=30% Similarity=0.454 Sum_probs=204.2
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
.++|.+.+.||.|+||.||++... |+.||+|.++......+++.+|+.++..++|+||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 357888999999999999999864 7889999998766567789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+++|.+++..... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 84 KGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999975432 258999999999999999999999 8999999999999999999999999999987643221
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
...++..|+|||++..+.++.++||||||+++|+|++ |+.||........ ........ . ...
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~~~~---~------~~~- 220 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPHVEKGY---R------MEA- 220 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHhcCC---C------CCC-
Confidence 1335678999999998899999999999999999997 9999976543221 11111000 0 000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
+......+..++.+|+..+|.+||++.++++.|+.
T Consensus 221 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 ---PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ---ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11112345566777999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.34 Aligned_cols=248 Identities=28% Similarity=0.440 Sum_probs=196.1
Q ss_pred eeeeccCceEEEEEEeC--C--CCEEEEEEecCChh--HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKGGSSQVYKGCLP--D--GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~--~--g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
+.||+|+||.||+|... + +..+|+|.+..... ..+.+.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46899999999999742 2 36899999986543 5678899999999999999999999875 5578999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
++|.+++.... .+++..+..++.|++.||.|||. .+++||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999997554 57899999999999999999999 889999999999999999999999999998765433221
Q ss_pred c-cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 508 T-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 508 ~-~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
. .....++..|+|||.+....++.++||||||+++|+|++ |+.||....... +..+..... .. . .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~~~~---~~-~-----~- 219 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLESGE---RL-P-----R- 219 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHcCC---cC-C-----C-
Confidence 1 111224568999999998899999999999999999998 999997654322 122111100 00 0 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
+......+..++..|+..+|.+||++.++++.|+...
T Consensus 220 ---~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 220 ---PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0111234556777899999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.02 Aligned_cols=254 Identities=25% Similarity=0.331 Sum_probs=191.0
Q ss_pred eeeeccCceEEEEEEeCC---CCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCC
Q 005450 354 NLIGKGGSSQVYKGCLPD---GKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 428 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~---g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gG 428 (696)
+.||+|+||.||+|...+ +..+|+|.++... .....+.+|+.++..++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998543 4579999987643 33457889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 429 SLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 429 sL~~~L~~~~~-~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
+|.+++..... ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975432 22346777888999999999999999 899999999999999999999999999997554433222
Q ss_pred ccccccccCCCCCcceeccC-------CCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 508 TCTDVAGTFGYLAPEYFMYG-------KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~-------~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
......|+..|+|||++... .++.++||||||+++|||++ |+.||............ +. +....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~-~~------~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-VR------EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-hh------cccCCC
Confidence 22335678899999988632 35789999999999999996 99999764432211110 00 111111
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
.++.+... ..+ .+..++..|+ .+|++|||+.+|++.|+
T Consensus 231 ~~~~~~~~-~~~---~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLP-LSD---RWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCC-CCh---HHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222111 112 2334455688 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.23 Aligned_cols=264 Identities=28% Similarity=0.415 Sum_probs=208.5
Q ss_pred ccChHHHHHhhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEe
Q 005450 337 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE 414 (696)
Q Consensus 337 ~f~~~el~~~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~ 414 (696)
.+.+.++..++++|.+.+.||+|+||.||++.. .+++.+|+|++.........+.+|+.++.++ +|||+++++++|..
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 456677778899999999999999999999986 4688999999987655567788899999999 79999999999875
Q ss_pred c-----CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCce
Q 005450 415 D-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 489 (696)
Q Consensus 415 ~-----~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~v 489 (696)
. +..++||||+++++|.++++........+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 4 35899999999999999887543333468999999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCcccccccccCCCCCcceeccC-----CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHH
Q 005450 490 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 564 (696)
Q Consensus 490 KL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~-----~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv 564 (696)
||+|||++......... .....|+..|+|||++... .++.++|||||||++|||++|+.||........ +.
T Consensus 168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF 243 (291)
T ss_pred EEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH
Confidence 99999998865542221 1235689999999998644 368899999999999999999999976543221 11
Q ss_pred hhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 565 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 565 ~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+... ....+.+ .......+..++..|++.+|++||++.++++
T Consensus 244 ~~~~~-----~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 KIPRN-----PPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHhcC-----CCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11110 0001111 1112234666777899999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.25 Aligned_cols=256 Identities=23% Similarity=0.398 Sum_probs=202.6
Q ss_pred cCceeeeeeeccCceEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCce
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~ 418 (696)
++|.+.+.||+|+||.||++.. ..+..+|+|.++.. ....+.+.+|+.+++++ +||||++++++|...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4688999999999999999974 23557999998754 34456789999999999 799999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
++||||+++|+|.++++.... ..+++.++..++.+++.||.|||+ ++|+|+||||+|||++.++.++|+|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999975432 248999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 499 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 499 ~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
...............++..|+|||++..+.++.++|||||||++|||++ |..||........ ...... .+.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~----~~~-- 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIK----EGY-- 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHH----cCC--
Confidence 6654332222222456788999999998899999999999999999998 9999876443221 111111 000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
...... .....+..++..|++.+|++||++.++++.|..
T Consensus 262 ---~~~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 262 ---RMAQPE----HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ---cCCCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 000000 112345566777999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=316.78 Aligned_cols=262 Identities=21% Similarity=0.313 Sum_probs=193.3
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhc---CCcceeEEeeEEEe-----cC
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTL---HHKNIISLLGFCFE-----DN 416 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L---~HpnIV~l~g~~~~-----~~ 416 (696)
+|.+.+.||+|+||+||+|... +|+.||+|.++... .....+.+|+.++..+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999865 68899999987532 2233456677777665 69999999999864 24
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCc
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGl 496 (696)
..++||||+.+ +|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCc
Confidence 58999999985 89888865432 348999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
+........ .....||+.|+|||++.+..++.++|||||||++|+|++|++||...........+............
T Consensus 155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 987654322 12356899999999999889999999999999999999999999765443222111100000000000
Q ss_pred c-------cccCcccCC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 577 T-------QLLDPALGN---NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 577 ~-------~llD~~L~~---~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. ..+.+.... .........+..++..||+.||++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 000000000 000111234556777899999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.26 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=199.8
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.++.+++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788999999999999999986 578899999987542 3456688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.++++... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 99999999986543 47899999999999999999999 899999999999999999999999999998664322
Q ss_pred CCcccccccccCCCCCcceec---cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 505 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~---~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
.. .....|++.|+|||.+. ...++.++|||||||++|||++|+.||....+...... +... .+ ..
T Consensus 161 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~--~~~~-----~~---~~ 228 (267)
T cd06646 161 AK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--MSKS-----NF---QP 228 (267)
T ss_pred cc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee--eecC-----CC---CC
Confidence 11 12356899999999874 34578899999999999999999999965433211110 0000 00 00
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L 621 (696)
+.+.. .......+..++..||+.+|++||++.++++.|
T Consensus 229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 PKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11110 011123455667789999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=308.10 Aligned_cols=247 Identities=26% Similarity=0.457 Sum_probs=197.7
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCChh
Q 005450 354 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 431 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL~ 431 (696)
+.||+|+||.||++...+++.|++|.+.... .....+.+|+++++++.||||+++++++...+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 4689999999999998779999999987543 35678999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCccccc
Q 005450 432 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 511 (696)
Q Consensus 432 ~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~ 511 (696)
+++..... .+++..+..++.+++.||.|||+ ++++||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKKN---RLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 99965432 57889999999999999999999 8999999999999999999999999999986543222111112
Q ss_pred ccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCCh
Q 005450 512 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 590 (696)
Q Consensus 512 ~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~ 590 (696)
..++..|+|||++.++.++.++||||||+++|+|++ |..||...........+.... .. .. +.
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~------~~------~~----~~ 218 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY------RM------PA----PQ 218 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC------CC------CC----Cc
Confidence 334677999999998899999999999999999999 888987654322222111100 00 00 01
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 591 DQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 591 ~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
.....+..++..|++.+|.+||++.++++.|+
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11234556777799999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=315.36 Aligned_cols=253 Identities=25% Similarity=0.417 Sum_probs=199.5
Q ss_pred HhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec------C
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFED------N 416 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~------~ 416 (696)
.+++.|...+.||+|+||.||+|... +++.||+|++.........+..|+.++..+ +||||++++++|... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 35677888999999999999999864 688999999976655567788999999998 699999999998753 4
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCc
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGl 496 (696)
..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||++++++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 58999999999999999875432 358899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceec-----cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccc
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 571 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~-----~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~ 571 (696)
+........ ......|++.|+|||++. ...++.++|||||||++|||++|+.||....+........ .
T Consensus 158 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~-~---- 230 (272)
T cd06637 158 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-R---- 230 (272)
T ss_pred ceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh-c----
Confidence 986544322 123367999999999986 3468889999999999999999999997544322211110 0
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 572 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 572 ~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.......+ .. ....+..++..||..+|.+|||+.++++
T Consensus 231 --~~~~~~~~----~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 --NPAPRLKS----KK----WSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --CCCCCCCC----CC----cCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000111 11 1123556667799999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=310.50 Aligned_cols=245 Identities=27% Similarity=0.411 Sum_probs=193.8
Q ss_pred eeeccCceEEEEEEe---CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCC
Q 005450 355 LIGKGGSSQVYKGCL---PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 428 (696)
Q Consensus 355 ~LG~G~fG~Vyka~~---~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gG 428 (696)
.||+|+||.||+|.. .++..+|+|+++.. ....+.+.+|+.++..+.||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 46788999998753 234678899999999999999999999885 45789999999999
Q ss_pred ChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcc
Q 005450 429 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 508 (696)
Q Consensus 429 sL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~ 508 (696)
+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||.|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999996543 48899999999999999999999 8999999999999999999999999999987654432211
Q ss_pred -cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccCC
Q 005450 509 -CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586 (696)
Q Consensus 509 -~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~ 586 (696)
.....++..|+|||.+....++.++|||||||++|||++ |+.||...........+. .+... ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-------~~~~~-----~~~~ 221 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-------SGERM-----ECPQ 221 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CCCCC-----CCCC
Confidence 112334678999999988889999999999999999998 999997654332222211 11100 0111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 587 ~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
..+ ..+..++..||+.||++||++.+|.+.|+.
T Consensus 222 ~~~----~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 222 RCP----PEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCC----HHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111 334556677999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=311.83 Aligned_cols=255 Identities=24% Similarity=0.423 Sum_probs=202.4
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-C---CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-D---GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~---g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
..+|.+.+.||+|+||.||+|... + +..+|+|.++.. ....+.+.+|+.++..++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357889999999999999999853 2 337999998753 3445688999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++++|.+++.... ..+++.+++.++.|++.||.|||+ ++++||||||+|||++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 999999999999997543 257899999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcc-cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 501 STSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 501 ~~~~~~~~-~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
........ .....++..|+|||++.+..++.++||||||+++||+++ |+.||........ ........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~~~~---~~-- 228 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIEEGY---RL-- 228 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHhCCC---cC--
Confidence 54332211 111234568999999998899999999999999999886 9999976543221 11111000 00
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
+ . .......+..++..|++.+|.+||+|.++++.|..
T Consensus 229 ---~-~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 ---P-A----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ---C-C----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0 0 01112345667778999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=318.73 Aligned_cols=260 Identities=23% Similarity=0.379 Sum_probs=201.2
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
++|.+.+.||+|+||.||++... ++..+|+|.++.. ......+.+|++++.+++||||++++++|..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999854 6888999998753 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++.... .+++..+..++.|+++||.|||+ ..+++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999999997543 47899999999999999999996 1479999999999999999999999999987654322
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC----------
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG---------- 574 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g---------- 574 (696)
.....|++.|+|||++.+..++.++||||||+++|+|++|+.||......................
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 ----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 123578999999999988889999999999999999999999997544322211111000000000
Q ss_pred -------ccccccC-------cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 575 -------KVTQLLD-------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 575 -------~l~~llD-------~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
...++.+ +.+... .....+..++.+||+.+|++||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSG---AFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCc---ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 011000 012246677788999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=326.11 Aligned_cols=240 Identities=23% Similarity=0.344 Sum_probs=192.6
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
+.||+|+||+||++... +++.||||+++.. ......+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 5789999999753 23456677899999888 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
|+|..++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 151 (318)
T cd05570 81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-- 151 (318)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence 99999887543 48999999999999999999999 8999999999999999999999999999875332221
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~ 587 (696)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.. .. ..+...
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-------~~------~~~~~~ 218 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-------DE------VRYPRW 218 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc-------CC------CCCCCc
Confidence 12235799999999999999999999999999999999999999976543222111110 00 001111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 005450 588 YDYDQMERMVLASILCIRRDPRARPQM-----SLVLK 619 (696)
Q Consensus 588 ~~~~e~~~l~~la~~Cl~~dP~~RPSm-----~eVL~ 619 (696)
. ...+..++..||+.||.+||++ .++++
T Consensus 219 ~----~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 219 L----SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred C----CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1 2345566677999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.86 Aligned_cols=209 Identities=25% Similarity=0.322 Sum_probs=179.8
Q ss_pred hHHHHHhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe
Q 005450 340 YQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFE 414 (696)
Q Consensus 340 ~~el~~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~ 414 (696)
..++....++|.+.+.||+|+||.||++... +++.+|+|++... ......+.+|+.++..++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4555666789999999999999999999865 6889999998642 2334567889999999999999999999999
Q ss_pred cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeec
Q 005450 415 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 494 (696)
Q Consensus 415 ~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DF 494 (696)
++..++||||+++|+|.+++... .++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999998643 36788889999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCCcccccccccCCCCCcceeccC----CCCCcccchhhHHHHHHHHhCCCCCCCCCc
Q 005450 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 495 GlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~----~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~ 557 (696)
|++......... ......||+.|+|||++... .++.++|||||||++|||++|+.||.....
T Consensus 187 G~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 252 (371)
T cd05622 187 GTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (371)
T ss_pred CceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH
Confidence 999876543221 22346799999999998753 388999999999999999999999987654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=326.85 Aligned_cols=199 Identities=27% Similarity=0.357 Sum_probs=170.4
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC-----
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----- 416 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~----- 416 (696)
..++|.+.+.||+|+||.||++.. .+|+.||+|++... ......+.+|+.++..++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999986 46899999998643 344567889999999999999999999986543
Q ss_pred -ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecC
Q 005450 417 -NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 495 (696)
Q Consensus 417 -~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFG 495 (696)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCC
Confidence 47999999976 56666642 36788899999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Q 005450 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 496 lA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~ 557 (696)
+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 169 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~ 227 (359)
T cd07876 169 LARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH 227 (359)
T ss_pred CccccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9976543221 2235789999999999988999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.31 Aligned_cols=247 Identities=26% Similarity=0.319 Sum_probs=192.1
Q ss_pred eeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCCh
Q 005450 356 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 430 (696)
Q Consensus 356 LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL 430 (696)
||+|+||.||++..+ +|+.||+|.+.... .....+..|++++.+++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 68999999986432 2234556799999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccc
Q 005450 431 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 510 (696)
Q Consensus 431 ~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~ 510 (696)
.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++........ ..
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~ 152 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---IT 152 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---ee
Confidence 988865432 347899999999999999999999 8999999999999999999999999999987654322 22
Q ss_pred cccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCCh
Q 005450 511 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 590 (696)
Q Consensus 511 ~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~ 590 (696)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ...... ..+.. ....+ .
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~--~~~~~~-~~~~~-----~~~~~-~ 223 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL--KRRTLE-DEVKF-----EHQNF-T 223 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH--HHHhhc-ccccc-----ccccC-C
Confidence 356899999999999888999999999999999999999999754332111111 111110 01000 00111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 591 DQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 591 ~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
..+..++..||+.||++||++.|+++.+.
T Consensus 224 ---~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 224 ---EESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred ---HHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 23455666799999999999987765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.62 Aligned_cols=204 Identities=25% Similarity=0.397 Sum_probs=177.0
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|...+.||+|+||.||++... +++.||+|+++.. ......+.+|+.++..++||||+++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999864 6899999999753 234567888999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999997543 47899999999999999999999 9999999999999999999999999999875432
Q ss_pred CCCC---------------------------------cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCC
Q 005450 503 SSSH---------------------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 549 (696)
Q Consensus 503 ~~~~---------------------------------~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~ 549 (696)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 1100 0011357999999999999999999999999999999999999
Q ss_pred CCCCCCCcc
Q 005450 550 KPISNDHPK 558 (696)
Q Consensus 550 ~Pf~~~~~~ 558 (696)
.||....+.
T Consensus 234 ~Pf~~~~~~ 242 (360)
T cd05627 234 PPFCSETPQ 242 (360)
T ss_pred CCCCCCCHH
Confidence 999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.11 Aligned_cols=270 Identities=26% Similarity=0.363 Sum_probs=203.6
Q ss_pred cCceeeeeeeccCceEEEEEEeC-----CCCEEEEEEecCChh--HHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCce
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-----DGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNL 418 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-----~g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~--~~~~ 418 (696)
.+|...+.||+|+||.||++... ++..+|||+++.... ....+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677899999999999999853 468899999986554 47789999999999999999999999987 5679
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
++||||+++++|.+++..... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999999975432 58999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcc-cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 499 WASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 499 ~~~~~~~~~~-~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
.......... .....++..|+|||++....++.++||||||+++|||++|+.|+............. .........+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLL 236 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHH
Confidence 7763322111 112345667999999988899999999999999999999999986543211100000 00000000000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
..+........+......+..++.+|++.+|.+||++.+|+++|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 01100000000111124566777889999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=326.69 Aligned_cols=258 Identities=24% Similarity=0.414 Sum_probs=199.5
Q ss_pred cCceeeeeeeccCceEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEe-cCc
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFE-DNN 417 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~-~~~ 417 (696)
++|.+.+.||+|+||.||+|.. .+++.||||+++.. ......+.+|+.++.++ +||||++++++|.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5789999999999999999973 35788999999753 33456788999999999 68999999998865 456
Q ss_pred eEEEEeecCCCChhhhhhcCCCC---------------------------------------------------------
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKD--------------------------------------------------------- 440 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~--------------------------------------------------------- 440 (696)
.++||||+++|+|.+++......
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 89999999999999998643210
Q ss_pred ------CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccccccc
Q 005450 441 ------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 514 (696)
Q Consensus 441 ------~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~G 514 (696)
...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1236888899999999999999999 8999999999999999999999999999986644322222223446
Q ss_pred cCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCChHHH
Q 005450 515 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQM 593 (696)
Q Consensus 515 T~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~ 593 (696)
++.|+|||++....++.++||||||+++|+|++ |..||......... .... ..+.... ..... .
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~~~~----~~~~~~~-----~~~~~----~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRL----KEGTRMR-----APDYT----T 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH--HHHH----hccCCCC-----CCCCC----C
Confidence 778999999988899999999999999999997 99999764332111 1100 0110000 00111 1
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 594 ERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 594 ~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
..+..++..||+.+|.+||++.+|++.|+.
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 245667778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=313.39 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=195.7
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
++|+..+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|++++.+++||||++++++|...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999985 57889999998653 34456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999997542 36788889999999999999999 899999999999999999999999999997654322
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchh-hHHhhhccccccCccccccCcc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-SLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~-~lv~~~~~~~~~g~l~~llD~~ 583 (696)
.....||..|+|||++....++.++||||||+++|+|++|+.||......... .......... .. ..+.
T Consensus 150 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~-----~~~~ 219 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DE-----DPPV 219 (279)
T ss_pred ----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-cc-----CCCC
Confidence 12357999999999999889999999999999999999999999653321110 0000000000 00 0011
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
+... .....+..++..|++.+|++||++.++++.
T Consensus 220 ~~~~---~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 LPVG---QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCC---cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1110 111235566677999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=339.36 Aligned_cols=246 Identities=23% Similarity=0.317 Sum_probs=204.1
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
+-|.+.+.||+|+.|.|-+|.+ .+|+.+|||++... ......+.+||-||+.+.|||++++|+++.+..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3478899999999999999985 58999999999764 234556889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++|.|++++-..+ .+++.+..+++.||+.|+.|+|. .+|+||||||+|+|||..+++||+|||+|-....
T Consensus 92 Eyv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999997665 58899999999999999999999 8999999999999999999999999999986655
Q ss_pred CCCCcccccccccCCCCCcceeccCCCC-CcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s-~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
+..- .+.||+|.|.|||++++.+|. .++||||.|||||.||||+.||.+++.......+..... .+.
T Consensus 165 gklL---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-----~MP---- 232 (786)
T KOG0588|consen 165 GKLL---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-----EMP---- 232 (786)
T ss_pred Cccc---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-----cCC----
Confidence 4322 347899999999999998875 489999999999999999999987654433333322111 111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.+-..+.+.++ ..|+..||..|.|+.+|+++
T Consensus 233 -----s~Is~eaQdLL---r~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 233 -----SNISSEAQDLL---RRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -----CcCCHHHHHHH---HHHhccCccccccHHHHhhC
Confidence 11223444444 34999999999999999984
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.95 Aligned_cols=260 Identities=28% Similarity=0.407 Sum_probs=200.6
Q ss_pred cCceeeeeeeccCceEEEEEEe-----CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--Cce
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 418 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-----~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~--~~~ 418 (696)
..|.+.+.||+|+||.||++.. .++..||+|.++.. ......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999973 35788999998754 34456799999999999999999999999875 568
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
++||||+++++|.+++.... ..+++..+..++.+++.||+|||+ ++|+||||||+|||++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence 99999999999999986543 257999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCc-ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccc---------hhhHHhhhc
Q 005450 499 WASTSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG---------QESLVMWAK 568 (696)
Q Consensus 499 ~~~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~---------~~~lv~~~~ 568 (696)
......... ......|+..|+|||++.+..++.++||||||+++|||++++.|+....... ......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV- 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-
Confidence 765433221 1123457778999999988889999999999999999999887753321100 00000000
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 569 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 569 ~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.....+.. ..........+..++.+|++.+|.+||++.++++.|+.
T Consensus 237 ~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 237 RVLEEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHHHcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 00000000 00111123467778888999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=320.39 Aligned_cols=258 Identities=24% Similarity=0.429 Sum_probs=201.7
Q ss_pred cCceeeeeeeccCceEEEEEEeC--------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecC
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 416 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~--------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~ 416 (696)
++|.+.+.||+|+||.||++... ....+|+|.++.. ......+.+|++++..+ +||||++++++|...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56888999999999999999742 3457899998853 34456788999999999 5999999999999999
Q ss_pred ceEEEEeecCCCChhhhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 484 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd 484 (696)
..++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 99999999999999999975321 12358899999999999999999999 8999999999999999
Q ss_pred CCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhH
Q 005450 485 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 563 (696)
Q Consensus 485 ~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~l 563 (696)
.++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|+|++ |..||...........
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999986654322211112234567999999998899999999999999999999 8999966543222111
Q ss_pred HhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 564 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 564 v~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
+. .+.... . .......+..++..|++.+|.+||++.++++.|...
T Consensus 249 ~~-------~~~~~~-----~----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 249 LR-------EGHRMD-----K----PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HH-------cCCCCC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11 111000 0 111122455677789999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.98 Aligned_cols=263 Identities=21% Similarity=0.336 Sum_probs=198.8
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
++|.+.+.||+|+||.||+|... +++.||+|.++... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57899999999999999999864 68899999987432 3345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
++ ++|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 58988886543 257889999999999999999999 899999999999999999999999999997654322
Q ss_pred CCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC--
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD-- 581 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD-- 581 (696)
. ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||...........+..............+++
T Consensus 159 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 159 K--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred C--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 1 11234678999999988653 578899999999999999999999987654333222211111111111111100
Q ss_pred -------cccCCC----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 582 -------PALGNN----YDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 582 -------~~L~~~----~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+..... ........+..++.+|++.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 00011223456777899999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.63 Aligned_cols=250 Identities=26% Similarity=0.475 Sum_probs=196.6
Q ss_pred eeeeccCceEEEEEEeCC-------CCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 354 NLIGKGGSSQVYKGCLPD-------GKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~-------g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+.||+|+||.||+|...+ +..+|+|.+.... .....+.+|+.+++.++||||++++++|......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998542 2579999886543 4567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCC---CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC-----ceEEeecCc
Q 005450 425 LSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-----EPQLSDFGL 496 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~---~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~-----~vKL~DFGl 496 (696)
+++++|.+++..... ....+++..++.++.|++.||.|||+ .+++|+||||+|||++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975322 22357899999999999999999998 8899999999999999877 899999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCc
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGK 575 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 575 (696)
+................++..|+|||++.++.++.++|||||||++|+|++ |+.||........ ..... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~~~~---~~~~ 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQHVT---AGGR 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HHHHh---cCCc
Confidence 986644322222223456788999999999999999999999999999998 9999975433221 11110 0000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 576 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 576 l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
+ .. .......+..++.+||+.+|.+||++.++++.|+
T Consensus 232 ~------~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 232 L------QK----PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred c------CC----cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 00 1111234566777899999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=309.39 Aligned_cols=238 Identities=25% Similarity=0.418 Sum_probs=190.9
Q ss_pred eeeeccCceEEEEEEeCCCC-----------EEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 354 NLIGKGGSSQVYKGCLPDGK-----------ELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~g~-----------~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
+.||+|+||.||+|...+.. .+++|++.........+.+|+.+++.++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999975433 57888887655447789999999999999999999999988 7889999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC-------ceEEeecC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-------EPQLSDFG 495 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~-------~vKL~DFG 495 (696)
||+++|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 80 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999976442 58899999999999999999999 8999999999999999887 79999999
Q ss_pred ccccccCCCCCcccccccccCCCCCcceeccC--CCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccc
Q 005450 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILS 572 (696)
Q Consensus 496 lA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~--~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~ 572 (696)
++...... ....++..|+|||++... .++.++||||||+++|+|++ |..||.............+.
T Consensus 154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~----- 222 (259)
T cd05037 154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ----- 222 (259)
T ss_pred cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-----
Confidence 99865431 124577889999999876 78999999999999999999 57777665432221111100
Q ss_pred cCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 573 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 573 ~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
.. + .......+..++..||..+|.+||++.++++.|+
T Consensus 223 -~~--------~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 -HR--------L----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -CC--------C----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0 0001145666777899999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.03 Aligned_cols=239 Identities=27% Similarity=0.338 Sum_probs=184.8
Q ss_pred eeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhc---CCcceeEEeeEEEecCceEEEEeecCC
Q 005450 356 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL---HHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 356 LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L---~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
||+|+||+||+|... +++.||||++.... .....+..|..++... .||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999864 68999999986432 2334455677777665 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-- 151 (330)
T cd05586 81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-- 151 (330)
T ss_pred ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence 99999987543 48899999999999999999999 8999999999999999999999999999875433221
Q ss_pred ccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~ 586 (696)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.. +.. .+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~-------~~~------~~~~ 218 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF-------GKV------RFPK 218 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc-------CCC------CCCC
Confidence 12346799999999998754 489999999999999999999999976543222111111 000 0111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 005450 587 NYDYDQMERMVLASILCIRRDPRARP----QMSLVLK 619 (696)
Q Consensus 587 ~~~~~e~~~l~~la~~Cl~~dP~~RP----Sm~eVL~ 619 (696)
..-. ..+..++..||+.||.+|| ++.++++
T Consensus 219 ~~~~---~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NVLS---DEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ccCC---HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1111 2334556679999999998 4566654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=315.38 Aligned_cols=250 Identities=23% Similarity=0.316 Sum_probs=197.2
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.|...+.||+|+||+||++.. .+++.+|+|.+.... .....+.+|++++..++|+||+++++++..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 367789999999999999986 478999999987542 233457889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+++++|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 9999999988865432 258999999999999999999999 89999999999999999999999999999765432
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
.. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+... . .... . .
T Consensus 156 ~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~--~-~~~~--~----~ 223 (285)
T cd05632 156 ES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR--V-LETE--E----V 223 (285)
T ss_pred Cc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh--h-hccc--c----c
Confidence 21 12357999999999999889999999999999999999999999765432221111110 0 0000 0 0
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLK 619 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPS-----m~eVL~ 619 (696)
....+ ...+..++..|++.+|.+||+ +.++++
T Consensus 224 ~~~~~----~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 YSAKF----SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cCccC----CHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11111 123455666799999999999 556554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=317.79 Aligned_cols=263 Identities=22% Similarity=0.252 Sum_probs=206.3
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChh---HHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCceEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLV 421 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~---~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~--~~~~~LV 421 (696)
++|...+.|++|.||.||+|.++ +++.||+|.++...+ .--.-++||.+|.+++|||||.+..+..- -+..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 46888899999999999999964 688999999986542 22346789999999999999999988763 4579999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
||||+. +|..+++..+ ..|...++..+..|+++||+|||. +.|+||||||+|+|++..|.+||+|||+|+.+.
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999987 9999998766 378999999999999999999999 889999999999999999999999999999888
Q ss_pred CCCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc-
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL- 579 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l- 579 (696)
..... ++..+-|.+|.|||.+.+. .|+...|+||+|||+.||+++++.|.+.....+...+-.......+..+..+
T Consensus 229 sp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 76433 4457889999999998865 6999999999999999999999999988776665544322211111111111
Q ss_pred -------------cCcccCCCCChH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 580 -------------LDPALGNNYDYD-QMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 580 -------------lD~~L~~~~~~~-e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.-..+...|... ..+.-+.+....|..||.+|-|+.+.|+
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 111122222111 1133344445588999999999999886
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.66 Aligned_cols=246 Identities=23% Similarity=0.368 Sum_probs=205.8
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
..+|.+.+.||+|.||.|-+|.. ..|+.||||.++++ +.+.-.+.+||+||+.|+||||+.++++|...+..+||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 34677788999999999999985 78999999999864 45667788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||..+|.|++++...+ .+++.+.+.++.||..|+.|+|. ++++|||||.+|||||.++++||+|||++..+.
T Consensus 132 MEYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999998665 58999999999999999999999 899999999999999999999999999998887
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCC-CcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s-~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
.... ..+++|+|-|.+||++++..|. +.+|-|||||+||.|+.|..||.+.+-. .++.. +..|...+
T Consensus 205 ~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lvrQ----Is~GaYrE-- 272 (668)
T KOG0611|consen 205 DKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLVRQ----ISRGAYRE-- 272 (668)
T ss_pred cccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHHHH----hhcccccC--
Confidence 6543 2358999999999999988774 6799999999999999999999875432 22221 11222111
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
++......-++.|||..||++|.|+.+|...
T Consensus 273 ---------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 273 ---------PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ---------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1111223445678999999999999998764
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.48 Aligned_cols=236 Identities=28% Similarity=0.344 Sum_probs=186.3
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHH-HHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~-iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
+.||+|+||+||+|... +|+.||+|++.... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 78999999997532 22344555555 56789999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 151 (323)
T cd05575 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-- 151 (323)
T ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--
Confidence 99999987543 47889999999999999999999 8999999999999999999999999999875432211
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~ 587 (696)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. +. ..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~-------~~------~~~~~~ 218 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN-------KP------LRLKPN 218 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc-------CC------CCCCCC
Confidence 22346799999999999999999999999999999999999999976543221111110 00 001111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHH
Q 005450 588 YDYDQMERMVLASILCIRRDPRARPQMS 615 (696)
Q Consensus 588 ~~~~e~~~l~~la~~Cl~~dP~~RPSm~ 615 (696)
. ...+..++..|++.||.+||++.
T Consensus 219 ~----~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 I----SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C----CHHHHHHHHHHhhcCHHhCCCCC
Confidence 1 22345566679999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=332.99 Aligned_cols=199 Identities=23% Similarity=0.329 Sum_probs=173.1
Q ss_pred hcCceeeeeeeccCceEEEEEEeC---CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~---~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
..+|.+.+.||+|+||.||++... .+..||+|.+.... .+.+|+++|+.++||||+++++++......++|||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 457999999999999999999753 46789999987543 34679999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
++. ++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++......
T Consensus 167 ~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 167 KYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 996 5888888433 258999999999999999999999 89999999999999999999999999999876554
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~ 557 (696)
..........||+.|+|||++....++.++|||||||++|||++|+.||.+...
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 333333346799999999999988999999999999999999999999976543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=328.70 Aligned_cols=255 Identities=28% Similarity=0.356 Sum_probs=199.9
Q ss_pred HhhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh---------------hHHHHHHHHHHHHHhcCCcceeEE
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---------------DVIKEFVLEIEIITTLHHKNIISL 408 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~---------------~~~~~~~~Ei~iL~~L~HpnIV~l 408 (696)
...++|.+.+.||+|.||.|-+|.. .+++.||||++.+.+ ...+...+||.||++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4457899999999999999999985 479999999997531 123578899999999999999999
Q ss_pred eeEEEe--cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC
Q 005450 409 LGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 486 (696)
Q Consensus 409 ~g~~~~--~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~ 486 (696)
+++..+ .+.+|||+|||..|.+...-. ....+++.++++|+.+++.||+|||. +|||||||||+|+||+.+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCC
Confidence 999865 568999999999988765432 22238999999999999999999999 999999999999999999
Q ss_pred CceEEeecCccccccCCCCC---cccccccccCCCCCcceeccCC----CCCcccchhhHHHHHHHHhCCCCCCCCCccc
Q 005450 487 FEPQLSDFGLAKWASTSSSH---ITCTDVAGTFGYLAPEYFMYGK----VNDKIDVYAFGVVLLELLTGRKPISNDHPKG 559 (696)
Q Consensus 487 ~~vKL~DFGlA~~~~~~~~~---~~~~~~~GT~~YlAPE~l~~~~----~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~ 559 (696)
|.+||+|||.+.....+... ......+|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||.++....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 99999999999877443211 1122368999999999988643 4557999999999999999999998765433
Q ss_pred hhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005450 560 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621 (696)
Q Consensus 560 ~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L 621 (696)
....+ ++..|.-....+.-+.+-.+++.+|++||+.|.+..+|..+.
T Consensus 327 l~~KI---------------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 327 LFDKI---------------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHHHH---------------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 22211 112221111223344555667779999999999999987654
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=308.72 Aligned_cols=248 Identities=29% Similarity=0.449 Sum_probs=197.9
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEE-ecCceEEEEeecC
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF-EDNNLLLVYDFLS 426 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~-~~~~~~LV~Ey~~ 426 (696)
.+|.+.+.||+|+||.||++.. .|..+|+|.++... ..+.+.+|+.+++.++|+|++++++++. .++..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 4688999999999999999976 47889999987543 3567899999999999999999999765 4567899999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+++|.+++..... ..+++..++.++.+++.||+|||+ ++|+||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 84 KGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999875432 347899999999999999999999 899999999999999999999999999987554322
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
....++..|+|||++....++.++|||||||++|+|++ |+.||....... +..... .+.. +...
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~----~~~~-----~~~~ 221 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVE----KGYK-----MDAP 221 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHh----cCCC-----CCCC
Confidence 12345678999999998899999999999999999998 999987543322 111111 0000 0111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
... ...+..++..|++.+|++|||+.++++.|+.
T Consensus 222 ~~~----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 222 DGC----PPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 111 2344556677999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=338.59 Aligned_cols=253 Identities=30% Similarity=0.452 Sum_probs=202.1
Q ss_pred CceeeeeeeccCceEEEEEEeCC--C--CE-EEEEEecC----ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 349 NFLAENLIGKGGSSQVYKGCLPD--G--KE-LAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~~--g--~~-vAVK~l~~----~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
+-...+.||+|+||.||+|.+.. + .. ||||..+. .+....+|++|.+++++++|||||++||++.....++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34456899999999999998642 2 23 89999884 3577889999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
||||+|.||+|.++|+..+. .++..++..++.+.|.||+|||+ +++|||||-..|+|++.++.+||+|||+++.
T Consensus 238 ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 99999999999999987654 58999999999999999999999 8999999999999999999999999999876
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
......... ...-...|+|||.+..+.|+.++|||||||++||+++ |..||.+.........+.. .+....
T Consensus 312 ~~~~~~~~~--~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~------~~~r~~ 383 (474)
T KOG0194|consen 312 GSQYVMKKF--LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK------NGYRMP 383 (474)
T ss_pred Ccceeeccc--cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh------cCccCC
Confidence 542111110 1124568999999999999999999999999999999 8999987655433222211 110000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.....+.++.. +...||..+|++||+|.++.+.|+..
T Consensus 384 ------~~~~~p~~~~~---~~~~c~~~~p~~R~tm~~i~~~l~~~ 420 (474)
T KOG0194|consen 384 ------IPSKTPKELAK---VMKQCWKKDPEDRPTMSTIKKKLEAL 420 (474)
T ss_pred ------CCCCCHHHHHH---HHHHhccCChhhccCHHHHHHHHHHH
Confidence 01123334444 44479999999999999999988653
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=322.71 Aligned_cols=256 Identities=21% Similarity=0.290 Sum_probs=195.4
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|+.++..++|+||++++++|.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999864 6899999999752 233456888999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999997532 258889999999999999999999 8999999999999999999999999999876544
Q ss_pred CCCCcccccccccCCCCCcceecc-----CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~-----~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
.... ......||+.|+|||++.. +.++.++|||||||++|+|++|+.||...........+. ......
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~------~~~~~~ 227 (331)
T cd05597 155 DGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM------NHKEHF 227 (331)
T ss_pred CCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH------cCCCcc
Confidence 3221 1122469999999999863 457889999999999999999999997654322211111 000000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.+ .+. ... -.+....++.. +.|...++..||++.++++.
T Consensus 228 ~~-~~~-~~~-~~~~~~~li~~-ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 QF-PPD-VTD-VSEEAKDLIRR-LICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cC-CCc-cCC-CCHHHHHHHHH-HccCcccccCCCCHHHHhcC
Confidence 00 000 001 12334444432 23555666668999998875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.05 Aligned_cols=242 Identities=21% Similarity=0.314 Sum_probs=188.2
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
+.||+|+||.||++... +++.||+|+++.. ....+.+.+|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 6789999999853 23456688899999888 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
|+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 151 (327)
T cd05617 81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-- 151 (327)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--
Confidence 99999886543 48999999999999999999999 8999999999999999999999999999875322211
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~ 587 (696)
......||+.|+|||++.+..++.++|||||||+||||++|+.||.............+......... ..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~p~~ 225 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP------IRIPRF 225 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC------CCCCCC
Confidence 12346799999999999989999999999999999999999999964322111111111100000000 011111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCH
Q 005450 588 YDYDQMERMVLASILCIRRDPRARPQM 614 (696)
Q Consensus 588 ~~~~e~~~l~~la~~Cl~~dP~~RPSm 614 (696)
.+ ..+..++..||+.||.+||++
T Consensus 226 ~~----~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 226 LS----VKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CC----HHHHHHHHHHhccCHHHcCCC
Confidence 11 234556667999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=319.32 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=198.9
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCC--EEEEEEecC--ChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGK--ELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~--~vAVK~l~~--~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~L 420 (696)
.++|.+.+.||+|+||.||+|... ++. .+++|.++. .......+.+|++++.++ +||||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357889999999999999999864 454 457777764 234566888999999999 89999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc
Q 005450 421 VYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 488 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~ 488 (696)
||||+++++|.+++..... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence 9999999999999975431 12357899999999999999999999 89999999999999999999
Q ss_pred eEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhh
Q 005450 489 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 567 (696)
Q Consensus 489 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~ 567 (696)
+||+|||++....... ......++..|+|||++....++.++|||||||++|||+| |..||........ ....
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~ 236 (303)
T cd05088 163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEKL 236 (303)
T ss_pred EEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---HHHH
Confidence 9999999986432211 1111234678999999988889999999999999999998 9999975443221 1111
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 568 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 568 ~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.. + ......... ...+..++..|++.+|++||++.++++.|...
T Consensus 237 ~~----~-----~~~~~~~~~----~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 237 PQ----G-----YRLEKPLNC----DDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred hc----C-----CcCCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 0 000000111 12455677789999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=307.48 Aligned_cols=249 Identities=27% Similarity=0.446 Sum_probs=203.0
Q ss_pred cCceeeeeeeccCceEEEEEEeCC-CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~-g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
++|...+.||.|+||.||++...+ ++.+++|.+..... .+.+.+|+++++.++||||+++++++......+++|||++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 578889999999999999999764 88999999986544 6789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+++|.+++.... ..+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 82 AGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999986543 358999999999999999999999 8999999999999999999999999999987654332
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~ 586 (696)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||....+......+ .. . ..+.+.
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~--~~-----~-----~~~~~~- 220 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--PN-----K-----PPPTLS- 220 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh--cc-----C-----CCCCCC-
Confidence 122355899999999999889999999999999999999999999765432211110 00 0 000010
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 587 ~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+......+..++..|++.+|.+||++.++++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 -DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 01111234556667799999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=309.47 Aligned_cols=246 Identities=26% Similarity=0.404 Sum_probs=193.1
Q ss_pred eeeccCceEEEEEEeC---CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCC
Q 005450 355 LIGKGGSSQVYKGCLP---DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 429 (696)
Q Consensus 355 ~LG~G~fG~Vyka~~~---~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGs 429 (696)
.||+|+||.||+|... ++..||+|++.... ...+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 45679999997643 34567899999999999999999999885 457899999999999
Q ss_pred hhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcc-
Q 005450 430 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT- 508 (696)
Q Consensus 430 L~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~- 508 (696)
|.+++.... ..+++..++.++.+++.||.|||+ ++++||||||+|||++.++.+||+|||++...........
T Consensus 81 L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 999987533 258999999999999999999999 8999999999999999999999999999986654332211
Q ss_pred cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccCCC
Q 005450 509 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587 (696)
Q Consensus 509 ~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~ 587 (696)
.....+++.|+|||++....++.++|||||||++|||++ |..||...........+.. +... .+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-------~~~~-----~~--- 219 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ-------GKRL-----DC--- 219 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-------CCCC-----CC---
Confidence 111234678999999988889999999999999999996 9999976544322221111 1100 01
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 588 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 588 ~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
+......+..++..||..+|++||++.+|.+.|+.
T Consensus 220 -~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 220 -PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred -CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 11112344556677999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=323.31 Aligned_cols=240 Identities=23% Similarity=0.337 Sum_probs=191.9
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEE
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~LV~ 422 (696)
+|...+.||+|+||.||++... +|+.||+|+++.. ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999854 6899999999753 234456788999998886 577888999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999986543 48899999999999999999999 8999999999999999999999999999875433
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+... ..
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------~~------ 218 (323)
T cd05615 154 DGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------NV------ 218 (323)
T ss_pred CCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------CC------
Confidence 221 122356999999999999889999999999999999999999999875442221111110 00
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQM 614 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm 614 (696)
.+.... ...+..++..|++.+|.+|++.
T Consensus 219 ~~p~~~----~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 SYPKSL----SKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCccC----CHHHHHHHHHHcccCHhhCCCC
Confidence 011111 2334556677999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=311.59 Aligned_cols=253 Identities=28% Similarity=0.377 Sum_probs=188.2
Q ss_pred eeeccCceEEEEEEeCC---CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCC
Q 005450 355 LIGKGGSSQVYKGCLPD---GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 429 (696)
Q Consensus 355 ~LG~G~fG~Vyka~~~~---g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGs 429 (696)
.||+|+||.||+|...+ ...+++|.+... ......+.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 346888887643 3445678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCC-CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcc
Q 005450 430 LEENLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 508 (696)
Q Consensus 430 L~~~L~~~~~~-~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~ 508 (696)
|.+++...... ...+.+.....++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999765422 2235678889999999999999999 8999999999999999999999999999875433222222
Q ss_pred cccccccCCCCCcceecc-------CCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 509 CTDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 509 ~~~~~GT~~YlAPE~l~~-------~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
.....+++.|+|||++.. ..++.++|||||||++|||++ |..||....+....... . .. ....+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--~----~~-~~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV--V----RE-QDIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH--h----hc-cCccCC
Confidence 223456788999998743 356889999999999999999 78888655432211110 0 00 011112
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
++.+...++ ..+..+...|+ .+|++||++.+|+++|.
T Consensus 232 ~~~~~~~~~----~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLDLKYS----DRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcccccCC----HHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222222222 22333444577 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.28 Aligned_cols=242 Identities=26% Similarity=0.321 Sum_probs=187.4
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHH-HHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~-iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
+.||+|+||+||++... +++.||+|++.... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 67889999997532 22234444444 56788999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
|+|.+++.... .+.+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-- 151 (325)
T cd05602 81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-- 151 (325)
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence 99999997543 47788888999999999999999 8999999999999999999999999999975432221
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~ 587 (696)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+. . ... .+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~-~------~~~------~~~~~ 218 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL-N------KPL------QLKPN 218 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH-h------CCc------CCCCC
Confidence 2234679999999999999899999999999999999999999997654322211110 0 000 01111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005450 588 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621 (696)
Q Consensus 588 ~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L 621 (696)
. ...+..++..|++.+|.+||++.+.+..+
T Consensus 219 ~----~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 219 I----TNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred C----CHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 1 12344555669999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.94 Aligned_cols=266 Identities=25% Similarity=0.311 Sum_probs=206.3
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChh---HHHHHHHHHHHHHhcCCcc-eeEEeeEEEecC------c
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSED---VIKEFVLEIEIITTLHHKN-IISLLGFCFEDN------N 417 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~---~~~~~~~Ei~iL~~L~Hpn-IV~l~g~~~~~~------~ 417 (696)
.|...+.||+|+||+||+|+. .+|+.||+|.++...+ ......+|+.+|+.++|+| |++|++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 455567799999999999985 5789999999986543 4566789999999999999 999999999877 7
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA 497 (696)
+++||||++. +|..++.........++...+..+..||+.||+|||+ ++|+||||||.||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence 9999999976 9999998665322356668899999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 498 KWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 498 ~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
+...-... ..+..++|.+|.|||++.+. .|+...||||+|||+.||++++..|.++....+...+-.......+..+
T Consensus 168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 96653322 24457899999999999876 7999999999999999999999999988775554333222111111111
Q ss_pred cc---ccCc--ccCCCC---C-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 577 TQ---LLDP--ALGNNY---D-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 577 ~~---llD~--~L~~~~---~-----~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.. +.+- .+.... + .........++.+|++.+|.+|.|+..++++
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11 1010 000000 0 0111356677788999999999999999875
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=335.08 Aligned_cols=258 Identities=25% Similarity=0.403 Sum_probs=201.3
Q ss_pred cCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCce
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNL 418 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~ 418 (696)
++|.+.+.||+|+||.||+|.+. .++.||+|+++.. ......+.+|+++|.++. ||||++++++|...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 45777899999999999999853 3468999999854 233457889999999997 99999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCC-----------------------------------------------------------
Q 005450 419 LLVYDFLSRGSLEENLHGNKK----------------------------------------------------------- 439 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~----------------------------------------------------------- 439 (696)
++||||+++|+|.++++....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999975421
Q ss_pred -----------------------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC
Q 005450 440 -----------------------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 484 (696)
Q Consensus 440 -----------------------------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd 484 (696)
....+++..+..++.||+.||.|||+ .+|+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEe
Confidence 11246778889999999999999999 8999999999999999
Q ss_pred CCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhH
Q 005450 485 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 563 (696)
Q Consensus 485 ~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~l 563 (696)
.++.+||+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||...........
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~ 353 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence 999999999999986543322222223457889999999998889999999999999999998 8999865433221111
Q ss_pred HhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 564 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 564 v~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
. .. .+. .+.. +......+..++..||+.+|.+||++.+|++.|+.
T Consensus 354 ~--~~----~~~-----~~~~----p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 354 A--IK----RGY-----RMAK----PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred H--HH----cCC-----CCCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 0 00 000 0000 11112345566667999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.57 Aligned_cols=236 Identities=28% Similarity=0.365 Sum_probs=185.7
Q ss_pred eeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHH-HHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~-iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
++||+|+||.||++... +|+.||+|++.... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 68899999987532 22344555554 67889999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
|+|...+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 151 (321)
T cd05603 81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-- 151 (321)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--
Confidence 99998886543 47888899999999999999999 8999999999999999999999999999875322211
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~ 587 (696)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. ..+ + .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~-~~~------~------~~--- 215 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL-HKP------L------QL--- 215 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh-cCC------C------CC---
Confidence 2234679999999999998899999999999999999999999997654322111110 000 0 01
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHH
Q 005450 588 YDYDQMERMVLASILCIRRDPRARPQMS 615 (696)
Q Consensus 588 ~~~~e~~~l~~la~~Cl~~dP~~RPSm~ 615 (696)
+......+..++..||+.+|.+||++.
T Consensus 216 -~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 -PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111223455667779999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=337.69 Aligned_cols=261 Identities=26% Similarity=0.355 Sum_probs=212.5
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-C-----cceeEEeeEEEecCceEEE
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-H-----KNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~-H-----pnIV~l~g~~~~~~~~~LV 421 (696)
+|.+.++||+|.||.|.+|.+ ++++.||||++++......+...|+.||..|+ | -|+|+++++|...+++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 789999999999999999985 56999999999999999999999999999997 4 4899999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC--CceEEeecCcccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--FEPQLSDFGLAKW 499 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~--~~vKL~DFGlA~~ 499 (696)
+|.+.. +|.++|+.+... .|+...++.++.||+.||.+||+ .+|||+||||+||||.+- ..+||+|||.|.+
T Consensus 267 fELL~~-NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ehhhhh-hHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999955 999999877653 58899999999999999999999 999999999999999643 4799999999987
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcc----------
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP---------- 569 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~---------- 569 (696)
...... ..+.+..|.|||++.+..|+.+.||||||||+.||++|.+.|.+++..++...+.....
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 765332 35688999999999999999999999999999999999999998887776655532221
Q ss_pred -----cccc-C-ccc-----c-----------------ccCcccC-------CCCChHHHHHHHHHHHHhcccCCCCCCC
Q 005450 570 -----ILSS-G-KVT-----Q-----------------LLDPALG-------NNYDYDQMERMVLASILCIRRDPRARPQ 613 (696)
Q Consensus 570 -----~~~~-g-~l~-----~-----------------llD~~L~-------~~~~~~e~~~l~~la~~Cl~~dP~~RPS 613 (696)
++.. . ... . ..+.... .......-..++.++..||..||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 1111 0 000 0 0000000 0011133456678888999999999999
Q ss_pred HHHHHHH
Q 005450 614 MSLVLKL 620 (696)
Q Consensus 614 m~eVL~~ 620 (696)
+.+.+++
T Consensus 496 p~qal~H 502 (586)
T KOG0667|consen 496 PAQALNH 502 (586)
T ss_pred HHHHhcC
Confidence 9999974
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=327.35 Aligned_cols=263 Identities=22% Similarity=0.275 Sum_probs=197.7
Q ss_pred HhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-----
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED----- 415 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~----- 415 (696)
...++|.+.+.||+|+||.||++... .++.||||.+... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999864 6889999998753 34456788999999999999999999988643
Q ss_pred -CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeec
Q 005450 416 -NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 494 (696)
Q Consensus 416 -~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DF 494 (696)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeC
Confidence 357999999976 67666642 37888999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhc--c---
Q 005450 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK--P--- 569 (696)
Q Consensus 495 GlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~--~--- 569 (696)
|+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.... +
T Consensus 164 g~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 164 GLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred cccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99986544322 223579999999999998899999999999999999999999997654322211110000 0
Q ss_pred -----------ccc-cCcc-----cccc-CcccC--CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 570 -----------ILS-SGKV-----TQLL-DPALG--NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 570 -----------~~~-~g~l-----~~ll-D~~L~--~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
... .... .... +.... ..........+..++..||+.||++|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 0000 0000 00000 00111122455677788999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=308.31 Aligned_cols=248 Identities=26% Similarity=0.382 Sum_probs=205.3
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|.||.||.|+. +++..||+|++.++. ....++.+|++|-+.|+||||+++|++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 35688999999999999999985 567889999998654 3456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
+||..+|+|...|..... ..+++.....++.|+|.||.|+|. ++||||||||+|+|++..+.+||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999985433 257888889999999999999999 899999999999999999999999999987655
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
.+ ...+.+||..|++||+..+..++.++|+|++|++.||++.|.+||......+....+... ++.+
T Consensus 176 ~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~----------~~~~ 241 (281)
T KOG0580|consen 176 SN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV----------DLKF 241 (281)
T ss_pred CC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc----------cccC
Confidence 32 223478999999999999999999999999999999999999999876633222222111 1111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
| ..-......++..|+..+|.+|.+..++++.
T Consensus 242 p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 P-------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred C-------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1 1112234456667999999999999998864
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=309.06 Aligned_cols=250 Identities=25% Similarity=0.424 Sum_probs=199.3
Q ss_pred CceeeeeeeccCceEEEEEEeCCCCEEEEEEecCC-------hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 349 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~-------~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
+|...+.||+|+||.||+|...+|+.+|+|.++.. ......+.+|+++++.++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47788999999999999999888999999988642 12345688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999997543 47889999999999999999999 889999999999999999999999999998653
Q ss_pred CCCCC----cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 502 TSSSH----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 502 ~~~~~----~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
..... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||...........+... .+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~- 227 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH-----RGLM- 227 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc-----cCCC-
Confidence 21111 1112356899999999999888999999999999999999999999754332211111000 0000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+.+... ....+..++..||+.+|.+||++.++++
T Consensus 228 ----~~~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 ----PRLPDS----FSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ----CCCCCC----CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111111 2234556667799999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=308.43 Aligned_cols=248 Identities=28% Similarity=0.452 Sum_probs=197.4
Q ss_pred eeeeccCceEEEEEEeCC--C--CEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKGGSSQVYKGCLPD--G--KELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~--g--~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
+.||+|++|.||+|.+.+ + ..||+|.+.... ...+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 3 368999998654 456789999999999999999999999988 899999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
++|.+++..... ..+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976542 358999999999999999999999 899999999999999999999999999998775533221
Q ss_pred c-cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 508 T-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 508 ~-~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
. .....++..|+|||++....++.++|||||||++|+|++ |+.||...........+.. ... .+..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~------~~~--~~~~---- 222 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK------EGE--RLER---- 222 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh------cCC--cCCC----
Confidence 1 122457889999999998899999999999999999998 9999965433221111110 000 0000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
+......+..++..|++.+|.+||++.++++.|.
T Consensus 223 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 ---PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0111234556777899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=311.14 Aligned_cols=249 Identities=26% Similarity=0.430 Sum_probs=193.6
Q ss_pred eeeeccCceEEEEEEeC-CCC--EEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKGGSSQVYKGCLP-DGK--ELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~-~g~--~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
++||+|+||.||+|... ++. .+++|.++.. ....+.+.+|++++.++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999875 344 4688988742 34567889999999999 799999999999999999999999999
Q ss_pred CChhhhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecC
Q 005450 428 GSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 495 (696)
Q Consensus 428 GsL~~~L~~~~~------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFG 495 (696)
|+|.+++..... ....+++..+..++.+++.||+|||+ ++++||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 999999875431 12347899999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccC
Q 005450 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 496 lA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
++....... .......++.|+|||++....++.++|||||||++|||++ |..||...........+ .. ..
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~---~~---~~ 228 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---PQ---GY 228 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH---hC---CC
Confidence 986332211 1111234667999999988899999999999999999997 99999654332211111 00 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 575 ~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.. .. .......+..++..|++.+|.+|||+.++++.|...
T Consensus 229 ~~------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 229 RL------EK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CC------CC----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00 00 111123456777789999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=314.37 Aligned_cols=250 Identities=25% Similarity=0.337 Sum_probs=197.4
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.|...+.||+|+||.||++... +++.||+|.+.... .....+.+|+.++..++|+||+++++.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677899999999999999864 68999999986532 233557789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+++++|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999998865432 358899999999999999999999 89999999999999999999999999999765433
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||............... .. ... ..
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~---~~--~~~----~~ 223 (285)
T cd05630 156 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL---VK--EVQ----EE 223 (285)
T ss_pred cc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh---hh--hhh----hh
Confidence 22 12357999999999999889999999999999999999999999764332111111000 00 000 00
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLK 619 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPS-----m~eVL~ 619 (696)
....++ ..+..++..||+.||.+||| +.++++
T Consensus 224 ~~~~~~----~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 YSEKFS----PDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCccCC----HHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 111111 23445666799999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.26 Aligned_cols=240 Identities=28% Similarity=0.336 Sum_probs=187.9
Q ss_pred eeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHH-HHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~-iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
+.||+|+||+||++.. .+|+.||+|++... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4689999999999985 47899999999753 233345556655 46778999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 151 (325)
T cd05604 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-- 151 (325)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--
Confidence 99999886543 58899999999999999999999 8999999999999999999999999999875432211
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~ 587 (696)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+. . +.+ .+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~------~-~~~------~~~~~ 218 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL------H-KPL------VLRPG 218 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH------c-CCc------cCCCC
Confidence 1234679999999999999999999999999999999999999997654322211111 0 000 00111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 588 YDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 588 ~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
....+..++..|++.+|.+||++.+.++
T Consensus 219 ----~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 219 ----ASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred ----CCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 1123445666799999999999864333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=306.44 Aligned_cols=249 Identities=22% Similarity=0.359 Sum_probs=200.8
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecC--ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
+|.+.+.||+|+||.||++... +++.+|+|.++. .....+.+.+|+.+++.++||||+++++++..++.+++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999864 688999999864 2345677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++++|.+++..... ..+++..+..++.+++.||.|||+ ++|+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999998864332 347889999999999999999999 8999999999999999999999999999976654322
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
. .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||...........+. .+.... +.
T Consensus 156 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~~-----~~ 221 (255)
T cd08219 156 Y--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-------QGSYKP-----LP 221 (255)
T ss_pred c--cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-------cCCCCC-----CC
Confidence 1 223568999999999998889999999999999999999999997654322211111 111111 11
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
... ...+..++..||+.+|++||++.+++..
T Consensus 222 ~~~----~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 SHY----SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccc----CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111 1234556677999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=327.38 Aligned_cols=194 Identities=25% Similarity=0.387 Sum_probs=166.6
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
...+|.+.+.||+|+||.||+|... ++..||+|+.... ....|+.++.+++||||+++++++...+..++||||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 3457999999999999999999865 5778999986543 234689999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+. ++|.+++.... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 139 ~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 139 YS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred cC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 95 58888886433 358999999999999999999999 899999999999999999999999999997543322
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCC
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 554 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~ 554 (696)
. .....||+.|+|||++.+..++.++|||||||++|||+++..|+..
T Consensus 212 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 212 A---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred c---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 1 1235699999999999999999999999999999999996665533
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=321.62 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=203.3
Q ss_pred cCceeeeeeeccCceEEEEEEeC--------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecC
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 416 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~--------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~ 416 (696)
.+|.+.+.||+|+||.||++... .+..||+|.++.. ....+.+.+|+.++.++ +||||++++++|..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888999999999999999742 1236899988753 34567899999999999 7999999999999999
Q ss_pred ceEEEEeecCCCChhhhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 484 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd 484 (696)
..+++|||+++|+|.+++..... ....+++.++..++.|++.||.|||+ ++|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 99999999999999999875321 12357899999999999999999999 8999999999999999
Q ss_pred CCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhH
Q 005450 485 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 563 (696)
Q Consensus 485 ~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~l 563 (696)
.++.+||+|||+++...............++..|+|||++....++.++||||||+++|||++ |..||...........
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999999986654332222222345678999999998899999999999999999998 8899876543222111
Q ss_pred HhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 564 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 564 v~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
+. .+.... .+......+..++..|++.+|.+||++.++++.|+...
T Consensus 249 ~~-------~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 249 LK-------EGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HH-------cCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 11 000000 01111234566777899999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=310.44 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=189.0
Q ss_pred eeeccCceEEEEEEeCCC---CEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCC
Q 005450 355 LIGKGGSSQVYKGCLPDG---KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 429 (696)
Q Consensus 355 ~LG~G~fG~Vyka~~~~g---~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGs 429 (696)
.||+|+||.||++...++ ..+++|.++.. ....+.+.+|+.++..++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975443 34667776643 2456789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCccc
Q 005450 430 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 509 (696)
Q Consensus 430 L~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~ 509 (696)
|.+++.........+.+..+..++.||+.||+|||+ .+++||||||+|||++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997654333356777888999999999999999 88999999999999999999999999998643322111122
Q ss_pred ccccccCCCCCcceecc-------CCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 510 TDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 510 ~~~~GT~~YlAPE~l~~-------~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
....|+..|+|||++.. ..++.++|||||||++|||++ |..||...........+. .+....+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-------~~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI-------KDQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------hhcccccCC
Confidence 23568899999998753 245789999999999999997 577886543322111111 111122333
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
+.+...+. ..+..+...|| .+|++||++.+|++.|.
T Consensus 232 ~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 43332222 23333445588 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=325.86 Aligned_cols=262 Identities=21% Similarity=0.255 Sum_probs=197.6
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec------
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------ 415 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~------ 415 (696)
..++|.+.+.||+|+||.||++... .++.||||++... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999864 6889999998753 34456788999999999999999999987543
Q ss_pred CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecC
Q 005450 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 495 (696)
Q Consensus 416 ~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFG 495 (696)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999975 77777642 36788999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhc-------
Q 005450 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK------- 568 (696)
Q Consensus 496 lA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~------- 568 (696)
+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 172 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9986644322 223578999999999999999999999999999999999999998765432221111000
Q ss_pred ---------------cccccCccccccCcccC---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 569 ---------------PILSSGKVTQLLDPALG---NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 569 ---------------~~~~~g~l~~llD~~L~---~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
+.........+....+. ..........+..++..|++.||.+|||+.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000000000 00001112345667778999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=308.66 Aligned_cols=251 Identities=26% Similarity=0.404 Sum_probs=198.6
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
++|.+.+.||+|+||.||+|.. .+++.||+|+++... .....+.+|+.++..++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4788889999999999999985 468899999987643 34456788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++++|.+++.... .+++.++..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 9999999986543 48899999999999999999999 8999999999999999999999999999876543221
Q ss_pred CcccccccccCCCCCcceec---cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 506 HITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~---~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
......||+.|+|||++. .+.++.++|||||||++|+|++|+.||....+.......... ... .+
T Consensus 162 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~--~~~--------~~ 229 (267)
T cd06645 162 --KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--NFQ--------PP 229 (267)
T ss_pred --ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc--CCC--------CC
Confidence 122357999999999874 456889999999999999999999999765432221111100 000 01
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+...... ...+..++..|++.+|++||++.++++
T Consensus 230 ~~~~~~~~--~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 230 KLKDKMKW--SNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccccCCC--CHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11110111 123456677799999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=327.28 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=206.6
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~L 420 (696)
...|.+.+.||+|.||.||++..+ +|+.+|+|++.+.. .....+.+|+.||+++. |||||.++++|.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456888899999999999999976 49999999997643 24578899999999998 9999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC----CceEEeecCc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD----FEPQLSDFGL 496 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~----~~vKL~DFGl 496 (696)
|||++.||.|.+.+... .+++..+..++.|++.++.|||+ .||+||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999765 28999999999999999999999 999999999999999643 4799999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
+...... ......+||++|+|||++....|+..+||||+||++|.|++|.+||.+.........+.....
T Consensus 186 a~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~------- 255 (382)
T KOG0032|consen 186 AKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF------- 255 (382)
T ss_pred ceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-------
Confidence 9988762 233458999999999999999999999999999999999999999988765544433322221
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.+.++.+ .......-.++..|+..||.+|+|+.++|+.
T Consensus 256 -~f~~~~w-----~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -DFTSEPW-----DDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -CCCCCCc-----cccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1111111 1112233344556999999999999999983
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.28 Aligned_cols=269 Identities=23% Similarity=0.330 Sum_probs=212.2
Q ss_pred HHhhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe-----
Q 005450 344 LSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----- 414 (696)
Q Consensus 344 ~~~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~----- 414 (696)
......|...+.||+|+||.|+.+.. .+|+.||||.+.. .....++..+|+.+|+.++|+||+.+++.+..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 34456677789999999999999985 5789999998873 44667889999999999999999999999865
Q ss_pred cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeec
Q 005450 415 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 494 (696)
Q Consensus 415 ~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DF 494 (696)
-+..|+|+|+| +-+|...++... .++......++.||++||.|+|+ .+|+||||||+|+|++.+..+||+||
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccc
Confidence 45799999999 459999997654 38888999999999999999999 88999999999999999999999999
Q ss_pred CccccccCCCCCcccccccccCCCCCcceec-cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccccc
Q 005450 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 573 (696)
Q Consensus 495 GlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~-~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 573 (696)
|+|+...........+..+.|.+|.|||++. ...|+...||||.||||.||++|++.|.+.+...+..++....+....
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 9999886543333446688999999999875 558999999999999999999999999998888877777655443332
Q ss_pred CccccccCcc-------cC--CCCChH-----HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 574 GKVTQLLDPA-------LG--NNYDYD-----QMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 574 g~l~~llD~~-------L~--~~~~~~-----e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
..+..+-... +. ...++. .....+.+...||..||.+|+|++|.|+.
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 2222221100 00 001111 11233444556999999999999998863
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=308.66 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=203.0
Q ss_pred HhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecC------
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN------ 416 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~------ 416 (696)
..+++|.+.+.||+|+||.||+|... +++.+++|++.........+.+|+.++.++ .|+||++++++|....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 35688999999999999999999974 678999999987766667899999999999 6999999999997654
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCc
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGl 496 (696)
..++||||+++++|.+++.........+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999987544333468999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceecc-----CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccc
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 571 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~-----~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~ 571 (696)
+......... .....|++.|+|||++.. ..++.++|||||||++|+|++|+.||......... .....
T Consensus 160 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~--- 232 (275)
T cd06608 160 SAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL--FKIPR--- 232 (275)
T ss_pred ceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH--HHhhc---
Confidence 8765443221 223568999999998753 34778999999999999999999999754332111 11000
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 572 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 572 ~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+.. +.+.. .......+..++.+||..||++|||+.++++
T Consensus 233 --~~~-----~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 --NPP-----PTLKS--PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred --cCC-----CCCCc--hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000 01110 1112345666777899999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=310.55 Aligned_cols=254 Identities=23% Similarity=0.418 Sum_probs=201.7
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCC----EEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~----~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
.+|.+.+.||+|+||.||+|..+ +|. .+|+|.++... .....+.+|+.++..++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56888999999999999999854 333 58999887643 455788899999999999999999999987 78999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++|+|.+++..... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 9999999999999975432 48899999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
.............++..|+|||.+....++.++||||||+++|||++ |+.||...........+.. +.. .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-------~~~--~ 230 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-------GER--L 230 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-------CCC--C
Confidence 54333222222234678999999988899999999999999999998 9999976544322221111 000 0
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
..+ ......+..++..||..+|.+||++.++++.|...
T Consensus 231 ~~~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 231 PQP-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred CCC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 000 01112355666779999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.55 Aligned_cols=250 Identities=26% Similarity=0.378 Sum_probs=203.1
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+|+..+.||.|+||.||.+.. .+++.+++|.+... ......+.+|++++++++|+||+++++++.+.+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999998874 56889999987642 45567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++.... ...+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997543 2358899999999999999999999 889999999999999999999999999998765433
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...........+. .+......
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-------~~~~~~~~---- 222 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV-------QGNYTPVV---- 222 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------cCCCCCCc----
Confidence 2 1233568999999999988889999999999999999999999997654322211111 11111110
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L 621 (696)
......+..++..|++.+|.+||++.++++.+
T Consensus 223 -----~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 -----SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -----cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11123455666679999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.97 Aligned_cols=249 Identities=26% Similarity=0.408 Sum_probs=200.7
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
..+|...+.||+|+||.||+|.. .+++.|++|.+.... ...+.+.+|+.+++.+.||||++++++|..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35789999999999999999985 478999999887543 3456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999998642 37889999999999999999999 899999999999999999999999999987654322
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
.. .....|++.|+|||++....++.++|||||||++|+|++|+.||....+... +..+.. .+. .. +
T Consensus 171 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~~----~~~-~~-----~ 236 (296)
T cd06654 171 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIAT----NGT-PE-----L 236 (296)
T ss_pred cc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHhc----CCC-CC-----C
Confidence 11 1234689999999999988899999999999999999999999976554222 111110 000 00 0
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. ........+..++..||..+|++||++.++++
T Consensus 237 ~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 Q--NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred C--CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0 01111234555667899999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=320.32 Aligned_cols=203 Identities=24% Similarity=0.308 Sum_probs=175.6
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||.||++... +++.||+|++.... .....+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999864 67899999987532 33455788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999997533 257889999999999999999999 9999999999999999999999999999986654
Q ss_pred CCCCcccccccccCCCCCcceecc-----CCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~-----~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~ 557 (696)
.... ......||+.|+|||++.. +.++.++|||||||+||+|++|+.||.....
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 213 (331)
T cd05624 155 DGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred CCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH
Confidence 3222 1223579999999999875 5688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=364.04 Aligned_cols=261 Identities=29% Similarity=0.528 Sum_probs=214.7
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
...|...++||+|+||.||+|.. .++..||||.++..... ...|++++++++||||++++++|.+.+..++||||+
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 34577788999999999999986 57899999998754322 234688999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++|+|.++++ .++|..+.+|+.|+++||+|||..+..+|+||||||+||+++.++.+++. ||.+......
T Consensus 766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 9999999995 27899999999999999999996555899999999999999999888876 6665433221
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
....||+.|+|||++.+..++.++|||||||++|||+||+.||..... ....++.|............++|+.+.
T Consensus 836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcccc
Confidence 123689999999999999999999999999999999999999954332 233456666655555556667777764
Q ss_pred CC--CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 586 NN--YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 586 ~~--~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
.. .+.+++..+..++.+||+.+|++||+|.+|++.|+...
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 43 34567778888999999999999999999999997543
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=309.96 Aligned_cols=263 Identities=25% Similarity=0.334 Sum_probs=200.1
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
++|...+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999875 68999999886432 234567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|++++.|..++.... .+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988888765432 48999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHh-hhccc-------cccC
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM-WAKPI-------LSSG 574 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~-~~~~~-------~~~g 574 (696)
... .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.........+. ..... ....
T Consensus 154 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred ccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 321 123468899999999875 457899999999999999999999998655432221111 00000 0000
Q ss_pred c-cccccCcccCCCCCh-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 575 K-VTQLLDPALGNNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 575 ~-l~~llD~~L~~~~~~-----~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. ......+......+. .....+..++..||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 000000110000000 11245667778899999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=307.47 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=200.9
Q ss_pred CceeeeeeeccCceEEEEEEeCC--CCEEEEEEecC-----------ChhHHHHHHHHHHHHHh-cCCcceeEEeeEEEe
Q 005450 349 NFLAENLIGKGGSSQVYKGCLPD--GKELAVKILKP-----------SEDVIKEFVLEIEIITT-LHHKNIISLLGFCFE 414 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~~--g~~vAVK~l~~-----------~~~~~~~~~~Ei~iL~~-L~HpnIV~l~g~~~~ 414 (696)
+|.+.+.||+|+||.||++.... ++.+|+|.+.. ......++.+|+.++.+ ++||||++++++|..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999754 68899998753 22345667889988875 799999999999999
Q ss_pred cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeec
Q 005450 415 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 494 (696)
Q Consensus 415 ~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DF 494 (696)
++..++||||+++++|.+++.........+++..++.++.|++.||.|||+ ..+++|+||||+|||++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999999886543334468999999999999999999995 157999999999999999999999999
Q ss_pred CccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC
Q 005450 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 495 GlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
|++....... ......|+..|+|||++.++.++.++||||||+++|+|++|+.||...........+. .+
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~-------~~ 228 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV-------EA 228 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHh-------hc
Confidence 9998765433 2233568999999999998889999999999999999999999997543322111110 01
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 575 ~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
... +.....+ ...+..++.+||+.||++||++.++..++.
T Consensus 229 ~~~----~~~~~~~----~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYE----PLPEGMY----SEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCC----cCCcccC----CHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111 1000011 134556667799999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=315.25 Aligned_cols=255 Identities=26% Similarity=0.396 Sum_probs=201.9
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
++|.+.+.||+|+||+||++... +|+.||+|++... ....+.+.+|++++..++||||+++++++...+.+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56788899999999999999864 6889999988653 34567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++.... .+++..+..++.+++.||.|||+ .++++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999987543 48899999999999999999996 1479999999999999999999999999987543322
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccch-----hhHHhhhccccccCccccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ-----ESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~-----~~lv~~~~~~~~~g~l~~l 579 (696)
. ....|+..|+|||++.++.++.++|||||||++|+|++|+.||........ ..+..+....... .
T Consensus 159 ~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---- 229 (284)
T cd06620 159 A----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-P---- 229 (284)
T ss_pred c----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-c----
Confidence 1 235789999999999888999999999999999999999999986543211 1111111111100 0
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L 621 (696)
.+.+... .....+..++..|++.||.+|||+.+++++.
T Consensus 230 -~~~~~~~---~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 -PPRLPSS---DFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -CCCCCch---hcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0111111 1123455667789999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=306.33 Aligned_cols=248 Identities=26% Similarity=0.420 Sum_probs=189.7
Q ss_pred eeeeccCceEEEEEEeC----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEE-ecCceEEEEeecC
Q 005450 354 NLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCF-EDNNLLLVYDFLS 426 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~-~~~~~~LV~Ey~~ 426 (696)
+.||+|+||.||+|... ++..+|+|.+... ....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998642 345678889999999999999999999876 4556899999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+|+|.+++..... .+.+..+..++.+++.||.|||+ .+++||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999999975432 46778888999999999999999 89999999999999999999999999999755432111
Q ss_pred --cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhC-CCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 507 --ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 507 --~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG-~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
.......+++.|+|||++....++.++|||||||++|||++| .+||....... +..... .+.. +.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~~----~~~~-----~~ 222 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYLL----QGRR-----LL 222 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHh----cCCC-----CC
Confidence 111224567789999999888999999999999999999995 55665433221 111110 0000 00
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.... . ...+..++..||+.+|++||++.++++.|+.
T Consensus 223 ~~~~-~---~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 223 QPEY-C---PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred CCCc-C---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0011 1 1345667778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=305.26 Aligned_cols=247 Identities=29% Similarity=0.476 Sum_probs=198.0
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
++|.+.+.||+|+||.||++.. +++.+|+|.++... ....+.+|+.++..++||||+++++++... ..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 4588899999999999999874 67889999987543 346788999999999999999999998754 57999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
++|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 83 GNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999975432 357899999999999999999999 899999999999999999999999999987654321
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~ 586 (696)
.....+..|+|||++.++.++.++|+||||+++|+|++ |+.||...........+.. +... + ...
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-------~~~~---~--~~~ 220 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-------GYRM---E--PPE 220 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-------CCCC---C--CCC
Confidence 11234678999999998899999999999999999998 9999976544322111111 1000 0 001
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 587 ~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
. ....+..++..|++.+|++||++.++++.|+.
T Consensus 221 ~----~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 G----CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred c----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1 12345567778999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.88 Aligned_cols=254 Identities=27% Similarity=0.376 Sum_probs=202.4
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCceEEEE
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVY 422 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~--~~~~~LV~ 422 (696)
+|.+.+.||.|+||.||++.. .++..+|+|++... ....+.+..|+.+++.++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999985 47889999998643 3455678899999999999999999998864 45689999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC--CCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~--~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||+++++|.+++.........+++..++.++.+|+.||.|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999765444456899999999999999999999321 288999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
...... .....|++.|+|||++....++.++|+||||+++|+|++|+.||....... +..... .+..
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----~~~~---- 227 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASKIK----EGKF---- 227 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHHHh----cCCC----
Confidence 553321 223568999999999998889999999999999999999999997654221 111111 1111
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
+.+ +......+..++..|++.+|.+||++.+|+++
T Consensus 228 -~~~----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 -RRI----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -CCC----ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111 11222455667777999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.73 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=199.9
Q ss_pred hcCceeeeeeeccCceEEEEEEeCC----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
..+|.+.+.||+|+||.||+|...+ ...++||..... ....+.+.+|+.+++.+.||||+++++++.. +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568889999999999999998643 246899988754 3456789999999999999999999999875 56789
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++|+|.+++.... ..+++..++.++.+++.||.|||+ .+++||||||+|||++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999997543 258999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
....... .....+++.|+|||++....++.++||||||+++|||++ |+.||...........+.... .+
T Consensus 158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~------~~--- 227 (270)
T cd05056 158 EDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE------RL--- 227 (270)
T ss_pred cccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC------cC---
Confidence 5542221 122345678999999988889999999999999999996 999997654332211111100 00
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
...... ...+..++.+|+..+|.+|||+.++++.|..
T Consensus 228 ---~~~~~~----~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 228 ---PMPPNC----PPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred ---CCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 011111 1245556677999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=303.30 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=203.5
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
.++|.+.+.||.|+||.||++... +++.+++|++.... ...+.+.+|+.+++.++||||+++++++...+.++++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357899999999999999999864 57889999987643 3567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++.... ..+++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 99999999987542 258899999999999999999999 899999999999999999999999999997655422
Q ss_pred CCcccccccccCCCCCcceeccC---CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYG---KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~---~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
. ......++..|+|||.+... .++.++||||||+++|+|++|+.||....+....... ....+ ..
T Consensus 156 ~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~--~~~~~--------~~ 223 (262)
T cd06613 156 A--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI--SKSNF--------PP 223 (262)
T ss_pred h--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhccC--------CC
Confidence 1 11235689999999998776 8899999999999999999999999765433222111 11000 00
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+.+. ........+..++.+||+.+|.+|||+.+|++
T Consensus 224 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PKLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0110 11222345667788899999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.06 Aligned_cols=203 Identities=25% Similarity=0.324 Sum_probs=174.1
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||.||++..+ +++.+|+|++... ......+.+|+.++..++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999865 5788999998642 223445788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999975332 58899999999999999999999 9999999999999999999999999999976543
Q ss_pred CCCCcccccccccCCCCCcceec-----cCCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~-----~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~ 557 (696)
.... ......||+.|+|||++. .+.++.++|||||||++|||++|+.||.....
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~ 213 (332)
T cd05623 155 DGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (332)
T ss_pred CCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence 2221 122357999999999986 34688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=316.32 Aligned_cols=199 Identities=26% Similarity=0.421 Sum_probs=162.8
Q ss_pred eeeeeccCceEEEEEEeC---CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCceEEEEeecCC
Q 005450 353 ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSR 427 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~---~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~--~~~~~LV~Ey~~g 427 (696)
.+.||+|+||+||+|... +++.||+|.+..... ...+.+|+.+++.++||||+++++++.. +...++||||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 368999999999999854 567899999975432 3457789999999999999999999864 4568999999865
Q ss_pred CChhhhhhcCC-----CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee----CCCCceEEeecCccc
Q 005450 428 GSLEENLHGNK-----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAK 498 (696)
Q Consensus 428 GsL~~~L~~~~-----~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL----d~~~~vKL~DFGlA~ 498 (696)
+|.+++.... .....+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 8888775322 122358899999999999999999999 899999999999999 456789999999998
Q ss_pred cccCCCCC-cccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCC
Q 005450 499 WASTSSSH-ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDH 556 (696)
Q Consensus 499 ~~~~~~~~-~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~ 556 (696)
........ .......||+.|+|||++.+. .++.++|||||||++|+|++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 76543221 122346789999999998764 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.50 Aligned_cols=247 Identities=28% Similarity=0.433 Sum_probs=201.2
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
++|...+.||.|++|.||+|... +++.||+|++... ......+.+|+++++.++|+||+++++++..+...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999864 6889999998753 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++... .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998753 57899999999999999999999 889999999999999999999999999998776542
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
.. .....|++.|+|||++.+..++.++||||||+++|+|++|+.||....+......+. .+ ..+.+
T Consensus 153 ~~--~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-------~~-----~~~~~ 218 (274)
T cd06609 153 SK--RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-------KN-----NPPSL 218 (274)
T ss_pred cc--cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-------hc-----CCCCC
Confidence 21 223568999999999998889999999999999999999999997654322111111 00 01111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.... ....+..++..||..+|++||++.++++
T Consensus 219 ~~~~---~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 219 EGNK---FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cccc---cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1110 1123455666799999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.53 Aligned_cols=263 Identities=24% Similarity=0.326 Sum_probs=196.5
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+|.+.+.||+|++|.||+|... ++..||+|.++.. ....+.+.+|+.++..++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5788999999999999999864 6899999998753 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
++ ++|.+++..... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 589888865432 2358899999999999999999999 899999999999999999999999999997654322
Q ss_pred CCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHH--hhhccc---cc----cC
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV--MWAKPI---LS----SG 574 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv--~~~~~~---~~----~g 574 (696)
. ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||............ .+..+. +. ..
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 R--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred c--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 1 11224578999999988654 5788999999999999999999999865432211100 000000 00 00
Q ss_pred ccc----cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 575 KVT----QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 575 ~l~----~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
... ......+... .......+..++..||+.||.+|||+.+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSA-VKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHh-cCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 0000000000 0001234456777899999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=306.85 Aligned_cols=238 Identities=25% Similarity=0.453 Sum_probs=187.0
Q ss_pred eeeeccCceEEEEEEeCC-------------CCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 354 NLIGKGGSSQVYKGCLPD-------------GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~-------------g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
+.||+|+||.||+|...+ ...+++|.+.... .....+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358999887643 34557888999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc-------eEEe
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-------PQLS 492 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~-------vKL~ 492 (696)
+||||+++++|..++.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999999886433 258899999999999999999999 89999999999999987654 8999
Q ss_pred ecCccccccCCCCCcccccccccCCCCCcceec-cCCCCCcccchhhHHHHHHHH-hCCCCCCCCCccchhhHHhhhccc
Q 005450 493 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELL-TGRKPISNDHPKGQESLVMWAKPI 570 (696)
Q Consensus 493 DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~-~~~~s~ksDVwSLGvvL~ELl-tG~~Pf~~~~~~~~~~lv~~~~~~ 570 (696)
|||++...... ....|+..|+|||++. ...++.++|||||||++|||+ +|+.||........... +..
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~--~~~-- 224 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF--YEG-- 224 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH--Hhc--
Confidence 99998755322 1245888999999887 467899999999999999998 58888865432221111 110
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005450 571 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621 (696)
Q Consensus 571 ~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L 621 (696)
.. .... .....+..++..||+.||.+||++.++++.|
T Consensus 225 ----~~-~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 ----QC-MLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ----Cc-cCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 0000 1123455677789999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=310.26 Aligned_cols=259 Identities=27% Similarity=0.439 Sum_probs=203.4
Q ss_pred ChHHHHHhhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEe--
Q 005450 339 NYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE-- 414 (696)
Q Consensus 339 ~~~el~~~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~-- 414 (696)
++.++....+.|.+.+.||.|+||.||+|.. .+++.+|+|++.........+..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 4555566778899999999999999999986 4688999999987666667788999999998 69999999999863
Q ss_pred ----cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceE
Q 005450 415 ----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 490 (696)
Q Consensus 415 ----~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vK 490 (696)
.+..+++|||+++|+|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+||++++++.++
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence 4578999999999999999875432 247788899999999999999999 8999999999999999999999
Q ss_pred EeecCccccccCCCCCcccccccccCCCCCcceec-----cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHh
Q 005450 491 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 565 (696)
Q Consensus 491 L~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~-----~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~ 565 (696)
|+|||++........ ......|++.|+|||++. ...++.++|||||||++|||++|+.||....+......+.
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 239 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP 239 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh
Confidence 999999876543221 122356899999999875 3468889999999999999999999997654322211111
Q ss_pred hhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 566 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 566 ~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+.. .+.+... .....+..++..||+.||.+||++.++++
T Consensus 240 ~~~------------~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 240 RNP------------PPKLKSK---KWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hCC------------CCCCccc---ccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 100 0001000 11134556677799999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.73 Aligned_cols=248 Identities=25% Similarity=0.429 Sum_probs=197.5
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 417 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----------~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~ 417 (696)
+|.+.+.||+|+||.||+|... +++.+|+|.+.... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999864 68899999886421 223568889999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA 497 (696)
.++||||+++++|.+++.... .+++..+..++.+++.||+|||+ .+++||||+|+||+++.++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999997543 47888999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCc----ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccccc
Q 005450 498 KWASTSSSHI----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 573 (696)
Q Consensus 498 ~~~~~~~~~~----~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 573 (696)
+......... ......|+..|+|||++..+.++.++|||||||++|+|++|+.||........ . ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~-~~~~----- 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--I-FKIG----- 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--H-HHHh-----
Confidence 8765321111 11234688999999999988899999999999999999999999976432111 1 1000
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 574 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 574 g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
....+.+.. .....+..++..||+.+|.+||++.++++
T Consensus 226 ----~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 ----ENASPEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----ccCCCcCCc----ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 001111111 11234555666799999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.40 Aligned_cols=257 Identities=22% Similarity=0.342 Sum_probs=198.7
Q ss_pred HHHhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 343 LLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 343 l~~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
++.+++++.....||+|+||.||+|... ++..|++|.+.... ...+.+.+|+.+++.++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3446677777789999999999999854 67889999887543 456788999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC-CCceEEeecCcccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKW 499 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~-~~~vKL~DFGlA~~ 499 (696)
||||+++++|.+++..... ....++..+..++.||+.||.|||+ .+|+||||||+||+++. ++.++|+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999975321 1122778888999999999999999 89999999999999976 67899999999976
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCC--CCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~--~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
....... .....|++.|+|||++.... ++.++||||||+++|+|++|+.||........ ..+......
T Consensus 159 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~----- 228 (268)
T cd06624 159 LAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK----- 228 (268)
T ss_pred cccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc-----
Confidence 5432221 12245899999999986543 78899999999999999999999965332111 111111000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..+.+.. .....+..++.+||+.+|.+|||+.++++
T Consensus 229 --~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 --IHPEIPE----SLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --cCCCCCc----ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0011111 11234556677899999999999999886
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=336.33 Aligned_cols=196 Identities=24% Similarity=0.319 Sum_probs=169.8
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
...+|.+.+.||+|+||.||++... .++.||||.... ..+.+|+++|++++|+||+++++++..++..++|||+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3557999999999999999999865 578899996432 3457899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+. ++|.+++.... ..++|..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 68888886433 258999999999999999999999 899999999999999999999999999998765433
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCC
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPIS 553 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~ 553 (696)
.........||+.|+|||++.+..++.++|||||||+||||++|..|+.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 2222234679999999999999999999999999999999999887654
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=324.11 Aligned_cols=260 Identities=23% Similarity=0.292 Sum_probs=194.6
Q ss_pred HhhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEec-----
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED----- 415 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~----- 415 (696)
...++|.+.+.||+|+||.||++.. .+++.||||++.... .....+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999985 468899999987532 3345678899999999999999999987543
Q ss_pred -CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeec
Q 005450 416 -NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 494 (696)
Q Consensus 416 -~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DF 494 (696)
...+++++++ +++|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCC
Confidence 4578999988 77998887532 48899999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccc--
Q 005450 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL-- 571 (696)
Q Consensus 495 GlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~-- 571 (696)
|+++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......
T Consensus 163 g~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 163 GLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred ccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9998664421 23568999999999876 568999999999999999999999997654322111110000000
Q ss_pred ------ccCccccccCcccCCCC--Ch-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 572 ------SSGKVTQLLDPALGNNY--DY-----DQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 572 ------~~g~l~~llD~~L~~~~--~~-----~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
........+. .+.... +. .....+..++..|++.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 238 EVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 000000 00 00123456777899999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=315.63 Aligned_cols=256 Identities=24% Similarity=0.430 Sum_probs=200.5
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCC----EEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~----~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
.++|...+.||+|+||.||+|... +|. .+|+|.+.... .....+.+|+.++..++||||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356788899999999999999853 444 57999887543 3345788999999999999999999998754 578
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+++||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccc
Confidence 9999999999999987543 257899999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
..............++..|+|||++.+..++.++|||||||++|||++ |+.||..........++.... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------~~~- 231 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE------RLP- 231 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC------CCC-
Confidence 654333222223456788999999998899999999999999999997 999997654322222211100 000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
.... ....+..++..||..+|++||++.++++.|+...
T Consensus 232 -----~~~~----~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 232 -----QPPI----CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred -----CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0011 1234566677899999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=309.27 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=198.3
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
+.|.+.+.||.|+||.||+|... +++.+++|.+.... ...+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999865 58999999987543 45678889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++++|..++.... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++........
T Consensus 92 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9999998876433 258899999999999999999999 8999999999999999999999999999875433211
Q ss_pred CcccccccccCCCCCcceec-----cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 506 HITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~-----~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
......+++.|+|||++. ...++.++|||||||++|+|++|+.||....+... ....... ..
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~-----~~---- 232 (292)
T cd06644 166 --RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKS-----EP---- 232 (292)
T ss_pred --ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHHHhcC-----CC----
Confidence 122356899999999985 34578899999999999999999999976543211 1111110 00
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+... .+......+..++..||+.+|++||++.++++
T Consensus 233 -~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 -PTLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -ccCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 01111234556677799999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=307.03 Aligned_cols=256 Identities=24% Similarity=0.397 Sum_probs=202.5
Q ss_pred cCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
++|.....||+|+||.||+|..+ +.+.+++|.+.... .....+.+|++++.+++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999853 34679999987543 24678999999999999999999999999989999
Q ss_pred EEEeecCCCChhhhhhcCCCC-----CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeec
Q 005450 420 LVYDFLSRGSLEENLHGNKKD-----PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 494 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~-----~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DF 494 (696)
+||||+++|+|.+++...... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999755421 1258999999999999999999999 88999999999999999999999999
Q ss_pred CccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhcccccc
Q 005450 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSS 573 (696)
Q Consensus 495 GlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~ 573 (696)
|++........ .......+++.|+|||.+....++.++||||||+++|+|++ |..||........ +.... .
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---~~~~~----~ 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---LNRLQ----A 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---HHHHH----c
Confidence 99875433221 12223456788999999988889999999999999999999 8889865433221 11111 0
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 574 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 574 g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
+.+.... ... ....+..++.+||+.+|.+||++.+++..|.
T Consensus 234 ~~~~~~~----~~~----~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELPV----PEG----CPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCCC----CCC----CCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111000 011 1235666777899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=354.25 Aligned_cols=259 Identities=26% Similarity=0.462 Sum_probs=208.7
Q ss_pred hcCceeeeeeeccCceEEEEEEeC--CCC----EEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP--DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~--~g~----~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~ 418 (696)
..+-...+.||+|+||.||.|... +|. .||||.++.. .....+|.+|..+|+.++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 345667889999999999999854 343 4899999864 57788999999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCC---CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecC
Q 005450 419 LLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 495 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~---~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFG 495 (696)
+|++|||++|+|..+|+..+. .+..++....+.++.+||+|+.||++ +++|||||-..|+||+....+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999986632 23568899999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccC
Q 005450 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 496 lA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
+|+.+...........-.-...|||||.++.+.++.|+|||||||+|||++| |..||.+.+..+....+ +..|
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~------~~gg 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV------LEGG 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH------HhCC
Confidence 9994443333222111112357999999999999999999999999999999 99999876654433222 1222
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 575 ~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
++.. +..-...+.+++.+||+.+|++||++..+++.+...
T Consensus 922 RL~~----------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 922 RLDP----------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred ccCC----------CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 2211 122234566788889999999999999999966543
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.91 Aligned_cols=264 Identities=22% Similarity=0.348 Sum_probs=196.7
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
-++|...+.||+|++|.||+|..+ +++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367899999999999999999865 68999999987532 223456789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+.+ +|.+++..... .+++..+..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~-~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLDT-DLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9985 99998875432 57899999999999999999999 89999999999999999999999999998754332
Q ss_pred CCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-chhhHHhhhccccccCcccc---
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK-GQESLVMWAKPILSSGKVTQ--- 578 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~-~~~~lv~~~~~~~~~g~l~~--- 578 (696)
.. ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||...... .+...+..............
T Consensus 157 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 157 SK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred Cc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 11 1122457889999999875 45889999999999999999999999755421 11111100000000000000
Q ss_pred -----------ccCcccCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 579 -----------LLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 579 -----------llD~~L~~~~-~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.....+.... .......+..++..|++.+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000 0111245566777899999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=302.09 Aligned_cols=250 Identities=31% Similarity=0.509 Sum_probs=199.8
Q ss_pred ceeeeeeeccCceEEEEEEeCC-----CCEEEEEEecCChh--HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 350 FLAENLIGKGGSSQVYKGCLPD-----GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~~-----g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
|.+.+.||.|+||.||++...+ +..+|+|.++.... ..+.+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998653 48899999986543 5678999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++++|.+++..... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999975432 128999999999999999999999 8999999999999999999999999999987665
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
...... ....+++.|+|||.+....++.++||||||+++|+|++ |+.||...........+.. +....
T Consensus 156 ~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-------~~~~~--- 224 (258)
T smart00219 156 DDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-------GYRLP--- 224 (258)
T ss_pred cccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-------CCCCC---
Confidence 422221 12337889999999988889999999999999999998 8888876433222111110 00000
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L 621 (696)
.... ....+..++..|+..+|++|||+.++++.|
T Consensus 225 --~~~~----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 --KPEN----CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCc----CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0011 123455567789999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=301.21 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=198.8
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe-cCceEEEEe
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYD 423 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~-~~~~~LV~E 423 (696)
+|.+.+.||+|++|.||++... +++.+|+|.+... ....+.+.+|++++++++|+|++++++.+.. +..+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999864 5789999998643 2445678899999999999999999998764 446899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+++++|.+++..... ..+++.++..++.+++.||.|||+ .+|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999975332 358999999999999999999999 89999999999999999999999999999876443
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||............. .+.+..
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-------~~~~~~----- 221 (257)
T cd08223 156 CD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-------EGKLPP----- 221 (257)
T ss_pred CC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-------hcCCCC-----
Confidence 22 1223568999999999998899999999999999999999999997544322111110 111111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
+ +......+..++..|++.+|++||++.++++.
T Consensus 222 ~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 M----PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred C----ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1 11122345667778999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=342.34 Aligned_cols=260 Identities=25% Similarity=0.321 Sum_probs=204.4
Q ss_pred hhcCceeeeeeeccCceEEEEEEeCCC-CEEEEEEecC-ChhHHHHHHHHHHHHHhcC-CcceeEEeeE-EEe------c
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLPDG-KELAVKILKP-SEDVIKEFVLEIEIITTLH-HKNIISLLGF-CFE------D 415 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~~g-~~vAVK~l~~-~~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~-~~~------~ 415 (696)
...++.+.+.|.+|||+.||+|.+..+ ..||+|++-. ++...+.+.+||++|++|+ |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 455788999999999999999997665 9999998754 5677888999999999997 9999999993 221 1
Q ss_pred CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecC
Q 005450 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 495 (696)
Q Consensus 416 ~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFG 495 (696)
-+.+|.||||.||.|-+++..+... .|++.++++|+.++++|+++||... .+|||||||-+||||+.+++.||||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 3578999999999999999866543 4999999999999999999999844 679999999999999999999999999
Q ss_pred ccccccCCCCCc-cc------ccccccCCCCCcceec---cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHh
Q 005450 496 LAKWASTSSSHI-TC------TDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 565 (696)
Q Consensus 496 lA~~~~~~~~~~-~~------~~~~GT~~YlAPE~l~---~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~ 565 (696)
.|.-........ .. -...-|+.|.|||++. +...++|+|||+|||+||-|+....||+......
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------ 265 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------ 265 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee------
Confidence 986332222110 00 0123589999999874 5579999999999999999999999998653221
Q ss_pred hhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCccc
Q 005450 566 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADV 627 (696)
Q Consensus 566 ~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~~~ 627 (696)
|++....-.-...+..++..++..||+.||.+||++-+|++.+......
T Consensus 266 -------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 266 -------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1111111111134556677777789999999999999999877554433
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=307.61 Aligned_cols=258 Identities=28% Similarity=0.394 Sum_probs=202.8
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~--~~~~LV~ 422 (696)
++|...+.||.|++|.||++... +++.+|+|.+.... .....+.+|+++++.++||||++++++|... +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46889999999999999999974 68899999987543 3567789999999999999999999998653 4689999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++++|.+++.........+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999876543344568899999999999999999999 8999999999999999999999999999875543
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCc--cchhhHHhhhccccccCcccccc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP--KGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~--~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... .....+..+.... ....+.
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 229 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPELK 229 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchhhc
Confidence 221 134578899999999988999999999999999999999999976532 1111222222110 000110
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+ .... .......+..++..||+.+|.+|||+.++++
T Consensus 230 ~-~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 230 D-EPGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred c-CCCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 0000 1122345667778899999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=304.36 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=211.1
Q ss_pred hhcCceeeeeeeccCceEEEEEE-eCCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecC-----ce
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NL 418 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~-~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~-----~~ 418 (696)
..++|.+.+.||+|||+.||++. ..+++.||+|.+.... +..+..++|++..++++|||+++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45789999999999999999998 5688999999987655 77889999999999999999999999886544 49
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
||+++|...|+|.+.+...+.....+++.++++|+.+|++||.+||... .++.||||||.|||+++.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999887776678999999999999999999999843 359999999999999999999999999987
Q ss_pred cccCCCCCcc-------cccccccCCCCCcceec---cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhc
Q 005450 499 WASTSSSHIT-------CTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 568 (696)
Q Consensus 499 ~~~~~~~~~~-------~~~~~GT~~YlAPE~l~---~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~ 568 (696)
...-...... ...-..|..|.|||.+. +...++++|||||||+||+|+.|..||+.....+.....
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL---- 253 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL---- 253 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE----
Confidence 5543211111 11134789999999986 446889999999999999999999999754432221110
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 569 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 569 ~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
...++.+.-.- .....+.+.+++.+|++.||.+||++.+++..+..
T Consensus 254 -Av~n~q~s~P~--------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 254 -AVQNAQISIPN--------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred -eeeccccccCC--------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 01111111111 11145678888889999999999999999988754
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.24 Aligned_cols=238 Identities=24% Similarity=0.421 Sum_probs=186.3
Q ss_pred eeeccCceEEEEEEeCC-------------------------CCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEE
Q 005450 355 LIGKGGSSQVYKGCLPD-------------------------GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISL 408 (696)
Q Consensus 355 ~LG~G~fG~Vyka~~~~-------------------------g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l 408 (696)
.||+|+||.||+|.... ...|++|++.... .....+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 1358999987643 334678889999999999999999
Q ss_pred eeEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC-
Q 005450 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF- 487 (696)
Q Consensus 409 ~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~- 487 (696)
+++|......++||||+++|+|..++.... ..+++..+..++.||++||+|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCc
Confidence 999999999999999999999999986533 257899999999999999999999 8999999999999997643
Q ss_pred ------ceEEeecCccccccCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHH-hCCCCCCCCCccc
Q 005450 488 ------EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELL-TGRKPISNDHPKG 559 (696)
Q Consensus 488 ------~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELl-tG~~Pf~~~~~~~ 559 (696)
.+|++|||++...... ....++..|+|||++.. ..++.++|||||||++|||+ +|+.||....+..
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3799999988643221 12357888999998875 56899999999999999995 6999997654432
Q ss_pred hhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 560 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 560 ~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
......... . +... ....+..++..||+.+|.+||++.++++.|.
T Consensus 230 ~~~~~~~~~------~--------~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERFYEKKH------R--------LPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHhcc------C--------CCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 211111000 0 0011 1124566777899999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.45 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=193.3
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHH-HHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEI-ITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~i-L~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
++|.+.+.||+|+||.||++... +|+.||+|+++... .....+..|+.+ ++.++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999865 69999999987542 334556667665 566789999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCC-ceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~-gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
|++ |+|.+++.........+++..++.++.|++.||.|||+ + +++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 58888886543333568999999999999999999998 5 899999999999999999999999999986643
Q ss_pred CCCCcccccccccCCCCCcceecc----CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMY----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~----~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
... .....|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||...... ...+..... +.
T Consensus 157 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~-----~~--- 224 (283)
T cd06617 157 SVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQVVE-----EP--- 224 (283)
T ss_pred ccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHHHHh-----cC---
Confidence 221 122568999999998864 45688999999999999999999999643221 111111100 00
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+.+... .....+..++..||..+|.+||++.++++
T Consensus 225 --~~~~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 --SPQLPAE---KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --CCCCCcc---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111100 01134556677799999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.80 Aligned_cols=198 Identities=27% Similarity=0.421 Sum_probs=161.9
Q ss_pred eeeeeccCceEEEEEEeC---CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCceEEEEeecCC
Q 005450 353 ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSR 427 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~---~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~--~~~~~LV~Ey~~g 427 (696)
.+.||+|+||.||+|... ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. +...++||||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 367999999999999864 457899999876432 3467789999999999999999999854 5578999999875
Q ss_pred CChhhhhhcCC-----CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee----CCCCceEEeecCccc
Q 005450 428 GSLEENLHGNK-----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAK 498 (696)
Q Consensus 428 GsL~~~L~~~~-----~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL----d~~~~vKL~DFGlA~ 498 (696)
+|.+++.... .....+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 7877764321 122358899999999999999999999 899999999999999 566789999999998
Q ss_pred cccCCCCC-cccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCC
Q 005450 499 WASTSSSH-ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISND 555 (696)
Q Consensus 499 ~~~~~~~~-~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~ 555 (696)
........ .......||+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76543221 112335789999999998764 5899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.51 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=198.6
Q ss_pred ceeeeeeeccCceEEEEEEeC----CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC------
Q 005450 350 FLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 416 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~----~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~------ 416 (696)
|.+.+.||+|+||.||+|... +++.+|||++... ....+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999753 4688999998753 345667889999999999999999999886532
Q ss_pred ceEEEEeecCCCChhhhhhcCC--CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeec
Q 005450 417 NLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 494 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~--~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DF 494 (696)
..+++++|+.+|+|.+++.... .....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875332 223357889999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhcccccc
Q 005450 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSS 573 (696)
Q Consensus 495 GlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~ 573 (696)
|+++...............+++.|++||.+....++.++||||||+++|+|++ |+.||........ ..+... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~~~~---~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNYLIK---G 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHHHHc---C
Confidence 99986654332222223446678999999988889999999999999999999 8999876543221 111110 0
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 574 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 574 g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.... ........+..++.+|++.+|.+||++.++++.|+.
T Consensus 232 ~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 232 NRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred CcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0000 011122467777888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=307.81 Aligned_cols=248 Identities=26% Similarity=0.414 Sum_probs=196.0
Q ss_pred ceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 350 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
|.+.+.||+|+||.||++... ++..+++|.+... ....+.+.+|+++++.++||||++++++|..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999865 5778899998753 35567889999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
++|..++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-- 158 (282)
T cd06643 87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-- 158 (282)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence 99999886432 258999999999999999999999 8999999999999999999999999999876543221
Q ss_pred ccccccccCCCCCcceec-----cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 508 TCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~-----~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
......||+.|+|||++. ...++.++|||||||++|+|++|+.||....+....... ... ....+..+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~--~~~-----~~~~~~~~ 231 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI--AKS-----EPPTLAQP 231 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH--hhc-----CCCCCCCc
Confidence 122356899999999984 345788999999999999999999999765432221111 110 00000001
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..+ ...+..++..||+.+|.+||++.++++
T Consensus 232 ---~~~----~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 232 ---SRW----SSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ---ccc----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 123455666799999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=311.52 Aligned_cols=263 Identities=26% Similarity=0.362 Sum_probs=199.5
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
++|.+.+.||+|+||.||+|..+ +++.||+|++.... ...+.+.+|++++..++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999975 58999999986432 245678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+++++|..+..... .+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999999988765432 48899999999999999999999 89999999999999999999999999999866443
Q ss_pred CCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhh-hccccccC-------
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMW-AKPILSSG------- 574 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~-~~~~~~~g------- 574 (696)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|++||...........+.. ........
T Consensus 154 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 GE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred cc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 32 1223568999999999875 4578899999999999999999999976543221111111 10000000
Q ss_pred c-cccccCcccCCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 575 K-VTQLLDPALGNNY-----DYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 575 ~-l~~llD~~L~~~~-----~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. ......+...... .......+..++..||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 0000000000000 0112345667778899999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=307.93 Aligned_cols=264 Identities=27% Similarity=0.382 Sum_probs=201.6
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
++|.+.+.||+|+||.||+|..+ +++.||+|.++.. ....+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36899999999999999999865 6889999998753 2345778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|++++.+..++... ..+++..+..++.+++.||.|||+ .+++||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99987776655432 247899999999999999999999 89999999999999999999999999999876654
Q ss_pred CCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhc-ccc--------cc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-PIL--------SS 573 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~-~~~--------~~ 573 (696)
... ......++..|+|||++... .++.++||||||+++|+|++|+.||................ ... ..
T Consensus 154 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred ccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 321 22346789999999999888 88999999999999999999999997654322211111100 000 00
Q ss_pred C-----ccccccCcc-cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 574 G-----KVTQLLDPA-LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 574 g-----~l~~llD~~-L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. ......++. +...++......+..++..||..+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 000000000 000011111355667777899999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=303.37 Aligned_cols=252 Identities=25% Similarity=0.414 Sum_probs=200.4
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
+|+..+.||+|++|.||++.. .+++.+|+|++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 578999999987432 245788999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC-ceEEeecCcccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKW 499 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~-~vKL~DFGlA~~ 499 (696)
||||+++++|.+++.... .+++..+..++.|++.||.|||+ ++++|+||||+||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999997543 47899999999999999999999 8999999999999998775 599999999987
Q ss_pred ccCCCCC--cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 500 ASTSSSH--ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 500 ~~~~~~~--~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
....... .......||..|+|||++.+..++.++||||||+++|+|++|+.||...........+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 228 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT----- 228 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC-----
Confidence 6543211 111235689999999999888899999999999999999999999975543322222111100000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+ ..+......+..++.+|++.+|.+||++.++++
T Consensus 229 ---~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ---AP----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---CC----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01 111122244556777899999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=300.80 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=203.4
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
++|.+.+.||.|+||+||+|.. .++..+++|++.... .....+.+|+++++.++|+||+++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4788999999999999999985 468899999987532 3567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++..... ...+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999975432 1358899999999999999999999 899999999999999999999999999998766543
Q ss_pred CCc--ccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 505 SHI--TCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 505 ~~~--~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
... ......|+..|+|||++... .++.++|+|||||++|+|++|+.||........ ....... . .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~--~--------~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQN--D--------P 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhcC--C--------C
Confidence 221 12235689999999998877 789999999999999999999999976544221 1111111 0 0
Q ss_pred cccCCCCC-hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 582 PALGNNYD-YDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 582 ~~L~~~~~-~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+.+..... ......+..++..|++.||++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111000 112244556667799999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=310.03 Aligned_cols=246 Identities=28% Similarity=0.420 Sum_probs=198.8
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
.|...+.||+|+||.||+|... ++..||+|.+... ....+.+.+|+.+++.++||||++++++|..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3566788999999999999864 6788999998743 344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++++|.+++... .+++..+..++.+++.||.|||+ ++++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKPG-----PLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999988642 47889999999999999999999 8999999999999999999999999999986654321
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....+..... +. ..+ ..+.+.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~~----~~~-----~~~~~~ 222 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---LI----PKN-----SPPTLE 222 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh---hh----hcC-----CCCCCC
Confidence 1223568999999999998889999999999999999999999997544322111 10 000 011111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
......+..++..||+.+|.+||++.++++.
T Consensus 223 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 ----GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1122345566777999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.16 Aligned_cols=252 Identities=23% Similarity=0.402 Sum_probs=198.3
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecC--ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
++|.+.+.||+|+||.||++... +|..||+|.++. .......+.+|++++.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999875 789999998875 334457889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|..++.... ....+++..+..++.+++.||.|||+ ..+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999887532 12368999999999999999999996 1589999999999999999999999999997654322
Q ss_pred CCcccccccccCCCCCcceeccC------CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~------~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
. ....|++.|+|||++.+. .++.++|||||||++|+|++|+.||.............. . ..+..
T Consensus 158 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~---~-~~~~~-- 227 (286)
T cd06622 158 A----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA---I-VDGDP-- 227 (286)
T ss_pred c----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH---H-hhcCC--
Confidence 1 234688999999998544 358899999999999999999999975433221111100 0 00000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+.+ +......+..++..||+.+|.+||++.++++
T Consensus 228 ---~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 ---PTL----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ---CCC----CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 111 1122334556677899999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.25 Aligned_cols=264 Identities=21% Similarity=0.295 Sum_probs=200.9
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+|.+.+.||.|+||.||+|.. .+|+.||+|++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478899999999999999986 47899999998753 23456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+ +++|.+++.... ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987543 358999999999999999999999 899999999999999999999999999998765433
Q ss_pred CCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccccc---------C
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS---------G 574 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~---------g 574 (696)
. .......|+..|+|||++... .++.++||||||+++|||++|.+||...........+......... .
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 2 112235689999999998654 4688999999999999999998888665432221111100000000 0
Q ss_pred ccccccCcccC----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 575 KVTQLLDPALG----NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 575 ~l~~llD~~L~----~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
....+..+.-. .....+....+..++..|++.+|++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00001122566677788999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=352.41 Aligned_cols=257 Identities=25% Similarity=0.359 Sum_probs=198.1
Q ss_pred HHhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--Cc
Q 005450 344 LSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NN 417 (696)
Q Consensus 344 ~~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~--~~ 417 (696)
....++|.+.+.||+|+||+||++... ++..+|+|++... ......|..|+.++..++||||++++++|... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344578999999999999999999864 5778999998743 34567789999999999999999999988653 56
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC----CCceEeecccccceeeCC--------
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS----AQRVIHRDVKSSNILLSD-------- 485 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~----~~gIIHrDLKpsNILLd~-------- 485 (696)
+||||||+++|+|.++|.........+++..++.|+.||+.||.|||+.+ ..+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999999764333346899999999999999999999832 145999999999999964
Q ss_pred ---------CCceEEeecCccccccCCCCCcccccccccCCCCCcceecc--CCCCCcccchhhHHHHHHHHhCCCCCCC
Q 005450 486 ---------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISN 554 (696)
Q Consensus 486 ---------~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~--~~~s~ksDVwSLGvvL~ELltG~~Pf~~ 554 (696)
.+.+||+|||++........ .....||+.|+|||++.. ..++.++||||||||||||++|+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 23489999999986644322 123579999999999864 4588999999999999999999999975
Q ss_pred CCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 555 DHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 555 ~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
...... ++.... .+ +.+...... ..+..++..||+.+|.+||++.+++.
T Consensus 246 ~~~~~q--li~~lk----~~-------p~lpi~~~S---~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANNFSQ--LISELK----RG-------PDLPIKGKS---KELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcHHH--HHHHHh----cC-------CCCCcCCCC---HHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 443221 111110 00 001000011 33555667799999999999999984
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=301.46 Aligned_cols=246 Identities=27% Similarity=0.435 Sum_probs=198.6
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC------hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~------~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
+|...+.||+|+||.||+|... +++.|++|.+... ....+.+.+|+.+++.++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999976 7899999988643 23567889999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++++|.+++.... .+++..+..++.+++.||.|||+ .+|+|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999997543 47899999999999999999999 899999999999999999999999999988664
Q ss_pred CCCCCcccccccccCCCCCcceeccCC-CCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~-~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
... ......|++.|+|||.+.... ++.++|+||||+++|+|++|+.||........ ...+.. .....
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~----~~~~~--- 221 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFKIGR----SKELP--- 221 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HHHHHh----cccCC---
Confidence 433 122356899999999987766 89999999999999999999999976542211 111111 00010
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+.. .....+..++.+||+.+|.+||++.++++
T Consensus 222 --~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 --PIPD----HLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --CcCC----CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0111 11234455667799999999999999885
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=304.93 Aligned_cols=254 Identities=26% Similarity=0.431 Sum_probs=197.5
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-----------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecC
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-----------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 416 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-----------~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~ 416 (696)
+|...+.||.|+||.||+|.. .+|+.+|+|.++... ...+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999985 468999999886321 12356788999999999999999999999999
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCc
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGl 496 (696)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999999997652 58889999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceeccCC--CCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~--~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
+................|+..|+|||++.... ++.++|+||||+++|+|++|..||........ +..... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~-----~ 227 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFKLGN-----K 227 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHHhhc-----c
Confidence 98654432222223356899999999987654 88999999999999999999999964432211 111100 0
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 575 ~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.....+...... .....+..++..|++.+|.+||++.+|++.
T Consensus 228 ~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 RSAPPIPPDVSM----NLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCcCCccccc----cCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 001111111111 112345556667999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=310.79 Aligned_cols=248 Identities=26% Similarity=0.402 Sum_probs=199.8
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
.+|.+.+.||+|+||.||++.. .+++.||+|.+.... ...+.+.+|+.+++.++||||++++++|..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6789999999999999999985 579999999987533 34466889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++++|.+++... .+++..+..++.+++.||.|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998642 47888999999999999999999 8999999999999999999999999999876544322
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||....+....... + ..+ ...+..
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-~-----~~~-~~~~~~---- 237 (297)
T cd06656 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-A-----TNG-TPELQN---- 237 (297)
T ss_pred C--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-c-----cCC-CCCCCC----
Confidence 1 12356899999999999888999999999999999999999999765432211100 0 000 000000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.......+..++..||+.+|++||++.++++
T Consensus 238 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 238 ---PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111123445666799999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=302.73 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=193.5
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC------hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCce
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNL 418 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~------~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~--~~~~ 418 (696)
.+|...+.||+|+||.||++... ++..|++|.+... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999864 6899999988642 2345678899999999999999999999875 3568
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
+++|||+++++|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999997543 47889999999999999999998 899999999999999999999999999998
Q ss_pred cccCCCCC-cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 499 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 499 ~~~~~~~~-~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
........ .......++..|+|||++.+..++.++|||||||++|||++|+.||........... .. ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~---~~---~~~--- 225 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK---IA---TQP--- 225 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH---Hh---cCC---
Confidence 65432111 111224689999999999988899999999999999999999999976433221110 00 000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..+.+....+ +.+.. ++.|+..+|++||++.+|++
T Consensus 226 --~~~~~~~~~~-~~~~~----li~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 --TNPQLPSHIS-EHARD----FLGCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCCCCchhcC-HHHHH----HHHHhcCChhhCcCHHHHhc
Confidence 0111111111 12222 23588899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=310.29 Aligned_cols=248 Identities=25% Similarity=0.425 Sum_probs=200.4
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
.+|...+.||.|++|.||+|.. .+|+.|++|.+.... ...+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4689999999999999999985 578999999886533 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++++|..++... .+++..+..++.+++.||.|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999988643 47899999999999999999999 8999999999999999999999999999876544322
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
. .....|++.|+|||.+....++.++|||||||++|+|++|+.||....+......+. ... ...+..+
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~-~~~------~~~~~~~--- 238 (296)
T cd06655 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNG------TPELQNP--- 238 (296)
T ss_pred c--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcC------CcccCCc---
Confidence 1 123468999999999998889999999999999999999999997765433222111 000 0000000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
... ...+..++..||..+|.+||++.++++
T Consensus 239 ~~~----~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 239 EKL----SPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccC----CHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 111 123445667799999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=315.10 Aligned_cols=199 Identities=23% Similarity=0.321 Sum_probs=166.1
Q ss_pred eeeeeecc--CceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 352 AENLIGKG--GSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 352 ~~~~LG~G--~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
+.++||+| +|++||++.. .+|+.||+|++... ....+.+.+|+++++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 7899999985 57899999999753 344566778999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++|+|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999865432 248899999999999999999999 8999999999999999999999999987543321111
Q ss_pred C-----cccccccccCCCCCcceecc--CCCCCcccchhhHHHHHHHHhCCCCCCCC
Q 005450 506 H-----ITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISND 555 (696)
Q Consensus 506 ~-----~~~~~~~GT~~YlAPE~l~~--~~~s~ksDVwSLGvvL~ELltG~~Pf~~~ 555 (696)
. .......++..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0 01112357788999999975 46899999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.17 Aligned_cols=253 Identities=25% Similarity=0.287 Sum_probs=202.5
Q ss_pred hcCceeeeeeeccCceEEEEEEeCC-CCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~-g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|...+.||.|.-|+||++.+.+ +..+|+|++.+. .....+...|-+||+.+.||.++.||..|..+...|||
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3457788999999999999999764 588999999864 34456778899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
||||+||+|..+++++.. ..|++..++.++.+++.||+|||. .|||+|||||+||||-++|++.|+||.|+....
T Consensus 156 meyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999999987654 469999999999999999999999 999999999999999999999999999976432
Q ss_pred CC---------------------------------CCC---------------------cccccccccCCCCCcceeccC
Q 005450 502 TS---------------------------------SSH---------------------ITCTDVAGTFGYLAPEYFMYG 527 (696)
Q Consensus 502 ~~---------------------------------~~~---------------------~~~~~~~GT~~YlAPE~l~~~ 527 (696)
.. ... .....++||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 10 000 001126799999999999999
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccC
Q 005450 528 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRD 607 (696)
Q Consensus 528 ~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~d 607 (696)
..+.++|+|+|||+|||||.|..||.+.+.......+...... +.+ ........-.++...|.+|
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~-------------Fp~--~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK-------------FPE--EPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc-------------CCC--CCcchhHHHHHHHHHhccC
Confidence 9999999999999999999999999987765443322211111 111 1112233344555588999
Q ss_pred CCCCCC----HHHHHH
Q 005450 608 PRARPQ----MSLVLK 619 (696)
Q Consensus 608 P~~RPS----m~eVL~ 619 (696)
|.+|.- +.||-+
T Consensus 376 P~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhhccccchHHhhc
Confidence 999998 666544
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=304.94 Aligned_cols=246 Identities=26% Similarity=0.419 Sum_probs=201.0
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
.|...+.||.|+||.||+|... ++..||+|++... ......+.+|+.+++.+.||||+++++++.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999864 6889999998753 345678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++++|.+++... .+++..+..++.+++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998642 47888999999999999999999 8999999999999999999999999999976654322
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
. .....++..|+|||++.+..++.++|+|||||++|||++|..||....+......+. .+. .
T Consensus 157 ~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-------~~~---------~ 218 (277)
T cd06640 157 K--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-------KNN---------P 218 (277)
T ss_pred c--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-------cCC---------C
Confidence 1 123468899999999988889999999999999999999999997654332211110 000 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
..........+..++..||+.+|.+||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11122233456677778999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=299.05 Aligned_cols=248 Identities=25% Similarity=0.379 Sum_probs=200.4
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+|...+.||+|+||.||++.. .+|+.||+|.+... ....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 488899999999999999985 46899999998642 34456889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+.+++|.+.+..... ..+++..++.++.|++.||.|||+ ++++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999875332 247889999999999999999999 899999999999999999999999999998654432
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
.. .....|++.|+|||++.+..++.++|+|||||++++|++|+.||...........+ .. +... ..
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~--~~-----~~~~-----~~ 221 (256)
T cd08218 156 EL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI--IR-----GSYP-----PV 221 (256)
T ss_pred hh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH--hc-----CCCC-----CC
Confidence 21 12356899999999999889999999999999999999999999765432221111 10 1100 01
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.......+..++.+|++.+|.+||++.+|++
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 ----SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ----cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1111234556677799999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=297.39 Aligned_cols=247 Identities=24% Similarity=0.355 Sum_probs=199.2
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+|...+.||+|+||.||++.. .+++.+|+|.+... ....+.+.+|+++++.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588899999999999999986 46889999998653 34467889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC-CceEEeecCccccccCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWASTS 503 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~-~~vKL~DFGlA~~~~~~ 503 (696)
+++++|.+++.... ...+++..+..++.+++.||.|||+ ++|+|+||||+||+++.+ +.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997543 2357899999999999999999999 899999999999999865 45899999999876543
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
... ....|+..|+|||.+....++.++||||||+++|+|++|+.||...........+.. +....+.
T Consensus 156 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~--- 222 (256)
T cd08220 156 SKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-------GTFAPIS--- 222 (256)
T ss_pred ccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-------cCCCCCC---
Confidence 221 235689999999999988899999999999999999999999976543222111110 0111111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. .....+..++..||+.+|.+|||+.++++
T Consensus 223 --~----~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 223 --D----RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --C----CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 11234556667799999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=309.93 Aligned_cols=255 Identities=23% Similarity=0.309 Sum_probs=199.7
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|...+.||+|+||.||++... +++.|++|.+.... .....+.+|++++..++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47899999999999999999864 57899999987542 33457889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++++|.+++.... .+++..+..++.+++.||.|||+ ++++||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999996543 47899999999999999999999 8999999999999999999999999999874221
Q ss_pred CCCC-------------cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcc
Q 005450 503 SSSH-------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 569 (696)
Q Consensus 503 ~~~~-------------~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~ 569 (696)
.... .......|+..|+|||++....++.++||||||+++|||++|..||.+.............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~-- 231 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD-- 231 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--
Confidence 1100 0111245788999999998889999999999999999999999999765432211111100
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 570 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 570 ~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.. ..+.... .....+..++..||+.+|++||+..+++++|+.
T Consensus 232 -----~~---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 -----DI---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -----cc---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00 0011000 111234566677999999999998777777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.65 Aligned_cols=252 Identities=27% Similarity=0.422 Sum_probs=199.4
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
.++|.+.+.||.|+||.||++... ++..+|+|++.... ...+.+..|++++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888999999999999999864 68999999987543 4557788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++.... ..+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 99999999987543 258999999999999999999999 899999999999999999999999999987654322
Q ss_pred CCcccccccccCCCCCcceec-----cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~-----~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
.. .....||+.|+|||++. ...++.++||||||+++|+|++|+.||........ ...+.. +....+
T Consensus 158 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~-----~~~~~~ 228 (280)
T cd06611 158 QK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKILK-----SEPPTL 228 (280)
T ss_pred cc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHHhc-----CCCCCc
Confidence 21 22356899999999875 33577899999999999999999999976543221 111111 000000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
..+ ..+ ...+..++..||+.+|.+||++.++++.
T Consensus 229 ~~~---~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 DQP---SKW----SSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCc---ccC----CHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 011 1234456667999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=299.22 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=193.4
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC------hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--Cce
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 418 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~------~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~--~~~ 418 (696)
.+|.+.+.||+|+||.||++... +|+.||+|.+... ....+.+.+|+.++..++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57899999999999999999864 6899999987532 23456788999999999999999999998763 468
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
++||||+++++|.+++.... .+++..+.+++.+++.||.|||+ .+|+|+||||+|||++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999987543 37788899999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC-cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 499 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 499 ~~~~~~~~-~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
........ .......|+..|+|||++.+..++.++|||||||++|+|++|+.||............ . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~--~----~~~--- 225 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI--A----TQP--- 225 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH--h----cCC---
Confidence 65432111 1122356899999999998888999999999999999999999999754322111100 0 000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..+.+ +......+..++..|+ .+|.+||+++++++
T Consensus 226 --~~~~~----~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 226 --TNPVL----PPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred --CCCCC----chhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 01111 1122233444455577 48999999999886
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=346.94 Aligned_cols=259 Identities=24% Similarity=0.347 Sum_probs=199.8
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||.||+|... +|+.||+|+++.. ....+++.+|++++..++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999864 6899999998753 234567999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCC-------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecC
Q 005450 423 DFLSRGSLEENLHGNKK-------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 495 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~-------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFG 495 (696)
||++||+|.+++..... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 12345677889999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCC----------------CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccc
Q 005450 496 LAKWASTSSS----------------HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 559 (696)
Q Consensus 496 lA~~~~~~~~----------------~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~ 559 (696)
+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621110 011123579999999999999999999999999999999999999997643221
Q ss_pred hhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhhC
Q 005450 560 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLKLLRG 623 (696)
Q Consensus 560 ~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPS-m~eVL~~L~~ 623 (696)
.. ........... .+ .... ...+..++..|++.||++||+ +.++++.|+.
T Consensus 239 i~----~~~~i~~P~~~----~p--~~~i----P~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 IS----YRDVILSPIEV----AP--YREI----PPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hh----hhhhccChhhc----cc--cccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 11000000000 00 0011 123455667799999999976 6666665543
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=294.94 Aligned_cols=250 Identities=29% Similarity=0.418 Sum_probs=204.4
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceEEEE
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVY 422 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~--~~~~LV~ 422 (696)
+|...+.||+|++|.||+|... +++.+++|++.... ...+.+.+|+.++++++||||+++++++... +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999976 78999999987654 4567899999999999999999999999988 8899999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++++|.+++.... .+++..++.++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999997553 58999999999999999999999 8999999999999999999999999999987766
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
...........++..|+|||.+....++.++||||||+++|+|++|+.||..... .... .+. .........
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~-~~~--~~~~~~~~~---- 224 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAA-LYK--IGSSGEPPE---- 224 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHH-HHh--ccccCCCcC----
Confidence 5432112335689999999999988899999999999999999999999976551 1111 111 000011111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+......+..++.+|++.+|++||++.++++
T Consensus 225 -----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 -----IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -----CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11111345666777899999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.39 Aligned_cols=239 Identities=23% Similarity=0.388 Sum_probs=187.4
Q ss_pred eeeeccCceEEEEEEeCC--------CCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 354 NLIGKGGSSQVYKGCLPD--------GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~--------g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+.||+|+||.||+|.... ...+++|.+.... ...+.+.+|+.++..+.||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998532 2348888886543 3456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc--------eEEeecCc
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--------PQLSDFGL 496 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~--------vKL~DFGl 496 (696)
+++|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999999976542 57899999999999999999999 89999999999999987765 59999998
Q ss_pred cccccCCCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCC-CCCCCCCccchhhHHhhhccccccC
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGR-KPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~-~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
+...... ....+++.|+|||++.+. .++.++||||||+++|+|++|. .||............. . ..
T Consensus 155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~-~-----~~ 222 (258)
T cd05078 155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE-D-----RH 222 (258)
T ss_pred ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH-c-----cc
Confidence 8654321 225688999999999864 5899999999999999999985 5655433322111110 0 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 575 ~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
. + +......+..++..||+.+|++|||+.++++.|+
T Consensus 223 ~--------~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 Q--------L----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c--------C----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 1 1111234566777799999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=305.69 Aligned_cols=249 Identities=29% Similarity=0.423 Sum_probs=199.3
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC------h---hHHHHHHHHHHHHHhcC-CcceeEEeeEEEecC
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS------E---DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDN 416 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~------~---~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~ 416 (696)
+.|...++||.|..++|-+++. ++|+++|+|++... + ...+.-.+|+.||+++. ||+|+++.++|+...
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3566778899999999998875 57899999998531 1 23345567999999985 999999999999999
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCc
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGl 496 (696)
.+++|+|.|+.|.|.++|...- .++++..++|+.|+++|++|||. ++|+||||||+|||++++.++||+|||+
T Consensus 97 F~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccce
Confidence 9999999999999999997543 68999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceecc------CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccc
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMY------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 570 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~------~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 570 (696)
|..+..+.. -.+.+|||+|+|||.+.. ..|+..+|+|++|||+|.||.|.+||-.....-...+++..+..
T Consensus 170 a~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 170 ACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred eeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 998876543 235899999999998853 36888999999999999999999999643322222233332222
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 571 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 571 ~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+.+..+.. -......++.+||+.||.+|.|+.|+|.
T Consensus 247 F~speWad-------------is~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 247 FRSPEWAD-------------ISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cCCcchhh-------------ccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 22221111 1123344666799999999999999886
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=306.46 Aligned_cols=243 Identities=27% Similarity=0.386 Sum_probs=198.7
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||.||++... +++.+|+|++.... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47899999999999999999864 68999999987532 34567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||+|+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999997653 58899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
. .....|++.|+|||.+....++.++||||||+++|+|++|+.||...........+. .+..
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~~------ 215 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL-------EGKV------ 215 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-------cCCc------
Confidence 3 123568999999999988889999999999999999999999997654221111110 0110
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLK 619 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~ 619 (696)
.+.... ...+..++..||..+|.+|| ++.++++
T Consensus 216 ~~~~~~----~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 RFPSFF----SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred cCCccC----CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 111111 23445566679999999999 6677664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=309.45 Aligned_cols=252 Identities=27% Similarity=0.350 Sum_probs=200.1
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|...+.||+|+||.||++... +++.||+|.+.... ...+.+..|++++..++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36889999999999999999875 58999999997543 34567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+.+++|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999875432 358899999999999999999999 8999999999999999999999999999876543
Q ss_pred CCCCc---------------------------ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCC
Q 005450 503 SSSHI---------------------------TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 555 (696)
Q Consensus 503 ~~~~~---------------------------~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~ 555 (696)
..... ......||..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 21110 111246899999999999888999999999999999999999999765
Q ss_pred CccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 005450 556 HPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ----MSLVLK 619 (696)
Q Consensus 556 ~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPS----m~eVL~ 619 (696)
........+. ... . .+.. .......+..++.+||+.+|++||+ +.++++
T Consensus 236 ~~~~~~~~~~-~~~------~------~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDETFSNIL-KKE------V------TFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHHHHHHHh-cCC------c------cCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 4322111110 000 0 0000 1112345666777799999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=306.36 Aligned_cols=262 Identities=21% Similarity=0.264 Sum_probs=193.9
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+|...+.||+|+||.||+|... +|+.+|+|.++... .....+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999864 68999999987532 2335677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++ +|.+++.... ..+++..+..++.||++||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CDQ-DLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 975 8888776432 258999999999999999999999 899999999999999999999999999998654332
Q ss_pred CCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccc-hhhHHhhhccccccC---ccccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKG-QESLVMWAKPILSSG---KVTQL 579 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~-~~~lv~~~~~~~~~g---~l~~l 579 (696)
.. .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||....... ....+.......... .+...
T Consensus 154 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 21 1234678999999998764 47899999999999999999999864433211 111110000000000 00000
Q ss_pred cCc----ccCCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 580 LDP----ALGNNY-----DYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 580 lD~----~L~~~~-----~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+. ...... .......+..++..||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 000000 0111234556677899999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=306.77 Aligned_cols=262 Identities=23% Similarity=0.294 Sum_probs=198.6
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~------~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
+|...+.||+|+||.||+|... +|+.||||.++... .....+..|++++..++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999864 68999999997543 2345677899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+ ++|+|+||||+|||++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 889999997543 258999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccccc------C
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS------G 574 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~------g 574 (696)
..... .....+++.|+|||++.+ ..++.++|||||||++|||++|.+||...........+......... .
T Consensus 154 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 154 SPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 43221 122457889999998864 45788999999999999999998888765432211111000000000 0
Q ss_pred ccccccCcccCCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 575 KVTQLLDPALGNNY-----DYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 575 ~l~~llD~~L~~~~-----~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+............ .......+..++..||+.+|.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000000001 1112345667778899999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=292.11 Aligned_cols=249 Identities=31% Similarity=0.468 Sum_probs=203.1
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
+|...+.||+|++|.||++... +++.+++|++.... .....+.+|+++++.++|||++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999975 78999999998754 366789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+++|.+++.... ..+++..+..++.+++.||.|||. .+++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999987643 358999999999999999999999 8999999999999999999999999999987665432
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~ 586 (696)
.....|+..|+|||++....++.++||||||+++|+|++|+.||............. . .....+.++
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~-----~~~~~~~~~---- 220 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA--T-----NGPPGLRNP---- 220 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH--h-----cCCCCcCcc----
Confidence 233578999999999988889999999999999999999999997654322111111 0 001111110
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 587 ~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.. ....+..++..|++.+|.+|||+.++++.
T Consensus 221 -~~--~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 -EK--WSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -cc--cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 12345566677999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=305.59 Aligned_cols=265 Identities=21% Similarity=0.255 Sum_probs=195.4
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCc-----
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNN----- 417 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~----- 417 (696)
++|.+.+.||+|+||.||+|... +|+.||+|.++... .....+.+|+.++..+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46899999999999999999864 68999999886532 23457888999999995 6999999999987665
Q ss_pred eEEEEeecCCCChhhhhhcCCCC-CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC-CCceEEeecC
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFG 495 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~-~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~-~~~vKL~DFG 495 (696)
.++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 898888654332 3468999999999999999999999 89999999999999998 8899999999
Q ss_pred ccccccCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhh-HHhhhc-cccc
Q 005450 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES-LVMWAK-PILS 572 (696)
Q Consensus 496 lA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~-lv~~~~-~~~~ 572 (696)
++......... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......... ...... +...
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99865432221 122357889999998865 457899999999999999999999997654322111 111000 0000
Q ss_pred ----cCc------cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 573 ----SGK------VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 573 ----~g~------l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
... ........+. .........+..++..||+.+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 0000000000 000112234566777899999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.03 Aligned_cols=203 Identities=25% Similarity=0.425 Sum_probs=171.0
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++++|.+.+.||+|+||.||+|.. .+|+.||+|++.... .....+.+|+.+++.++|+||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 467899999999999999999985 468899999987532 22346778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+. ++|.+++.... ..+.+..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 67777765432 246788899999999999999999 8999999999999999999999999999975433
Q ss_pred CCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~ 557 (696)
... ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.....
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 156 PSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred CCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 221 11234578999999998754 578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=308.98 Aligned_cols=205 Identities=27% Similarity=0.421 Sum_probs=171.4
Q ss_pred CceeeeeeeccCceEEEEEEeC---CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceE
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP---DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLL 419 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~---~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~--~~~~ 419 (696)
.|.+.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++..++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999964 47899999998632 3346678899999999999999999999988 7899
Q ss_pred EEEeecCCCChhhhhhcCCCC-CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC----CCceEEeec
Q 005450 420 LVYDFLSRGSLEENLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD----DFEPQLSDF 494 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~-~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~----~~~vKL~DF 494 (696)
+||||+++ +|.+++...... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 777766533322 2368899999999999999999999 89999999999999999 899999999
Q ss_pred CccccccCCCC-CcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCc
Q 005450 495 GLAKWASTSSS-HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 495 GlA~~~~~~~~-~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~ 557 (696)
|++........ ........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99987654332 1122335789999999988754 578999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=306.05 Aligned_cols=266 Identities=24% Similarity=0.326 Sum_probs=196.1
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC------
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 416 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~------ 416 (696)
-++|.+.+.||+|+||.||+|... +++.||||.+... ......+.+|+.++++++||||++++++|....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999864 6899999988642 223345678999999999999999999987654
Q ss_pred --ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeec
Q 005450 417 --NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 494 (696)
Q Consensus 417 --~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DF 494 (696)
..++||||+.+ +|.+.+.... ..+++.+++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcC
Confidence 35999999965 8888876443 258999999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCC--cccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccc
Q 005450 495 GLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 571 (696)
Q Consensus 495 GlA~~~~~~~~~--~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~ 571 (696)
|++......... .......++..|+|||++.+. .++.++||||||+++|||++|+.||...........+.......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999866543221 112235678899999988654 47889999999999999999999998765443322222211110
Q ss_pred ccCccccc-----cCc-ccCCCC---------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 572 SSGKVTQL-----LDP-ALGNNY---------DYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 572 ~~g~l~~l-----lD~-~L~~~~---------~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
........ .+. .+.... ..-....+..++..||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000 000 000000 0001123456777899999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=305.49 Aligned_cols=263 Identities=23% Similarity=0.316 Sum_probs=198.6
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLV 421 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~--~~~~LV 421 (696)
++|...+.||.|+||.||+|..+ +++.+++|.++... .....+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999975 68899999997532 2334577899999999999999999999877 899999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+.+ +|.+++..... .+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999975 99998875432 58999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHh----------hhc--
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM----------WAK-- 568 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~----------~~~-- 568 (696)
.... ......+++.|+|||++.+. .++.++||||||+++|+|++|+.||...........+. |..
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 4321 12234678999999998754 46889999999999999999999998654332211110 000
Q ss_pred --cccccCccccccCcccCCCCChH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 569 --PILSSGKVTQLLDPALGNNYDYD-QMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 569 --~~~~~g~l~~llD~~L~~~~~~~-e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+..............+...+... ....+..++..||+.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000011111111111112111 2334556677799999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=295.88 Aligned_cols=251 Identities=28% Similarity=0.451 Sum_probs=199.7
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+|...+.||+|+||.||++... +++.|++|.++... ...+.+..|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999864 78999999987643 3677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++.... .+++..+..++.+++.||.|||+ .+|+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999997542 47889999999999999999999 899999999999999999999999999998765433
Q ss_pred CCcc--cccccccCCCCCcceeccCC---CCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 505 SHIT--CTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 505 ~~~~--~~~~~GT~~YlAPE~l~~~~---~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
.... .....+++.|+|||++.... ++.++||||||+++|+|++|+.||......... ..... .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~--~~~~~----~~~---- 223 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI--MFHVG----AGH---- 223 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH--HHHHh----cCC----
Confidence 2211 11356889999999998766 889999999999999999999999754322111 11000 000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+.+.... .....+..++..|++.+|.+||++.+++.
T Consensus 224 -~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 -KPPIPDSL--QLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCccc--ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111 01233445667899999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=300.33 Aligned_cols=245 Identities=28% Similarity=0.452 Sum_probs=198.2
Q ss_pred ceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 350 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
|...+.||.|+||.||+|.. .++..+|+|++.... .....+.+|+.++..++||||+++++++..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 66788999999999999985 468899999986432 345678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+++|.+++... .+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 86 ~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 86 GGSALDLLEPG-----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999998642 47899999999999999999999 8999999999999999999999999999876644321
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~ 586 (696)
......|+..|+|||++....++.++|+|||||++|+|++|..||...........+. .+.. +.+..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------~~~~-----~~~~~ 223 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-------KNNP-----PTLEG 223 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-------cCCC-----CCCCc
Confidence 1123568899999999988889999999999999999999999997544322111110 0000 11111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 587 ~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.....+..++..|++.+|.+||++.++++.
T Consensus 224 ----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 ----NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 112345556677999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=299.57 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=200.4
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
+|.+.+.||.|+||.||++... +++.||+|++.... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999875 68999999997532 456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+.+++|.+++... ..+++..+..++.++++||.|||+ ++++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999999754 257899999999999999999999 89999999999999999999999999998866543
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
.. .....|+..|+|||++....++.++|+||||+++|+|++|+.||................. .. +.
T Consensus 154 ~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~--------~~ 220 (258)
T cd05578 154 TL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--AD--------VL 220 (258)
T ss_pred cc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--cc--------cc
Confidence 21 2235688999999999988899999999999999999999999987654322222111110 00 01
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQM--SLVL 618 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm--~eVL 618 (696)
. +......+..++..||+.+|.+||++ .+++
T Consensus 221 ~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 Y----PATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred C----cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1 11112455566677999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=294.53 Aligned_cols=252 Identities=23% Similarity=0.395 Sum_probs=205.2
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
++|.+.+.||+|++|.||++... +++.|++|++.... .....+.+|+.++..++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46889999999999999999876 59999999988654 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++... ..+++..++.++.|+++||.|||+. .+++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999754 2588999999999999999999972 679999999999999999999999999998765433
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
... ....++..|+|||.+....++.++|+||||+++|+|++|+.||..........+..+... ... +.+
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~-----~~~ 223 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD----GPP-----PSL 223 (264)
T ss_pred Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc----CCC-----CCC
Confidence 221 235688999999999988999999999999999999999999977653222222222110 000 111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.... ....+..++..|+..+|.+||++.++++
T Consensus 224 ~~~~---~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 224 PAEE---FSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred Cccc---CCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1110 2245666677799999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=300.10 Aligned_cols=262 Identities=24% Similarity=0.322 Sum_probs=199.4
Q ss_pred ceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceEEEEe
Q 005450 350 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVYD 423 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~--~~~~LV~E 423 (696)
|.+.+.||.|+||.||+|... +++.+|+|.+... ......+.+|+++++.++|||++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667899999999999999865 5889999999865 33456788999999999999999999999887 89999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+++ +|.+++.... ..+++..++.++.++++||.|||+ .+++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 8988886542 358999999999999999999999 89999999999999999999999999999877554
Q ss_pred CCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc---
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL--- 579 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l--- 579 (696)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..............+
T Consensus 154 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred Ccc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 321 1223467889999998764 45789999999999999999999999766543322211111000000000000
Q ss_pred -----------cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 580 -----------LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 580 -----------lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
....+...+.......+..++..|++.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000011111346677888899999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=330.61 Aligned_cols=201 Identities=21% Similarity=0.243 Sum_probs=161.1
Q ss_pred hcCceeeeeeeccCceEEEEEEeCC--CCEEE------------------EEEecCChhHHHHHHHHHHHHHhcCCccee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPD--GKELA------------------VKILKPSEDVIKEFVLEIEIITTLHHKNII 406 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~--g~~vA------------------VK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV 406 (696)
.++|.+.+.||+|+||+||++..+. +...+ .|.+.........+.+|+.+|..++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999986432 22222 222223334556788999999999999999
Q ss_pred EEeeEEEecCceEEEEeecCCCChhhhhhcCCCC-CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC
Q 005450 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 485 (696)
Q Consensus 407 ~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~-~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~ 485 (696)
++++++...+..|+|++++. ++|.+++...... ........+..|+.||+.||.|||+ ++||||||||+||||+.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECC
Confidence 99999999999999999985 4777776533211 1223456677899999999999999 89999999999999999
Q ss_pred CCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCC
Q 005450 486 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 552 (696)
Q Consensus 486 ~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf 552 (696)
++.+||+|||+++.+....... .....||+.|+|||++.+..++.++|||||||+||||++|..++
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999998765432221 12367999999999999999999999999999999999987543
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.68 Aligned_cols=246 Identities=26% Similarity=0.439 Sum_probs=197.9
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcC---CcceeEEeeEEEecCceEEEE
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~---HpnIV~l~g~~~~~~~~~LV~ 422 (696)
.|...+.||+|+||.||+|.. .+++.||+|.++.. ......+.+|+.+++.++ |||+++++++|..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999996 57899999998653 345567889999999997 999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++++|.+++... .+++..+..++.+++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999998643 47899999999999999999999 8999999999999999999999999999987755
Q ss_pred CCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
.... .....|+..|+|||++..+ .++.++|+|||||++|+|++|+.||......... .... .. ..
T Consensus 154 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~---~~~~----~~-----~~ 219 (277)
T cd06917 154 NSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM---MLIP----KS-----KP 219 (277)
T ss_pred Cccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh---hccc----cC-----CC
Confidence 4322 2235689999999998754 4688999999999999999999999765432211 1110 00 01
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+.+.... ....+..++..||+.+|.+||++.++++
T Consensus 220 ~~~~~~~---~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 220 PRLEDNG---YSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCccc---CCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111110 1234555667799999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=304.31 Aligned_cols=250 Identities=27% Similarity=0.383 Sum_probs=200.2
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
+++|.+.+.||+|.|+.||++.. ++|+.+|+|+++.. ....+++.+|++|-..|+||||++|.+.+.+....|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45788889999999999999874 68999999998743 346788999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC---CCceEEeecCcccc
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLAKW 499 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~---~~~vKL~DFGlA~~ 499 (696)
|+|.|++|..-|-.. ..+++..+-.++.||++||.|+|. ++|||||+||+|+||.. ..-+||+|||+|..
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999998766543 257888889999999999999999 99999999999999953 34589999999998
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
++.. .....++|||+|||||++....|+..+|||+.|||||-||.|++||.+.+......-++...--+..
T Consensus 163 l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~------ 233 (355)
T KOG0033|consen 163 VNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPS------ 233 (355)
T ss_pred eCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCC------
Confidence 8732 2334588999999999999999999999999999999999999999885543332222211111110
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+... .-.++.+.+ +..||..||.+|.|+.|.|+
T Consensus 234 --~~w~--~is~~Ak~L---vrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 234 --PEWD--TVTPEAKSL---IRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --cccC--cCCHHHHHH---HHHHhccChhhhccHHHHhC
Confidence 0110 012334444 44599999999999999886
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=301.09 Aligned_cols=253 Identities=27% Similarity=0.428 Sum_probs=200.3
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
++|...+.||.|+||.||++... +++.+|+|.+... ......+.+|++++++++||||+++++++...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999875 6899999998764 34557789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++.... ..+++..+..++.+++.||.|||+ ..+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999997653 358889999999999999999997 3679999999999999999999999999987654322
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
.. ...++..|+|||++.+..++.++||||||+++|+|++|+.||........ ............ ..+.+
T Consensus 156 ~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~------~~~~~ 224 (265)
T cd06605 156 AK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNE------PPPRL 224 (265)
T ss_pred hh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcC------CCCCC
Confidence 11 15688999999999988999999999999999999999999975432111 111111111100 00111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.... ....+..++..||..+|.+||++.+++.
T Consensus 225 ~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 225 PSGK---FSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred Chhh---cCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1110 1233556667799999999999999885
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=303.09 Aligned_cols=262 Identities=24% Similarity=0.323 Sum_probs=196.1
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+|...+.||.|++|.||+|... +|+.||||.++... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5888999999999999999864 68999999887532 2345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+. ++|..++..... ..+++..+..++.+++.||+|||+ ++++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 589988865432 358899999999999999999999 899999999999999999999999999987654332
Q ss_pred CCcccccccccCCCCCcceeccCC-CCCcccchhhHHHHHHHHhCCCCCCCCCccchh-hHHhhhccccc----------
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-SLVMWAKPILS---------- 572 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~-~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~-~lv~~~~~~~~---------- 572 (696)
.. .....+++.|+|||++.+.. ++.++||||||+++|+|+||+.||......... ....+......
T Consensus 155 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 RT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred cc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 21 22345789999999887644 688999999999999999999999765432211 11111100000
Q ss_pred --cCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 573 --SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 573 --~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
...........+.. ........+..++.+|++.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000000 00001123445677899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=299.82 Aligned_cols=264 Identities=22% Similarity=0.337 Sum_probs=198.4
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
+|...+.||.|++|.||+|... +|..||||.++... .....+.+|+.++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999975 68899999987542 33467788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++ +|.+++..... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 88888865432 2358999999999999999999999 8999999999999999999999999999976543221
Q ss_pred CcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC-cc
Q 005450 506 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD-PA 583 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD-~~ 583 (696)
......+|+.|++||++.+. .++.++|||||||++|+|++|+.||...........+..............+.+ +.
T Consensus 156 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 --TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred --ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 11234578999999988654 578899999999999999999999987654332211110000000000000000 00
Q ss_pred cCCC-----------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 584 LGNN-----------YDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 584 L~~~-----------~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+... ........+..++..|++.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 00111234556677799999999999999885
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=318.17 Aligned_cols=263 Identities=26% Similarity=0.424 Sum_probs=213.2
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
+...+.+.||+|-||.|.++....+..||||.++... ...++|..|+++|.+|+||||+.|+|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 4456788999999999999999888999999999754 45689999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++|+|.+++....... +.-..-..|+.||+.|++||.+ .++|||||.+.|+|++.++++||+|||+++-+-....
T Consensus 618 EnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred hcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 9999999998664321 3445566799999999999999 8999999999999999999999999999997666655
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh--CCCCCCCCCccchhhHHhhhccccccCcc-ccccCc
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPKGQESLVMWAKPILSSGKV-TQLLDP 582 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt--G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l-~~llD~ 582 (696)
+......+-...|||||.+..++++.++|||+||+++||+++ ...||..... +..+.....++..+.. .-+..|
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCcceeccCC
Confidence 555445566789999999999999999999999999999765 8889875433 2233333333332221 122222
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
.. ....+.++++.||+++-.+||+++++...|+.+.
T Consensus 770 ~~-------cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 770 PA-------CPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred Cc-------CcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 22 2245667888899999999999999999887543
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=313.06 Aligned_cols=266 Identities=23% Similarity=0.342 Sum_probs=197.2
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-----Cc
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 417 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~-----~~ 417 (696)
.+++|.+.+.||+|+||.||+|.. .+|+.||+|.+... ......+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 357899999999999999999985 47899999998742 23456788899999999999999999987644 35
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA 497 (696)
.++||||+.+ +|.+.+... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccce
Confidence 8999999975 888777532 48899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCc-ccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCc
Q 005450 498 KWASTSSSHI-TCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 575 (696)
Q Consensus 498 ~~~~~~~~~~-~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 575 (696)
.......... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||...+.......+...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 8664432211 1223578999999998754 4689999999999999999999999976543221111100000000001
Q ss_pred cccccCcc-------c--CCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 576 VTQLLDPA-------L--GNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 576 l~~llD~~-------L--~~~~~-----~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
+..+.+.. + ..... ......+..++..||+.+|.+|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11101000 0 00000 0112346677778999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=300.85 Aligned_cols=252 Identities=29% Similarity=0.440 Sum_probs=204.8
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
.+++|...+.||+|++|.||++..+ ++..+++|++.........+.+|++++..++|+||+++++++...+..++|+||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 4667888899999999999999976 688999999987655667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++.... ..+++..+..++.+++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 97 MDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred cCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999998654 358999999999999999999999 899999999999999999999999999987554332
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
. ......++..|+|||++.+..++.++||||||+++|+|++|+.||....+......+ .. .......++
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~--~~-----~~~~~~~~~-- 239 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI--TT-----KGIPPLKNP-- 239 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--Hh-----cCCCCCcch--
Confidence 1 112345889999999998888999999999999999999999999765443221111 10 001111110
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
......+..++..|++.+|.+||++.++++
T Consensus 240 -----~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 240 -----EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -----hhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 001134556677799999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=310.85 Aligned_cols=261 Identities=22% Similarity=0.281 Sum_probs=197.9
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec------
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------ 415 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~------ 415 (696)
..++|...+.||+|+||.||++.. .+|+.||+|++... ......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999986 47899999998642 34456788899999999999999999988643
Q ss_pred CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecC
Q 005450 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 495 (696)
Q Consensus 416 ~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFG 495 (696)
...++||||+.+ +|.+.+... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD------LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCc
Confidence 357999999965 888877532 7788899999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhh---------
Q 005450 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMW--------- 566 (696)
Q Consensus 496 lA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~--------- 566 (696)
++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9987654322 2235689999999999989999999999999999999999999976543221111100
Q ss_pred -----------hc--cccccCccccccCcccC----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 567 -----------AK--PILSSGKVTQLLDPALG----NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 567 -----------~~--~~~~~g~l~~llD~~L~----~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.. +......+.+++...+. ..........+..++..||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 00000011111111110 0001112344566777899999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.34 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=203.6
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+|.+.+.||+|+||.||++.. .+++.+++|.+... ......+.+|+.+++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 588899999999999999975 47889999998753 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++.........+++..++.++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999987644334568999999999999999999999 899999999999999999999999999998776542
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
. ....|++.|+|||++.+..++.++|+||||+++|+|++|+.||...........+. .+....+
T Consensus 158 ~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~~~----- 221 (256)
T cd08530 158 A----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-------RGKYPPI----- 221 (256)
T ss_pred c----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-------cCCCCCC-----
Confidence 1 22458899999999998889999999999999999999999997654322211111 1111111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.......+..++..|++.+|++||++.++++.
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 ----PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ----chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11223446667778999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.54 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=204.5
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~LV~ 422 (696)
...|.+++.||+||.+.||++...+.+.||+|.+.. ......-|.+|+..|.+|+ |.+||+|++|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 456889999999999999999988888898887754 3466788999999999996 999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||=+ .+|..+|.+.... ...| .++.+..|++.|+.++|. +||||.||||.|+|+-. |.+||+|||+|..+..
T Consensus 440 E~Gd-~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eccc-ccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 9864 4999999876543 2334 778899999999999999 99999999999999975 4899999999999988
Q ss_pred CCCCcccccccccCCCCCcceeccC-----------CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYG-----------KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 571 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~-----------~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~ 571 (696)
+.+.......+||+.||+||.+... +.+.++||||||||||+|+.|++||..... . |+
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~--~a---- 580 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----Q--IA---- 580 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----H--HH----
Confidence 8877777778999999999988533 356789999999999999999999964321 1 11
Q ss_pred ccCccccccCcccCCCCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 572 SSGKVTQLLDPALGNNYDY-DQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 572 ~~g~l~~llD~~L~~~~~~-~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
++..+.||.-.-+|+. ..-..++.++..||.+||.+||+..|+|+.
T Consensus 581 ---Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 ---KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 3344455533322221 111127777888999999999999999973
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=307.58 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=195.6
Q ss_pred ceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 350 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
|.....||+|+||.||++... +++.||+|.+.... ...+.+.+|+.++..++||||++++++|..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334457999999999999864 68999999986532 3456788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
++|..++... .+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 103 ~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~- 173 (297)
T cd06659 103 GALTDIVSQT-----RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK- 173 (297)
T ss_pred CCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-
Confidence 9999987542 47899999999999999999999 89999999999999999999999999998755433221
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~ 587 (696)
.....|++.|+|||++....++.++|||||||++|||++|+.||....+......+. .. . .+....
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~----~-----~~~~~~- 239 (297)
T cd06659 174 -RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR---DS----P-----PPKLKN- 239 (297)
T ss_pred -ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---cc----C-----CCCccc-
Confidence 123568999999999998889999999999999999999999997654322211111 00 0 000000
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 588 YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 588 ~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.......+..++..|++.+|.+||++.++++.
T Consensus 240 -~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 -AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00011234556667999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.17 Aligned_cols=261 Identities=23% Similarity=0.306 Sum_probs=196.7
Q ss_pred ceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 350 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
|.+.+.||.|++|.||+|... +|..||+|++.... .....+.+|+++++.++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999864 79999999987532 23457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
+ ++|.+++..... ..+++..+..++.|+++||.|||+ ++++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 689999875542 358999999999999999999999 8999999999999999999999999999976543221
Q ss_pred CcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhH-Hhhhcccc--------ccCc
Q 005450 506 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL-VMWAKPIL--------SSGK 575 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~l-v~~~~~~~--------~~g~ 575 (696)
. .....+++.|+|||++.+. .++.++||||||+++|+|++|+.||........... ..+..... ....
T Consensus 155 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 T--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred c--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 1 1224578999999988754 578899999999999999999999976543221111 11100000 0000
Q ss_pred ----cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 576 ----VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 576 ----l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.......... .........+..++.+|++.+|.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 001111245667788899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=298.08 Aligned_cols=259 Identities=24% Similarity=0.297 Sum_probs=192.3
Q ss_pred ceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEec--CceEEEEe
Q 005450 350 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLH-HKNIISLLGFCFED--NNLLLVYD 423 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~--~~~~LV~E 423 (696)
|.+.+.||+|+||.||++.. .+++.||+|+++.. ........+|+.++.++. |+||+++++++.+. +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56789999999999999985 46899999998753 222334557889999886 99999999999987 88999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+.+ +|.+.+.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++. +.+||+|||++......
T Consensus 81 ~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMDM-NLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCCc-cHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 9974 8888876533 258999999999999999999999 89999999999999999 99999999999866543
Q ss_pred CCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHH-hhhcc-------ccccC
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV-MWAKP-------ILSSG 574 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv-~~~~~-------~~~~g 574 (696)
... ....+++.|+|||++.. +.++.++|||||||++|||++|..||...+..+..... ..... .....
T Consensus 153 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 153 PPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred CCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence 222 23468899999997654 55788999999999999999999999765542211111 00000 00000
Q ss_pred ccccccCcc-cCCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 575 KVTQLLDPA-LGNN---YDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 575 ~l~~llD~~-L~~~---~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.......+. .... ........+..++..||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000 0000 00112356677778899999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=306.40 Aligned_cols=245 Identities=26% Similarity=0.392 Sum_probs=194.4
Q ss_pred eeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCC
Q 005450 352 AENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 429 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGs 429 (696)
....||+|+||.||++... ++..||||.+.... ...+.+.+|+.+++.++||||+++++.+..++..++||||+++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 3456999999999999864 68899999986533 445678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCccc
Q 005450 430 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 509 (696)
Q Consensus 430 L~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~ 509 (696)
|.+++... .+++..+..++.+|+.||.|||+ ++|+||||||+||++++++.++|+|||++......... .
T Consensus 106 L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~ 175 (292)
T cd06658 106 LTDIVTHT-----RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--R 175 (292)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--C
Confidence 99988532 47889999999999999999999 89999999999999999999999999998765433221 1
Q ss_pred ccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCC
Q 005450 510 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 589 (696)
Q Consensus 510 ~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~ 589 (696)
....|++.|+|||++....++.++||||||+++|||++|+.||...........+.. .+.+.+.....
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~------------~~~~~~~~~~~ 243 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD------------NLPPRVKDSHK 243 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------cCCCccccccc
Confidence 235689999999999888899999999999999999999999976543222111110 01111111111
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 590 YDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 590 ~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
....+..++..|+..+|.+|||+.++++.
T Consensus 244 --~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 --VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11233445556999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=302.26 Aligned_cols=245 Identities=27% Similarity=0.408 Sum_probs=194.7
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
..|...+.||+|+||+||+|... +|+.||+|.+... ....+.+.+|+++++.++||||++++++|...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999864 6899999988632 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+. |+|.+.+.... ..+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 57777765432 258999999999999999999999 8999999999999999999999999999876543
Q ss_pred CCCCcccccccccCCCCCcceec---cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~---~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
. ....|++.|+|||++. .+.++.++||||||+++|||++|+.||...........+.+. ..
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-------~~--- 231 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-------DS--- 231 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-------CC---
Confidence 2 2246889999999874 456889999999999999999999999765432211111100 00
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
+.+. .......+..++..||+.+|.+||++.+++..
T Consensus 232 --~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 --PTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0010 11122345666778999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=304.93 Aligned_cols=263 Identities=24% Similarity=0.327 Sum_probs=196.4
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~--~~~~L 420 (696)
.++|.+.+.||+|+||.||+|... +|+.||+|.++... .....+.+|+.++.+++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999864 68999999987432 2233567899999999999999999998764 46899
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999975 8888886543 358999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccc-
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ- 578 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~- 578 (696)
...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||....+......+..............
T Consensus 159 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 543211 122346888999998865 4578999999999999999999999987654433222211110000000000
Q ss_pred -------cc--C----cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 579 -------LL--D----PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 579 -------ll--D----~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+ . ..+...+. .....+..++..|++.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFP-WLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcccccccccccCCCCCchHHhcc-ccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 0 00000000 01233455677899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=290.43 Aligned_cols=250 Identities=28% Similarity=0.418 Sum_probs=204.0
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+|.+.+.||.|+||.||++... +++.+++|++.... .....+.+|+++++.++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888999999999999999964 68999999987542 4567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++.........+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997654333578999999999999999999999 899999999999999999999999999998765543
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
. ......|++.|+|||.+....++.++|+||||+++++|++|+.||............ .. ..... +
T Consensus 158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~--~~-----~~~~~-----~ 223 (258)
T cd08215 158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI--LK-----GQYPP-----I 223 (258)
T ss_pred c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHH--hc-----CCCCC-----C
Confidence 1 222357899999999998888999999999999999999999999765432211111 00 01111 1
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.. .....+..++.+||..+|.+||++.++++
T Consensus 224 ~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 PS----QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CC----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11 11234556677799999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=294.42 Aligned_cols=249 Identities=23% Similarity=0.375 Sum_probs=198.6
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+|...+.||+|+||.||++..+ +|..+|+|.+... ....+.+.+|+.+++.++|+||+++++++......++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999865 5889999998653 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc-eEEeecCccccccCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-PQLSDFGLAKWASTS 503 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~-vKL~DFGlA~~~~~~ 503 (696)
+++++|.+++..... ..+++..+..++.+++.||.|||+ .+++|+||||+||++++++. +||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999875432 357899999999999999999999 89999999999999998854 699999999866543
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
... .....|++.|+|||++....++.++|+||||+++|+|++|+.||........ +... . .+....+
T Consensus 156 ~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~---~-~~~~~~~---- 222 (257)
T cd08225 156 MEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL---VLKI---C-QGYFAPI---- 222 (257)
T ss_pred ccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HHHH---h-cccCCCC----
Confidence 221 1234689999999999888899999999999999999999999975433221 1100 0 0111111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.......+..++.+|++.+|++|||+.++++.
T Consensus 223 -----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 -----SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -----CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01111345566677999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=301.36 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=199.9
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
++|.+.+.||+|+||.||++.. .+++.||+|.+... ....+.+.+|+.+++.++||||++++++|...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788999999999999999985 46889999998643 344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++++|.+++... .+++..+..++.+++.||.|||+ ++++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998643 37889999999999999999999 8999999999999999999999999999876544322
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
. .....|++.|+|||++..+.++.++||||||+++|+|++|+.||...........+. ..+. +.+.
T Consensus 171 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~------~~~~------~~~~ 236 (293)
T cd06647 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TNGT------PELQ 236 (293)
T ss_pred c--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh------cCCC------CCCC
Confidence 1 123468999999999988889999999999999999999999997654322211100 0000 0000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
........+..++..||+.+|++||++.+++.+
T Consensus 237 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 --NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011112234556677999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=300.71 Aligned_cols=264 Identities=21% Similarity=0.297 Sum_probs=195.2
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
++|.+.+.||+|++|.||+|... +|+.||+|.+.... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999865 78999999986532 334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC-CCceEEeecCccccccC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWAST 502 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~-~~~vKL~DFGlA~~~~~ 502 (696)
|++ ++|.+.+..... ..+++..+..++.||+.||+|||+ ++++||||||+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 488887754332 246788888999999999999999 89999999999999985 55799999999976543
Q ss_pred CCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCc------
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK------ 575 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~------ 575 (696)
... ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+...........
T Consensus 156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 PVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred Ccc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 221 12234678999999988654 578999999999999999999999976543322111100000000000
Q ss_pred cccccC--cccCC----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 576 VTQLLD--PALGN----NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 576 l~~llD--~~L~~----~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+..... +.... .........+..++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 00000 000111234566777899999999999999986
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=301.06 Aligned_cols=254 Identities=25% Similarity=0.375 Sum_probs=192.1
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEee
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+|...+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999864 68999999987532 44567889999999996 99999999999999999999999
Q ss_pred cCCCChhhhhhcC-CCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 425 LSRGSLEENLHGN-KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 425 ~~gGsL~~~L~~~-~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
+.. +|.++.... ......+++..+..++.+++.||+|||+ ..+|+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 665543211 1112358999999999999999999996 148999999999999999999999999999765443
Q ss_pred CCCcccccccccCCCCCcceeccC---CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYG---KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~---~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
... ....|++.|+|||++... .++.++|||||||++|+|++|+.||....... ..+. .... +.
T Consensus 162 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~----~~~~-~~----- 227 (288)
T cd06616 162 IAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF-DQLT----QVVK-GD----- 227 (288)
T ss_pred Ccc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH-HHHh----hhcC-CC-----
Confidence 222 224689999999998766 68999999999999999999999997543110 1110 0000 00
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+.+...........+..++..||+.+|.+|||+.+|++
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011111111122335666777899999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=300.27 Aligned_cols=266 Identities=25% Similarity=0.341 Sum_probs=197.4
Q ss_pred HhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC----
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN---- 416 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~---- 416 (696)
...++|.+.+.||+|+||.||+|..+ +|+.||+|.++.. ......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999975 6889999999753 233456778999999999999999999987654
Q ss_pred ------ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceE
Q 005450 417 ------NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 490 (696)
Q Consensus 417 ------~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vK 490 (696)
..++|+||+++ +|...+.... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEE
Confidence 78999999986 7777776432 358999999999999999999999 8999999999999999999999
Q ss_pred EeecCccccccCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcc
Q 005450 491 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 569 (696)
Q Consensus 491 L~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~ 569 (696)
|+|||++......... ......++..|+|||++.. ..++.++|||||||++|+|++|+.||...........+.....
T Consensus 157 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 157 LADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235 (302)
T ss_pred eCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999876543321 1122456888999998764 3578899999999999999999999976543322211111100
Q ss_pred ccccCccccc--------cCc------ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 570 ILSSGKVTQL--------LDP------ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 570 ~~~~g~l~~l--------lD~------~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.........+ .++ .+...+. .....+..++..||+.+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000000 000 0000000 01234566777799999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=309.42 Aligned_cols=265 Identities=24% Similarity=0.316 Sum_probs=197.7
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecC---ChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec--Cce
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFED--NNL 418 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~--~~~ 418 (696)
..++|.+.+.||+|+||.||+|... +|+.+|+|.+.. .......+.+|+.++.++ +||||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888999999999999999865 688999998854 223445677899999999 999999999998653 368
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
++||||++ ++|..++... .+.+..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 4999888643 47889999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC---cccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC
Q 005450 499 WASTSSSH---ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 499 ~~~~~~~~---~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
........ .......||+.|+|||++.. ..++.++||||||+++|+|++|+.||...........+..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 66543321 12233568999999998764 467889999999999999999999997655433222111111100000
Q ss_pred c--------cccccCcccCC------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 575 K--------VTQLLDPALGN------NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 575 ~--------l~~llD~~L~~------~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. ...+++..... .........+..++..||+.+|.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 0 00001000000 000011245667777899999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=294.47 Aligned_cols=241 Identities=24% Similarity=0.314 Sum_probs=192.9
Q ss_pred eeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCCh
Q 005450 356 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 430 (696)
Q Consensus 356 LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL 430 (696)
||.|+||.||++... +++.+|+|++.... ...+.+.+|+.+++.++||||+++++++.+++..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 58999999987532 3456789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccc
Q 005450 431 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 510 (696)
Q Consensus 431 ~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~ 510 (696)
.+++.... .+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 99997643 37889999999999999999999 899999999999999999999999999998765532 112
Q ss_pred cccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCCh
Q 005450 511 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 590 (696)
Q Consensus 511 ~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~ 590 (696)
...|++.|+|||++....++.++|+||||+++|+|++|..||............... .... .. .++.
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~-----~~----~~~~ 217 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL----KGNG-----KL----EFPN 217 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh----ccCC-----CC----CCCc
Confidence 356899999999998888999999999999999999999999766531111111100 0000 00 0111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005450 591 DQMERMVLASILCIRRDPRARPQ-----MSLVLK 619 (696)
Q Consensus 591 ~e~~~l~~la~~Cl~~dP~~RPS-----m~eVL~ 619 (696)
.....+..++..||+.+|++||+ +.|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11234566777799999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=297.42 Aligned_cols=261 Identities=22% Similarity=0.290 Sum_probs=199.7
Q ss_pred ceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 350 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
|.+.+.||.|++|.||++... +++.+++|.++... .....+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999864 78899999987543 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++ +|.+++.... ..+++..++.++.+++.||.|||+ .+|+|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 76 8888886533 358999999999999999999999 8999999999999999999999999999987765431
Q ss_pred CcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC---
Q 005450 506 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD--- 581 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD--- 581 (696)
......++..|+|||.+... .++.++||||||+++|+|++|+.||...........+..............+.+
T Consensus 154 --~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 154 --PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred --cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 12235688899999998876 789999999999999999999999976654332211110000000000000000
Q ss_pred ---cccC-------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 582 ---PALG-------NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 582 ---~~L~-------~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..+. ..........+..++..||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0001122345667788899999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=331.33 Aligned_cols=267 Identities=24% Similarity=0.431 Sum_probs=220.8
Q ss_pred cccChHHHHHhhcC---------ceeeeeeeccCceEEEEEEeC----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc
Q 005450 336 RLFNYQDLLSATSN---------FLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTL 400 (696)
Q Consensus 336 ~~f~~~el~~~t~~---------f~~~~~LG~G~fG~Vyka~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L 400 (696)
..++|++-..+... ..+.++||.|.||.||+|.++ ....||||.++.. +....+|+.|..||.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 34555555444443 457899999999999999975 2356999999974 56678899999999999
Q ss_pred CCcceeEEeeEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccc
Q 005450 401 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 480 (696)
Q Consensus 401 ~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsN 480 (696)
.||||++|.|+.......+||.|||++|+|+.+|..+.. .|.+.+..-++.+|+.|+.||-+ +++|||||-..|
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARN 761 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARN 761 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhh
Confidence 999999999999999999999999999999999986653 59999999999999999999999 999999999999
Q ss_pred eeeCCCCceEEeecCccccccCCCCCcccccccc--cCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCc
Q 005450 481 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG--TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 557 (696)
Q Consensus 481 ILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~G--T~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~ 557 (696)
||++.+...|++|||+++.+.++. ...+++.-| ...|.|||.+.+.+++.++||||||||+||.++ |.+||-+...
T Consensus 762 ILVNsnLvCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 762 ILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred eeeccceEEEeccccceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence 999999999999999999886655 222232323 468999999999999999999999999999887 9999987765
Q ss_pred cchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 558 KGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 558 ~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
.+....++..- ++.. +.+-...+.++++.||++|-.+||++.+|+..|.+..
T Consensus 841 QdVIkaIe~gy------RLPp----------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 841 QDVIKAIEQGY------RLPP----------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred HHHHHHHHhcc------CCCC----------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 55444443221 2222 3334467888899999999999999999999997654
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.20 Aligned_cols=265 Identities=23% Similarity=0.331 Sum_probs=199.4
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEe----cCce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~----~~~~ 418 (696)
.++|.+.+.||+|+||.||++.. .+|+.||+|++.... .....+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 47899999999999999999985 468999999987532 345677889999999999999999998763 3568
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
++||||+. ++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999996 58999886543 48999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC--cccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccc---
Q 005450 499 WASTSSSH--ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS--- 572 (696)
Q Consensus 499 ~~~~~~~~--~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~--- 572 (696)
........ .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||...........+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 66443221 11123578999999998865 4689999999999999999999999977654333222111100000
Q ss_pred -----cCccccccCcc-cCCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 573 -----SGKVTQLLDPA-LGNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 573 -----~g~l~~llD~~-L~~~~~-----~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
...+....+.. ...... ......+..++..||+.+|++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00011111000 000111 112345667777899999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=287.67 Aligned_cols=246 Identities=29% Similarity=0.472 Sum_probs=200.9
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+|.+.+.||+|++|.||++... +++.|++|.+.... .....+.+|++++.+++|||++++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 67899999997654 4667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++.... .+++..+..++.+++.||.|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999987552 58999999999999999999999 899999999999999999999999999998776543
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
.. .....++..|+|||++....++.++||||||+++|+|++|+.||........ .+.... ... +.+
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~----~~~~~~---~~~-----~~~ 219 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA----LFRIVQ---DDH-----PPL 219 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHhc---cCC-----CCC
Confidence 32 2235689999999999888889999999999999999999999975442111 111100 000 011
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
... ....+..++..||..+|++||++.+++.
T Consensus 220 ~~~----~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 PEG----ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCC----CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111 1234456667799999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=297.86 Aligned_cols=246 Identities=26% Similarity=0.379 Sum_probs=197.0
Q ss_pred ceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 350 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
|...+.||+|++|.||++.. .+++.+++|.+.... ...+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44567999999999999985 478899999886433 3456688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
++|.+++... .+++..+..++.+++.||.|||+ ++|+||||+|+||+++.++.++|+|||++.........
T Consensus 101 ~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~- 171 (285)
T cd06648 101 GALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR- 171 (285)
T ss_pred CCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-
Confidence 9999998752 47889999999999999999999 89999999999999999999999999998755443221
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~ 587 (696)
.....|++.|+|||++....++.++||||||+++|+|++|+.||....+......+.... .+.+...
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~------------~~~~~~~ 238 (285)
T cd06648 172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL------------PPKLKNL 238 (285)
T ss_pred -cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC------------CCCCccc
Confidence 123568999999999988889999999999999999999999997654322221111110 0111100
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 588 YDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 588 ~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
......+..++.+||+.+|++||++.++++
T Consensus 239 --~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 --HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 001134566677799999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.37 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=208.8
Q ss_pred ceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCC
Q 005450 350 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 428 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gG 428 (696)
|.+.+.||+|+||.||++.+ ..|+.+|||.+... .+.+++..||.|+.++..|++|++||.|+....+++|||||..|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 55677899999999999986 47999999998754 45688999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcc
Q 005450 429 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 508 (696)
Q Consensus 429 sL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~ 508 (696)
++.+++.-..+ .+++.++-.|+...++||+|||. ..-||||||..||||+.+|.+||+|||.|..+.... ..
T Consensus 114 SiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AK 185 (502)
T KOG0574|consen 114 SISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AK 185 (502)
T ss_pred cHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH--Hh
Confidence 99999976543 68999999999999999999999 788999999999999999999999999998765532 23
Q ss_pred cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCC
Q 005450 509 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 588 (696)
Q Consensus 509 ~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~ 588 (696)
..++.|||.|||||++..-.|+.++||||||++..||..|++||.+.++......+-- -..|.+. .
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT------------~PPPTF~--K 251 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT------------KPPPTFK--K 251 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC------------CCCCCCC--C
Confidence 3468999999999999999999999999999999999999999988766432221110 0011111 1
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 589 DYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 589 ~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
+..+...+..++..||-.+|++|-|+.++++.
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 33445667777888999999999999998874
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=308.17 Aligned_cols=263 Identities=21% Similarity=0.311 Sum_probs=197.4
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-----Cc
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 417 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~-----~~ 417 (696)
.++|.+.+.||+|+||+||++.. .+++.||||.+... ......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46799999999999999999985 46899999998752 33456778899999999999999999988654 35
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA 497 (696)
.++||||+. ++|.+++.... .+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 899999996 68988886443 58899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcc-------
Q 005450 498 KWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP------- 569 (696)
Q Consensus 498 ~~~~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~------- 569 (696)
........ ......++..|+|||++.. ..++.++|||||||++|+|++|+.||...........+.....
T Consensus 156 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 86654321 1223568899999998864 4689999999999999999999999976543221111110000
Q ss_pred -ccccCcccccc-------CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 570 -ILSSGKVTQLL-------DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 570 -~~~~g~l~~ll-------D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
..........+ ++.+.. ........+..++.+||+.+|.+|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000000 000000 001122445677788999999999999999874
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=292.38 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=195.1
Q ss_pred ceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhc---CCcceeEEeeEEEecCc-----
Q 005450 350 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTL---HHKNIISLLGFCFEDNN----- 417 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L---~HpnIV~l~g~~~~~~~----- 417 (696)
|.+.+.||+|+||.||+|..+ +++.||+|.++... .....+.+|+.++.++ .||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677899999999999999976 48999999997432 2234566788877766 59999999999988776
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA 497 (696)
.+++|||+.+ +|.+++..... ..+++..++.++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 9999999975 89888865432 258999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc-
Q 005450 498 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV- 576 (696)
Q Consensus 498 ~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l- 576 (696)
......... ....++..|+|||++.+..++.++|||||||++|+|++|+.||...........+............
T Consensus 155 ~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 155 RIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence 876543221 2245788999999999889999999999999999999999999765543222111100000000000
Q ss_pred ------ccccCcccCC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 577 ------TQLLDPALGN---NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 577 ------~~llD~~L~~---~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
...+...... .........+..++..||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 001122345566777899999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=298.92 Aligned_cols=256 Identities=17% Similarity=0.191 Sum_probs=182.7
Q ss_pred hcCceeeeeeeccCceEEEEEEeCC----CCEEEEEEecCChhH------------HHHHHHHHHHHHhcCCcceeEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPSEDV------------IKEFVLEIEIITTLHHKNIISLLG 410 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~----g~~vAVK~l~~~~~~------------~~~~~~Ei~iL~~L~HpnIV~l~g 410 (696)
.++|.+.+.||+|+||.||+|...+ +..+|+|+....... ......+...+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999998654 456677765432211 011223344556678999999999
Q ss_pred EEEecC----ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC
Q 005450 411 FCFEDN----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 486 (696)
Q Consensus 411 ~~~~~~----~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~ 486 (696)
++.... ..+++++++.. ++.+.+.... .+++..+..|+.|++.||+|||+ ++|+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCC
Confidence 876543 34677887644 6666665432 25678889999999999999999 899999999999999999
Q ss_pred CceEEeecCccccccCCCCC-----cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchh
Q 005450 487 FEPQLSDFGLAKWASTSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 561 (696)
Q Consensus 487 ~~vKL~DFGlA~~~~~~~~~-----~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~ 561 (696)
+.++|+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 99999999999876432211 1112246999999999999999999999999999999999999999866332211
Q ss_pred -hH--HhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 562 -SL--VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 562 -~l--v~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
.. ..+...+ ..+++ ...... ..+..++..|++.+|++||++.++++.|.
T Consensus 243 ~~~~~~~~~~~~-~~~~~--------~~~~~~---~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCDFIKRL-HEGKI--------KIKNAN---KFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHHHHHHh-hhhhh--------ccCCCC---HHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 10 1111111 11111 001112 33455566699999999999999998763
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=292.79 Aligned_cols=245 Identities=24% Similarity=0.382 Sum_probs=195.2
Q ss_pred eeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCCh
Q 005450 356 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 430 (696)
Q Consensus 356 LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL 430 (696)
||.|+||.||++... +|+.+++|++.... .....+.+|++++.+++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 48999999997543 3556788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC-----
Q 005450 431 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----- 505 (696)
Q Consensus 431 ~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~----- 505 (696)
.+++.... .+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997543 58899999999999999999999 8999999999999999999999999999876543321
Q ss_pred -CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 506 -HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 506 -~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
........++..|+|||++....++.++||||||+++|+|++|..||...........+.. +... .
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~------~ 220 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN-------GKIE------W 220 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------CCcC------C
Confidence 1122235688999999999888899999999999999999999999976543322111110 0000 0
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
.. .......+..++..|++.+|.+|||+..+.+.|+
T Consensus 221 ~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 PE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred Cc--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00 0001234556667799999999999966666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=291.93 Aligned_cols=264 Identities=26% Similarity=0.403 Sum_probs=204.4
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEee
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+......||.|..|+|+++... +|..+|||.+..+ ....++++..++++...+ +|+||+.+|||..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3455678999999999999864 6899999999864 456778888999888776 89999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
|.. -++.++..... ++++..+-++...++.||.||.. .++|||||+||+|||+|+.|++||||||++.++.+..
T Consensus 173 Ms~-C~ekLlkrik~---piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 173 MST-CAEKLLKRIKG---PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHH-HHHHHHHHhcC---CchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 954 56666665443 58888888999999999999997 4789999999999999999999999999999887765
Q ss_pred CCcccccccccCCCCCcceecc---CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 505 SHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~---~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
.+.. ..|.+.|||||.+.- .+|+-++||||||++|+||.||+.||.+.+.+-.. +..... +. .
T Consensus 247 Ahtr---sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~-ltkvln------~e----P 312 (391)
T KOG0983|consen 247 AHTR---SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV-LTKVLN------EE----P 312 (391)
T ss_pred cccc---ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH-HHHHHh------cC----C
Confidence 5443 579999999999863 47899999999999999999999999875543221 111111 11 1
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh------hCCccchhhhhhh
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL------RGDADVTKWARLQ 634 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L------~~~~~~~~~~~~~ 634 (696)
|.|..... ....+..+...||++|+.+||...++++.- ....++..|....
T Consensus 313 P~L~~~~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF~dV 369 (391)
T KOG0983|consen 313 PLLPGHMG--FSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWFKDV 369 (391)
T ss_pred CCCCcccC--cCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHHHHH
Confidence 33332221 122344455569999999999999998732 1235666786543
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=294.90 Aligned_cols=248 Identities=27% Similarity=0.366 Sum_probs=200.9
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~LV 421 (696)
++|.+.+.||+|+||.||++... +|+.||+|++... ......+.+|++++.+++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47899999999999999999864 7899999998752 234567889999999999 99999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999997653 58999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCC------------------cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhH
Q 005450 502 TSSSH------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 563 (696)
Q Consensus 502 ~~~~~------------------~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~l 563 (696)
..... .......|+..|+|||++....++.++||||||+++++|++|+.||........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--- 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--- 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---
Confidence 43321 122235688999999999888899999999999999999999999976542111
Q ss_pred HhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 005450 564 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQM----SLVLK 619 (696)
Q Consensus 564 v~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm----~eVL~ 619 (696)
...... . .. .++......+..++..||+.+|.+||++ .++++
T Consensus 231 ~~~~~~------~----~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQKILK------L----EY----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHh------c----CC----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111000 0 00 0111112345667777999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=296.50 Aligned_cols=241 Identities=24% Similarity=0.322 Sum_probs=184.5
Q ss_pred eeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHH---hcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 355 LIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIIT---TLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 355 ~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~---~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
+||+|+||.||++... +++.+|+|.+.... .....+.+|..++. ..+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 68999999886532 12223444544433 3479999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 999999887543 48999999999999999999999 8999999999999999999999999999875543221
Q ss_pred cccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 507 ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
....||+.|+|||.+.. ..++.++|||||||++|+|++|+.||..........+..... ..+..+.
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~~~~~ 219 (279)
T cd05633 153 ---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----------TVNVELP 219 (279)
T ss_pred ---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh----------cCCcCCc
Confidence 22469999999998864 458999999999999999999999997654332221111100 0011111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 620 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~~ 620 (696)
..+ ...+..++..||+.||.+|| ++.+++++
T Consensus 220 ~~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 DSF----SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccc----CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 111 23445566679999999999 59988875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=300.11 Aligned_cols=244 Identities=27% Similarity=0.411 Sum_probs=193.5
Q ss_pred ceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 350 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
|...+.||+|+||.||++.. .++..+|+|.+... ......+.+|+++++.++|||++++++++..++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 56678899999999999985 46889999998642 24456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+.+ +|.+.+.... ..+++..+..++.+++.||.|||+ ++|+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~g-~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 975 7877775432 258899999999999999999999 89999999999999999999999999998754332
Q ss_pred CCcccccccccCCCCCcceec---cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 505 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~---~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
....|++.|+|||++. .+.++.++|||||||++|+|++|+.||.......... .+... + .
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~~~~~----~-~----- 241 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQN----E-S----- 241 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH--HHHhc----c-C-----
Confidence 2346899999999973 4578999999999999999999999997643222111 11110 0 0
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L 621 (696)
+... .......+..++..||+.+|.+||++.++++.+
T Consensus 242 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 242 PTLQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred CCCC---CccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 0000 111123455667789999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.75 Aligned_cols=243 Identities=25% Similarity=0.332 Sum_probs=189.9
Q ss_pred eeccCceEEEEEEe-CCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCCh
Q 005450 356 IGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 430 (696)
Q Consensus 356 LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL 430 (696)
||+|+||+||++.. .+|+.||+|.+.... .....+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999985 468999999986532 2345667899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccc
Q 005450 431 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 510 (696)
Q Consensus 431 ~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~ 510 (696)
.+++..... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~ 152 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IK 152 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cc
Confidence 999975543 358899999999999999999999 8999999999999999999999999999986654221 12
Q ss_pred cccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCCh
Q 005450 511 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 590 (696)
Q Consensus 511 ~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~ 590 (696)
...++..|+|||++.++.++.++||||||+++|+|++|+.||...........+... ... ....+...+
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~-------~~~~~~~~~-- 221 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR--TLE-------MAVEYPDKF-- 221 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc--ccc-------ccccCCccC--
Confidence 346888999999998888999999999999999999999999765432111111100 000 000011111
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005450 591 DQMERMVLASILCIRRDPRARP-----QMSLVLK 619 (696)
Q Consensus 591 ~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~ 619 (696)
...+..++..||+.+|.+|| ++.++++
T Consensus 222 --~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 --SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred --CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 22345566679999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=299.22 Aligned_cols=265 Identities=21% Similarity=0.292 Sum_probs=195.9
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecC------
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 416 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~------ 416 (696)
.++|.+.+.||.|+||.||+|... +++.+|+|++.... .....+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999864 68999999886422 22346778999999999999999999875433
Q ss_pred --ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeec
Q 005450 417 --NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 494 (696)
Q Consensus 417 --~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DF 494 (696)
.+++||||+.+ +|...+.... ..+++..+..++.|+++||.|||+ ++|+||||||+|||++.++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcC
Confidence 46999999975 7777776432 258999999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCC---------cccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHH
Q 005450 495 GLAKWASTSSSH---------ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 564 (696)
Q Consensus 495 GlA~~~~~~~~~---------~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv 564 (696)
|++......... ...+...|++.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999865443221 112235678999999987654 5889999999999999999999999765543322221
Q ss_pred hhhccccccC------cccccc--------CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 565 MWAKPILSSG------KVTQLL--------DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 565 ~~~~~~~~~g------~l~~ll--------D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.......... .+.... .+.+...+ ......+..++..|++.+|.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1110000000 001100 00000000 011245667788899999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=289.41 Aligned_cols=249 Identities=23% Similarity=0.360 Sum_probs=194.4
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC------hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--Cce
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 418 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~------~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~--~~~ 418 (696)
.+|.+.+.||+|+||.||+|.. .+++.||+|.+... ......+.+|++++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5789999999999999999986 46899999987532 23456788999999999999999999998764 458
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
+++|||+++++|.+++.... .+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999987543 37888999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCC-CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 499 WASTSSS-HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 499 ~~~~~~~-~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||........ ...... .+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~----~~--- 225 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--IFKIAT----QP--- 225 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--HHHHHc----CC---
Confidence 6543211 1111235689999999999988899999999999999999999999976432221 111110 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..+.+ +......+..++..|++ +|..||+..+++.
T Consensus 226 --~~~~~----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 --TKPML----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --CCCCC----CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 01111 11122345555566888 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.20 Aligned_cols=260 Identities=23% Similarity=0.308 Sum_probs=196.3
Q ss_pred ceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChh--HHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEeec
Q 005450 350 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED--VIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
|.+.+.||.|++|+||+|... +++.|+||.+..... ......+|+..+.+++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 667889999999999999975 578899999875422 2234557999999999 999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
+|+|.+.+.... ...+++..+..++.|++.+|.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 789999887554 2358999999999999999999999 8999999999999999999999999999986654322
Q ss_pred CcccccccccCCCCCcceec-cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHh-hhcc---------ccccC
Q 005450 506 HITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM-WAKP---------ILSSG 574 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~-~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~-~~~~---------~~~~g 574 (696)
. ....|+..|+|||++. ...++.++|+||||+++++|++|+.||............. +... .....
T Consensus 155 ~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 Y---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred c---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 2 2356889999999885 4458899999999999999999999997664432211110 0000 00000
Q ss_pred ccccccC----cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 575 KVTQLLD----PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 575 ~l~~llD----~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+...+. ..+..... .....+..++..|++.+|++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000 00000000 11345667788899999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=319.16 Aligned_cols=242 Identities=27% Similarity=0.409 Sum_probs=197.4
Q ss_pred ceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 350 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
|.-.+.||.|+||-||.|.+ .+...||||.+..+ .....+++.|+..|.+++|||++.+.|+|..+...+|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 44457799999999999985 46788999999754 34567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
|-| +-.+++.-.+ .++-+.++..|..+.+.||+|||+ ++.||||||..||||++.|.|||+|||.|-......
T Consensus 108 ClG-SAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn 180 (948)
T KOG0577|consen 108 CLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN 180 (948)
T ss_pred Hhc-cHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence 955 8888776433 368888999999999999999999 899999999999999999999999999997665532
Q ss_pred CCcccccccccCCCCCcceec---cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 505 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~---~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
.++|||.|||||++. .|.|+.|+||||||++..||...++|+.+.+... .+...+. .-.
T Consensus 181 ------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--ALYHIAQ----------Nes 242 (948)
T KOG0577|consen 181 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQ----------NES 242 (948)
T ss_pred ------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH--HHHHHHh----------cCC
Confidence 378999999999874 6789999999999999999999999987654321 2221111 111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
|.|. ..++...+..++-.||+.-|.+|||..++++
T Consensus 243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 2222 2334445556666799999999999999886
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.03 Aligned_cols=261 Identities=23% Similarity=0.308 Sum_probs=191.9
Q ss_pred eeeecc--CceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKG--GSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G--~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
..||+| +||+||++.. .+|+.||+|++... ....+.+.+|+.++..++||||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999986 47999999998753 23457788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999876532 248899999999999999999999 899999999999999999999999998654332211110
Q ss_pred -----ccccccccCCCCCcceeccC--CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccc-------c--
Q 005450 508 -----TCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI-------L-- 571 (696)
Q Consensus 508 -----~~~~~~GT~~YlAPE~l~~~--~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~-------~-- 571 (696)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||................+. .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 00112356779999998763 5789999999999999999999999765432211000000000 0
Q ss_pred ---------------------ccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 572 ---------------------SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 572 ---------------------~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..+......+..+...........+..++..||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000000111111111112223456777888899999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=306.51 Aligned_cols=257 Identities=22% Similarity=0.334 Sum_probs=192.3
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC------
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 416 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~------ 416 (696)
.++|...+.||+|+||.||+|.. .+|+.||+|.+... ......+.+|+.++..++||||++++++|....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 37899999999999999999985 47899999998642 233456889999999999999999999987543
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCc
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGl 496 (696)
..++|+||+.. +|..++. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46999999964 7766552 147889999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCc
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 575 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 575 (696)
++...... ....+|+.|+|||++.. ..++.++|||||||++|||++|+.||...........+....+... ..
T Consensus 164 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~ 237 (342)
T cd07879 164 ARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG-PE 237 (342)
T ss_pred CcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC-HH
Confidence 97653321 23467899999999876 4688999999999999999999999987543322222111110000 00
Q ss_pred ccccc---------C--cccC-CCC---ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 576 VTQLL---------D--PALG-NNY---DYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 576 l~~ll---------D--~~L~-~~~---~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+...+ . +... ... .......+..++..||+.||.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000 0 0000 000 0011234556777899999999999999985
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=289.39 Aligned_cols=243 Identities=22% Similarity=0.273 Sum_probs=187.3
Q ss_pred eeeeccCceEEEEEEe-CCCCEEEEEEecCCh----hHHHHHHHHHHH-HHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEI-ITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~i-L~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
+.||.|+||.||+|.. .+|+.||+|++.... .....+..|..+ ....+|+|++++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999986 468999999997543 122334455544 3455899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999997543 47889999999999999999999 8999999999999999999999999999875433
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~ 587 (696)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+... ... .....
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------~~~--~~~~~--- 216 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR-------RIN--WPEEV--- 216 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-------ccC--CCCcc---
Confidence 12356889999999998888999999999999999999999999765432211111100 000 00000
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 588 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 588 ~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
.......+..++..||+.+|++||++.++.++|.
T Consensus 217 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 -KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred -cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 0011234566777799999999998876666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.15 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=193.0
Q ss_pred cCceeeeeeeccCceEEEEEEeCC-CCEEEEEEecCCh--hHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEe
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~-g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~LV~E 423 (696)
++|.+.+.||+|+||.||+|..++ ++.||||+++... .....+..|+.++.... ||||++++++|......++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 568889999999999999999764 8999999997542 34456777888777775 9999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+.+ +|.+++.... ..+++..+..++.+++.||.|||+ ..+|+||||+|+||+++.++.+||+|||++......
T Consensus 95 ~~~~-~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMST-CLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccCc-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9854 7777765432 268999999999999999999996 148999999999999999999999999999766443
Q ss_pred CCCcccccccccCCCCCcceeccCC----CCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGK----VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~----~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
... ....++..|+|||++.... ++.++||||||+++|+|++|+.||...... ...+...... ....
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~-----~~~~- 238 (296)
T cd06618 169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQE-----EPPS- 238 (296)
T ss_pred Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHhcC-----CCCC-
Confidence 222 2245788999999987543 888999999999999999999999653221 1111111110 0000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
+.. .......+..++.+||+.+|.+||++.++++.
T Consensus 239 ----~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 ----LPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ----CCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 00112346667778999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=307.45 Aligned_cols=247 Identities=20% Similarity=0.331 Sum_probs=204.7
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
..-|.+++.||+|.|..|-+|++ =+|..||||++.+.+ -....+.+|++.|+.++|||||+||++......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 34577788999999999988874 489999999998754 34567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC-CCCceEEeecCcccccc
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd-~~~~vKL~DFGlA~~~~ 501 (696)
|+-++|+|+++|-+.. ..+++....+++.||+.|+.|+|+ ..+|||||||+|+.+- .-|-+||+|||++..+.
T Consensus 97 ELGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 9999999999997554 368999999999999999999999 8899999999999875 45789999999998776
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCC-cccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~-ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
.+.. -++.+|+..|.|||++.+..|+. ++||||||||||-|++|+.||+..+..+....++
T Consensus 171 PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm--------------- 232 (864)
T KOG4717|consen 171 PGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM--------------- 232 (864)
T ss_pred Ccch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh---------------
Confidence 6543 24578999999999999888875 7999999999999999999998766544333322
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
|-.. ..+.-....+-.++..||.+||.+|.+.+||..
T Consensus 233 DCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 233 DCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 2111 122333455666777799999999999999874
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.69 Aligned_cols=264 Identities=22% Similarity=0.271 Sum_probs=195.0
Q ss_pred hcCce-eeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhH---------------HHHHHHHHHHHHhcCCcceeEEe
Q 005450 347 TSNFL-AENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDV---------------IKEFVLEIEIITTLHHKNIISLL 409 (696)
Q Consensus 347 t~~f~-~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~---------------~~~~~~Ei~iL~~L~HpnIV~l~ 409 (696)
.++|. +.+.||.|+||+||+|... +++.||||.++..... ...+.+|++++..++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34565 4578999999999999864 6899999998753211 12477899999999999999999
Q ss_pred eEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCce
Q 005450 410 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 489 (696)
Q Consensus 410 g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~v 489 (696)
+++..++..++||||+. |+|.+++.... .+++.....++.|++.||.|||+ .+|+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCE
Confidence 99999999999999997 58999886432 47889999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCC------------CCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCC
Q 005450 490 QLSDFGLAKWASTSS------------SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDH 556 (696)
Q Consensus 490 KL~DFGlA~~~~~~~------------~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~ 556 (696)
+|+|||++....... .........+++.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999998665111 00111224578899999998754 47899999999999999999999998765
Q ss_pred ccchhhHHhhhccccccCcccccc------------CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 557 PKGQESLVMWAKPILSSGKVTQLL------------DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 557 ~~~~~~lv~~~~~~~~~g~l~~ll------------D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.......+...........+.... .+.+... .......+..++..|++.+|.+||++.+++.
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 433222111110000000000000 0000000 0111234556777899999999999999986
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=302.76 Aligned_cols=263 Identities=23% Similarity=0.302 Sum_probs=200.7
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC-----ceE
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLL 419 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~-----~~~ 419 (696)
+|.+.+.||.|+||.||++... +++.+|+|.+... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999975 5899999998753 344577899999999999999999999998765 789
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+||||+.+ +|.+++.... .+++..+..++.+++.||.|||+ ++|+||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~~-~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchhh-hHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999984 8988886543 58999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCC-cccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC---
Q 005450 500 ASTSSSH-ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG--- 574 (696)
Q Consensus 500 ~~~~~~~-~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g--- 574 (696)
....... .......+|+.|+|||++.+. .++.++||||||+++|+|++|+.||...........+..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 7654311 112235689999999999877 79999999999999999999999998765433222221111110000
Q ss_pred -----ccccccCc-ccCCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 575 -----KVTQLLDP-ALGNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 575 -----~l~~llD~-~L~~~~~-----~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.....+.. ......+ ......+..++..||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00000000 0000000 011234556777799999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=293.20 Aligned_cols=250 Identities=26% Similarity=0.361 Sum_probs=193.2
Q ss_pred CceeeeeeeccCceEEEEEEe----CCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCce
Q 005450 349 NFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~ 418 (696)
+|.+.+.||.|+||.||++.. .+|..||+|+++... ...+.+.+|+.++..+ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999985 478999999997532 2346678899999999 599999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
++||||+++++|.+++.... .+++..+..++.|+++||.|||+ .+++||||||+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999987543 47888999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCCCCCcceeccC--CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 499 WASTSSSHITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 499 ~~~~~~~~~~~~~~~GT~~YlAPE~l~~~--~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
......... .....|+..|+|||++..+ .++.++||||||+++|+|++|+.||........... .........
T Consensus 154 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~--~~~~~~~~~-- 228 (290)
T cd05613 154 EFHEDEVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAE--ISRRILKSE-- 228 (290)
T ss_pred ecccccccc-cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHH--HHHHhhccC--
Confidence 664432221 1235689999999998753 477899999999999999999999975432211111 111111100
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLK 619 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~ 619 (696)
+.. +......+..++..|++.+|.+|| ++.++++
T Consensus 229 -----~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 -----PPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -----CCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 001 111123445566679999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=321.00 Aligned_cols=251 Identities=27% Similarity=0.422 Sum_probs=200.9
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCC-EEEEEEecC-ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGK-ELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~-~vAVK~l~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
+.|.++..||-|+||.||+|..++.. ..|.|++.. ++...+.|+-||+||..+.||+||+|++.|+.++.+++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 35778899999999999999876543 457787764 4567889999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
.||-.+.++-.... .+.+.++..++.+++.||.|||+ ++|||||||..|||++-+|.++|+|||.+-.... .
T Consensus 112 ~GGAVDaimlEL~r---~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t 183 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR---VLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T 183 (1187)
T ss_pred CCchHhHHHHHhcc---ccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh--H
Confidence 99999998875543 68999999999999999999999 8999999999999999999999999999753322 1
Q ss_pred CcccccccccCCCCCcceec-----cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 506 HITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~-----~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
......+.|||+|||||+++ ...|+.++||||||++|.||..+.+|-..-++......+ ++ ....-++
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi--aK-----SePPTLl 256 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI--AK-----SEPPTLL 256 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH--hh-----cCCCccc
Confidence 22234589999999999875 447999999999999999999999998665543222111 11 1111222
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
. +..+...+-.+...||..||+.||++++++++
T Consensus 257 q-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 Q-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred C-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2 22233444556667999999999999999874
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=296.91 Aligned_cols=260 Identities=25% Similarity=0.298 Sum_probs=191.3
Q ss_pred eeeeeeccCceEEEEEEeCCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCC
Q 005450 352 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 428 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gG 428 (696)
+.+.+|.|+++.||++.. +++.||||+++.. ....+.+.+|+++++.++||||+++++++...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 334455556666666554 7999999998753 355678999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC---
Q 005450 429 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--- 505 (696)
Q Consensus 429 sL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~--- 505 (696)
+|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999975432 247889999999999999999999 8999999999999999999999999999875533211
Q ss_pred --CcccccccccCCCCCcceecc--CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhc----ccccc----
Q 005450 506 --HITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK----PILSS---- 573 (696)
Q Consensus 506 --~~~~~~~~GT~~YlAPE~l~~--~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~----~~~~~---- 573 (696)
........++..|+|||++.. ..++.++|||||||++|||++|+.||........ +..... ..+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchh
Confidence 111123457889999999875 3588999999999999999999999976443211 111000 00000
Q ss_pred ---Ccccc----ccCcccC----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 574 ---GKVTQ----LLDPALG----NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 574 ---g~l~~----llD~~L~----~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..... ..++... ..........+..++..||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000 0111100 0111122345666777899999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=293.72 Aligned_cols=254 Identities=26% Similarity=0.354 Sum_probs=197.4
Q ss_pred CceeeeeeeccCceEEEEEEe----CCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCce
Q 005450 349 NFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~ 418 (696)
+|.+.+.||+|++|.||++.. .+++.||||+++... ...+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478899999999999999874 367889999987532 2345688999999999 599999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
++||||+++++|.+++.... .+++..+..++.|+++||.|||+ .+++||||||+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999986532 47889999999999999999999 899999999999999999999999999988
Q ss_pred cccCCCCCcccccccccCCCCCcceeccCC--CCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 499 WASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 499 ~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~--~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
.......... ....|+..|+|||.+.+.. .+.++||||||+++|+|++|..||............ .......
T Consensus 154 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~--~~~~~~~--- 227 (288)
T cd05583 154 EFLAEEEERA-YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI--SRRILKS--- 227 (288)
T ss_pred cccccccccc-ccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH--HHHHHcc---
Confidence 6544322211 2256899999999987654 788999999999999999999999654322111110 1100000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.+.....++ ..+..++..||+.+|++|||+.++.+.|+.
T Consensus 228 ----~~~~~~~~~----~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 ----KPPFPKTMS----AEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ----CCCCCcccC----HHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 011111111 234456667999999999999988887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.68 Aligned_cols=268 Identities=23% Similarity=0.287 Sum_probs=199.8
Q ss_pred cChHHHHHhhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEE
Q 005450 338 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCF 413 (696)
Q Consensus 338 f~~~el~~~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~ 413 (696)
....++...+++|.+.+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|++++.+++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34556677889999999999999999999985 578999999987532 23466888999999999999999999886
Q ss_pred ec------CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC
Q 005450 414 ED------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 487 (696)
Q Consensus 414 ~~------~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~ 487 (696)
.. +..+++++++ +++|.+++... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCC
Confidence 43 3478888877 77998887532 47899999999999999999999 8999999999999999999
Q ss_pred ceEEeecCccccccCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhh
Q 005450 488 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMW 566 (696)
Q Consensus 488 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~ 566 (696)
.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..
T Consensus 158 ~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (345)
T cd07877 158 ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232 (345)
T ss_pred CEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999998765332 123568999999998865 4688899999999999999999999976543222111111
Q ss_pred hccccccCcc---------------ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 567 AKPILSSGKV---------------TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 567 ~~~~~~~g~l---------------~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.......... .......+.. ........+..++..|++.+|.+||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000 0000000000 000112345677778999999999999998863
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.35 Aligned_cols=208 Identities=28% Similarity=0.384 Sum_probs=182.2
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|...++||+|.||.|.+++. .+|+.||+|++++. ++....-..|-++|...+||++..|.-.|+..+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 5677889999999999999885 47999999999874 344555667999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+.||.|.-+|.+.+ .|++...+.+..+|+.||.|||+ ++||+||||.+|+|||.+|++||+|||+++..-.
T Consensus 248 eyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 248 EYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999999887643 58888899999999999999999 8999999999999999999999999999984332
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHH
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 564 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv 564 (696)
...+..+++|||.|+|||++....|...+|+|.+|||+|||++|+.||...+......++
T Consensus 321 --~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI 380 (516)
T KOG0690|consen 321 --YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI 380 (516)
T ss_pred --ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH
Confidence 223445699999999999999999999999999999999999999999877655444444
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=317.84 Aligned_cols=245 Identities=26% Similarity=0.371 Sum_probs=198.3
Q ss_pred eeeeccCceEEEEEEeCC-CCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCChh
Q 005450 354 NLIGKGGSSQVYKGCLPD-GKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 431 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~-g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL~ 431 (696)
-+||+|.||+||-|++.+ ...+|||-+... ....+-+..||.+.++|+|.|||+++|.|.+++.+-|.||.++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 479999999999999755 457899988753 355677889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC-CCCceEEeecCccccccCCCCCcccc
Q 005450 432 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCT 510 (696)
Q Consensus 432 ~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd-~~~~vKL~DFGlA~~~~~~~~~~~~~ 510 (696)
.+|...- .+..-.+.+.-.+..||++||.|||. +.|||||||-+|+|++ -.|.+||+|||-++.+...... ..
T Consensus 661 sLLrskW-GPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~--TE 734 (1226)
T KOG4279|consen 661 SLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC--TE 734 (1226)
T ss_pred HHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCcc--cc
Confidence 9997432 22233788889999999999999999 8899999999999995 5789999999999988664433 23
Q ss_pred cccccCCCCCcceeccC--CCCCcccchhhHHHHHHHHhCCCCCCCCCcc-chhhHHhhhccccccCccccccCcccCCC
Q 005450 511 DVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPK-GQESLVMWAKPILSSGKVTQLLDPALGNN 587 (696)
Q Consensus 511 ~~~GT~~YlAPE~l~~~--~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~-~~~~lv~~~~~~~~~g~l~~llD~~L~~~ 587 (696)
++.||..|||||++..| .|..++|||||||++.||.||++||..-... .....+...+ ....
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK---------------vHP~ 799 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK---------------VHPP 799 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee---------------cCCC
Confidence 57899999999999876 5889999999999999999999999653321 1111111100 0122
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 588 YDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 588 ~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
++.+.......+++.|+.++|.+||++.++|+
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 34445556666788899999999999999986
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=301.68 Aligned_cols=263 Identities=22% Similarity=0.327 Sum_probs=197.1
Q ss_pred HHHHhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe-cC
Q 005450 342 DLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DN 416 (696)
Q Consensus 342 el~~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~-~~ 416 (696)
++..++++|.+.+.||.|+||.||++... +++.||+|++... ....+.+.+|++++..++||||++++++|.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34557889999999999999999999854 7899999987542 2345678899999999999999999999875 56
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCc
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGl 496 (696)
..++||||+ +++|.+++... .+++..+..++.|+++||.|||+ ++|+||||||+|||++.++.++|+|||+
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccc
Confidence 789999998 56898888642 36788888999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhH-Hhhh-------
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL-VMWA------- 567 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~l-v~~~------- 567 (696)
+....... ....++..|+|||++.+ ..++.++||||||+++|+|++|+.||........... ....
T Consensus 155 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 229 (328)
T cd07856 155 ARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229 (328)
T ss_pred ccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 87543321 22457889999998765 5689999999999999999999999976543221111 1100
Q ss_pred -ccccccCccccccCc-ccCCCCCh-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 568 -KPILSSGKVTQLLDP-ALGNNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 568 -~~~~~~g~l~~llD~-~L~~~~~~-----~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
...... ....++.. ......+. .....+..++..|++.+|++||++.+++.
T Consensus 230 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 230 INTICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred HHhccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 00000000 00001111 11245566677799999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=307.51 Aligned_cols=211 Identities=26% Similarity=0.343 Sum_probs=184.9
Q ss_pred hHHHHHhhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEe
Q 005450 340 YQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFE 414 (696)
Q Consensus 340 ~~el~~~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~ 414 (696)
++-.-...+.|..-++||+||||.||-+.. .+|+.||+|.+.+.. ......++|-.||.+++.++||.+--.|..
T Consensus 177 lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT 256 (591)
T KOG0986|consen 177 LELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET 256 (591)
T ss_pred HHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence 333334456789999999999999998874 579999999886432 334457789999999999999999999999
Q ss_pred cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeec
Q 005450 415 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 494 (696)
Q Consensus 415 ~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DF 494 (696)
.+.++||+..|.||+|.-+|...+. ..|++..+..++.+|+.||++||+ .+||+|||||+|||||+.|+++|+|+
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeecc
Confidence 9999999999999999999876654 469999999999999999999999 99999999999999999999999999
Q ss_pred CccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCcc
Q 005450 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 558 (696)
Q Consensus 495 GlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~ 558 (696)
|+|..+....... ..+||.||||||+++++.|+...|+|||||+||||+.|+.||......
T Consensus 332 GLAvei~~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK 392 (591)
T KOG0986|consen 332 GLAVEIPEGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK 392 (591)
T ss_pred ceEEecCCCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence 9999887765443 358999999999999999999999999999999999999999765443
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=289.32 Aligned_cols=249 Identities=20% Similarity=0.344 Sum_probs=193.6
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecC------ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP------SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~------~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
+|.+.+.||+|+||.||++... .+..+++|+++. .......+..|+.++..++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999864 345566666553 122344677899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++++|.+++.........+++..++.++.|++.||.|||+ .+++|+||||+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999987543334568999999999999999999999 89999999999999976 469999999998664
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
..... .....|++.|+|||++....++.++|+||||+++|+|++|..||....... ...... .+. .
T Consensus 157 ~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~~~~~~----~~~-----~ 222 (260)
T cd08222 157 GSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---VVLRIV----EGP-----T 222 (260)
T ss_pred CCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHH----cCC-----C
Confidence 43221 123568999999999988889999999999999999999999996543211 111110 011 1
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+.+ +......+..++..|++.+|++||++.++++
T Consensus 223 ~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 PSL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111 1112234556677899999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=289.63 Aligned_cols=240 Identities=25% Similarity=0.333 Sum_probs=184.3
Q ss_pred eeeccCceEEEEEEe-CCCCEEEEEEecCCh----hHHHHHHHHHH---HHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 355 LIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIE---IITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 355 ~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~---iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
+||+|+||.||++.. .+++.||+|++.... .....+..|.. ++....||||+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999986 468899999986532 11222344443 4444579999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
|++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 999999886432 58999999999999999999999 8899999999999999999999999999875543221
Q ss_pred cccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
....|+..|+|||++..+ .++.++|||||||++|+|++|+.||............ .... ...+.+.
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~---------~~~~~~~ 219 (278)
T cd05606 153 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTL---------TMAVELP 219 (278)
T ss_pred ---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HHhh---------ccCCCCC
Confidence 235699999999998754 6899999999999999999999999765332221111 0000 0011111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLK 619 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~ 619 (696)
... ...+..++..|+..+|.+|| ++.++++
T Consensus 220 ~~~----s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 220 DSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CcC----CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 111 23455566679999999999 9999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=312.96 Aligned_cols=256 Identities=23% Similarity=0.401 Sum_probs=208.7
Q ss_pred HhhcCceeeeeeeccCceEEEEEEeCC-CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~~~-g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.-..+......||-|-||.||.|.++. .-.||||.++......++|+.|..+|+.++|||+|+|+|+|..+..+|||+|
T Consensus 264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 334556778899999999999999764 5679999999888888999999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
||..|+|.++|....+ ..++-...+.++.||..|++||.. +++|||||-..|.|+.++..+|++||||++++..+
T Consensus 344 fM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred cccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 9999999999986543 245667788999999999999999 89999999999999999999999999999988764
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
..... ....-.+-|.|||-+.+..++.|+|||+|||+|||+.| |..||.+.+......+. ..
T Consensus 419 TYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL----------------Ek 481 (1157)
T KOG4278|consen 419 TYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL----------------EK 481 (1157)
T ss_pred ceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH----------------hc
Confidence 32211 11223567999999999999999999999999999999 99999765432222221 11
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
-..-+.+......+..++..||+.+|.+||++.|+-+.|+
T Consensus 482 gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 482 GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 1111112222345677777899999999999998877654
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=293.51 Aligned_cols=242 Identities=26% Similarity=0.388 Sum_probs=192.8
Q ss_pred eeeeccCceEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCChh
Q 005450 354 NLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 431 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL~ 431 (696)
..||+|+||.||++.. .+|+.||||.+.... .....+.+|+.+++.++|+||+++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5789999999999986 578999999886433 34567889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCccccc
Q 005450 432 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 511 (696)
Q Consensus 432 ~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~ 511 (696)
+++... .+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++......... ...
T Consensus 106 ~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~ 175 (292)
T cd06657 106 DIVTHT-----RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKS 175 (292)
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccc
Confidence 987532 47889999999999999999999 89999999999999999999999999998765443221 123
Q ss_pred ccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCChH
Q 005450 512 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 591 (696)
Q Consensus 512 ~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~ 591 (696)
..|++.|+|||++....++.++|+||||+++|+|++|..||................ .+.+... ..
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~------------~~~~~~~--~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------PPKLKNL--HK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC------------CcccCCc--cc
Confidence 568999999999988889999999999999999999999997644322211111100 0011000 00
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 592 QMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 592 e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
....+..++.+||+.+|.+||++.++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 1123445566799999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=301.80 Aligned_cols=260 Identities=22% Similarity=0.303 Sum_probs=195.0
Q ss_pred HhhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC----
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN---- 416 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~---- 416 (696)
...++|.+.+.||+|+||.||++.. .+|..||||++... ......+.+|+.+++.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3467899999999999999999985 47899999998642 234567889999999999999999999987654
Q ss_pred --ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeec
Q 005450 417 --NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 494 (696)
Q Consensus 417 --~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DF 494 (696)
..++||||+ +++|.+++... .+++..+..++.|+++||.|||+ .+|+||||||+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeec
Confidence 358999999 77998887532 47899999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccc---
Q 005450 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI--- 570 (696)
Q Consensus 495 GlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~--- 570 (696)
|++....... ....+++.|+|||++.. ..++.++|+||||+++|+|++|+.||...........+......
T Consensus 163 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 163 GLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9998654321 23467899999998875 45889999999999999999999999765432211111000000
Q ss_pred -----cccCc-------cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 571 -----LSSGK-------VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 571 -----~~~g~-------l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+.... +.......+. .........+..++..|++.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 0000000000 000011223566777899999999999999885
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=285.97 Aligned_cols=245 Identities=24% Similarity=0.272 Sum_probs=186.8
Q ss_pred HhhcCceeeeee--eccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEE
Q 005450 345 SATSNFLAENLI--GKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 345 ~~t~~f~~~~~L--G~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~L 420 (696)
...++|.+.+.+ |.|+||.||++.. .++..+|+|.+...... . .|+.....+ +||||++++++|...+..++
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--~--~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN--A--IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc--h--hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 334566666666 9999999999985 46889999998753211 1 122222222 69999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC-ceEEeecCcccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKW 499 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~-~vKL~DFGlA~~ 499 (696)
||||+++++|.+++.... .+++..+..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||++..
T Consensus 87 v~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 999999999999997543 58999999999999999999999 8899999999999999988 999999999876
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
..... ...|+..|+|||++.+..++.++||||||+++|+|++|+.||........ ....+..... ... ..
T Consensus 160 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~--~~~-~~ 229 (267)
T PHA03390 160 IGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQQ--KKL-PF 229 (267)
T ss_pred cCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhhc--ccC-Cc
Confidence 64322 24589999999999988999999999999999999999999975433221 1111111110 000 00
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLK 619 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPS-m~eVL~ 619 (696)
. . .....+..++..||+.+|.+||+ +.++++
T Consensus 230 ----~-~----~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 230 ----I-K----NVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----c-c----ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 0 11234555666799999999996 688874
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=298.27 Aligned_cols=262 Identities=21% Similarity=0.264 Sum_probs=191.3
Q ss_pred CceeeeeeeccCceEEEEEEeC-C--CCEEEEEEecCC---hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec----Cc
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-D--GKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED----NN 417 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~--g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~----~~ 417 (696)
+|.+.+.||+|+||.||++... . +..||+|.+... ....+.+.+|++++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999864 3 788999998742 23356788899999999 599999999976432 45
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA 497 (696)
.+++++|+. ++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788899886 58999886433 58899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC--cccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC
Q 005450 498 KWASTSSSH--ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 498 ~~~~~~~~~--~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
+........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 866543221 11123578999999998765 468999999999999999999999997654322111111100000000
Q ss_pred ccccccC---------------cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 575 KVTQLLD---------------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 575 ~l~~llD---------------~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+..+.+ ..+.. ........+..++..|++.+|.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 00000 00001234566777899999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.53 Aligned_cols=264 Identities=22% Similarity=0.334 Sum_probs=193.7
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEec---------
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFED--------- 415 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~--------- 415 (696)
..+|.+.+.||.|+||.||+|.. .+|+.||+|.+.... ...+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46899999999999999999986 468999999886543 4456788999999999999999999876543
Q ss_pred -----CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC-CCCce
Q 005450 416 -----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEP 489 (696)
Q Consensus 416 -----~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd-~~~~v 489 (696)
...++||||++ ++|.+++... .+++..++.++.||+.||.|||+ .+|+||||||+||+++ .++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceE
Confidence 35799999997 4898887532 47899999999999999999999 8999999999999997 45678
Q ss_pred EEeecCccccccCCCCCc-ccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhh
Q 005450 490 QLSDFGLAKWASTSSSHI-TCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 567 (696)
Q Consensus 490 KL~DFGlA~~~~~~~~~~-~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~ 567 (696)
||+|||++.......... ......|+..|+|||++.. ..++.++|||||||++|+|++|+.||....+..........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999998664322211 1122457889999998754 46888999999999999999999999766543322221111
Q ss_pred ccccccCccccccC---c-----ccCCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 568 KPILSSGKVTQLLD---P-----ALGNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 568 ~~~~~~g~l~~llD---~-----~L~~~~~-----~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+...........+ . ....... ......+..++..||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 11111100000000 0 0000000 011234556777899999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=314.71 Aligned_cols=247 Identities=25% Similarity=0.439 Sum_probs=195.3
Q ss_pred eeeeeccCceEEEEEEeC-CCCEEEEEEec-----CChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc--eEEEEee
Q 005450 353 ENLIGKGGSSQVYKGCLP-DGKELAVKILK-----PSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN--LLLVYDF 424 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~-----~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~--~~LV~Ey 424 (696)
..+||+|+|-+||+|.+. +|.+||--.++ ......++|..|+++|+.|+||||+++|.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 457999999999999974 57788754333 234556899999999999999999999999987655 8899999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC-CCceEEeecCccccccCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~-~~~vKL~DFGlA~~~~~~ 503 (696)
|..|+|..|+.+.+. .+...+..|+.||++||.|||+.. .+|||||||.+||||+. .|.+||+|+|||......
T Consensus 125 ~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999987764 677899999999999999999976 68999999999999975 489999999999988764
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
.. ..++|||.|||||++. ..|++.+||||||+.++||+|+..||..-....+ +......-.....+..
T Consensus 200 ~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ--IYKKV~SGiKP~sl~k----- 267 (632)
T KOG0584|consen 200 HA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ--IYKKVTSGIKPAALSK----- 267 (632)
T ss_pred cc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH--HHHHHHcCCCHHHhhc-----
Confidence 32 2378999999999987 7899999999999999999999999976543222 1111111111112222
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HhhCC
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK--LLRGD 624 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~--~L~~~ 624 (696)
....+++.++. .|+.. ..+|||+.|+|+ .|..+
T Consensus 268 ----V~dPevr~fIe---kCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 268 ----VKDPEVREFIE---KCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ----cCCHHHHHHHH---HHhcC-chhccCHHHHhhChhhccc
Confidence 23344455444 49999 999999999997 44443
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=292.97 Aligned_cols=245 Identities=29% Similarity=0.409 Sum_probs=192.9
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecC----ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~----~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.|...+.||+|+||.||+|... ++..+|+|.+.. ......++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999964 678899998863 23445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+. |+|.+.+.... ..+++..+..++.+++.||.|||+ .+++||||||+|||++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 58888775433 247889999999999999999999 89999999999999999999999999998765432
Q ss_pred CCCcccccccccCCCCCcceec---cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~---~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
....|++.|+|||++. .+.++.++|||||||++|+|++|+.||.......... .+.. +..
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~~-----~~~---- 231 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQ-----NES---- 231 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--HHhh-----cCC----
Confidence 2346889999999874 3568889999999999999999999986643221111 1111 000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L 621 (696)
+... .......+..++.+||+.+|.+||++.++++..
T Consensus 232 -~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 -PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -CCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0110 111223355667779999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=288.00 Aligned_cols=260 Identities=23% Similarity=0.317 Sum_probs=198.3
Q ss_pred ceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 350 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
|...+.||+|++|.||+|... +++.+|+|++... ....+.+..|+.+++.++|+||+++++++......++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999965 5899999999864 344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
+ ++|.+++.... ..+++..+..++.+++.||.|||+ .+|+||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 49999997643 258999999999999999999999 8999999999999999999999999999986654322
Q ss_pred CcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccc------------
Q 005450 506 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS------------ 572 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~------------ 572 (696)
. .....++..|+|||++... .++.++||||||+++|||++|+.||...........+........
T Consensus 154 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 T--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred c--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 1 1224567889999998766 789999999999999999999999977553222111100000000
Q ss_pred -cCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 573 -SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 573 -~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
...............+ ......+..++..||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000000000 011345677778899999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=330.74 Aligned_cols=252 Identities=27% Similarity=0.439 Sum_probs=190.9
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe---------
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--------- 414 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~--------- 414 (696)
.++|...++||+||||.||+++.+ ||+.||||.+... ......+.+|+.+|.+|+|||||+++..+.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 456778899999999999999965 8999999998765 5666788999999999999999999742110
Q ss_pred ---------------------------------------------------------------------c----------
Q 005450 415 ---------------------------------------------------------------------D---------- 415 (696)
Q Consensus 415 ---------------------------------------------------------------------~---------- 415 (696)
+
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 005450 416 -------------------------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464 (696)
Q Consensus 416 -------------------------------~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH 464 (696)
..+||-||||+...|.++++.+.... .-...++++.+|++||.|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHH
Confidence 12678899999878887777654211 35678899999999999999
Q ss_pred cCCCCceEeecccccceeeCCCCceEEeecCcccccc----------C------CCCCcccccccccCCCCCcceeccC-
Q 005450 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS----------T------SSSHITCTDVAGTFGYLAPEYFMYG- 527 (696)
Q Consensus 465 ~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~----------~------~~~~~~~~~~~GT~~YlAPE~l~~~- 527 (696)
+ +|||||||||.||+|++++.+||+|||+|+... . .......+..+||.-|+|||++...
T Consensus 715 ~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 D---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred h---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9 899999999999999999999999999998621 0 1111123457899999999999755
Q ss_pred --CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcc
Q 005450 528 --KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIR 605 (696)
Q Consensus 528 --~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~ 605 (696)
+|+.|+|+|||||||+||+. ||..... ....+. .++.+.+..- ..+..+++..-..++.++++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra~iL~----~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSME--RASILT----NLRKGSIPEP------ADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHH--HHHHHH----hcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence 49999999999999999985 5654321 111211 1223333332 12233444455667778999
Q ss_pred cCCCCCCCHHHHHH
Q 005450 606 RDPRARPQMSLVLK 619 (696)
Q Consensus 606 ~dP~~RPSm~eVL~ 619 (696)
.||.+|||+.|+|+
T Consensus 857 hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 857 HDPSKRPTATELLN 870 (1351)
T ss_pred CCCccCCCHHHHhh
Confidence 99999999999986
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=316.83 Aligned_cols=203 Identities=31% Similarity=0.438 Sum_probs=175.2
Q ss_pred CceeeeeeeccCceEEEEEE-eCCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec------CceE
Q 005450 349 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NNLL 419 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~-~~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~------~~~~ 419 (696)
.|...+.||+||||.||+|+ ..+|+.||||.++.. ....+...+|+++|++++|||||++++.-.+. ...+
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 35567889999999999999 568999999999873 35567888999999999999999999886543 4678
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC--CCC--ceEEeecC
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDF--EPQLSDFG 495 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd--~~~--~vKL~DFG 495 (696)
+|||||.||+|...|.... ....+++.+.+.++..+..||.|||+ ++|+||||||.||++- .+| ..||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 9999999999999997654 34579999999999999999999999 9999999999999983 334 36999999
Q ss_pred ccccccCCCCCcccccccccCCCCCcceec-cCCCCCcccchhhHHHHHHHHhCCCCCCCCCcc
Q 005450 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 558 (696)
Q Consensus 496 lA~~~~~~~~~~~~~~~~GT~~YlAPE~l~-~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~ 558 (696)
.|+-++++. .+..++||+.|++||++. .+.|+.-+|.|||||++|+.+||..||......
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 999887765 344589999999999998 488999999999999999999999999765433
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=291.26 Aligned_cols=243 Identities=27% Similarity=0.437 Sum_probs=191.5
Q ss_pred ceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 350 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
|...+.||+|+||.||+|.. .+|..|++|.+... ......+.+|+++++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55667899999999999986 46889999998642 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+. |+|.+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 57887776433 258899999999999999999999 8999999999999999999999999999864322
Q ss_pred CCcccccccccCCCCCcceec---cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 505 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~---~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
.....|+..|+|||++. .+.++.++|||||||++|+|++|..||.............. ........
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~ 242 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------NDSPTLQS 242 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-------cCCCCCCc
Confidence 12356899999999984 45688899999999999999999999976543222211110 01111111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
..++ ..+..++..||+.+|.+||++.++++.
T Consensus 243 ----~~~~----~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 ----NEWT----DSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----cccC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 234556667999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=301.72 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=196.8
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc----
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN---- 417 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~---- 417 (696)
..++|.+.+.||+|++|.||+|... +++.||+|++... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999875 6889999998753 2344667889999999999999999998876554
Q ss_pred --eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecC
Q 005450 418 --LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 495 (696)
Q Consensus 418 --~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFG 495 (696)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+ .+|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 5699998864 248999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccccc-
Q 005450 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS- 573 (696)
Q Consensus 496 lA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~- 573 (696)
++...... .....+|..|+|||.+.. ..++.++|||||||++|+|++|+.||...........+....+...+
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99865432 123468899999998865 36788999999999999999999999765443221111100000000
Q ss_pred -------CccccccCccc-CCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 574 -------GKVTQLLDPAL-GNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 574 -------g~l~~llD~~L-~~~~~-----~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.....++.... ..... ......+..++..|++.+|.+|||+.+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000000 00000 011345677788899999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=307.22 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=201.1
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
....|.+.+.||+|.|+.|.++.+ .++..||||++.++. .....+.+|+++|..++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 356799999999999999999985 469999999998643 3345588999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+.+|.++++|..... .....+..++.|+..|++|||+ +.|+|||||++||||+.+.++||+|||++.++.
T Consensus 134 ~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999987764 4557888999999999999999 899999999999999999999999999999887
Q ss_pred CCCCCcccccccccCCCCCcceeccCCC-CCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~-s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
..... .+.+|++.|.|||++++.+| .+.+|+||+|++||-|++|..||++....+...-+...+. ++
T Consensus 207 ~~~~l---qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~-----rI---- 274 (596)
T KOG0586|consen 207 YGLML---QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY-----RI---- 274 (596)
T ss_pred ccccc---cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee-----cc----
Confidence 54433 34789999999999998765 5689999999999999999999987654332211110000 01
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
++.....+-.++..+|-.+|.+|+++.++.+
T Consensus 275 --------p~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 275 --------PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred --------cceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 1111122333444578899999999998765
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=278.46 Aligned_cols=235 Identities=29% Similarity=0.352 Sum_probs=190.4
Q ss_pred eeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCCh
Q 005450 356 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 430 (696)
Q Consensus 356 LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL 430 (696)
||.|+||.||++... +++.+++|++.... .....+..|+.+++.++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999865 58999999987543 3456888999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccc
Q 005450 431 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 510 (696)
Q Consensus 431 ~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~ 510 (696)
.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~ 151 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTN 151 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--ccc
Confidence 99997553 47899999999999999999999 8999999999999999999999999999987654321 123
Q ss_pred cccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCCh
Q 005450 511 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 590 (696)
Q Consensus 511 ~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~ 590 (696)
...++..|+|||.+.+...+.++|+||||+++|+|++|+.||....... ....... +. ..+ +.
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~~----~~------~~~----~~ 214 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEKILK----DP------LRF----PE 214 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHhc----CC------CCC----CC
Confidence 3568999999999988888999999999999999999999996554311 1111100 00 001 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHH
Q 005450 591 DQMERMVLASILCIRRDPRARPQMSL 616 (696)
Q Consensus 591 ~e~~~l~~la~~Cl~~dP~~RPSm~e 616 (696)
.....+..++..|+..+|++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11234556677799999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=302.37 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=205.7
Q ss_pred HhhcCceeeeeeeccCceEEEEEEeC---CCC--EEEEEEecC--ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCLP---DGK--ELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 417 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~~---~g~--~vAVK~l~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~ 417 (696)
.........++||.|-||.||+|... .|+ .||||..+. ..+..+.|+.|.-+|+++.||||++|+|+|.+ ..
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 34445566789999999999999853 233 588999886 34668899999999999999999999999976 47
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA 497 (696)
.+||||.++-|.|..+|+.++. .++......++.||+.||.|||+ .++|||||-..|||+...--+||+|||++
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred eeEEEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchh
Confidence 8999999999999999987764 68888999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 498 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 498 ~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
+++......... ...-..-|||||.++...++.++|||.|||.+||++. |..||.+-...+... .+..|.-
T Consensus 539 R~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-------~iEnGeR 610 (974)
T KOG4257|consen 539 RYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-------HIENGER 610 (974)
T ss_pred hhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-------EecCCCC
Confidence 998876554432 2334567999999999999999999999999999988 999998754332211 1122211
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.. . +..-.-.+..++.+||..+|.+||++.++...|..
T Consensus 611 lP-----~----P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 611 LP-----C----PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred CC-----C----CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 11 1 11122345677888999999999999998877754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=319.01 Aligned_cols=144 Identities=31% Similarity=0.452 Sum_probs=131.2
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||.||+|... +++.||||+++.. ......+..|+.++..++||||+++++++...+..||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67999999999999999999975 6899999999753 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
||+.+++|.+++.... .+++..++.|+.||+.||+|||. ++||||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997543 47888999999999999999999 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=309.28 Aligned_cols=246 Identities=26% Similarity=0.416 Sum_probs=203.6
Q ss_pred eeeeeeccCceEEEEEEeC--CCC--EEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 352 AENLIGKGGSSQVYKGCLP--DGK--ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~--~g~--~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
..++||+|.||.|++|.+. +|+ .||||+++... .....|++|+.+|.+|+|||+++|||+..+ ....||||++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3577999999999999864 455 47999998754 357899999999999999999999999987 6889999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
+.|+|.+.|+... ...|.......++.|||.|+.||.. +++|||||-..||||-..-.+||+||||.+.+.....
T Consensus 193 plGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred ccchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999998733 3468888999999999999999999 9999999999999999888999999999998877655
Q ss_pred Ccccc-cccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 506 HITCT-DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 506 ~~~~~-~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
+..+. ...-.+.|+|||.+...+++.++|||+|||+||||+| |..||-+-........++ .. .+
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~-------------er 333 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AG-------------ER 333 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-cc-------------cc
Confidence 54332 2334668999999999999999999999999999999 899997755433222222 11 11
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
|. -+....+++..+++.||..+|.+|||+..|.+
T Consensus 334 Lp--RPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 334 LP--RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CC--CCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 11 13445678888899999999999999999864
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=328.75 Aligned_cols=221 Identities=25% Similarity=0.301 Sum_probs=192.9
Q ss_pred ChHHHHHhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEE
Q 005450 339 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCF 413 (696)
Q Consensus 339 ~~~el~~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~ 413 (696)
...++....++|.+.++||+|+||.|..++.+ +++.||+|++++.+ ....-|..|-.||..-+.+-|++++-.|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 35667777889999999999999999999864 68889999998733 34556888999999999999999999999
Q ss_pred ecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEee
Q 005450 414 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 493 (696)
Q Consensus 414 ~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~D 493 (696)
+++++|+|||||+||+|..++.... .+++..++.++.+|+.||+-||+ .|+|||||||+|||||..|++||+|
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeecc
Confidence 9999999999999999999997654 48889999999999999999999 9999999999999999999999999
Q ss_pred cCccccccCCCCCcccccccccCCCCCcceec----c-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhh
Q 005450 494 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFM----Y-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 567 (696)
Q Consensus 494 FGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~----~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~ 567 (696)
||.+..+..+.. ..+...+|||.|++||++. + +.|+..+|+||+||++|||+.|..||..+.-.+....++..
T Consensus 219 FGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h 296 (1317)
T KOG0612|consen 219 FGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH 296 (1317)
T ss_pred chhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence 999988875443 3445678999999999985 3 57999999999999999999999999887665555555543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-33 Score=306.45 Aligned_cols=239 Identities=27% Similarity=0.360 Sum_probs=190.1
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+..|.....+|.|+|+.|-++.. .+++..++|++.... .+..+|+.++... +||||+++.+.|.++.+.|+|||.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 45677777899999999988875 578899999998652 2334577666665 699999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee-CCCCceEEeecCccccccCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL-d~~~~vKL~DFGlA~~~~~~ 503 (696)
+.|+-|.+.+..... +. ..+..|+.+|+.|+.|||. +|||||||||+|||+ +..++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred ccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999888865432 33 7778899999999999999 999999999999999 68899999999999876654
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
+...+-|..|.|||++....|++.+||||||++||+||+|+.||...... ..+.. .+..+...+.
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~----~i~~~~~s~~---- 534 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT----RIQMPKFSEC---- 534 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH----hhcCCccccc----
Confidence 33456799999999999999999999999999999999999999865443 11111 1112222211
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
-.+..+. ++.+||+.||.+||+|.++..
T Consensus 535 -----vS~~AKd---Ll~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 535 -----VSDEAKD---LLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -----cCHHHHH---HHHHhccCChhhCcChhhhcc
Confidence 1233334 445699999999999999874
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-33 Score=286.36 Aligned_cols=207 Identities=28% Similarity=0.465 Sum_probs=174.4
Q ss_pred ChHHHHHhhcCceeeeeeeccCceEEEEEE-eCCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcC-CcceeEEeeEEEec
Q 005450 339 NYQDLLSATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE-DVIKEFVLEIEIITTLH-HKNIISLLGFCFED 415 (696)
Q Consensus 339 ~~~el~~~t~~f~~~~~LG~G~fG~Vyka~-~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~ 415 (696)
.++++...|+ ++||+|+|+.|-.+. +.+|.+||||++.+.. ....+..+|++++.+.+ |+||++|++||+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3666666664 579999999998876 6799999999997654 55678999999999996 99999999999999
Q ss_pred CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc---eEEe
Q 005450 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLS 492 (696)
Q Consensus 416 ~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~---vKL~ 492 (696)
...|||||.|.||+|...|++.+ .|++.++.++...|+.||+|||. +||.||||||+|||...... +|||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK----HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeee
Confidence 99999999999999999998765 58999999999999999999999 99999999999999976655 7999
Q ss_pred ecCccccccC--CCCC---cccccccccCCCCCcceec-----cCCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Q 005450 493 DFGLAKWAST--SSSH---ITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 493 DFGlA~~~~~--~~~~---~~~~~~~GT~~YlAPE~l~-----~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~ 557 (696)
||.+.--... +-+. ..-.+.+|+..|||||+.. ...|+.++|.||||||||-||+|.+||.+...
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 9988653221 1111 1123478999999999763 23688899999999999999999999987544
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-33 Score=290.92 Aligned_cols=243 Identities=24% Similarity=0.346 Sum_probs=197.2
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~ 419 (696)
...+|....+||+|+||.|.++..+ +.+.||||++++. .++.+--+.|-++|... +-|.++++..+|+.-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 3457888999999999999999865 4677999999863 44555566788888776 4689999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+||||+.||+|--.+++.++ |.+..+..++.+|+-||-+||+ +|||+||||..|||||.+|++||+|||+++.
T Consensus 427 FVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999999987764 7778888999999999999999 9999999999999999999999999999984
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
.-.. ..+..+++|||.|+|||++.+..|+..+|+|||||+||||+.|++||.+++..+.-..++-..-
T Consensus 500 ni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv---------- 567 (683)
T KOG0696|consen 500 NIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV---------- 567 (683)
T ss_pred cccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC----------
Confidence 3322 2344568999999999999999999999999999999999999999998876554433332110
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQM 614 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm 614 (696)
.++.......+.+....+...|.+|.-.
T Consensus 568 -------syPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 568 -------SYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred -------cCcccccHHHHHHHHHHhhcCCccccCC
Confidence 1222223344445555678899988643
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-33 Score=328.48 Aligned_cols=253 Identities=26% Similarity=0.367 Sum_probs=197.3
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
+-+|.....||.|.||.||.|.. .+|...|+|.++... ...+...+|+.++..++|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 44677788999999999999985 568889999887543 34566789999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
|||++|+|.+.+...+ ..++.....+..|++.|+.|||+ +|||||||||.||||+.+|.+|++|||.|.....
T Consensus 1314 EyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecC
Confidence 9999999999997543 35566667789999999999999 9999999999999999999999999999987765
Q ss_pred CC--CCcccccccccCCCCCcceeccCC---CCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 503 SS--SHITCTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 503 ~~--~~~~~~~~~GT~~YlAPE~l~~~~---~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
.. .........||+.|||||++.+.+ -.-+.||||||||.+||+||++||...+. +..+|+.-. .|...
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e~aIMy~V~---~gh~P 1460 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---EWAIMYHVA---AGHKP 1460 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---hhHHHhHHh---ccCCC
Confidence 42 111223468999999999997543 45589999999999999999999976543 233443221 12222
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L 621 (696)
++... . ..+-. .++-+||+.||.+|=++.|+++.-
T Consensus 1461 q~P~~-----l-s~~g~---dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1461 QIPER-----L-SSEGR---DFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred CCchh-----h-hHhHH---HHHHHHHhcCchhhhHHHHHHHhh
Confidence 22111 1 11112 233459999999998888777653
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=303.60 Aligned_cols=260 Identities=26% Similarity=0.426 Sum_probs=216.3
Q ss_pred hHHHHHhhcCceeeeeeeccCceEEEEEE-eCCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEe---
Q 005450 340 YQDLLSATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE--- 414 (696)
Q Consensus 340 ~~el~~~t~~f~~~~~LG~G~fG~Vyka~-~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~--- 414 (696)
++.+-.-++-|.+.+.||+|.+|.||++. .++++..|+|++....+..+++..|.+||+.+ .|||++.++|+|..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 33444456789999999999999999998 46799999999998887778888999999988 59999999999874
Q ss_pred --cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEe
Q 005450 415 --DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 492 (696)
Q Consensus 415 --~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~ 492 (696)
++.++||||||.+|+..+++.+.. ...+.|..+..|+.+++.||.+||. ..+||||||-.|||++.++.+||+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEe
Confidence 568999999999999999998766 4579999999999999999999999 889999999999999999999999
Q ss_pred ecCccccccCCCCCcccccccccCCCCCcceeccC-----CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhh
Q 005450 493 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 567 (696)
Q Consensus 493 DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~-----~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~ 567 (696)
|||++..+..+... ..+.+|||.|||||++... .|+..+|+||||++..||.-|.+|+.+..+.....++-
T Consensus 166 DFGvSaQldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip-- 241 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-- 241 (953)
T ss_pred eeeeeeeeeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC--
Confidence 99999877654433 3457899999999999643 47778999999999999999999998877643322211
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 568 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 568 ~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
++ ..|.|. -+..+.+.+..++..||..|-++||++.+++++
T Consensus 242 ----RN------PPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 242 ----RN------PPPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----CC------CCcccc--chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11 112222 144567778888888999999999999999873
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=289.65 Aligned_cols=260 Identities=27% Similarity=0.373 Sum_probs=194.3
Q ss_pred eeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHh--cCCcceeEEeeEEEecC----ceEEEEeec
Q 005450 352 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFEDN----NLLLVYDFL 425 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~--L~HpnIV~l~g~~~~~~----~~~LV~Ey~ 425 (696)
..++||+|.||.||+|.+. ++.||||++.. .....|..|-+|.+. ++|+||++++++-.... .++||++|.
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~--~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPE--QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCH--HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 3567999999999999984 49999999985 445778888888775 57999999999876555 899999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC------CCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG------SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~------~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+.|+|.++|..+ .++|....+|+.-+++||+|||+. ...+|+|||||++||||.+|++..|+|||+|..
T Consensus 291 ~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 291 PKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred cCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 999999999866 489999999999999999999973 246799999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCC-CC-----CcccchhhHHHHHHHHhCCCCCCC-CCccchhhHH--------
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGK-VN-----DKIDVYAFGVVLLELLTGRKPISN-DHPKGQESLV-------- 564 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~-~s-----~ksDVwSLGvvL~ELltG~~Pf~~-~~~~~~~~lv-------- 564 (696)
+..+........-+||..|||||++.+.- +. .+.||||+|.|||||++...-+.. ..+.-+.-..
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 88765555444578999999999987442 22 258999999999999997655431 1111110000
Q ss_pred ---hhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 565 ---MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 565 ---~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
++. -......-..+.|.... ...+..+...+-.||..||+.|.|+.=|-+++...
T Consensus 446 ~e~mq~-~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 446 LEEMQE-LVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred HHHHHH-HHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 000 00111111122222221 13344555556669999999999998887776543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=278.25 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=192.8
Q ss_pred hhcCceee-eeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEe----cCce
Q 005450 346 ATSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE----DNNL 418 (696)
Q Consensus 346 ~t~~f~~~-~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~----~~~~ 418 (696)
.|++|.+. ++||-|-.|.|-.+..+ +|+.+|+|++..+.. ..+|+++.-.. .|||||.++++|.. ...+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K----ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK----ARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH----HHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 46667655 57999999999988754 788999999986553 45677765555 59999999998853 3468
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC---CCceEEeecC
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFG 495 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~---~~~vKL~DFG 495 (696)
.+|||.|+||.|...++..+. ..|++.++-.|..||..|+.|||+ ++|.||||||+|+|... |..+||+|||
T Consensus 135 LiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred EeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccc
Confidence 899999999999999987664 469999999999999999999999 99999999999999964 4568999999
Q ss_pred ccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----chhhHHhhhcccc
Q 005450 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK----GQESLVMWAKPIL 571 (696)
Q Consensus 496 lA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~----~~~~lv~~~~~~~ 571 (696)
+|+...... ...+.+-||.|.|||++...+|+..+|+||+||++|-||+|.+||...... +....++....-+
T Consensus 210 FAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 210 FAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred cccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 999665422 233478999999999999999999999999999999999999999765432 1111221111111
Q ss_pred ccCccccccCcccCCCCChHHHHH-HHHHHHHhcccCCCCCCCHHHHHH
Q 005450 572 SSGKVTQLLDPALGNNYDYDQMER-MVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 572 ~~g~l~~llD~~L~~~~~~~e~~~-l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. +-.++++.. ...++...|..+|.+|.|+.+++.
T Consensus 287 P--------------~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 287 P--------------EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred C--------------ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1 112333333 233444578999999999999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=294.27 Aligned_cols=214 Identities=26% Similarity=0.379 Sum_probs=180.4
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
+-|..++.||-|+||.|.+++.- +...||+|.+++.+ ........|-.||.....+-||+||-.|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 35888999999999999999854 46678999998643 33345667999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc--
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA-- 500 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~-- 500 (696)
||++||++-.+|.+.+ .|.+..++.++.++..|+++.|. .|+|||||||+|||||.+|++||+||||+.-+
T Consensus 709 dYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred eccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeecccccccee
Confidence 9999999999998765 58899999999999999999999 99999999999999999999999999998522
Q ss_pred -------cCCCCC-------------------------------cccccccccCCCCCcceeccCCCCCcccchhhHHHH
Q 005450 501 -------STSSSH-------------------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 542 (696)
Q Consensus 501 -------~~~~~~-------------------------------~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL 542 (696)
..+... ......+||+.|+|||++....|+..+|+||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 111000 001125699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCccc-hhhHHhhhc
Q 005450 543 LELLTGRKPISNDHPKG-QESLVMWAK 568 (696)
Q Consensus 543 ~ELltG~~Pf~~~~~~~-~~~lv~~~~ 568 (696)
|||+.|+.||..+.+.+ +..++.|..
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw~~ 888 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINWRN 888 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeehhh
Confidence 99999999999887754 444555543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=271.27 Aligned_cols=220 Identities=21% Similarity=0.188 Sum_probs=174.3
Q ss_pred cCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCChhhhhhcC
Q 005450 359 GGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGN 437 (696)
Q Consensus 359 G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~ 437 (696)
|.+|.||++.. .+++.||+|.++... .+.+|...+....||||+++++++...+..++||||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 89999999986 478899999998653 2334555566667999999999999999999999999999999998654
Q ss_pred CCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccccccccCC
Q 005450 438 KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 517 (696)
Q Consensus 438 ~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~ 517 (696)
. .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++....... ....++..
T Consensus 80 ~----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 80 L----NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred c----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 3 48899999999999999999999 899999999999999999999999999886554321 12446778
Q ss_pred CCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHH
Q 005450 518 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMV 597 (696)
Q Consensus 518 YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~ 597 (696)
|+|||++....++.++||||||+++|||++|+.||......... . ....+...+ ...+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~-----~------------~~~~~~~~~----~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT-----H------------TTLNIPEWV----SEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccc-----c------------cccCCcccC----CHHHH
Confidence 99999998888999999999999999999999887543211000 0 000011111 12345
Q ss_pred HHHHHhcccCCCCCCCHH
Q 005450 598 LASILCIRRDPRARPQMS 615 (696)
Q Consensus 598 ~la~~Cl~~dP~~RPSm~ 615 (696)
.++..|++.||.+||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 566679999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-33 Score=282.11 Aligned_cols=253 Identities=26% Similarity=0.332 Sum_probs=193.2
Q ss_pred eeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeecC
Q 005450 351 LAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 351 ~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
+-...||.|+||+|+|-.. +.|+..|||+++.. +...+++..|.+...+- +.||||++||.++.++..++.||+|+
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 3457899999999999875 57999999999864 35667888898876555 68999999999999999999999996
Q ss_pred CCChhhhhhcC-CCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 427 RGSLEENLHGN-KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 427 gGsL~~~L~~~-~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
- +|+.+...- ......+++...-.|....+.||.||.. ...||||||||+||||+..|.+||||||++..+..+..
T Consensus 147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA 223 (361)
T KOG1006|consen 147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA 223 (361)
T ss_pred h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH
Confidence 5 777654311 1122358888888999999999999997 47899999999999999999999999999987665432
Q ss_pred CcccccccccCCCCCcceecc--CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 506 HITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~--~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
.+..+|...|||||.+.. ..|+-++||||||++|||+.||+.|+...+.. .+.+.+ ...|....+..+.
T Consensus 224 ---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-feql~~-----Vv~gdpp~l~~~~ 294 (361)
T KOG1006|consen 224 ---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-FEQLCQ-----VVIGDPPILLFDK 294 (361)
T ss_pred ---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-HHHHHH-----HHcCCCCeecCcc
Confidence 233679999999999863 35899999999999999999999999765431 111111 1112222222211
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
-.......|..++..|+.+|-..||+..++++
T Consensus 295 ----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 295 ----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ----cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 12223445666677799999999999998876
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=261.45 Aligned_cols=237 Identities=30% Similarity=0.407 Sum_probs=191.2
Q ss_pred CceEEEEEEeC-CCCEEEEEEecCChh-H-HHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCChhhhhhc
Q 005450 360 GSSQVYKGCLP-DGKELAVKILKPSED-V-IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 436 (696)
Q Consensus 360 ~fG~Vyka~~~-~g~~vAVK~l~~~~~-~-~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~ 436 (696)
+||.||+|... +|+.+++|++..... . .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 589999999976432 2 57899999999999999999999999999999999999999999999875
Q ss_pred CCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccccccccC
Q 005450 437 NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 516 (696)
Q Consensus 437 ~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~ 516 (696)
.. .+++..++.++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 43 27889999999999999999999 899999999999999999999999999998776543 222356889
Q ss_pred CCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHH
Q 005450 517 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERM 596 (696)
Q Consensus 517 ~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l 596 (696)
.|++||.+....++.++||||||+++++|++|..||...... .....+... +.... ..........+
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~~----~~~~~-------~~~~~~~~~~~ 217 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIGK----PKPPF-------PPPEWKISPEA 217 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhc----cCCCC-------ccccccCCHHH
Confidence 999999998888999999999999999999999999763221 111111110 00000 00000022456
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 005450 597 VLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 597 ~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 67778899999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=286.59 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=197.0
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh--------hHHHHHHHHHHHHHhcCCcceeEEeeEEE-ec
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--------DVIKEFVLEIEIITTLHHKNIISLLGFCF-ED 415 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~--------~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~-~~ 415 (696)
..++|....+||+|||+.||+|++ ...+.||||+-..++ ...+...+|.+|.+.|.||.||++|++|. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 345788999999999999999985 457889999875432 23456788999999999999999999986 55
Q ss_pred CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC---CCceEEe
Q 005450 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLS 492 (696)
Q Consensus 416 ~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~---~~~vKL~ 492 (696)
+.+|-|+|||+|.+|+-+|...+ .+++.+++.|+.||+.||.||.... .+|||-||||.||||.. -|.+||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence 67899999999999999998765 4899999999999999999999855 78999999999999954 4789999
Q ss_pred ecCccccccCCCCCc-----ccccccccCCCCCcceeccC----CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhH
Q 005450 493 DFGLAKWASTSSSHI-----TCTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 563 (696)
Q Consensus 493 DFGlA~~~~~~~~~~-----~~~~~~GT~~YlAPE~l~~~----~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~l 563 (696)
|||+++.+....... ......||.+|++||.|.-+ +.+.|+||||.|||+|..+.|+.||..+.... .+
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dI 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DI 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HH
Confidence 999999887654331 22347899999999998644 68889999999999999999999997654321 11
Q ss_pred HhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005450 564 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 618 (696)
Q Consensus 564 v~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL 618 (696)
.. ...++....+.-...|.. ..+.+. ++..||+.--++|....++.
T Consensus 694 Lq-eNTIlkAtEVqFP~KPvV-----sseAka---FIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 LQ-ENTILKATEVQFPPKPVV-----SSEAKA---FIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred Hh-hhchhcceeccCCCCCcc-----CHHHHH---HHHHHHHhhhhhhhhHHHHc
Confidence 11 111222111111111111 123333 34459999999998776654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=294.71 Aligned_cols=208 Identities=27% Similarity=0.363 Sum_probs=183.8
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCC-EEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGK-ELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~-~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
.++..+..||-||||.|=+...++.. .+|+|++++. ....+....|-+||...+.|+||++|-.|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45667788999999999998875543 4899998863 244567788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
|-|-||.|+..|...+ .|...+...++..+++|++|||+ ++||+|||||+|.||+.+|.+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999997665 58888999999999999999999 9999999999999999999999999999998877
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHh
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 565 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~ 565 (696)
+... -+++|||.|.|||++.....+.++|.||||+++|||++|.+||.+.++....+++.
T Consensus 573 g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL 632 (732)
T KOG0614|consen 573 GRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL 632 (732)
T ss_pred CCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 5443 34899999999999999999999999999999999999999999988766655543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=277.30 Aligned_cols=271 Identities=27% Similarity=0.385 Sum_probs=206.6
Q ss_pred HHHHhhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHh--cCCcceeEEeeEEEecC---
Q 005450 342 DLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFEDN--- 416 (696)
Q Consensus 342 el~~~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~--L~HpnIV~l~g~~~~~~--- 416 (696)
...+...+..+.+.||+|.||.||+|.+ .|..||||++...++ ..+.+|.+|++. |+|+||+.+++.-..++
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch--hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 3445667788999999999999999998 678899999986443 567788888886 48999999998765443
Q ss_pred -ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc-----CCCCceEeecccccceeeCCCCceE
Q 005450 417 -NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS-----GSAQRVIHRDVKSSNILLSDDFEPQ 490 (696)
Q Consensus 417 -~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~-----~~~~gIIHrDLKpsNILLd~~~~vK 490 (696)
.++||.+|.+.|+|+|+|... .++....++++.-+|.||+|||. ++...|.|||||+.|||+..++...
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 689999999999999999864 47888999999999999999996 3446799999999999999999999
Q ss_pred EeecCccccccCCCCC--cccccccccCCCCCcceeccCC----C--CCcccchhhHHHHHHHHhC----------CCCC
Q 005450 491 LSDFGLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMYGK----V--NDKIDVYAFGVVLLELLTG----------RKPI 552 (696)
Q Consensus 491 L~DFGlA~~~~~~~~~--~~~~~~~GT~~YlAPE~l~~~~----~--s~ksDVwSLGvvL~ELltG----------~~Pf 552 (696)
|+|+|||......... ......+||-.|||||++...- + -..+||||||.|+||+... +.||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 9999999877665332 2334578999999999986431 1 1258999999999998763 4566
Q ss_pred CCCCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 553 SNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 553 ~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
.+--+.+.....| +......++...++++. ...+.+..|..++..||..||..|-|+-.+-+.|....
T Consensus 437 yd~Vp~DPs~eeM--rkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 437 YDVVPSDPSFEEM--RKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred ccCCCCCCCHHHH--hcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 5433322221111 11122222222222222 24577888999999999999999999998888776543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=273.65 Aligned_cols=204 Identities=28% Similarity=0.425 Sum_probs=172.1
Q ss_pred cCceeeeeeeccCceEEEEEEeC---C--CCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEe-cCce
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP---D--GKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNL 418 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~---~--g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~-~~~~ 418 (696)
..|...+.||+|.||.||+|... + .+.+|+|.++.++ .......+|+.+++.++|||++.|..+|.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46788899999999999999632 2 3479999998653 234567899999999999999999999987 7789
Q ss_pred EEEEeecCCCChhhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC----CceEEee
Q 005450 419 LLVYDFLSRGSLEENLHGNK-KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD----FEPQLSD 493 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~-~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~----~~vKL~D 493 (696)
+|++||.+. +|..+|+-.. .....++-..+..|+.||+.|+.|||+ +=|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 8999886332 222467888999999999999999999 679999999999999877 8999999
Q ss_pred cCccccccCCCCCc-ccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCC
Q 005450 494 FGLAKWASTSSSHI-TCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISND 555 (696)
Q Consensus 494 FGlA~~~~~~~~~~-~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~ 555 (696)
||+|+.+...-... ....++-|++|.|||.+.+. .|+.+.|||+.|||+.||+|-.+.|.+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999887654433 33447789999999998865 6999999999999999999999888754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=296.38 Aligned_cols=262 Identities=18% Similarity=0.217 Sum_probs=168.9
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-C----CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeE------EEe
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-D----GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF------CFE 414 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~----g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~------~~~ 414 (696)
..++|.+.+.||+|+||.||+|.+. + +..||+|.+...... +.+..| .+....+.++..++.. +..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 4678999999999999999999964 4 689999998753321 111111 1122222222222211 245
Q ss_pred cCceEEEEeecCCCChhhhhhcCCCC----------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccc
Q 005450 415 DNNLLLVYDFLSRGSLEENLHGNKKD----------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 478 (696)
Q Consensus 415 ~~~~~LV~Ey~~gGsL~~~L~~~~~~----------------~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKp 478 (696)
+...++||||+.+++|.+++...... ........+..++.||+.||.|||+ ++|+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCH
Confidence 66899999999999999998743210 0011234466899999999999999 8999999999
Q ss_pred cceeeCC-CCceEEeecCccccccCCCCCcccccccccCCCCCcceeccC----------------------CCCCcccc
Q 005450 479 SNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG----------------------KVNDKIDV 535 (696)
Q Consensus 479 sNILLd~-~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~----------------------~~s~ksDV 535 (696)
+|||++. ++.+||+|||+|+.+...... ......||+.|+|||.+... .++.++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999986 578999999999866543322 22346799999999965322 24556799
Q ss_pred hhhHHHHHHHHhCCCCCCCCCccch-------hhHHhhhccccccCccccccCcccCCCCC--hHHHHHHHHHHHHhccc
Q 005450 536 YAFGVVLLELLTGRKPISNDHPKGQ-------ESLVMWAKPILSSGKVTQLLDPALGNNYD--YDQMERMVLASILCIRR 606 (696)
Q Consensus 536 wSLGvvL~ELltG~~Pf~~~~~~~~-------~~lv~~~~~~~~~g~l~~llD~~L~~~~~--~~e~~~l~~la~~Cl~~ 606 (696)
|||||+||||+++..|+......-. ..+..|...... ...+.+...+. .........++..||+.
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP------RASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc------ccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 9999999999997766532210000 001112111000 00000000000 00011223566779999
Q ss_pred CCCCCCCHHHHHHH
Q 005450 607 DPRARPQMSLVLKL 620 (696)
Q Consensus 607 dP~~RPSm~eVL~~ 620 (696)
||++|||+.+++++
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999974
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=285.63 Aligned_cols=197 Identities=28% Similarity=0.448 Sum_probs=171.4
Q ss_pred eeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 352 AENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
..++||.|-||+||-|.. ++|+.||||++.+- ......+.+|+.||.+++||.||.+...|+..+..++|||.+.|
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 368999999999999985 68999999998652 24447788999999999999999999999999999999999977
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC---CceEEeecCccccccCCC
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~---~~vKL~DFGlA~~~~~~~ 504 (696)
.-|+.+|...+ ..+++..-..++.||+.||.|||. ++|+|+||||+||||... -.+||||||+|+.+....
T Consensus 648 DMLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 648 DMLEMILSSEK---GRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hHHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 55555554333 368888889999999999999999 999999999999999643 469999999999998765
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~ 557 (696)
.. ..++|||.|+|||++....|+..-|+||.|||+|--|+|..||..+..
T Consensus 722 FR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd 771 (888)
T KOG4236|consen 722 FR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED 771 (888)
T ss_pred hh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc
Confidence 43 347899999999999999999999999999999999999999976543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=296.21 Aligned_cols=251 Identities=25% Similarity=0.424 Sum_probs=206.5
Q ss_pred ceeeeeeeccCceEEEEEEe-CCC----CEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 350 FLAENLIGKGGSSQVYKGCL-PDG----KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~-~~g----~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
....++||.|+||+||+|.+ +.| -+||+|++... .....+++.|+-+|.++.|||+++|+++|.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34568899999999999984 444 46899988754 355788999999999999999999999998764 89999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
+||+.|.|.++++..+. .+.....+.|..||++||.|||. ++++||||-..|||+..-..+||.|||+|+.+..
T Consensus 777 q~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999987543 67889999999999999999998 9999999999999999999999999999998887
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
...........-.+-|||=|.+....|+.++|||||||++||++| |..|+.+....+...+..... ++.+
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge------RLsq--- 921 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE------RLSQ--- 921 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc------cCCC---
Confidence 766555443444677999999999999999999999999999999 999998766544433332211 1111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
++.-..++..+++.||..|+..||+++++...+..
T Consensus 922 -------PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 922 -------PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred -------CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 22223456677788999999999999998877654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=298.91 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=200.7
Q ss_pred CceeeeeeeccCceEEEEEEeC----C----CCEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCc
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP----D----GKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 417 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~----~----g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~ 417 (696)
+..+.+.||+|.||.|++|... . ...||||.++... ...+.+..|+++|..+ +|+||+.++|+|...+.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 3345568999999999999742 1 4568999998643 5578899999999998 59999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCC---CCC---------CCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC
Q 005450 418 LLLVYDFLSRGSLEENLHGNK---KDP---------AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 485 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~---~~~---------~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~ 485 (696)
+++|+||+..|+|.++|...+ ... ..++....+.++.|||.|++||++ .++|||||-..|||+.+
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecC
Confidence 999999999999999998765 000 138889999999999999999999 88999999999999999
Q ss_pred CCceEEeecCccccccCCCCCcccccccc--cCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhh
Q 005450 486 DFEPQLSDFGLAKWASTSSSHITCTDVAG--TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 562 (696)
Q Consensus 486 ~~~vKL~DFGlA~~~~~~~~~~~~~~~~G--T~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~ 562 (696)
+..+||+|||+|+.......... ..-.| ...|||||.+....|+.|+|||||||+||||+| |..||.+-.. ...
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~~~ 530 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--TEE 530 (609)
T ss_pred CCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--HHH
Confidence 99999999999986555433321 11122 235999999999999999999999999999999 9999976221 111
Q ss_pred HHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 563 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 563 lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
+..+ +..|.-.+. +......+..++..||+.+|++||++.++.+.|..
T Consensus 531 l~~~----l~~G~r~~~---------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 531 LLEF----LKEGNRMEQ---------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHHH----HhcCCCCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 2222 222221111 11113445577778999999999999999998876
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=276.17 Aligned_cols=262 Identities=20% Similarity=0.299 Sum_probs=205.8
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCC--c----ceeEEeeEEEecCceE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHH--K----NIISLLGFCFEDNNLL 419 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~H--p----nIV~l~g~~~~~~~~~ 419 (696)
+++|.+..++|+|.||.|-.+.+. .+..||||+++.-....+..+-|+++|.++.+ | -++++.+||.-.++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 788999999999999999998754 47899999999888777888889999999942 3 3889999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC--------------
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-------------- 485 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~-------------- 485 (696)
||+|.+ |-++.++|..+.- .+++...++.++.|++++++|||+ .+++|-||||+|||+..
T Consensus 168 ivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccc
Confidence 999998 5699999987654 468889999999999999999999 99999999999999841
Q ss_pred ------CCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccc
Q 005450 486 ------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 559 (696)
Q Consensus 486 ------~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~ 559 (696)
+..++|+|||.|.+-.... ..++.|..|.|||++.+-.++.++||||+||||+||.+|...|...+..+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3458999999998766544 23678999999999999999999999999999999999999998766433
Q ss_pred hhhHHhhhc-c-------------ccccCc-----------cccccCcccC----CCCChHHHHHHHHHHHHhcccCCCC
Q 005450 560 QESLVMWAK-P-------------ILSSGK-----------VTQLLDPALG----NNYDYDQMERMVLASILCIRRDPRA 610 (696)
Q Consensus 560 ~~~lv~~~~-~-------------~~~~g~-----------l~~llD~~L~----~~~~~~e~~~l~~la~~Cl~~dP~~ 610 (696)
...+..... | .+..+. .....++... ..-...+...++.++..||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 221111100 1 111111 1111111100 0112345567888888899999999
Q ss_pred CCCHHHHHH
Q 005450 611 RPQMSLVLK 619 (696)
Q Consensus 611 RPSm~eVL~ 619 (696)
|+|+.|++.
T Consensus 397 RiTl~EAL~ 405 (415)
T KOG0671|consen 397 RITLREALS 405 (415)
T ss_pred cccHHHHhc
Confidence 999999885
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=246.89 Aligned_cols=214 Identities=24% Similarity=0.353 Sum_probs=178.6
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+|...+.||+|.||+||+|+. ++++.||+|.++..+ .......+||-+|+.++|.|||++++....++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 345567899999999999985 467889999998543 3456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
|.. +|..+...-.. .++......++.|+++||.++|+ +++.|||+||.|+||+.+|++||+|||+|+.+.-..
T Consensus 83 cdq-dlkkyfdslng---~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 965 88888865443 57888999999999999999999 899999999999999999999999999999776543
Q ss_pred CCcccccccccCCCCCcceeccCC-CCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhcccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPIL 571 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~-~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~ 571 (696)
.. +..-+-|.+|.+|.++.+.+ |+...|+||.|||+.|+.. |++.|.+.+-.++...+-|.....
T Consensus 156 rc--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p 222 (292)
T KOG0662|consen 156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222 (292)
T ss_pred Ee--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCC
Confidence 22 12245799999999988664 8999999999999999998 777788777666655555544333
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=266.01 Aligned_cols=198 Identities=23% Similarity=0.382 Sum_probs=175.1
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecC----ChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~----~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~L 420 (696)
.++|...++||+|+|..|..+.+ ++.+.||+|++++ ..+++.-...|-.+..+. +||++|.+..+|..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46789999999999999999986 4678899999985 334556667788887776 69999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
|.||++||+|--.+++++ .++++.++.+..+|+.||.|||+ +|||+||||..|+|||..|++||+|+|+++..
T Consensus 329 vieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999998887765 48899999999999999999999 99999999999999999999999999999844
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCC
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPIS 553 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~ 553 (696)
-.. ..+..+++|||.|+|||++.+..|...+|+|+|||+++||+.|+.||.
T Consensus 402 l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 402 LGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred CCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 322 123346899999999999999999999999999999999999999996
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=280.82 Aligned_cols=205 Identities=22% Similarity=0.313 Sum_probs=155.5
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-----------------CCCCEEEEEEecCChh-HHHH--------------HHHH
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-----------------PDGKELAVKILKPSED-VIKE--------------FVLE 393 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-----------------~~g~~vAVK~l~~~~~-~~~~--------------~~~E 393 (696)
..++|.+.++||+|+||+||+|.. .+++.||||.++.... ..++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999963 2456899999875322 1222 3346
Q ss_pred HHHHHhcCCcce-----eEEeeEEEe--------cCceEEEEeecCCCChhhhhhcCCC--------------------C
Q 005450 394 IEIITTLHHKNI-----ISLLGFCFE--------DNNLLLVYDFLSRGSLEENLHGNKK--------------------D 440 (696)
Q Consensus 394 i~iL~~L~HpnI-----V~l~g~~~~--------~~~~~LV~Ey~~gGsL~~~L~~~~~--------------------~ 440 (696)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776554 677787753 3568999999999999999875321 0
Q ss_pred CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccccccccCCCCC
Q 005450 441 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 520 (696)
Q Consensus 441 ~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlA 520 (696)
...++|..+..++.|++.+|.|||+ .+|+||||||+|||++.++.+||+|||++.......... .....+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeC
Confidence 1235678899999999999999999 889999999999999999999999999997654432211 112335889999
Q ss_pred cceeccCC----------------------CCCcccchhhHHHHHHHHhCCC-CCCC
Q 005450 521 PEYFMYGK----------------------VNDKIDVYAFGVVLLELLTGRK-PISN 554 (696)
Q Consensus 521 PE~l~~~~----------------------~s~ksDVwSLGvvL~ELltG~~-Pf~~ 554 (696)
||.+.... ...+.||||+|||+|+|++|.. ||..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 99875332 1235799999999999999875 6653
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-31 Score=266.56 Aligned_cols=266 Identities=26% Similarity=0.390 Sum_probs=197.2
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--------c
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--------D 415 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~--------~ 415 (696)
+.|.-..+||+|.||.||+|+. +.|+.||+|++-- .+..-....+|+++|..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3455567899999999999985 4678889886532 22334567899999999999999999998853 2
Q ss_pred CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecC
Q 005450 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 495 (696)
Q Consensus 416 ~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFG 495 (696)
..+||||++++. +|.-+|.... ..++..++.++..++..||.|+|+ ..|+|||+|+.|+||+.++.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccc
Confidence 348999999977 8888886543 368999999999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCC--CcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhc----
Q 005450 496 LAKWASTSSS--HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK---- 568 (696)
Q Consensus 496 lA~~~~~~~~--~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~---- 568 (696)
+|+.++.... ...+++.+-|.+|++||.+.+. .|+++.|||..|||+.||.||.+-|.+.....+..++...-
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 9987655322 2335667789999999988754 79999999999999999999999998877666655553221
Q ss_pred ----cccccCcccccc--CcccCCCCC--hHHH------HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 569 ----PILSSGKVTQLL--DPALGNNYD--YDQM------ERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 569 ----~~~~~g~l~~ll--D~~L~~~~~--~~e~------~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
|-...-.+.+.+ .|.-.+.+. .+.+ ...+.+.-.++..||.+|+.+.+++..
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111111111111 111111110 0000 122333445889999999999999864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=253.96 Aligned_cols=202 Identities=27% Similarity=0.384 Sum_probs=170.2
Q ss_pred ceeeeeeeccCceEEEEEEe-CCCCEEEEEEecC--ChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeec
Q 005450 350 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~--~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
......||+|++|.|-+-++ .+|...|+|.++. +.+..++.++|+++..+. .+|++|.+||....+...++.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 33456799999999977764 6899999999875 356667888999887665 6999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
+- +|+.+...--.....+++..+-+|+..+..||.|||+ ...+||||+||+||||+.+|++|+||||++..+.++..
T Consensus 128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 65 8888776554555678999999999999999999998 47899999999999999999999999999987766432
Q ss_pred CcccccccccCCCCCcceecc----CCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Q 005450 506 HITCTDVAGTFGYLAPEYFMY----GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~----~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~ 557 (696)
.. -..|...|||||.+.. ..|+-|+||||||++++||.+++.||.....
T Consensus 205 kt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 205 KT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred HH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 22 2468889999998863 3689999999999999999999999976543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=236.50 Aligned_cols=210 Identities=35% Similarity=0.606 Sum_probs=182.8
Q ss_pred eeccCceEEEEEEeCC-CCEEEEEEecCChh--HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCChhh
Q 005450 356 IGKGGSSQVYKGCLPD-GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 432 (696)
Q Consensus 356 LG~G~fG~Vyka~~~~-g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL~~ 432 (696)
||+|.+|.||++...+ ++.+++|++..... ....+.+|++++..++|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 89999999987654 36789999999999999999999999999899999999999999999
Q ss_pred hhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC-CCceEEeecCccccccCCCCCccccc
Q 005450 433 NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTD 511 (696)
Q Consensus 433 ~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~-~~~vKL~DFGlA~~~~~~~~~~~~~~ 511 (696)
++.... ..+++..+..++.+++.+|.|||+ .+++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 987542 257899999999999999999999 89999999999999999 89999999999986655432 1223
Q ss_pred ccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCCh
Q 005450 512 VAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 590 (696)
Q Consensus 512 ~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~ 590 (696)
..+...|++||.+... .++.+.|+|+||+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 5688899999999877 888999999999999999
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005450 591 DQMERMVLASILCIRRDPRARPQMSLVLKLL 621 (696)
Q Consensus 591 ~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L 621 (696)
..+..++..|++.+|.+||++.++++.|
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3455566679999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=270.77 Aligned_cols=236 Identities=27% Similarity=0.321 Sum_probs=195.5
Q ss_pred chhHHhHhhhccccccccChHHHHHhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHh
Q 005450 321 PKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITT 399 (696)
Q Consensus 321 ~~~le~l~~~~~~~~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~ 399 (696)
+.+...+++.+...--.|.+.-.+..-++|.+....|+|-|++|.+|.+. -|..||||++++++...+.=+.|++||++
T Consensus 405 ~~~~~~L~DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkK 484 (752)
T KOG0670|consen 405 PRVNPGLQDNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKK 484 (752)
T ss_pred cccCCccccCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHH
Confidence 33444455555444445566666667889999999999999999999864 57899999999998888888999999999
Q ss_pred cCC------cceeEEeeEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEe
Q 005450 400 LHH------KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 473 (696)
Q Consensus 400 L~H------pnIV~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIH 473 (696)
|+. -|+++|+-.|...+++|||+|-+. .+|.++|...+.. ..|....+..++.|++-||..|.. .+|+|
T Consensus 485 L~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~---c~vlH 559 (752)
T KOG0670|consen 485 LNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKK---CGVLH 559 (752)
T ss_pred hhccCchhhhHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHh---cCeee
Confidence 963 489999999999999999999884 4999999877653 467888999999999999999999 88999
Q ss_pred ecccccceeeCCC-CceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCC
Q 005450 474 RDVKSSNILLSDD-FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 552 (696)
Q Consensus 474 rDLKpsNILLd~~-~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf 552 (696)
.||||.|||+++. ..+||||||.|.+...... +...-+..|.|||++.+-.|+...|+||.||+||||.||+..|
T Consensus 560 aDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlF 635 (752)
T KOG0670|consen 560 ADIKPDNILVNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILF 635 (752)
T ss_pred cccCccceEeccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceec
Confidence 9999999999875 5689999999987765432 2234567799999999999999999999999999999999999
Q ss_pred CCCCccchhhHHh
Q 005450 553 SNDHPKGQESLVM 565 (696)
Q Consensus 553 ~~~~~~~~~~lv~ 565 (696)
.+........+.|
T Consensus 636 pG~TNN~MLrl~m 648 (752)
T KOG0670|consen 636 PGRTNNQMLRLFM 648 (752)
T ss_pred CCCCcHHHHHHHH
Confidence 8766544444433
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=259.70 Aligned_cols=263 Identities=21% Similarity=0.334 Sum_probs=201.1
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-----C---cceeEEeeEEEe---
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----H---KNIISLLGFCFE--- 414 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~-----H---pnIV~l~g~~~~--- 414 (696)
..+|.+.++||.|.|++||++.+ .+.+.||+|+.+......+..+.||++|++++ | .+||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 46899999999999999999986 45778999999988888888999999999984 3 369999999974
Q ss_pred -cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC--------
Q 005450 415 -DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-------- 485 (696)
Q Consensus 415 -~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~-------- 485 (696)
+.+.+||+|++ |.+|..+|..... ..++...+.+|+.||+.||.|||.. .+|||-||||+||||..
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeeeccccchhhh
Confidence 56899999999 6699999976554 3588899999999999999999985 57999999999999830
Q ss_pred --------------------------------------------------------------------------------
Q 005450 486 -------------------------------------------------------------------------------- 485 (696)
Q Consensus 486 -------------------------------------------------------------------------------- 485 (696)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred --------------------------C----------------------------------------------------C
Q 005450 486 --------------------------D----------------------------------------------------F 487 (696)
Q Consensus 486 --------------------------~----------------------------------------------------~ 487 (696)
. -
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 0 0
Q ss_pred ceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccc----hh--
Q 005450 488 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG----QE-- 561 (696)
Q Consensus 488 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~----~~-- 561 (696)
.+||+|||-|.|.... ++..+.|..|.|||++.+..|+..+||||++|++|||+||...|....... ..
T Consensus 392 ~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi 466 (590)
T KOG1290|consen 392 RVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI 466 (590)
T ss_pred eEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence 1466666666655442 233457899999999999999999999999999999999999997543222 11
Q ss_pred hHHhhh-----ccc-----------cccCccccc-------cCcccCC--CCChHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005450 562 SLVMWA-----KPI-----------LSSGKVTQL-------LDPALGN--NYDYDQMERMVLASILCIRRDPRARPQMSL 616 (696)
Q Consensus 562 ~lv~~~-----~~~-----------~~~g~l~~l-------lD~~L~~--~~~~~e~~~l~~la~~Cl~~dP~~RPSm~e 616 (696)
.+++.. +.+ -+.|.+..+ +...|.. .+..++...+..+..=||+.+|++|||+.+
T Consensus 467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 111110 011 112222111 1111222 345677888888888899999999999999
Q ss_pred HHH
Q 005450 617 VLK 619 (696)
Q Consensus 617 VL~ 619 (696)
.++
T Consensus 547 cl~ 549 (590)
T KOG1290|consen 547 CLK 549 (590)
T ss_pred Hhc
Confidence 886
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-29 Score=281.77 Aligned_cols=247 Identities=26% Similarity=0.400 Sum_probs=186.3
Q ss_pred ceeeeeeeccCceE-EEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeecCC
Q 005450 350 FLAENLIGKGGSSQ-VYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 350 f~~~~~LG~G~fG~-Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
|...+++|.|..|+ ||+|.. .|+.||||++-. .......+|+..|+.- .|||||++++.-.+...+||..|.|..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~--e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE--EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh--HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 34456789999987 699987 678999998864 3345667899999988 499999999999999999999999955
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC---C--CceEEeecCccccccC
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---D--FEPQLSDFGLAKWAST 502 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~---~--~~vKL~DFGlA~~~~~ 502 (696)
+|.+++.....+.....-...+.+..|++.||++||+ .+||||||||.||||+. + ..++|+|||+++.+..
T Consensus 588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 9999998642211122224557789999999999999 89999999999999975 2 4689999999998876
Q ss_pred CCCC-cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhC-CCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 503 SSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 503 ~~~~-~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG-~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
+... .......||-||+|||++....-+..+||||||||+|+.++| .+||.+.... +.+++.- ...+..
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~NIl~~------~~~L~~-- 734 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QANILTG------NYTLVH-- 734 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhhhhcC------ccceee--
Confidence 5443 223457899999999999988888899999999999999995 9999764322 1111110 001111
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+....+. ....++..|++.+|..||++.+|+.
T Consensus 735 ---L~~~~d~----eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 ---LEPLPDC----EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ---eccCchH----HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1111111 3344555699999999999999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-29 Score=255.67 Aligned_cols=265 Identities=23% Similarity=0.336 Sum_probs=197.7
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-----CceE
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NNLL 419 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~-----~~~~ 419 (696)
+.+..+.||-|+||.||...++ +|+.||.|.+..- -...+++.+|+.+|..++|.|++..++...-. .++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3456789999999999998864 7999999988653 24567899999999999999999988876432 3578
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+++|.|.. +|..+|- .+..++-..+.-+..||++||.|||+ .+|.||||||.|+|++.|..+||||||+|+.
T Consensus 134 V~TELmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccc
Confidence 89998865 7776664 34568888888899999999999999 8999999999999999999999999999997
Q ss_pred ccCCCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccc--------
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI-------- 570 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~-------- 570 (696)
....... .++.-+-|..|.|||++++. .|+...||||.|||+.||+..+..|....+..+..++.-....
T Consensus 206 ee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 6654433 23445678999999999966 6999999999999999999999999988887766554321110
Q ss_pred cccCccccccC-----cccCCCC----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 571 LSSGKVTQLLD-----PALGNNY----DYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 571 ~~~g~l~~llD-----~~L~~~~----~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
-.+|.-..++. |.+.--+ ....-..-+.+..+++..||++|.+..+.+..+-
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 01111111111 1110000 0111223344455688999999999888876553
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=235.18 Aligned_cols=198 Identities=35% Similarity=0.503 Sum_probs=173.3
Q ss_pred ceeeeeeeccCceEEEEEEeCC-CCEEEEEEecCChh--HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 350 FLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~~-g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
|...+.||.|++|.||++...+ ++.+++|.+..... ..+.+.+|++.+..++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999765 89999999986542 56789999999999999999999999999899999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+++|.+++..... .+++..+..++.+++.+|.|||+ .+++|+||+|.||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999976532 17889999999999999999999 89999999999999999999999999999877654311
Q ss_pred cccccccccCCCCCccee-ccCCCCCcccchhhHHHHHHHHhCCCCCCC
Q 005450 507 ITCTDVAGTFGYLAPEYF-MYGKVNDKIDVYAFGVVLLELLTGRKPISN 554 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l-~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~ 554 (696)
......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 155 -~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 -LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12235688899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=254.70 Aligned_cols=264 Identities=23% Similarity=0.326 Sum_probs=210.5
Q ss_pred hHHHHHhhcCceeeeeeeccCceEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeE
Q 005450 340 YQDLLSATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 411 (696)
Q Consensus 340 ~~el~~~t~~f~~~~~LG~G~fG~Vyka~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~ 411 (696)
.+++....++++...++-+|.||.||+|.+ ++.+.|.+|.++.. ......+..|.-.+..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 355666677888889999999999999964 34456788888753 4556788999999999999999999999
Q ss_pred EEe-cCceEEEEeecCCCChhhhhhcCC----CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC
Q 005450 412 CFE-DNNLLLVYDFLSRGSLEENLHGNK----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 486 (696)
Q Consensus 412 ~~~-~~~~~LV~Ey~~gGsL~~~L~~~~----~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~ 486 (696)
+.+ ....+++|.++.-|+|..+|..-+ .....+...+...++.|++.|++|||+ ++|||.||-..|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhh
Confidence 875 457899999999999999997322 223456777888999999999999999 999999999999999999
Q ss_pred CceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHh
Q 005450 487 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 565 (696)
Q Consensus 487 ~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~ 565 (696)
..+||+|=.+++-+-..+.+.-...--....||+||.+....|+..+|||||||+||||+| |+.|+..-++.+....+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 9999999999986655444433333345667999999999999999999999999999999 999999888877665543
Q ss_pred hhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 566 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 566 ~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
-.. ++.+.++ -++ .++.++.-||...|++||++++++.-|.
T Consensus 513 dGy------RlaQP~N-------CPD---eLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 513 DGY------RLAQPFN-------CPD---ELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred ccc------eecCCCC-------CcH---HHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 221 2222111 123 3445555699999999999999998775
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=239.19 Aligned_cols=196 Identities=23% Similarity=0.446 Sum_probs=168.6
Q ss_pred hhcCceeeeeeeccCceEEEEEE-eCCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEec--CceEEE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFED--NNLLLV 421 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~-~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~--~~~~LV 421 (696)
..++|++.+.+|+|.++.||.|. ..++..++||++++-+ .+.+.+|+.||..|. ||||++|++...+. ....||
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 35689999999999999999998 4678899999999754 367889999999998 99999999998753 568899
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC-CceEEeecCccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWA 500 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~-~~vKL~DFGlA~~~ 500 (696)
+||+.+.+...+.. .++...+..++.+++.||+|+|+ +||+|||+||.|++||.. -.++|+|+|+|.++
T Consensus 114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999988776654 36667888999999999999999 999999999999999965 46999999999998
Q ss_pred cCCCCCcccccccccCCCCCcceec-cCCCCCcccchhhHHHHHHHHhCCCCCCCCC
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDH 556 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~-~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~ 556 (696)
...... ...+.+..|--||.+. ...|+..-|+|||||+|..|+..+.||....
T Consensus 184 Hp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 184 HPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred CCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 875433 3356788899999875 5578999999999999999999999986543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=264.27 Aligned_cols=197 Identities=24% Similarity=0.367 Sum_probs=169.9
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHH---------HHHHHHHHHHhcC---CcceeEEeeEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIK---------EFVLEIEIITTLH---HKNIISLLGFCF 413 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~---------~~~~Ei~iL~~L~---HpnIV~l~g~~~ 413 (696)
..+|...+.+|.|+||.|++|.++ +...|+||.+.+++--.. ..-.||.||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 356889999999999999999975 567899999987543222 2456999999997 999999999999
Q ss_pred ecCceEEEEeecC-CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEe
Q 005450 414 EDNNLLLVYDFLS-RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 492 (696)
Q Consensus 414 ~~~~~~LV~Ey~~-gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~ 492 (696)
+++.+||+||... |-+|.++|.... .+++.+...|+.|++.|+++||+ .+|||||||-+|+.++.+|-+||+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEe
Confidence 9999999999764 458999997554 58999999999999999999999 999999999999999999999999
Q ss_pred ecCccccccCCCCCcccccccccCCCCCcceeccCCCCC-cccchhhHHHHHHHHhCCCCCCC
Q 005450 493 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISN 554 (696)
Q Consensus 493 DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~-ksDVwSLGvvL~ELltG~~Pf~~ 554 (696)
|||.|-....+. ...++||.+|.|||++.+.+|-- .-|||++|++||.++....||.+
T Consensus 713 dfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 713 DFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999987655433 34478999999999999888754 58999999999999999999853
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=263.61 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=202.8
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
.++|.....+|.|.||.|||+++ ..++..|+|+++-. .++..-+.+|+-+++..+||||+.+++.+.....++++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 35788889999999999999996 47899999999864 36677788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+.+|+|.+..+... .+++.++-.+.++.++||.|||+ ++-+|||||-.|||+++.|.+|+.|||.+-.+....
T Consensus 94 cgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh
Confidence 99999999887654 58888999999999999999999 888999999999999999999999999987665533
Q ss_pred CCcccccccccCCCCCccee---ccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 505 SHITCTDVAGTFGYLAPEYF---MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l---~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
. ....+.||+.|||||+. ..+.|..++|||++|+...|+-.-++|...-.+... +.+..+..+ -.
T Consensus 167 ~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~--l~LmTkS~~--------qp 234 (829)
T KOG0576|consen 167 A--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA--LFLMTKSGF--------QP 234 (829)
T ss_pred h--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH--HHHhhccCC--------CC
Confidence 2 23458899999999976 467899999999999999999998888765444222 111111111 11
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
|.+++...+ ...+-.++..|+..+|.+||+++.+|.
T Consensus 235 p~lkDk~kw--s~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLKDKTKW--SEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CcccCCccc--hHHHHHHHHHHhcCCCccCCChhhhee
Confidence 233332222 233444556699999999999987654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-27 Score=242.08 Aligned_cols=200 Identities=26% Similarity=0.366 Sum_probs=168.6
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec------C
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------N 416 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~------~ 416 (696)
..+|...+.+|.|.- .|.-+.+. .++.||+|.+... ....++..+|..++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456777788999988 66666543 5889999987542 34567788999999999999999999998643 4
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCc
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGl 496 (696)
..|+|||+|.. +|...++. .++-.++..|+.|++.|+.|||+ .+|+||||||+||++..+..+||.|||+
T Consensus 95 e~y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchh
Confidence 68999999965 89888872 35667889999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccch
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 560 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~ 560 (696)
|+..... ...+..+.|..|.|||++.+..|.+.+||||+||++.||++|+..|.+.+..++
T Consensus 165 ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ 225 (369)
T KOG0665|consen 165 ARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQ 225 (369)
T ss_pred hcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHH
Confidence 9866654 234567899999999999988899999999999999999999999987654443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-26 Score=272.69 Aligned_cols=196 Identities=21% Similarity=0.285 Sum_probs=139.0
Q ss_pred hcCC-cceeEEeeEE-------EecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCc
Q 005450 399 TLHH-KNIISLLGFC-------FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 470 (696)
Q Consensus 399 ~L~H-pnIV~l~g~~-------~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~g 470 (696)
.++| +||++++++| .+...+++++||+ +++|.++|.... ..+++.+++.|+.||++||.|||+ ++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHS---QG 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence 3455 5888888887 3335678889988 559999997432 358999999999999999999999 89
Q ss_pred eEeecccccceeeCC-------------------CCceEEeecCccccccCCCC--------------CcccccccccCC
Q 005450 471 VIHRDVKSSNILLSD-------------------DFEPQLSDFGLAKWASTSSS--------------HITCTDVAGTFG 517 (696)
Q Consensus 471 IIHrDLKpsNILLd~-------------------~~~vKL~DFGlA~~~~~~~~--------------~~~~~~~~GT~~ 517 (696)
|+||||||+||||+. ++.+||+|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 44566667776654221000 000112468999
Q ss_pred CCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHH
Q 005450 518 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMV 597 (696)
Q Consensus 518 YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~ 597 (696)
|+|||++.+..|+.++|||||||+||||++|..|+..... ......... +.+.. ........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~~---------~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHRV---------LPPQI-----LLNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHhh---------cChhh-----hhcCHHHH
Confidence 9999999999999999999999999999999888753211 010010000 11110 01112234
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 005450 598 LASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 598 ~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.++.+||+.+|.+||+|.++++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 5667799999999999999986
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=236.17 Aligned_cols=200 Identities=27% Similarity=0.396 Sum_probs=166.0
Q ss_pred HhhcCceeeeeeeccCceEEEEEEeC----CCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceE
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~~----~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~ 419 (696)
...+.|...++||+|.|++||++.+. ..+.||+|.+.... ...++..|+++|..+. +.||+++.+++..++...
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 34567889999999999999999853 46789999887543 2356889999999996 899999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC-CCceEEeecCccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAK 498 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~-~~~vKL~DFGlA~ 498 (696)
+|+||++.....+++.. ++...+..++..++.||.++|. +|||||||||+|+|.+. .+.-.|+|||+|.
T Consensus 112 ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHH
Confidence 99999999988888863 5678899999999999999999 99999999999999985 4567899999998
Q ss_pred cccCCC---------------------------------CC---------cccccccccCCCCCcceec-cCCCCCcccc
Q 005450 499 WASTSS---------------------------------SH---------ITCTDVAGTFGYLAPEYFM-YGKVNDKIDV 535 (696)
Q Consensus 499 ~~~~~~---------------------------------~~---------~~~~~~~GT~~YlAPE~l~-~~~~s~ksDV 535 (696)
...... .. .......||+||.|||++. .+..++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 321100 00 0011257999999999876 5578899999
Q ss_pred hhhHHHHHHHHhCCCCCCCC
Q 005450 536 YAFGVVLLELLTGRKPISND 555 (696)
Q Consensus 536 wSLGvvL~ELltG~~Pf~~~ 555 (696)
||.|||++-+++++.||...
T Consensus 262 ws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eeccceeehhhccccccccC
Confidence 99999999999999999654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-25 Score=222.81 Aligned_cols=251 Identities=22% Similarity=0.360 Sum_probs=184.6
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeE-EEecCceEEEEe
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGF-CFEDNNLLLVYD 423 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~-~~~~~~~~LV~E 423 (696)
.+.|.+.+.||+|-||.+-++.++ +.+.+++|.+.......++|.+|..---.| .|.||+..|+. |+..+.+++++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 356888999999999999999875 567899999988878889999998776666 48999988865 566678889999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC--CCCceEEeecCcccccc
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd--~~~~vKL~DFGlA~~~~ 501 (696)
|++.|+|...+... .+.+....+++.|++.||.|+|+ .++||||||.+||||- +...+||||||+.+..+
T Consensus 103 ~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999988653 46778888999999999999999 8999999999999993 33479999999987554
Q ss_pred CCCCCcccccccccCCCCCcceeccC-----CCCCcccchhhHHHHHHHHhCCCCCCCCCccch--hhHHhhhccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ--ESLVMWAKPILSSG 574 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~-----~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~--~~lv~~~~~~~~~g 574 (696)
.... ...-+..|.+||..... ...+.+|||.||+++|..+||+.||+......+ .....|......
T Consensus 175 ~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-- 247 (378)
T KOG1345|consen 175 TTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-- 247 (378)
T ss_pred ceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc--
Confidence 4322 23346679999976422 357789999999999999999999985433222 223333332111
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005450 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621 (696)
Q Consensus 575 ~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L 621 (696)
.+...+.+ + .+...+++ ..-+.++|++|=...++-++.
T Consensus 248 ~~P~~F~~-----f-s~~a~r~F---kk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 248 ALPKKFNP-----F-SEKALRLF---KKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred cCchhhcc-----c-CHHHHHHH---HHhcCCcccccchhHHHHHHH
Confidence 11111111 1 12233333 336778888886666655544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=209.44 Aligned_cols=166 Identities=23% Similarity=0.231 Sum_probs=123.8
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
|+|.+++.... ..+++..++.|+.|++.||.|||+ ++ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc---
Confidence 68999997543 258999999999999999999998 54 999999999999999 99998765422
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~ 587 (696)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......... +..+...... . ++.- ..
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~------~-~~~~-~~ 130 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-LEILLNGMPA------D-DPRD-RS 130 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-HHHHHHHhcc------C-Cccc-cc
Confidence 25899999999999999999999999999999999999999754432211 1111110000 0 0000 00
Q ss_pred CChHHH--HHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 588 YDYDQM--ERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 588 ~~~~e~--~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
...... ..+..++..||+.+|.+||++.++++.+..
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 011111 247778888999999999999999987753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-22 Score=204.53 Aligned_cols=258 Identities=30% Similarity=0.436 Sum_probs=195.0
Q ss_pred ceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChh----HHHHHHHHHHHHHhcCCc-ceeEEeeEEEecCceEEEEee
Q 005450 350 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED----VIKEFVLEIEIITTLHHK-NIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~----~~~~~~~Ei~iL~~L~Hp-nIV~l~g~~~~~~~~~LV~Ey 424 (696)
|...+.||.|+||.||++... ..+++|.+..... ....+.+|+.++..+.|+ +|+++++++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999976 8899999876432 467899999999999988 799999999777778999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC-ceEEeecCccccccCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTS 503 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~-~vKL~DFGlA~~~~~~ 503 (696)
+.+++|.+++...... ..+.......++.+++.++.|+|+ .+++|||+||+||+++..+ .++++|||++......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999776544311 257888999999999999999999 8899999999999999988 7999999999865554
Q ss_pred CCCc----ccccccccCCCCCcceecc---CCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---chhhHHhhhcccccc
Q 005450 504 SSHI----TCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK---GQESLVMWAKPILSS 573 (696)
Q Consensus 504 ~~~~----~~~~~~GT~~YlAPE~l~~---~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~---~~~~lv~~~~~~~~~ 573 (696)
.... ......||..|+|||.+.. ..++...|+||+|++++++++|..||...... .......+.....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence 3321 2345789999999999987 57888999999999999999999997665431 1111111111100
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 574 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 574 g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.................+..+...|+..+|..|.++......
T Consensus 234 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001112344455566889999999998876653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=224.24 Aligned_cols=165 Identities=20% Similarity=0.187 Sum_probs=130.5
Q ss_pred HhhcCceeeeeeeccCceEEEEEEeC--CCCEEEEEEecCC------hhHHHHHHHHHHHHHhcCCcceeE-EeeEEEec
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIIS-LLGFCFED 415 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~~--~g~~vAVK~l~~~------~~~~~~~~~Ei~iL~~L~HpnIV~-l~g~~~~~ 415 (696)
...++|.+.+.||+|+||+||+|... +++.+|||++... ......|.+|+++|.+++|+|+++ ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34567999999999999999999764 5777899986532 234567899999999999999985 4432
Q ss_pred CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecc-cccceeeCCCCceEEeec
Q 005450 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV-KSSNILLSDDFEPQLSDF 494 (696)
Q Consensus 416 ~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDL-KpsNILLd~~~~vKL~DF 494 (696)
+..+|||||++|++|... ... . ...++.++++||.|||+ +||+|||| ||+|||++.++.+||+||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~~-------~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RPH-------G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Ccc-------c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 468999999999999732 110 0 14578899999999999 89999999 999999999999999999
Q ss_pred CccccccCCCCCcc------cccccccCCCCCcceeccC
Q 005450 495 GLAKWASTSSSHIT------CTDVAGTFGYLAPEYFMYG 527 (696)
Q Consensus 495 GlA~~~~~~~~~~~------~~~~~GT~~YlAPE~l~~~ 527 (696)
|+|+.+........ .++..+++.|+|||++...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99997755432111 1346789999999998644
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-22 Score=215.19 Aligned_cols=257 Identities=24% Similarity=0.271 Sum_probs=191.5
Q ss_pred CceeeeeeeccCceEEEEEEeCCC--CEEEEEEecCChh-HHHHHHHHHHHHHhcCC----cceeEEeeEE-EecCceEE
Q 005450 349 NFLAENLIGKGGSSQVYKGCLPDG--KELAVKILKPSED-VIKEFVLEIEIITTLHH----KNIISLLGFC-FEDNNLLL 420 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~~g--~~vAVK~l~~~~~-~~~~~~~Ei~iL~~L~H----pnIV~l~g~~-~~~~~~~L 420 (696)
+|.+.+.||+|+||.||++..... ..+|+|....... ....+..|+.++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999997553 5899998876432 12267889999998873 6899999998 47778999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC-----CceEEeecC
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-----FEPQLSDFG 495 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~-----~~vKL~DFG 495 (696)
||+.+ |.+|.++..... ...|+..+...|+.|++.+|.+||+ .|++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 779999886554 3579999999999999999999999 999999999999999865 358999999
Q ss_pred ccc--cccCCCCC----c-c-cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhh
Q 005450 496 LAK--WASTSSSH----I-T-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 567 (696)
Q Consensus 496 lA~--~~~~~~~~----~-~-~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~ 567 (696)
+++ .+...... . . ...+.||..|.++....+...+.+.|+||++.++.||+.|..||...............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 33222211 1 1 12356999999999999999999999999999999999999999665432222111111
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 568 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 568 ~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.. ...... .......+...+.. .+-..+...+|....+.+.|+.
T Consensus 253 ~~-------~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 253 PR-------KLLTDR--FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred hh-------hhcccc--ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHH
Confidence 00 000000 11112233333333 3555789999999999888654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=194.07 Aligned_cols=202 Identities=22% Similarity=0.299 Sum_probs=172.5
Q ss_pred cCceeeeeeeccCceEEEEEE-eCCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEeec
Q 005450 348 SNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~-~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
-+|.+.+.||+|.||..+.|. +-+++.||||.-... ....++..|.+..+.|. .++|...+-|..++-+-.||+|++
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc-CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 478999999999999999998 458999999976542 23456778888888885 699999999999999999999998
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC-----CceEEeecCccccc
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-----FEPQLSDFGLAKWA 500 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~-----~~vKL~DFGlA~~~ 500 (696)
|.+|++++.-... .|+.+++.-||.|++.-++|+|+ +.+|+|||||+|+||... ..+.|+|||+|+.+
T Consensus 107 -GPSLEDLFD~CgR---~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGR---RFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred -CcCHHHHHHHhcC---cccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 7799999875443 69999999999999999999999 889999999999999743 35899999999988
Q ss_pred cCCCCCc--c---cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Q 005450 501 STSSSHI--T---CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 501 ~~~~~~~--~---~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~ 557 (696)
.+..+.. . .....||..||+--...+...+.+.|.-|||-|+++.|-|..||.+-..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 7654332 1 2236799999999999988999999999999999999999999987543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-21 Score=225.39 Aligned_cols=253 Identities=21% Similarity=0.243 Sum_probs=185.7
Q ss_pred eeeeeeeccCceEEEEEEeC-CCCEEEEEEec----CCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 351 LAENLIGKGGSSQVYKGCLP-DGKELAVKILK----PSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 351 ~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~----~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
...+++|.|++|.|+..... ..+..+.|..+ ... .....+..|+.+-..++|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999977776532 33334443322 221 22233667888888899999998888887776666669
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++ +|..++.... .+...++..++.|++.|+.|+|. .||.|||||++|++++.++.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 9999987652 47778899999999999999999 9999999999999999999999999999987766
Q ss_pred CCCC--cccccccccCCCCCcceeccCCCCCc-ccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 503 SSSH--ITCTDVAGTFGYLAPEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 503 ~~~~--~~~~~~~GT~~YlAPE~l~~~~~s~k-sDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
.... .....++|+..|+|||.+....|++. .||||.|++++.|++|+.||.......+....+ .. ....++..-
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~--~~-~~~~~~~~~ 549 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN--NY-SDQRNIFEG 549 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh--cc-ccccccccC
Confidence 5443 44556889999999999999999875 899999999999999999997665443321000 00 000000000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. .............++..+|+.+|.+|-|+.+|++
T Consensus 550 ~-----~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 P-----NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred h-----HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 0011122334445666799999999999999986
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=187.69 Aligned_cols=257 Identities=21% Similarity=0.281 Sum_probs=192.4
Q ss_pred hhcCceeeeeeeccCceEEEEEE-eCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC-cceeEEeeEEEecCceEEEEe
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~-~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~g~~~~~~~~~LV~E 423 (696)
..+.|.+.+.||.|+||.+|.|. ..+|..||||+-.... ....+..|.++...|++ ..|..+..|..+...-.+|||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 45789999999999999999998 5789999999876532 23467789999999985 678888888889999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC---CceEEeecCccccc
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKWA 500 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~---~~vKL~DFGlA~~~ 500 (696)
.+ |.+|++++.-... .|+..+++-++-|++.-++|+|. +++|||||||+|+|+.-+ ..+.|+|||+|+.+
T Consensus 92 LL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhh
Confidence 98 7799998864332 58899999999999999999999 889999999999999643 56899999999987
Q ss_pred cCCCCCc-----ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCc
Q 005450 501 STSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 575 (696)
Q Consensus 501 ~~~~~~~-----~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 575 (696)
.+..+.. ......||..|.+--...+...+.+.|+-|+|.+|.++.-|..||++-............ .+.+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI----~EkK 240 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI----SEKK 240 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH----HHhh
Confidence 6543321 223467999999888777777888999999999999999999999886554332222111 1112
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 576 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 576 l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+.-.+. .|...++.+ +......|=..-=++-|...-+-+
T Consensus 241 ~s~~ie-~LC~G~P~E----F~myl~Y~R~L~F~E~Pdy~ylrq 279 (341)
T KOG1163|consen 241 MSTPIE-VLCKGFPAE----FAMYLNYCRGLGFEEKPDYMYLRQ 279 (341)
T ss_pred cCCCHH-HHhCCCcHH----HHHHHHHHhhcCCCCCCcHHHHHH
Confidence 222222 222333332 222333476666677777654444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.5e-21 Score=193.67 Aligned_cols=170 Identities=14% Similarity=0.174 Sum_probs=133.7
Q ss_pred hhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCCh----hHHHH------HHHHHHHHHhcCCcceeEEeeEEEec
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE----DVIKE------FVLEIEIITTLHHKNIISLLGFCFED 415 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~----~~~~~------~~~Ei~iL~~L~HpnIV~l~g~~~~~ 415 (696)
..++|...++||.|+||.||+... ++..+|+|++++.. ..... +.+|+..+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 367899999999999999999766 57789999997532 22223 57899999999999999999886643
Q ss_pred --------CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC
Q 005450 416 --------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 487 (696)
Q Consensus 416 --------~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~ 487 (696)
+..+|||||++|.+|.++.. ++. ....+++.+|..+|. .|++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC
Confidence 35899999999999988732 222 245689999999999 9999999999999999988
Q ss_pred ceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHH
Q 005450 488 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 546 (696)
Q Consensus 488 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELl 546 (696)
++|+|||........... ..++....|+.++|||+||+++..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987644321111 11444456778999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-20 Score=187.52 Aligned_cols=139 Identities=20% Similarity=0.221 Sum_probs=108.5
Q ss_pred eeeeeccCceEEEEEEeCCCCEEEEEEecCChh---H-------H-----------------HHHHHHHHHHHhcCCcce
Q 005450 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED---V-------I-----------------KEFVLEIEIITTLHHKNI 405 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~---~-------~-----------------~~~~~Ei~iL~~L~HpnI 405 (696)
...||+|+||.||+|...+|+.||||+++.... . . .....|++++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 467999999999999988999999999975421 0 1 122349999999988776
Q ss_pred eEEeeEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH-hcCCCCceEeecccccceeeC
Q 005450 406 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL-HSGSAQRVIHRDVKSSNILLS 484 (696)
Q Consensus 406 V~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yL-H~~~~~gIIHrDLKpsNILLd 484 (696)
.....+.. ...+|||||++++++...+... ..+++.....++.|++.+|.|| |+ .+|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE
Confidence 44333222 2348999999998776543222 2578899999999999999999 67 8899999999999998
Q ss_pred CCCceEEeecCcccccc
Q 005450 485 DDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 485 ~~~~vKL~DFGlA~~~~ 501 (696)
++.++|+|||+|....
T Consensus 153 -~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 -DGKLYIIDVSQSVEHD 168 (190)
T ss_pred -CCcEEEEEccccccCC
Confidence 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=179.28 Aligned_cols=141 Identities=23% Similarity=0.229 Sum_probs=111.0
Q ss_pred eeeeeccCceEEEEEEeCCCCEEEEEEecCChhH---------------------------HHHHHHHHHHHHhcCCcce
Q 005450 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV---------------------------IKEFVLEIEIITTLHHKNI 405 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~---------------------------~~~~~~Ei~iL~~L~HpnI 405 (696)
.+.||+|+||.||+|...+|+.||||+++..... ...+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999999864210 1224578999999999987
Q ss_pred eEEeeEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC
Q 005450 406 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 485 (696)
Q Consensus 406 V~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~ 485 (696)
.....+... ..+|||||++|+++....... ..++......++.+++.+|.+||+ ..||+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence 544444332 348999999988654432221 246778889999999999999997 26899999999999999
Q ss_pred CCceEEeecCccccccC
Q 005450 486 DFEPQLSDFGLAKWAST 502 (696)
Q Consensus 486 ~~~vKL~DFGlA~~~~~ 502 (696)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-20 Score=218.41 Aligned_cols=249 Identities=21% Similarity=0.249 Sum_probs=182.4
Q ss_pred CceeeeeeeccCceEEEEEEeCCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 349 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
+|...+.||.+.|=.|.+|.++.|. |+||++-+.. ...++...|++ ...++|||.+++.-+-..+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6777899999999999999998887 9999986543 22344444555 566789999999988888888999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc--cc
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW--AS 501 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~--~~ 501 (696)
|+.+ +|+|.|.... .+...+...|+.|++.||.-+|+ .||+|||||.+||||+.-+-+.|+||.--+- ++
T Consensus 102 yvkh-nLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhccch----HHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9966 9999886543 47778889999999999999999 9999999999999999999999999976652 22
Q ss_pred CCCCC---cccccccccCCCCCcceeccC-----------CCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhh
Q 005450 502 TSSSH---ITCTDVAGTFGYLAPEYFMYG-----------KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 566 (696)
Q Consensus 502 ~~~~~---~~~~~~~GT~~YlAPE~l~~~-----------~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~ 566 (696)
.++.. ....+...-..|+|||.|... ..+++.||||+||++.||++ |++||.- ..+..+
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aY 247 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAY 247 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhH
Confidence 22111 111122233469999988542 16778999999999999998 7888853 222222
Q ss_pred hcc--ccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 567 AKP--ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 567 ~~~--~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
... ...+--+.++-|+ .+-.+++.|+++||.+|-++++.|+.-+|..
T Consensus 248 r~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 248 RSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred hccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 111 0000011111121 2334556699999999999999998776654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=182.39 Aligned_cols=188 Identities=15% Similarity=0.099 Sum_probs=143.5
Q ss_pred eeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHH-----HHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEee
Q 005450 351 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIK-----EFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 351 ~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~-----~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
.+...|++|+||+||.+.. .+..++.+.+........ .+.+|+++|.+|. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997765 778888887776544333 5889999999995 5889999886 457999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecc-cccceeeCCCCceEEeecCccccccCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV-KSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDL-KpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
+.|.+|...+.. ....++.+++.+|.++|+ +||+|||| ||+|||++.++.++|+|||+|......
T Consensus 80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999998754321 113477899999999999 99999999 799999999999999999999855543
Q ss_pred CCC---cc--------cccccccCCCCCcceeccC-CCC-CcccchhhHHHHHHHHhCCCCCCCCCc
Q 005450 504 SSH---IT--------CTDVAGTFGYLAPEYFMYG-KVN-DKIDVYAFGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 504 ~~~---~~--------~~~~~GT~~YlAPE~l~~~-~~s-~ksDVwSLGvvL~ELltG~~Pf~~~~~ 557 (696)
... .. ..-...++.|++|+...-- ..+ ...+.++-|..+|.++|++.|+-.+..
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 210 00 0012368889999854321 222 467899999999999999998765543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-20 Score=190.23 Aligned_cols=244 Identities=21% Similarity=0.375 Sum_probs=182.7
Q ss_pred eeeeeccCceEEEEEEeCCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCC
Q 005450 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 429 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGs 429 (696)
..+|.+...|..|+|++ .|..+++|+++..+ ...+.|..|.-.|+-+.||||+.+++.|....++.++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 34577888899999998 45567778876532 344678889999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEe--ecCccccccCCCCCc
Q 005450 430 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS--DFGLAKWASTSSSHI 507 (696)
Q Consensus 430 L~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~--DFGlA~~~~~~~~~~ 507 (696)
|+..|+.... ...+-.++.+++..+++|++|||+-. .-|.---|.+..++||++..++|+ |--++.
T Consensus 274 lynvlhe~t~--vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf--------- 341 (448)
T KOG0195|consen 274 LYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------- 341 (448)
T ss_pred HHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee---------
Confidence 9999997643 34566788999999999999999843 223344688999999999888775 221111
Q ss_pred ccccccccCCCCCcceeccCCC---CCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKV---NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~---s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
......-.|.|++||.++...- -..+|+|||.++||||.|...||.+-.+.+..-.+.. .-+
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial---------------egl 406 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL---------------EGL 406 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh---------------ccc
Confidence 1122345788999999986543 3469999999999999999999987665433211110 011
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.-.+++.-...+..++..|+..||.+||.+..|+-+|++.
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 1222333344566666779999999999999999888754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.2e-20 Score=204.68 Aligned_cols=185 Identities=30% Similarity=0.371 Sum_probs=157.8
Q ss_pred eeeccCceEEEEEEe----CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEeecC
Q 005450 355 LIGKGGSSQVYKGCL----PDGKELAVKILKPSE---DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 355 ~LG~G~fG~Vyka~~----~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
.+|+|.||.|++... ..|..||+|++++.. ........|..++...+ ||.++++...++.+..++++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998653 357789999887532 11125566888888887 9999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
||.|...+.... .+.......+...++-+++++|+ .+|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhccccCC----chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 999999887554 36677777888899999999999 9999999999999999999999999999986654322
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 554 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~ 554 (696)
.+||..|||||++. .....+|.||||++++||+||..||..
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 27999999999998 567789999999999999999999976
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2e-18 Score=204.05 Aligned_cols=200 Identities=23% Similarity=0.261 Sum_probs=162.1
Q ss_pred HHHHhhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcC---CcceeEEeeEEEecCce
Q 005450 342 DLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNL 418 (696)
Q Consensus 342 el~~~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~---HpnIV~l~g~~~~~~~~ 418 (696)
++......|.+.+.||+|+||+||+|...+|+.||+|+-++.... +|.--.+++.+|+ -+.|..+...+.-.+.-
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 444455679999999999999999999888999999999875322 1111223334443 23455566666667888
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC-------CCCceEE
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-------DDFEPQL 491 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd-------~~~~vKL 491 (696)
+||+||.+.|+|.+++...+ .++|...+.++.|++..+++||. .+|||+||||+|.||. +...++|
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~----~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNK----VMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeeeccccccHHHhhccCC----CCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEE
Confidence 99999999999999998444 58999999999999999999999 9999999999999994 2345899
Q ss_pred eecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCC
Q 005450 492 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRK 550 (696)
Q Consensus 492 ~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~ 550 (696)
+|||.+.-+..-........+++|-++-.+|+..+..+++.+|.|.|..+++-||.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999986654444445556889999999999999999999999999999999999975
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.4e-18 Score=176.95 Aligned_cols=200 Identities=24% Similarity=0.325 Sum_probs=133.5
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecC----ChhHHHHHHHHHHHHHhcCC----------cceeEEeeE--
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHH----------KNIISLLGF-- 411 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~----~~~~~~~~~~Ei~iL~~L~H----------pnIV~l~g~-- 411 (696)
.+...+.||.|+++.||.+.+. +|+.+|+|+... .....+.+.+|.-.+..+.+ -.++-.++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3556789999999999999975 589999998753 23456777777655554322 122222221
Q ss_pred -------EEecC--------ceEEEEeecCCCChhhhhh---cCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEe
Q 005450 412 -------CFEDN--------NLLLVYDFLSRGSLEENLH---GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 473 (696)
Q Consensus 412 -------~~~~~--------~~~LV~Ey~~gGsL~~~L~---~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIH 473 (696)
+.... ..+++|+-+. ++|.+++. ........+....+..+..|+++.+++||. .|++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence 11111 3477888884 48888754 222222234556677888999999999999 99999
Q ss_pred ecccccceeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceecc--------CCCCCcccchhhHHHHHHH
Q 005450 474 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY--------GKVNDKIDVYAFGVVLLEL 545 (696)
Q Consensus 474 rDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~--------~~~s~ksDVwSLGvvL~EL 545 (696)
+||||+|+|++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|+||++||.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999887655442211 234578999997643 2578899999999999999
Q ss_pred HhCCCCCCCCCc
Q 005450 546 LTGRKPISNDHP 557 (696)
Q Consensus 546 ltG~~Pf~~~~~ 557 (696)
.+|+.||....+
T Consensus 244 WC~~lPf~~~~~ 255 (288)
T PF14531_consen 244 WCGRLPFGLSSP 255 (288)
T ss_dssp HHSS-STCCCGG
T ss_pred HHccCCCCCCCc
Confidence 999999976543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-17 Score=168.18 Aligned_cols=134 Identities=20% Similarity=0.246 Sum_probs=103.9
Q ss_pred eeeeeeccCceEEEEEEeCCCCEEEEEEecCC-hhHHHHHHHHHHHHHhc-----CCcceeEEeeEEEecC---c-eEEE
Q 005450 352 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS-EDVIKEFVLEIEIITTL-----HHKNIISLLGFCFEDN---N-LLLV 421 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~L-----~HpnIV~l~g~~~~~~---~-~~LV 421 (696)
....||+|+||.||. .+.....+||++... ....+.+.+|+.++..+ .||||+++++++.++. . +.+|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 357899999999996 443333479988754 23456789999999999 5799999999998863 3 3378
Q ss_pred Eee--cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHH-HHHhcCCCCceEeecccccceeeCC----CCceEEeec
Q 005450 422 YDF--LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL-EYLHSGSAQRVIHRDVKSSNILLSD----DFEPQLSDF 494 (696)
Q Consensus 422 ~Ey--~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL-~yLH~~~~~gIIHrDLKpsNILLd~----~~~vKL~DF 494 (696)
+|| +.+|+|.+++... .+++. ..++.+++.++ +|||+ ++|+||||||+|||++. ++.++|+||
T Consensus 84 ~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred ecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 999 5579999999653 24444 35677888777 99999 99999999999999974 347999995
Q ss_pred Ccc
Q 005450 495 GLA 497 (696)
Q Consensus 495 GlA 497 (696)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-17 Score=185.77 Aligned_cols=215 Identities=20% Similarity=0.376 Sum_probs=158.8
Q ss_pred HHhcCCcceeEEeeEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecc
Q 005450 397 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV 476 (696)
Q Consensus 397 L~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDL 476 (696)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+... ...++|.....++..|+.||.|||... . ..|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeee
Confidence 35688999999999999999999999999999999999763 346899999999999999999999832 2 299999
Q ss_pred cccceeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccC-------CCCCcccchhhHHHHHHHHhCC
Q 005450 477 KSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-------KVNDKIDVYAFGVVLLELLTGR 549 (696)
Q Consensus 477 KpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~-------~~s~ksDVwSLGvvL~ELltG~ 549 (696)
++.|.++|..+.+||+|||+.................-..-|.|||.+... ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998876531111111112234569999998753 1467799999999999999999
Q ss_pred CCCCCCCccch-hhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 550 KPISNDHPKGQ-ESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 550 ~Pf~~~~~~~~-~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.||........ ..++.+... .....+-|.+.... +....++.++..||..+|.+||++..|-..++.
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred CccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence 99986433222 233333221 11111222221110 222257777888999999999999998776654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.6e-17 Score=170.00 Aligned_cols=142 Identities=20% Similarity=0.188 Sum_probs=111.7
Q ss_pred CceeeeeeeccCceEEEEEE--eCCCCEEEEEEecCChh-------------------------HHHHHHHHHHHHHhcC
Q 005450 349 NFLAENLIGKGGSSQVYKGC--LPDGKELAVKILKPSED-------------------------VIKEFVLEIEIITTLH 401 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~--~~~g~~vAVK~l~~~~~-------------------------~~~~~~~Ei~iL~~L~ 401 (696)
.|.+.+.||+|+||.||+|. ..+|+.||+|+++.... ....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57888999999999999998 56899999999875320 1123568999999997
Q ss_pred Cc--ceeEEeeEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCc-eEeecccc
Q 005450 402 HK--NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-VIHRDVKS 478 (696)
Q Consensus 402 Hp--nIV~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~g-IIHrDLKp 478 (696)
+. .+.+++++ ...++||||++|++|........ .+.......++.+++.+|.+||. .+ |+||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCCh
Confidence 53 34444443 24589999999988876553221 24555678899999999999999 88 99999999
Q ss_pred cceeeCCCCceEEeecCccccccC
Q 005450 479 SNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 479 sNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
+||+++ ++.++|+|||.+.....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCC
Confidence 999999 88999999999875443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.5e-17 Score=164.21 Aligned_cols=133 Identities=23% Similarity=0.392 Sum_probs=113.8
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 354 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+.||+|++|.||+|.. +|..+++|+..... .....+.+|++++..+.|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 77789999866421 1124578899999999999988888887778889999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
++|++|.+++.... + .+..++.+++.+|.+||+ .+++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986421 2 788999999999999999 8999999999999999 78899999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.9e-17 Score=162.52 Aligned_cols=144 Identities=20% Similarity=0.206 Sum_probs=113.0
Q ss_pred HHHHhhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChh-----------------------HHHHHHHHHHHHH
Q 005450 342 DLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-----------------------VIKEFVLEIEIIT 398 (696)
Q Consensus 342 el~~~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~-----------------------~~~~~~~Ei~iL~ 398 (696)
++......|.+.+.||+|+||.||++...+|+.||||+++.... ....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 33334445788899999999999999988999999998764321 1123667899999
Q ss_pred hcCCcc--eeEEeeEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecc
Q 005450 399 TLHHKN--IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV 476 (696)
Q Consensus 399 ~L~Hpn--IV~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDL 476 (696)
.+.|++ +...++. ...++||||++|++|...... .....++.+++.++.++|+ .+|+||||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl 151 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYK---HGIIHGDL 151 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHH---CCCCcCCC
Confidence 998874 4444442 456899999999999775431 2345788999999999999 89999999
Q ss_pred cccceeeCCCCceEEeecCccccccC
Q 005450 477 KSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 477 KpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+||++++++.++|+|||++.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-16 Score=159.15 Aligned_cols=129 Identities=21% Similarity=0.349 Sum_probs=107.2
Q ss_pred eeeccCceEEEEEEeCCCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 355 LIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 355 ~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
+||+|+||.||+|.. +|..+++|...... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 67889999865321 12356788999999999887666665666677789999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+|++|.+.+.... . .++.+++.+|.+||+ .+++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-----H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999875321 0 789999999999999 8999999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-16 Score=184.11 Aligned_cols=139 Identities=19% Similarity=0.320 Sum_probs=113.4
Q ss_pred HhhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEe-cCC---h-----hHHHHHHHHHHHHHhcCCcceeEEeeEEEec
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KPS---E-----DVIKEFVLEIEIITTLHHKNIISLLGFCFED 415 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l-~~~---~-----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~ 415 (696)
.....|...+.||+|+||+||+|...+.. +++|+. ... . ...+++.+|++++..++|++++....++...
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 33445677899999999999999875443 444432 211 1 1235688999999999999999888888887
Q ss_pred CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecC
Q 005450 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 495 (696)
Q Consensus 416 ~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFG 495 (696)
...++||||++|++|.+++. ....++.+++.+|.|||+ .+|+||||||+|||+ .++.++|+|||
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCc
Confidence 88899999999999999885 346789999999999999 899999999999999 57799999999
Q ss_pred ccccc
Q 005450 496 LAKWA 500 (696)
Q Consensus 496 lA~~~ 500 (696)
+++..
T Consensus 473 la~~~ 477 (535)
T PRK09605 473 LGKYS 477 (535)
T ss_pred ccccC
Confidence 98753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.9e-17 Score=191.20 Aligned_cols=171 Identities=30% Similarity=0.444 Sum_probs=127.9
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
.++|..+++|..|+||-||...++ ..+.+|+|+-+. ....+. |+.....|++|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~lilRn------ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NLILRN------ILTFAGNPFVV------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-chhhhc------cccccCCccee-------------------
Confidence 457889999999999999999875 456788854432 211111 33333444444
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
|+-...+...+. ++. +++.+++|||+ .+|+|||+||+|.+|+.-|++|++|||+.+.......
T Consensus 136 --gDc~tllk~~g~----lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 --GDCATLLKNIGP----LPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred --chhhhhcccCCC----Ccc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 455555654443 222 23778999999 9999999999999999999999999999875432111
Q ss_pred -------------CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccch
Q 005450 506 -------------HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 560 (696)
Q Consensus 506 -------------~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~ 560 (696)
......++||+.|+|||++....|...+|+|++|+|+||.+-|..||.++.+++.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel 266 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 266 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence 0112347899999999999999999999999999999999999999999876554
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.2e-17 Score=181.45 Aligned_cols=187 Identities=25% Similarity=0.330 Sum_probs=133.0
Q ss_pred eeeeccCceEEEEEEeCCC----CEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEee-------EEE-----ecC
Q 005450 354 NLIGKGGSSQVYKGCLPDG----KELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLG-------FCF-----EDN 416 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~g----~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g-------~~~-----~~~ 416 (696)
+..+..+++.++......+ ..+..+...... .......+++-.+....|-+..-+.+ .+. ...
T Consensus 250 k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~ 329 (516)
T KOG1033|consen 250 KSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKV 329 (516)
T ss_pred ccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccccccc
Confidence 4445555555554443222 234444444333 33344445555544444333322222 111 123
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCc
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGl 496 (696)
.+|+.|+++...+|.+||.+... ....++.....++.|++.|++| ++.+|||+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 58999999999999999975543 2356888999999999999999 5689999999999999999999999999
Q ss_pred cccccCCC----CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh
Q 005450 497 AKWASTSS----SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 547 (696)
Q Consensus 497 A~~~~~~~----~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt 547 (696)
........ .....+.-.||..||+||.+.+..|+.|+||||||+||+||+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 98766554 1222344679999999999999999999999999999999997
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.9e-15 Score=140.45 Aligned_cols=136 Identities=23% Similarity=0.255 Sum_probs=115.5
Q ss_pred eeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC--cceeEEeeEEEecCceEEEEeecCCCC
Q 005450 352 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLVYDFLSRGS 429 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~H--pnIV~l~g~~~~~~~~~LV~Ey~~gGs 429 (696)
+.+.||.|.++.||++...+ ..+++|....... ...+..|+.++..++| .++++++.++...+..+++|||++++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 35789999999999999755 7899999876544 5678899999999986 589999999888888999999999877
Q ss_pred hhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 430 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 430 L~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
+..+ +......++.+++.+|.+||.....+++|+|++|.||++++++.++++|||.+...
T Consensus 80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 7654 34566778999999999999854457999999999999999899999999998643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.4e-15 Score=159.79 Aligned_cols=195 Identities=24% Similarity=0.312 Sum_probs=131.1
Q ss_pred CCcceeEEeeEEEe---------------------------cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHH
Q 005450 401 HHKNIISLLGFCFE---------------------------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVA 453 (696)
Q Consensus 401 ~HpnIV~l~g~~~~---------------------------~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia 453 (696)
+|||||+++++|.+ ...+|+||.-.+. +|.+++..+. .+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence 59999999988753 2358899988755 8999987553 3455667799
Q ss_pred HHHHHHHHHHhcCCCCceEeecccccceee--CCCC--ceEEeecCccccccCCCCC----cccccccccCCCCCcceec
Q 005450 454 MGVAEALEYLHSGSAQRVIHRDVKSSNILL--SDDF--EPQLSDFGLAKWASTSSSH----ITCTDVAGTFGYLAPEYFM 525 (696)
Q Consensus 454 ~qIa~aL~yLH~~~~~gIIHrDLKpsNILL--d~~~--~vKL~DFGlA~~~~~~~~~----~~~~~~~GT~~YlAPE~l~ 525 (696)
.|+++|+.|||+ +||.|||+|++|||| |+|+ .+.|+|||++-.-....-. ...-+.-|.-.-||||++.
T Consensus 348 aQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 999999999999 999999999999998 4444 3679999988533221111 1112345778899999986
Q ss_pred cCC------CCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHH
Q 005450 526 YGK------VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLA 599 (696)
Q Consensus 526 ~~~------~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~l 599 (696)
... .-.|+|.|+.|.+.||+++...||.......... ..+ .+..+ |.+.+..++ ..+ ++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~-r~Y-----qe~qL-----Palp~~vpp-~~r---ql 489 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT-RTY-----QESQL-----PALPSRVPP-VAR---QL 489 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech-hhh-----hhhhC-----CCCcccCCh-HHH---HH
Confidence 331 2348999999999999999999997632211111 001 11112 222222222 222 33
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 005450 600 SILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 600 a~~Cl~~dP~~RPSm~eVL~ 619 (696)
+...+++||.+||+..-...
T Consensus 490 V~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred HHHHhcCCccccCCccHHHh
Confidence 34478999999999654333
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.1e-15 Score=148.43 Aligned_cols=137 Identities=21% Similarity=0.262 Sum_probs=99.3
Q ss_pred eeeeeccCceEEEEEEeCCCCEEEEEEecCChhH---HHH----------------------HHHHHHHHHhcCCcc--e
Q 005450 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV---IKE----------------------FVLEIEIITTLHHKN--I 405 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~---~~~----------------------~~~Ei~iL~~L~Hpn--I 405 (696)
.+.||+|+||+||+|...+|+.||||+++..... ... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998753211 111 134666666665432 4
Q ss_pred eEEeeEEEecCceEEEEeecCCCChhhh-hhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC
Q 005450 406 ISLLGFCFEDNNLLLVYDFLSRGSLEEN-LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 484 (696)
Q Consensus 406 V~l~g~~~~~~~~~LV~Ey~~gGsL~~~-L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd 484 (696)
.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. ..+|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE
Confidence 444443 346999999999654322 21111 01 5677899999999999997 26799999999999999
Q ss_pred CCCceEEeecCccccccC
Q 005450 485 DDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 485 ~~~~vKL~DFGlA~~~~~ 502 (696)
++.++|+|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 88999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=4e-14 Score=146.49 Aligned_cols=134 Identities=15% Similarity=0.182 Sum_probs=104.6
Q ss_pred eeee-ccCceEEEEEEeCCCCEEEEEEecCCh--------------hHHHHHHHHHHHHHhcCCcce--eEEeeEEEecC
Q 005450 354 NLIG-KGGSSQVYKGCLPDGKELAVKILKPSE--------------DVIKEFVLEIEIITTLHHKNI--ISLLGFCFEDN 416 (696)
Q Consensus 354 ~~LG-~G~fG~Vyka~~~~g~~vAVK~l~~~~--------------~~~~~~~~Ei~iL~~L~HpnI--V~l~g~~~~~~ 416 (696)
..|| .||.|+||+.... +..++||++.... .....+.+|++++..+.|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5688 8999999998774 7789999885311 223567889999999998775 67777654432
Q ss_pred c----eEEEEeecCC-CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEE
Q 005450 417 N----LLLVYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 491 (696)
Q Consensus 417 ~----~~LV~Ey~~g-GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL 491 (696)
. .++|||+++| .+|.+++... .++.. .+.+++.+|.+||+ .||+||||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEE
Confidence 2 3599999997 6899887542 23333 35689999999999 99999999999999999889999
Q ss_pred eecCccccc
Q 005450 492 SDFGLAKWA 500 (696)
Q Consensus 492 ~DFGlA~~~ 500 (696)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.1e-15 Score=173.08 Aligned_cols=203 Identities=27% Similarity=0.345 Sum_probs=164.7
Q ss_pred CceeeeeeeccCceEEEEEEeCC--CCEEEEEEecCC---hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEE
Q 005450 349 NFLAENLIGKGGSSQVYKGCLPD--GKELAVKILKPS---EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~~--g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~LV~ 422 (696)
.|.+.+.||+|+|+.|-...... ...+|+|.+... .........|..+-..+. |+|++.+++.....+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 34556679999999998776533 345667766543 344455556777777777 999999999999999999999
Q ss_pred eecCCCChhhhh-hcCCCCCCCCChHHHHHHHHHHHHHHHHHh-cCCCCceEeecccccceeeCCCC-ceEEeecCcccc
Q 005450 423 DFLSRGSLEENL-HGNKKDPAAFGWSERYKVAMGVAEALEYLH-SGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKW 499 (696)
Q Consensus 423 Ey~~gGsL~~~L-~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH-~~~~~gIIHrDLKpsNILLd~~~-~vKL~DFGlA~~ 499 (696)
+|..|+++.+.+ +... ...+....-.++.|+..++.|+| . .++.||||||+|.+++..+ .++++|||+|..
T Consensus 101 ~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred CcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988 4322 13455667789999999999999 6 8899999999999999999 999999999998
Q ss_pred ccC-CCCCcccccccc-cCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Q 005450 500 AST-SSSHITCTDVAG-TFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 500 ~~~-~~~~~~~~~~~G-T~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~ 557 (696)
+.. ..........+| ++.|+|||...+ ....+..|+||.|+++.-+++|..|+.....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 877 555555556788 999999999887 4567789999999999999999999876544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.8e-13 Score=153.46 Aligned_cols=141 Identities=22% Similarity=0.288 Sum_probs=100.0
Q ss_pred eeeeeccCceEEEEEEeCCCCEEEEEEecCChhH-------------------------------HH----------HHH
Q 005450 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV-------------------------------IK----------EFV 391 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~-------------------------------~~----------~~~ 391 (696)
.+.||.|++|.||+|.+++|+.||||+.++.-.. .+ +|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 4689999999999999999999999999764100 00 134
Q ss_pred HHHHHHHhcC----CcceeEEeeEE-EecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHH-HHHHHhc
Q 005450 392 LEIEIITTLH----HKNIISLLGFC-FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE-ALEYLHS 465 (696)
Q Consensus 392 ~Ei~iL~~L~----HpnIV~l~g~~-~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~-aL~yLH~ 465 (696)
+|.+.+.++. |.+-+.+-..+ ......+|||||++|++|.+....... .. .+..++..++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHh
Confidence 4555555542 22222222222 223467999999999999987653211 11 23456666665 4678888
Q ss_pred CCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 466 ~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
.|++|+|+||.||+++.++.++|+|||++..++.
T Consensus 276 ---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 ---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8999999999999999999999999999876653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=2e-13 Score=155.58 Aligned_cols=172 Identities=17% Similarity=0.202 Sum_probs=105.2
Q ss_pred CchhHHhHhhhccccccccChHHHHHh------------hcCceeeeeeeccCceEEEEEEeCC-CCEEEEEEecCCh--
Q 005450 320 LPKELEGLHEKYSATCRLFNYQDLLSA------------TSNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSE-- 384 (696)
Q Consensus 320 ~~~~le~l~~~~~~~~~~f~~~el~~~------------t~~f~~~~~LG~G~fG~Vyka~~~~-g~~vAVK~l~~~~-- 384 (696)
+|+++.+...+.......|++++.... -..|.. +.||.|++|.||+|.+++ |+.||||++++.-
T Consensus 80 lP~~~~~eL~~Lqd~vpp~~~~~~~~~ie~elG~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~ 158 (537)
T PRK04750 80 FPPDIADELALLQDRVPPFDGALARAIIEKALGGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILP 158 (537)
T ss_pred CCHHHHHHHHHHHcCCCCCCHHHHHHHHHHHhCCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHH
Confidence 344444334444444455555443332 234665 789999999999999887 9999999998641
Q ss_pred ---------------------------------hHHHH------HHHHHHHHHhcC----CcceeEEeeEEEe-cCceEE
Q 005450 385 ---------------------------------DVIKE------FVLEIEIITTLH----HKNIISLLGFCFE-DNNLLL 420 (696)
Q Consensus 385 ---------------------------------~~~~~------~~~Ei~iL~~L~----HpnIV~l~g~~~~-~~~~~L 420 (696)
+..+. +.+|...+.+++ +.+.+.+-.++.+ ....+|
T Consensus 159 ~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VL 238 (537)
T PRK04750 159 VIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVM 238 (537)
T ss_pred HHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceE
Confidence 00111 223333333332 3333332222222 356789
Q ss_pred EEeecCCCChhhh--hhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC----ceEEeec
Q 005450 421 VYDFLSRGSLEEN--LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 494 (696)
Q Consensus 421 V~Ey~~gGsL~~~--L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~----~vKL~DF 494 (696)
||||++|+.|.+. +...+.+...+....+..++.|+ +. .|++|+|+||.||+++.++ .++++||
T Consensus 239 vmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDF 308 (537)
T PRK04750 239 VMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FR---DGFFHADMHPGNIFVSYDPPENPRYIALDF 308 (537)
T ss_pred EEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEec
Confidence 9999999999874 32222111122222233333333 33 7899999999999999888 9999999
Q ss_pred CccccccC
Q 005450 495 GLAKWAST 502 (696)
Q Consensus 495 GlA~~~~~ 502 (696)
|++..++.
T Consensus 309 Givg~l~~ 316 (537)
T PRK04750 309 GIVGSLNK 316 (537)
T ss_pred ceEEECCH
Confidence 99987755
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.9e-12 Score=122.72 Aligned_cols=130 Identities=22% Similarity=0.198 Sum_probs=97.2
Q ss_pred eeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCccee-EEeeEEEecCceEEEEeecCCCChh
Q 005450 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFLSRGSLE 431 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV-~l~g~~~~~~~~~LV~Ey~~gGsL~ 431 (696)
.+.|+.|.++.||++... +..|++|+..........+..|+.++..+.+.+++ +++.+. ....++||||++|.++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 467899999999998864 77899999876543334567899999998765544 444443 33468999999998876
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC--CCceEeecccccceeeCCCCceEEeecCccc
Q 005450 432 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 432 ~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~--~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
... . ....++.+++++|..||... ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 80 ~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 530 0 11235678999999999832 23369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.6e-11 Score=128.58 Aligned_cols=155 Identities=21% Similarity=0.300 Sum_probs=118.6
Q ss_pred HHHHhcCCcceeEEeeEEEec-----CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCC
Q 005450 395 EIITTLHHKNIISLLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469 (696)
Q Consensus 395 ~iL~~L~HpnIV~l~g~~~~~-----~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~ 469 (696)
.-|-++-|.|||+++.|+.+. ....++.|||..|+|..+|++.+.....+......+++.||+.||.|||+.. .
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 345566799999999988643 3578999999999999999987766667888888899999999999999855 7
Q ss_pred ceEeecccccceeeCCCCceEEeecCccccccCCCCC-c--ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHH
Q 005450 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH-I--TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 546 (696)
Q Consensus 470 gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~-~--~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELl 546 (696)
.|+|+++...-|++..++-+|+.-- ........... . ....-.+-++|.|||+=...+.+..+|||+||...+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 8999999999999999888887521 11101000000 0 001124678999999877777888999999999999998
Q ss_pred hCCCC
Q 005450 547 TGRKP 551 (696)
Q Consensus 547 tG~~P 551 (696)
-+..-
T Consensus 277 ilEiq 281 (458)
T KOG1266|consen 277 ILEIQ 281 (458)
T ss_pred Hheec
Confidence 87653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2e-11 Score=136.96 Aligned_cols=247 Identities=22% Similarity=0.245 Sum_probs=176.3
Q ss_pred Cceeeeeeec--cCceEEEEEEe---CCCCEEEEEEecC--C-hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceE
Q 005450 349 NFLAENLIGK--GGSSQVYKGCL---PDGKELAVKILKP--S-EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 349 ~f~~~~~LG~--G~fG~Vyka~~---~~g~~vAVK~l~~--~-~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~ 419 (696)
.|.+...+|. |.+|.||.+.. .++..+|+|.-+. . ......-.+|+....+++ |+|.++.+..+...+.++
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566788999 99999999875 4688899987432 1 122333455666666664 999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHH----HHHHHhcCCCCceEeecccccceeeCCC-CceEEeec
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE----ALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDF 494 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~----aL~yLH~~~~~gIIHrDLKpsNILLd~~-~~vKL~DF 494 (696)
+-+|++. .+|..+.+.... .++....+.++..... ||.++|. .+++|-|+||.||++..+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCc
Confidence 9999885 688888775543 3555666677777777 9999999 889999999999999999 88999999
Q ss_pred CccccccCCCCCccc---ccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccc
Q 005450 495 GLAKWASTSSSHITC---TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 571 (696)
Q Consensus 495 GlA~~~~~~~~~~~~---~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~ 571 (696)
|+...+......... ....|..-|++||..+ +-++...|||+||.++++-.+|..+...... ..|.. +
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~~--~ 338 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWSQ--L 338 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC------CCccc--c
Confidence 999887765422211 2235778899999877 6788999999999999999998776543211 01211 1
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 572 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 572 ~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+.+. +..++...-...+-....++++.+|..|++.+.+..
T Consensus 339 r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 RQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1111 111111111122223666799999999999887664
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.3e-10 Score=113.75 Aligned_cols=136 Identities=17% Similarity=0.199 Sum_probs=99.5
Q ss_pred eeeeeccCceEEEEEEeCC-------CCEEEEEEecCC-------------h----------hHHHHHH----HHHHHHH
Q 005450 353 ENLIGKGGSSQVYKGCLPD-------GKELAVKILKPS-------------E----------DVIKEFV----LEIEIIT 398 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~-------g~~vAVK~l~~~-------------~----------~~~~~~~----~Ei~iL~ 398 (696)
...||.|--+.||.|...+ +..+|||+.+.+ + ...+.+. +|.+.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 479999998631 0 0112223 7999999
Q ss_pred hcCC--cceeEEeeEEEecCceEEEEeecCCCChhh-hhhcCCCCCCCCChHHHHHHHHHHHHHHHHH-hcCCCCceEee
Q 005450 399 TLHH--KNIISLLGFCFEDNNLLLVYDFLSRGSLEE-NLHGNKKDPAAFGWSERYKVAMGVAEALEYL-HSGSAQRVIHR 474 (696)
Q Consensus 399 ~L~H--pnIV~l~g~~~~~~~~~LV~Ey~~gGsL~~-~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yL-H~~~~~gIIHr 474 (696)
++.. -++..++++ ..-+|||||+.+..+.. .+... .++......+..+++.+|..| |. .+|||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~---~glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKE---CNLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 9863 456666654 46789999998754432 22211 234455677889999999999 78 899999
Q ss_pred cccccceeeCCCCceEEeecCcccccc
Q 005450 475 DVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 475 DLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
||++.|||+++ +.+.|+|||.+....
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 99999999974 689999999886544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.4e-10 Score=114.57 Aligned_cols=141 Identities=20% Similarity=0.277 Sum_probs=110.9
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEecCChh--HHHHHHHHHHHHHhcCC--cceeEEeeEEEec---CceEEEEeecC
Q 005450 354 NLIGKGGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHH--KNIISLLGFCFED---NNLLLVYDFLS 426 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~L~H--pnIV~l~g~~~~~---~~~~LV~Ey~~ 426 (696)
+.|+.|..+.||++...+|+.+++|+...... ....+..|.+++..+.+ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778999999876443 45678899999999976 4467777776653 25689999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--------------------------------------- 467 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~--------------------------------------- 467 (696)
|.++.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988876532 13566777788888888888888521
Q ss_pred --------------CCceEeecccccceeeCC--CCceEEeecCcccc
Q 005450 468 --------------AQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKW 499 (696)
Q Consensus 468 --------------~~gIIHrDLKpsNILLd~--~~~vKL~DFGlA~~ 499 (696)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.4e-09 Score=105.38 Aligned_cols=130 Identities=23% Similarity=0.335 Sum_probs=101.0
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEecCC---------hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 354 NLIGKGGSSQVYKGCLPDGKELAVKILKPS---------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~---------~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
..+++|+-+.+|.+... |.++++|.-.+. +-...+-.+|.+++.+++--.|...+-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999998663 444777754331 12235567899999999866666666667777888999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
++|..|.+.+... ...++..+-.-+.-||. .+|+|+||.++||++..+. +.++||||+.+
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888654 13466677777888999 8999999999999998774 99999999863
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.6e-09 Score=121.33 Aligned_cols=165 Identities=24% Similarity=0.292 Sum_probs=126.7
Q ss_pred eCCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChH
Q 005450 369 LPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWS 447 (696)
Q Consensus 369 ~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~ 447 (696)
..++.+|.|+.++... .......+-++.|+.++||||++++..+......|||+|-+. .|..++... +..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence 4577888888876543 344556778899999999999999999999999999999884 577777643 245
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccC
Q 005450 448 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 527 (696)
Q Consensus 448 ~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~ 527 (696)
.....+.||+.||.|||+. .+++|++|.-..|+++..|+.||++|-++........... ...---.|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~--~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAK--SLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccc--cchhhhcccChhhcCcc
Confidence 6667889999999999963 5799999999999999999999999988765444322111 11122346777765433
Q ss_pred CCCCcccchhhHHHHHHHHhC
Q 005450 528 KVNDKIDVYAFGVVLLELLTG 548 (696)
Q Consensus 528 ~~s~ksDVwSLGvvL~ELltG 548 (696)
. -..|.|-||++++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.2e-10 Score=126.34 Aligned_cols=244 Identities=22% Similarity=0.171 Sum_probs=167.2
Q ss_pred hhcCceeeeeeeccCceEEEEEEe--CCCCEEEEEEecCChh---HHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSED---VIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~--~~g~~vAVK~l~~~~~---~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~ 419 (696)
.+.+|.....||.|.|+.||.... .++..|++|.+.+.-. ....-..|+-+...+ .|.+++..+..+......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 356788899999999999998764 4688899998765321 111123455555555 4888999888888888888
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC-CceEEeecCccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAK 498 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~-~~vKL~DFGlA~ 498 (696)
+--||++++++...+.. ...+....++++..+++.++.++|+ +.++|+|+||+||++..+ +.-++.|||++.
T Consensus 343 ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccc
Confidence 99999999988876622 2246677888999999999999999 899999999999999886 788999999986
Q ss_pred cccCCCCCcccccccccCCCC--CcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 499 WASTSSSHITCTDVAGTFGYL--APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 499 ~~~~~~~~~~~~~~~GT~~Yl--APE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
.+.-.. ....++-++. +|+......+..+.|+||||.-+.+.++|...-... +.|.. +..+..
T Consensus 416 ~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~--------~~~~~--i~~~~~ 480 (524)
T KOG0601|consen 416 RLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG--------VQSLT--IRSGDT 480 (524)
T ss_pred ccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccc--------cccee--eecccc
Confidence 422111 1122333344 455555567888999999999999999986532211 11111 111111
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L 621 (696)
+.+.. ...+. ..++..++..++..||.+.++..+.
T Consensus 481 -----p~~~~--~~~~~---q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 481 -----PNLPG--LKLQL---QVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred -----cCCCc--hHHhh---hhhhhhhcCCccccchhhhhhcccc
Confidence 11111 11222 2333448889999999988765543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.1e-08 Score=100.43 Aligned_cols=141 Identities=22% Similarity=0.293 Sum_probs=105.9
Q ss_pred eeeeeeccCceEEEEEEeCCCCEEEEEEecCC---------hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 352 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS---------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~---------~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
...+|-+|+-+.|+++.. .|+.++||.-... .-..++..+|+++|.+++--.|.-..-++.+.+.-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999887 6777777754321 223467788999999987656665556677777889999
Q ss_pred eecCC-CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc---eEEeecCccc
Q 005450 423 DFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLAK 498 (696)
Q Consensus 423 Ey~~g-GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~---vKL~DFGlA~ 498 (696)
||++| .++.+++....... ........++..|-+.+.-||. .+|||+||.++||+|..++. +.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchh
Confidence 99987 47777776543321 1122226778888889999999 88999999999999965543 5899999974
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.4e-10 Score=132.17 Aligned_cols=206 Identities=23% Similarity=0.306 Sum_probs=150.2
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
..+.|.+.+-+-.|.++.++.+.-. .|...++|+..... ...+....+-.++-..++|.++...--+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4456777788889999999877632 34444555444322 122333334444444556777776666666778999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
+++|+.+++|...|+... ..+.......+..+..+++|||. ..+.|||++|.|+|+..+++.+++|||.....
T Consensus 882 ~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccc
Confidence 999999999999998665 23444445566778889999998 66899999999999999999999999844321
Q ss_pred cCC----CC---------------------C----cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCC
Q 005450 501 STS----SS---------------------H----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551 (696)
Q Consensus 501 ~~~----~~---------------------~----~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~P 551 (696)
... .. . .......||+.|++||...+......+|+|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 110 00 0 001225689999999999999999999999999999999999999
Q ss_pred CCCCCcc
Q 005450 552 ISNDHPK 558 (696)
Q Consensus 552 f~~~~~~ 558 (696)
|....+.
T Consensus 1035 ~na~tpq 1041 (1205)
T KOG0606|consen 1035 FNAETPQ 1041 (1205)
T ss_pred CCCcchh
Confidence 9877654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.5e-08 Score=99.66 Aligned_cols=125 Identities=23% Similarity=0.306 Sum_probs=84.7
Q ss_pred EEEEEEeCCCCEEEEEEecCC---------------h------------hHHHHHHHHHHHHHhcCCc--ceeEEeeEEE
Q 005450 363 QVYKGCLPDGKELAVKILKPS---------------E------------DVIKEFVLEIEIITTLHHK--NIISLLGFCF 413 (696)
Q Consensus 363 ~Vyka~~~~g~~vAVK~l~~~---------------~------------~~~~~~~~Ei~iL~~L~Hp--nIV~l~g~~~ 413 (696)
.||.|...+|..+|||+.+.. . .......+|.+.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999999999999998641 0 1123466799999999865 466666542
Q ss_pred ecCceEEEEeecC--CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH-HhcCCCCceEeecccccceeeCCCCceE
Q 005450 414 EDNNLLLVYDFLS--RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY-LHSGSAQRVIHRDVKSSNILLSDDFEPQ 490 (696)
Q Consensus 414 ~~~~~~LV~Ey~~--gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~y-LH~~~~~gIIHrDLKpsNILLd~~~~vK 490 (696)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|. .||+|+||.+.|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEE
Confidence 4589999999 65555544321 1234456677788875555 567 899999999999999988 999
Q ss_pred EeecCcccccc
Q 005450 491 LSDFGLAKWAS 501 (696)
Q Consensus 491 L~DFGlA~~~~ 501 (696)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999886443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=9.9e-08 Score=100.56 Aligned_cols=139 Identities=18% Similarity=0.168 Sum_probs=100.3
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEecCCh--hHHH----------HHHHHHHHHHhcCCcc--eeEEeeEEEe-----
Q 005450 354 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIK----------EFVLEIEIITTLHHKN--IISLLGFCFE----- 414 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~--~~~~----------~~~~Ei~iL~~L~Hpn--IV~l~g~~~~----- 414 (696)
+.+-.-....|++... +|+.|.||...... ...+ .+.+|.+.+..+..-+ .+.++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445667655 67889999875433 1122 3778999998885433 3344555543
Q ss_pred cCceEEEEeecCCC-ChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC-------C
Q 005450 415 DNNLLLVYDFLSRG-SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-------D 486 (696)
Q Consensus 415 ~~~~~LV~Ey~~gG-sL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~-------~ 486 (696)
....+||||++++. +|.+++..... ...+...+..++.+++..+.-||. .||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCC
Confidence 23578999999986 89998853221 134556777899999999999999 99999999999999975 4
Q ss_pred CceEEeecCccc
Q 005450 487 FEPQLSDFGLAK 498 (696)
Q Consensus 487 ~~vKL~DFGlA~ 498 (696)
..+.|+||+.+.
T Consensus 182 ~~~~LIDl~r~~ 193 (268)
T PRK15123 182 LKLSVIDLHRAQ 193 (268)
T ss_pred ceEEEEECCccc
Confidence 679999999875
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=6.4e-08 Score=110.25 Aligned_cols=171 Identities=19% Similarity=0.261 Sum_probs=106.6
Q ss_pred CchhHHhHhhhccccccccChHHHHHhh------------cCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCCh---
Q 005450 320 LPKELEGLHEKYSATCRLFNYQDLLSAT------------SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE--- 384 (696)
Q Consensus 320 ~~~~le~l~~~~~~~~~~f~~~el~~~t------------~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~--- 384 (696)
+|++..+...+....+..|++++....- ..|. .+.|+.++-|.||+|.+++|+.||||+.+++-
T Consensus 86 ~p~e~~~eL~~LQD~vpp~~~~~~~~iie~eLG~~iee~F~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~ 164 (517)
T COG0661 86 VPPEYAEELAKLQDRVPPFPFEEAERIIEEELGRPIEELFSEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRER 164 (517)
T ss_pred cCHHHHHHHHHhhcCCCCCCHHHHHHHHHHHhCCCHHHHHHHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHH
Confidence 4444444444444555555554443322 1232 36799999999999999999999999988630
Q ss_pred ----------------------------hHHH----H------HHHHHHHHHhcC-----CcceeEEeeEEEecCceEEE
Q 005450 385 ----------------------------DVIK----E------FVLEIEIITTLH-----HKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 385 ----------------------------~~~~----~------~~~Ei~iL~~L~-----HpnIV~l~g~~~~~~~~~LV 421 (696)
...+ . +.+|..-+.+++ .+++.-..-|..-.+..+|+
T Consensus 165 i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLt 244 (517)
T COG0661 165 IEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLT 244 (517)
T ss_pred HHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEE
Confidence 0011 1 223333344432 24433333333334678999
Q ss_pred EeecCCCChhhhh--hcCCCCCCCCChHHHHHHHHHHHHH-HHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 422 YDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEA-LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 422 ~Ey~~gGsL~~~L--~~~~~~~~~l~~~~~~~Ia~qIa~a-L~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
|||++|-.+.+.. ...+ ++.+ .|+..++++ +..+-. .|++|.|..|.||+++.++.+.+.|||+..
T Consensus 245 mE~i~Gi~i~d~~~l~~~g-----~d~k---~ia~~~~~~f~~q~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g 313 (517)
T COG0661 245 MEWIDGIKISDIAALKSAG-----IDRK---ELAELLVRAFLRQLLR---DGFFHADPHPGNILVRSDGRIVLLDFGIVG 313 (517)
T ss_pred EEeeCCEecccHHHHHhcC-----CCHH---HHHHHHHHHHHHHHHh---cCccccCCCccceEEecCCcEEEEcCccee
Confidence 9999999999874 3322 3322 233333322 122222 679999999999999999999999999987
Q ss_pred cccC
Q 005450 499 WAST 502 (696)
Q Consensus 499 ~~~~ 502 (696)
.++.
T Consensus 314 ~l~~ 317 (517)
T COG0661 314 RLDP 317 (517)
T ss_pred cCCH
Confidence 6654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.8e-07 Score=103.70 Aligned_cols=170 Identities=21% Similarity=0.278 Sum_probs=129.0
Q ss_pred CceEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEE----ecCceEEEEeecCCC-Chhh
Q 005450 360 GSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCF----EDNNLLLVYDFLSRG-SLEE 432 (696)
Q Consensus 360 ~fG~Vyka~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~----~~~~~~LV~Ey~~gG-sL~~ 432 (696)
-..+.|++.. -||..|++|++...+ ........-+++++++.|+|+|++.++|. .+..+++||+|.++. +|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3467899885 489999999995432 22234455678999999999999999886 345789999999864 7777
Q ss_pred hhhcCCC-----------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 433 NLHGNKK-----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 433 ~L~~~~~-----------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
+...... .....++..+|.++.|+..||.++|+ .|+.-+-|.+.+||++.+.+++|+..|+.....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 5543321 22456788999999999999999999 788889999999999999999999888876655
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~P 551 (696)
.+.. |-+. --.+-|.=.||.+++.|.||..-
T Consensus 445 ~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 5431 1111 12256888899999999999553
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.6e-07 Score=94.24 Aligned_cols=133 Identities=20% Similarity=0.221 Sum_probs=95.8
Q ss_pred ceeeeeeeccCceEEEEEEeCCCCEEEEEEecCCh-----------------------hHHHHHHHHHHHHHhcCCc--c
Q 005450 350 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-----------------------DVIKEFVLEIEIITTLHHK--N 404 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~-----------------------~~~~~~~~Ei~iL~~L~Hp--n 404 (696)
..+.+.||-|--+.||.|..+.|.++|||.-+... -......+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678899999999999999999999999865210 1123466799999999754 6
Q ss_pred eeEEeeEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC
Q 005450 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 484 (696)
Q Consensus 405 IV~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd 484 (696)
+.+.+++ +.-.+||||++|-.|...--. .-.... |+..|++-+.-+-. .||||+|+.+-|||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~~------~en~~~---il~~il~~~~~~~~---~GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRLD------VENPDE---ILDKILEEVRKAYR---RGIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccCc------ccCHHH---HHHHHHHHHHHHHH---cCccccCCchheEEEe
Confidence 7777765 566899999999776654310 111222 33333333333334 7899999999999999
Q ss_pred CCCceEEeecCccc
Q 005450 485 DDFEPQLSDFGLAK 498 (696)
Q Consensus 485 ~~~~vKL~DFGlA~ 498 (696)
++|.+.++||--+.
T Consensus 237 ~dg~~~vIDwPQ~v 250 (304)
T COG0478 237 EDGDIVVIDWPQAV 250 (304)
T ss_pred cCCCEEEEeCcccc
Confidence 99999999996543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.4e-07 Score=104.18 Aligned_cols=172 Identities=21% Similarity=0.263 Sum_probs=109.0
Q ss_pred CCchhHHhHhhhccccccccChHHHHHhhcC---------c--eeeeeeeccCceEEEEEEeCCCCEEEEEEecCCh---
Q 005450 319 ELPKELEGLHEKYSATCRLFNYQDLLSATSN---------F--LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE--- 384 (696)
Q Consensus 319 ~~~~~le~l~~~~~~~~~~f~~~el~~~t~~---------f--~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~--- 384 (696)
-+|++.-.........+..|+++++...-.. | -..+.||.-+.|.||+|++++|+.||||+-++.-
T Consensus 121 llP~Eyv~~L~~LqD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~ 200 (538)
T KOG1235|consen 121 LLPKEYVKTLSELQDQAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKL 200 (538)
T ss_pred cCcHHHHHHHHHHhccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHH
Confidence 3566666656666667777777776554321 1 1246799999999999999999999999987620
Q ss_pred -----------------------------hHHHH------HHHHHHH----HHhcCCcc------eeEEeeEEEecCceE
Q 005450 385 -----------------------------DVIKE------FVLEIEI----ITTLHHKN------IISLLGFCFEDNNLL 419 (696)
Q Consensus 385 -----------------------------~~~~~------~~~Ei~i----L~~L~Hpn------IV~l~g~~~~~~~~~ 419 (696)
+..+. |.+|.+- ...+.|-+ |.+++-.+ ....+
T Consensus 201 ~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RV 278 (538)
T KOG1235|consen 201 IMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRV 278 (538)
T ss_pred HHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceE
Confidence 11112 2223322 22233444 33333322 34789
Q ss_pred EEEeecCCCChhhhh--hcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC----CCceEEee
Q 005450 420 LVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD----DFEPQLSD 493 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L--~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~----~~~vKL~D 493 (696)
|+||||+|..+.+.- ...+ ++... |+..+.++ |++.-...|++|+|-.|.||+++. ++.+.+-|
T Consensus 279 LtME~~~G~~i~Dl~~i~~~g-----i~~~~---i~~~l~~~--~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllD 348 (538)
T KOG1235|consen 279 LTMEYVDGIKINDLDAIDKRG-----ISPHD---ILNKLVEA--YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLD 348 (538)
T ss_pred EEEEecCCccCCCHHHHHHcC-----CCHHH---HHHHHHHH--HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEc
Confidence 999999999888753 3332 33333 33333332 222111267999999999999983 67899999
Q ss_pred cCccccccC
Q 005450 494 FGLAKWAST 502 (696)
Q Consensus 494 FGlA~~~~~ 502 (696)
||+...+..
T Consensus 349 hGl~~~is~ 357 (538)
T KOG1235|consen 349 HGLYAVISH 357 (538)
T ss_pred ccccccccH
Confidence 999876654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=7.6e-07 Score=96.75 Aligned_cols=194 Identities=17% Similarity=0.213 Sum_probs=126.3
Q ss_pred eeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeE------EEecC-ceEEEEe
Q 005450 352 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGF------CFEDN-NLLLVYD 423 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~------~~~~~-~~~LV~E 423 (696)
..+.||+|+-+.+|-.- .-...+.|++.......+.-+ +..|... .||-+-.=+.| .-.+. ..-+.|.
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk--~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK--VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHHH--HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 45779999999999532 222345677764332211111 1122222 34432221111 11122 2567788
Q ss_pred ecCCCC-hhhhhh--cCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 424 FLSRGS-LEENLH--GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 424 y~~gGs-L~~~L~--~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
.+++.. +..++. ..+.....+.|...++++..++.+.+-||. .|.+-+|++++|+|+++++.+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 777652 222221 112233457899999999999999999999 88899999999999999999999985443322
Q ss_pred cCCCCCcccccccccCCCCCcceec-----cCCCCCcccchhhHHHHHHHHhC-CCCCCCC
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTG-RKPISND 555 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~-----~~~~s~ksDVwSLGvvL~ELltG-~~Pf~~~ 555 (696)
..+. .....+|...|.+||.-. +..-+...|-|.||+++++||.| ++||.+.
T Consensus 168 ~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 168 ANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred cCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 2221 122367999999999654 44567789999999999999886 9999764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.4e-06 Score=88.07 Aligned_cols=107 Identities=19% Similarity=0.202 Sum_probs=83.8
Q ss_pred HHHHHHHHHHHHhcCC--cceeEEeeEEEecC----ceEEEEeecCCC-ChhhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 005450 387 IKEFVLEIEIITTLHH--KNIISLLGFCFEDN----NLLLVYDFLSRG-SLEENLHGNKKDPAAFGWSERYKVAMGVAEA 459 (696)
Q Consensus 387 ~~~~~~Ei~iL~~L~H--pnIV~l~g~~~~~~----~~~LV~Ey~~gG-sL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~a 459 (696)
.....+|...+..|.. -.+.+.+++..... ..+||+|++++. +|.+++..... .+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHH
Confidence 3467788888888853 33555666665422 458999999985 79998875332 4456678899999999
Q ss_pred HHHHhcCCCCceEeecccccceeeCCCC---ceEEeecCccccc
Q 005450 460 LEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLSDFGLAKWA 500 (696)
Q Consensus 460 L~yLH~~~~~gIIHrDLKpsNILLd~~~---~vKL~DFGlA~~~ 500 (696)
+.-||. .||+|+|+++.|||++.+. .+.|+||+-++..
T Consensus 131 i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 9999999999999999887 7999999987644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.34 E-value=4.4e-06 Score=84.75 Aligned_cols=136 Identities=19% Similarity=0.156 Sum_probs=100.9
Q ss_pred eeccCceEEEEEEeCCCCEEEEEEecCC-------hhHHHHHHHHHHHHHhcCCc--ceeEEeeEEEe-----cCceEEE
Q 005450 356 IGKGGSSQVYKGCLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTLHHK--NIISLLGFCFE-----DNNLLLV 421 (696)
Q Consensus 356 LG~G~fG~Vyka~~~~g~~vAVK~l~~~-------~~~~~~~~~Ei~iL~~L~Hp--nIV~l~g~~~~-----~~~~~LV 421 (696)
-|+||.+.|++-.. +|+.+-+|.-... .-....|.+|+..|..|..- .+.++. ++.. ....+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 47899999999765 4446888876521 12456899999999998632 244444 3321 1246899
Q ss_pred EeecCC-CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc--eEEeecCccc
Q 005450 422 YDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--PQLSDFGLAK 498 (696)
Q Consensus 422 ~Ey~~g-GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~--vKL~DFGlA~ 498 (696)
+|-+.| -+|.+++..... ...+...+..++.+++..+.-||. .|+.|+|+.+.|||++.++. ++++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997764 488888865432 235667778999999999999999 99999999999999986666 9999997654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=3e-07 Score=105.25 Aligned_cols=153 Identities=22% Similarity=0.355 Sum_probs=97.8
Q ss_pred HHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcc--c-----ccccccCCCCCcceec
Q 005450 453 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT--C-----TDVAGTFGYLAPEYFM 525 (696)
Q Consensus 453 a~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~--~-----~~~~GT~~YlAPE~l~ 525 (696)
+.+++.||.|+|. ..++||++|.|++|.++.++..||+.|+++........... + .-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3445589999998 36799999999999999999999999998865444211100 0 0022456799999999
Q ss_pred cCCCCCcccchhhHHHHHHHHhCCCC-CCCCCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhc
Q 005450 526 YGKVNDKIDVYAFGVVLLELLTGRKP-ISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCI 604 (696)
Q Consensus 526 ~~~~s~ksDVwSLGvvL~ELltG~~P-f~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl 604 (696)
....+.++|+|||||++|.+..|..+ +............... ...+.. ....+.+.+..+. ....+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~---~~~~~~------~~s~~~p~el~~~----l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL---LNAGAF------GYSNNLPSELRES----LKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc---cccccc------cccccCcHHHHHH----HHHHh
Confidence 98899999999999999999955444 4332211111111000 000000 0012223333333 33478
Q ss_pred ccCCCCCCCHHHHHHH
Q 005450 605 RRDPRARPQMSLVLKL 620 (696)
Q Consensus 605 ~~dP~~RPSm~eVL~~ 620 (696)
..++.-||++.+++..
T Consensus 250 ~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLSI 265 (700)
T ss_pred cCCcccCcchhhhhcc
Confidence 8999999988876643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.28 E-value=9.2e-06 Score=81.53 Aligned_cols=144 Identities=21% Similarity=0.263 Sum_probs=87.3
Q ss_pred eeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCc--ceeEEeeEEEe---cCceEEEEeecCC
Q 005450 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGFCFE---DNNLLLVYDFLSR 427 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hp--nIV~l~g~~~~---~~~~~LV~Ey~~g 427 (696)
.+.|+.|..+.||+....+ ..+++|+.... .....+..|..++..+... .+.+++.++.. ....+++|++++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 4678999999999998877 69999998766 5667788899998888533 35566664432 3347899999999
Q ss_pred CChhh----------------hh---hcCCCCCCCCChHH---------HHHH------------HHHHHH-HHHHHhc-
Q 005450 428 GSLEE----------------NL---HGNKKDPAAFGWSE---------RYKV------------AMGVAE-ALEYLHS- 465 (696)
Q Consensus 428 GsL~~----------------~L---~~~~~~~~~l~~~~---------~~~I------------a~qIa~-aL~yLH~- 465 (696)
..+.. .+ +........+.+.. .... ...+.+ .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88877 11 11110101111111 0000 111222 2333332
Q ss_pred ---CCCCceEeecccccceeeC-CCCceEEeecCccc
Q 005450 466 ---GSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAK 498 (696)
Q Consensus 466 ---~~~~gIIHrDLKpsNILLd-~~~~vKL~DFGlA~ 498 (696)
.....++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2347799999999999999 56666799998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.28 E-value=9.9e-06 Score=83.32 Aligned_cols=138 Identities=17% Similarity=0.245 Sum_probs=86.6
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc--eeEEeeEEEecCceEEEEeecCCCC-h
Q 005450 354 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN--IISLLGFCFEDNNLLLVYDFLSRGS-L 430 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hpn--IV~l~g~~~~~~~~~LV~Ey~~gGs-L 430 (696)
..||+|..+.||+. .|..+++|...... ......+|.+++..+..-. +.+.+.++...+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 57899999999983 35568899887633 3345688999999986433 4677788777777889999999963 2
Q ss_pred hhh---------------------hhcCCCCCCCCChHHHH-HHHH----------HHHH-HHHHHhc-CCCCceEeecc
Q 005450 431 EEN---------------------LHGNKKDPAAFGWSERY-KVAM----------GVAE-ALEYLHS-GSAQRVIHRDV 476 (696)
Q Consensus 431 ~~~---------------------L~~~~~~~~~l~~~~~~-~Ia~----------qIa~-aL~yLH~-~~~~gIIHrDL 476 (696)
... ||..... ........ .+.. .+.+ ...+|.. .....++|+|+
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~--~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCD--TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC--CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 111 1211101 11111100 0000 0011 1222221 12245799999
Q ss_pred cccceeeCCCCceEEeecCccc
Q 005450 477 KSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 477 KpsNILLd~~~~vKL~DFGlA~ 498 (696)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999887 9999998875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.1e-05 Score=82.23 Aligned_cols=136 Identities=15% Similarity=0.156 Sum_probs=91.0
Q ss_pred hhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHH----------HHHHHHHHHhcCC---cceeEEeeE-
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKE----------FVLEIEIITTLHH---KNIISLLGF- 411 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~----------~~~Ei~iL~~L~H---pnIV~l~g~- 411 (696)
...+|...+++-......|.+... +|+.+++|..+......++ ..+++..+..++. -.+..++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 356788888888888888887666 6688999998763321111 1223333333322 222222222
Q ss_pred ----EEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC
Q 005450 412 ----CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 487 (696)
Q Consensus 412 ----~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~ 487 (696)
+......+|+|||++|..|.+... +.. .++..+.+++.-||. .|++|+|..|.|++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-
Confidence 222345679999999988876542 111 245667788999999 999999999999999965
Q ss_pred ceEEeecCccc
Q 005450 488 EPQLSDFGLAK 498 (696)
Q Consensus 488 ~vKL~DFGlA~ 498 (696)
.++++||+..+
T Consensus 172 ~i~iID~~~k~ 182 (229)
T PF06176_consen 172 GIRIIDTQGKR 182 (229)
T ss_pred cEEEEECcccc
Confidence 59999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.13 E-value=4.4e-07 Score=102.86 Aligned_cols=184 Identities=22% Similarity=0.193 Sum_probs=136.6
Q ss_pred eeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc-eeEEeeEEEecCceEEEEeecCCC-Ch
Q 005450 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVYDFLSRG-SL 430 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~g~~~~~~~~~LV~Ey~~gG-sL 430 (696)
-.-+++|+++.+||.+-.-.+....+.+... ....-++++|.+++||| .+..++-+..+...+++++++.++ +-
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 3456899999999977544444556666543 34556889999999999 777777787788899999999887 22
Q ss_pred hhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccc
Q 005450 431 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 510 (696)
Q Consensus 431 ~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~ 510 (696)
..... .....+...+...+...-+++|+|||+ ..-+||| ||+..+ +..+..||+.+..+.... ...
T Consensus 323 ~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~ 388 (829)
T KOG0576|consen 323 ALEMT---VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPR 388 (829)
T ss_pred cccCC---hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---ccc
Confidence 21111 111233444555667777889999998 3348998 888776 589999999988776644 233
Q ss_pred cccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCC
Q 005450 511 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 554 (696)
Q Consensus 511 ~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~ 554 (696)
...+|+.++|||+...+.+..+.|.|++|+--.+|--|-+|-..
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 47899999999999999999999999999988888888777544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.12 E-value=3e-05 Score=79.93 Aligned_cols=140 Identities=19% Similarity=0.159 Sum_probs=86.4
Q ss_pred eeccCc-eEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEeecCCCChhhh
Q 005450 356 IGKGGS-SQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSLEEN 433 (696)
Q Consensus 356 LG~G~f-G~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL~~~ 433 (696)
|-.|.+ ..||+.... +..+++|+..... ...+.+|++++..+. +--+.+++++....+..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444555 789998764 4788999887543 345678999988884 34466778877766678999999999877643
Q ss_pred h-------------------hcCCCCCCCCC--hHHHHHHHH--------------------HHHHHHHHHhc----CCC
Q 005450 434 L-------------------HGNKKDPAAFG--WSERYKVAM--------------------GVAEALEYLHS----GSA 468 (696)
Q Consensus 434 L-------------------~~~~~~~~~l~--~~~~~~Ia~--------------------qIa~aL~yLH~----~~~ 468 (696)
. |........+. ......... .+...+..|-. ...
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 11111010111 000000000 01111222211 112
Q ss_pred CceEeecccccceeeCCCCceEEeecCccc
Q 005450 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 469 ~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
..++|+|+.|.|||++++..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 558999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.04 E-value=7.7e-05 Score=77.15 Aligned_cols=151 Identities=23% Similarity=0.246 Sum_probs=97.9
Q ss_pred ChHHHHHhhcCceeee---eeeccCceEEEEEEeCCCCEEEEEEecCChhH--------------------H-----HHH
Q 005450 339 NYQDLLSATSNFLAEN---LIGKGGSSQVYKGCLPDGKELAVKILKPSEDV--------------------I-----KEF 390 (696)
Q Consensus 339 ~~~el~~~t~~f~~~~---~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~--------------------~-----~~~ 390 (696)
+...+....+...+.. .|..|--+.||+|...++..+|||+++..... . .-.
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3445555555555544 45577778899999989999999999753111 0 112
Q ss_pred HHHHHHHHhcC--CcceeEEeeEEEecCceEEEEeecCCCChh-hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 005450 391 VLEIEIITTLH--HKNIISLLGFCFEDNNLLLVYDFLSRGSLE-ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 467 (696)
Q Consensus 391 ~~Ei~iL~~L~--HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL~-~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~ 467 (696)
..|..-|.++. +-.+.+.+++. .-.|||||+....+. -.|.. ..+...+...+..++++.+.-|-.
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~-- 184 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYK-- 184 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHH--
Confidence 34666666664 44455556554 568999999664111 11111 112222455666667766666654
Q ss_pred CCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 468 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 468 ~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
..++||+||..-|||+. ++.+.|+|||-|....
T Consensus 185 ~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 25799999999999999 7799999999886544
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.4e-05 Score=78.26 Aligned_cols=105 Identities=25% Similarity=0.268 Sum_probs=83.3
Q ss_pred HHHHHHHHhcCC-cceeEEeeEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCC
Q 005450 391 VLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469 (696)
Q Consensus 391 ~~Ei~iL~~L~H-pnIV~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~ 469 (696)
..|.-++..+++ +++++++|+| ..++|.||...+++..... .-..-...+|..|.+|+.++++.+.+|++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357888888876 6999999999 4477899998876653210 001112368999999999999999999987656
Q ss_pred ceEeecccccceeeCCCCceEEeecCccccc
Q 005450 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 470 gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
.+.-.|++++|+-+++++++|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 6888999999999999999999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.92 E-value=8.3e-05 Score=75.99 Aligned_cols=142 Identities=20% Similarity=0.238 Sum_probs=83.7
Q ss_pred eeeeeccCceEEEEEEeCC--CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc-eeEEeeEEEecCceEEEEeecCCCC
Q 005450 353 ENLIGKGGSSQVYKGCLPD--GKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVYDFLSRGS 429 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~--g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~g~~~~~~~~~LV~Ey~~gGs 429 (696)
.+.|..|-...+|+....+ ++.|++|+........-...+|+.++..+...+ ..+++..+. -.++|||++|.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 4567888889999987664 678999987654322223347888888885433 344444332 248999999977
Q ss_pred hhhh-----------------hhcCCCCC--------CCCChHHHHHHHH----------------------HHH---HH
Q 005450 430 LEEN-----------------LHGNKKDP--------AAFGWSERYKVAM----------------------GVA---EA 459 (696)
Q Consensus 430 L~~~-----------------L~~~~~~~--------~~l~~~~~~~Ia~----------------------qIa---~a 459 (696)
+... +|...... ....|..+..+.. .+. ..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 12111110 0111222212111 111 11
Q ss_pred H-HHHhc-CCCCceEeecccccceeeCC-CCceEEeecCccc
Q 005450 460 L-EYLHS-GSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAK 498 (696)
Q Consensus 460 L-~yLH~-~~~~gIIHrDLKpsNILLd~-~~~vKL~DFGlA~ 498 (696)
| ..+.. .....++|+|+.+.|||+++ ++.+.|+||..|.
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 1 11211 12357999999999999998 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.84 E-value=9.7e-05 Score=75.96 Aligned_cols=73 Identities=15% Similarity=0.224 Sum_probs=47.8
Q ss_pred eeeeccCce-EEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCc---ceeEEeeEEEec---CceEEEEeecC
Q 005450 354 NLIGKGGSS-QVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK---NIISLLGFCFED---NNLLLVYDFLS 426 (696)
Q Consensus 354 ~~LG~G~fG-~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hp---nIV~l~g~~~~~---~~~~LV~Ey~~ 426 (696)
+.|+.||.. .||+. +..+++|+.+.. .....+.+|.+++..+... .+..+++..... ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~-~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA-GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc-chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 567877776 48874 346888876652 2345788899999888532 344444443322 23488999999
Q ss_pred CCChh
Q 005450 427 RGSLE 431 (696)
Q Consensus 427 gGsL~ 431 (696)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 97774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00021 Score=86.80 Aligned_cols=149 Identities=14% Similarity=0.298 Sum_probs=93.6
Q ss_pred eeeeeccCceEEEEEEeCCC---CEEEEEEecCCh--hHHHHHHHHHHHHHhcC-Ccce--eEEeeEEEec---CceEEE
Q 005450 353 ENLIGKGGSSQVYKGCLPDG---KELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNI--ISLLGFCFED---NNLLLV 421 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g---~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~-HpnI--V~l~g~~~~~---~~~~LV 421 (696)
.+.|+.|.++.+|+....++ ..+++|+..... .....+.+|+++|+.+. |+++ .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999876554 467888765432 22356889999999996 6664 7888887654 467899
Q ss_pred EeecCCCChhh-----------------------hhhcCCCCC-------CCCCh--HHHHHH---------------HH
Q 005450 422 YDFLSRGSLEE-----------------------NLHGNKKDP-------AAFGW--SERYKV---------------AM 454 (696)
Q Consensus 422 ~Ey~~gGsL~~-----------------------~L~~~~~~~-------~~l~~--~~~~~I---------------a~ 454 (696)
|||++|..+.+ .||...... ....+ .++..+ ..
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99999865321 122211100 00011 011111 11
Q ss_pred HHHHHHHHHhcCC--------CCceEeecccccceeeCCC-Cc-eEEeecCcccccc
Q 005450 455 GVAEALEYLHSGS--------AQRVIHRDVKSSNILLSDD-FE-PQLSDFGLAKWAS 501 (696)
Q Consensus 455 qIa~aL~yLH~~~--------~~gIIHrDLKpsNILLd~~-~~-vKL~DFGlA~~~~ 501 (696)
.+...+.+|..+- ...+||+|+++.|||++.+ +. .-|.||.++...+
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 2334466774421 1359999999999999853 34 5699999886543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00024 Score=71.76 Aligned_cols=127 Identities=24% Similarity=0.387 Sum_probs=93.4
Q ss_pred eeeeeccCceEEEEEEeCCCCEEEEEEecCCh-----------------hHHHHHHHHHHHHHhcC------CcceeEEe
Q 005450 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-----------------DVIKEFVLEIEIITTLH------HKNIISLL 409 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~-----------------~~~~~~~~Ei~iL~~L~------HpnIV~l~ 409 (696)
...||+|+.-.|| .+++.....||+..+.. ...++..+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy--~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCY--QHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEE--ECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 4579999999999 46777888999988654 23566777877776666 78899999
Q ss_pred eEEEecCceEEEEeecCCC------ChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee
Q 005450 410 GFCFEDNNLLLVYDFLSRG------SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 483 (696)
Q Consensus 410 g~~~~~~~~~LV~Ey~~gG------sL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL 483 (696)
|+..++-.+-+|+|.+.+. +|.+++.... ++. ...+.+. +-..||-. ..|+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~-~~~~~L~---~f~~~l~~---~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE-ELRQALD---EFKRYLLD---HHIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH-HHHHHHH---HHHHHHHH---cCCeecCCCcccEEE
Confidence 9999999999999987643 6777774332 333 3333333 44456666 779999999999999
Q ss_pred CCC---C-ceEEee
Q 005450 484 SDD---F-EPQLSD 493 (696)
Q Consensus 484 d~~---~-~vKL~D 493 (696)
... . .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 533 2 577887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00044 Score=69.89 Aligned_cols=124 Identities=22% Similarity=0.344 Sum_probs=90.9
Q ss_pred cCceeeeeeeccCc-eEEEEEEeCCCCEEEEEEecC---C------------h-------hHHHHHHHHHHHHHhcC---
Q 005450 348 SNFLAENLIGKGGS-SQVYKGCLPDGKELAVKILKP---S------------E-------DVIKEFVLEIEIITTLH--- 401 (696)
Q Consensus 348 ~~f~~~~~LG~G~f-G~Vyka~~~~g~~vAVK~l~~---~------------~-------~~~~~~~~Ei~iL~~L~--- 401 (696)
.+++..+.||.|.- |.||++.. +|+.||+|+++. . . ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78899999999999 99999988 677999999431 0 0 12335778888888775
Q ss_pred Ccce--eEEeeEEEec------------------CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHH
Q 005450 402 HKNI--ISLLGFCFED------------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 461 (696)
Q Consensus 402 HpnI--V~l~g~~~~~------------------~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~ 461 (696)
+.++ |+.+||..-. ..+.||.||++... .+. ..-+.+|.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHH
Confidence 4456 8999997422 12467888776633 112 223456777788
Q ss_pred HHhcCCCCceEeecccccceeeCCCCceEEeecCcc
Q 005450 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497 (696)
Q Consensus 462 yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA 497 (696)
.+|. .||+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 8999 89999999999987 3599999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00014 Score=71.61 Aligned_cols=130 Identities=20% Similarity=0.271 Sum_probs=89.9
Q ss_pred eeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeE-EeeEEEecCceEEEEeecCCCCh
Q 005450 352 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS-LLGFCFEDNNLLLVYDFLSRGSL 430 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~-l~g~~~~~~~~~LV~Ey~~gGsL 430 (696)
..+.||+|.+|.||++... |..+|+|+-+.+ .....+..|.++|..+.--++.+ ++.|. .-++.|||+.|-+|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d-s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRD-SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCC-cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcch
Confidence 4577999999999999874 458899987753 34567889999999998766654 34432 33455999999888
Q ss_pred hhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccc-cceeeCCCCceEEeecCcccccc
Q 005450 431 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKS-SNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 431 ~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKp-sNILLd~~~~vKL~DFGlA~~~~ 501 (696)
.++-.... .+-+..+++.---|.. .||-|..|.- ..++|.+++.+.|+||.-|.+..
T Consensus 100 ~~~~~~~~-----------rk~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 100 GKLEIGGD-----------RKHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhhccc-----------HHHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 87654321 1233445555444555 7888988864 44444444489999999887443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00027 Score=75.23 Aligned_cols=142 Identities=24% Similarity=0.330 Sum_probs=86.5
Q ss_pred eeeeeccCceEEEEEEeCC-------CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcce-eEEeeEEEecCceEEEEee
Q 005450 353 ENLIGKGGSSQVYKGCLPD-------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~-------g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~g~~~~~~~~~LV~Ey 424 (696)
.+.|..|-...+|+....+ ++.+++|+............+|.+++..+....+ .++++++. + .+||||
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 3556777778999988655 5789999987654444456778888888864333 34555543 2 368999
Q ss_pred cCCCChhhh-----------------hhcCCCCC-------CCCChHHHHH--------------------------HHH
Q 005450 425 LSRGSLEEN-----------------LHGNKKDP-------AAFGWSERYK--------------------------VAM 454 (696)
Q Consensus 425 ~~gGsL~~~-----------------L~~~~~~~-------~~l~~~~~~~--------------------------Ia~ 454 (696)
++|..+... +|...... ...-|..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776431 12211110 0001111111 111
Q ss_pred HHHHHHHHHhc------CCCCceEeecccccceeeCCC----CceEEeecCccc
Q 005450 455 GVAEALEYLHS------GSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAK 498 (696)
Q Consensus 455 qIa~aL~yLH~------~~~~gIIHrDLKpsNILLd~~----~~vKL~DFGlA~ 498 (696)
.+...+.+|-. .....++|+|+.+.|||++++ +.+.|+||..|.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22223334432 234689999999999999985 789999998774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00022 Score=74.18 Aligned_cols=137 Identities=14% Similarity=0.153 Sum_probs=79.5
Q ss_pred eeccCceEEEEEEeCCCCEEEEEEecCChhHH-HHHHHHHHHHHhcCCcce-eEEeeEEEecCceEEEEeecCCCChhhh
Q 005450 356 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVI-KEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFLSRGSLEEN 433 (696)
Q Consensus 356 LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~-~~~~~Ei~iL~~L~HpnI-V~l~g~~~~~~~~~LV~Ey~~gGsL~~~ 433 (696)
+..|-.+.+|+.. .+++.+++|+........ -...+|.++++.+....+ .+++..+ .-++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcccccc
Confidence 4567778899876 467789999876543221 235678889988864333 3334333 23689999998766421
Q ss_pred -----------------hhcCCCCCCCCChHHH-HHHHHH---------HHHHHHHHhc-----CCCCceEeecccccce
Q 005450 434 -----------------LHGNKKDPAAFGWSER-YKVAMG---------VAEALEYLHS-----GSAQRVIHRDVKSSNI 481 (696)
Q Consensus 434 -----------------L~~~~~~~~~l~~~~~-~~Ia~q---------Ia~aL~yLH~-----~~~~gIIHrDLKpsNI 481 (696)
||........++.... ..+..+ +...+..+-. .....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 2222211112222111 111111 1111222211 1124689999999999
Q ss_pred eeCCCCceEEeecCccc
Q 005450 482 LLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 482 LLd~~~~vKL~DFGlA~ 498 (696)
++++++ +.|+||..|.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999876 7899998774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00081 Score=72.05 Aligned_cols=77 Identities=10% Similarity=0.013 Sum_probs=58.1
Q ss_pred eeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC---cceeEEeeEEEe---cCceEEEEeec
Q 005450 352 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH---KNIISLLGFCFE---DNNLLLVYDFL 425 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~H---pnIV~l~g~~~~---~~~~~LV~Ey~ 425 (696)
..+.||.|..+.||+....+++ +++|..+. ......+..|.+.|+.|.. -.+.+++++|.. .+..+||||++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 4567999999999998766664 77787543 2133578889999998853 367888888754 35689999999
Q ss_pred CCCCh
Q 005450 426 SRGSL 430 (696)
Q Consensus 426 ~gGsL 430 (696)
+|.++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00038 Score=73.73 Aligned_cols=143 Identities=16% Similarity=0.184 Sum_probs=86.9
Q ss_pred eeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc--eeEEeeE------EEecCceEEEEee
Q 005450 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN--IISLLGF------CFEDNNLLLVYDF 424 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hpn--IV~l~g~------~~~~~~~~LV~Ey 424 (696)
.+.|..|....+|+....+ ..+++|+... .....+..|++++..+.+.+ +.+++.. ....+..++||+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 5677888888999987644 4689998875 23355667888888875322 4444431 2234567899999
Q ss_pred cCCCChhh--------------hhhcCCCC-------CCCCChHHHH----------HHHHHHHHHHHHHhc----CCCC
Q 005450 425 LSRGSLEE--------------NLHGNKKD-------PAAFGWSERY----------KVAMGVAEALEYLHS----GSAQ 469 (696)
Q Consensus 425 ~~gGsL~~--------------~L~~~~~~-------~~~l~~~~~~----------~Ia~qIa~aL~yLH~----~~~~ 469 (696)
++|..+.. .+|..... .....|.... .....+..++.++.. ....
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99976532 11111000 0111222211 011123334445443 2236
Q ss_pred ceEeecccccceeeCCCCceEEeecCccc
Q 005450 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 470 gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
+++|+|+.|.|||++++..+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 79999999999999998777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.002 Score=71.83 Aligned_cols=75 Identities=19% Similarity=0.233 Sum_probs=55.7
Q ss_pred eeeeeccCceEEEEEEeCCC-CEEEEEEecCC--------hhHHHHHHHHHHHHHhcC---CcceeEEeeEEEecCceEE
Q 005450 353 ENLIGKGGSSQVYKGCLPDG-KELAVKILKPS--------EDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g-~~vAVK~l~~~--------~~~~~~~~~Ei~iL~~L~---HpnIV~l~g~~~~~~~~~L 420 (696)
.+.||.|.+..||++...+| +.++||+-.+. ....+++..|.+.|..+. ..++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46789999999999998877 58999985421 124567778888888863 2456777776 3456789
Q ss_pred EEeecCCCC
Q 005450 421 VYDFLSRGS 429 (696)
Q Consensus 421 V~Ey~~gGs 429 (696)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998754
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0018 Score=69.55 Aligned_cols=142 Identities=18% Similarity=0.231 Sum_probs=78.1
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCc--ceeEEee------EEEecCceEEEEeec
Q 005450 354 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLG------FCFEDNNLLLVYDFL 425 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hp--nIV~l~g------~~~~~~~~~LV~Ey~ 425 (696)
+.|+.|....+|+....+| .+++|++.. ...+.+..|+.++..|... .+.+.+. +....+..+++++|+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 4567788889999877665 688998762 1223444455666555321 1233332 122345679999999
Q ss_pred CCCChhh-----------h---hhcCCCC-------CCCCCh-HHHHH------------HH-HHHHHHHHHHhc----C
Q 005450 426 SRGSLEE-----------N---LHGNKKD-------PAAFGW-SERYK------------VA-MGVAEALEYLHS----G 466 (696)
Q Consensus 426 ~gGsL~~-----------~---L~~~~~~-------~~~l~~-~~~~~------------Ia-~qIa~aL~yLH~----~ 466 (696)
+|..+.. . +|..... ...+.| ..... .+ ..+...++.+.. .
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 9975421 1 1211110 001112 11111 11 111122233321 1
Q ss_pred CCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 467 ~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
-..++||+|+.|.|||++++...-|+||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 24689999999999999976555799998764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0026 Score=68.11 Aligned_cols=145 Identities=17% Similarity=0.188 Sum_probs=84.3
Q ss_pred eeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCc--ceeEEeeE------EEecCceEEEEe
Q 005450 352 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGF------CFEDNNLLLVYD 423 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hp--nIV~l~g~------~~~~~~~~LV~E 423 (696)
..+.++.|....+|+....+| .+++|+..... .......|++++..|... .+.+++.. ....+..+++++
T Consensus 26 ~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred eccccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 356678888889999876555 58889876532 123445667777776422 23344332 112456789999
Q ss_pred ecCCCChhh--------------hhhcCCCC---C--C---CCChHHHHH------------HHHHHHHHHHHHhc----
Q 005450 424 FLSRGSLEE--------------NLHGNKKD---P--A---AFGWSERYK------------VAMGVAEALEYLHS---- 465 (696)
Q Consensus 424 y~~gGsL~~--------------~L~~~~~~---~--~---~l~~~~~~~------------Ia~qIa~aL~yLH~---- 465 (696)
|++|..+.. .+|..... + . .-.|..... ....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999865421 12211110 0 0 011221110 11123344555542
Q ss_pred CCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 466 ~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
....+++|+|+.+.||++++++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 234789999999999999988767899998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.00041 Score=74.23 Aligned_cols=151 Identities=21% Similarity=0.257 Sum_probs=102.9
Q ss_pred ccccccccChHHHHHhhcC---ceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChh----------------------
Q 005450 331 YSATCRLFNYQDLLSATSN---FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED---------------------- 385 (696)
Q Consensus 331 ~~~~~~~f~~~el~~~t~~---f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~---------------------- 385 (696)
|.-+..-|+|--|.+..++ +.+.+.||-|.-+-||.+-...|++.++|+-+....
T Consensus 72 YRLTy~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWly 151 (465)
T KOG2268|consen 72 YRLTYAGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLY 151 (465)
T ss_pred eEeeeccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhh
Confidence 3334444555555555543 678899999999999999999999999997542110
Q ss_pred -HHHHHHHHHHHHHhcCC--cceeEEeeEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 005450 386 -VIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 462 (696)
Q Consensus 386 -~~~~~~~Ei~iL~~L~H--pnIV~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~y 462 (696)
..-...+|...|+.|.. --+.+.+++ +.-++|||++.|..|...-+-. +..+++.-+.++ +.-
T Consensus 152 LSRlaa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-------d~~~ly~~lm~~---Iv~ 217 (465)
T KOG2268|consen 152 LSRLAATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-------DPPTLYDDLMGL---IVR 217 (465)
T ss_pred hHHHHHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC-------ChHHHHHHHHHH---HHH
Confidence 01124567778887753 234455555 4568999999998887654321 223333333333 344
Q ss_pred HhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 463 LH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
|-. +|+||+|..-=||++++++.++++||--..
T Consensus 218 la~---~GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 218 LAN---HGLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred HHH---cCceecccchheeEEecCCCEEEeechHhh
Confidence 445 899999999999999999999999996543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0021 Score=78.16 Aligned_cols=196 Identities=18% Similarity=0.171 Sum_probs=130.8
Q ss_pred HHHHHHHHHhcCCcceeEEeeEEEecCce----EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc
Q 005450 390 FVLEIEIITTLHHKNIISLLGFCFEDNNL----LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 465 (696)
Q Consensus 390 ~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~----~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~ 465 (696)
..-|++.+.++.|+|++.++.|..+.... .+..+++..-++...++... ..+..+.+.+..++.+||.|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHHHH
Confidence 33466778888999999999998765433 34457788888888876544 46778888999999999999999
Q ss_pred CCCCceEeeccccc---ceeeCCCCceEEe--ecCccccccCCCCCcccccccccCCCCCcceeccCCCCCc--ccchhh
Q 005450 466 GSAQRVIHRDVKSS---NILLSDDFEPQLS--DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK--IDVYAF 538 (696)
Q Consensus 466 ~~~~gIIHrDLKps---NILLd~~~~vKL~--DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~k--sDVwSL 538 (696)
....|.-+..+ +--.+..+...++ ||+..+.+........ ..-+..|.+||......+..+ .|+|.+
T Consensus 305 ---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 ---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred ---hccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHH
Confidence 44455444444 4444566677777 9988876665433221 234556788887776555544 799999
Q ss_pred HHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005450 539 GVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 618 (696)
Q Consensus 539 GvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL 618 (696)
|..+..+..|..+-.... ....+++... .. .+......|+..++++|+++.+++
T Consensus 379 gll~~~~~~~~~i~~~~~------------------~~~~~l~~~~----~~----~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA------------------VPVSLLDVLS----TS----ELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCccccccc------------------chhhhhcccc----ch----hhhhhhhhhcchhhhhccchhhhh
Confidence 999999998866532111 0011111111 00 223334459999999999999998
Q ss_pred HHh
Q 005450 619 KLL 621 (696)
Q Consensus 619 ~~L 621 (696)
...
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0071 Score=64.17 Aligned_cols=70 Identities=17% Similarity=0.103 Sum_probs=42.8
Q ss_pred eeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC--cc-eeEEeeEEEecCceEEEEeecCCCCh
Q 005450 356 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KN-IISLLGFCFEDNNLLLVYDFLSRGSL 430 (696)
Q Consensus 356 LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~H--pn-IV~l~g~~~~~~~~~LV~Ey~~gGsL 430 (696)
.+.|-...||.....+|..+++|.-+. ......+.+|.++|..+.. |- +.+++.. ..-+++|+++.|..+
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~-~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~----~~~~~~y~~i~G~p~ 91 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPRR-PDVSERAAAEKRVLALVRKHLPVQVPDWRVH----TPELIAYPKLPGVPA 91 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecCC-HHHHHHHHHHHHHHHHHHhcCCCCCCceeee----cCceEEEeccCCCcc
Confidence 344555566765556788999998863 3445678899999998863 21 1222211 123567777776544
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0062 Score=66.68 Aligned_cols=143 Identities=15% Similarity=0.222 Sum_probs=84.0
Q ss_pred eeeeeeccCceEEEEEEeCC-----CCEEEEEEecCChhHHHHHHHHHHHHHhcCCccee-EEeeEEEecCceEEEEeec
Q 005450 352 AENLIGKGGSSQVYKGCLPD-----GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~-----g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV-~l~g~~~~~~~~~LV~Ey~ 425 (696)
....|-.|-...+|+....+ ++.|++|+........-.-.+|..++..+..-++. ++++++..+ .|++|+
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 34456568888999987532 36899998876432222236788888888644433 445555322 589999
Q ss_pred CCCChhhh-----------------hhcCCCC--CCCCChHHHHHHHHHH-----------------HHHHHHH----hc
Q 005450 426 SRGSLEEN-----------------LHGNKKD--PAAFGWSERYKVAMGV-----------------AEALEYL----HS 465 (696)
Q Consensus 426 ~gGsL~~~-----------------L~~~~~~--~~~l~~~~~~~Ia~qI-----------------a~aL~yL----H~ 465 (696)
++.+|... +|..... .....|..+.++..++ ...+..| ..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 88776421 2222111 0112233333332211 1112222 21
Q ss_pred -CCCCceEeecccccceeeCC-CCceEEeecCccc
Q 005450 466 -GSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAK 498 (696)
Q Consensus 466 -~~~~gIIHrDLKpsNILLd~-~~~vKL~DFGlA~ 498 (696)
.....++|+|+++.|||+++ ++.+.|+||..|.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 22357899999999999986 4679999998764
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.00028 Score=86.98 Aligned_cols=162 Identities=11% Similarity=-0.034 Sum_probs=117.5
Q ss_pred HHHHHHHHHHhcCCcceeEEeeEEE--ecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhc-
Q 005450 389 EFVLEIEIITTLHHKNIISLLGFCF--EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS- 465 (696)
Q Consensus 389 ~~~~Ei~iL~~L~HpnIV~l~g~~~--~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~- 465 (696)
....|.+-++...|+++.....=.. +..+.+.+++|+.+|.+...|-+.......+...-....-.+......-.|.
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 3444555666778998877665443 2346788999999999999887554443344433333333333455555554
Q ss_pred -CCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHH
Q 005450 466 -GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLE 544 (696)
Q Consensus 466 -~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~E 544 (696)
+...-.+|+++|+-|.+|..+..+|+.++|+.+....... ..+...+++.|+.|++.+.-+++.++|+|..|+-+|+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 2234579999999999999999999999999984433222 2234678889999999998899999999999999999
Q ss_pred HHhCCCCC
Q 005450 545 LLTGRKPI 552 (696)
Q Consensus 545 LltG~~Pf 552 (696)
+.-|..+|
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 99888877
|
|
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.01 Score=55.94 Aligned_cols=87 Identities=26% Similarity=0.404 Sum_probs=64.2
Q ss_pred EEEEEEecCcchHHHHhHHHHhhcCCCCeEEEEEeeeccccc-ccCCcchh-----hhhHHHHHHHHHHHHhccccccee
Q 005450 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIV-DRDGKSSL-----LSLVKAFDSVLAVYEGFCNLKQVD 91 (696)
Q Consensus 18 ~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~hv~~~~~~~-~~~~~~~~-----~~~~~~~~~~l~~~~~~c~~kq~~ 91 (696)
.|||++.....|+..|.||+.-....|+.|+.|||....... ...+.... -...+....+|+.+...|....+.
T Consensus 1 ~ILVavD~S~~s~~al~~a~~~a~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 80 (146)
T cd01989 1 SVAVAVDKDKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKLEVASAYKQEEDKEAKELLLPYRCFCSRKGVQ 80 (146)
T ss_pred CEEEEecCccccHHHHHHHHHhccCCCCcEEEEEeccCcccCCCCccchHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCe
Confidence 489999999999999999999888899999999998643221 11111101 122346678899999999888888
Q ss_pred eEEEEecCccccc
Q 005450 92 LKLKICRGTEDHR 104 (696)
Q Consensus 92 l~~~~~~~~~~~~ 104 (696)
.+..+..|.++.+
T Consensus 81 ~~~~~~~g~~~~~ 93 (146)
T cd01989 81 CEDVVLEDDDVAK 93 (146)
T ss_pred EEEEEEeCCcHHH
Confidence 8988888765544
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.02 Score=62.59 Aligned_cols=139 Identities=23% Similarity=0.254 Sum_probs=95.2
Q ss_pred eeeeeeccCceEEEEEEeCCCCEEEEEEecCC--------------------------h-hHHHHHHHHHHHHHhcCCcc
Q 005450 352 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS--------------------------E-DVIKEFVLEIEIITTLHHKN 404 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~--------------------------~-~~~~~~~~Ei~iL~~L~Hpn 404 (696)
+...|..|--+.||.+...+|..+|||+++.+ . ...-....|++-|.+|+.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 44678899999999999999999999998742 0 11122345788888887544
Q ss_pred eeEEeeEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC
Q 005450 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 484 (696)
Q Consensus 405 IV~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd 484 (696)
|.-.--.... .-+|||+|+....- -... .....++...+..+-.+++.-+.-|-+. .++||.||.--|+|+-
T Consensus 228 IP~PePIlLk--~hVLVM~FlGrdgw---~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 228 IPCPEPILLK--NHVLVMEFLGRDGW---AAPK-LKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCceeee--cceEeeeeccCCCC---cCcc-cccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEE
Confidence 4332222222 34799999964211 1111 1123466677888888888888888774 4699999999999986
Q ss_pred CCCceEEeecCcccc
Q 005450 485 DDFEPQLSDFGLAKW 499 (696)
Q Consensus 485 ~~~~vKL~DFGlA~~ 499 (696)
+ |.+.|+|-+-+.-
T Consensus 300 d-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 D-GKLYIIDVSQSVE 313 (520)
T ss_pred C-CEEEEEEcccccc
Confidence 4 5899999876643
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.014 Score=63.60 Aligned_cols=142 Identities=19% Similarity=0.288 Sum_probs=81.3
Q ss_pred eeeeeccCceEEEEEEeCC----CCEEEEEEecCChhHHHHHHHHHHHHHhcCCccee-EEeeEEEecCceEEEEeecCC
Q 005450 353 ENLIGKGGSSQVYKGCLPD----GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~----g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV-~l~g~~~~~~~~~LV~Ey~~g 427 (696)
.+.|..|-...+|+....+ +..|++|+........-.-.+|..+++.+..-++. ++++++. + . +|.+|+++
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~-G--~i~~fi~g 94 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-N-G--MIQSFINA 94 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-C-c--EeehhhcC
Confidence 3455557778899886543 34799998876433222345788888888755543 4555552 2 2 58999987
Q ss_pred CChhh-----------------hhhcCCCC--CCCCChHHHHHHHHHH----------------------HHHHHHH---
Q 005450 428 GSLEE-----------------NLHGNKKD--PAAFGWSERYKVAMGV----------------------AEALEYL--- 463 (696)
Q Consensus 428 GsL~~-----------------~L~~~~~~--~~~l~~~~~~~Ia~qI----------------------a~aL~yL--- 463 (696)
..|.. .+|..... ...-.|..+.++..++ ..-+..+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 76532 12221111 0011233333322221 1111111
Q ss_pred h-c-CCCCceEeecccccceeeCC-CCceEEeecCccc
Q 005450 464 H-S-GSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAK 498 (696)
Q Consensus 464 H-~-~~~~gIIHrDLKpsNILLd~-~~~vKL~DFGlA~ 498 (696)
. . ....-++|.|+.+.|||+++ ++.++++||..|.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1 1 11234799999999999975 5689999998774
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.058 Score=57.35 Aligned_cols=30 Identities=33% Similarity=0.416 Sum_probs=25.8
Q ss_pred CCceEeecccccceeeCCCCceEEeecCccc
Q 005450 468 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 468 ~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 368999999999999988 578999998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.033 Score=59.55 Aligned_cols=75 Identities=21% Similarity=0.278 Sum_probs=49.2
Q ss_pred eeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcC---CcceeEEeeEEEecCceEEEEeecCC
Q 005450 351 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 351 ~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~---HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
...+.|+.|....+|+.. .+++.+.||+-. ......|..|.+-|+.|. --.+.+++++....+..+|||||++.
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 345678989999999877 678889999887 333356777888888774 44678889988877788999999987
Q ss_pred C
Q 005450 428 G 428 (696)
Q Consensus 428 G 428 (696)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 7
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.0054 Score=61.91 Aligned_cols=123 Identities=22% Similarity=0.228 Sum_probs=62.3
Q ss_pred CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcce-eEEeeEEEecCceEEEEeecCCCChhhh-----------------
Q 005450 372 GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFLSRGSLEEN----------------- 433 (696)
Q Consensus 372 g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~g~~~~~~~~~LV~Ey~~gGsL~~~----------------- 433 (696)
.+.|+|++........-.-..|..+++.+..-++ .++++++.. .+|++|+++..|...
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~ 77 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLAK 77 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHHH
Confidence 4678999988775555566778888888865444 455555422 267799977665321
Q ss_pred hhcCCC---CCCCCChHHHHHH--------------------------HHHHHHHHHHHhc-CCCCceEeecccccceee
Q 005450 434 LHGNKK---DPAAFGWSERYKV--------------------------AMGVAEALEYLHS-GSAQRVIHRDVKSSNILL 483 (696)
Q Consensus 434 L~~~~~---~~~~l~~~~~~~I--------------------------a~qIa~aL~yLH~-~~~~gIIHrDLKpsNILL 483 (696)
+|.... ....-.|.....+ ...+......|-. ....-++|+|+.|.|||+
T Consensus 78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~ 157 (211)
T PF01633_consen 78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI 157 (211)
T ss_dssp HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence 111100 0111112222222 1111111222211 112568999999999999
Q ss_pred -CCCCceEEeecCccc
Q 005450 484 -SDDFEPQLSDFGLAK 498 (696)
Q Consensus 484 -d~~~~vKL~DFGlA~ 498 (696)
+.++.++|+||..|.
T Consensus 158 ~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 158 NNKDGEVKLIDFEYAG 173 (211)
T ss_dssp TSSSSCEEE--GTT-E
T ss_pred ccCCCeEEEecHHHHh
Confidence 888999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.035 Score=61.04 Aligned_cols=72 Identities=18% Similarity=0.227 Sum_probs=49.1
Q ss_pred eeeccCceEEEEEEeCCC-CEEEEEEecC-------C-hhHHHHHHHHHHHHHhcC--Ccc-eeEEeeEEEecCceEEEE
Q 005450 355 LIGKGGSSQVYKGCLPDG-KELAVKILKP-------S-EDVIKEFVLEIEIITTLH--HKN-IISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 355 ~LG~G~fG~Vyka~~~~g-~~vAVK~l~~-------~-~~~~~~~~~Ei~iL~~L~--Hpn-IV~l~g~~~~~~~~~LV~ 422 (696)
.||-|....||++..++| +.++||+-.+ + .-...+...|.+.|.... -|. +.+++.| +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999998765 6899997542 1 233456667888887664 343 4444433 455667999
Q ss_pred eecCCC
Q 005450 423 DFLSRG 428 (696)
Q Consensus 423 Ey~~gG 428 (696)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.054 Score=58.69 Aligned_cols=148 Identities=16% Similarity=0.270 Sum_probs=82.5
Q ss_pred eeeeeccCceEEEEEEeCCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCC--cceeEEeeEEEecC--ceEEEEeec
Q 005450 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDN--NLLLVYDFL 425 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~L~H--pnIV~l~g~~~~~~--~~~LV~Ey~ 425 (696)
.+.+-.|....+|..... ++.+++. ... .........+|..+|+.+.- .-+...+++|.++. ..+.||+|+
T Consensus 30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 344433433445554443 7888888 332 12334556678888888753 23445567776665 679999999
Q ss_pred CCCChhhhhhcCCC---------------------CC-------------CCCChHHHHHHH--------HHHHHHHHHH
Q 005450 426 SRGSLEENLHGNKK---------------------DP-------------AAFGWSERYKVA--------MGVAEALEYL 463 (696)
Q Consensus 426 ~gGsL~~~L~~~~~---------------------~~-------------~~l~~~~~~~Ia--------~qIa~aL~yL 463 (696)
+|..+.+.+..... .. ....|...+..+ -....-..||
T Consensus 108 eGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl 187 (321)
T COG3173 108 EGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL 187 (321)
T ss_pred cceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence 98533322211100 00 000111111100 0111223344
Q ss_pred hcC-----CCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 464 HSG-----SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 464 H~~-----~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
+.. ....++|+|+.+.||+++++.-+=|.||+++...+.
T Consensus 188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 331 124689999999999999988899999999875443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.075 Score=57.67 Aligned_cols=73 Identities=14% Similarity=0.156 Sum_probs=48.0
Q ss_pred ccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCc--ceeEEe---e--EEEecCceEEEEeecCCCCh
Q 005450 358 KGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLL---G--FCFEDNNLLLVYDFLSRGSL 430 (696)
Q Consensus 358 ~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hp--nIV~l~---g--~~~~~~~~~LV~Ey~~gGsL 430 (696)
.+.-..||+....+|..+++|+.++.......+..|++.+..|... .++... | +...++..+.++++++|...
T Consensus 35 ~s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 35 NSYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred ccccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 3445679998888889999999976554556677788887776421 122211 1 12234567889999988753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.085 Score=59.03 Aligned_cols=73 Identities=15% Similarity=0.156 Sum_probs=52.4
Q ss_pred eeeeeeccCceEEEEEEeCCCCEEEEEEecC-----Ch---hHHHHHHHHHHHHHhcC---CcceeEEeeEEEecCceEE
Q 005450 352 AENLIGKGGSSQVYKGCLPDGKELAVKILKP-----SE---DVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~-----~~---~~~~~~~~Ei~iL~~L~---HpnIV~l~g~~~~~~~~~L 420 (696)
..+.||.|....||+.... +..++||+-.+ .. -...+...|.+.|..+. ..++.+++.++. +..++
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 3567899999999998764 55799998652 11 13445555677776664 247888888886 45688
Q ss_pred EEeecCC
Q 005450 421 VYDFLSR 427 (696)
Q Consensus 421 V~Ey~~g 427 (696)
+|||+++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 9999977
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.039 Score=59.25 Aligned_cols=31 Identities=16% Similarity=0.226 Sum_probs=28.0
Q ss_pred CCceEeecccccceeeCCCCceEEeecCccc
Q 005450 468 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 468 ~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
..+++|+|+.+.|||+++++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 4689999999999999999899999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.06 Score=58.68 Aligned_cols=140 Identities=22% Similarity=0.363 Sum_probs=84.2
Q ss_pred eeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc------eeEEeeEEE--ec--CceEEEEeec
Q 005450 356 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN------IISLLGFCF--ED--NNLLLVYDFL 425 (696)
Q Consensus 356 LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hpn------IV~l~g~~~--~~--~~~~LV~Ey~ 425 (696)
|.+ .-..+|+....+|+. ++|+..+. ....++..|+..|..|.-.+ +..+=|-.. -. ...+-+++|+
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 444 456789888877776 99999987 55566777888887774211 222222111 12 3678899999
Q ss_pred CCCChhh---------------hhhcCCC-----CC---CCCChHH-------------HHHHHHHHHHHHHHHhc----
Q 005450 426 SRGSLEE---------------NLHGNKK-----DP---AAFGWSE-------------RYKVAMGVAEALEYLHS---- 465 (696)
Q Consensus 426 ~gGsL~~---------------~L~~~~~-----~~---~~l~~~~-------------~~~Ia~qIa~aL~yLH~---- 465 (696)
+|..+.. .||.... .+ ....|.. ......++...+..+..
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 9988872 1111100 11 1233431 01233344444444443
Q ss_pred CCCCc---eEeecccccceeeCCCCc-eEEeecCccc
Q 005450 466 GSAQR---VIHRDVKSSNILLSDDFE-PQLSDFGLAK 498 (696)
Q Consensus 466 ~~~~g---IIHrDLKpsNILLd~~~~-vKL~DFGlA~ 498 (696)
.-... +||+|+.|.||+++.+.. .-++||+-+.
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 11123 999999999999999875 8899998764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.18 Score=62.91 Aligned_cols=142 Identities=25% Similarity=0.316 Sum_probs=80.3
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-------CcceeEEe-e----EEEe-cC--ce
Q 005450 354 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-------HKNIISLL-G----FCFE-DN--NL 418 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~-------HpnIV~l~-g----~~~~-~~--~~ 418 (696)
+.|+ |..-.+|+....+|..+++|+.+... .......|..+|..|. -|.+++.. | .... ++ ..
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 4564 45677899888888899999998653 2233334555554442 23444332 1 1111 12 46
Q ss_pred EEEEeecCCCChhhhh-----------------hc----CCC--CCCCCChHH-----------------HHHHHHHHHH
Q 005450 419 LLVYDFLSRGSLEENL-----------------HG----NKK--DPAAFGWSE-----------------RYKVAMGVAE 458 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L-----------------~~----~~~--~~~~l~~~~-----------------~~~Ia~qIa~ 458 (696)
+-+|+|++|..|.+.. +. ... ....+.|.. ...++.++++
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 7789999998776511 10 000 011233322 1222223333
Q ss_pred HHH-----HHhcCCCCceEeecccccceeeCCCC--ceE-EeecCccc
Q 005450 459 ALE-----YLHSGSAQRVIHRDVKSSNILLSDDF--EPQ-LSDFGLAK 498 (696)
Q Consensus 459 aL~-----yLH~~~~~gIIHrDLKpsNILLd~~~--~vK-L~DFGlA~ 498 (696)
.+. .|. .-..++||+|+.+.|||++.++ .+. |+|||-+.
T Consensus 189 ~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 189 RFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 222 122 2246799999999999999875 555 99999875
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.84 E-value=0.17 Score=56.27 Aligned_cols=76 Identities=17% Similarity=0.274 Sum_probs=47.3
Q ss_pred eeeeeeccCceEEEEEEeCCC--CE-----EEEEEecCChhHHHHHHHHHHHHHhcCCccee-EEeeEEEecCceEEEEe
Q 005450 352 AENLIGKGGSSQVYKGCLPDG--KE-----LAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~g--~~-----vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV-~l~g~~~~~~~~~LV~E 423 (696)
..+.|..|-...+|++...++ .. |.+++........-.-.+|++++..+...++. ++++.+. -++|+|
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e 129 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE 129 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence 345666688899999875433 22 44444332222222235689999999755544 5555553 269999
Q ss_pred ecCCCChh
Q 005450 424 FLSRGSLE 431 (696)
Q Consensus 424 y~~gGsL~ 431 (696)
|++|.+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99998765
|
|
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.14 Score=45.72 Aligned_cols=81 Identities=17% Similarity=0.196 Sum_probs=60.9
Q ss_pred EEEEEEecCcchHHHHhHHHHhhcCCCCeEEEEEeeecccccccCCcchhhhhHHHHHHHHHHHHhcccccceeeEEEEe
Q 005450 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKIC 97 (696)
Q Consensus 18 ~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~hv~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~kq~~l~~~~~ 97 (696)
+|||++..+..++.++.||+..+.+.|..|.+|||......... .............|.-|...|....+.++..+.
T Consensus 1 ~ilv~i~~~~~~~~~l~~a~~~a~~~~~~i~~l~v~~~~~~~~~---~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 77 (130)
T cd00293 1 RILVAVDGSEESERALRWAARLARRLGAELVLLHVVDPPPSSAA---ELAELLEEEARALLEALREALAEAGVKVETVVL 77 (130)
T ss_pred CEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCCCCcch---hHHHHHHHHHHHHHHHHHHHHhcCCCceEEEEe
Confidence 48999999999999999999999999999999999864332100 001112245567778888888888888888888
Q ss_pred cCcc
Q 005450 98 RGTE 101 (696)
Q Consensus 98 ~~~~ 101 (696)
.|..
T Consensus 78 ~~~~ 81 (130)
T cd00293 78 EGDP 81 (130)
T ss_pred cCCC
Confidence 8765
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.73 E-value=0.14 Score=52.71 Aligned_cols=152 Identities=16% Similarity=0.153 Sum_probs=92.7
Q ss_pred cCceEEEEEEeCCCCEEEEEEecCChh--HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCCChhhhhhc
Q 005450 359 GGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 436 (696)
Q Consensus 359 G~fG~Vyka~~~~g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~ 436 (696)
|+.++.-.+..+-|. ..+|.++.... ....|..+.+++.+++ .|+++..- ....+-++.|+|.....
T Consensus 73 ~gNsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 445555444433333 44555544332 3355678889998886 47777733 34456788888743110
Q ss_pred CCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcccccccccC
Q 005450 437 NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 516 (696)
Q Consensus 437 ~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~ 516 (696)
.. ..++..=+.+|.-.|+.. .+.+|+|..|+|||-|..|.+||.|=+... . .+.
T Consensus 142 -------~~----~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~------------~~V 195 (308)
T PF07387_consen 142 -------NF----SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--E------------NQV 195 (308)
T ss_pred -------ch----hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhh--h------------hee
Confidence 00 112222246788889755 789999999999999999999999976431 1 111
Q ss_pred CCCCcceeccCCCCCcccchhhHHHHHHHHhCCC
Q 005450 517 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRK 550 (696)
Q Consensus 517 ~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~ 550 (696)
-|.--| +...+.++.+-+|=.-++++.....
T Consensus 196 ~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 196 NMVNIE---YESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred eEEeee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence 122212 2356777888777777777776443
|
The function of this family is unknown. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.56 E-value=0.12 Score=57.60 Aligned_cols=74 Identities=16% Similarity=0.099 Sum_probs=51.1
Q ss_pred eeeeeccCceEEEEEEeCC-CCEEEEEEecC----C---hhHHHHHHHHHHHHHhcC--Cc-ceeEEeeEEEecCceEEE
Q 005450 353 ENLIGKGGSSQVYKGCLPD-GKELAVKILKP----S---EDVIKEFVLEIEIITTLH--HK-NIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~-g~~vAVK~l~~----~---~~~~~~~~~Ei~iL~~L~--Hp-nIV~l~g~~~~~~~~~LV 421 (696)
.+.||-|.-..||++...+ ++.|+||+-.+ . .-..++...|.++|+... -| .+.+++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 5678999999999999753 57899997542 1 234566777888888764 34 34445544 44566788
Q ss_pred EeecCCC
Q 005450 422 YDFLSRG 428 (696)
Q Consensus 422 ~Ey~~gG 428 (696)
||+++..
T Consensus 112 MEdL~~~ 118 (409)
T PRK12396 112 MEDLSDH 118 (409)
T ss_pred HHhCccc
Confidence 9988653
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.26 Score=55.91 Aligned_cols=142 Identities=18% Similarity=0.220 Sum_probs=82.6
Q ss_pred eeeeeeccCceEEEEEEeCC---------CCEEEEEEecCChhHHHHHHHHHHHHHhcCCccee-EEeeEEEecCceEEE
Q 005450 352 AENLIGKGGSSQVYKGCLPD---------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLV 421 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~---------g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV-~l~g~~~~~~~~~LV 421 (696)
..+.|..|-.-.+|+....+ ++.|++++.-......-.-..|..++..+...+|- ++++.+. -..|
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 45677778888899987542 46899999876443333445688888877644443 4445442 3568
Q ss_pred EeecCCCChhh-----------------hhhcCCC---CCCCC-----ChHHHHHHHHHH--------------------
Q 005450 422 YDFLSRGSLEE-----------------NLHGNKK---DPAAF-----GWSERYKVAMGV-------------------- 456 (696)
Q Consensus 422 ~Ey~~gGsL~~-----------------~L~~~~~---~~~~l-----~~~~~~~Ia~qI-------------------- 456 (696)
.||++|..|.. .+|.... .+..+ .|..+.++...+
T Consensus 185 ~efi~g~~l~~~dl~~~~~~~~iA~~L~~lH~~~~~~~~~~~f~~~p~~f~~i~~~~~~~~~~~~~~~~~~~~~~l~~e~ 264 (442)
T PTZ00296 185 EEWLYGDPLRIDDLKNPSILIGIANVLGKFHTLSRKRHLPEHWDRTPCIFKMMEKWKNQLSKYKNIEKYQRDIHKYIKES 264 (442)
T ss_pred EEeeCCccCCHHHcCCHHHHHHHHHHHHHHhcccccccCchhccCCCcHHHHHHHHHHHHHhhccchHhHhhHHHHHHHH
Confidence 99999875531 1222110 00011 133332222211
Q ss_pred HHHHHHHh-------cCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 457 AEALEYLH-------SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 457 a~aL~yLH-------~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
.....+|. ......++|.|+-+.|||.+++ .++|+||-.|.
T Consensus 265 ~~l~~~l~~~~~l~~~~~~~VfCHNDl~~~NiL~~~~-~l~LIDfEYAg 312 (442)
T PTZ00296 265 EKFIKFMKVYSKSDNLANDIVFCHNDLQENNIINTNK-CLRLIDFEYSG 312 (442)
T ss_pred HHHHHHHHhhcccccccCCeeEEeCCCCccceeecCC-CEEEEeecccc
Confidence 11223332 1123568999999999998755 49999997663
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=93.85 E-value=0.33 Score=51.04 Aligned_cols=78 Identities=21% Similarity=0.127 Sum_probs=56.0
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec-CCCChhh
Q 005450 354 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL-SRGSLEE 432 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~-~gGsL~~ 432 (696)
..+..|..+.|+.+...+|.+.++|+..+......+..-+ ..|...+-...|++++.-. ..-.|.+|.+ ++.+|.+
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g~-~~L~~w~G~GaVrll~~d~--~~~AlLLErl~~g~~L~~ 84 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARGE-AALRWWNGRGAVRLLAADP--ERGALLLERLDPGRSLAS 84 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhHH-hHhheeCCCCceeeecccc--ccchhhhhhccCCCchhh
Confidence 4466799999999999999999999998755433332222 4477777778899998753 3557888988 4456765
Q ss_pred hh
Q 005450 433 NL 434 (696)
Q Consensus 433 ~L 434 (696)
..
T Consensus 85 ~~ 86 (253)
T PF04655_consen 85 LP 86 (253)
T ss_pred cc
Confidence 54
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 696 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-55 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-55 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-47 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-47 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-33 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-22 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 9e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 408 bits (1052), Expect = e-139
Identities = 115/314 (36%), Positives = 181/314 (57%), Gaps = 5/314 (1%)
Query: 325 EGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE 384
E E + + F+ ++L A+ NF +N++G+GG +VYKG L DG +AVK LK
Sbjct: 7 EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 66
Query: 385 D--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 442
+F E+E+I+ H+N++ L GFC LLVY +++ GS+ L +
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 443 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502
W +R ++A+G A L YLH ++IHRDVK++NILL ++FE + DFGLAK
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 562
+H+T T V GT G++APEY GK ++K DV+ +GV+LLEL+TG++ +
Sbjct: 187 KDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 563 --LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620
L+ W K +L K+ L+D L NY +++E+++ ++LC + P RP+MS V+++
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 621 LRGDADVTKWARLQ 634
L GD +W Q
Sbjct: 306 LEGDGLAERWEEWQ 319
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 384 bits (988), Expect = e-129
Identities = 109/315 (34%), Positives = 174/315 (55%), Gaps = 6/315 (1%)
Query: 312 STDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPD 371
S +T + DL AT+NF + LIG G +VYKG L D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 372 GKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 430
G ++A+K P S I+EF EIE ++ H +++SL+GFC E N ++L+Y ++ G+L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 431 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 490
+ +L+G+ + W +R ++ +G A L YLH+ + +IHRDVKS NILL ++F P+
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 491 LSDFGLAKWA-STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 549
++DFG++K +H++ T V GT GY+ PEYF+ G++ +K DVY+FGVVL E+L R
Sbjct: 180 ITDFGISKKGTELDQTHLS-TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 550 KPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPR 609
I P+ +L WA ++G++ Q++DP L + + + + ++ C+
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 610 ARPQMSLVLKLLRGD 624
RP M VL L
Sbjct: 299 DRPSMGDVLWKLEYA 313
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 352 bits (905), Expect = e-117
Identities = 95/311 (30%), Positives = 159/311 (51%), Gaps = 23/311 (7%)
Query: 329 EKYSATCRLFNYQDLLSATSNF------LAENLIGKGGSSQVYKGCLPDGKELAVKILKP 382
E F++ +L + T+NF + N +G+GG VYKG + + +AVK L
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 383 SEDV-----IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGN 437
D+ ++F EI+++ H+N++ LLGF + ++L LVY ++ GSL + L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 438 KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497
P W R K+A G A + +LH IHRD+KS+NILL + F ++SDFGLA
Sbjct: 125 DGTPP-LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 498 KWAST-SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 556
+ + + + +T + + GT Y+APE + G++ K D+Y+FGVVLLE++TG + D
Sbjct: 181 RASEKFAQTVMT-SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV--DE 236
Query: 557 PKGQESLVMWAKPILSS-GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMS 615
+ + L+ + I + +D + + D +E M + C+ RP +
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 616 LVLKLLRGDAD 626
V +LL+
Sbjct: 296 KVQQLLQEMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 9e-78
Identities = 73/318 (22%), Positives = 121/318 (38%), Gaps = 28/318 (8%)
Query: 326 GLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED 385
G H + ++ ++L + + +G V+K + +AVKI +
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDK 60
Query: 386 VIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDP 441
+ E+ + + H+NI+ +G + L L+ F +GSL + L N
Sbjct: 61 QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS- 119
Query: 442 AAFGWSERYKVAMGVAEALEYLHS-------GSAQRVIHRDVKSSNILLSDDFEPQLSDF 494
W+E +A +A L YLH G + HRD+KS N+LL ++ ++DF
Sbjct: 120 ----WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175
Query: 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGR 549
GLA S GT Y+APE +ID+YA G+VL EL +
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 550 KPISNDHPKGQESL--VMWAKPILSSGK---VTQLLDPALGNNYDYDQMERMVLASIL-C 603
+ + P L + V + P L + + M+ +I C
Sbjct: 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295
Query: 604 IRRDPRARPQMSLVLKLL 621
D AR V + +
Sbjct: 296 WDHDAEARLSAGCVGERI 313
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 6e-62
Identities = 74/273 (27%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
E ++G+G V K K++A+K ++ SE K F++E+ ++ ++H NI+ L G C
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 472
N + LV ++ GSL LHG + P + + + ++ + YLHS + +I
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 473 HRDVKSSNILLSDDFE-PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 531
HRD+K N+LL ++ DFG A T T+ G+ ++APE F ++
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 532 KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 591
K DV+++G++L E++T RKP + V P L N
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDE----------IGGPAFRIMWAVHNGTRPPLIKNLPKP 232
Query: 592 QMERMVLASIL--CIRRDPRARPQMSLVLKLLR 622
+ S++ C +DP RP M ++K++
Sbjct: 233 ------IESLMTRCWSKDPSQRPSMEEIVKIMT 259
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 7e-61
Identities = 65/319 (20%), Positives = 110/319 (34%), Gaps = 43/319 (13%)
Query: 338 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEII 397
+ N LIG+G VYKG L D + +AVK+ + + F+ E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIY 59
Query: 398 TT--LHHKNIISLLGFCFEDN-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 450
+ H NI + LLV ++ GSL + L + D W
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD-----WVSSC 114
Query: 451 KVAMGVAEALEYLHSGSAQR------VIHRDVKSSNILLSDDFEPQLSDFGLAK------ 498
++A V L YLH+ + + HRD+ S N+L+ +D +SDFGL+
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 499 WASTSSSHITCTDVAGTFGYLAPEYFM-------YGKVNDKIDVYAFGVVLLELLTGRKP 551
GT Y+APE ++D+YA G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 552 ISNDHPKGQESL----VMWAKPILSSGK---VTQLLDPALGNNYDYDQMERMVLASIL-- 602
+ + + + P + + P + + + L +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 603 CIRRDPRARPQMSLVLKLL 621
C +D AR + +
Sbjct: 295 CWDQDAEARLTAQXAEERM 313
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 3e-60
Identities = 85/280 (30%), Positives = 134/280 (47%), Gaps = 37/280 (13%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLL 409
+ IG G V++ G ++AVKIL + + EF+ E+ I+ L H NI+ +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 410 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
G + NL +V ++LSRGSL LH R +A VA+ + YLH+
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYGK 528
++HR++KS N+L+ + ++ DFGL++ AST S AGT ++APE
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEWMAPEVLRDEP 215
Query: 529 VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA------KPILSSGKVTQLLDP 582
N+K DVY+FGV+L EL T ++P N +P Q V+ A + + L+P
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNP-AQ---VVAAVGFKCKRLEIPRN-----LNP 266
Query: 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
+ +E C +P RP + ++ LLR
Sbjct: 267 QV-----AAIIEG-------CWTNEPWKRPSFATIMDLLR 294
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-57
Identities = 82/290 (28%), Positives = 120/290 (41%), Gaps = 52/290 (17%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-----VIKEFVLEIEIITTLHHKNIIS 407
E +IG GG +VY+ G E+AVK + D I+ E ++ L H NII+
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 467
L G C ++ NL LV +F G L L G + A+ +A + YLH +
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIP-----PDILVNWAVQIARGMNYLHDEA 125
Query: 468 AQRVIHRDVKSSNILLSDDFEPQ--------LSDFGLAKWASTSSSHITCTDVAGTFGYL 519
+IHRD+KSSNIL+ E ++DFGLA+ ++ AG + ++
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWM 181
Query: 520 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-------PILS 572
APE + DV+++GV+L ELLTG P V + PI S
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-LA---VAYGVAMNKLALPIPS 237
Query: 573 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
+ ME C DP +RP + +L L
Sbjct: 238 T------CPEPF-----AKLMED-------CWNPDPHSRPSFTNILDQLT 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 2e-56
Identities = 74/289 (25%), Positives = 123/289 (42%), Gaps = 46/289 (15%)
Query: 353 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSED--------VIKEFVLEIEIITTLHHK 403
E IGKGG V+KG + D +A+K L + +EF E+ I++ L+H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 404 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 463
NI+ L G N +V +F+ G L L WS + ++ + +A +EY+
Sbjct: 84 NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP---IKWSVKLRLMLDIALGIEYM 138
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKWASTSSSHITCTDVAGTFGY 518
+ ++HRD++S NI L E ++DFGL++ + S + + G F +
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV-----SGLLGNFQW 192
Query: 519 LAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK- 575
+APE +K D Y+F ++L +LTG P + + I G
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEGLR 248
Query: 576 --VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
+ + P L + +E C DP+ RP S ++K L
Sbjct: 249 PTIPEDCPPRL-----RNVIEL-------CWSGDPKKRPHFSYIVKELS 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 4e-54
Identities = 76/279 (27%), Positives = 125/279 (44%), Gaps = 38/279 (13%)
Query: 356 IGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
IG G VYKG ++AVK+L + ++ F E+ ++ H NI+ +G+
Sbjct: 32 IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 472
L +V + SL +LH ++ F + +A A ++YLH+ + +I
Sbjct: 90 TAPQ-LAIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 473 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE---YFMYGKV 529
HRD+KS+NI L +D ++ DFGLA S S ++G+ ++APE
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 530 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA------KPILSSGKVTQLLDPA 583
+ + DVYAFG+VL EL+TG+ P SN + + Q ++ P LS KV
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLSPDLS--KVRSNCPKR 257
Query: 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
+ M C+++ RP +L +
Sbjct: 258 M-----KRLMAE-------CLKKKRDERPSFPRILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-53
Identities = 54/284 (19%), Positives = 108/284 (38%), Gaps = 46/284 (16%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 409
+ + S +++KG G ++ VK+LK S ++F E + H N++ +L
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 410 GFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 467
G C + L+ ++ GSL LH S+ K A+ +A + +LH+
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLHT-L 130
Query: 468 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 525
+ + S ++++ +D ++S + ++APE
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKK 183
Query: 526 -YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP------KGQESLVMWAKPILSSGKVTQ 578
D+++F V+L EL+T P ++ E L +P + G
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL----RPTIPPG---- 235
Query: 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
+ P + M+ C+ DP RP+ +++ +L
Sbjct: 236 -ISPHV-----SKLMKI-------CMNEDPAKRPKFDMIVPILE 266
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-52
Identities = 59/290 (20%), Positives = 108/290 (37%), Gaps = 49/290 (16%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 409
LIGKG QVY G E+A++++ +ED +K F E+ H+N++ +
Sbjct: 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 410 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
G C +L ++ +L + K ++ ++A + + + YLH+ +
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLHA---K 149
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAK---WASTSSSHITCTDVAGTFGYLAPEYFMY 526
++H+D+KS N+ D+ + ++DFGL G +LAPE
Sbjct: 150 GILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 527 GKV---------NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA-----KPILS 572
+ DV+A G + EL P ++W KP LS
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----EAIIWQMGTGMKPNLS 264
Query: 573 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
+ + D + C + RP + ++ +L
Sbjct: 265 QIGM----GKEI-----SDILLF-------CWAFEQEERPTFTKLMDMLE 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-50
Identities = 68/295 (23%), Positives = 115/295 (38%), Gaps = 34/295 (11%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLG 410
IGKG +V+ G G+++AVK+ +E+ + E EI T + H+NI+ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIA 98
Query: 411 FCFEDN----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
+ L L+ D+ GSL + L D K+A L +LH+
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLD-----AKSMLKLAYSSVSGLCHLHTE 153
Query: 467 SAQR-----VIHRDVKSSNILLSDDFEPQLSDFGLA--KWASTSSSHITCTDVAGTFGYL 519
+ HRD+KS NIL+ + ++D GLA + T+ I GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 520 APE------YFMYGKVNDKIDVYAFGVVLLELLTGRKPISN----DHPKGQESLVMWAKP 569
PE + + D+Y+FG++L E+ P +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 570 ILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKLLR 622
+ + L P+ N + D+ R + ++ C +P +R V K L
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLR-QMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 6e-50
Identities = 62/287 (21%), Positives = 116/287 (40%), Gaps = 40/287 (13%)
Query: 353 ENLIGKGGSSQVYKG-CLPDGKELAVKIL-KPSEDVIKEFVLEIEIITTLHHKNIISLLG 410
++GKG Q K G+ + +K L + E+ + F+ E++++ L H N++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 411 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 470
++D L + +++ G+L + + WS+R A +A + YLHS
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 471 VIHRDVKSSNILLSDDFEPQLSDFGLAK------------WASTSSSHITCTDVAGTFGY 518
+IHRD+ S N L+ ++ ++DFGLA+ + V G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 519 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK---PILSSGK 575
+APE ++K+DV++FG+VL E++ + P+ + +
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN- 247
Query: 576 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
P+ + R C DP RP + L
Sbjct: 248 ----CPPSF-----FPITVR-------CCDLDPEKRPSFVKLEHWLE 278
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-49
Identities = 68/294 (23%), Positives = 114/294 (38%), Gaps = 34/294 (11%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLG 410
+GKG +V++G G+ +AVKI ++ K + E E+ T L H+NI+ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE--KSWFRETELYNTVMLRHENILGFIA 69
Query: 411 FC----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
L L+ + GSL + L D ++ + +A L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLD-----TVSCLRIVLSIASGLAHLHIE 124
Query: 467 SAQR-----VIHRDVKSSNILLSDDFEPQLSDFGLA--KWASTSSSHITCTDVAGTFGYL 519
+ HRD+KS NIL+ + + ++D GLA ST+ + GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 520 APE------YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH----PKGQESLVMWAKP 569
APE ++D++AFG+VL E+ P +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 570 ILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKLL 621
+ P + N + D LA ++ C ++P AR + K L
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLT-SLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 7e-48
Identities = 76/295 (25%), Positives = 120/295 (40%), Gaps = 34/295 (11%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLG 410
+ IGKG +V++G G+E+AVKI E+ + + E EI T L H+NI+ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIA 103
Query: 411 FCFEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
+DN L LV D+ GSL + L+ K+A+ A L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT-----VEGMIKLALSTASGLAHLHME 158
Query: 467 SAQR-----VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH--ITCTDVAGTFGYL 519
+ HRD+KS NIL+ + ++D GLA +++ I GT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 520 APE------YFMYGKVNDKIDVYAFGVVLLELLTGRKPISND----HPKGQESLVMWAKP 569
APE + + + D+YA G+V E+ P +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 570 ILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKLLR 622
+ Q L P + N + + R V+A I+ C + AR + K L
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALR-VMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 7e-41
Identities = 77/283 (27%), Positives = 130/283 (45%), Gaps = 33/283 (11%)
Query: 348 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHH 402
+NF E IG+G S+VY+ CL DG +A+K ++ + + EI+++ L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 403 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEAL 460
N+I EDN L +V + G L + KK ER K + + AL
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI--PERTVWKYFVQLCSAL 149
Query: 461 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 520
E++HS +RV+HRD+K +N+ ++ +L D GL ++ S+ ++ + GT Y++
Sbjct: 150 EHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMS 204
Query: 521 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ-L 579
PE N K D+++ G +L E+ + P D SL K+ Q
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCK---------KIEQCD 254
Query: 580 LDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKL 620
P ++Y + L ++ CI DP RP ++ V +
Sbjct: 255 YPPLPSDHYSEE------LRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 1e-38
Identities = 73/300 (24%), Positives = 133/300 (44%), Gaps = 35/300 (11%)
Query: 328 HEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPS 383
H +S+ L + ++ IG+G + DG++ +K + + S
Sbjct: 4 HHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS 63
Query: 384 EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA 443
+E E+ ++ + H NI+ E+ +L +V D+ G L + ++ K
Sbjct: 64 SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-- 121
Query: 444 FGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501
+ E + + AL+++H ++++HRD+KS NI L+ D QL DFG+A+ +
Sbjct: 122 --FQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 561
++ GT YL+PE N+K D++A G VL EL T + K
Sbjct: 177 STVEL-ARA-CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK--- 231
Query: 562 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLK 619
+LV+ K+ P + +Y YD L S++ +R+PR RP ++ +L+
Sbjct: 232 NLVL---------KIISGSFPPVSLHYSYD------LRSLVSQLFKRNPRDRPSVNSILE 276
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-38
Identities = 76/291 (26%), Positives = 122/291 (41%), Gaps = 41/291 (14%)
Query: 349 NFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNII 406
++L +G+GG S V L DG A+K IL + +E E ++ +H NI+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 407 SLLGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 462
L+ +C + L+ F RG+L + K + + +G+ LE
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS----TSSSHITCTDVA---GT 515
+H+ + HRD+K +NILL D+ +P L D G A S +T D A T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 516 FGYLAPEYF---MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 572
Y APE F + ++++ DV++ G VL ++ G P KG +S+ +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVAL------- 258
Query: 573 SGKVTQLLDPALGNNYDYDQMERM--VLASIL--CIRRDPRARPQMSLVLK 619
A+ N Q R L +L + DP RP + L+L
Sbjct: 259 ----------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 65/292 (22%), Positives = 119/292 (40%), Gaps = 55/292 (18%)
Query: 348 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII 406
+F LIG GG QV+K DGK +K +K + + + E++ + L H NI+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER---EVKALAKLDHVNIV 67
Query: 407 SLLGFCFED-----------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 449
G C++ L + +F +G+LE+ + + + +
Sbjct: 68 HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK----LDKV 122
Query: 450 Y--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507
++ + + ++Y+HS +++I+RD+K SNI L D + ++ DFGL
Sbjct: 123 LALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179
Query: 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 567
GT Y++PE ++D+YA G++L ELL +
Sbjct: 180 R---SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE----TSKFFTDLR 232
Query: 568 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
I+S +D+ E+ +L + + P RP S +L+
Sbjct: 233 DGIISDI---------------FDKKEKTLLQK--LLSKKPEDRPNTSEILR 267
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 8e-37
Identities = 59/297 (19%), Positives = 117/297 (39%), Gaps = 47/297 (15%)
Query: 348 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKN 404
++F +G+GG V++ D A+K L E ++ + E++ + L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 405 IISLLGFCFEDNN------------LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 452
I+ E N L + + +L++ ++G S +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHI 123
Query: 453 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK----------WAST 502
+ +AEA+E+LHS + ++HRD+K SNI + D ++ DFGL +
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 562
++ T GT Y++PE + K+D+++ G++L ELL +P +
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---------YPFSTQM 231
Query: 563 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
+ + + K L E +++ + P RP+ +++
Sbjct: 232 ERVRTLTDVRNLKFPPLFT-------QKYPCEYVMVQD--MLSPSPMERPEAINIIE 279
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 65/267 (24%), Positives = 108/267 (40%), Gaps = 33/267 (12%)
Query: 355 LIGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLG 410
IG+G VYKG E+A L K ++ + F E E++ L H NI+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 411 FCF----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
++LV + ++ G+L+ L K + + L++LH+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR 148
Query: 467 SAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 525
+ +IHRD+K NI ++ ++ D GLA S V GT ++APE +
Sbjct: 149 TPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE 203
Query: 526 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585
K ++ +DVYAFG+ +LE+ T P S Q ++SG D
Sbjct: 204 -EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR------RVTSGVKPASFDKVA- 255
Query: 586 NNYDYDQMERMVLASILCIRRDPRARP 612
+ ++ CIR++ R
Sbjct: 256 -----IPEVKEIIE--GCIRQNKDERY 275
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 72/264 (27%), Positives = 119/264 (45%), Gaps = 37/264 (14%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
IGKG +V+KG K +A+KI L+ +ED I++ EI +++ + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 470
+D L ++ ++L GS + L E + + + L+YLHS ++
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPGP-------LDETQIATILREILKGLDYLHS---EK 139
Query: 471 VIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 529
IHRD+K++N+LLS+ E +L+DFG+ + T T GT ++APE
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAPEVIKQSAY 196
Query: 530 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA-KPILSSGKVTQLLDPALGNNY 588
+ K D+++ G+ +EL G P S HP M I + P L NY
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHP-------MKVLFLIPKNNP------PTLEGNY 243
Query: 589 DYDQMERMVLASILCIRRDPRARP 612
++ V C+ ++P RP
Sbjct: 244 S-KPLKEFV---EACLNKEPSFRP 263
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-35
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 356 IGKGGSSQVYKGCL-PDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
IG+G +V+ G L D +AVK + D+ +F+ E I+ H NI+ L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 472
+ + +V + + G L ++ A +EYL S + I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLES---KCCI 235
Query: 473 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKVN 530
HRD+ + N L+++ ++SDFG+++ + + APE YG+ +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGV--YAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 531 DKIDVYAFGVVLLELLT-GRKP 551
+ DV++FG++L E + G P
Sbjct: 294 SESDVWSFGILLWETFSLGASP 315
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-35
Identities = 53/251 (21%), Positives = 95/251 (37%), Gaps = 25/251 (9%)
Query: 322 KELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSS--QVYKG-CLPDGKELAVK 378
H + + ++ + +IGKG V P G+ + V+
Sbjct: 2 AHHHHHHMENLYFQGMSSFLP---EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVR 58
Query: 379 IL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLH 435
+ S +++ E+ + +H NI+ DN L +V F++ GS ++ +
Sbjct: 59 RINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 118
Query: 436 GNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 493
+ D G +E + GV +AL+Y+H +HR VK+S+IL+S D + LS
Sbjct: 119 THFMD----GMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSG 171
Query: 494 FGLAKWASTS-----SSHITCTDVAGTFGYLAPEYFMYGKV--NDKIDVYAFGVVLLELL 546
+ H +L+PE + K D+Y+ G+ EL
Sbjct: 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231
Query: 547 TGRKPISNDHP 557
G P +
Sbjct: 232 NGHVPFKDMPA 242
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 64/286 (22%), Positives = 107/286 (37%), Gaps = 30/286 (10%)
Query: 345 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTL 400
S ++ IG G + K DGK L K L +E + V E+ ++ L
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 401 HHKNIISLLG-FCFEDNNLL-LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 458
H NI+ N L +V ++ G L + K+ +V +
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 459 ALEYLHS--GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 516
AL+ H V+HRD+K +N+ L +L DFGLA+ + +S GT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTP 180
Query: 517 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576
Y++PE N+K D+++ G +L EL P + Q+ L K+
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAG---------KI 228
Query: 577 TQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKL 620
+ + Y + L I+ + RP + +L+
Sbjct: 229 REGKFRRIPYRYSDE------LNEIITRMLNLKDYHRPSVEEILEN 268
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 47/223 (21%), Positives = 86/223 (38%), Gaps = 43/223 (19%)
Query: 354 NLIGKGGSSQVYKGCLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN--IISL 408
IG GGSS+V++ + A+K + + + + EI + L + II L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 409 LGFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 459
+ D + +V +L + S++ W + EA
Sbjct: 94 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWE-------RKSYWKN-------MLEA 139
Query: 460 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 519
+ +H ++H D+K +N L+ D +L DFG+A ++ + GT Y+
Sbjct: 140 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 520 APEYFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 551
PE K++ K DV++ G +L + G+ P
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 72/271 (26%), Positives = 114/271 (42%), Gaps = 27/271 (9%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
IG G ++ V C P +++A+K L+ + + E + EI+ ++ HH NI+S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGW--SERY--KVAMGVAEALEYLHSGSA 468
+ L LV LS GS+ + + E + V E LEYLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--- 139
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC---TDVAGTFGYLAPEYFM 525
IHRDVK+ NILL +D Q++DFG++ + +T GT ++APE
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 526 YGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584
+ + K D+++FG+ +EL TG P P M + L
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGAAPYHKYPP-------MKVLMLTLQNDPPSLETGVQ 252
Query: 585 GNNYDYD---QMERMVLASILCIRRDPRARP 612
+M+ LC+++DP RP
Sbjct: 253 DKEMLKKYGKSFRKMI---SLCLQKDPEKRP 280
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 53/205 (25%), Positives = 81/205 (39%), Gaps = 15/205 (7%)
Query: 353 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIIS 407
L+G+GG VY+ + +A+K++ + E L +++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 467
+ F D L + ++ L L + + + AL+ H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAH--- 151
Query: 468 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA-GTFGYLAPEYFMY 526
A HRDVK NIL+S D L DFG+A +T+ +T GT Y+APE F
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 527 GKVNDKIDVYAFGVVLLELLTGRKP 551
+ D+YA VL E LTG P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP 234
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 63/271 (23%), Positives = 121/271 (44%), Gaps = 39/271 (14%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLL 409
+G GG S VY ++A+K + E+ +K F E+ + L H+NI+S++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 410 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
ED+ LV +++ +L E + + + + +++ H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAH---DM 130
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEYFMYGK 528
R++HRD+K NIL+ + ++ DFG+AK + S + +T T+ V GT Y +PE
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 529 VNDKIDVYAFGVVLLELLTGRKPISNDHPKG------QESLVMWAKPILSSGKVTQLLDP 582
++ D+Y+ G+VL E+L G P + + Q+S+ P +++ V + +
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-----PNVTT-DVRKDIPQ 242
Query: 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQ 613
+L ++L +D R +
Sbjct: 243 SL---------SNVILR---ATEKDKANRYK 261
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 69/301 (22%), Positives = 125/301 (41%), Gaps = 50/301 (16%)
Query: 347 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI 405
S+F ++G+G QV K D + A+K ++ +E+ + + E+ ++ +L+H+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 406 ISLLGFCFEDNN-------------LLLVYDFLSRGSLEENLH-GNKKDPAAFGWSERYK 451
+ E N L + ++ G+L + +H N W +
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----R 120
Query: 452 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC-- 509
+ + EAL Y+HS Q +IHRD+K NI + + ++ DFGLAK S +
Sbjct: 121 LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 510 ----------TDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 558
T GT Y+A E G N+KID+Y+ G++ E++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST------- 230
Query: 559 GQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 618
G E + + K L S + P +N + + ++ ++ DP RP +L
Sbjct: 231 GMERVNILKK--LRSVSIE--FPPDFDDNKMKVE--KKIIRLLID--HDPNKRPGARTLL 282
Query: 619 K 619
Sbjct: 283 N 283
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 47/223 (21%), Positives = 86/223 (38%), Gaps = 43/223 (19%)
Query: 354 NLIGKGGSSQVYKGCLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN--IISL 408
IG GGSS+V++ + A+K + + + + EI + L + II L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 409 LGFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 459
+ D + +V +L + S++ W + EA
Sbjct: 75 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWE-------RKSYWKN-------MLEA 120
Query: 460 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 519
+ +H ++H D+K +N L+ D +L DFG+A ++ + GT Y+
Sbjct: 121 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 520 APEYFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 551
PE K++ K DV++ G +L + G+ P
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 64/272 (23%), Positives = 103/272 (37%), Gaps = 38/272 (13%)
Query: 348 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKE---FVLEIEIITTL-HH 402
+F + +G G +V+K DG+ AVK K+ + E+ + H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 403 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 462
+ L E L L + SL+++ + A+ ++ + AL +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL-CGPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
LHS Q ++H DVK +NI L +L DFGL T+ + G Y+APE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPE 226
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582
G DV++ G+ +LE+ + P G E W + L G L P
Sbjct: 227 LLQ-GSYGTAADVFSLGLTILEVACNMEL-----PHGGEG---WQQ--LRQGY----LPP 271
Query: 583 ALGNNYDYDQMERMVLASIL--CIRRDPRARP 612
+ L S+L + DP+ R
Sbjct: 272 EFTAGLSSE------LRSVLVMMLEPDPKLRA 297
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 354 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISL 408
+GKG VY LA+K+L ++ V + E+EI + L H NI+ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHS 465
G+ + + L+ ++ G++ L K A +E +A AL Y HS
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-------LANALSYCHS 127
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 525
+RVIHRD+K N+LL E +++DFG + A +S C GT YL PE
Sbjct: 128 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIE 180
Query: 526 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 558
++K+D+++ GV+ E L G+ P + +
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 57/293 (19%), Positives = 101/293 (34%), Gaps = 57/293 (19%)
Query: 347 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK---PSEDVIKEFVLEIEIITTL-H 401
T+ F IG G V+K DG A+K K + + E+ L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 402 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 461
H +++ ED+++L+ ++ + GSL + + N + + F +E + + V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQ-------------------LSDFGLAKWAST 502
Y+HS ++H D+K SNI +S P + D G S+
Sbjct: 130 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 503 SSSHITCTDVAGTFGYLAPEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQE 561
G +LA E + K D++A + ++ N
Sbjct: 187 PQVEE------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235
Query: 562 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARP 612
W + + G++ P + + +L I DP RP
Sbjct: 236 ---QWHE--IRQGRL-----PRIPQVLSQE------FTELLKVMIHPDPERRP 272
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 16/215 (7%)
Query: 347 TSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI 405
F +G+G VYK G+ +A+K + D ++E + EI I+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-LQEIIKEISIMQQCDSPHV 86
Query: 406 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYL 463
+ G F++ +L +V ++ GS+ + + K +E + + LEYL
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK-----TLTEDEIATILQSTLKGLEYL 141
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPE 522
H R IHRD+K+ NILL+ + +L+DFG+ + T + T V GT ++APE
Sbjct: 142 HF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPFWMAPE 195
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557
N D+++ G+ +E+ G+ P ++ HP
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 46/223 (20%), Positives = 85/223 (38%), Gaps = 43/223 (19%)
Query: 354 NLIGKGGSSQVYKGCLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN--IISL 408
IG GGSS+V++ + A+K + + + + EI + L + II L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 409 LGFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 459
+ D + +V +L + S++ W + EA
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWE-------RKSYWKN-------MLEA 167
Query: 460 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 519
+ +H ++H D+K +N L+ D +L DFG+A ++ + G Y+
Sbjct: 168 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 520 APEYFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 551
PE K++ K DV++ G +L + G+ P
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-32
Identities = 61/282 (21%), Positives = 113/282 (40%), Gaps = 34/282 (12%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIIS 407
+F ++++G G + + D +++AVK + P + E++++ H N+I
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVIR 82
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 467
+ + + L +L+E + ++ A E + L +LHS
Sbjct: 83 YFCTEKDRQFQYIAIE-LCAATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 468 AQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKW-ASTSSSHITCTDVAGTFGYLAP 521
++HRD+K NIL+S +SDFGL K A S + V GT G++AP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 522 EYF---MYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 577
E +D+++ G V +++ G P +++ ++ L
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--RQANILLGACSLDCLHPE 253
Query: 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
+ D + +E+M I DP+ RP VLK
Sbjct: 254 KHEDVIA-----RELIEKM-------IAMDPQKRPSAKHVLK 283
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 65/321 (20%), Positives = 123/321 (38%), Gaps = 50/321 (15%)
Query: 350 FLAENLIGKGGSSQVYKGCL-PDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNII 406
F + +G G V+K P G +A K+ L+ + + + E++++ + I+
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 464
G + D + + + + GSL++ L + P E+ KV++ V + L YL
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP------EQILGKVSIAVIKGLTYLR 148
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 524
+++HRDVK SNIL++ E +L DFG++ S GT Y++PE
Sbjct: 149 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERL 202
Query: 525 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584
+ + D+++ G+ L+E+ GR PI K E + ++ + P
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 585 GNNYDYDQMERM-----VLASIL----------------------CIRRDPRARP----- 612
N +L I+ C+ ++P R
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322
Query: 613 -QMSLVLKLLRGDADVTKWAR 632
+ + + + D W
Sbjct: 323 MVHAFIKRSDAEEVDFAGWLC 343
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLL 409
++G GG S+V+ L D +++AVK+L+ F E + L+H I+++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 410 GFCFEDNNLL----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 465
+ +V +++ +L + +H +V +AL + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSH- 133
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEYF 524
+IHRDVK +NI++S ++ DFG+A+ + S + +T T V GT YL+PE
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 525 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557
V+ + DVY+ G VL E+LTG P + D P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 61/229 (26%), Positives = 107/229 (46%), Gaps = 25/229 (10%)
Query: 342 DLLSATSNFLAE---------NLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDV 386
+L+ A + + +IG+G VY G L DGK++ AVK L
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 387 IKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFG 445
+ +F+ E I+ H N++SLLG C + + L+V ++ G L + +P
Sbjct: 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-- 127
Query: 446 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505
+ + VA+ ++YL ++++ +HRD+ + N +L + F +++DFGLA+
Sbjct: 128 -KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183
Query: 506 HITCTDVAGTF--GYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
+ ++A E K K DV++FGV+L EL+T G P
Sbjct: 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-32
Identities = 63/243 (25%), Positives = 105/243 (43%), Gaps = 26/243 (10%)
Query: 353 ENLIGKGGSSQVYKGC---LPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNII 406
+ +GKG V L D AVK L+ D ++F EI+I+ LH I+
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 407 SLLGFCFED--NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
G + +L LV ++L G L + L ++ A S + + + +EYL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLG 144
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL----- 519
S +R +HRD+ + NIL+ + +++DFGLAK + G
Sbjct: 145 S---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV----VREPGQSPIFWY 197
Query: 520 APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578
APE + + DV++FGVVL EL T K S ++ + + + ++ +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP--SAEFLRMMGCERDVPALSRLLE 255
Query: 579 LLD 581
LL+
Sbjct: 256 LLE 258
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-32
Identities = 55/201 (27%), Positives = 102/201 (50%), Gaps = 8/201 (3%)
Query: 353 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
++ +G G +VY+G +AVK LK ++EF+ E ++ + H N++ LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
C + ++ +F++ G+L + L + + +A ++ A+EYL +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEK---KNF 339
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 531
IHR++ + N L+ ++ +++DFGL++ T ++ + APE Y K +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 532 KIDVYAFGVVLLELLT-GRKP 551
K DV+AFGV+L E+ T G P
Sbjct: 399 KSDVWAFGVLLWEIATYGMSP 419
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-32
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
IGKG V G G ++AVK +K + F+ E ++T L H N++ LLG
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 413 FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
E+ L +V +++++GSL + L + G K ++ V EA+EYL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 310
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKV 529
+HRD+ + N+L+S+D ++SDFGL K + T G APE K
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 363
Query: 530 NDKIDVYAFGVVLLELLT-GRKP 551
+ K DV++FG++L E+ + GR P
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVP 386
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 61/254 (24%), Positives = 103/254 (40%), Gaps = 28/254 (11%)
Query: 309 SPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGC 368
P + D++ L ++L+ + +Y +Q +G+G +V++
Sbjct: 31 GPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPR------------VGRGSFGEVHRMK 78
Query: 369 -LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427
G + AVK + E E E+ L I+ L G E + + + L
Sbjct: 79 DKQTGFQCAVKKV-RLEVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134
Query: 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD- 486
GSL + + K E LEYLH+ +R++H DVK+ N+LLS D
Sbjct: 135 GSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDG 187
Query: 487 FEPQLSDFGLAK---WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 543
L DFG A S +T + GT ++APE M + K+D+++ ++L
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMML 247
Query: 544 ELLTGRKPISNDHP 557
+L G P +
Sbjct: 248 HMLNGCHPWTQYFR 261
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 353 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 406
+IG+G VY G L DGK++ AVK L + +F+ E I+ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 407 SLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 465
SLLG C + + L+V ++ G L + +P + + VA+ +++L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFL-- 208
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----A 520
++++ +HRD+ + N +L + F +++DFGLA+ T L A
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVKWMA 264
Query: 521 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
E K K DV++FGV+L EL+T G P
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 62/294 (21%), Positives = 117/294 (39%), Gaps = 40/294 (13%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKI--LKPSEDVIKEFVLEIEII-TTLHHKNIISLLGF 411
+G+G V K +P G+ +AVK + K +++++I T+ ++ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 469
F + ++ + + + SL++ E K+A+ + +ALE+LHS
Sbjct: 75 LFREGDVWICMELMD-TSLDKFYKQVIDKGQTI--PEDILGKIAVSIVKALEHLHS--KL 129
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 529
VIHRDVK SN+L++ + ++ DFG++ + + AG Y+APE
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERINPELN 186
Query: 530 ND----KIDVYAFGVVLLELLTGRKPISN-DHPKGQESLVMWAKPILSSGKVTQLLDPAL 584
K D+++ G+ ++EL R P + P Q V+ P L
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS------------PQL 234
Query: 585 GNNYDYDQMERMVLASILCIRRDPRARP------QMSLVLKLLRGDADVTKWAR 632
+ + C++++ + RP Q DV + +
Sbjct: 235 PADKFSAEFVDFTSQ---CLKKNSKERPTYPELMQHPFFTLHESKGTDVASFVK 285
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 51/207 (24%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 353 ENLIGKGGSSQVYKGCL-PDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNI 405
++G G VYKG P+G+++ A+K L+ S KE + E ++ ++ + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 406 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 465
LLG C + L+ + G L + + +K + G + +A+ + YL
Sbjct: 80 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED 135
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 525
+R++HRD+ + N+L+ +++DFGLAK ++A E +
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 526 YGKVNDKIDVYAFGVVLLELLT-GRKP 551
+ + DV+++GV + EL+T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 74/297 (24%), Positives = 125/297 (42%), Gaps = 57/297 (19%)
Query: 347 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKN 404
F L+G G QVYKG + G+ A+K++ + D +E EI ++ HH+N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 405 IISLLG------FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGV 456
I + G D+ L LV +F GS+ + + K + E + + +
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL----KEEWIAYICREI 138
Query: 457 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGT 515
L +LH +VIHRD+K N+LL+++ E +L DFG+ A+ T T GT
Sbjct: 139 LRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGT 192
Query: 516 FGYLAPEYFMYGKVND-----KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA--- 567
++APE + D K D+++ G+ +E+ G P+ + HP M A
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALFL 245
Query: 568 -----KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
P L S K ++ + + C+ ++ RP ++K
Sbjct: 246 IPRNPAPRLKSKKWSKKF--------------QSFIE--SCLVKNHSQRPATEQLMK 286
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLL 409
L+GKG + VY+ + G E+A+K++ +++ E++I L H +I+ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 410 GFCFED-NNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHS 465
FED N + LV + G + L K + A R+ + + + YLHS
Sbjct: 78 N-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEA-----RHFMHQ-IITGMLYLHS 130
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--HITCTDVAGTFGYLAPEY 523
++HRD+ SN+LL+ + +++DFGLA + C GT Y++PE
Sbjct: 131 ---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC----GTPNYISPEI 183
Query: 524 FMYGKVNDKIDVYAFGVVLLELLTGRKP 551
+ DV++ G + LL GR P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 21/212 (9%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCF 413
+G G +VYK G A K+++ SE+ ++++++EIEI+ T H I+ LLG +
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 414 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 471
D L ++ +F G+++ + + G +E V + EAL +LHS +R+
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHS---KRI 138
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 530
IHRD+K+ N+L++ + + +L+DFG+ AK T + GT ++APE M +
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPYWMAPEVVMCETMK 195
Query: 531 D-----KIDVYAFGVVLLELLTGRKPISNDHP 557
D K D+++ G+ L+E+ P +P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 21/209 (10%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
IGKG V G G ++AVK +K + F+ E ++T L H N++ LLG
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 413 FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
E+ L +V +++++GSL + L + G K ++ V EA+EYL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKV 529
+HRD+ + N+L+S+D ++SDFGL K AS++ G APE K
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-------TGKLPVKWTAPEALREKKF 191
Query: 530 NDKIDVYAFGVVLLELLT-GRKP---ISN 554
+ K DV++FG++L E+ + GR P I
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPL 220
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 68/285 (23%), Positives = 112/285 (39%), Gaps = 47/285 (16%)
Query: 353 ENLIGKGGSSQVYKGC---LPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNII 406
+GKG V L D AVK L+ +E+ +++F EIEI+ +L H NI+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 407 SLLGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
G C+ L L+ ++L GSL + L +K+ + + + + +EYL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 131
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL----- 519
+ +R IHRD+ + NIL+ ++ ++ DFGL K G
Sbjct: 132 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK----VKEPGESPIFWY 184
Query: 520 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579
APE K + DV++FGVVL EL T + + + + + + + +L
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 580 LD------------PALGNNYDYDQMERMVLASILCIRRDPRARP 612
L + Y M C + RP
Sbjct: 245 LKNNGRLPRPDGCPDEI-----YMIMTE-------CWNNNVNQRP 277
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
+G G V G ++AVK++K EF E + + L H ++ G C
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 472
++ + +V +++S G L L + K S+ ++ V E + +L + + I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 473 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------APEYFMY 526
HRD+ + N L+ D ++SDFG+ ++ + + G APE F Y
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRY-------VLDDQYVSSVGTKFPVKWSAPEVFHY 179
Query: 527 GKVNDKIDVYAFGVVLLELLT-GRKP 551
K + K DV+AFG+++ E+ + G+ P
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 50/217 (23%), Positives = 89/217 (41%), Gaps = 30/217 (13%)
Query: 355 LIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 411
++G+G ++ V++G G A+K+ + + E E++ L+HKNI+ L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 412 CFED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 466
E+ + +L+ +F GSL L A+G E V V + +L
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLRE- 130
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
++HR++K NI+ + Q L+DFG A+ + GT YL P+
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185
Query: 523 YFMYGKVND--------KIDVYAFGVVLLELLTGRKP 551
+ + +D+++ GV TG P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 63/242 (26%), Positives = 106/242 (43%), Gaps = 23/242 (9%)
Query: 353 ENLIGKGGSSQVYKGC---LPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNII 406
+GKG V L D AVK L+ +E+ +++F EIEI+ +L H NI+
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 407 SLLGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
G C+ L L+ ++L GSL + L +K+ + + + + +EYL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 162
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL----- 519
+ +R IHRD+ + NIL+ ++ ++ DFGL K + G
Sbjct: 163 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK----VKEPGESPIFWY 215
Query: 520 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579
APE K + DV++FGVVL EL T + + + + + + + +L
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275
Query: 580 LD 581
L
Sbjct: 276 LK 277
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-31
Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 16/209 (7%)
Query: 351 LAENLIGKGGSSQVYKGCL-PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNI 405
+A+ +G G V +G K++ A+K+LK + +E + E +I+ L + I
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 406 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 465
+ L+G C + L+LV + G L + L G +++ S ++ V+ ++YL
Sbjct: 73 VRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL-- 126
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEY 523
+ +HRD+ + N+LL + ++SDFGL+K S+ T AG + + APE
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT-ARSAGKWPLKWYAPEC 184
Query: 524 FMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
+ K + + DV+++GV + E L+ G+KP
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 66/296 (22%), Positives = 118/296 (39%), Gaps = 45/296 (15%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEII-TTLHHKNIISLLGF 411
+G G QV+K G +AVK +++ K +++++++ + I+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 469
+ ++ + + + + + P ER K+ + + +AL YL
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIP------ERILGKMTVAIVKALYYLKE--KH 144
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 529
VIHRDVK SNILL + + +L DFG++ AG Y+APE
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPDP 201
Query: 530 ND-----KIDVYAFGVVLLELLTGRKPISNDHPK-GQESLVMWAKPILSSGKVTQLLDPA 583
+ DV++ G+ L+EL TG+ P N + V+ +P P
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP------------PL 249
Query: 584 LGNNYDY-DQMERMVLASILCIRRDPRARP------QMSLVLKLLRGDADVTKWAR 632
L + + + V C+ +D R RP + S + + + DV W +
Sbjct: 250 LPGHMGFSGDFQSFVKD---CLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFK 302
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 413
IG+G S VY + G+E+A++ + + KE ++ EI ++ + NI++ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 414 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 471
+ L +V ++L+ GSL + + E V +ALE+LHS +V
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHS---NQV 137
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 531
IHRD+KS NILL D +L+DFG A + + + GT ++APE
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 532 KIDVYAFGVVLLELLTGRKPISNDHP 557
K+D+++ G++ +E++ G P N++P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENP 221
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 76/284 (26%), Positives = 117/284 (41%), Gaps = 53/284 (18%)
Query: 356 IGKGGSSQVYKGCL---PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 408
+G+G +V C DG AVK LK + EI+I+ TL+H++II
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 409 LGFCFED--NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
G C + +L LV +++ GSL + L + G ++ A + E + YLH+
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHA- 152
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----AP 521
Q IHRD+ + N+LL +D ++ DFGLAK + G AP
Sbjct: 153 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYAP 206
Query: 522 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580
E K DV++FGV L ELLT S P L+ A+ ++ ++T+LL
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP--PTKFLELIGIAQGQMTVLRLTELL 264
Query: 581 D------------PALGNNYDYDQMERMVLASILCIRRDPRARP 612
+ + Y M+ C + RP
Sbjct: 265 ERGERLPRPDKCPAEV-----YHLMKN-------CWETEASFRP 296
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLL 409
+GKG VY + +A+K+L S+ V + EIEI + L H NI+ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 410 GFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSG 466
+ + + L+ +F RG L + L + + +A E +A+AL Y H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-------LADALHYCHE- 132
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 526
++VIHRD+K N+L+ E +++DFG + A + C GT YL PE
Sbjct: 133 --RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYLPPEMIEG 186
Query: 527 GKVNDKIDVYAFGVVLLELLTGRKP 551
++K+D++ GV+ E L G P
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 70/318 (22%), Positives = 137/318 (43%), Gaps = 55/318 (17%)
Query: 356 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 407
+G+G VY+G + D E A+K + S EF+ E ++ + +++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALE 461
LLG + L++ + ++RG L+ L + A ++A +A+ +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD--VAGTFGYL 519
YL +A + +HRD+ + N ++++DF ++ DFG+ + I TD G G L
Sbjct: 153 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-------IYETDYYRKGGKGLL 202
Query: 520 -----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAKPI 570
+PE G DV++FGVVL E+ T +P +SN ++ L
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQVLRF----- 252
Query: 571 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKW 630
+ G + L P + ++ M C + +P+ RP ++ ++ + + +
Sbjct: 253 VMEGGL--LDKPDNCPDMLFELMRM-------CWQYNPKMRPSFLEIISSIKEEME-PGF 302
Query: 631 ARLQVNASEESEMLDDES 648
+ SEE+++ + E
Sbjct: 303 REVSFYYSEENKLPEPEE 320
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 53/284 (18%), Positives = 93/284 (32%), Gaps = 32/284 (11%)
Query: 295 DSGAIVPVGNEIVSSPLSTDHDST---ELPKELEGLHEKYSATCRLFNYQ---DLLSATS 348
S V N IV +P L K + + C+L + + +
Sbjct: 6 SSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSK 65
Query: 349 NFLAENLIGKGGSSQVYKGC------LPDGKELAVKILKPSEDVIKEFVL---EIEIITT 399
+L+G+G +QVY+ + ++ +K+ KP+ EF + +E +
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKP 123
Query: 400 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP-AAFGWSERYKVAMGVAE 458
+ N +LV + S G+L ++ K P AM +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 459 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEP-----------QLSDFGLAKWASTSSSHI 507
+E +H +IH D+K N +L + F L D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
T T G+ E N +ID + + +L G
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-31
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 353 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP---SEDVIKEFVLEIEIITTLHHKNI 405
++G+G V +G L DG L AVK +K S+ I+EF+ E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 406 ISLLGFCFEDN-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG--VAE 458
I LLG C E + +++ F+ G L L ++ + + + +A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 459 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV--AGTF 516
+EYL S + +HRD+ + N +L DD ++DFGL+K I D G
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK-------IYSGDYYRQGRI 208
Query: 517 GYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
+ A E K DV+AFGV + E+ T G P
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 406
+ +IGKG VY G D + A+K L ++ F+ E ++ L+H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 407 SLLGFCF-EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 465
+L+G + ++ ++ G L + + +++P + + VA +EYL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV---KDLISFGLQVARGMEYL-- 140
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEY 523
+ Q+ +HRD+ + N +L + F +++DFGLA+ + + A E
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 524 FMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
+ K DV++FGV+L ELLT G P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 33/219 (15%)
Query: 356 IGKGGSSQVYKGCL--PDGKEL--AVKILKP---SEDVIKEFVLEIEIITTLHHKNIISL 408
+GKG V + L DG + AVK+LK + I+EF+ E + H ++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 409 LGFCFED------NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEAL 460
+G +++ F+ G L L ++P + + +A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 461 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV--AGTFGY 518
EYL S++ IHRD+ + N +L++D ++DFGL++ I D G
Sbjct: 151 EYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK-------IYSGDYYRQGCASK 200
Query: 519 L-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
L A E DV+AFGV + E++T G+ P
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-30
Identities = 54/200 (27%), Positives = 102/200 (51%), Gaps = 8/200 (4%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
E +G+G +V+ G +A+K LKP + F+ E +++ L H+ ++ L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 472
E+ + +V +++S+GSL + L G + +A +A + Y+ +
Sbjct: 249 SEE-PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MNYV 302
Query: 473 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 532
HRD++++NIL+ ++ +++DFGLA+ + + + APE +YG+ K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 533 IDVYAFGVVLLELLT-GRKP 551
DV++FG++L EL T GR P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
IG G V+ G + ++A+K ++ ++F+ E E++ L H ++ L G C
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 472
E + LV +F+ G L + L + F + + V E + YL VI
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 473 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKVN 530
HRD+ + N L+ ++ ++SDFG+ ++ + F +PE F + + +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 531 DKIDVYAFGVVLLELLT-GRKP 551
K DV++FGV++ E+ + G+ P
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIP 205
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 353 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 406
E +IG G S +V G L P +++ A+K LK +E ++F+ E I+ H NII
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
L G ++V +++ GSL+ L + F + + GV + YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYL--- 167
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----AP 521
S +HRD+ + N+L+ + ++SDFGL++ T G + AP
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD----AAYTTTGGKIPIRWTAP 223
Query: 522 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
E + + DV++FGVV+ E+L G +P
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 51/287 (17%)
Query: 353 ENLIGKGGSSQVYKGCLP-----DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNI 405
+G+G +V G+++AVK LKP + I + EIEI+ L+H+NI
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 406 ISLLGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 463
+ G C ED + L+ +FL GSL+E L NK ++ K A+ + + ++YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL 142
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL---- 519
S ++ +HRD+ + N+L+ + + ++ DFGL K T + T
Sbjct: 143 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT----VKDDRDSPVFW 195
Query: 520 -APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 577
APE M K DV++FGV L ELLT S ++ ++ ++
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP--MALFLKMIGPTHGQMTVTRLV 253
Query: 578 QLLD------------PALGNNYDYDQMERMVLASILCIRRDPRARP 612
L + Y M + C P R
Sbjct: 254 NTLKEGKRLPCPPNCPDEV-----YQLMRK-------CWEFQPSNRT 288
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 353 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP----SEDVIKEFVLEIEIITTLHHKN 404
+G G V +G P GK + AVK LKP + + +F+ E+ + +L H+N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
+I L G + +V + GSL + L ++ F + A+ VAE + YL
Sbjct: 83 LIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYL- 137
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPE 522
++R IHRD+ + N+LL+ ++ DFGL + + H + + APE
Sbjct: 138 --ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-HRKVPFAWCAPE 194
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
+ D + FGV L E+ T G++P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 51/206 (24%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
+G G V G ++A+K++K EF+ E +++ L H+ ++ L G C
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 472
+ + ++ ++++ G L L + F + ++ V EA+EYL +++ +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL---ESKQFL 142
Query: 473 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------APEYFMY 526
HRD+ + N L++D ++SDFGL+++ + + + G PE MY
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRY-------VLDDEYTSSVGSKFPVRWSPPEVLMY 195
Query: 527 GKVNDKIDVYAFGVVLLELLT-GRKP 551
K + K D++AFGV++ E+ + G+ P
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 33/293 (11%), Positives = 71/293 (24%), Gaps = 51/293 (17%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLL 409
+ G S V+ + ++ A+K+ + S ++ L ++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 410 GFC--------------------------FEDNNLLLVYDFL--SRGSLEENLHGNKKDP 441
+ N LL+ L L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 442 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501
G + + + L S + ++H N+ + D L D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 502 TSSSHITCTDVAGTFGYLAPEYFM--YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 559
T + Y E+ ++ + G+ + + P P
Sbjct: 246 T-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 560 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 612
+ S + + + A G+ + ++ L D R R
Sbjct: 301 KGSWKRPSLRVPGTD------SLAFGSCTPLPDFVKTLIGRFL--NFDRRRRL 345
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 17/212 (8%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEII-TTLHHKNIISLLGF 411
IG+G V K P G+ +AVK E K+ +++++++ + I+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 469
F + + + + +S S ++ E K+ + +AL +L
Sbjct: 90 LFREGDCWICMELMS-TSFDKFYKYVYSVLDD-VIPEEILGKITLATVKALNHLKE--NL 145
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 529
++IHRD+K SNILL +L DFG++ S I T AG Y+APE
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---IAKTRDAGCRPYMAPERIDPSAS 202
Query: 530 ND----KIDVYAFGVVLLELLTGRKPISNDHP 557
+ DV++ G+ L EL TGR P +
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 351 LAENLIGKGGSSQVYKGCLPDGKEL---AVKILKP---SEDVIKEFVLEIEIITTLHHKN 404
L + +G G V KG K + AVKILK + E + E ++ L +
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
I+ ++G C E + +LV + G L + L N+ ++ V+ ++YL
Sbjct: 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYL- 133
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPE 522
+HRD+ + N+LL ++SDFGL+K ++ G + + APE
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPE 190
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
Y K + K DV++FGV++ E + G+KP
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-30
Identities = 55/214 (25%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
E +G G +V+ ++AVK +KP ++ F+ E ++ TL H ++ L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 472
++ + ++ +F+++GSL + L ++ + + +AE + ++ + I
Sbjct: 253 TKE-PIYIITEFMAKGSLLDFLKSDEGSK--QPLPKLIDFSAQIAEGMAFI---EQRNYI 306
Query: 473 HRDVKSSNILLSDDFEPQLSDFGLAKWAS----TSSSH----ITCTDVAGTFGYLAPEYF 524
HRD++++NIL+S +++DFGLA+ T+ I T APE
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT---------APEAI 357
Query: 525 MYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 554
+G K DV++FG++L+E++T GR P +SN
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 67/261 (25%), Positives = 120/261 (45%), Gaps = 30/261 (11%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 413
IG+G + V G+++AVK++ + +E + E+ I+ H N++ +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 414 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 471
L ++ +FL G+L + + + +E V V +AL YLH+ Q V
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVR-------LNEEQIATVCEAVLQALAYLHA---QGV 162
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 531
IHRD+KS +ILL+ D +LSDFG A S + GT ++APE
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRSLYAT 220
Query: 532 KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 591
++D+++ G++++E++ G P +D P +++ + S P L N++
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKR----LRDSPP------PKLKNSHKVS 268
Query: 592 QMERMVLASILCIRRDPRARP 612
+ R L + RDP+ R
Sbjct: 269 PVLRDFLE--RMLVRDPQERA 287
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-30
Identities = 54/268 (20%), Positives = 95/268 (35%), Gaps = 49/268 (18%)
Query: 355 LIGKGGSSQVYKG--CLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLG 410
I GG +Y +G+ + +K L S D + E + + + H +I+ +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 411 FCFEDNNLL-----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 465
F + +V +++ SL+ + +E + + AL YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH- 199
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 525
+ +++ D+K NI+L+++ + +L D G S + + GT G+ APE
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGY-----LYGTPGFQAPEIVR 250
Query: 526 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585
D+Y G L L + + G DP L
Sbjct: 251 -TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------LPEDDPVLK 292
Query: 586 NNYDYDQMERMVLASILCIRRDPRARPQ 613
YD R++ I DPR R
Sbjct: 293 ---TYDSYGRLLRR---AIDPDPRQRFT 314
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 353 ENLIGKGGSSQVYKGCLPDGK-ELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
++ +G G +VY+G +AVK LK ++EF+ E ++ + H N++ LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
C + ++ +F++ G+L + L + + +A ++ A+EYL +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----APEYFMY 526
IHRD+ + N L+ ++ +++DFGL++ + T A APE Y
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAKFPIKWTAPESLAY 186
Query: 527 GKVNDKIDVYAFGVVLLELLT-GRKP 551
K + K DV+AFGV+L E+ T G P
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 59/229 (25%), Positives = 107/229 (46%), Gaps = 40/229 (17%)
Query: 356 IGKGGSSQVYKG----CLPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISL 408
+G+G +V+ P ++ AVK LK + K+F E E++T L H++I+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KVAMGV 456
G C + + L++V++++ G L + L + D + +A +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 457 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD--VAG 514
A + YL ++Q +HRD+ + N L+ + ++ DFG+++ + TD G
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-------DVYSTDYYRVG 192
Query: 515 TFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 554
L PE MY K + DV++FGV+L E+ T G++P +SN
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-30
Identities = 54/200 (27%), Positives = 102/200 (51%), Gaps = 8/200 (4%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
E +G+G +V+ G +A+K LKP + F+ E +++ L H+ ++ L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 472
E+ + +V +++S+GSL + L G + +A +A + Y+ +
Sbjct: 332 SEE-PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MNYV 385
Query: 473 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 532
HRD++++NIL+ ++ +++DFGLA+ + + + APE +YG+ K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 533 IDVYAFGVVLLELLT-GRKP 551
DV++FG++L EL T GR P
Sbjct: 445 SDVWSFGILLTELTTKGRVP 464
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 409
+GKGG ++ ++ + A KI+ ++ +EI I +L H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 410 GFCFED-NNLLLVYDFLSRGSLEENLHGNKK--DPAAFGWSERYKVAMGVAEALEYLHSG 466
G FED + + +V + R SL E K +P A RY + + +YLH
Sbjct: 82 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----RYYL-RQIVLGCQYLHR- 133
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--HITCTDVAGTFGYLAPEYF 524
RVIHRD+K N+ L++D E ++ DFGLA + C GT Y+APE
Sbjct: 134 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYIAPEVL 187
Query: 525 MYGKVNDKIDVYAFGVVLLELLTGRKP 551
+ ++DV++ G ++ LL G+ P
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 39/228 (17%)
Query: 356 IGKGGSSQVYKG----CLPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISL 408
+G+G +V+ LP+ ++ AVK LK SE ++F E E++T L H++I+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 409 LGFCFEDNNLLLVYDFLSRGSL-----------EENLHGNKKDPAAFGWSERYKVAMGVA 457
G C E LL+V++++ G L + G P G + VA VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 458 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV--AGT 515
+ YL + +HRD+ + N L+ ++ DFG+++ I TD G
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-------DIYSTDYYRVGG 218
Query: 516 FGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 554
L PE +Y K + DV++FGVVL E+ T G++P +SN
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 41/233 (17%)
Query: 353 ENLIGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKN 404
+G+ +VYKG P + A+K LK + +EF E + L H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENL------------HGNKKDPAAFGWSERYKV 452
++ LLG +D L +++ + S G L E L ++ +A + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 453 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 511
+A +EYL S+ V+H+D+ + N+L+ D ++SD GL + + D
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-------EVYAADY 183
Query: 512 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 554
L APE MYGK + D++++GVVL E+ + G +P SN
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-29
Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 16/245 (6%)
Query: 315 HDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGK 373
+P + +S L + + L + +A+ +G G V +G K
Sbjct: 303 DKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK 362
Query: 374 EL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 429
++ A+K+LK + +E + E +I+ L + I+ L+G C + L+LV + G
Sbjct: 363 QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 421
Query: 430 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 489
L + L G +++ S ++ V+ ++YL + +HR++ + N+LL +
Sbjct: 422 LHKFLVGKREE---IPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYA 475
Query: 490 QLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKVNDKIDVYAFGVVLLELLT 547
++SDFGL+K S+ T AG + APE + K + + DV+++GV + E L+
Sbjct: 476 KISDFGLSKALGADDSYYT-ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
Query: 548 -GRKP 551
G+KP
Sbjct: 535 YGQKP 539
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-29
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 355 LIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
++G+G ++ V++G G A+K+ + + E E++ L+HKNI+ L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 412 CFED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 466
E+ + +L+ +F GSL L A+G E V V + +L
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLRE- 130
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
++HR++K NI+ + Q L+DFG A+ + GT YL P+
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185
Query: 523 YFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 551
+ YG +D+++ GV TG P
Sbjct: 186 MYERAVLRKDHQKKYGA---TVDLWSIGVTFYHAATGSLP 222
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 409
+GKGG ++ ++ + A KI+ ++ +EI I +L H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 410 GFCFED-NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
G FED + + +V + R SL E +P A RY + + +YLH
Sbjct: 108 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----RYYL-RQIVLGCQYLHR- 159
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--HITCTDVAGTFGYLAPEYF 524
RVIHRD+K N+ L++D E ++ DFGLA + C GT Y+APE
Sbjct: 160 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYIAPEVL 213
Query: 525 MYGKVNDKIDVYAFGVVLLELLTGRKP 551
+ ++DV++ G ++ LL G+ P
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 356 IGKGGSSQVYKGCL-PDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 408
+G G VYKG P+G+++ A+K L+ S KE + E ++ ++ + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 468
LG C + L+ + G L + + +K + G + +A+ + YL
Sbjct: 83 LGICLTST-VQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED--- 135
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 528
+R++HRD+ + N+L+ +++DFGLAK ++A E ++
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 529 VNDKIDVYAFGVVLLELLT-GRKP 551
+ DV+++GV + EL+T G KP
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
+G G +V+ G ++AVK LK F+ E ++ L H+ ++ L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 472
++ + ++ +++ GSL + L ++ +A +AE + ++ + I
Sbjct: 78 TQE-PIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131
Query: 473 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------APEYFMY 526
HRD++++NIL+SD +++DFGLA+ I + G APE Y
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARL-------IEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 527 GKVNDKIDVYAFGVVLLELLT-GRKP---ISN 554
G K DV++FG++L E++T GR P ++N
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 353 ENLIGKGGSSQVYKGCL--PDGKEL---AVKILKP--SEDVIKEFVLEIEIITTLHHKNI 405
+ +IG G +VYKG L GK+ A+K LK +E +F+ E I+ H NI
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 406 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 465
I L G + ++++ +++ G+L++ L + F + + G+A ++YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYL-- 163
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----A 520
+ +HRD+ + NIL++ + ++SDFGL++ + G + A
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE----ATYTTSGGKIPIRWTA 218
Query: 521 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
PE Y K DV++FG+V+ E++T G +P
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
++GKG VY G L + +A+K I + + EI + L HKNI+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 470
E+ + + + + GSL L + +E+ + E L+YLH +
Sbjct: 89 SENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQ 142
Query: 471 VIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 529
++HRD+K N+L+ + ++SDFG +K + + GT Y+APE G
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEIIDKGPR 200
Query: 530 --NDKIDVYAFGVVLLELLTGRKPISN-DHP 557
D+++ G ++E+ TG+ P P
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEP 231
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 44/226 (19%), Positives = 93/226 (41%), Gaps = 33/226 (14%)
Query: 356 IGKGGSSQVYKGCLPDGKELAVKILK------------------PSEDVIKEFVLEIEII 397
+ +G +++ C D K A+K + + +F E++II
Sbjct: 39 LNQGKFNKIIL-CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 398 TTLHHKNIISLLGFCFED-NNLLLVYDFLSRGSL----EENLHGNKKDPAAFGWSERYKV 452
T + ++ ++ G + + + ++Y+++ S+ E +K +
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 453 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 512
V + Y+H+ + + HRDVK SNIL+ + +LSDFG +++ +
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR--- 211
Query: 513 AGTFGYLAPEYFMYGKV--NDKIDVYAFGVVLLELLTGRKPISNDH 556
GT+ ++ PE+F K+D+++ G+ L + P S
Sbjct: 212 -GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 353 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 406
+ ++G G +V G L P KE+ A+K LK +E ++F+ E I+ H NII
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
L G + +++V +++ GSL+ L + F + + G+A ++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL--- 163
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----AP 521
S +HRD+ + NIL++ + ++SDFGL + G + +P
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE----AAYTTRGGKIPIRWTSP 219
Query: 522 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
E Y K DV+++G+VL E+++ G +P
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 25/221 (11%)
Query: 347 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLH 401
F IG G VY + + + +A+K + K S + ++ + E+ + L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 402 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEA 459
H N I G ++ LV ++ GS + L +KK E V G +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQG 166
Query: 460 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 519
L YLHS +IHRDVK+ NILLS+ +L DFG AS + + GT ++
Sbjct: 167 LAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGS---ASIMAPANS---FVGTPYWM 217
Query: 520 APEYFMYGKV---NDKIDVYAFGVVLLELLTGRKPISNDHP 557
APE + + K+DV++ G+ +EL + P+ N +
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 353 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 406
IG+G V++G P+ L A+K K S+ V ++F+ E + H +I+
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
L+G +N + ++ + + G L L K + A ++ AL YL
Sbjct: 80 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYL--- 132
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------A 520
++R +HRD+ + N+L+S + +L DFGL+++ + + A
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-------MEDSTYYKASKGKLPIKWMA 185
Query: 521 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
PE + + DV+ FGV + E+L G KP
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-29
Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 22/230 (9%)
Query: 353 ENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISL 408
+G G +V E A+KI+ S + + E+ ++ L H NI+ L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 466
F + N LV + G L + + K ++E + V + YLH
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMK------FNEVDAAVIIKQVLSGVTYLHK- 154
Query: 467 SAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523
++HRD+K N+LL D ++ DFGL+ + GT Y+APE
Sbjct: 155 --HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEV 209
Query: 524 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 573
K ++K DV++ GV+L LL G P + V K S
Sbjct: 210 LR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS 258
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 356 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 407
+G G +VY+G D L AVK L SE +F++E II+ +H+NI+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLH 464
+G + ++ + ++ G L+ L + P++ + VA +A +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQL---SDFGLAKWASTSSSHITCTD--VAGTFGYL 519
IHRD+ + N LL+ ++ DFG+A+ I G L
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRASYYRKGGCAML 207
Query: 520 -----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
PE FM G K D ++FGV+L E+ + G P
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 353 ENLIGKGGSSQVYKGCL-PDGKEL----AVKILK--PSEDVIKEFVLEIEIITTLHHKNI 405
++G G V+KG P+G+ + +K+++ + + I +L H +I
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 406 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 465
+ LLG C + L LV +L GSL +++ ++ G + +A+ + YL
Sbjct: 78 VRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYL-- 131
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 525
++HR++ + N+LL + Q++DFG+A + ++ ++A E
Sbjct: 132 -EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 526 YGKVNDKIDVYAFGVVLLELLT-GRKP 551
+GK + DV+++GV + EL+T G +P
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLLG 410
+GKG +V G+E AVK++ + + + E++++ L H NI+ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 411 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSA 468
F + LV + + G L + + K+ +SE ++ V + Y+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKR------FSEVDAARIIRQVLSGITYMHK--- 144
Query: 469 QRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 525
+++HRD+K N+LL S D ++ DFGL+ S D GT Y+APE
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLH 201
Query: 526 YGKVNDKIDVYAFGVVLLELLTGRKP 551
G ++K DV++ GV+L LL+G P
Sbjct: 202 -GTYDEKCDVWSTGVILYILLSGCPP 226
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 50/224 (22%), Positives = 91/224 (40%), Gaps = 43/224 (19%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKEL--------AVKILKP-SEDVIKEFVLEIEIITTLHHK 403
+G+G ++++KG + + +K+L + + F +++ L HK
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 404 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 463
+++ G C + +LV +F+ GSL+ L NK + +VA +A A+ +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHFL 129
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQ--------LSDFGLAKWASTSSSHITCTDVAGT 515
+IH +V + NILL + + + LSD G++ V
Sbjct: 130 ---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI------------TVLPK 174
Query: 516 FGY------LAPEYFMYGKV-NDKIDVYAFGVVLLELLT-GRKP 551
+ PE K N D ++FG L E+ + G KP
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 67/307 (21%), Positives = 119/307 (38%), Gaps = 61/307 (19%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEI-ITTLHHKNII 406
+ ++E ++G G S V G+ +AVK + D ++EI++ + H N+I
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI--DFCDIALMEIKLLTESDDHPNVI 72
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 463
D L + + L +L+ E+ + + ++ + +A + +L
Sbjct: 73 RYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQ-------------LSDFGLAK--WASTSSSHIT 508
HS ++IHRD+K NIL+S +SDFGL K + SS
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 509 CTDVAGTFGYLAPEYFM-------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 561
+ +GT G+ APE ++ ID+++ G V +L+ K HP G +
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK-----HPFGDK 243
Query: 562 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL---------CIRRDPRARP 612
I+ + D+M+ + S++ I DP RP
Sbjct: 244 YSRESN--IIR-------------GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP 288
Query: 613 QMSLVLK 619
VL+
Sbjct: 289 TAMKVLR 295
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 356 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 407
+G G +VY+G D L AVK L SE +F++E II+ +H+NI+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLH 464
+G + ++ + ++ G L+ L + P++ + VA +A +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQL---SDFGLAKWASTSSSHITCTD--VAGTFGYL 519
IHRD+ + N LL+ ++ DFG+A+ I G L
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRAGYYRKGGCAML 248
Query: 520 -----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
PE FM G K D ++FGV+L E+ + G P
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 63/231 (27%), Positives = 111/231 (48%), Gaps = 42/231 (18%)
Query: 353 ENLIGKGGSSQVYKGCL-PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 406
+++IG+G QV K + DG + A+K +K S+D ++F E+E++ L HH NII
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KVAM 454
+LLG C L L ++ G+L + L ++ ++ A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 455 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD--V 512
VA ++YL S ++ IHRD+ + NIL+ +++ +++DFGL++ + V
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----------GQEVYV 196
Query: 513 AGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 554
T G L A E Y DV+++GV+L E+++ G P ++
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 25/222 (11%)
Query: 353 ENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTL-HHKNIISLL 409
++ +GG + VY+ + G+E A+K +L E+ + + E+ + L H NI+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 410 GFCF-------EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 462
L+ L +G L E L + K+ A+++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA--------- 513
+H +IHRD+K N+LLS+ +L DFG A S +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 514 -GTFGYLAPEYF-MYGK--VNDKIDVYAFGVVLLELLTGRKP 551
T Y PE +Y + +K D++A G +L L + P
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 65/211 (30%), Positives = 90/211 (42%), Gaps = 25/211 (11%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKI-----LKPSEDVIKEFVL-EIEIITTLHHKNIISL 408
IGKG S V + G++ AVKI S + E + E I L H +I+ L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 466
L D L +V++F+ L + K+ A F +SE + EAL Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSEAVASHYMRQILEALRYCHD- 148
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE- 522
+IHRDVK +LL+ L FG+A S GT ++APE
Sbjct: 149 --NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGTPHFMAPEV 204
Query: 523 --YFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
YGK +DV+ GV+L LL+G P
Sbjct: 205 VKREPYGK---PVDVWGCGVILFILLSGCLP 232
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 353 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 406
++G+G +VY+G G+++ AVK K + D ++F+ E I+ L H +I+
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
L+G E+ ++ + G L L NK ++ + +A+ YL
Sbjct: 77 KLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKV---LTLVLYSLQICKAMAYL--- 129
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYL-----A 520
+ +HRD+ NIL++ +L DFGL+++ I D + L +
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSRY-------IEDEDYYKASVTRLPIKWMS 182
Query: 521 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
PE + + DV+ F V + E+L+ G++P
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-28
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 353 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 406
IG+G V++G P+ + A+K K S+ V ++F+ E + H +I+
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
L+G +N + ++ + + G L L K + A ++ AL YL
Sbjct: 455 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYL--- 507
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV-AGTFGYL-----A 520
++R +HRD+ + N+L+S + +L DFGL+++ + + + G L A
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-------MEDSTYYKASKGKLPIKWMA 560
Query: 521 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
PE + + DV+ FGV + E+L G KP
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-28
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 353 ENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISL 408
++GKG +V K +E AVK++ + E+E++ L H NI+ L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 466
+ ++ +V + + G L + + K+ +SE ++ V + Y+H
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMHK- 139
Query: 467 SAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523
++HRD+K NILL D + ++ DFGL+ ++ D GT Y+APE
Sbjct: 140 --HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEV 194
Query: 524 FMYGKVNDKIDVYAFGVVLLELLTGRKP 551
G ++K DV++ GV+L LL+G P
Sbjct: 195 LR-GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-28
Identities = 63/253 (24%), Positives = 104/253 (41%), Gaps = 46/253 (18%)
Query: 334 TCRLFNYQDLLSATSNFLAENL---------IGKGGSSQVYKGC-LPDGKELAVKILKPS 383
++F + DL + + L +G G +V K++A++I+
Sbjct: 112 RNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKR 171
Query: 384 EDVIKEFVL---------EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL 434
+ I EIEI+ L+H II + F F+ + +V + + G L + +
Sbjct: 172 KFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV 230
Query: 435 HGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ-- 490
GNK+ E + A++YLH +IHRD+K N+LLS E
Sbjct: 231 VGNKR------LKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLI 281
Query: 491 -LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE------YFMYGKVNDKIDVYAFGVVLL 543
++DFG +K +S + GT YLAPE Y + +D ++ GV+L
Sbjct: 282 KITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNR---AVDCWSLGVILF 335
Query: 544 ELLTGRKPISNDH 556
L+G P S
Sbjct: 336 ICLSGYPPFSEHR 348
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 57/238 (23%), Positives = 102/238 (42%), Gaps = 49/238 (20%)
Query: 356 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 407
IG+G +V++ LP AVK+LK S D+ +F E ++ + NI+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY----------------- 450
LLG C + L++++++ G L E L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 451 ---KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507
+A VA + YL S ++ +HRD+ + N L+ ++ +++DFGL++ +I
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-------NI 224
Query: 508 TCTD--VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 554
D A + PE Y + + DV+A+GVVL E+ + G +P +++
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 56/238 (23%), Positives = 107/238 (44%), Gaps = 49/238 (20%)
Query: 356 IGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 407
+G+G +V K K AVK+LK S +++ + E ++ ++H ++I
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG------------ 455
L G C +D LLL+ ++ GSL L ++K + S + +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 456 --------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507
+++ ++YL + +++HRD+ + NIL+++ + ++SDFGL++ +
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD-------V 200
Query: 508 TCTD--VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 554
D V + G + A E + DV++FGV+L E++T G P I
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 59/219 (26%), Positives = 89/219 (40%), Gaps = 33/219 (15%)
Query: 353 ENLIGKGGSSQVYKG-CLPDGKELAVKILK--------------PSEDVIKEFVLEIEII 397
+G G +V E A+K++K E +E EI ++
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 398 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMG 455
+L H NII L + LV +F G L E + K + E +
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK------FDECDAANIMKQ 154
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDV 512
+ + YLH ++HRD+K NILL + ++ DFGL+ + S D
Sbjct: 155 ILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDR 208
Query: 513 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
GT Y+APE K N+K DV++ GV++ LL G P
Sbjct: 209 LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 44/313 (14%), Positives = 97/313 (30%), Gaps = 48/313 (15%)
Query: 355 LIGKGGSSQVYKGC-LPDGKELAVKIL----KPSEDVIKEFVLEIEIITTL----HHKNI 405
++G+ + G+ V + +P + IK+ E+ + L + K
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 406 ISLLGFCFEDN-----------------------NLLLVYDFL--SRGSLEENLHGNKKD 440
L F F + + +Y + + + E L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 441 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500
+ R ++ + V L LH ++H ++ +I+L L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 501 STSSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISND 555
S+ A + + D + G+ + + P ++D
Sbjct: 262 GASAV-SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320
Query: 556 HPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMS 615
G + + + V LL+ L Y + +R++ + + R ++S
Sbjct: 321 AALGGSEWIFRSCKNIPQP-VRALLEGFL----RYPKEDRLLPLQAMETPEYEQLRTELS 375
Query: 616 LVLKLLRGDADVT 628
L L + D + T
Sbjct: 376 AALPLYQTDGEPT 388
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 51/226 (22%), Positives = 94/226 (41%), Gaps = 37/226 (16%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTL-HHK 403
+G G +V + + AVK+LK D + + E++I++ L H+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 404 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY----------KVA 453
NI++LLG C +L++ ++ G L L + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 454 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-- 511
VA+ + +L +++ IHRDV + N+LL++ ++ DFGLA+ I
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-------DIMNDSNY 220
Query: 512 VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
+ L APE + DV+++G++L E+ + G P
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 40/317 (12%), Positives = 93/317 (29%), Gaps = 71/317 (22%)
Query: 355 LIGKGGSSQVYKGC-LPDGKELAVKIL----KPSEDVIKE-------------------- 389
++G+ + G+ V + +P + IK+
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 390 -----FVLEIEIITTLHHKNIISLLGFC--FEDNNLLLVYDFL--SRGSLEENLHGNKKD 440
F+ +++ K +I + + +Y + + + E L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 441 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500
+ R ++ + V L LH ++H ++ +I+L L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 501 STSSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGR 549
+ + G+ PE + D +A G+V+ +
Sbjct: 257 GAR------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 550 KPISNDHPKGQESLVMWAKPILSSGK---VTQLLDPALGNNYDYDQMERMVLASILCIRR 606
PI+ D G + + + + L + +R++ +
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRY--------PKEDRLLPLQAM---E 359
Query: 607 DP---RARPQMSLVLKL 620
P + R ++S L L
Sbjct: 360 TPEYEQLRTELSAALPL 376
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 61/207 (29%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCF 413
IG G S + E AVKI+ S+ E EIEI+ H NII+L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQHPNIITLKDVYD 86
Query: 414 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 471
+ + +V + + G L + + K +SER V + + +EYLH+ Q V
Sbjct: 87 DGKYVYVVTELMKGGELLDKILRQKF------FSEREASAVLFTITKTVEYLHA---QGV 137
Query: 472 IHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 525
+HRD+K SNIL D+ + DFG AK + T ++APE
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQ 195
Query: 526 -YGKVNDKIDVYAFGVVLLELLTGRKP 551
Y D+++ GV+L +LTG P
Sbjct: 196 GYDA---ACDIWSLGVLLYTMLTGYTP 219
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-27
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 23/223 (10%)
Query: 349 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNI 405
+ + +G GG V + G+++A+K + S + + LEI+I+ L+H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 406 ISLL------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVA 457
+S ++ LL ++ G L + L+ + G E + ++
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDIS 131
Query: 458 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAG 514
AL YLH R+IHRD+K NI+L + + D G AK CT+ G
Sbjct: 132 SALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVG 185
Query: 515 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557
T YLAPE K +D ++FG + E +TG +P +
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 41/227 (18%)
Query: 356 IGKGGSSQVYKGCLPDGKEL--------AVKILKP--SEDVIKEFVLEIEIITTL-HHKN 404
+G+G QV + AVK+LK +E + + V E+E++ + HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KV 452
II+LLG C +D L ++ ++ S+G+L E L + + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 453 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 511
+A +EYL ++Q+ IHRD+ + N+L++++ +++DFGLA+ I D
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-------DINNIDY 212
Query: 512 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
T G L APE + DV++FGV++ E+ T G P
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 41/227 (18%)
Query: 356 IGKGGSSQVYKGCLPDGKEL--------AVKILKP--SEDVIKEFVLEIEIITTL-HHKN 404
+G+G QV + AVK+LK +E + + V E+E++ + HKN
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KV 452
II+LLG C +D L ++ ++ S+G+L E L + + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 453 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 511
+A +EYL ++Q+ IHRD+ + N+L++++ +++DFGLA+ I D
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD-------INNIDY 258
Query: 512 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
T G L APE + DV++FGV++ E+ T G P
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 9e-27
Identities = 59/248 (23%), Positives = 89/248 (35%), Gaps = 58/248 (23%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKILK------PSEDVIKEFVLEIEIITTLHHKNIISL 408
IG+G V A+KI+ + ++ E+ ++ LHH NI L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 409 LGFCFEDNNLLLVYDFLSRGSL----------------------------------EENL 434
++ + LV + G L
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 435 HGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQ 490
++ F E+ + + AL YLH+ Q + HRD+K N L S FE +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIK 210
Query: 491 LSDFGLAKW--ASTSSSHITCTDVAGTFGYLAPE-----YFMYGKVNDKIDVYAFGVVLL 543
L DFGL+K + + T AGT ++APE YG K D ++ GV+L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP---KCDAWSAGVLLH 267
Query: 544 ELLTGRKP 551
LL G P
Sbjct: 268 LLLMGAVP 275
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 44/218 (20%)
Query: 353 ENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLG 410
++G G S+V+ GK A+K +K S + EI ++ + H+NI++L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 411 FCFED-NNLLLVYDFLS----------RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 459
+E + LV +S RG E KD + V V A
Sbjct: 74 I-YESTTHYYLVMQLVSGGELFDRILERGVYTE------KDAS--------LVIQQVLSA 118
Query: 460 LEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 516
++YLH ++HRD+K N+L ++ + ++DFGL+K + GT
Sbjct: 119 VKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTP 171
Query: 517 GYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 551
GY+APE Y K +D ++ GV+ LL G P
Sbjct: 172 GYVAPEVLAQKPYSK---AVDCWSIGVITYILLCGYPP 206
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
+G G V+ G E +K + S+ +++ EIE++ +L H NII +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 470
+ +N+ +V + G L E + + A SE Y ++ + AL Y HS Q
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKAL--SEGYVAELMKQMMNALAYFHS---QH 144
Query: 471 VIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 527
V+H+D+K NIL S ++ DFGLA+ + T+ AGT Y+APE F
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-R 200
Query: 528 KVNDKIDVYAFGVVLLELLTGRKP 551
V K D+++ GVV+ LLTG P
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 53/227 (23%), Positives = 104/227 (45%), Gaps = 28/227 (12%)
Query: 351 LAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISL 408
L++ ++G G + +V + G++ A+K+L S +E ++ +I+ +
Sbjct: 32 LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE----VDHHWQASGGPHIVCI 87
Query: 409 LGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALE 461
L +E+ LL++ + + G L + ++ AF +ER ++ + A++
Sbjct: 88 LDV-YENMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQAF--TEREAAEIMRDIGTAIQ 142
Query: 462 YLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 518
+LHS + HRDVK N+L D +L+DFG AK + ++ C T Y
Sbjct: 143 FLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC----YTPYY 195
Query: 519 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 565
+APE K + D+++ GV++ LL G P ++ + +
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK 242
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 356 IGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 412
+G G V++ C+ G+ K + + K V EI I+ LHH +I+L
Sbjct: 59 LGSGAFGVVHR-CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA- 116
Query: 413 FED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 469
FED ++L+ +FLS G L + + +D + SE E L+++H
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRI--AAED---YKMSEAEVINYMRQACEGLKHMHE---H 168
Query: 470 RVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 527
++H D+K NI+ + DFGLA + T + APE
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDRE 225
Query: 528 KVNDKIDVYAFGVVLLELLTGRKP 551
V D++A GV+ LL+G P
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
+GKG +V K +E AVK++ + E+E++ L H NI+ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 469
+ ++ +V + + G L + + K+ +SE ++ V + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMHK---H 140
Query: 470 RVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 525
++HRD+K NILL D + ++ DFGL+ ++ D GT Y+APE
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG 197
Query: 526 -YGKVNDKIDVYAFGVVLLELLTGRKP 551
Y + K DV++ GV+L LL+G P
Sbjct: 198 TYDE---KCDVWSAGVILYILLSGTPP 221
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 64/234 (27%), Positives = 112/234 (47%), Gaps = 44/234 (18%)
Query: 356 IGKGGSSQVYKGCLPDGKEL--------AVKILKP--SEDVIKEFVLEIEIITTL-HHKN 404
+G+G QV + AVK+LK +E + + + E+E++ + HKN
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK----------VAM 454
II+LLG C +D L ++ ++ S+G+L E L + + ++ + V+
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 455 G--VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 511
VA +EYL ++++ IHRD+ + N+L+++D +++DFGLA+ I D
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-------DIHHIDY 246
Query: 512 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISND 555
T G L APE + DV++FGV+L E+ T G P + +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 62/234 (26%), Positives = 110/234 (47%), Gaps = 40/234 (17%)
Query: 345 SATSNF-----LAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEII 397
S + F L E+++G+G ++V L +E AVKI++ I+ V E+E++
Sbjct: 5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEML 64
Query: 398 TTL-HHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVA 453
H+N++ L+ F FE+ + LV++ + GS+ ++H + ++E V
Sbjct: 65 YQCQGHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRRH------FNELEASVVV 117
Query: 454 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP---QLSDFGLAK-----WASTSSS 505
VA AL++LH+ + + HRD+K NIL + ++ DF L + S
Sbjct: 118 QDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 506 HITCTDVAGTFGYLAPE--------YFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
G+ Y+APE +Y K + D+++ GV+L LL+G P
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDK---RCDLWSLGVILYILLSGYPP 225
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 55/226 (24%), Positives = 100/226 (44%), Gaps = 40/226 (17%)
Query: 356 IGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 406
+G+G QV + + AVK+LK + + + E++I+ + HH N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 407 SLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KVA 453
+LLG C + L+++ +F G+L L + + + + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 454 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV- 512
VA+ +E+L ++++ IHRD+ + NILLS+ ++ DFGLA+ I
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD-------IYKDPDY 204
Query: 513 -AGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
L APE + DV++FGV+L E+ + G P
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 351 LAENLIGKGGSSQVYKGC-LPDGKELAVK-ILKPSEDVIKEFVLEIEIITTL-HHKNIIS 407
L + +G+G S K + AVK I K E ++ EI + H NI+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVK 70
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHS 465
L + + LV + L+ G L E + K +SE + + A+ ++H
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKH------FSETEASYIMRKLVSAVSHMHD 124
Query: 466 GSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
V+HRD+K N+L +D+ E ++ DFG A+ + + T Y APE
Sbjct: 125 ---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK--TPCFTLHYAAPE 179
Query: 523 YFM---YGKVNDKIDVYAFGVVLLELLTGRKP 551
Y + D+++ GV+L +L+G+ P
Sbjct: 180 LLNQNGYDE---SCDLWSLGVILYTMLSGQVP 208
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 38/227 (16%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKILKPS----------EDVIKEFVLEIEIITTL-HHK 403
+G+G SS V + P KE AVKI+ + +++ + + E++I+ + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 404 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALE 461
NII L + LV+D + +G L + L SE+ K+ + E +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT------LSEKETRKIMRALLEVIC 138
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 521
LH ++HRD+K NILL DD +L+DFG + +V GT YLAP
Sbjct: 139 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAP 192
Query: 522 EYFM---------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 559
E YGK ++D+++ GV++ LL G P +
Sbjct: 193 EIIECSMNDNHPGYGK---EVDMWSTGVIMYTLLAGSPPFWHRKQML 236
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 60/206 (29%), Positives = 86/206 (41%), Gaps = 26/206 (12%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 413
IG+G +V A K I K + + F EIEI+ +L H NII L F
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-F 75
Query: 414 ED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 470
ED ++ LV + + G L E + + + E ++ V A+ Y H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRV------FRESDAARIMKDVLSAVAYCHK---LN 126
Query: 471 VIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 525
V HRD+K N L S D +L DFGLA GT Y++P+
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL 183
Query: 526 YGKVNDKIDVYAFGVVLLELLTGRKP 551
YG + D ++ GV++ LL G P
Sbjct: 184 YGP---ECDEWSAGVMMYVLLCGYPP 206
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL---------EIEIITTLHHKNI 405
+G G +V K++A+KI+ + I EIEI+ L+H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 406 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYL 463
I + F F+ + +V + + G L + + GNK+ E + A++YL
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR------LKEATCKLYFYQMLLAVQYL 130
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLA 520
H +IHRD+K N+LLS E ++DFG +K +S + GT YLA
Sbjct: 131 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLA 184
Query: 521 PE------YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 556
PE Y + +D ++ GV+L L+G P S
Sbjct: 185 PEVLVSVGTAGYNR---AVDCWSLGVILFICLSGYPPFSEHR 223
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 54/228 (23%), Positives = 103/228 (45%), Gaps = 27/228 (11%)
Query: 350 FLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIIS 407
+ ++G G + +V + ++ A+K+L+ +E +E+ +I+
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVR 119
Query: 408 LLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEAL 460
++ +E+ LL+V + L G L + + AF +ER ++ + EA+
Sbjct: 120 IVDV-YENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAF--TEREASEIMKSIGEAI 174
Query: 461 EYLHSGSAQRVIHRDVKSSNILLSDDFEP---QLSDFGLAKWASTSSSHITCTDVAGTFG 517
+YLHS + HRDVK N+L + +L+DFG AK ++ + + T T
Sbjct: 175 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPY 228
Query: 518 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 565
Y+APE K + D+++ GV++ LL G P ++H +
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 43/205 (20%), Positives = 83/205 (40%), Gaps = 24/205 (11%)
Query: 356 IGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 413
+G+G V++ C+ K K +K EI I+ H+NI+ L
Sbjct: 13 LGRGEFGIVHR-CVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 414 EDNNLLLVYDFLSRGSL-----EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 468
L+++++F+S + N+++ ++ V EAL++LHS
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSY--------VHQVCEALQFLHS--- 120
Query: 469 QRVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 526
+ H D++ NI+ + +FG A+ + + Y APE +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQH 177
Query: 527 GKVNDKIDVYAFGVVLLELLTGRKP 551
V+ D+++ G ++ LL+G P
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
+GKG S V + G E A KI+ K S ++ E I L H NI+ L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 469
E++ LV+D ++ G L E++ + +SE + E++ Y HS
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREF------YSEADASHCIQQILESIAYCHS---N 124
Query: 470 RVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 525
++HR++K N+LL+ + L+DFGLA + S AGT GYL+PE
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKK 181
Query: 526 --YGKVNDKIDVYAFGVVLLELLTGRKP 551
Y K +D++A GV+L LL G P
Sbjct: 182 DPYSK---PVDIWACGVILYILLVGYPP 206
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 52/227 (22%), Positives = 91/227 (40%), Gaps = 41/227 (18%)
Query: 356 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 406
+G G +V + + + AVK+LKP + + E+++++ L +H NI+
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG----------- 455
+LLG C L++ ++ G L L + S
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 456 ---VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 512
VA+ + +L +++ IHRD+ + NILL+ ++ DFGLA+ I
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-------DIKNDSN 200
Query: 513 --AGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
L APE + DV+++G+ L EL + G P
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 349 NFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNI 405
++G G QV+K C G +LA KI+K KE V EI ++ L H N+
Sbjct: 90 TVSKTEILGGGRFGQVHK-CEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL 148
Query: 406 ISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEY 462
I L FE N+++LV +++ G L + + + + +E + E + +
Sbjct: 149 IQLYDA-FESKNDIVLVMEYVDGGELFDRI--IDES---YNLTELDTILFMKQICEGIRH 202
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLA 520
+H ++H D+K NIL + Q+ DFGLA+ GT +LA
Sbjct: 203 MHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLA 256
Query: 521 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
PE Y V+ D+++ GV+ LL+G P
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-25
Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 25/206 (12%)
Query: 356 IGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 412
+G G V++ G A K + + KE V EI+ ++ L H +++L
Sbjct: 165 LGTGAFGVVHR-VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 413 FEDNNLLLVYDFLSRGSL-----EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 467
+DN ++++Y+F+S G L +E+ ++ + + V + L ++H
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY--------MRQVCKGLCHMHE-- 273
Query: 468 AQRVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 525
+H D+K NI+ + +L DFGL S GT + APE
Sbjct: 274 -NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAE 329
Query: 526 YGKVNDKIDVYAFGVVLLELLTGRKP 551
V D+++ GV+ LL+G P
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 51/232 (21%), Positives = 94/232 (40%), Gaps = 46/232 (19%)
Query: 356 IGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 406
+G G +V + AVK+LK + + E++++T L H+NI+
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG----------- 455
+LLG C + L++++ G L L ++ + + +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 456 --------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507
VA+ +E+L + +HRD+ + N+L++ ++ DFGLA+ I
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-------DI 222
Query: 508 TCTD--VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
V L APE G K DV+++G++L E+ + G P
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 54/240 (22%), Positives = 100/240 (41%), Gaps = 27/240 (11%)
Query: 328 HEKYSATCRLFNYQDLLSATSNF-----LAENLIGKGGSSQVYKG-CLPDGKELAVKIL- 380
H +S+ L + NF L +G+G + V + G+E A K L
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 381 --KPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHG 436
+ +D E + EI ++ +I+L +E+ + ++L+ ++ + G +
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV-YENTSEIILILEYAAGGEIFSLCL- 121
Query: 437 NKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ---L 491
+ SE ++ + E + YLH ++H D+K NILLS + +
Sbjct: 122 -PELAEMV--SENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKI 175
Query: 492 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
DFG+++ + ++ GT YLAPE Y + D++ G++ LLT P
Sbjct: 176 VDFGMSRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
+GKG S V + G E A KI+ K S ++ E I L H NI+ L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 469
E++ LV+D ++ G L E++ + +SE + E++ Y HS
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREF------YSEADASHCIQQILESIAYCHS---N 147
Query: 470 RVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 525
++HR++K N+LL+ + L+DFGLA + S AGT GYL+PE
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKK 204
Query: 526 --YGKVNDKIDVYAFGVVLLELLTGRKP 551
Y K +D++A GV+L LL G P
Sbjct: 205 DPYSK---PVDIWACGVILYILLVGYPP 229
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 37/218 (16%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKILK---------PSEDVIKEFVLEIEIITTLH-HKN 404
IG+G SS V + G E AVKI++ E+V + E I+ + H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEY 462
II+L+ + + LV+D + +G L + L SE+ + + EA+ +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA------LSEKETRSIMRSLLEAVSF 215
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
LH+ ++HRD+K NILL D+ + +LSDFG + ++ GT GYLAPE
Sbjct: 216 LHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPE 269
Query: 523 ---------YFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
+ YGK ++D++A GV+L LL G P
Sbjct: 270 ILKCSMDETHPGYGK---EVDLWACGVILFTLLAGSPP 304
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
+GKG S V + + G+E A I+ K S ++ E I L H NI+ L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 469
E+ + L++D ++ G L E++ + +SE + EA+ + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREY------YSEADASHCIQQILEAVLHCHQ---M 129
Query: 470 RVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 525
V+HR++K N+LL +L+DFGLA AGT GYL+PE
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAGTPGYLSPEVLRK 187
Query: 526 --YGKVNDKIDVYAFGVVLLELLTGRKP 551
YGK +D++A GV+L LL G P
Sbjct: 188 DPYGK---PVDLWACGVILYILLVGYPP 212
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 49/247 (19%), Positives = 93/247 (37%), Gaps = 32/247 (12%)
Query: 383 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 442
S + ++I + KN + L L + + +L++ +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD-WMNRRCSLE 159
Query: 443 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502
+ + +AEA+E+LHS + ++HRD+K SNI + D ++ DFGL
Sbjct: 160 DREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
Query: 503 SSSHITC----------TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 552
T T GT Y++PE + K+D+++ G++L ELL
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST- 275
Query: 553 SNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 612
E + + + + K L E M++ +L P RP
Sbjct: 276 ------QMERVRIITD--VRNLKFPLLFT-------QKYPQEHMMVQDMLS--PSPTERP 318
Query: 613 QMSLVLK 619
+ + +++
Sbjct: 319 EATDIIE 325
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 34/213 (15%)
Query: 355 LIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIK----EFVL-EIEIITTLHHKNI 405
++G+G S V +E A+KIL+ +IK +V E ++++ L H
Sbjct: 37 ILGEGSFSTVVLARELA---TSREYAIKILE-KRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 406 ISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALE 461
+ L F F+D+ L + G L + + F +E + ALE
Sbjct: 93 VKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-------IVSALE 144
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 521
YLH + +IHRD+K NILL++D Q++DFG AK S S GT Y++P
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 522 EYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 551
E K D++A G ++ +L+ G P
Sbjct: 202 ELLTEKSACKS---SDLWALGCIIYQLVAGLPP 231
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 356 IGKGGSSQVYKGCL--PDGKELAVKILK------PSEDVIKEFVL-EIEIITTLHHKNII 406
+G G + V K C G E A K +K V +E + E+ I+ + H N+I
Sbjct: 20 LGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 464
+L +++L+ + +S G L + L SE + + + YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLA 520
+ +++ H D+K NI+L D P L DFGLA ++ GT ++A
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVA 186
Query: 521 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
PE Y + + D+++ GV+ LL+G P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 413
+G+G +S VY+ K A+K+LK + D K EI ++ L H NII L F
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-KKIVRTEIGVLLRLSHPNIIKLKEI-F 117
Query: 414 ED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 470
E + LV + ++ G L + + +SER + EA+ YLH
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGY------YSERDAADAVKQILEAVAYLHE---NG 168
Query: 471 VIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 525
++HRD+K N+L + D +++DFGL+K V GT GY APE
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGC 225
Query: 526 -YGKVNDKIDVYAFGVVLLELLTGRKP 551
YG ++D+++ G++ LL G +P
Sbjct: 226 AYGP---EVDMWSVGIITYILLCGFEP 249
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILK-------PSEDVIKEFVLEIEIITTLHHKNIIS 407
+G G + V K GKE A K +K +E E+ I+ + H NII+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHS 465
L +++L+ + +S G L + L + +E + + + + YLHS
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKES------LTEDEATQFLKQILDGVHYLHS 126
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAP 521
+R+ H D+K NI+L D P L DFG+A + ++ GT ++AP
Sbjct: 127 ---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAP 180
Query: 522 EYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
E Y + + D+++ GV+ LL+G P
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 356 IGKGGSSQVYKGCL--PDGKELAVKILK------PSEDVIKEFVL-EIEIITTLHHKNII 406
+G G + V K C G E A K +K V +E + E+ I+ + H NII
Sbjct: 20 LGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 464
+L +++L+ + +S G L + L SE + + + YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLA 520
+ +++ H D+K NI+L D P L DFGLA ++ GT ++A
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVA 186
Query: 521 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
PE Y + + D+++ GV+ LL+G P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 46/220 (20%)
Query: 356 IGKGGSSQVYKGCL--PDGKELAVKILK------PSEDVIKEFVL-EIEIITTLHHKNII 406
+G G + V K C G + A K +K V +E + E+ I+ + H N+I
Sbjct: 19 LGSGQFAVVKK-CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 407 SLLGFCFED-NNLLLVYDFLS----------RGSLEENLHGNKKDPAAFGWSERYKVAMG 455
+L +E+ +++L+ + ++ + SL E ++ F
Sbjct: 78 TLHEV-YENKTDVILILELVAGGELFDFLAEKESLTE------EEATEF--------LKQ 122
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTD 511
+ + YLHS ++ H D+K NI+L D P+ + DFGLA + +
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 176
Query: 512 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
+ GT ++APE Y + + D+++ GV+ LL+G P
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 38/215 (17%)
Query: 355 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFV----LEIEIITTLHHKNIISLL 409
IGKG +V D K++ A+K + + V + V E++I+ L H +++L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 410 GFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAE---ALEY 462
+ F+D ++ +V D L G L +L N + + + E AL+Y
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-----F-----ICELVMALDY 130
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
L + QR+IHRD+K NILL + ++DF +A + T +AGT Y+APE
Sbjct: 131 LQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT---MAGTKPYMAPE 184
Query: 523 YFM------YGKVNDKIDVYAFGVVLLELLTGRKP 551
F Y +D ++ GV ELL GR+P
Sbjct: 185 MFSSRKGAGYSFA---VDWWSLGVTAYELLRGRRP 216
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 56/267 (20%), Positives = 102/267 (38%), Gaps = 44/267 (16%)
Query: 308 SSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG 367
SS H S +P+ +L ++ S + L+G GG VY G
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 368 C-LPDGKELAVKILK-------PSEDVIKEFVLEIEIITTLHHK--NIISLLGFCFEDNN 417
+ D +A+K ++ +E+ ++ + +I LL + ++
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 418 LLLV----------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
+L+ +DF+ RG+L+E V EA+ + H+
Sbjct: 123 FVLILERPEPVQDLFDFITERGALQEE--------------LARSFFWQVLEAVRHCHN- 167
Query: 467 SAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 525
V+HRD+K NIL+ + E +L DFG + GT Y PE+
Sbjct: 168 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 221
Query: 526 YGKVN-DKIDVYAFGVVLLELLTGRKP 551
Y + + V++ G++L +++ G P
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 3e-21
Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 36/233 (15%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNII 406
++F +IG+GG +VY D ++ A+K L + IK + L+ + ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD--KKRIKM---KQGETLALNERIML 243
Query: 407 SL-----------LGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYK 451
SL + + F L + D ++ G L +L + F +E
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE--- 300
Query: 452 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 511
+ LE++H+ + V++RD+K +NILL + ++SD GLA S H +
Sbjct: 301 ----IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 512 VAGTFGYLAPEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPISNDHPKGQESL 563
GT GY+APE G D D ++ G +L +LL G P K + +
Sbjct: 352 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 40/279 (14%), Positives = 84/279 (30%), Gaps = 57/279 (20%)
Query: 355 LIGKGGSSQVYKGCLPD---GKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIIS 407
G Q ++ D +++A+ + P +DV++E + ++ + +
Sbjct: 38 FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 467
+L L+V +++ GSL+E + A + +A A + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA------IRAMQSLAAAADAAH--- 146
Query: 468 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 527
V S + +S D G +
Sbjct: 147 RAGVALSIDHPSRVRVSID--------GDVV--------------LAYPATMPD------ 178
Query: 528 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587
N + D+ G L LL R P+ + + Q ++PA +
Sbjct: 179 -ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-------RDTAGQPIEPADIDR 230
Query: 588 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 626
Q+ + ++ D R +L+ + + A
Sbjct: 231 DIPFQISAVAAR---SVQGDGGIRSASTLLNLMQQATAV 266
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 8e-21
Identities = 50/222 (22%), Positives = 86/222 (38%), Gaps = 46/222 (20%)
Query: 355 LIGKGGSSQVYKGC-LPDGKELAVKIL------KPSEDVIKEFV-LEIEIITTLH----H 402
L+GKGG V+ G L D ++A+K++ S LE+ ++ + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 403 KNIISLLGFCFEDNNLLLV----------YDFL-SRGSLEENLHGNKKDPAAFGWSERYK 451
+I LL + +LV +D++ +G L E
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG--------------PSRC 143
Query: 452 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCT 510
V A+++ HS + V+HRD+K NIL+ +L DFG
Sbjct: 144 FFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD- 199
Query: 511 DVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKP 551
GT Y PE+ + + V++ G++L +++ G P
Sbjct: 200 ---GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-20
Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 355 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKE------FVLEIEIITTLHHKNIIS 407
++G+GG +V+ + +L A K L + +K+ ++E +I+ +H + I+S
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLN--KKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 408 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVAEALEYL 463
L + FE +L LV ++ G + +++ +D F E + A + LE+L
Sbjct: 250 LA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF--QEPRAIFYTAQ-IVSGLEHL 305
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523
H + +I+RD+K N+LL DD ++SD GLA + T AGT G++APE
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKG-YAGTPGFMAPEL 360
Query: 524 FMYGKVNDKIDVYAFGVVLLELLTGRKP 551
+ + + +D +A GV L E++ R P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 44/226 (19%)
Query: 349 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK---------PSEDVIKEFVLEIEIIT 398
+ + +G G V+ KE+ VK +K + + + LEI I++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 399 TLHHKNIISLLGFCFEDNNLLLV----------YDFLSRGSLEENLHGNKKDPAAFGWSE 448
+ H NII +L LV + F+ R H +P A
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-------HPRLDEPLA----- 132
Query: 449 RYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HI 507
Y + A+ YL + +IHRD+K NI++++DF +L DFG A + +
Sbjct: 133 SYIFRQ-LVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188
Query: 508 TCTDVAGTFGYLAPEYFMYGKVND--KIDVYAFGVVLLELLTGRKP 551
C GT Y APE M G ++++++ GV L L+ P
Sbjct: 189 FC----GTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 33/225 (14%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIK----EFVL-EIEIITTLH 401
F +G G +V + A+KIL + V+K E L E I+ ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 402 HKNIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVA 457
++ L F F+DN NL +V ++++ G + +L + A F Y A +
Sbjct: 100 FPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-----Y--AAQIV 151
Query: 458 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 517
EYLHS +I+RD+K N+L+ Q++DFG AK T T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWT-LCGTPE 203
Query: 518 YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 559
LAPE + Y K +D +A GV++ E+ G P D P
Sbjct: 204 ALAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 56/229 (24%)
Query: 349 NFLAENLIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKN 404
L ++G+G +V+ K D ++L A+K+LK K + + + T ++
Sbjct: 27 ELLK--VLGQGSFGKVFLVKKISGSDARQLYAMKVLK------KATLKVRDRVRTKMERD 78
Query: 405 IISL--------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKV 452
I+ L + F+ + L L+ DFL G L L + F Y
Sbjct: 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-----Y-- 131
Query: 453 AMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 509
+AE AL++LHS +I+RD+K NILL ++ +L+DFGL+K I
Sbjct: 132 ---LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDH 179
Query: 510 TDVAGTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 551
A +F G Y+APE + + D ++FGV++ E+LTG P
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQS---ADWWSFGVLMFEMLTGTLP 225
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 32/215 (14%)
Query: 355 LIGKGGSSQVYKGC-LPDGKELAVKILK-----PSEDVIKEFVLEIEIITTLHHKNIISL 408
L+G+G +V + AVKILK + EI+++ L HKN+I L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 409 LGFCF--EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA--------E 458
+ + E + +V ++ G E + + A +
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE-----------MLDSVPEKRFPVCQAHGYFCQLID 120
Query: 459 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 518
LEYLHS Q ++H+D+K N+LL+ ++S G+A+ ++ TC G+ +
Sbjct: 121 GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 519 LAPEYFMYGKVND--KIDVYAFGVVLLELLTGRKP 551
PE K+D+++ GV L + TG P
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 71/277 (25%), Positives = 109/277 (39%), Gaps = 56/277 (20%)
Query: 311 LSTDHDSTELPKE--LEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVY--- 365
L D D L K ++ +Y T +DL ++ +IG+G +V
Sbjct: 32 LVYDLDFPALRKNKNIDNFLSRYKDTIN--KIRDLRMKAEDYEVVKVIGRGAFGEVQLVR 89
Query: 366 -KGCLPDGKELAVKILKPSEDVIK----EFVL-EIEIITTLHHKNIISLLGFCFEDN-NL 418
K K A+K+L E +IK F E +I+ + ++ L + F+D+ L
Sbjct: 90 HKS---TRKVYAMKLLSKFE-MIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYL 144
Query: 419 LLVYDF---------LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
+V ++ +S + E A F +E V AL+ +HS
Sbjct: 145 YMVMEYMPGGDLVNLMSNYDVPE-------KWARFYTAE-------VVLALDAIHS---M 187
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE------- 522
IHRDVK N+LL +L+DFG + T V GT Y++PE
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGG 246
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 559
YG+ D ++ GV L E+L G P D G
Sbjct: 247 DGYYGRE---CDWWSVGVFLYEMLVGDTPFYADSLVG 280
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
IGKG ++V + G+E+A+KI+ + + +++ E+ I+ L+H NI+ L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 412 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
+ L L+ ++ S G + + L HG K+ A R + A++Y H +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA-----R-SKFRQIVSAVQYCHQ---K 133
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYLAPEYFMYGK 528
R++HRD+K+ N+LL D +++DFG + + C G Y APE F GK
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAPPYAAPELFQ-GK 188
Query: 529 VND--KIDVYAFGVVLLELLTGRKP 551
D ++DV++ GV+L L++G P
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 66/236 (27%), Positives = 103/236 (43%), Gaps = 42/236 (17%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 406
+L L+GKG +V A+KILK KE ++ E+ TL ++
Sbjct: 151 EYLK--LLGKGTFGKVILVKEKATGRYYAMKILK------KEVIVAKDEVAHTLTENRVL 202
Query: 407 SL--------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAM 454
L + F+ + L V ++ + G L +L + D A F +E
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE------ 256
Query: 455 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 514
+ AL+YLHS + V++RD+K N++L D +++DFGL K I
Sbjct: 257 -IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK------EGIKDGATMK 307
Query: 515 TF----GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP-ISNDHPKGQESLVM 565
TF YLAPE +D + GVV+ E++ GR P + DH K E ++M
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 363
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-19
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 29/210 (13%)
Query: 355 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKE------FVLEIEIITTLHHKNIIS 407
++GKGG +V + ++ A K L+ + IK+ + E +I+ ++ + ++S
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLE--KKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 408 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDP-----AAFGWSERYKVAMGVAEALE 461
L + +E + L LV ++ G L+ +++ + A F +E + LE
Sbjct: 249 L-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-------ICCGLE 300
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 521
LH +R+++RD+K NILL D ++SD GLA V GT GY+AP
Sbjct: 301 DLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKGRV-GTVGYMAP 354
Query: 522 EYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
E + D +A G +L E++ G+ P
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 48/228 (21%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 406
++L L+GKG +V A+KIL+ KE ++ E+ T+ ++
Sbjct: 8 DYLK--LLGKGTFGKVILVREKATGRYYAMKILR------KEVIIAKDEVAHTVTESRVL 59
Query: 407 SL--------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAM 454
L + F+ + L V ++ + G L +L + + A F +E
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE------ 113
Query: 455 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 514
+ ALEYLHS + V++RD+K N++L D +++DFGL K I+
Sbjct: 114 -IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATMK 163
Query: 515 TF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISND 555
TF G YLAPE YG+ +D + GVV+ E++ GR P N
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFYNQ 208
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 20/216 (9%)
Query: 344 LSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK-PSEDVIKEFVL-EIEIITTL 400
+S++S F +G G + VYKG G +A+K +K SE+ + EI ++ L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 401 HHKNIISLLGFCFEDNNLLLVYDFLS---RGSLEENLHGNKKDPAAFGWSERYKVAMGVA 457
H+NI+ L +N L LV++F+ + ++ P + +
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDS--RTVGNTPRGLELNLVKYFQWQLL 118
Query: 458 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 517
+ L + H +++HRD+K N+L++ + +L DFGLA+ + + V T
Sbjct: 119 QGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLW 173
Query: 518 YLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 549
Y AP+ M Y ID+++ G +L E++TG+
Sbjct: 174 YRAPDVLMGSRTYST---SIDIWSCGCILAEMITGK 206
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 7e-19
Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 356 IGKGGSSQVYKGC---LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
+G+G VYK D K+ A+K ++ + EI ++ L H N+ISL
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE-GTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 413 FE--DNNLLLVYDFLS---RGSLEENLHGNKKDPAA-FGWSERYKVAMGVAEALEYLHSG 466
D + L++D+ ++ + + + + + YLH+
Sbjct: 88 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA- 146
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWAST---SSSHITCTDVAGTFGYL 519
V+HRD+K +NIL+ + + ++D G A+ ++ + + V TF Y
Sbjct: 147 --NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--TFWYR 202
Query: 520 APEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 552
APE + Y K ID++A G + ELLT +PI
Sbjct: 203 APELLLGARHYTK---AIDIWAIGCIFAELLT-SEPI 235
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 47/232 (20%)
Query: 348 SNFLAENLIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIK----EFVL-EIEIIT 398
+F +G G +V+ + +G+ A+K+LK E V++ E E +++
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLS 61
Query: 399 TLHHKNIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAM 454
+ H II + F+D + ++ D++ G L L +++ A F +E
Sbjct: 62 IVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE------ 114
Query: 455 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 514
V ALEYLHS + +I+RD+K NILL + +++DFG AK DV
Sbjct: 115 -VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK---------YVPDVTY 161
Query: 515 TF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 559
T G Y+APE Y K ID ++FG+++ E+L G P + +
Sbjct: 162 TLCGTPDYIAPEVVSTKPYNKS---IDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 53/235 (22%)
Query: 355 LIGKGGSSQVYKGC-LPDGKELAVKIL---------------------------KPSEDV 386
IGKG V D A+K+L
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 387 IKEFVLEIEIITTLHHKNIISLLGFCFE------DNNLLLVYDFLSRGSL-EENLHGNKK 439
I++ EI I+ L H N++ L E +++L +V++ +++G + E
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLS 135
Query: 440 DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499
+ A + + +EYLH Q++IHRD+K SN+L+ +D +++DFG++
Sbjct: 136 EDQAR------FYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVN---DKIDVYAFGVVLLELLTGRKP 551
S + ++ T GT ++APE + +DV+A GV L + G+ P
Sbjct: 187 FKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 52/228 (22%)
Query: 349 NFLAENLIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFVLEIE-------II 397
L ++GKGG +V+ K + ++ A+K+LK + +I + I+
Sbjct: 20 ELLR--VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK--KAMIVRNAKDTAHTKAERNIL 75
Query: 398 TTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 453
+ H I+ L+ + F+ L L+ ++LS G L L D A F Y
Sbjct: 76 EEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-----Y--- 126
Query: 454 MGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 510
+AE AL +LH + +I+RD+K NI+L+ +L+DFGL K I
Sbjct: 127 --LAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK------ESIHDG 175
Query: 511 DVAGTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 551
V TF G Y+APE M + + +D ++ G ++ ++LTG P
Sbjct: 176 TVTHTFCGTIEYMAPEILMRSGHNRA---VDWWSLGALMYDMLTGAPP 220
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 24/214 (11%)
Query: 349 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFV-----LEIEIITTLHH 402
+ IG+G V+K + +A+K ++ +D E V EI ++ L H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKH 60
Query: 403 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 462
KNI+ L D L LV++F + L++ + + L +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
HS + V+HRD+K N+L++ + E +L++FGLA+ + V T Y P+
Sbjct: 117 CHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPD 171
Query: 523 YFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 552
Y ID+++ G + EL +P+
Sbjct: 172 VLFGAKLYST---SIDMWSAGCIFAELANAGRPL 202
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 49/225 (21%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 406
F+ ++GKG +V + + +L AVK+LK K+ +L+ ++ T+ K I+
Sbjct: 26 EFIR--VLGKGSFGKVMLARVKETGDLYAVKVLK------KDVILQDDDVECTMTEKRIL 77
Query: 407 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 453
SL L CF+ + L V +F++ G L ++ +++ A F +E
Sbjct: 78 SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE----- 132
Query: 454 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 513
+ AL +LH + +I+RD+K N+LL + +L+DFG+ K I
Sbjct: 133 --IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK------EGICNGVTT 181
Query: 514 GTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 551
TF G Y+APE YG +D +A GV+L E+L G P
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPA---VDWWAMGVLLYEMLCGHAP 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 50/228 (21%), Positives = 94/228 (41%), Gaps = 48/228 (21%)
Query: 350 FLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIIS 407
+ ++G G + +V + ++ A+K+L+ +E +E+ +I+
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVR 75
Query: 408 LLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEAL 460
++ +E+ LL+V + L G L + + AF +ER ++ + EA+
Sbjct: 76 IVDV-YENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAF--TEREASEIMKSIGEAI 130
Query: 461 EYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 517
+YLHS + HRDVK N+L + +L+DFG AK + G
Sbjct: 131 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK------------ETTGE-- 173
Query: 518 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 565
Y K D+++ GV++ LL G P ++H +
Sbjct: 174 -------KYDK---SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 211
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLLGF 411
IG+G V+K G+ +A+K SED VIK+ L EI ++ L H N+++LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
L LV+++ ++ L + + +A+ + H
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHK---HNC 123
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM----YG 527
IHRDVK NIL++ +L DFG A+ + D T Y +PE + YG
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFAR--LLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181
Query: 528 KVNDKIDVYAFGVVLLELLTGR 549
+DV+A G V ELL+G
Sbjct: 182 P---PVDVWAIGCVFAELLSGV 200
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 2e-18
Identities = 86/435 (19%), Positives = 154/435 (35%), Gaps = 56/435 (12%)
Query: 150 MNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPV 209
MN+ + V G+ ++ ++ + L+ V
Sbjct: 138 MNVHKRCVMNVPSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYV 197
Query: 210 QNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTR-- 267
+ + P + D+ + + W L
Sbjct: 198 KLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFM 257
Query: 268 -QPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEG 326
S+ + K S VP + L + ++ + +
Sbjct: 258 GSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKA 317
Query: 327 LHEKYSATCRLFNYQDLLSATS----NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILK 381
EK + T F+ NFL ++GKG +V EL AVKILK
Sbjct: 318 PEEKTANTISKFDNNGNRDRMKLTDFNFLM--VLGKGSFGKVMLSERKGTDELYAVKILK 375
Query: 382 PSEDVIKEFVLEI-EIITTLHHKNIISL---------LGFCFE-DNNLLLVYDFLSRGSL 430
K+ V++ ++ T+ K +++L L CF+ + L V ++++ G L
Sbjct: 376 ------KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429
Query: 431 EENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 487
++ + A F +E +A L +L S + +I+RD+K N++L +
Sbjct: 430 MYHIQQVGRFKEPHAVFYAAE-------IAIGLFFLQS---KGIIYRDLKLDNVMLDSEG 479
Query: 488 EPQLSDFGLAKWASTSSSHITCTDVAGTF-G---YLAPE---YFMYGKVNDKIDVYAFGV 540
+++DFG+ K +I TF G Y+APE Y YGK +D +AFGV
Sbjct: 480 HIKIADFGMCK------ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS---VDWWAFGV 530
Query: 541 VLLELLTGRKPISND 555
+L E+L G+ P +
Sbjct: 531 LLYEMLAGQAPFEGE 545
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 43/222 (19%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 406
+FL +IGKG +V + AVK+L+ K+ +L+ E + +N++
Sbjct: 41 HFLK--VIGKGSFGKVLLARHKAEEVFYAVKVLQ------KKAILKKKEEKHIMSERNVL 92
Query: 407 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 453
L F F+ + L V D+++ G L +L + A F +E
Sbjct: 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE----- 147
Query: 454 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 513
+A AL YLHS +++RD+K NILL L+DFGL K +I
Sbjct: 148 --IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK------ENIEHNSTT 196
Query: 514 GTF-G---YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
TF G YLAPE + +D + G VL E+L G P
Sbjct: 197 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 41/220 (18%)
Query: 355 LIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIKE----FVLEIEIITTLHHKNII 406
+IG+G S+V K G+ A+KI+ + + + F E +++ + I
Sbjct: 68 VIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 407 SLLGFCFEDN-NLLLVYDFLSRGSLEENL--HGNK--KDPAAFGWSERYKVAMGVAEALE 461
L F F+D L LV ++ G L L G + + A F +E + A++
Sbjct: 125 QLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE-------IVMAID 176
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 521
+H +HRD+K NILL +L+DFG + + V GT YL+P
Sbjct: 177 SVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSP 232
Query: 522 E----------YFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
E YG D +A GV E+ G+ P
Sbjct: 233 EILQAVGGGPGTGSYGPE---CDWWALGVFAYEMFYGQTP 269
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-18
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 39/225 (17%)
Query: 348 SNFLAENLIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIKE----FVLEIEIITT 399
+F +IG+G +V K K A+KIL E + + F E +++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVN 130
Query: 400 LHHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKK----DPAAFGWSERYKVAM 454
K I +L + F+D NNL LV D+ G L L + + A F +E
Sbjct: 131 GDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE------ 183
Query: 455 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 514
+ A++ +H +HRD+K NIL+ + +L+DFG + + V G
Sbjct: 184 -MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-G 238
Query: 515 TFGYLAPEYFM--------YGKVNDKIDVYAFGVVLLELLTGRKP 551
T Y++PE YG D ++ GV + E+L G P
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPE---CDWWSLGVCMYEMLYGETP 280
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 49/225 (21%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 406
+ L +IG+G ++V L + A+K++K KE V + +I K++
Sbjct: 12 DLLR--VIGRGSYAKVLLVRLKKTDRIYAMKVVK------KELVNDDEDIDWVQTEKHVF 63
Query: 407 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 453
L CF+ ++ L V ++++ G L ++ +K + A F +E
Sbjct: 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE----- 118
Query: 454 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 513
++ AL YLH + +I+RD+K N+LL + +L+D+G+ K + D
Sbjct: 119 --ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------EGLRPGDTT 167
Query: 514 GTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 551
TF G Y+APE YG +D +A GV++ E++ GR P
Sbjct: 168 STFCGTPNYIAPEILRGEDYGFS---VDWWALGVLMFEMMAGRSP 209
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 43/226 (19%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 406
++GKG +V+ + A+K LK K+ VL ++ T+ K ++
Sbjct: 20 ILHK--MLGKGSFGKVFLAEFKKTNQFFAIKALK------KDVVLMDDDVECTMVEKRVL 71
Query: 407 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 453
SL + F+ NL V ++L+ G L ++ K A F +E
Sbjct: 72 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE----- 126
Query: 454 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 513
+ L++LHS + +++RD+K NILL D +++DFG+ K ++
Sbjct: 127 --IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK------ENMLGDAKT 175
Query: 514 GTF-G---YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 555
TF G Y+APE + K N +D ++FGV+L E+L G+ P
Sbjct: 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 354 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLL 409
L+G+G V K G+ +A+K S+D ++K+ + EI+++ L H+N+++LL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 410 GFCFEDNNLLLVYDFLSRGSLEENLHGN-KKDPAAFGWSERYKVAMGVAEALEYLHSGSA 468
C + LV++F+ + + + + P + K + + + HS
Sbjct: 91 EVCKKKKRWYLVFEFV-----DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS--- 142
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM--- 525
+IHRD+K NIL+S +L DFG A+ + ++ D T Y APE +
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 526 -YGKVNDKIDVYAFGVVLLELLTGR 549
YGK +DV+A G ++ E+ G
Sbjct: 201 KYGK---AVDVWAIGCLVTEMFMGE 222
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 409
IG G V + +A+K + +P ++ K E+ ++ ++HKNII LL
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 410 ------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEY 462
F+D + +V + + + NL + ER + + +++
Sbjct: 93 FTPQKSLEEFQD--VYIVMELM-----DANLCQVIQME---LDHERMSYLLYQMLCGIKH 142
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
LHS +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y APE
Sbjct: 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPE 196
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLTGR 549
+ + +D+++ G ++ E++ G
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 342 DLLSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFV----L-EI 394
D+ S + + +G+G + VYK + +A+K I K+ + L EI
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 395 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 454
+++ L H NII LL +N+ LV+DF+ LE + K + S +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII---KDNSLVLTPSHIKAYML 119
Query: 455 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 514
+ LEYLH ++HRD+K +N+LL ++ +L+DFGLAK + + T V
Sbjct: 120 MTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-- 174
Query: 515 TFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 552
T Y APE YG +D++A G +L ELL R P
Sbjct: 175 TRWYRAPELLFGARMYGV---GVDMWAVGCILAELLL-RVPF 212
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 46/227 (20%)
Query: 349 NFLAENLIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFVLEI--EIITTLHH 402
L ++G G +V+ K D +L A+K+LK K +++ T
Sbjct: 57 ELLK--VLGTGAYGKVFLVRKISGHDTGKLYAMKVLK------KATIVQKAKTTEHTRTE 108
Query: 403 KNIISL---------LGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSER 449
+ ++ L + F+ L L+ D+++ G L +L ++
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI----- 163
Query: 450 YKVAMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506
Y V E ALE+LH +I+RD+K NILL + L+DFGL+K +
Sbjct: 164 Y-----VGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215
Query: 507 ITCTDVAGTFGYLAPEYFMYGKV--NDKIDVYAFGVVLLELLTGRKP 551
GT Y+AP+ G + +D ++ GV++ ELLTG P
Sbjct: 216 RAYD-FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 43/222 (19%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 406
NFL ++GKG +V EL AVKILK K+ V++ ++ T+ K ++
Sbjct: 23 NFLM--VLGKGSFGKVMLSERKGTDELYAVKILK------KDVVIQDDDVECTMVEKRVL 74
Query: 407 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 453
+L L CF+ + L V ++++ G L ++ + A F +E
Sbjct: 75 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE----- 129
Query: 454 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 513
+A L +L S + +I+RD+K N++L + +++DFG+ K +I
Sbjct: 130 --IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK------ENIWDGVTT 178
Query: 514 GTF-G---YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
TF G Y+APE Y +D +AFGV+L E+L G+ P
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 8e-18
Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 43/222 (19%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 406
+ L +IG+G ++V L + A++++K KE V + +I K++
Sbjct: 55 DLLR--VIGRGSYAKVLLVRLKKTDRIYAMRVVK------KELVNDDEDIDWVQTEKHVF 106
Query: 407 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 453
L CF+ ++ L V ++++ G L ++ +K + A F +E
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE----- 161
Query: 454 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 513
++ AL YLH + +I+RD+K N+LL + +L+D+G+ K + D
Sbjct: 162 --ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------EGLRPGDTT 210
Query: 514 GTF-G---YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 551
TF G Y+APE +D +A GV++ E++ GR P
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 8e-18
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 32/216 (14%)
Query: 355 LIGKGGSSQVYKGC-LPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 409
+G G +V G G ++AVKIL S DV+ + EI+ + H +II L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 410 GFCFE----DNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYL 463
++ + +V +++S G L + + HG ++ A R ++ + A++Y
Sbjct: 77 ---YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA-----R-RLFQQILSAVDYC 127
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYLAPE 522
H V+HRD+K N+LL +++DFGL+ S +C G+ Y APE
Sbjct: 128 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPNYAAPE 180
Query: 523 YFMYGKVND--KIDVYAFGVVLLELLTGRKPISNDH 556
G++ ++D+++ GV+L LL G P ++H
Sbjct: 181 VIS-GRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-17
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 409
IG G V + +A+K + +P ++ K E+ ++ ++HKNIISLL
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 410 ----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLH 464
E ++ LV + + + NL + ER + + +++LH
Sbjct: 130 FTPQKTLEEFQDVYLVMELM-----DANLCQVIQMEL---DHERMSYLLYQMLCGIKHLH 181
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 524
S +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y APE
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVI 235
Query: 525 MYGKVNDKIDVYAFGVVLLELLTGR 549
+ + +D+++ G ++ E++ +
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 345 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFV-----LEIEIITT 399
+ +G+G VYK G+ +A+K ++ + E + EI ++
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--DEGIPSTAIREISLLKE 75
Query: 400 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 459
LHH NI+SL+ + L LV++F+ + L++ L ++ S+ +
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL---DENKTGLQDSQIKIYLYQLLRG 131
Query: 460 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 519
+ + H R++HRD+K N+L++ D +L+DFGLA+ T V T Y
Sbjct: 132 VAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYR 186
Query: 520 APEYFM----YGKVNDKIDVYAFGVVLLELLTGR 549
AP+ M Y +D+++ G + E++TG+
Sbjct: 187 APDVLMGSKKYST---SVDIWSIGCIFAEMITGK 217
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 24/206 (11%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 412
IG G + +AVK + I E V EI +L H NI+
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 413 FEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 470
+L ++ ++ S G L E + G + A R+ ++ + Y HS +
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEA-----RFFFQQLLS-GVSYCHS---MQ 136
Query: 471 VIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSS-HITCTDVAGTFGYLAPEYFMYG 527
+ HRD+K N LL P+L DFG +K + S T GT Y+APE +
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----GTPAYIAPEVLL-R 191
Query: 528 KVND--KIDVYAFGVVLLELLTGRKP 551
+ D DV++ GV L +L G P
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 355 LIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 411
+G+G +V + +AVKI+ D + EI I L+H+N++ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 412 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
E N L ++ S G L + + +P A + +A + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRFFHQLMA-GVVYLHG---I 124
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----HITCTDVAGTFGYLAPEYFM 525
+ HRD+K N+LL + ++SDFGLA ++ + C GT Y+APE
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPELLK 180
Query: 526 YGKVND--KIDVYAFGVVLLELLTGRKP 551
+ +DV++ G+VL +L G P
Sbjct: 181 -RREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVK--ILKPSEDVIKEFVLEIEIITTLHHKNI 405
++ + +G+G + VYKG L A+K L+ E + E+ ++ L H NI
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 406 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG-VAEALEYLH 464
++L + +L LV+++L +++L D K+ + + L Y H
Sbjct: 63 VTLHDIIHTEKSLTLVFEYL-----DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 524
Q+V+HRD+K N+L+++ E +L+DFGLA+ S + V T Y P+
Sbjct: 118 R---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDIL 172
Query: 525 M----YGKVNDKIDVYAFGVVLLELLTGR 549
+ Y +ID++ G + E+ TGR
Sbjct: 173 LGSTDYST---QIDMWGVGCIFYEMATGR 198
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 51/215 (23%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 347 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHH 402
+++ +G G V G+++A+K + +P + I K E+ ++ + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 403 KNIISLL------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-G 455
+N+I LL + LV F+ + +L + E+ + +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFS---EEKIQYLVYQ 134
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 515
+ + L+Y+HS V+HRD+K N+ +++D E ++ DFGLA+ A T T
Sbjct: 135 MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVT 186
Query: 516 FGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGR 549
Y APE + + N +D+++ G ++ E+LTG+
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 44/230 (19%)
Query: 347 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKN 404
F E + G+G V G G +A+K +++ +E + ++ + LHH N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 405 IISLLGF-------CFEDNNLLLVYDFLSRGSLEENLH--------GNKKDPAAFGWSER 449
I+ L + D L +V ++ + + LH P
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEY-----VPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 450 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHIT 508
+++ + LH S V HRD+K N+L+ D +L DFG AK S S ++
Sbjct: 136 FQLIRSIG----CLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 509 --CTDVAGTFGYLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGRKPI 552
C+ Y APE Y +D+++ G + E++ G +PI
Sbjct: 191 YICSRY-----YRAPELIFGNQHYTT---AVDIWSVGCIFAEMMLG-EPI 231
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 7e-17
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFV-----LEIEIITTLHHK 403
+ IG+G VYK G+ A+K ++ ++ E + EI I+ L H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHS 60
Query: 404 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 463
NI+ L L+LV++ L + L++ L + + + Y
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523
H +RV+HRD+K N+L++ + E +++DFGLA+ T V T Y AP+
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDV 171
Query: 524 FM----YGKVNDKIDVYAFGVVLLELLTGR 549
M Y ID+++ G + E++ G
Sbjct: 172 LMGSKKYST---TIDIWSVGCIFAEMVNGT 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 48/229 (20%)
Query: 347 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKN 404
++ +IG G VY+ G+ +A+K K +D K F E++I+ L H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQD--KRFKNRELQIMRKLDHCN 108
Query: 405 IISLLGF------CFEDNNLLLVYDFLSRGSLEENLH--------GNKKDPAAFGWSERY 450
I+ L F ++ L LV D+ + E ++ + P + Y
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 451 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHIT- 508
++ +A Y+HS + HRD+K N+LL D +L DFG AK +++
Sbjct: 164 QLFRSLA----YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 509 -CTDVAGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 552
C+ Y APE Y IDV++ G VL ELL G+ PI
Sbjct: 217 ICSRY-----YRAPELIFGATDYTS---SIDVWSAGCVLAELLLGQ-PI 256
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 355 LIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 411
+G+G +V + +AVKI+ D + EI I L+H+N++ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 412 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
E N L ++ S G L + + +P A + +A + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRFFHQLMA-GVVYLHG---I 124
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----HITCTDVAGTFGYLAPEYFM 525
+ HRD+K N+LL + ++SDFGLA ++ + C GT Y+APE
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPELLK 180
Query: 526 YGKVND--KIDVYAFGVVLLELLTGRKP 551
+ +DV++ G+VL +L G P
Sbjct: 181 -RREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 45/217 (20%), Positives = 85/217 (39%), Gaps = 30/217 (13%)
Query: 348 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-----EIEIITTLH 401
+ +G+G +VYK + +A+K ++ + +E V E+ ++ L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQ 91
Query: 402 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 461
H+NII L ++ L L++++ E +L + +
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKWASTSSSHITCTDVAGTF 516
+ HS +R +HRD+K N+LLS + + DFGLA+ T + T
Sbjct: 147 FCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TL 201
Query: 517 GYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 549
Y PE + Y +D+++ + E+L
Sbjct: 202 WYRPPEILLGSRHYST---SVDIWSIACIWAEMLMKT 235
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 355 LIGKGGSSQVYKGC-LPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 409
+G+G +V +++A+K + D+ EI + L H +II L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 410 GFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 460
++++V +D++ + + E+ E + + A+
Sbjct: 76 DVITTPTDIVMVIEYAGGELFDYIVEKKRMTED--------------EGRRFFQQIICAI 121
Query: 461 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYL 519
EY H +++HRD+K N+LL D+ +++DFGL+ + + +C G+ Y
Sbjct: 122 EYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYA 174
Query: 520 APEYFMYGKVND--KIDVYAFGVVLLELLTGRKP 551
APE GK+ ++DV++ G+VL +L GR P
Sbjct: 175 APEVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCF 413
+G+G S+V++ + + +++ VKILKP + K+ EI+I+ L NII+L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNIITLAD-IV 100
Query: 414 ED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 470
+D LV++ ++ ++ F E K AL+Y HS
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-------ALDYCHS---MG 150
Query: 471 VIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE----YFM 525
++HRDVK N+++ + + +L D+GLA++ + + + PE Y M
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQM 207
Query: 526 YGKVNDKIDVYAFGVVLLELLTGRKPI 552
Y +D+++ G +L ++ ++P
Sbjct: 208 YDY---SLDMWSLGCMLASMIFRKEPF 231
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 51/224 (22%), Positives = 95/224 (42%), Gaps = 39/224 (17%)
Query: 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNI 405
+ +IG G V++ L + E+A+K +L+ +E ++I+ + H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRE----LQIMRIVKHPNV 94
Query: 406 ISLLGFCF------EDNNLLLVYDFLSRGSLEENLH--------GNKKDPAAFGWSERYK 451
+ L F + ++ L LV ++ + E ++ + P Y+
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEY-----VPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 452 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCT 510
+ +A Y+HS + HRD+K N+LL +L DFG AK +
Sbjct: 150 LLRSLA----YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK---ILIAGEPNV 199
Query: 511 DVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPI 552
+ Y APE ++G ID+++ G V+ EL+ G +P+
Sbjct: 200 SYICSRYYRAPE-LIFGATNYTTNIDIWSTGCVMAELMQG-QPL 241
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 35/221 (15%)
Query: 347 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVI--KEFVLEIEIITTLHHK 403
+ + IG+G V + +A+K + P E + + EI+I+ H+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 404 NIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM 454
NII + + ++ +V D + E +L+ + +
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSN------DHICYFL 134
Query: 455 -GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC-TDV 512
+ L+Y+HS + V+HRD+K SN+LL+ + ++ DFGLA+ A H T+
Sbjct: 135 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 513 AGTFGYLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGR 549
T Y APE Y K ID+++ G +L E+L+ R
Sbjct: 192 VATRWYRAPEIMLNSKGYTK---SIDIWSVGCILAEMLSNR 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 41/221 (18%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKE-F----VLEIEIITTLHHKNIISLL 409
IG+G +V+K G+++A+K + + KE F + EI+I+ L H+N+++L+
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLI 82
Query: 410 GFCFED--------NNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 459
C ++ LV+DF L N+ F SE +V +
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLLNG 136
Query: 460 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW----ASTSSSHITCTDVAGT 515
L Y+H +++HRD+K++N+L++ D +L+DFGLA+ ++ + T V T
Sbjct: 137 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV--T 191
Query: 516 FGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 552
Y PE + YG ID++ G ++ E+ T R PI
Sbjct: 192 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEMWT-RSPI 228
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 80.3 bits (197), Expect = 1e-15
Identities = 110/642 (17%), Positives = 190/642 (29%), Gaps = 170/642 (26%)
Query: 50 LHVLANNAIVDRDGKS------SLLS------LVKAFDSVLAVYEGFCNL--KQVDLKLK 95
L V + + + D K S+LS ++ + D+V F L KQ ++ K
Sbjct: 22 LSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQK 81
Query: 96 ICRGTEDHRRNSLLDVIH-RSISMSKITGQKNSKV--VTDDGSSITSKPVDDLGGSVMNL 152
L+ I S +T + + +D V L + L
Sbjct: 82 FVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQ-PYLKL 140
Query: 153 EQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNV 212
QAL++ R +N I G G+G +A+ +
Sbjct: 141 RQALLELRPA-------KNVLIDG-------------------VLGSGKTWVALDVCLSY 174
Query: 213 EAASTS------ITMLVRQLPES--RPGWPLLRRAIFPDRRAPDRSS---LRKISVVQWA 261
+ + + PE+ LL + D SS LR S+
Sbjct: 175 KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL 234
Query: 262 LRLPTRQP---SYLANSDVKQITYDPGDNESINLN-------GDSGAIVPVGNEIVSSPL 311
RL +P L +V + + NL+ + +
Sbjct: 235 RRLLKSKPYENCLLVLLNV----QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS 290
Query: 312 STDHDSTELPKELEGLHEKYSATCRLFNYQDL--LSATSNFLAENLIG---KGGSS--QV 364
H T P E++ L KY CR QDL T+N ++I + G +
Sbjct: 291 LDHHSMTLTPDEVKSLLLKY-LDCRP---QDLPREVLTTNPRRLSIIAESIRDGLATWDN 346
Query: 365 YKGCLPDGK----ELAVKILKPSE-------------DV-IKEFVLEI-----------E 395
+K D E ++ +L+P+E I +L +
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMV 406
Query: 396 IITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 455
++ LH SL+ + + + Y
Sbjct: 407 VVNKLHKY---SLV---EKQPKESTIS-----------IPS------------IY----- 432
Query: 456 VAEALEYLHSGSAQRVIHRD-VKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTD 511
LE + +HR V NI SDD P D + S H+ +
Sbjct: 433 ----LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD---QYFYSHIGHHLKNIE 485
Query: 512 VAGTFGYLAPEY----FMYGKV-NDKIDVYAFGVV---LLELLTGRKPISNDHPKGQESL 563
+ F+ K+ +D A G + L +L + I ++ PK + +
Sbjct: 486 HPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLV 545
Query: 564 ------VMWAKPILSSGKVTQLLDPALGNNYD--YDQMERMV 597
+ + L K T LL AL + +++ + V
Sbjct: 546 NAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.7 bits (167), Expect = 4e-12
Identities = 57/498 (11%), Positives = 130/498 (26%), Gaps = 152/498 (30%)
Query: 270 SYLANSDVKQITYDPGDNESINL-------NGDSGAIVPVGNEIVSSPLSTDHD------ 316
S L+ ++ I + + V L ++
Sbjct: 44 SILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMV-----QKFVEEVLRINYKFLMSPI 98
Query: 317 STELPKELEGLHEKYSATC-RLFN---------------YQDLLSATSNFLAENLI---G 357
TE ++ + Y RL+N Y L A + G
Sbjct: 99 KTE-QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG 157
Query: 358 KGGSSQVYKGCLPDGKE-LAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 416
GS GK +A+ + S V + +I + L C
Sbjct: 158 VLGS----------GKTWVALDVCL-SYKVQCKMDFKIFWLN----------LKNCNSPE 196
Query: 417 NLL-----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR- 470
+L L+Y + + + L S +
Sbjct: 197 TVLEMLQKLLYQI--DPNWTSRSDHSSNIKLRIHSIQAEL--------RRLLKSKPYENC 246
Query: 471 -VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 529
++ +V+++ + F + C + T + +V
Sbjct: 247 LLVLLNVQNAKAW--NAF-----NLS-------------CKILLTT---------RFKQV 277
Query: 530 NDKIDVYAFGVVLLELLTGRKPISNDHPKG---QESLVMWAK-----------------P 569
D + + L+ H E + K P
Sbjct: 278 TDFLSAATTTHISLD----------HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP 327
Query: 570 ILSSGKVTQLLD-PALGNNY---DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625
S + D A +N+ + D++ ++ +S+ + +P +M L + A
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVL--EPAEYRKMFDRLSVFPPSA 385
Query: 626 DVTK------WARLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMS-SIEQS 678
+ W + + ++ ++ S ++ + + + + +E
Sbjct: 386 HIPTILLSLIWFDVI---KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENE 442
Query: 679 VSLEDYLLGRWSRSSSFD 696
+L ++ ++ +FD
Sbjct: 443 YALHRSIVDHYNIPKTFD 460
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 39/212 (18%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 409
+G G V G ++A+K + +P + + K E+ ++ + H+N+I LL
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 410 ------GFCFEDNNLLLVYDFLSRGSLEENLHGN-KKDPAAFGWSERYKVAM-GVAEALE 461
F D LV F+ +L K + +R + + + + L
Sbjct: 93 FTPDETLDDFTD--FYLVMPFM-----GTDLGKLMKHEKLG---EDRIQFLVYQMLKGLR 142
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 521
Y+H+ +IHRD+K N+ +++D E ++ DFGLA+ A + T T Y AP
Sbjct: 143 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAP 194
Query: 522 E----YFMYGKVNDKIDVYAFGVVLLELLTGR 549
E + Y + +D+++ G ++ E++TG+
Sbjct: 195 EVILNWMRYTQ---TVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 35/210 (16%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 409
+G G V G +AVK + +P + +I K E+ ++ + H+N+I LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 410 ----GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM-GVAEAL 460
E N++ LV + +L+ K + + + + L
Sbjct: 97 FTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTD------DHVQFLIYQILRGL 145
Query: 461 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 520
+Y+HS +IHRD+K SN+ +++D E ++ DFGLA+ + T T Y A
Sbjct: 146 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-----TGYVATRWYRA 197
Query: 521 PEYFM-YGKVNDKIDVYAFGVVLLELLTGR 549
PE + + N +D+++ G ++ ELLTGR
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 355 LIGKGGSSQVYKGC-LPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 409
+G G +V G G ++AVKIL S DV+ + EI+ + H +II L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 410 GFCFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 467
+++ +V +++S G L + + +G + + R ++ ++Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES-----RRLFQQILS-GVDYCHR-- 134
Query: 468 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYLAPEYFMY 526
V+HRD+K N+LL +++DFGL+ S +C G+ Y APE
Sbjct: 135 -HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPNYAAPEVIS- 188
Query: 527 GKVND--KIDVYAFGVVLLELLTGRKP 551
G++ ++D+++ GV+L LL G P
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 355 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK------NII 406
+IGKG QV K + +A+K+++ + ++ EI I+ L + N+I
Sbjct: 104 VIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 407 SLLG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 465
+L F F N++ + ++ LS +L E + NK F K A + + L+ LH
Sbjct: 163 HMLENFTFR-NHICMTFELLSM-NLYELIKKNKFQG--FSLPLVRKFAHSILQCLDALHK 218
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523
R+IH D+K NILL + DFG + T + F Y APE
Sbjct: 219 ---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRF-YRAPEV 270
Query: 524 FMYGKVNDKIDVYAFGVVLLELLTGR 549
+ + ID+++ G +L ELLTG
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 48/216 (22%), Positives = 82/216 (37%), Gaps = 36/216 (16%)
Query: 356 IGKGGSSQVYKGCLPDGKELAVK-ILKPSEDVIKEFVL-----------EIEIITTLHHK 403
I G V G +G +A+K + D +L EI ++ HH
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 404 NIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVA 457
NI+ L + L LV + + +L D + + M +
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVISPQHIQYFMYHIL 144
Query: 458 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 517
L LH V+HRD+ NILL+D+ + + DF LA+ + ++ T
Sbjct: 145 LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK---THYVTHRW 198
Query: 518 YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGR 549
Y APE + + K +D+++ G V+ E+ +
Sbjct: 199 YRAPELVMQFKGFTK---LVDMWSAGCVMAEMFNRK 231
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 41/218 (18%), Positives = 89/218 (40%), Gaps = 34/218 (15%)
Query: 355 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH----------- 401
+G G S V+ + + +A+KI++ + + EI+++ ++
Sbjct: 26 KLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 402 HKNIISLLG-FCFEDNN---LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA 457
+I+ LL F + N +++V++ L +L + + +++ +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRG--IPLIYVKQISKQLL 141
Query: 458 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ------LSDFGLAKWASTSSSHITCTD 511
L+Y+H +IH D+K N+L+ P+ ++D G A W T+
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY-----DEHYTN 194
Query: 512 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 549
T Y +PE + D+++ ++ EL+TG
Sbjct: 195 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 53/226 (23%), Positives = 93/226 (41%), Gaps = 31/226 (13%)
Query: 345 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVL-----EIEII 397
ATS + IG G VYK G +A+K + P+ + E+ ++
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 398 TTLH---HKNIISLL-----GFCFEDNNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWS 447
L H N++ L+ + + LV++ + + + +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA------ 119
Query: 448 ERYKVAMG-VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506
E K M L++LH+ ++HRD+K NIL++ +L+DFGLA+ S
Sbjct: 120 ETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQ 173
Query: 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 552
+ T V T Y APE + +D+++ G + E+ RKP+
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 48/219 (21%), Positives = 94/219 (42%), Gaps = 42/219 (19%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVI--KEFVLEIEIITTLHHKNIISLL--- 409
+G+G V P G+ +A+K ++P + + + EI+I+ H+NII++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 410 --GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM-GVAEALEY 462
N + ++ + + + +LH + + + A++
Sbjct: 79 RPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSD------DHIQYFIYQTLRAVKV 127
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG----- 517
LH + VIHRD+K SN+L++ + + ++ DFGLA+ S++ + +
Sbjct: 128 LHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 518 ---YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGR 549
Y APE Y + +DV++ G +L EL R
Sbjct: 185 TRWYRAPEVMLTSAKYSR---AMDVWSCGCILAELFLRR 220
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 54/226 (23%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 345 SATSNFLAENLIGKGGSSQVYKG--CLPDGKELAVKILKPSEDVIKEFV----L-EIEII 397
A + IG+G +V+K G+ +A+K ++ +E + + E+ ++
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG--EEGMPLSTIREVAVL 65
Query: 398 TTLH---HKNIISLL-----GFCFEDNNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWS 447
L H N++ L + L LV++ + + + + +
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT------ 119
Query: 448 ERYKVAMG-VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506
E K M + L++LHS RV+HRD+K NIL++ + +L+DFGLA+ S
Sbjct: 120 ETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQ 173
Query: 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 552
+ T V T Y APE + +D+++ G + E+ RKP+
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 54/250 (21%), Positives = 87/250 (34%), Gaps = 58/250 (23%)
Query: 347 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKN 404
+ + +G G V + + GK A+K K +D + E++I+ L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK--KVLQD--PRYKNRELDIMKVLDHVN 61
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER--------------- 449
II L+ + + + + N +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 450 ---YKVAMGVAE-------------------ALEYLHSGSAQRVIHRDVKSSNILL-SDD 486
+KV A+ ++HS + HRD+K N+L+ S D
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKD 178
Query: 487 FEPQLSDFGLAKWASTSSSHIT--CTDVAGTFGYLAPEYFMYGKVN--DKIDVYAFGVVL 542
+L DFG AK S + C+ Y APE M G ID+++ G V
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPE-LMLGATEYTPSIDLWSIGCVF 232
Query: 543 LELLTGRKPI 552
EL+ G KP+
Sbjct: 233 GELILG-KPL 241
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 354 NLIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTL------HHKNI 405
+LIGKG QV K + + +A+KI+K + + + +E+ ++ + I
Sbjct: 60 SLIGKGSFGQVVK-AYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 406 ISLLG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
+ L F F N+L LV++ LS +L + L + K A + AL +L
Sbjct: 119 VHLKRHFMFR-NHLCLVFEMLSY-NLYDLLRNTNFRG--VSLNLTRKFAQQMCTALLFLA 174
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
+ +IH D+K NILL + + DFG +S + F Y +PE
Sbjct: 175 TPEL-SIIHCDLKPENILLCNPKRSAIKIVDFG----SSCQLGQRIYQYIQSRF-YRSPE 228
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLTGR 549
+ + ID+++ G +L+E+ TG
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 62/289 (21%), Positives = 106/289 (36%), Gaps = 58/289 (20%)
Query: 347 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHH 402
N++ ++LIG+G VY K +A+K + + ED+I K + EI I+ L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 403 KNIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG-V 456
II L + + L +V + + +L K P E K + +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLT-EEHIKTILYNL 138
Query: 457 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 516
++H +IHRD+K +N LL+ D ++ DFGLA+ ++ D+
Sbjct: 139 LLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 517 G--------------------YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGRKPI 552
Y APE Y K ID+++ G + ELL +
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK---SIDIWSTGCIFAELLNMLQSH 252
Query: 553 SNDHPKGQESLVMWAKPI---LSSGKVTQLLDPALGNNYDY-DQMERMV 597
ND P+ S ++ + + DQ+ +
Sbjct: 253 INDPTNR--------FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIF 293
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 44/221 (19%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLL---- 409
+G GG+ V+ K +A+K + ++ + L EI+II L H NI+ +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 410 ----------GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM- 454
G E N++ +V +++ E +L E ++ M
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLE------EHARLFMY 127
Query: 455 GVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITC-TDV 512
+ L+Y+HS + V+HRD+K +N+ + ++D ++ DFGLA+ SH ++
Sbjct: 128 QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 513 AGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 549
T Y +P + Y K ID++A G + E+LTG+
Sbjct: 185 LVTKWYRSPRLLLSPNNYTK---AIDMWAAGCIFAEMLTGK 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 60/315 (19%), Positives = 112/315 (35%), Gaps = 64/315 (20%)
Query: 285 GDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLL 344
+ +SG V H S++ + H + R Y+
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDR---YEIR- 58
Query: 345 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTL 400
+LIG G V + + + +A+K IL+ ED+I K + EI I+ L
Sbjct: 59 ---------HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 401 HHKNIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM- 454
+H +++ +L + + L +V + + + + P K +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLT-ELHIKTLLY 163
Query: 455 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 514
+ ++Y+HS ++HRD+K +N L++ D ++ DFGLA+ + + ++
Sbjct: 164 NLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 515 TFG-------------------------YLAPEYFM----YGKVNDKIDVYAFGVVLLEL 545
Y APE + Y + IDV++ G + EL
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE---AIDVWSIGCIFAEL 277
Query: 546 LTGRKPISNDHPKGQ 560
L K H
Sbjct: 278 LNMIKENVAYHADRG 292
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 4/100 (4%)
Query: 453 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 512
+ VA+ +E+L ++++ IHRD+ + NILLS+ ++ DFGLA+ ++ D
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 513 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 551
++APE + DV++FGV+L E+ + G P
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 23/99 (23%), Positives = 48/99 (48%), Gaps = 10/99 (10%)
Query: 356 IGKGGSSQVYKGCL------PDGKELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 406
+G+G QV + + +AVK+LK + + + E++I+ + HH N++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 407 SLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAF 444
+LLG C + L+++ +F G+L L + + +
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 53/232 (22%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLH-HKNIISLLG 410
+GKG V+K G+ +AVK I ++ + EI I+T L H+NI++LL
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 411 FCFEDNN--LLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM-GVAEALEYL 463
DN+ + LV+D++ E +LH N +P + + + + ++YL
Sbjct: 77 VLRADNDRDVYLVFDYM-----ETDLHAVIRANILEP------VHKQYVVYQLIKVIKYL 125
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------ 517
HSG ++HRD+K SNILL+ + +++DFGL++ ++
Sbjct: 126 HSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 518 -------------YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGRKPI 552
Y APE Y K ID+++ G +L E+L KPI
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTK---GIDMWSLGCILGEIL-CGKPI 230
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 48/222 (21%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 355 LIGKGGSSQVYKGCL---PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK------NI 405
+G+G +V + C+ G+ +AVKI+K + + EI+++ L+
Sbjct: 21 TLGEGAFGKVVE-CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 406 ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
+ +L FE ++ +V++ L S + + N P F K+A + +++ +LH
Sbjct: 80 VQMLE-WFEHHGHICIVFELLGL-STYDFIKENGFLP--FRLDHIRKMAYQICKSVNFLH 135
Query: 465 SGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------ 517
S ++ H D+K NIL D+ + + + I D FG
Sbjct: 136 S---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD----FGSATYDD 188
Query: 518 -----------YLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 548
Y APE + + DV++ G +L+E G
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 46/222 (20%), Positives = 84/222 (37%), Gaps = 40/222 (18%)
Query: 355 LIGKGGSSQVYKGC--LPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHK------NI 405
+G+G +V + C GK A+KI++ + LEI ++ + K
Sbjct: 26 NLGEGTFGKVVE-CLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 406 ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
+ + F ++ + ++ L + + E L N P + +A + AL +LH
Sbjct: 85 VLMSD-WFNFHGHMCIAFELLGK-NTFEFLKENNFQP--YPLPHVRHMAYQLCHALRFLH 140
Query: 465 SGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------ 517
++ H D+K NIL + +FE ++ + S ++ I D FG
Sbjct: 141 E---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD----FGSATFDH 193
Query: 518 -----------YLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 548
Y PE + DV++ G +L E G
Sbjct: 194 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 48/222 (21%), Positives = 85/222 (38%), Gaps = 36/222 (16%)
Query: 355 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-----HHKNIIS 407
+G G +V C + + K AVK+++ + + +E +I+ + ++ NI+
Sbjct: 42 KMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 408 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
G F +++ L+++ L SL E + N + F + + + +AL YL
Sbjct: 101 YHG-KFMYYDHMCLIFEPLGP-SLYEIITRNNYNG--FHIEDIKLYCIEILKALNYLRK- 155
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA--------GTFG- 517
+ H D+K NILL D + + TF
Sbjct: 156 --MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS 213
Query: 518 -----------YLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 548
Y APE + + D+++FG VL EL TG
Sbjct: 214 DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 41/180 (22%), Positives = 65/180 (36%), Gaps = 21/180 (11%)
Query: 349 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNII 406
NF IG G ++ G L + +A+K+ + LE L I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-PQLHLEYRFYKQLGSGDGIP 68
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
+ F +V + L SLE+ +L F +A+ + +EY+H
Sbjct: 69 QVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRT-----FSLKTVLMIAIQLISRMEYVH 122
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAK--WASTSSSHITCTDVAGTFG 517
S + +I+RDVK N L+ + DF LAK + HI + G
Sbjct: 123 S---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 45/257 (17%), Positives = 90/257 (35%), Gaps = 74/257 (28%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH--------HKNII 406
+G G S V+ + K +A+K++K +E + + EI ++ ++ + ++
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 407 SLLGFCFE-----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 461
LL F+ ++ +V++ L L + + + K+ V + L+
Sbjct: 105 QLLD-DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQG--LPLPCVKKIIQQVLQGLD 160
Query: 462 YLHSGSAQRVIHRDVKSSNILL-------------------------------------- 483
YLH+ R+IH D+K NILL
Sbjct: 161 YLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 484 -----------SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 532
++ + +++D G A W + T Y + E + N
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTP 273
Query: 533 IDVYAFGVVLLELLTGR 549
D+++ + EL TG
Sbjct: 274 ADIWSTACMAFELATGD 290
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 38/173 (21%), Positives = 69/173 (39%), Gaps = 21/173 (12%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCF 413
IG+G +++G L + +++A+K +P + E L I ++ F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76
Query: 414 EDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
E + +LV D L SLE+ +L G K F A + ++ +H + +
Sbjct: 77 EGLHNVLVIDLLGP-SLEDLLDLCGRK-----FSVKTVAMAAKQMLARVQSIHE---KSL 127
Query: 472 IHRDVKSSNILLSDDFEPQ-----LSDFGLAK--WASTSSSHITCTDVAGTFG 517
++RD+K N L+ + DFG+ K + HI + G
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 6e-09
Identities = 42/273 (15%), Positives = 76/273 (27%), Gaps = 71/273 (26%)
Query: 344 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV---------IKEFVLEI 394
T IG+G +V++ D +A+KI+ +E + EI
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 395 EIITTLH---------HKNIISLLGFC------------------------------FED 415
I L + I L F+D
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 475
+ L +V +F G E + + + + +L ++ R HRD
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSS-----LATAKSILHQLTASLAVAE--ASLRFEHRD 187
Query: 476 VKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTD-----------VAGTFGYLAPE 522
+ N+LL +L K ++ + ++ D V + +
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDED 247
Query: 523 YFMYGKVNDKIDVY-AFGVVLLELLTGRKPISN 554
F G + + D+Y P SN
Sbjct: 248 LFT-GDGDYQFDIYRLMKKENNNRWGEYHPYSN 279
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 33/184 (17%), Positives = 67/184 (36%), Gaps = 33/184 (17%)
Query: 349 NFLAENLIGKGGSSQVYKGC---------LPDGKELAVKILKPSEDVIKEF--------V 391
+ ++ + +Y+ P ++ ++K+ + E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 392 LEIEIITTLH---HKNIISLLGF-CFEDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFG 445
L++ L+ I + +GF +D LV L R SL+ ++
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHV----LS 157
Query: 446 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTS 503
+VA + +ALE+LH +H +V + NI + + + Q L+ +G A S
Sbjct: 158 ERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
Query: 504 SSHI 507
H+
Sbjct: 215 GKHV 218
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 34/177 (19%), Positives = 65/177 (36%), Gaps = 34/177 (19%)
Query: 355 LIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEI-----------ITTLHH 402
IG GG +Y ++ A ++K + + L E+ I
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVK--VEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 403 KNIISLLGF----------CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 452
+ + LG + +V + L L++ N F S ++
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGT----FKKSTVLQL 156
Query: 453 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHI 507
+ + + LEY+H +H D+K++N+LL Q L+D+GL+ + +H
Sbjct: 157 GIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 19/171 (11%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCF 413
IG G +Y G + G+E+A+K+ + + + +E +I + I ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75
Query: 414 EDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
E + ++V + L SLE+ N K F +A + +EY+HS +
Sbjct: 76 EGDYNVMVMELLGP-SLEDLFNFCSRK-----FSLKTVLLLADQMISRIEYIHS---KNF 126
Query: 472 IHRDVKSSNILL---SDDFEPQLSDFGLAK--WASTSSSHITCTDVAGTFG 517
IHRDVK N L+ + DFGLAK + + HI + G
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 32/170 (18%), Positives = 64/170 (37%), Gaps = 35/170 (20%)
Query: 355 LIGKGGSSQVYKGCLPDGKELAVKI-----LKPSED-------------VIKEFVLEIEI 396
IG+GG +Y + + + ++PS++ E + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 397 ITTLHHKNIISLLGFCFEDNNLL----LVYDFLSRGSLEE--NLHGNKKDPAAFGWSERY 450
L + + G D N ++ D L++ + + F
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKR-----FSRKTVL 155
Query: 451 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAK 498
++++ + + LEY+H +H D+K+SN+LL+ Q L D+GLA
Sbjct: 156 QLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 42/218 (19%)
Query: 356 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCF 413
IG G ++Y G + +E+A+K+ + + E +I L I ++ F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLLYESKIYRILQGGTGIPNVRWFGV 73
Query: 414 EDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
E + +LV D L SLE+ N K +A + +E++HS +
Sbjct: 74 EGDYNVLVMDLLGP-SLEDLFNFCSRK-----LSLKTVLMLADQMINRVEFVHS---KSF 124
Query: 472 IHRDVKSSNILLSDDFEPQ---LSDFGLAK--WASTSSSHI---TCTDVAGTFGYLAPEY 523
+HRD+K N L+ + DFGLAK +++ HI ++ GT Y +
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS--- 181
Query: 524 FMYGKVN----------DKIDVYAFGVVLLELLTGRKP 551
VN D D+ + G VL+ L G P
Sbjct: 182 -----VNTHLGIEQSRRD--DLESLGYVLMYFLRGSLP 212
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 696 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.04 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.65 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.45 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.41 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.34 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.3 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.2 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.15 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.09 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.71 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.69 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.52 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.44 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.41 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.38 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.32 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.26 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.22 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.2 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.2 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.56 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.03 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.42 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 94.84 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 94.25 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.86 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 93.71 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.92 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 92.72 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 92.71 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 92.51 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 92.26 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 90.61 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 90.45 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 89.29 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 88.9 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 87.85 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 86.92 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 85.42 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 85.11 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 84.73 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 84.38 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.79 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.63 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 80.39 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=445.74 Aligned_cols=257 Identities=26% Similarity=0.465 Sum_probs=211.1
Q ss_pred cCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
++|.+.+.||+|+||+||+|.+. ++..||||+++.. ....++|.+|+++|++++|||||+++++|.+++.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57889999999999999999853 4778999999864 3556789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCC---------CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEE
Q 005450 421 VYDFLSRGSLEENLHGNK---------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 491 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~---------~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL 491 (696)
|||||++|+|.++|+... ..+..++|.+++.|+.||+.||.|||+ ++||||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 999999999999997643 234579999999999999999999999 89999999999999999999999
Q ss_pred eecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccc
Q 005450 492 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPI 570 (696)
Q Consensus 492 ~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~ 570 (696)
+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||...........+..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~---- 245 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ---- 245 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH----
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----
Confidence 99999987765444434444679999999999999999999999999999999999 9999987654332222221
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 571 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 571 ~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
+.... ..... ...+..++..||+.||++|||+.+|++.|+.
T Consensus 246 ---~~~~~-----~p~~~----~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 246 ---GRVLQ-----RPRTC----PQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp ---TCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCC-----CCccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11111 11111 2345567778999999999999999998864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-52 Score=446.32 Aligned_cols=258 Identities=24% Similarity=0.416 Sum_probs=204.0
Q ss_pred cCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
++|.+.+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|+++|++++|||||+++++|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56888999999999999999853 4788999999864 4556789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCC-----------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCce
Q 005450 421 VYDFLSRGSLEENLHGNKK-----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 489 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~-----------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~v 489 (696)
|||||++|+|.++|+.... ....++|.+++.|+.||+.||+|||+ ++||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 9999999999999976432 12468999999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhc
Q 005450 490 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 568 (696)
Q Consensus 490 KL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~ 568 (696)
||+|||+|+...........+...||+.|||||++.+..|+.++|||||||+||||+| |+.||...........+....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~ 277 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999997765544444445789999999999999999999999999999999999 999998765433222222111
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 569 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 569 ~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
. +......+ ..+..++..||+.||++||||.+|++.|+..
T Consensus 278 ~------------~~~p~~~~----~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 278 E------------LERPRACP----PEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp C------------CCCCTTCC----HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred C------------CCCccccc----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 0 01111122 3455667789999999999999999999754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=443.12 Aligned_cols=258 Identities=26% Similarity=0.398 Sum_probs=210.7
Q ss_pred cCceeeeeeeccCceEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
+++.+.+.||+|+||+||+|.+ .+++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+.+.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 3467789999999999999985 25678999999753 344678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC
Q 005450 420 LVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 487 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~ 487 (696)
||||||++|+|.++|..... ....++|..++.|+.||+.||+|||+ ++||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence 99999999999999975432 12458999999999999999999999 8999999999999999999
Q ss_pred ceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhh
Q 005450 488 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 566 (696)
Q Consensus 488 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~ 566 (696)
.+||+|||+|+...........+...||+.|||||++.++.|+.++|||||||+||||+| |+.||.+.........+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~- 261 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR- 261 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH-
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 999999999987755444334445789999999999999999999999999999999998 899998765433222221
Q ss_pred hccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 567 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 567 ~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.+.... ..... ...+..++..||+.||.+||||.+|++.|+.-
T Consensus 262 ------~~~~~~-----~p~~~----~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 262 ------NRQVLP-----CPDDC----PAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ------TTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ------cCCCCC-----Ccccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111 11111 23456677789999999999999999999753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=439.15 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=199.9
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.++|.+.+.||+|+||+||+|.+++ .||||+++. +....+.|.+|+++|++++|||||+++++|.+ +.++||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3567889999999999999998754 699999874 34566789999999999999999999999865 57899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
||+||+|.++|+... ..++|.++..|+.||+.||+|||+ ++||||||||+||||++++.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999999997543 258999999999999999999999 89999999999999999999999999999877654
Q ss_pred CCCcccccccccCCCCCcceecc---CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~---~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
.........+||+.|||||++.+ +.|+.++|||||||+||||+||+.||.+........... ........+..
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~-- 261 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV--GRGYASPDLSK-- 261 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH--HTTCCCCCSTT--
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH--hcCCCCCCccc--
Confidence 44334455789999999999863 468999999999999999999999998655432221111 11000111111
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
+ ..+....+..++..||+.||++||||.+|++.|+.
T Consensus 262 ---~----~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 262 ---L----YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp ---S----CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred ---c----cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 11112345566778999999999999999988853
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-51 Score=439.56 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=201.0
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+++|++++|||||+++++|.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999986 57999999999753 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|++||+|.++|...+. ..+++..++.|+.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999975432 357889999999999999999999 99999999999999999999999999999876532
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.........+.. +... .
T Consensus 179 ~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-------~~~~-----~ 244 (350)
T 4b9d_A 179 V--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS-------GSFP-----P 244 (350)
T ss_dssp H--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------TCCC-----C
T ss_pred c--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-------CCCC-----C
Confidence 1 122346899999999999999999999999999999999999999987654332222211 1111 1
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+...++ ..+..++..||+.||.+|||+.|+++
T Consensus 245 ~~~~~s----~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 VSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122 23455666799999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=434.74 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=208.1
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||+||+|.. .+|+.||||++... ....+.+.+|+++|++++|||||+++++|.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5699999999999999999986 57999999999753 234577999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||++||+|.+++...+ .+++..+..|+.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999997654 58999999999999999999999 9999999999999999999999999999998865
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
..........+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+.......+.....
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~------------- 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY------------- 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-------------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence 5444445568999999999999999999999999999999999999999987654332222221110
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 618 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL 618 (696)
.+...+. + .+..++..||+.||.+|||+.|++
T Consensus 252 ~~p~~~s-~---~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DFPEKFF-P---KARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCTTCC-H---HHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCcccC-H---HHHHHHHHHccCCHhHCcChHHHc
Confidence 1111222 2 344566679999999999998864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=435.05 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=205.6
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
..|...+.||+|+||+||+|... +|+.||||++.... ...+.+.+|+++|+.++|||||+++++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999864 79999999996533 33456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
+||+|.+++... .+++..+..|+.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999999753 48999999999999999999999 9999999999999999999999999999997765433
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
. ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.........+.... .+.+.
T Consensus 226 ~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------------~~~~~ 291 (346)
T 4fih_A 226 R--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------PPRLK 291 (346)
T ss_dssp C--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS------------CCCCS
T ss_pred c--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC------------CCCCC
Confidence 2 235789999999999999999999999999999999999999998765443332222110 01110
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. .......+..++..||+.||.+|||+.|+++
T Consensus 292 ~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 N--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp C--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c--cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0011123445666799999999999999886
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=428.74 Aligned_cols=269 Identities=26% Similarity=0.317 Sum_probs=201.6
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC----ceEEEEe
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----NLLLVYD 423 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~----~~~LV~E 423 (696)
.+|.+.+.||+|+||+||+|.+ +|+.||||+++........+..|+.++.+++|||||+++++|.+.+ .++||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4688899999999999999987 6899999999865543334445666677899999999999998764 5799999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC-----CCceEeecccccceeeCCCCceEEeecCccc
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-----AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~-----~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
||++|+|.++|+.. .++|..+.+++.|++.||+|||+.+ ..+||||||||+||||+.++.+||+|||+|+
T Consensus 82 y~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999754 4899999999999999999999831 2489999999999999999999999999998
Q ss_pred cccCCCCCc--ccccccccCCCCCcceeccC------CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhc--
Q 005450 499 WASTSSSHI--TCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-- 568 (696)
Q Consensus 499 ~~~~~~~~~--~~~~~~GT~~YlAPE~l~~~------~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~-- 568 (696)
......... .....+||+.|||||++.+. .|+.++|||||||+||||+||+.||.......... ..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~~~~~~ 235 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVPSD 235 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTSCSS
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hhccccc
Confidence 776543321 22346799999999998754 47789999999999999999998875433211100 00000
Q ss_pred c---ccccCccccccCcccCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 569 P---ILSSGKVTQLLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 569 ~---~~~~g~l~~llD~~L~~~~-~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
+ .+........++|.+.... ..+....+..++..||+.||.+||||.||++.|+.
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 0 0000001111222222221 23455677888899999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=432.68 Aligned_cols=251 Identities=23% Similarity=0.260 Sum_probs=202.9
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
+.|...+.||+|+||.||+|.. .+|+.||||+++.... +.+|+.+++.++|||||+++++|.+++.+||||||++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 5688899999999999999996 4699999999986432 2469999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC-ceEEeecCccccccCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~-~vKL~DFGlA~~~~~~~~ 505 (696)
||+|.++|.... .+++..+..|+.||+.||+|||+ ++||||||||+||||+.++ ++||+|||+|+.......
T Consensus 134 gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 134 GGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999997653 58999999999999999999999 8999999999999999987 699999999997765322
Q ss_pred C---cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 506 H---ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 506 ~---~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
. .....++||+.|||||++.+..|+.++|||||||+||||++|+.||...........+....+ .+.
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-----~~~----- 276 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP-----PIR----- 276 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC-----GGG-----
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC-----Cch-----
Confidence 1 122346899999999999999999999999999999999999999987665443332221111 000
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.+...++ ..+..++..||+.||.+|||+.|+++.|..
T Consensus 277 ~~~~~~s----~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 277 EIPPSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp GSCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hcCccCC----HHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 1111111 234455667999999999999999988753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=416.16 Aligned_cols=244 Identities=27% Similarity=0.393 Sum_probs=194.9
Q ss_pred ceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe----cCceEEE
Q 005450 350 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLV 421 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~----~~~~~LV 421 (696)
|...+.||+|+||+||+|.. .++..||+|++... ....+.|.+|+++|++++|||||+++++|.+ ++.+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 36678899999999999986 46899999998643 3456789999999999999999999999875 3458999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCc--eEeecccccceeeCC-CCceEEeecCccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSD-DFEPQLSDFGLAK 498 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~g--IIHrDLKpsNILLd~-~~~vKL~DFGlA~ 498 (696)
||||+||+|.+++.... .+++..+..|+.||+.||+|||+ ++ ||||||||+||||+. ++.+||+|||+|+
T Consensus 108 mEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 99999999999997643 58999999999999999999998 66 999999999999984 7899999999998
Q ss_pred cccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 499 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 499 ~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
..... .....+||+.|||||++. ++|+.++|||||||+||||+||+.||........ +..... .+....
T Consensus 181 ~~~~~----~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~~i~----~~~~~~ 249 (290)
T 3fpq_A 181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVT----SGVKPA 249 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHT----TTCCCG
T ss_pred eCCCC----ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHHHHH----cCCCCC
Confidence 65432 223478999999999886 5799999999999999999999999976443221 111111 111111
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.++ .. ..+ .+..++..||+.||.+|||+.++++
T Consensus 250 ~~~----~~-~~~---~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 SFD----KV-AIP---EVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGG----GC-CCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC----cc-CCH---HHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 11 112 3445666799999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=430.78 Aligned_cols=260 Identities=24% Similarity=0.375 Sum_probs=210.3
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCC-cceeEEeeEEEec-
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHH-KNIISLLGFCFED- 415 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~H-pnIV~l~g~~~~~- 415 (696)
..++|.+.+.||+|+||+||+|... .++.||||+++.. ....+.|.+|+++|.++.| ||||+++++|.+.
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 4578999999999999999999853 2468999999764 3456789999999999965 9999999999764
Q ss_pred CceEEEEeecCCCChhhhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee
Q 005450 416 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 483 (696)
Q Consensus 416 ~~~~LV~Ey~~gGsL~~~L~~~~~------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL 483 (696)
+.++||||||++|+|.++|+.... ....++|..+..|+.||+.||+|||+ ++||||||||+||||
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceee
Confidence 568999999999999999975431 12458999999999999999999999 899999999999999
Q ss_pred CCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhh
Q 005450 484 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 562 (696)
Q Consensus 484 d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~ 562 (696)
++++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||.+........
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999998766555555556789999999999999999999999999999999998 999998754332211
Q ss_pred HHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 563 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 563 lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
... ..+.. +...... . ..+..++..||+.||.+|||+.+|+++|+.
T Consensus 299 --~~i----~~g~~-----~~~p~~~-~---~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 299 --RRL----KEGTR-----MRAPDYT-T---PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp --HHH----HHTCC-----CCCCTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHH----HcCCC-----CCCCccC-C---HHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 111 11110 1111111 1 245556677999999999999999998864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=414.59 Aligned_cols=244 Identities=20% Similarity=0.329 Sum_probs=189.0
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+++|++++|||||++++++.+.+.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5899999999999999999986 47999999999753 234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+ +|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 679999997654 58999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCcccccccccCCCCCcceeccCCC-CCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~-s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
... ....+||+.|+|||++.+..| +.++|||||||+||+|++|+.||.+.........+.....
T Consensus 165 ~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~------------ 229 (275)
T 3hyh_A 165 GNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY------------ 229 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC------------
T ss_pred CCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 332 234789999999999998776 5799999999999999999999977543322222211110
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+....+ ..+..++..||+.||++|||+.|+++
T Consensus 230 -~~p~~~s----~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 -TLPKFLS----PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -CCCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCCCC----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0111112 23445666799999999999999987
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=436.64 Aligned_cols=248 Identities=26% Similarity=0.372 Sum_probs=206.0
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
+.|...+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5699999999999999999996 479999999997543 33456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
+||+|.+++... .+++..+..|+.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 231 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999999753 48999999999999999999999 9999999999999999999999999999997765433
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
. ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.........+.... .+.+.
T Consensus 303 ~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------------~~~~~ 368 (423)
T 4fie_A 303 R--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------PPRLK 368 (423)
T ss_dssp C--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC------------CCCCS
T ss_pred c--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC------------CCCCc
Confidence 2 235789999999999999999999999999999999999999998765543332222111 01111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.. ......+..++..||+.||.+|||+.|+++
T Consensus 369 ~~--~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 NL--HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CT--TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cc--ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 10 001123445666799999999999999886
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=421.92 Aligned_cols=246 Identities=26% Similarity=0.350 Sum_probs=195.1
Q ss_pred cCceeeeeeeccCceEEEEEEe----CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~----~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
++|.+.+.||+|+||+||+|.. .+++.||||+++... .....+.+|+++|++++|||||+++++|.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999985 257899999997532 233468889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||++||+|.+++.... .+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999997654 58999999999999999999999 99999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
...... ....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+.......+.....
T Consensus 177 ~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~----------- 243 (304)
T 3ubd_A 177 IDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL----------- 243 (304)
T ss_dssp ----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------
T ss_pred cCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----------
Confidence 443322 2347899999999999999999999999999999999999999987654433322221110
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQM-----SLVLK 619 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm-----~eVL~ 619 (696)
.+....+ ..+..++..||+.||.+|||+ +|+++
T Consensus 244 --~~p~~~s----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 --GMPQFLS----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp --CCCTTSC----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred --CCCCcCC----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 0111112 234456667999999999994 56654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=408.53 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=186.6
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc-------
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN------- 417 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~------- 417 (696)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+++|++++|||||+++++|.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4699999999999999999986 47999999998643 3456789999999999999999999999976553
Q ss_pred -----eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEe
Q 005450 418 -----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 492 (696)
Q Consensus 418 -----~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~ 492 (696)
+|+||||+++|+|.+++...... ....+..++.|+.||+.||+|||+ ++||||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEc
Confidence 79999999999999999865432 235667789999999999999999 899999999999999999999999
Q ss_pred ecCccccccCCCCC----------cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhh
Q 005450 493 DFGLAKWASTSSSH----------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 562 (696)
Q Consensus 493 DFGlA~~~~~~~~~----------~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~ 562 (696)
|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||+||||++ ||..... ...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--RVR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--HHH
Confidence 99999877553221 11234679999999999999999999999999999999996 7754211 111
Q ss_pred HHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 563 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 563 lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..... ......... .........++..||+.||.+|||+.++++
T Consensus 236 ~~~~~----~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TLTDV----RNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHH----HTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHH----hcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111 011111110 011123345677899999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=399.06 Aligned_cols=285 Identities=37% Similarity=0.673 Sum_probs=247.6
Q ss_pred ccChHHHHHhhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec
Q 005450 337 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFED 415 (696)
Q Consensus 337 ~f~~~el~~~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~ 415 (696)
.+++.++...+++|...+.||+|+||.||+|...+|+.||||++... ....+.+.+|+.++..++||||++++++|.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 34555666788999999999999999999999888999999998764 35567899999999999999999999999999
Q ss_pred CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecC
Q 005450 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 495 (696)
Q Consensus 416 ~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFG 495 (696)
+..++||||+++|+|.+++.........+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999997665544568999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCc
Q 005450 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 575 (696)
Q Consensus 496 lA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 575 (696)
+++...............||+.|+|||++.++.++.++||||||+++|||++|+.||....+........|.......+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 99876543333333446799999999999999999999999999999999999999988776666666666655556667
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 576 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 576 l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
+..++++.+......+....+..++..||+.||++|||+.++++.|+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 7788888887777888888899999999999999999999999998743
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=400.06 Aligned_cols=298 Identities=37% Similarity=0.710 Sum_probs=255.3
Q ss_pred cccccChHHHHHhhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChh--HHHHHHHHHHHHHhcCCcceeEEeeE
Q 005450 334 TCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGF 411 (696)
Q Consensus 334 ~~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~L~HpnIV~l~g~ 411 (696)
....|++.++...+++|.+.+.||+|+||.||+|...+|+.||||++..... ....+.+|++++..++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 4567899999999999999999999999999999988899999999986432 22368899999999999999999999
Q ss_pred EEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEE
Q 005450 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 491 (696)
Q Consensus 412 ~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL 491 (696)
|...+..++||||+++|+|.+++.........+++..+..|+.|++.||.|||+.+..+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999999877655567999999999999999999999932229999999999999999999999
Q ss_pred eecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCC--ccchhhHHhhhcc
Q 005450 492 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH--PKGQESLVMWAKP 569 (696)
Q Consensus 492 ~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~--~~~~~~lv~~~~~ 569 (696)
+|||++.......... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .........|...
T Consensus 176 ~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 9999998775543332 234669999999999998999999999999999999999999996321 1123345566777
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCccchhhhh
Q 005450 570 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWAR 632 (696)
Q Consensus 570 ~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~~~~~~~~ 632 (696)
......+..+.+..+...+.......+..++..||+.||.+|||+.+|+++|++......|..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~ 317 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEE 317 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC-
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhh
Confidence 777778888888888888888889999999999999999999999999999998766655543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=406.99 Aligned_cols=265 Identities=22% Similarity=0.334 Sum_probs=203.3
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe------cC
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------DN 416 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~------~~ 416 (696)
.++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+++|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 46899999999999999999986 57999999999753 3455778899999999999999999998764 36
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCc
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGl 496 (696)
.+|||||||+ |+|.+++.... .+++..+..|+.||+.||.|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecce
Confidence 7899999996 68999997543 58999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCC--CcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccccc
Q 005450 497 AKWASTSSS--HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 573 (696)
Q Consensus 497 A~~~~~~~~--~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 573 (696)
|+.+..... .......+||+.|+|||++.+. .|+.++||||+|||+|||++|+.||.+.+...+...+.........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 987654321 2233457899999999998865 5699999999999999999999999887665544443322111110
Q ss_pred Cccc--------cccCccc-CCCCChH-----HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 574 GKVT--------QLLDPAL-GNNYDYD-----QMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 574 g~l~--------~llD~~L-~~~~~~~-----e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.... ..+.... ....+.. ....+..++..||+.||.+|||+.|+++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 0000000 0000111 1134456677899999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=397.49 Aligned_cols=200 Identities=27% Similarity=0.418 Sum_probs=172.3
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC----CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~----~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~L 420 (696)
..+.|.+.+.||+|+||+||+|..+ +++.||||.+..... ..++.+|+++|..+ +||||++++++|.+.+++||
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 4678999999999999999999753 467899999876543 35678999999998 69999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC-CceEEeecCcccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKW 499 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~-~~vKL~DFGlA~~ 499 (696)
||||+++|+|.+++. .+++.++..++.||+.||+|||+ +|||||||||+|||++.+ +.+||+|||+|+.
T Consensus 98 vmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 98 AMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 999999999999984 37899999999999999999999 999999999999999876 7999999999986
Q ss_pred ccCCCCC--------------------------cccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCC
Q 005450 500 ASTSSSH--------------------------ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPI 552 (696)
Q Consensus 500 ~~~~~~~--------------------------~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf 552 (696)
....... ......+||+.|+|||++.+. .|+.++||||+|||+|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 5443211 112336799999999999865 5899999999999999999999999
Q ss_pred CCCC
Q 005450 553 SNDH 556 (696)
Q Consensus 553 ~~~~ 556 (696)
....
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 6544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=414.34 Aligned_cols=252 Identities=22% Similarity=0.286 Sum_probs=207.4
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++... ....+.+.+|+++|+.++|||||+++++|.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36899999999999999999986 47999999998754 34567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC--CceEEeecCccccccC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--FEPQLSDFGLAKWAST 502 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~--~~vKL~DFGlA~~~~~ 502 (696)
|+||+|.++|.... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 236 ~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999999986433 258999999999999999999999 999999999999999854 8999999999998765
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
... ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.........+......+. .
T Consensus 310 ~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~---------~ 377 (573)
T 3uto_A 310 KQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD---------D 377 (573)
T ss_dssp TSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC---------S
T ss_pred CCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC---------c
Confidence 432 2346899999999999999999999999999999999999999987665443332221111100 0
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.....+. ..+..++..||+.||.+|||+.|++++
T Consensus 378 ~~~~~~s----~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 378 SAFSGIS----EDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GGGTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccCCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111 234456677999999999999999983
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=413.73 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=197.7
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~ 418 (696)
-++|.+.++||+|+||.||+|... +|+.||||+++... ........++.++..++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999864 79999999996432 1222333446677778999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
||||||++||+|.++|.... .+++..+..|+.||+.||+|||+ ++||||||||+||||+.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999997654 58999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 499 WASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 499 ~~~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
....... ...+||+.|||||++.. ..|+.++|||||||+||||++|+.||.+........+...... ..
T Consensus 341 ~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~----~~-- 410 (689)
T 3v5w_A 341 DFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----MA-- 410 (689)
T ss_dssp ECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH----CC--
T ss_pred ecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC----CC--
Confidence 7765432 24689999999999975 4799999999999999999999999976544333222111100 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLK 619 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPS-----m~eVL~ 619 (696)
..+...+. ..+..++..||+.||.+|++ +.+|++
T Consensus 411 ----~~~p~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 ----VELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----CCCCTTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----CCCCccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 01111122 23445666799999999998 677765
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=377.57 Aligned_cols=269 Identities=25% Similarity=0.317 Sum_probs=210.4
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc----eEEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----LLLVY 422 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~----~~LV~ 422 (696)
.++|.+.+.||+|+||+||+|... ++.||||+++........+..|+.++.+++||||+++++++..... +++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 467999999999999999999875 7899999998776666677789999999999999999999987553 69999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCC----------ceEeecccccceeeCCCCceEEe
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ----------RVIHRDVKSSNILLSDDFEPQLS 492 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~----------gIIHrDLKpsNILLd~~~~vKL~ 492 (696)
||+++|+|.+++... .+++..++.++.|++.||.|||+ . +|+||||||+|||++.++.+||+
T Consensus 102 e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred ecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 999999999999754 38999999999999999999998 6 99999999999999999999999
Q ss_pred ecCccccccCCCCCcccccccccCCCCCcceeccC-----CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhh
Q 005450 493 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 567 (696)
Q Consensus 493 DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~-----~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~ 567 (696)
|||+++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||...............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999877655443333446799999999998863 5667899999999999999999999875443221111110
Q ss_pred ccccccCcc-----ccccCcccCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 568 KPILSSGKV-----TQLLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 568 ~~~~~~g~l-----~~llD~~L~~~~-~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
........+ .....+.+...+ .......+..++..||+.||.+|||+.+|++.|+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000000000 000111111111 123445677788889999999999999999999754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=363.37 Aligned_cols=283 Identities=31% Similarity=0.564 Sum_probs=230.3
Q ss_pred ccccccChHHHHHhhcCceee------eeeeccCceEEEEEEeCCCCEEEEEEecCC-----hhHHHHHHHHHHHHHhcC
Q 005450 333 ATCRLFNYQDLLSATSNFLAE------NLIGKGGSSQVYKGCLPDGKELAVKILKPS-----EDVIKEFVLEIEIITTLH 401 (696)
Q Consensus 333 ~~~~~f~~~el~~~t~~f~~~------~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~-----~~~~~~~~~Ei~iL~~L~ 401 (696)
.....|++.++..++++|... +.||+|+||.||+|.. +++.||||++... ....+.+.+|+.++..++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 345789999999999999887 8999999999999987 6889999998642 345678999999999999
Q ss_pred CcceeEEeeEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccce
Q 005450 402 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 481 (696)
Q Consensus 402 HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNI 481 (696)
||||+++++++.+.+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+ ++|+||||||+||
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Ni 164 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANI 164 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHE
Confidence 99999999999999999999999999999999874332 2358999999999999999999999 8999999999999
Q ss_pred eeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchh
Q 005450 482 LLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 561 (696)
Q Consensus 482 LLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~ 561 (696)
|++.++.+||+|||++................||+.|+|||++. +.++.++||||||+++|+|++|+.||.........
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 243 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence 99999999999999998766543333334467999999999876 46899999999999999999999999865443221
Q ss_pred hHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 562 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 562 ~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
..+... .......+...+++.+. .........+..++..||+.+|.+|||+.+|++.|+.
T Consensus 244 ~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~ 303 (307)
T 2nru_A 244 LDIKEE-IEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303 (307)
T ss_dssp THHHHH-HHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHHH-hhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 111100 00112234444444442 3355566778888899999999999999999999974
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=374.15 Aligned_cols=260 Identities=25% Similarity=0.394 Sum_probs=211.4
Q ss_pred hcCceeeeeeeccCceEEEEEEe--------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL--------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 415 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~--------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~ 415 (696)
.++|.+.+.||+|+||.||+|.. .++..||||+++.. ....+.+.+|+.++..+ +||||++++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 46799999999999999999985 24567999999864 34567899999999999 899999999999999
Q ss_pred CceEEEEeecCCCChhhhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee
Q 005450 416 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 483 (696)
Q Consensus 416 ~~~~LV~Ey~~gGsL~~~L~~~~~------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL 483 (696)
+.+++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 999999999999999999976532 12358999999999999999999999 899999999999999
Q ss_pred CCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhh
Q 005450 484 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 562 (696)
Q Consensus 484 d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~ 562 (696)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||..........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999987665443333334568899999999999999999999999999999999 999998755433222
Q ss_pred HHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 563 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 563 lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
.+... .. +.. +......+..++..||+.+|.+||++.++++.|+...
T Consensus 317 ~~~~~-------~~-----~~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 317 LLKEG-------HR-----MDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHHTT-------CC-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcC-------CC-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 21111 00 001 1111234556677799999999999999999997543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=356.61 Aligned_cols=257 Identities=23% Similarity=0.378 Sum_probs=212.6
Q ss_pred hhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
..++|.+.+.||+|+||.||++...++..||+|+++......+.+.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 34679999999999999999999988889999999877666678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp TTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999997543 258999999999999999999999 8999999999999999999999999999987655432
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
. ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+...... ..+
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------~~~-- 227 (268)
T 3sxs_A 160 V-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL---------YRP-- 227 (268)
T ss_dssp E-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---------CCC--
T ss_pred h-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC---------CCC--
Confidence 2 2223457788999999998899999999999999999999 99999765543322221111100 001
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
.... ..+..++..||+.+|.+|||+.++++.|+...
T Consensus 228 --~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 228 --HLAS---DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp --TTSC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred --CcCh---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1111 23555667799999999999999999998654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=364.22 Aligned_cols=258 Identities=25% Similarity=0.456 Sum_probs=208.1
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecC-ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
.++|.+.+.||+|+||+||++... +++.||+|++.. .....+.+.+|++++.+++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467999999999999999999964 689999998865 446678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999998643 258999999999999999999999 899999999999999999999999999998765433
Q ss_pred CCcc------------cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccc
Q 005450 505 SHIT------------CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 572 (696)
Q Consensus 505 ~~~~------------~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~ 572 (696)
.... .....||+.|+|||++.+..++.++||||||+++|||++|..||............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-------- 234 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-------- 234 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--------
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--------
Confidence 2211 11367999999999999999999999999999999999999999765433221100
Q ss_pred cCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 573 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 573 ~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
......+.......+ ..+..++..||+.||.+|||+.++++.|+..
T Consensus 235 --~~~~~~~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 235 --NVRGFLDRYCPPNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp --CHHHHHHHTCCTTCC----TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --hhhccccccCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001111111111111 2345566779999999999999999988754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=356.80 Aligned_cols=255 Identities=24% Similarity=0.418 Sum_probs=210.4
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
.++|.+.+.||+|+||.||+|...+++.||+|++.......+.+.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 46799999999999999999998889999999998766666789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 89 ~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 161 (269)
T 4hcu_A 89 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 161 (269)
T ss_dssp TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence 999999997543 258999999999999999999999 8999999999999999999999999999986644221
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
.......||+.|+|||++....++.++||||||+++|+|++ |+.||...........+.... .....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~------------~~~~~ 229 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------------RLYKP 229 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------------CCCCC
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc------------cCCCC
Confidence 11223457888999999999999999999999999999999 999997655432221111100 00011
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.. . ...+..++..||+.||.+||++.++++.|+..
T Consensus 230 ~~-~---~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 230 RL-A---STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp TT-S---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Cc-C---CHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 11 1 13355566779999999999999999998743
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=360.41 Aligned_cols=249 Identities=25% Similarity=0.390 Sum_probs=205.6
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
.++|.+.+.||+|+||+||+|.. .+|+.||||++.... ...+.+.+|+.+++.++||||++++++|...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999985 578999999986533 3456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++|+|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999754 37899999999999999999999 899999999999999999999999999998766543
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... ..+..
T Consensus 171 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-------~~~~~--- 238 (297)
T 3fxz_A 171 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-------PELQN--- 238 (297)
T ss_dssp CC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-------CCCSC---
T ss_pred cc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------CCCCC---
Confidence 32 2346799999999999999999999999999999999999999977654332222211110 00000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+......+..++..||+.||.+|||+.++++
T Consensus 239 ----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 ----PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1111233555667799999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=368.16 Aligned_cols=247 Identities=24% Similarity=0.409 Sum_probs=205.5
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
..++|.+.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356899999999999999999986 68999999999653 35567789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999997543 48899999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCC-CcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s-~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
... .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.........+..... .
T Consensus 166 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----~----- 232 (328)
T 3fe3_A 166 VGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-----R----- 232 (328)
T ss_dssp SSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----C-----
T ss_pred CCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----C-----
Confidence 432 22346899999999999988775 789999999999999999999987654333222221110 0
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+ +......+..++..||+.||.+|||+.++++
T Consensus 233 ---~----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 233 ---I----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ---C----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ---C----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0111123455666799999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=364.79 Aligned_cols=256 Identities=26% Similarity=0.400 Sum_probs=206.1
Q ss_pred hcCceeeeeeeccCceEEEEEEeC----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
.++|.+.+.||+|+||.||+|... .+..||||+++.. ....+.+.+|+.++..++||||++++++|.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999974 3456999999863 4556789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999997543 258999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCc-ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 501 STSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 501 ~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...........+.....
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~--------- 272 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR--------- 272 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC---------
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC---------
Confidence 5543221 2223456889999999998999999999999999999999 9999976554332222211100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
... +......+..++..||+.||.+|||+.+|++.|+..
T Consensus 273 ---~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 273 ---LPA----PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp ---CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCC----CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001 111123455667779999999999999999999754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=369.28 Aligned_cols=269 Identities=23% Similarity=0.371 Sum_probs=213.3
Q ss_pred cChHHHHHhhcCceeeeeeeccCceEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEE
Q 005450 338 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISL 408 (696)
Q Consensus 338 f~~~el~~~t~~f~~~~~LG~G~fG~Vyka~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l 408 (696)
+.........++|.+.+.||+|+||.||+|.+ .+++.||||+++.. ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34444455678899999999999999999973 35688999999864 34557799999999999 79999999
Q ss_pred eeEEEecCc-eEEEEeecCCCChhhhhhcCCCC-----------------------------------------------
Q 005450 409 LGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKD----------------------------------------------- 440 (696)
Q Consensus 409 ~g~~~~~~~-~~LV~Ey~~gGsL~~~L~~~~~~----------------------------------------------- 440 (696)
+++|.+.+. .++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987554 89999999999999999765421
Q ss_pred ---------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 441 ---------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 441 ---------------~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1228999999999999999999999 8999999999999999999999999999987755544
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||................ .. ...
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~------~~-----~~~ 317 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG------TR-----MRA 317 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT------CC-----CCC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC------CC-----CCC
Confidence 444445678999999999999999999999999999999998 999997765433221111110 00 001
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.... ...+..++..||+.||.+|||+.+++++|+..
T Consensus 318 ~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 318 PDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1111 12355566779999999999999999999743
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=362.27 Aligned_cols=257 Identities=30% Similarity=0.488 Sum_probs=200.6
Q ss_pred hhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
..++|.+.+.||+|+||+||+|.. +|+.||||++... ....+.+.+|++++.+++||||+++++++...+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 346799999999999999999986 6889999999754 345678999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCc--eEeecccccceeeCCCCceEEeecCccccc
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~g--IIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||+++|+|.+++..... ...+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||+++..
T Consensus 114 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp ECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred ecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999975431 1238899999999999999999999 77 999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+......
T Consensus 190 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~---------- 257 (309)
T 3p86_A 190 ASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR---------- 257 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC----------
T ss_pred ccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------
Confidence 44322 123467999999999999999999999999999999999999999876543322222111100
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
..+...++ ..+..++..||+.+|.+|||+.++++.|+..
T Consensus 258 -~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 258 -LEIPRNLN----PQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp -CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01111112 2355667779999999999999999998743
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=361.00 Aligned_cols=260 Identities=24% Similarity=0.347 Sum_probs=210.6
Q ss_pred cccChHHHHHhhcC----------ceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCc
Q 005450 336 RLFNYQDLLSATSN----------FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHK 403 (696)
Q Consensus 336 ~~f~~~el~~~t~~----------f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~Hp 403 (696)
..|+++++..+++. |...+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.++..++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45677777777654 778889999999999999975 79999999997543 4456788999999999999
Q ss_pred ceeEEeeEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee
Q 005450 404 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 483 (696)
Q Consensus 404 nIV~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL 483 (696)
||++++++|...+..++||||+++++|.+++... .+++..+..++.|++.||.|||+ .+|+||||||+|||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEE
Confidence 9999999999999999999999999999998643 48999999999999999999999 899999999999999
Q ss_pred CCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhH
Q 005450 484 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 563 (696)
Q Consensus 484 d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~l 563 (696)
+.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~ 252 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred CCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999876553322 2346799999999999999999999999999999999999999976544322111
Q ss_pred HhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 564 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 564 v~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+... ..+.+.. .......+..++..||+.||.+|||+.++++
T Consensus 253 ~~~~------------~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 253 LRDS------------PPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHS------------SCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhcC------------CCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1100 0011100 0011123455666799999999999999987
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=360.26 Aligned_cols=259 Identities=25% Similarity=0.421 Sum_probs=211.8
Q ss_pred hcCceeeeeeeccCceEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~ 418 (696)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|++++..++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 56799999999999999999985 34578999999753 35567899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCC--------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKK--------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 478 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~--------------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKp 478 (696)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence 999999999999999986543 12348899999999999999999999 8999999999
Q ss_pred cceeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCc
Q 005450 479 SNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 557 (696)
Q Consensus 479 sNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~ 557 (696)
+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987765444333334567899999999998899999999999999999999 9999987655
Q ss_pred cchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 558 KGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 558 ~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
......+..... ....... ...+..++..||+.||.+||++.++++.|+..
T Consensus 259 ~~~~~~~~~~~~------------~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 259 ERLFNLLKTGHR------------MERPDNC----SEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GGHHHHHHTTCC------------CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhhcCCc------------CCCCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 433222211110 0011111 23455667779999999999999999998743
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=363.81 Aligned_cols=251 Identities=20% Similarity=0.245 Sum_probs=207.8
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
.++|.+.+.||+|+||.||++... +++.||+|+++........+.+|+.++..++||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 578999999999999999999865 6889999999877777778899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC--CCceEEeecCccccccCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~--~~~vKL~DFGlA~~~~~~ 503 (696)
++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++......
T Consensus 84 ~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 84 SGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999997543 258999999999999999999999 89999999999999987 789999999999877553
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+......+ +..
T Consensus 158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---------~~~ 225 (321)
T 1tki_A 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF---------DEE 225 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC---------CHH
T ss_pred Cc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC---------Chh
Confidence 32 234679999999999998889999999999999999999999998765433222221111100 000
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..... ...+..++..||+.||.+|||+.++++
T Consensus 226 ~~~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 226 AFKEI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00011 134556677899999999999999997
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=355.95 Aligned_cols=254 Identities=22% Similarity=0.399 Sum_probs=207.1
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
.++|.+.+.||+|+||.||++...++..||+|+++......+.+.+|++++..++||||+++++++.+.+..++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 46799999999999999999999888899999998766566789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 103 ~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 103 NGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 999999997533 258999999999999999999999 89999999999999999999999999999866442211
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+..... ....
T Consensus 177 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~------------~~~~ 243 (283)
T 3gen_A 177 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------------LYRP 243 (283)
T ss_dssp -STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC------------CCCC
T ss_pred -cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC------------CCCC
Confidence 1223457888999999998999999999999999999998 9999977554332222211100 0001
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.. .. ..+..++..||+.+|.+|||+.++++.|+.
T Consensus 244 ~~-~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 244 HL-AS---EKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp TT-CC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred Cc-CC---HHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 11 11 345566777999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=368.19 Aligned_cols=274 Identities=23% Similarity=0.300 Sum_probs=215.6
Q ss_pred ccccChHHHHHhhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-----CcceeEE
Q 005450 335 CRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----HKNIISL 408 (696)
Q Consensus 335 ~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~-----HpnIV~l 408 (696)
...|++++.....++|.+.+.||+|+||+||+|.. .+++.||||+++........+..|+.++..++ ||||+++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34566667777789999999999999999999986 57899999999987777788889999999997 9999999
Q ss_pred eeEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC---
Q 005450 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD--- 485 (696)
Q Consensus 409 ~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~--- 485 (696)
++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccc
Confidence 99999999999999999 8999999986543 248899999999999999999999 89999999999999975
Q ss_pred ----------------------CCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHH
Q 005450 486 ----------------------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 543 (696)
Q Consensus 486 ----------------------~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ 543 (696)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 7889999999998655432 2357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCccchhhHHhhhccccccCc--------cccccC-----cccCCCCC-hHH---------------HH
Q 005450 544 ELLTGRKPISNDHPKGQESLVMWAKPILSSGK--------VTQLLD-----PALGNNYD-YDQ---------------ME 594 (696)
Q Consensus 544 ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~--------l~~llD-----~~L~~~~~-~~e---------------~~ 594 (696)
+|++|+.||...........+........... ....++ ........ ... ..
T Consensus 251 ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred HHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence 99999999987654333222221111000000 000000 00000000 000 13
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 595 RMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 595 ~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+..++..||+.||.+|||+.++++
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhc
Confidence 4557788899999999999999985
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=363.99 Aligned_cols=261 Identities=25% Similarity=0.436 Sum_probs=211.0
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 417 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~ 417 (696)
..++|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+.++..++||||++++++|.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4678999999999999999999864 3478999999864 3456789999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCCC--------------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKD--------------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 477 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~--------------------~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLK 477 (696)
.++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 99999999999999999764321 1468999999999999999999999 899999999
Q ss_pred ccceeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCC
Q 005450 478 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDH 556 (696)
Q Consensus 478 psNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~ 556 (696)
|+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999987654333223334678999999999998999999999999999999999 999997654
Q ss_pred ccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 557 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 557 ~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
.......+. .+.... +....+ ..+..++..||+.||.+||++.++++.|+...
T Consensus 282 ~~~~~~~~~-------~~~~~~-----~~~~~~----~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 282 HEEVIYYVR-------DGNILA-----CPENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp HHHHHHHHH-------TTCCCC-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hHHHHHHHh-------CCCcCC-----CCCCCC----HHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 332221111 111111 111111 34556677799999999999999999998654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=357.80 Aligned_cols=264 Identities=22% Similarity=0.329 Sum_probs=203.6
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.++|.+.+.||+|+||+||+|...+|+.||+|+++... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46799999999999999999999889999999997532 345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+++ +|.+.+.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9985 8888887543 258999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc---
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL--- 579 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l--- 579 (696)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...............
T Consensus 173 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 173 VRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp CC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred ccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 222 233578999999999876 56899999999999999999999999876554433222111110000000000
Q ss_pred ---cCcccC--CCCCh-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 580 ---LDPALG--NNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 580 ---lD~~L~--~~~~~-----~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+.... ..... .....+..++..||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000 00000 11234566777899999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=353.48 Aligned_cols=262 Identities=24% Similarity=0.386 Sum_probs=202.3
Q ss_pred hhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHh--cCCcceeEEeeEEEec----CceE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFED----NNLL 419 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~--L~HpnIV~l~g~~~~~----~~~~ 419 (696)
..++|.+.+.||+|+||+||+|.. +|+.||||++.... ...+..|.+++.. ++||||+++++++... ...+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 356899999999999999999987 78999999997543 3556667777776 7899999999997653 4589
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh--------cCCCCceEeecccccceeeCCCCceEE
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH--------SGSAQRVIHRDVKSSNILLSDDFEPQL 491 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH--------~~~~~gIIHrDLKpsNILLd~~~~vKL 491 (696)
+||||+++|+|.+++... .+++..++.++.|++.||.||| + ++|+||||||+|||++.++.+||
T Consensus 83 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEE
T ss_pred EehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEE
Confidence 999999999999999542 5899999999999999999999 6 89999999999999999999999
Q ss_pred eecCccccccCCCCCcc--cccccccCCCCCcceeccC------CCCCcccchhhHHHHHHHHhC----------CCCCC
Q 005450 492 SDFGLAKWASTSSSHIT--CTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTG----------RKPIS 553 (696)
Q Consensus 492 ~DFGlA~~~~~~~~~~~--~~~~~GT~~YlAPE~l~~~------~~s~ksDVwSLGvvL~ELltG----------~~Pf~ 553 (696)
+|||+++.......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 99999987665433221 2235799999999999876 455799999999999999999 88886
Q ss_pred CCCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 554 NDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 554 ~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.............. ..........+.. ..+.......+..++..||+.||.+|||+.+|++.|+.
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 235 DVVPNDPSFEDMRK-VVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TTSCSSCCHHHHHH-HHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCCCcchhhhhH-HHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 54432221111100 0000111111100 01122345677788888999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=362.50 Aligned_cols=256 Identities=22% Similarity=0.384 Sum_probs=201.6
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCE----EEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKE----LAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~----vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
.++|.+.+.||+|+||+||+|... +++. ||+|.++.. ....+.+.+|+.++.+++||||++++++|... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 357999999999999999999853 4543 588887643 24557899999999999999999999999875 588
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+||||+.+|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999999986542 58999999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
..............||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+......
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------- 238 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-------- 238 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--------
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC--------
Confidence 766544444444567889999999999999999999999999999999 99999876544333322211110
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
..+......+..++..||+.+|.+||++.++++.|+...
T Consensus 239 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 239 --------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp --------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 001111234666777899999999999999999987643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=364.20 Aligned_cols=253 Identities=24% Similarity=0.340 Sum_probs=203.0
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.++|.+.+.||+|+||+||+|... +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999865 78999999986543 334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999997543 58999999999999999999999 89999999999999999999999999999876544
Q ss_pred CCCcccccccccCCCCCcceeccCCC-CCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~-s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
..........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ...+...... ..+
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~-------~~~ 230 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKTY-------LNP 230 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTTCTT-------STT
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhccccc-------CCc
Confidence 33333345689999999999987765 77899999999999999999999765543222 1122111100 000
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.......+..++..||+.||.+|||+.++++.
T Consensus 231 ------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 ------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00111334556777999999999999999863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=373.59 Aligned_cols=256 Identities=23% Similarity=0.405 Sum_probs=207.2
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
..++|.+.+.||+|+||.||+|... +++.||||+++.. ......|.+|++++++++||||++++++|...+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467899999999999999999975 7899999999754 344567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 192 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp ECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999999999997543 258899999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
...........+++.|+|||++..+.++.++|||||||++|||++ |+.||...........+.... .+
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~------~~----- 334 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG------RL----- 334 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC------CC-----
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------CC-----
Confidence 221111122346788999999999999999999999999999998 999997755432222221110 00
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
...... . ..+..++..||+.||.+|||+.++++.|+.
T Consensus 335 -~~~~~~-~---~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 335 -PCPELC-P---DAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp -CCCTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCCC-C---HHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 001111 1 245556677999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=372.95 Aligned_cols=260 Identities=23% Similarity=0.378 Sum_probs=208.4
Q ss_pred hcCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~ 418 (696)
.++|.+.+.||+|+||.||+|... +++.||||+++.. ......+.+|+.++.+++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 357899999999999999999842 4678999999753 45566789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCC---CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC---ceEEe
Q 005450 419 LLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLS 492 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~---~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~---~vKL~ 492 (696)
++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999976432 22458999999999999999999999 8999999999999999554 59999
Q ss_pred ecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhcccc
Q 005450 493 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPIL 571 (696)
Q Consensus 493 DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~ 571 (696)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+.....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~-- 304 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR-- 304 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--
Confidence 9999986543332223334668999999999999999999999999999999998 9999977654332222211100
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 572 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 572 ~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
....... ...+..++..||+.+|.+||++.+|++.|+...
T Consensus 305 ----------~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 305 ----------MDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp ----------CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------CCCCccC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 0001111 123556677799999999999999999987543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=360.37 Aligned_cols=271 Identities=24% Similarity=0.339 Sum_probs=200.7
Q ss_pred hcCceeeeeeeccCceEEEEEEe-----CCCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-----~~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~--~~~~ 418 (696)
.++|.+.+.||+|+||+||++.. .+++.||||++... ....+.+.+|++++.+++||||++++++|.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46799999999999999999983 36889999999764 3556789999999999999999999999865 3568
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
++||||+++|+|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 999999999999999976532 58999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC-cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 499 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 499 ~~~~~~~~-~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||.......................+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 77554322 12223457888999999999999999999999999999999999986432110000000000000000000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
..+........+......+..++..||+.||.+|||+.++++.|+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0000000001111112345666777999999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=366.72 Aligned_cols=261 Identities=26% Similarity=0.403 Sum_probs=211.9
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC--------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEe
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFE 414 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~--------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~ 414 (696)
..++|.+.+.||+|+||.||+|... .+..||||+++.. ......+.+|++++..+ +||||++++++|..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3468999999999999999999852 3457999999764 35567899999999999 89999999999999
Q ss_pred cCceEEEEeecCCCChhhhhhcCCCC------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccccee
Q 005450 415 DNNLLLVYDFLSRGSLEENLHGNKKD------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 482 (696)
Q Consensus 415 ~~~~~LV~Ey~~gGsL~~~L~~~~~~------------~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNIL 482 (696)
.+..++||||+++|+|.+++...... ...+++..++.|+.||+.||.|||+ .+|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence 99999999999999999999765421 2358999999999999999999999 89999999999999
Q ss_pred eCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchh
Q 005450 483 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQE 561 (696)
Q Consensus 483 Ld~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~ 561 (696)
++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |+.||.........
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999987765443333344668899999999999999999999999999999999 99999765533222
Q ss_pred hHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 562 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 562 ~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
..+..... ....... ...+..++..||+.||.+|||+.+|++.|+...
T Consensus 304 ~~~~~~~~------------~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 304 KLLKEGHR------------MDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HHHHTTCC------------CCCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCCC------------CCCCccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 22111100 0001111 234556677799999999999999999997543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.44 Aligned_cols=259 Identities=22% Similarity=0.356 Sum_probs=203.8
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecC----ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~----~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|+||.||++.. .+++.||+|++.. .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46799999999999999999986 4789999999853 345567899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999997653 58999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... ..... ..... .
T Consensus 163 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~--~~~~~-----~~~~~-~ 233 (294)
T 4eqm_A 163 ETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI--KHIQD-----SVPNV-T 233 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH--HHHSS-----CCCCH-H
T ss_pred ccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHhhc-----cCCCc-c
Confidence 43222 2234679999999999999999999999999999999999999997754322211 11100 00000 0
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhhCCc
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARP-QMSLVLKLLRGDA 625 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RP-Sm~eVL~~L~~~~ 625 (696)
....... ...+..++..|++.||.+|| ++.++.+.|....
T Consensus 234 ~~~~~~~----~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 234 TDVRKDI----PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHSCTTS----CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred hhcccCC----CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 0111111 23455566779999999999 7999998887543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=358.80 Aligned_cols=262 Identities=23% Similarity=0.367 Sum_probs=194.5
Q ss_pred HhhcCceeeeeeeccCceEEEEEEeCCC----CEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCLPDG----KELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 417 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~~~g----~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~ 417 (696)
...++|.+.+.||+|+||.||+|..... ..||||+++.. ....+.+.+|++++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 3457899999999999999999986543 27999999763 3556789999999999999999999999987665
Q ss_pred e------EEEEeecCCCChhhhhhcCC--CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCce
Q 005450 418 L------LLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 489 (696)
Q Consensus 418 ~------~LV~Ey~~gGsL~~~L~~~~--~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~v 489 (696)
. ++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCE
Confidence 5 99999999999999986432 223358999999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhc
Q 005450 490 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 568 (696)
Q Consensus 490 KL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~ 568 (696)
||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+....
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 9999999987655443333334567889999999999999999999999999999999 999998765443322221111
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 569 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 569 ~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
.. .. .......+..++..||+.||.+|||+.++++.|+...
T Consensus 257 ~~------------~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 257 RL------------KQ----PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp CC------------CC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC------------CC----CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 00 1111234566777899999999999999999987543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=364.93 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=204.8
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 417 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~ 417 (696)
..++|.+.+.||+|+||.||++... +|+.||+|+++... ...+.+.+|+.++..++||||++++++|.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3567999999999999999999865 68999999997532 135788999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC----ceEEee
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSD 493 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~----~vKL~D 493 (696)
.++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 999999999999999996543 58999999999999999999999 8999999999999998877 799999
Q ss_pred cCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccccc
Q 005450 494 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 573 (696)
Q Consensus 494 FGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 573 (696)
||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 163 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---- 235 (361)
T 2yab_A 163 FGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY---- 235 (361)
T ss_dssp CSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC----
T ss_pred cCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----
Confidence 999987765332 2346799999999999988999999999999999999999999987654332222111100
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 574 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 574 g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. +++...... ...+..++..||..||.+|||+.++++
T Consensus 236 -~----~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 -D----FDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -C----CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -C----CCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 011110111 123455666799999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=362.70 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=204.1
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|+||+||++... +|+.||+|+++.. ......+.+|+.++..++||||+++++++...+.+++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367999999999999999999865 6899999999753 23456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999997543 48899999999999999999999 899999999999999999999999999998643
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....
T Consensus 157 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~------------ 222 (337)
T 1o6l_A 157 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------------ 222 (337)
T ss_dssp CTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------
T ss_pred cCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 3222 22346899999999999999999999999999999999999999976544322222211100
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 620 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~~ 620 (696)
.+...++ ..+..++..||+.||.+|| ++.++++.
T Consensus 223 -~~p~~~s----~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 -RFPRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCCCCC----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0111111 2345566679999999999 89998864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=361.96 Aligned_cols=261 Identities=23% Similarity=0.388 Sum_probs=209.0
Q ss_pred hcCceeeeeeeccCceEEEEEEe------CCCCEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCc
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 417 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~------~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~ 417 (696)
.++|.+.+.||+|+||.||+|.. .++..||||+++... ...+.+.+|+.++.++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46899999999999999999985 245689999997532 3457889999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCCC-------------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKD-------------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 478 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~-------------------~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKp 478 (696)
.++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCh
Confidence 99999999999999999765321 1247899999999999999999999 8999999999
Q ss_pred cceeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCc
Q 005450 479 SNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 557 (696)
Q Consensus 479 sNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~ 557 (696)
+|||++.++.+||+|||++................||+.|+|||++.++.++.++||||||+++|+|++ |+.||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987765544444445678999999999998999999999999999999998 9999977654
Q ss_pred cchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 558 KGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 558 ~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
....... ... +. .... +......+..++..||+.||.+|||+.++++.|+...
T Consensus 281 ~~~~~~~--~~~----~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 281 DANFYKL--IQN----GF-----KMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp SHHHHHH--HHT----TC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHH--Hhc----CC-----CCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 3221111 110 00 0001 1111234555667799999999999999999997543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=352.66 Aligned_cols=271 Identities=20% Similarity=0.284 Sum_probs=210.5
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecC--ceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~--~~~LV 421 (696)
.++|.+.+.||+|+||+||+|... +|+.||||+++... ...+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999875 58999999997533 34577889999999999999999999998765 78999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee----CCCCceEEeecCcc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLA 497 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL----d~~~~vKL~DFGlA 497 (696)
|||+++++|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999976432 2248999999999999999999999 899999999999999 78888999999999
Q ss_pred ccccCCCCCcccccccccCCCCCcceec--------cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhh-HHhhhc
Q 005450 498 KWASTSSSHITCTDVAGTFGYLAPEYFM--------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES-LVMWAK 568 (696)
Q Consensus 498 ~~~~~~~~~~~~~~~~GT~~YlAPE~l~--------~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~-lv~~~~ 568 (696)
+........ ....||+.|+|||++. ...++.++|||||||++|||++|+.||.......... ......
T Consensus 164 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 877654322 2357999999999986 5789999999999999999999999997544322211 111100
Q ss_pred cccccCccc---ccc------Ccc--cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 569 PILSSGKVT---QLL------DPA--LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 569 ~~~~~g~l~---~ll------D~~--L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.......+. ... ++. ....+.......+..++..||+.||++|||+.++++....+
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 000000000 000 001 11123445556677788889999999999999999988643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=355.46 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=210.8
Q ss_pred hcCceeeeeeeccCceEEEEEEe------CCCCEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCc
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 417 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~------~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~ 417 (696)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|+.++.++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46799999999999999999984 356789999998643 4457899999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCCC--------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKD--------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 483 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~--------------~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL 483 (696)
.++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 99999999999999999765421 2248999999999999999999999 899999999999999
Q ss_pred CCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhh
Q 005450 484 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 562 (696)
Q Consensus 484 d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~ 562 (696)
+.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |+.||..........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 9999999999999987766554433444668899999999999999999999999999999999 999997755432211
Q ss_pred HHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 563 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 563 lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
... ... ......... ...+..++..||+.||.+|||+.++++.|+.
T Consensus 259 ~~~--~~~---------~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 259 KMI--KEG---------FRMLSPEHA----PAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp HHH--HHT---------CCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHh--ccC---------CCCCCcccC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 111 000 000011111 2345566677999999999999999999974
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=368.35 Aligned_cols=256 Identities=24% Similarity=0.399 Sum_probs=196.4
Q ss_pred hcCceeeeeeeccCceEEEEEEeC----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
.++|.+.+.||+|+||.||+|... ++..||||+++.. ....+.|.+|+.++.+++||||++++++|.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357899999999999999999864 5778999999853 4556789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999997543 358999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCc-ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 501 STSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 501 ~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...........+.....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~--------- 268 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR--------- 268 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE---------
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 5533221 1122346788999999999999999999999999999998 9999976543322221111000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
..........+..++..||+.+|.+||++.+|++.|+..
T Consensus 269 -------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 269 -------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp -------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 000111223466677789999999999999999999754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=351.32 Aligned_cols=263 Identities=23% Similarity=0.341 Sum_probs=199.6
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
++|.+.+.||+|+||+||+|...+|+.||+|++.... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999999889999999997543 2346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++ +|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 986 9999887543 258899999999999999999999 899999999999999999999999999998765432
Q ss_pred CCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc---cc--
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV---TQ-- 578 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l---~~-- 578 (696)
.. .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+............ ..
T Consensus 155 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 155 RK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence 21 2235789999999998754 5899999999999999999999999876543322211111000000000 00
Q ss_pred ccCcccCC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 579 LLDPALGN-------NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 579 llD~~L~~-------~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+++.+.. .+.......+..++..||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 01111100 000111234556777799999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=346.50 Aligned_cols=255 Identities=24% Similarity=0.409 Sum_probs=209.7
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
.++|.+.+.||+|+||.||++...+++.||+|++.......+.+.+|++++..++||||+++++++.+.+..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 46799999999999999999998888999999998776566789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 87 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 87 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 999999997653 258899999999999999999999 8999999999999999999999999999986643211
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
.......||+.|+|||++....++.++||||||+++|+|++ |+.||...........+.... .....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~------------~~~~~ 227 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------------RLYKP 227 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------------CCCCC
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC------------cCCCC
Confidence 11123457889999999998899999999999999999999 899997654332211111100 00001
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.. . ...+..++..||+.||.+||++.++++.|+..
T Consensus 228 ~~-~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 228 RL-A---STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp TT-S---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc-C---cHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 1 23455667779999999999999999998743
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.17 Aligned_cols=257 Identities=24% Similarity=0.400 Sum_probs=214.1
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
..++|.+.+.||+|+||.||+|... ++..||+|++.......+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 4678999999999999999999975 488899999998777788999999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++..... ..+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 91 ~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 91 MTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred CCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999976433 358999999999999999999999 899999999999999999999999999998776543
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
.. ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+..... ..
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~------------~~ 232 (288)
T 3kfa_A 166 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------------ME 232 (288)
T ss_dssp SE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC------------CC
T ss_pred cc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC------------CC
Confidence 22 2233567889999999999999999999999999999999 9999977654332222211100 00
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
..... ...+..++..||+.||.+|||+.++++.|+..
T Consensus 233 ~~~~~----~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 233 RPEGC----PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC----CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 11111 13455667779999999999999999998753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=357.34 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=204.1
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~ 418 (696)
.++|.+.+.||+|+||.||++... +|+.||+|+++... ...+.+.+|+.++..++||||++++++|...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356999999999999999999865 68999999987532 1357899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC----ceEEeec
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 494 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~----~vKL~DF 494 (696)
++||||+++++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999996543 58999999999999999999999 8999999999999999887 7999999
Q ss_pred CccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC
Q 005450 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 495 GlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
|+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.......
T Consensus 163 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--- 236 (326)
T 2y0a_A 163 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF--- 236 (326)
T ss_dssp TTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC---
T ss_pred CCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc---
Confidence 99987754332 223679999999999998899999999999999999999999997654432222111111000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 575 ~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
........ ...+..++..||+.||.+|||+.++++.
T Consensus 237 ------~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 237 ------EDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ------CHHHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ------CccccccC----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000111 1234556667999999999999999974
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=359.84 Aligned_cols=256 Identities=22% Similarity=0.408 Sum_probs=203.8
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCE----EEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKE----LAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~----vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
.++|.+.+.||+|+||+||+|... +++. ||+|.+.... .....+.+|+.++..++||||++++++|. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 357999999999999999999854 4543 7888875432 33456788999999999999999999986 56799
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 9999999999999997543 258899999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
..............||+.|+|||++.++.++.++|||||||++|+|++ |+.||...........+........ ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~ 240 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ----PQ 240 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC----CT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC----CC
Confidence 766554444455678899999999999999999999999999999999 9999987654443333322111110 00
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
... ..+..++..||+.||.+||++.++++.|+...
T Consensus 241 ~~~------------~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 241 ICT------------IDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp TBC------------TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred cCc------------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011 12344666799999999999999999997654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=347.38 Aligned_cols=261 Identities=18% Similarity=0.208 Sum_probs=208.1
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+.++..+ +|+|++++++++......++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 46799999999999999999995 578999999987543 234678899999999 799999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc-----eEEeecCcccc
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-----PQLSDFGLAKW 499 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~-----vKL~DFGlA~~ 499 (696)
+ +++|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+++.
T Consensus 88 ~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 88 L-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp C-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9 9999999986532 58999999999999999999999 89999999999999987776 99999999987
Q ss_pred ccCCCCC-----cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC
Q 005450 500 ASTSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 500 ~~~~~~~-----~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 7654332 11234679999999999999999999999999999999999999998765433322221111000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 575 ~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
... .+...++ ..+..++..||+.||.+||++.+|++.|+..
T Consensus 241 ~~~-----~~~~~~~----~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 241 PLR-----ELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp CHH-----HHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cHH-----HHHhhCc----HHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 011 1111111 3455666779999999999999999998743
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=358.37 Aligned_cols=259 Identities=21% Similarity=0.223 Sum_probs=206.9
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|++++..+ +||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 46899999999999999999985 578999999987543 234688999999999 899999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc-----eEEeecCcccc
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-----PQLSDFGLAKW 499 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~-----vKL~DFGlA~~ 499 (696)
+ +++|.+++.... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 87 L-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred C-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9 999999998642 268999999999999999999999 89999999999999998887 99999999987
Q ss_pred ccCCCCCc-----ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC
Q 005450 500 ASTSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 500 ~~~~~~~~-----~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~---- 235 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT---- 235 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH----
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh----
Confidence 65433221 123467999999999999999999999999999999999999999876544332222111000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 575 ~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.... ....+....+ .+..++..||+.+|.+||++.+|++.|+.
T Consensus 236 ~~~~-~~~~~~~~~p-----~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 236 KRAT-PIEVLCENFP-----EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp HHHS-CHHHHTTTCH-----HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred hccC-CHHHHhccCh-----HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 0000 0001111111 45666677999999999999999998863
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=362.18 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=203.4
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
.++|.+.+.||+|+||.||++... +|+.||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999864 6899999999753 345677899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC---CceEEeecCcccc
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKW 499 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~---~~vKL~DFGlA~~ 499 (696)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||++..
T Consensus 108 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999987543 58999999999999999999999 899999999999999865 4599999999987
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+........
T Consensus 181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~------- 250 (362)
T 2bdw_A 181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP------- 250 (362)
T ss_dssp CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-------
T ss_pred ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence 654332 2346799999999999988999999999999999999999999977543322221111110000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.+.. . .....+..++..||+.||.+||++.++++.
T Consensus 251 -~~~~-~----~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 -SPEW-D----TVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -TTGG-G----GSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -cccc-c----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 0 011234556667999999999999999863
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=362.14 Aligned_cols=251 Identities=23% Similarity=0.357 Sum_probs=195.3
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCC--cceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~H--pnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|+||.||++...+++.||||++... ....+.+.+|+.++..++| |||+++++++...+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4679999999999999999999989999999998753 3456788999999999986 9999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|| +.+++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 56889999998653 58899999999999999999999 8999999999999997 5789999999998776
Q ss_pred CCCCCcccccccccCCCCCcceecc-----------CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccc
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 570 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~-----------~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 570 (696)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .+...
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~---- 233 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-KLHAI---- 233 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHHHH----
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-HHHHH----
Confidence 5444333345679999999999865 6789999999999999999999999975432111 11111
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 571 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 571 ~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
+++.....++......+..++..||+.||.+|||+.++++.
T Consensus 234 ---------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 234 ---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11111111111112345566677999999999999999873
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=345.08 Aligned_cols=249 Identities=31% Similarity=0.489 Sum_probs=193.1
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|+||.||+|... |+.||||+++... ...+.+.+|++++..++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999974 8899999987532 2346788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCc---eEeecccccceeeCC--------CCceE
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR---VIHRDVKSSNILLSD--------DFEPQ 490 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~g---IIHrDLKpsNILLd~--------~~~vK 490 (696)
|||+++++|.+++... .+++..++.++.|++.||.|||+ ++ |+||||||+|||++. ++.+|
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceE
Confidence 9999999999998632 58999999999999999999999 66 999999999999986 67899
Q ss_pred EeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccc
Q 005450 491 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 570 (696)
Q Consensus 491 L~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 570 (696)
|+|||++........ ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+....
T Consensus 157 l~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-- 230 (271)
T 3dtc_A 157 ITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK-- 230 (271)
T ss_dssp ECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC--
T ss_pred EccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC--
Confidence 999999986654322 23569999999999999999999999999999999999999997654332221111110
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 571 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 571 ~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.. ....... ...+..++..||+.||.+|||+.++++.|+.
T Consensus 231 -----~~----~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 -----LA----LPIPSTC----PEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp -----CC----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred -----CC----CCCCccc----CHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 00 0011111 2345566777999999999999999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.27 Aligned_cols=263 Identities=22% Similarity=0.272 Sum_probs=198.8
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
++|.+.+.||+|+||+||+|... +|+.||||+++.. ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999864 6899999999743 3455788899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+++ +|.+.+.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9986 6666555432 258999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcccccccccCCCCCcceeccCC-CCCcccchhhHHHHHHHHhCCCCCCCCCcc-chhhHHhhhccccccCcc---cc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPK-GQESLVMWAKPILSSGKV---TQ 578 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~-~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~-~~~~lv~~~~~~~~~g~l---~~ 578 (696)
... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... .....+............ ..
T Consensus 155 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 155 VRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 222 23467899999999998765 899999999999999999988886443322 111111111000000000 00
Q ss_pred ccC---------cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 579 LLD---------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 579 llD---------~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..+ ..............+..++..||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 00000011112234556667799999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=377.93 Aligned_cols=257 Identities=22% Similarity=0.409 Sum_probs=209.7
Q ss_pred hhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
..++|.+.+.||+|+||.||+|..+++..||||+++......+.|.+|+.+|++++||||+++++++. .+..++||||+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 35678999999999999999999988899999999977666789999999999999999999999986 66799999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 265 ~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 265 AKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp TTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999975321 247889999999999999999999 8999999999999999999999999999987643211
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
.......+|+.|+|||++..+.++.++|||||||+||||++ |+.||.+.........+.... .+ ..
T Consensus 340 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~------~~------~~ 406 (454)
T 1qcf_A 340 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY------RM------PR 406 (454)
T ss_dssp -HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC------CC------CC
T ss_pred -eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------CC------CC
Confidence 11122456789999999999999999999999999999999 999998655433222211110 00 00
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
.... ...+..++..||+.||.+|||+.+|++.|+...
T Consensus 407 ~~~~----~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 407 PENC----PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 1111 234556677899999999999999999998654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.08 Aligned_cols=260 Identities=25% Similarity=0.403 Sum_probs=209.0
Q ss_pred hcCceeeeeeeccCceEEEEEEe--------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL--------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 415 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~--------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~ 415 (696)
.++|.+.+.||+|+||.||+|.. .++..||||+++.. ....+.+.+|+.++..+ +||||++++++|...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 46799999999999999999985 35678999999864 35567899999999999 899999999999999
Q ss_pred CceEEEEeecCCCChhhhhhcCCCC------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee
Q 005450 416 NNLLLVYDFLSRGSLEENLHGNKKD------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 483 (696)
Q Consensus 416 ~~~~LV~Ey~~gGsL~~~L~~~~~~------------~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL 483 (696)
+..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 9999999999999999999765421 1348899999999999999999999 899999999999999
Q ss_pred CCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhh
Q 005450 484 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 562 (696)
Q Consensus 484 d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~ 562 (696)
+.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |+.||..........
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 9999999999999987765433333334567899999999998899999999999999999999 999997654332222
Q ss_pred HHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 563 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 563 lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
.+.... . ....... ...+..++..||+.+|.+||++.++++.|+...
T Consensus 271 ~~~~~~-------~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 271 LLKEGH-------R-----MDKPANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HHHHTC-------C-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcCC-------C-----CCCCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111110 0 0011111 234556667799999999999999999997543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=362.86 Aligned_cols=253 Identities=25% Similarity=0.335 Sum_probs=201.8
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~------~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
++|.+.+.||+|+||+||+|.. .+|+.||||++.... ...+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4689999999999999999986 478999999986422 235778999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc---eEEeecCcc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLA 497 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~---vKL~DFGlA 497 (696)
||||+++++|.+.+.........+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999998886543333458999999999999999999999 89999999999999986654 999999999
Q ss_pred ccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 498 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 498 ~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........+.. +...
T Consensus 181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~--------~~~~ 250 (351)
T 3c0i_A 181 IQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK--------GKYK 250 (351)
T ss_dssp EECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHH--------TCCC
T ss_pred eEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHc--------CCCC
Confidence 87765332 2234679999999999998899999999999999999999999997642211111110 0000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.++.....+ ...+..++..||+.||.+|||+.++++
T Consensus 251 --~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 --MNPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000111 134555667799999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=365.48 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=199.2
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~L 420 (696)
.++|.+.+.||+|+||+||++... +|+.||||+++.. ......+.+|..++..+ +||||+++++++.+.+.+|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999864 6899999999753 23456788999999988 69999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++++||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999997653 48999999999999999999999 89999999999999999999999999999854
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....
T Consensus 175 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~----------- 241 (353)
T 3txo_A 175 ICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV----------- 241 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------
T ss_pred ccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 33222 22346899999999999988999999999999999999999999987654433222211110
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQM------SLVLK 619 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm------~eVL~ 619 (696)
.+...+ ...+..++..||+.||.+||++ .++++
T Consensus 242 --~~p~~~----~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 --VYPTWL----HEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --CCCTTS----CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --CCCCCC----CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 011111 1234556667999999999998 66765
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=349.80 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=194.5
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChh---------------------------HHHHHHHHHHHHH
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSED---------------------------VIKEFVLEIEIIT 398 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~---------------------------~~~~~~~Ei~iL~ 398 (696)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999986 4688999999875321 2356889999999
Q ss_pred hcCCcceeEEeeEEEe--cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecc
Q 005450 399 TLHHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV 476 (696)
Q Consensus 399 ~L~HpnIV~l~g~~~~--~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDL 476 (696)
.++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+ ++|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCC
Confidence 9999999999999986 5679999999999999886542 258999999999999999999999 89999999
Q ss_pred cccceeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCC---CCCcccchhhHHHHHHHHhCCCCCC
Q 005450 477 KSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPIS 553 (696)
Q Consensus 477 KpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~---~s~ksDVwSLGvvL~ELltG~~Pf~ 553 (696)
||+|||++.++.+||+|||++......... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999876543322 23467999999999998655 4778999999999999999999997
Q ss_pred CCCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 554 NDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 554 ~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..........+... ... . + ..... ...+..++..||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~-------~~~-~--~-~~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERIMCLHSKIKSQ-------ALE-F--P-DQPDI----AEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSHHHHHHHHHHC-------CCC-C--C-SSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccHHHHHHHHhcc-------cCC-C--C-Ccccc----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 65432211111110 000 0 0 00111 134556667799999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=347.53 Aligned_cols=255 Identities=23% Similarity=0.399 Sum_probs=207.7
Q ss_pred hhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
..++|.+.+.||+|+||.||+|...++..||||+++......+.+.+|++++..++||||+++++++. .+..++||||+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 34679999999999999999999888889999999876666788999999999999999999999986 45689999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++++|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp TTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999999964321 248899999999999999999999 8999999999999999999999999999987754322
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
. ......+|+.|+|||++.++.++.++||||||+++|+|++ |+.||...........+.... ....
T Consensus 165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------------~~~~ 231 (279)
T 1qpc_A 165 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------RMVR 231 (279)
T ss_dssp E-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------CCCC
T ss_pred c-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc------------CCCC
Confidence 1 2223457889999999998899999999999999999999 999997654332211111100 0011
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.... ...+..++..|++.||.+|||+.++++.|+.
T Consensus 232 ~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 232 PDNC----PEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cccc----cHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 1111 1345566677999999999999999998874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=364.60 Aligned_cols=265 Identities=18% Similarity=0.221 Sum_probs=203.2
Q ss_pred hhcCceeeeeeeccCceEEEEEEeCC------CCEEEEEEecCChhH------------HHHHHHHHHHHHhcCCcceeE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPSEDV------------IKEFVLEIEIITTLHHKNIIS 407 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~~------g~~vAVK~l~~~~~~------------~~~~~~Ei~iL~~L~HpnIV~ 407 (696)
..++|.+.+.||+|+||.||+|.+.+ ++.||||++...... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999998754 478999998764321 112345666777888999999
Q ss_pred EeeEEEec----CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee
Q 005450 408 LLGFCFED----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 483 (696)
Q Consensus 408 l~g~~~~~----~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL 483 (696)
+++++... ...+|||||+ +++|.+++.... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEE
Confidence 99999875 4589999999 999999997643 358999999999999999999999 899999999999999
Q ss_pred C--CCCceEEeecCccccccCCCCCc-----ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCC
Q 005450 484 S--DDFEPQLSDFGLAKWASTSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 556 (696)
Q Consensus 484 d--~~~~vKL~DFGlA~~~~~~~~~~-----~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~ 556 (696)
+ .++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8 88999999999998765432221 1123569999999999999899999999999999999999999998543
Q ss_pred ccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 557 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 557 ~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
..... +.+.... ....+..++++.+.......+ +..++..||+.+|.+||++.+|++.|+.
T Consensus 266 ~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~~---~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 266 KDPKY--VRDSKIR-YRENIASLMDKCFPAANAPGE---IAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp TCHHH--HHHHHHH-HHHCHHHHHHHHSCTTCCCHH---HHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred cCHHH--HHHHHHH-hhhhHHHHHHHhcccccCHHH---HHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 32211 1111100 112344445544432223333 4455566999999999999999998864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=378.60 Aligned_cols=257 Identities=23% Similarity=0.396 Sum_probs=212.1
Q ss_pred hcCceeeeeeeccCceEEEEEEeCC-CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~-g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
..+|.+.+.||+|+||.||+|.... +..||||+++......+.|.+|+.+|++++||||++++++|...+..+|||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 4678999999999999999999764 889999999877666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++|+|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 299 ~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 299 TYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp TTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999976432 358999999999999999999999 8999999999999999999999999999987654321
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
.......+|+.|+|||++..+.++.++|||||||+||||++ |+.||...........+.... . ...
T Consensus 374 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------~------~~~ 440 (495)
T 1opk_A 374 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------R------MER 440 (495)
T ss_dssp -ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC------C------CCC
T ss_pred -eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------C------CCC
Confidence 12223456789999999999999999999999999999999 999998765433222211100 0 000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
+......+..++..||+.||.+|||+.+|++.|+...
T Consensus 441 ----~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 441 ----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ----CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1111234556667799999999999999999998654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=358.07 Aligned_cols=243 Identities=22% Similarity=0.263 Sum_probs=191.5
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||+||+|... +|+.||||++... ......+..|+..+..+ +||||++++++|.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 7999999998653 23444556666666655 8999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+ +++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 137 e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 669999887543 258999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
... .....||+.|+|||++.+ .++.++|||||||++|||++|..|+..... ..... .+.. .+
T Consensus 210 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~~~-----~~~~----~~ 271 (311)
T 3p1a_A 210 AGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----WQQLR-----QGYL----PP 271 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----HHHHT-----TTCC----CH
T ss_pred CCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHh-----ccCC----Cc
Confidence 332 223569999999998875 799999999999999999999877654211 11101 0111 11
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+.... ...+..++..||+.||.+|||+.++++
T Consensus 272 ~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 EFTAGL----SSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccCC----CHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111111 234556677799999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=351.61 Aligned_cols=268 Identities=24% Similarity=0.374 Sum_probs=212.6
Q ss_pred ChHHHHHhhcCceeeeeeeccCceEEEEEEe------CCCCEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCcceeEEe
Q 005450 339 NYQDLLSATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLL 409 (696)
Q Consensus 339 ~~~el~~~t~~f~~~~~LG~G~fG~Vyka~~------~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L-~HpnIV~l~ 409 (696)
.........++|.+.+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3334444568899999999999999999973 356889999998643 4556889999999999 799999999
Q ss_pred eEEEecC-ceEEEEeecCCCChhhhhhcCCCC------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecc
Q 005450 410 GFCFEDN-NLLLVYDFLSRGSLEENLHGNKKD------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV 476 (696)
Q Consensus 410 g~~~~~~-~~~LV~Ey~~gGsL~~~L~~~~~~------------~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDL 476 (696)
++|...+ ..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+ ++|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccC
Confidence 9998754 589999999999999999865431 1237899999999999999999999 89999999
Q ss_pred cccceeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCC
Q 005450 477 KSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISND 555 (696)
Q Consensus 477 KpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~ 555 (696)
||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987765544444445678999999999999999999999999999999998 99999765
Q ss_pred CccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 556 HPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 556 ~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
............ +.. ....... ...+..++..||+.||.+|||+.++++.|+..
T Consensus 255 ~~~~~~~~~~~~------~~~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 255 KIDEEFCRRLKE------GTR-----MRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCSHHHHHHHHH------TCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhHHHHHHhcc------Ccc-----CCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 433221111000 000 0011111 13455666779999999999999999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.73 Aligned_cols=254 Identities=23% Similarity=0.366 Sum_probs=194.7
Q ss_pred hcCceeeeeeeccCceEEEEEEeCC----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
.++|.+.+.||+|+||.||+|.... +..||+|+++.. ....+.+.+|+.++.+++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4679999999999999999998642 457999998753 345678999999999999999999999984 567899
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 93 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999997543 258999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
...... ......+|+.|+|||++....++.++||||||+++|||++ |+.||...........+..... .
T Consensus 167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~-------~-- 236 (281)
T 1mp8_A 167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-------L-- 236 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-------C--
T ss_pred Cccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC-------C--
Confidence 553322 1223457889999999998999999999999999999997 9999987654332222211100 0
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.+.... ...+..++..||+.||.+|||+.++++.|+..
T Consensus 237 ---~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 ---PMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ---CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011111 23455666779999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=351.38 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=196.8
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecC--ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc------
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN------ 417 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~------ 417 (696)
.++|.+.+.||+|+||.||+|... +|+.||||+++. .....+.+.+|+.++++++||||++++++|.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357999999999999999999975 799999999874 33456789999999999999999999999876542
Q ss_pred ---------------------------------------------------eEEEEeecCCCChhhhhhcCCCCCCCCCh
Q 005450 418 ---------------------------------------------------LLLVYDFLSRGSLEENLHGNKKDPAAFGW 446 (696)
Q Consensus 418 ---------------------------------------------------~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~ 446 (696)
.++||||+++++|.+++..... .....+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 8999999999999999986543 234567
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC----------cccccccccC
Q 005450 447 SERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH----------ITCTDVAGTF 516 (696)
Q Consensus 447 ~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~----------~~~~~~~GT~ 516 (696)
..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 7889999999999999999 89999999999999999999999999999877654221 1123357999
Q ss_pred CCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHH
Q 005450 517 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERM 596 (696)
Q Consensus 517 ~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l 596 (696)
.|+|||++.+..++.++|||||||++|||++|..|+... ........ ....... .......+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~~~~----~~~~~~~---------~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIITDVR----NLKFPLL---------FTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHHHHH----TTCCCHH---------HHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHHHhh----ccCCCcc---------cccCChhH
Confidence 999999999999999999999999999999987765211 11111110 0010000 01112334
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 005450 597 VLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 597 ~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..++..||+.||.+|||+.++++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCCCcCCCHHHHhh
Confidence 56677899999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=351.40 Aligned_cols=265 Identities=21% Similarity=0.296 Sum_probs=200.0
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh------hHHHHHHHHHHHHHhcC---CcceeEEeeEEEec
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE------DVIKEFVLEIEIITTLH---HKNIISLLGFCFED 415 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~------~~~~~~~~Ei~iL~~L~---HpnIV~l~g~~~~~ 415 (696)
.+++|.+.+.||+|+||+||+|.. .+|+.||||+++... .....+.+|+.+++.++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999996 578999999986321 22345667777777664 99999999999876
Q ss_pred C-----ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceE
Q 005450 416 N-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 490 (696)
Q Consensus 416 ~-----~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vK 490 (696)
. ..++||||+. ++|.+++..... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEE
Confidence 5 4899999997 599999976543 248999999999999999999999 8999999999999999999999
Q ss_pred EeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccc
Q 005450 491 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 570 (696)
Q Consensus 491 L~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 570 (696)
|+|||+++........ ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+......
T Consensus 161 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 161 LADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp ECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999876543322 3467999999999999999999999999999999999999999876654433222211111
Q ss_pred cccCcccccc---CcccCCC--C-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 571 LSSGKVTQLL---DPALGNN--Y-----DYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 571 ~~~g~l~~ll---D~~L~~~--~-----~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.......... ...+... . ..+....+..++..||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1111110000 0000000 0 0111234566777899999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=354.01 Aligned_cols=244 Identities=26% Similarity=0.361 Sum_probs=202.6
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|+||.||++... +|+.||+|+++... ...+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999864 79999999997532 3356788899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999997653 48899999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... .+
T Consensus 158 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------~~----- 220 (318)
T 1fot_A 158 DV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------EL----- 220 (318)
T ss_dssp SC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-------CC-----
T ss_pred Cc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------CC-----
Confidence 42 22367999999999999999999999999999999999999999775443222111111 00
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLK 619 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~ 619 (696)
.+...++ ..+..++..||+.||.+|| ++.++++
T Consensus 221 -~~p~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 -RFPPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -CCCTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCC----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0111111 2345566679999999999 8888875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=353.83 Aligned_cols=266 Identities=21% Similarity=0.377 Sum_probs=212.4
Q ss_pred HHHHhhcCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEE
Q 005450 342 DLLSATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCF 413 (696)
Q Consensus 342 el~~~t~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~ 413 (696)
+.....++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 33445678999999999999999999754 47789999997543 44567899999999999999999999999
Q ss_pred ecCceEEEEeecCCCChhhhhhcCC------CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC
Q 005450 414 EDNNLLLVYDFLSRGSLEENLHGNK------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 487 (696)
Q Consensus 414 ~~~~~~LV~Ey~~gGsL~~~L~~~~------~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~ 487 (696)
+.+..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCC
Confidence 9999999999999999999987532 112357899999999999999999999 8999999999999999999
Q ss_pred ceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhh
Q 005450 488 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 566 (696)
Q Consensus 488 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~ 566 (696)
.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 999999999987655433333334567899999999998999999999999999999999 8999976543322211111
Q ss_pred hccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCcc
Q 005450 567 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 626 (696)
Q Consensus 567 ~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~~ 626 (696)
+.... ..... ...+..++..||+.||.+|||+.++++.|+....
T Consensus 256 -------~~~~~-----~~~~~----~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 256 -------GGLLD-----KPDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -------TCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -------CCcCC-----CCCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11100 01111 1335556677999999999999999999986543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=369.54 Aligned_cols=252 Identities=24% Similarity=0.315 Sum_probs=203.5
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
.++|.+.+.||+|+||.||++.. .+|+.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 56799999999999999999985 578999999997543 44567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC---CCCceEEeecCcccc
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKW 499 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd---~~~~vKL~DFGlA~~ 499 (696)
||+++|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++..
T Consensus 90 E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 90 DLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp CCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999997653 48999999999999999999999 8999999999999998 567899999999987
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+......+
T Consensus 163 ~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-------- 232 (444)
T 3soa_A 163 VEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF-------- 232 (444)
T ss_dssp CCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--------
T ss_pred ecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC--------
Confidence 6553322 234679999999999998899999999999999999999999997765433222222111100
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
..+.. ... . ..+..++..||+.||.+|||+.++++.
T Consensus 233 ~~~~~-~~~-s---~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 PSPEW-DTV-T---PEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CTTTT-TTS-C---HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred Ccccc-ccC-C---HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00100 011 1 234456667999999999999999873
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=351.76 Aligned_cols=271 Identities=25% Similarity=0.355 Sum_probs=200.9
Q ss_pred hHHHHHhhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhc--CCcceeEEeeEEEec--
Q 005450 340 YQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL--HHKNIISLLGFCFED-- 415 (696)
Q Consensus 340 ~~el~~~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L--~HpnIV~l~g~~~~~-- 415 (696)
........++|.+.+.||+|+||.||+|... |+.||||++..... ..+..|.+++..+ +||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 3334445678999999999999999999875 89999999975443 3445555565554 899999999999887
Q ss_pred --CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC-----CCceEeecccccceeeCCCCc
Q 005450 416 --NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-----AQRVIHRDVKSSNILLSDDFE 488 (696)
Q Consensus 416 --~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~-----~~gIIHrDLKpsNILLd~~~~ 488 (696)
...++||||+++|+|.+++... .+++..++.++.|++.||.|||+.+ ..+|+||||||+|||++.++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 6899999999999999999754 4899999999999999999999820 129999999999999999999
Q ss_pred eEEeecCccccccCCCCCcc--cccccccCCCCCcceeccCCCCCc------ccchhhHHHHHHHHhC----------CC
Q 005450 489 PQLSDFGLAKWASTSSSHIT--CTDVAGTFGYLAPEYFMYGKVNDK------IDVYAFGVVLLELLTG----------RK 550 (696)
Q Consensus 489 vKL~DFGlA~~~~~~~~~~~--~~~~~GT~~YlAPE~l~~~~~s~k------sDVwSLGvvL~ELltG----------~~ 550 (696)
+||+|||+++.......... .....||+.|+|||++.+..++.+ +|||||||++|||++| +.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 99999999986654332211 123579999999999987776665 9999999999999999 56
Q ss_pred CCCCCCccchhhHHhhhccccccCccccccCcccCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 551 PISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 551 Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~-~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
||............... ...... ..+.+...+ .......+..++..||+.||.+|||+.+|++.|+..
T Consensus 261 p~~~~~~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 261 PYHDLVPSDPSYEDMRE--IVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TTTTTSCSSCCHHHHHH--HHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cHhhhcCCCCchhhhHH--HHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 66543322211100000 000000 111111111 123456677788889999999999999999999754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=365.67 Aligned_cols=250 Identities=23% Similarity=0.351 Sum_probs=195.3
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcC--CcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLH--HKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~--HpnIV~l~g~~~~~~~~~LV~ 422 (696)
.+|.+.+.||+|+||.||++...+++.||||++... ....+.+.+|+.+|..++ ||||+++++++...+.+++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999999888999999998643 355678999999999996 599999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
| +.+++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||+++....
T Consensus 136 E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 56889999998654 57889999999999999999999 8999999999999996 57899999999987765
Q ss_pred CCCCcccccccccCCCCCcceecc-----------CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 571 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~-----------~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~ 571 (696)
...........||+.|+|||++.. ..++.++|||||||+||||++|+.||........ .+....
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-~~~~~~---- 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-KLHAII---- 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHH----
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-HHHHHh----
Confidence 443333345679999999999865 4689999999999999999999999975432111 111111
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 572 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 572 ~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
++.....++......+..++..||+.||.+|||+.++++.
T Consensus 282 ---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 ---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111101111112345566677999999999999999863
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.23 Aligned_cols=258 Identities=29% Similarity=0.467 Sum_probs=192.8
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.++|.+.+.||+|+||+||+|.... .+|||+++.. ....+.+.+|+.++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4679999999999999999998643 5999999753 35567899999999999999999999965 5567899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 100 WCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred ecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999996543 358999999999999999999999 89999999999999999999999999999866543
Q ss_pred CCCcccccccccCCCCCcceec---cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~---~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
..........||+.|+|||++. ...++.++||||||+++|+|++|+.||............ ... +.....+
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~----~~~~~~~ 247 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM--VGR----GSLSPDL 247 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHH--HHH----TSCCCCT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHH--hcc----cccCcch
Confidence 3333334467999999999986 567888999999999999999999999765443221111 110 1111100
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
. .+.. .....+..++..||+.+|.+|||+.++++.|+..
T Consensus 248 ~-~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 248 S-KVRS----NCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp T-SSCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred h-hccc----cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 0 0111 1123456667779999999999999999999754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=343.60 Aligned_cols=251 Identities=30% Similarity=0.507 Sum_probs=199.9
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChh----H----HHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSED----V----IKEFVLEIEIITTLHHKNIISLLGFCFEDNN 417 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~----~----~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~ 417 (696)
.++|.+.+.||+|+||+||+|.. .+++.||+|++..... . .+.+.+|+.++.+++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46899999999999999999986 5789999999864321 1 167899999999999999999999986544
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCc--eEeecccccceeeCCCCc-----eE
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFE-----PQ 490 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~g--IIHrDLKpsNILLd~~~~-----vK 490 (696)
++||||+++|+|.+.+.... ..+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 79999999999999887543 268999999999999999999999 77 999999999999988776 99
Q ss_pred EeecCccccccCCCCCcccccccccCCCCCccee--ccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhc
Q 005450 491 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF--MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 568 (696)
Q Consensus 491 L~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l--~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~ 568 (696)
|+|||+++..... .....||+.|+|||++ ....++.++|||||||++|+|++|+.||................
T Consensus 170 l~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 244 (287)
T 4f0f_A 170 VADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244 (287)
T ss_dssp ECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred eCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence 9999999754332 2346799999999998 34568899999999999999999999997655433322211111
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 569 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 569 ~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.. ..+.+.... ...+..++..||+.||.+|||+.++++.|+.
T Consensus 245 ~~---------~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 245 EG---------LRPTIPEDC----PPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp SC---------CCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred cC---------CCCCCCccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 10 011111111 2345566677999999999999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=362.56 Aligned_cols=252 Identities=21% Similarity=0.262 Sum_probs=193.4
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
.++|.+.+.||+|+||+||++... +++.||||++.......+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 467999999999999999999975 7899999999876655577889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc--eEEeecCccccccCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--PQLSDFGLAKWASTS 503 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~--vKL~DFGlA~~~~~~ 503 (696)
++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+++.....
T Consensus 99 ~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 99 SGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999997543 48999999999999999999999 89999999999999987765 999999999754332
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCc-ccchhhHHHHHHHHhCCCCCCCCCccchhh-HHhhhccccccCccccccC
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPISNDHPKGQES-LVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~k-sDVwSLGvvL~ELltG~~Pf~~~~~~~~~~-lv~~~~~~~~~g~l~~llD 581 (696)
.. .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.......... .+..... ...
T Consensus 172 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~----~~~----- 239 (361)
T 3uc3_A 172 SQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS----VKY----- 239 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT----TCC-----
T ss_pred CC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc----CCC-----
Confidence 21 223579999999999988887766 899999999999999999998654432211 1111100 000
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.+... ......+..++..||+.||.+|||+.++++.
T Consensus 240 -~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 -SIPDD--IRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -CCCTT--SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -CCCCc--CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00000 0011344566677999999999999999873
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=372.45 Aligned_cols=264 Identities=22% Similarity=0.233 Sum_probs=208.9
Q ss_pred cChHHHHHhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChh----HHHHHHHHHHHHHhcCCcceeEEeeEE
Q 005450 338 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED----VIKEFVLEIEIITTLHHKNIISLLGFC 412 (696)
Q Consensus 338 f~~~el~~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~----~~~~~~~Ei~iL~~L~HpnIV~l~g~~ 412 (696)
+.+.++...+++|.+.+.||+|+||+||+|... +++.||+|+++.... ....+.+|+.++..++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 456667777899999999999999999999975 578899999975321 223488899999999999999999999
Q ss_pred EecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEe
Q 005450 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 492 (696)
Q Consensus 413 ~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~ 492 (696)
.+.+.++|||||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++||||||||+||||+.++.+||+
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEc
Confidence 99999999999999999999997643 258999999999999999999999 899999999999999999999999
Q ss_pred ecCccccccCCCCCcccccccccCCCCCcceec-----cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhh
Q 005450 493 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 567 (696)
Q Consensus 493 DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~-----~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~ 567 (696)
|||+|+........ .....+||+.|+|||++. .+.|+.++|||||||++|||++|+.||...........+...
T Consensus 218 DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 296 (437)
T 4aw2_A 218 DFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 296 (437)
T ss_dssp CCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred chhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhc
Confidence 99999876554332 223468999999999987 567999999999999999999999999876544333222211
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005450 568 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA--RPQMSLVLKL 620 (696)
Q Consensus 568 ~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~--RPSm~eVL~~ 620 (696)
...+ .+ |...... .+ .+..++..||+.+|++ ||++.++++.
T Consensus 297 ~~~~---~~-----p~~~~~~-s~---~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 297 KERF---QF-----PTQVTDV-SE---NAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHC---CC-----CSSCCCS-CH---HHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccc---cC-----CcccccC-CH---HHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1000 00 0000111 12 3344555688777777 9999999873
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=363.43 Aligned_cols=248 Identities=27% Similarity=0.375 Sum_probs=202.8
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||.||++... +++.||+|++.... .....+.+|+.++..++||||++++++|.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57999999999999999999864 68899999997532 34567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+.||+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 95 e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999997643 48999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCcccccccccCCCCCcceecc---CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~---~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
... ....+||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+........
T Consensus 168 ~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-------- 236 (384)
T 4fr4_A 168 ETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV-------- 236 (384)
T ss_dssp TCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--------
T ss_pred CCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--------
Confidence 332 234689999999999863 458999999999999999999999998655443333322211100
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLK 619 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPS-m~eVL~ 619 (696)
.. ++......+..++..||+.||.+||+ +.++++
T Consensus 237 --~~----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 --VT----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --CC----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --cC----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 00 11111234556677799999999999 777664
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=355.24 Aligned_cols=261 Identities=25% Similarity=0.278 Sum_probs=201.0
Q ss_pred HHHhhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC------hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec
Q 005450 343 LLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFED 415 (696)
Q Consensus 343 l~~~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~------~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~ 415 (696)
+....++|.+.+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+.++..++||||++++++|.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 445667899999999999999999986 46889999998643 34567899999999999999999999999999
Q ss_pred CceEEEEeecCCCChhhhhhcCCCC------------------------------------CCCCChHHHHHHHHHHHHH
Q 005450 416 NNLLLVYDFLSRGSLEENLHGNKKD------------------------------------PAAFGWSERYKVAMGVAEA 459 (696)
Q Consensus 416 ~~~~LV~Ey~~gGsL~~~L~~~~~~------------------------------------~~~l~~~~~~~Ia~qIa~a 459 (696)
+..++||||+++|+|.+++...... ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998521110 1123567788999999999
Q ss_pred HHHHhcCCCCceEeecccccceeeCCCC--ceEEeecCccccccCCCCC--cccccccccCCCCCcceecc--CCCCCcc
Q 005450 460 LEYLHSGSAQRVIHRDVKSSNILLSDDF--EPQLSDFGLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMY--GKVNDKI 533 (696)
Q Consensus 460 L~yLH~~~~~gIIHrDLKpsNILLd~~~--~vKL~DFGlA~~~~~~~~~--~~~~~~~GT~~YlAPE~l~~--~~~s~ks 533 (696)
|.|||+ ++|+||||||+|||++.++ .+||+|||++......... .......||+.|+|||++.. ..++.++
T Consensus 181 l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 999999 8999999999999998776 8999999999866442221 12234679999999999875 6789999
Q ss_pred cchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC
Q 005450 534 DVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ 613 (696)
Q Consensus 534 DVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPS 613 (696)
|||||||++|||++|+.||...........+........ .+.. ......+..++..||+.||.+||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~-----~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE--------NPNY-----NVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT--------SGGG-----GGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccC--------Cccc-----ccCCHHHHHHHHHHcCCChhHCCC
Confidence 999999999999999999977654332222111111000 0000 001134555667799999999999
Q ss_pred HHHHHH
Q 005450 614 MSLVLK 619 (696)
Q Consensus 614 m~eVL~ 619 (696)
+.++++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=347.54 Aligned_cols=263 Identities=24% Similarity=0.291 Sum_probs=198.9
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
++|.+.+.||+|+||+||+|... +|+.||||++.... ...+.+.+|++++.+++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999975 58999999986543 345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+++++|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999886543 48999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccc--------ccC
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL--------SSG 574 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~--------~~g 574 (696)
... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+....... ...
T Consensus 156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 156 SDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred ccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 322 233579999999999875 578999999999999999999999998765543332221110000 000
Q ss_pred -ccccccCcccCCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 575 -KVTQLLDPALGNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 575 -~l~~llD~~L~~~~~-----~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
......-+....... ......+..++..||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000000000000 011234566777899999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=339.74 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=204.0
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
..++|.+.+.||+|+||.||+|... +|+.||+|++... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999864 6899999998653 34567788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc---eEEeecCccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLAK 498 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~---vKL~DFGlA~ 498 (696)
|||+++++|.+.+.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++. +||+|||++.
T Consensus 84 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 99999999999887543 48999999999999999999999 89999999999999986655 9999999998
Q ss_pred cccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 499 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 499 ~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.......
T Consensus 157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------- 226 (284)
T 3kk8_A 157 EVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY------- 226 (284)
T ss_dssp ECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-------
T ss_pred EcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC-------
Confidence 7654332 223679999999999999999999999999999999999999997755433222221111000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..+.. ... ...+..++..||+.||.+|||+.++++
T Consensus 227 -~~~~~-~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 -PSPEW-DTV----TPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -CTTTT-TTS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -Cchhh-ccc----CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000 011 123455666799999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=355.08 Aligned_cols=252 Identities=18% Similarity=0.228 Sum_probs=201.5
Q ss_pred hhcCceeeeeeeccCceEEEEEE------eCCCCEEEEEEecCChhHHHHHHHHHHHHHhcC---CcceeEEeeEEEecC
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGC------LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDN 416 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~------~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~---HpnIV~l~g~~~~~~ 416 (696)
..++|.+.+.||+|+||+||+|. ..+++.||||+++... ..++..|++++..++ |+||+++++++...+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 45789999999999999999994 4578999999998643 456778888888887 999999999999999
Q ss_pred ceEEEEeecCCCChhhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC----------
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---------- 485 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~-~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~---------- 485 (696)
..++||||+++|+|.+++..... ....+++..++.|+.||+.||+|||+ ++|+||||||+||||+.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999974321 22468999999999999999999999 89999999999999998
Q ss_pred -CCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHH
Q 005450 486 -DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 564 (696)
Q Consensus 486 -~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv 564 (696)
++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence 89999999999987654333344455789999999999999999999999999999999999999995432211
Q ss_pred hhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHhhC
Q 005450 565 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRAR-PQMSLVLKLLRG 623 (696)
Q Consensus 565 ~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~R-PSm~eVL~~L~~ 623 (696)
| . +...+......+... .+...|++.+|.+| |++.++.+.|+.
T Consensus 293 -~--------~----~~~~~~~~~~~~~~~---~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 293 -C--------K----PEGLFRRLPHLDMWN---EFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp -E--------E----ECSCCTTCSSHHHHH---HHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred -e--------e----echhccccCcHHHHH---HHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 0 0 111111112233333 34455999999998 567887777753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=353.24 Aligned_cols=260 Identities=23% Similarity=0.365 Sum_probs=208.9
Q ss_pred hcCceeeeeeeccCceEEEEEEeCC------CCEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCc
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 417 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~------g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~ 417 (696)
.++|.+.+.||+|+||.||+|.... +..||+|+++... ...+.+.+|+.++..+ +||||++++++|...+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4789999999999999999998532 3479999997643 4567899999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCC----------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC
Q 005450 418 LLLVYDFLSRGSLEENLHGNKK----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 487 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~----------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~ 487 (696)
.++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCC
Confidence 9999999999999999864321 12357899999999999999999999 8999999999999999999
Q ss_pred ceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhh
Q 005450 488 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 566 (696)
Q Consensus 488 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~ 566 (696)
.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||..............
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 281 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence 999999999987665544433444668899999999998999999999999999999999 9999976544322111110
Q ss_pred hccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 567 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 567 ~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.. . ....... . ...+..++..||+.||.+|||+.++++.|+..
T Consensus 282 ~~--~---------~~~~~~~-~---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 282 DG--Y---------QMAQPAF-A---PKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HT--C---------CCCCCTT-C---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cC--C---------CCCCCCC-C---CHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 00 0 0000111 1 13455667779999999999999999998743
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=358.50 Aligned_cols=207 Identities=23% Similarity=0.306 Sum_probs=179.7
Q ss_pred hcCceeeeeeecc--CceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAENLIGKG--GSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G--~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
.++|.+.+.||+| +||+||+|... +|+.||||+++.. ....+.+.+|+.+++.++||||++++++|.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 5679999999999 99999999975 7999999999753 3556778899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++|+|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 104 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999976532 248999999999999999999999 89999999999999999999999999998654
Q ss_pred cCCCC-----CcccccccccCCCCCcceecc--CCCCCcccchhhHHHHHHHHhCCCCCCCCCcc
Q 005450 501 STSSS-----HITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 558 (696)
Q Consensus 501 ~~~~~-----~~~~~~~~GT~~YlAPE~l~~--~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~ 558 (696)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 243 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 32211 111223579999999999987 57999999999999999999999999775543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=353.51 Aligned_cols=248 Identities=25% Similarity=0.346 Sum_probs=193.5
Q ss_pred hcCceeeeeeeccCceEEEEEEe----CCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 417 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~ 417 (696)
.++|.+.+.||+|+||.||++.. .+|+.||+|+++... .....+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999986 478999999997642 344567889999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA 497 (696)
.++||||+++++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999997543 47899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 498 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 498 ~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.....
T Consensus 169 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-------- 238 (327)
T 3a62_A 169 KESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-------- 238 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--------
T ss_pred cccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC--------
Confidence 75443222 12346799999999999988999999999999999999999999987554322211111100
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 620 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~~ 620 (696)
.+...+ ...+..++..||+.||.+|| ++.++++.
T Consensus 239 -----~~p~~~----~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 -----NLPPYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -----CCCTTS----CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -----CCCCCC----CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 011111 13445566679999999999 77788763
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=367.22 Aligned_cols=250 Identities=29% Similarity=0.431 Sum_probs=203.7
Q ss_pred hhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC-ceEEEEee
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-NLLLVYDF 424 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~-~~~LV~Ey 424 (696)
..++|.+.+.||+|+||.||+|... |+.||||+++... ..+.|.+|+.++++++||||+++++++.+.. ..++||||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 3467899999999999999999874 7799999998654 4578999999999999999999999987765 79999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++|+|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 999999999986432 247899999999999999999999 899999999999999999999999999998544321
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
....+|+.|+|||++.+..++.++|||||||+||||++ |+.||...........+.... . ..
T Consensus 344 -----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~------~------~~ 406 (450)
T 1k9a_A 344 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------K------MD 406 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC------C------CC
T ss_pred -----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------C------CC
Confidence 12357899999999999999999999999999999998 999998765433322221110 0 00
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
..... ...+..++..||+.||.+|||+.++++.|+.
T Consensus 407 ~p~~~----~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 407 APDGC----PPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11111 2345556677999999999999999998864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=353.68 Aligned_cols=264 Identities=23% Similarity=0.365 Sum_probs=190.6
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
..++|.+.+.||+|+||.||+|... +|+.||+|+++... .....+.+|+.+++.++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3568999999999999999999864 68999999987532 33467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCC--CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 423 DFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~--~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||++ |+|.+++.... .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 59999886432 223458999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccccc------
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS------ 573 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~------ 573 (696)
...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.........
T Consensus 159 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 159 GIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp TSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred CCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 543221 223579999999999876 46899999999999999999999999876554332222111000000
Q ss_pred ---------------CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 574 ---------------GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 574 ---------------g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..+.+.+.+...... ...+..++..||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPL----DGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCC----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccchhHHHhhcccccccC----CHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 001111111111111 234566777799999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=360.67 Aligned_cols=252 Identities=21% Similarity=0.243 Sum_probs=205.0
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... .....+.+|+.++..++||||++++++|.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999864 68999999997643 4456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC--CCceEEeecCccccccC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWAST 502 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~--~~~vKL~DFGlA~~~~~ 502 (696)
+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999987543 358999999999999999999999 89999999999999974 57799999999987755
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...... +++
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~---------~~~ 271 (387)
T 1kob_A 204 DEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE---------FDE 271 (387)
T ss_dssp TSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC---------CCS
T ss_pred Ccc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------CCc
Confidence 332 22357999999999999999999999999999999999999999875543222111111000 011
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
...... ...+..++..||+.||.+|||+.++++.
T Consensus 272 ~~~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 DAFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp STTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccC----CHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111111 2345566777999999999999999974
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=341.94 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=205.5
Q ss_pred hcCceeee-eeeccCceEEEEEEeC---CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAEN-LIGKGGSSQVYKGCLP---DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~-~LG~G~fG~Vyka~~~---~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
.++|.+.+ .||+|+||.||+|... ++..||||+++.. ....+.+.+|++++..++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35566666 9999999999999853 6788999999863 45677899999999999999999999999 5667999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999996433 358999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCc-ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 501 STSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 501 ~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
....... ......||+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+.. +..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~-------~~~-- 231 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-------GKR-- 231 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-------TCC--
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc-------CCc--
Confidence 5443221 1223457899999999998899999999999999999998 9999977554332222111 100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
+.+.... ...+..++..||+.+|.+||++.++++.|+..
T Consensus 232 ---~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 232 ---MECPPEC----PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp ---CCCCTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCc----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111111 23455667779999999999999999999754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=348.61 Aligned_cols=260 Identities=25% Similarity=0.390 Sum_probs=196.7
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC----CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC--
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-- 416 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~----~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~-- 416 (696)
..++|.+.+.||+|+||.||+|... ++..||+|+++.. ....+.+.+|+.++.+++||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 4578999999999999999999753 3458999999753 345678999999999999999999999998754
Q ss_pred ---ceEEEEeecCCCChhhhhhcCC--CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEE
Q 005450 417 ---NLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 491 (696)
Q Consensus 417 ---~~~LV~Ey~~gGsL~~~L~~~~--~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL 491 (696)
..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEE
Confidence 3599999999999999985432 223468999999999999999999999 89999999999999999999999
Q ss_pred eecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccc
Q 005450 492 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPI 570 (696)
Q Consensus 492 ~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~ 570 (696)
+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+.....
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~- 267 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR- 267 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC-
Confidence 99999987655433223334567889999999999999999999999999999999 9999977654332222111100
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 571 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 571 ~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
+...... ...+..++..||+.||.+|||+.++++.|+..
T Consensus 268 -----------~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 268 -----------LKQPEDC----LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp -----------CCCBTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----------CCCCccc----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0011111 23456667779999999999999999998743
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=358.22 Aligned_cols=244 Identities=23% Similarity=0.306 Sum_probs=203.4
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|+||.||++... +|+.||||+++... ...+.+.+|++++..++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 468999999999999999999964 78999999997532 3456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceecc
Confidence 99999999999997643 48999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... .+
T Consensus 193 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-------~~----- 255 (350)
T 1rdq_E 193 GR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-------KV----- 255 (350)
T ss_dssp SC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------CC-----
T ss_pred CC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-------CC-----
Confidence 42 12367999999999999999999999999999999999999999876543222221111 10
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLK 619 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPS-----m~eVL~ 619 (696)
.+...++ ..+..++..||+.||.+||+ +.++++
T Consensus 256 -~~p~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 -RFPSHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCCTTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCC----HHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 0111112 23455667799999999998 788775
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=339.16 Aligned_cols=250 Identities=20% Similarity=0.357 Sum_probs=201.9
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~--~~~~LV 421 (696)
.++|.+.+.||+|+||.||+|... ++.||||+++.. ....+.+.+|+.++.+++||||+++++++... +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357899999999999999999984 889999999864 35567899999999999999999999999876 788999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCc--eEeecccccceeeCCCCceEEeecCcccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~g--IIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
|||+++|+|.+++..... ..+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999986432 258999999999999999999999 77 99999999999999999999999988754
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCC---cccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVND---KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~---ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
... ....||+.|+|||++.+..++. ++||||||+++|||++|+.||...........+... +
T Consensus 163 ~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------~-- 227 (271)
T 3kmu_A 163 FQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE------G-- 227 (271)
T ss_dssp TSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS------C--
T ss_pred ecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc------C--
Confidence 322 2356899999999998765554 799999999999999999999765443221111110 0
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
..+.+....+ ..+..++..||+.||.+|||+.++++.|+..
T Consensus 228 ---~~~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 228 ---LRPTIPPGIS----PHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp ---CCCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 0111111112 2355566679999999999999999998753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=369.51 Aligned_cols=262 Identities=22% Similarity=0.244 Sum_probs=207.9
Q ss_pred cChHHHHHhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEE
Q 005450 338 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFC 412 (696)
Q Consensus 338 f~~~el~~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~ 412 (696)
+.+++.....++|.+.+.||+|+||.||++... +|+.||||+++... .....+.+|..++..++||||++++++|
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 455666677899999999999999999999974 79999999997532 2234578899999999999999999999
Q ss_pred EecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEe
Q 005450 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 492 (696)
Q Consensus 413 ~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~ 492 (696)
.+.+.+||||||++||+|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+||||+.++++||+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEe
Confidence 99999999999999999999997543 258999999999999999999999 899999999999999999999999
Q ss_pred ecCccccccCCCCCcccccccccCCCCCcceec-------cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHh
Q 005450 493 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 565 (696)
Q Consensus 493 DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~-------~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~ 565 (696)
|||+++........ .....+||+.|+|||++. .+.|+.++|||||||++|||++|+.||...........+.
T Consensus 205 DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 283 (412)
T 2vd5_A 205 DFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283 (412)
T ss_dssp CCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred echhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999876553322 223468999999999987 3578999999999999999999999998765443322221
Q ss_pred hhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 005450 566 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRAR---PQMSLVLK 619 (696)
Q Consensus 566 ~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~R---PSm~eVL~ 619 (696)
.....+. -+.+...++ ..+..++..||+ +|.+| |++.++++
T Consensus 284 ~~~~~~~--------~p~~~~~~s----~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 284 HYKEHLS--------LPLVDEGVP----EEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp THHHHCC--------CC----CCC----HHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred hcccCcC--------CCccccCCC----HHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1110000 011111111 234455667998 99998 68999876
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=361.23 Aligned_cols=249 Identities=23% Similarity=0.386 Sum_probs=202.5
Q ss_pred HhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCce
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~ 418 (696)
...++|.+.+.||+|+||.||+|..+ +|+.||||+++.. ......+..|..++..+ +||||+++++++.+.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34678999999999999999999975 6889999999753 23456778899999987 899999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
++||||++||+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 99999999999999997643 48999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 499 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 499 ~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....+
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--------- 235 (345)
T 1xjd_A 167 ENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP--------- 235 (345)
T ss_dssp CCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred hcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 6543222 22347899999999999999999999999999999999999999987654332222211111
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMS-LVLK 619 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~-eVL~ 619 (696)
.+...++ ..+..++..||+.||.+||++. ++++
T Consensus 236 ----~~p~~~s----~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 236 ----FYPRWLE----KEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ----CCCTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCCcccC----HHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 1111111 2345566679999999999987 5543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=350.50 Aligned_cols=266 Identities=27% Similarity=0.385 Sum_probs=202.9
Q ss_pred cCceeeeeeeccCceEEEEEE-----eCCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEec--Cce
Q 005450 348 SNFLAENLIGKGGSSQVYKGC-----LPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 418 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~-----~~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~--~~~ 418 (696)
..|.+.+.||+|+||.||++. ..+++.||||+++... ...+.+.+|+.++..++||||+++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 458899999999999999998 3478899999998543 3457889999999999999999999999876 678
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccc
Confidence 99999999999999996543 258999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC-cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC---
Q 005450 499 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG--- 574 (696)
Q Consensus 499 ~~~~~~~~-~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g--- 574 (696)
........ .......||..|+|||++.+..++.++||||||+++|+|++|+.|+...... ......+.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHGQMTVT 250 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCGGGHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCcccccCHH
Confidence 77654332 1223456889999999999999999999999999999999999986432110 000000000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 575 ~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.+...+........+......+..++..||+.||.+|||+.++++.|+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 0000000000011111222456667778999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=352.47 Aligned_cols=256 Identities=22% Similarity=0.375 Sum_probs=198.8
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCE----EEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKE----LAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~----vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
.++|.+.+.||+|+||+||+|... +++. ||+|.+... ....+.+.+|+.++..++||||++++++|... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cce
Confidence 467999999999999999999853 4543 577777542 34567899999999999999999999999875 488
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+|++|+.+|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999976542 58999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
..............||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+.......
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~------- 239 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP------- 239 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-------
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 765444333334567889999999999999999999999999999999 999998765544333222111000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
. +......+..++..||+.||.+||++.++++.|+...
T Consensus 240 -----~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 240 -----Q----PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -----C----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----C----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0 1111224556677799999999999999999998654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=354.66 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=187.9
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
..++|.+.+.||+|+||.||+|... +++.||||+++... ..+.+.+|+.++.+++||||++++++|...+..++||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 4578999999999999999999975 58899999998643 346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC---CCceEEeecCcccccc
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLAKWAS 501 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~---~~~vKL~DFGlA~~~~ 501 (696)
+++|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++...
T Consensus 130 ~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 130 VTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999997543 48999999999999999999999 89999999999999975 8899999999998665
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...... ... ....
T Consensus 203 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~i~~-----~~~-~~~~ 272 (349)
T 2w4o_A 203 HQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM-FRRILN-----CEY-YFIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH-HHHHHT-----TCC-CCCT
T ss_pred cccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH-HHHHHh-----CCC-ccCC
Confidence 4322 23367999999999999889999999999999999999999999765433211 100000 000 0001
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+. .. .....+..++..||+.||++|||+.++++
T Consensus 273 ~~-~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 PW-WD----EVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TT-TT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ch-hh----hCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10 01 11234556677799999999999999987
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=371.84 Aligned_cols=256 Identities=24% Similarity=0.421 Sum_probs=203.7
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
.++|.+.+.||+|+||.||+|..+++..||||+++......+.|.+|+.++++++||||+++++++.+ +..++||||++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 46789999999999999999999888889999998765556789999999999999999999999876 67899999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+|+|.+++..... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 262 ~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 262 KGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp TCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999974321 248899999999999999999999 89999999999999999999999999999876543221
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
......+|+.|+|||++..+.++.++|||||||+||||++ |+.||.+.........+.... .. ...
T Consensus 337 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~------~~------~~~ 403 (452)
T 1fmk_A 337 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------RM------PCP 403 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------CC------CCC
T ss_pred -cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------CC------CCC
Confidence 1223457889999999999999999999999999999999 999997655432222211110 00 001
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
.. ....+..++..||+.||.+|||+.++++.|+...
T Consensus 404 ~~----~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 404 PE----CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 11 1234556677899999999999999999998654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=340.00 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=203.8
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999875 7899999998643 3456788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999999986542 58999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCcccccccccCCCCCcceeccCCC-CCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~-s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
..........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......... ...+...... ..+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~-------~~~ 230 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKTY-------LNP 230 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHTTCTT-------STT
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhhcccc-------cCc
Confidence 32222334679999999999987665 77899999999999999999999765543221 1122111000 000
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.......+..++..||+.||.+|||+.++++
T Consensus 231 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 ------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0011123455677799999999999999876
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=352.98 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=193.7
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc----
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN---- 417 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~---- 417 (696)
.++|.+.+.||+|+||.||++.. .+++.||||+++.. ......+.+|+.++.+++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999996 57899999999753 3445678999999999999999999999987654
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA 497 (696)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 399999999999999997543 48999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC-cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 498 KWASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 498 ~~~~~~~~~-~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...................
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----- 238 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP----- 238 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-----
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC-----
Confidence 876543222 22233679999999999999999999999999999999999999997765432211111100000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. ......+ ...+..++..||+.||.+||++.+++.
T Consensus 239 ~----~~~~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 239 P----SARHEGL----SADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp H----HHHSTTC----CHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred c----ccccCCC----CHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 0 0001111 123455667799999999998776654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=367.49 Aligned_cols=260 Identities=23% Similarity=0.287 Sum_probs=207.7
Q ss_pred ChHHHHHhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEE
Q 005450 339 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCF 413 (696)
Q Consensus 339 ~~~el~~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~ 413 (696)
.+.++....++|.+.+.||+|+||+||++... +++.||+|+++... .....+.+|+.++..++||||++++++|.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34556667789999999999999999999965 68999999997532 12235788999999999999999999999
Q ss_pred ecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEee
Q 005450 414 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 493 (696)
Q Consensus 414 ~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~D 493 (696)
+.+.+|+||||++||+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++++||+|
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEec
Confidence 999999999999999999999753 37899999999999999999999 8999999999999999999999999
Q ss_pred cCccccccCCCCCcccccccccCCCCCcceeccCC----CCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcc
Q 005450 494 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK----VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 569 (696)
Q Consensus 494 FGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~----~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~ 569 (696)
||+|+....... ......+||+.|+|||++.... ++.++|||||||++|||++|+.||...........+.....
T Consensus 212 FG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 290 (410)
T 3v8s_A 212 FGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 290 (410)
T ss_dssp CTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred cceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc
Confidence 999987654322 1233478999999999998655 88999999999999999999999987654433322221110
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005450 570 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA--RPQMSLVLKL 620 (696)
Q Consensus 570 ~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~--RPSm~eVL~~ 620 (696)
.+. . +. ... -. ..+..++..||+.+|.+ ||++.+|+++
T Consensus 291 ~~~---~-----p~-~~~-~s---~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 SLT---F-----PD-DND-IS---KEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HCC---C-----CT-TCC-CC---HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccc---C-----CC-ccc-cc---HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000 0 00 001 11 23444556699989988 9999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=347.33 Aligned_cols=254 Identities=29% Similarity=0.499 Sum_probs=197.1
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
++|.+.+.||+|+||.||++.. .++.||||++... ...+.+.+|++++.+++||||+++++++. +..++||||+++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence 5789999999999999999987 4788999999754 34578999999999999999999999886 458999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc-eEEeecCccccccCCCCC
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-PQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~-vKL~DFGlA~~~~~~~~~ 506 (696)
|+|.+++..... ...+++..++.++.|++.||.|||+.+.++|+||||||+|||++.++. +||+|||++.......
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-- 160 (307)
T 2eva_A 84 GSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-- 160 (307)
T ss_dssp CBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence 999999976532 124788999999999999999999855568999999999999988876 7999999997654321
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~ 586 (696)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......... +.+... .+.. +.+..
T Consensus 161 ---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~---~~~~-----~~~~~ 227 (307)
T 2eva_A 161 ---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVH---NGTR-----PPLIK 227 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHHHH---TTCC-----CCCBT
T ss_pred ---ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHHHh---cCCC-----CCccc
Confidence 2346999999999999889999999999999999999999999764432211 111110 0110 11111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 587 ~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
..+ ..+..++..||+.||.+|||+.++++.|+...
T Consensus 228 ~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 228 NLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred ccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 112 23555667799999999999999999997543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=359.01 Aligned_cols=247 Identities=25% Similarity=0.308 Sum_probs=195.7
Q ss_pred eeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCCC
Q 005450 351 LAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 428 (696)
Q Consensus 351 ~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~gG 428 (696)
...+.||+|+||.||+|.. .+|+.||+|+++... ...+.+.+|++++.+++||||++++++|...+..+|||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3467899999999999986 578999999998643 45678999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee--CCCCceEEeecCccccccCCCCC
Q 005450 429 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL--SDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 429 sL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL--d~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++........
T Consensus 172 ~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 172 ELFDRIIDES---YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp EEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred cHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 9999887543 258899999999999999999999 899999999999999 66789999999999877553322
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~ 586 (696)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...... +..... .
T Consensus 246 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--------~~~~~~-~ 313 (373)
T 2x4f_A 246 ---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD--------LEDEEF-Q 313 (373)
T ss_dssp ---CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--------SCSGGG-T
T ss_pred ---ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--------CChhhh-c
Confidence 2356999999999999889999999999999999999999999876543322211111000 000000 1
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 587 ~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+ ...+..++..||+.||.+|||+.++++
T Consensus 314 ~~----~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 314 DI----SEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cC----CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11 134556677799999999999999997
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=343.56 Aligned_cols=251 Identities=21% Similarity=0.359 Sum_probs=199.8
Q ss_pred hcCceeeeeeeccCceEEEEEEeCC-C-------CEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPD-G-------KELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 417 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~-g-------~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~ 417 (696)
.++|.+.+.||+|+||+||+|.... + ..||+|++.... ...+.+.+|+.++.+++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4679999999999999999998643 3 479999997543 556789999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc--------e
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--------P 489 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~--------v 489 (696)
.++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccccee
Confidence 999999999999999998653 248899999999999999999999 89999999999999998877 9
Q ss_pred EEeecCccccccCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhc
Q 005450 490 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 568 (696)
Q Consensus 490 KL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~ 568 (696)
||+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|||++|..|+................
T Consensus 161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (289)
T 4fvq_A 161 KLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234 (289)
T ss_dssp EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred eeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc
Confidence 99999998654321 23568999999999987 679999999999999999999655543332221111111000
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCcc
Q 005450 569 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 626 (696)
Q Consensus 569 ~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~~ 626 (696)
. .+.. .. . ..+..++..||+.||.+|||+.++++.|+....
T Consensus 235 ~-----~~~~--------~~-~---~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 235 H-----QLPA--------PK-A---AELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp C-----CCCC--------CS-S---CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred C-----CCCC--------CC-C---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0 1111 00 1 124456667999999999999999999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=358.16 Aligned_cols=245 Identities=22% Similarity=0.343 Sum_probs=199.8
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999996 578999999997532 2235788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+ +|+|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 679999886543 48999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCCCCcceeccCCC-CCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~-s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
.... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+ ..+.
T Consensus 160 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-------~~~~----- 224 (336)
T 3h4j_B 160 DGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-------NSCV----- 224 (336)
T ss_dssp TSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-------CSSC-----
T ss_pred CCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-------HcCC-----
Confidence 4332 234679999999999987776 68999999999999999999999765432211100 0000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..+.... ...+..++..||+.||.+|||+.++++
T Consensus 225 -~~~p~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 225 -YVMPDFL----SPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp -CCCCTTS----CHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred -CCCcccC----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0011111 123455667799999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=340.24 Aligned_cols=255 Identities=22% Similarity=0.363 Sum_probs=202.4
Q ss_pred hhcCceeeeeeeccCceEEEEEEeCC----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~~----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
..++|.+.+.||+|+||+||+|...+ +..||+|++... ....+.+.+|+.++..++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35689999999999999999998532 346999999864 3556789999999999999999999999865 4679
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 9999999999999997543 258899999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+......
T Consensus 163 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~-------- 233 (281)
T 3cc6_A 163 IEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL-------- 233 (281)
T ss_dssp C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC--------
T ss_pred ccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC--------
Confidence 6553322 1223567889999999998999999999999999999998 99999765544332222211110
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
...... ...+..++..||+.||.+||++.++++.|+..
T Consensus 234 ----~~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 234 ----PKPDLC----PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ----CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCC----CHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 000111 13355666779999999999999999999754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=346.14 Aligned_cols=252 Identities=27% Similarity=0.381 Sum_probs=197.9
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.++|.+.+.||+|+||.||++.. .++..+|+|++.... ...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 35689999999999999999986 468999999987543 345788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee---CCCCceEEeecCccccc
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL---d~~~~vKL~DFGlA~~~ 500 (696)
|+++|+|.+++.........+++..++.++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999986543223468999999999999999999999 899999999999999 45678999999999866
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
..... .....||+.|+|||++. +.++.++||||||+++|+|++|+.||.............+..+... .
T Consensus 178 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-----~-- 246 (285)
T 3is5_A 178 KSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA-----V-- 246 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----C--
T ss_pred CCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc-----c--
Confidence 54322 23367999999999886 5789999999999999999999999987654332222222111100 0
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..... ...+..++..||+.||.+|||+.++++
T Consensus 247 ---~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 ---ECRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -----CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---ccCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00011 123455667799999999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=355.53 Aligned_cols=271 Identities=24% Similarity=0.315 Sum_probs=207.3
Q ss_pred cCceeeeeeeccCceEEEEEEe-----CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEE--ecCceE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCF--EDNNLL 419 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-----~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~--~~~~~~ 419 (696)
++|.+.+.||+|+||.||++.. .+++.||||++.... ...+.+.+|++++.+++||||+++++++. ..+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5799999999999999999983 468899999997653 45577999999999999999999999987 456689
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+||||+++++|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccccee
Confidence 99999999999999975432 58999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCc-ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 500 ASTSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 500 ~~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........... .+.........+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERDVPALSRLLE 255 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C----CCHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccccccccHHHHHH
Confidence 75543321 22235688999999999998999999999999999999999999865322110000 00000000000111
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
.+........+......+..++..||+.||.+|||+.++++.|+...
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111111112222344566677799999999999999999998654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.36 Aligned_cols=266 Identities=27% Similarity=0.364 Sum_probs=204.0
Q ss_pred ceeeeeeeccCceEEEEEEe-----CCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceEE
Q 005450 350 FLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLL 420 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~-----~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~--~~~~L 420 (696)
|.+.+.||+|+||+||++.. .+++.||||+++... ...+.+.+|+++++.++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48899999999999999864 268899999998643 4567899999999999999999999999874 57899
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++|+|.+++... .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999754 38899999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCc-ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 501 STSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 501 ~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ....+.........+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHH
Confidence 6543221 12335688899999999988999999999999999999999999865321100 000000000000011111
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
++.......+......+..++..||+.||.+|||+.++++.|+..
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111111111122224566677789999999999999999999753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=341.61 Aligned_cols=255 Identities=24% Similarity=0.385 Sum_probs=199.6
Q ss_pred cCceeeeeeeccCceEEEEEEeCC----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEE-ecCceEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCF-EDNNLLL 420 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~-~~~~~~L 420 (696)
.+|.+.+.||+|+||+||+|...+ ...+|+|.++.. ....+.+.+|+.++++++||||++++++|. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 468899999999999999998542 235899998753 345678999999999999999999999865 4567899
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999997543 357899999999999999999999 89999999999999999999999999999866
Q ss_pred cCCCCC--cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 501 STSSSH--ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 501 ~~~~~~--~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
...... .......||+.|+|||.+.+..++.++||||||+++|+|++ |.+||...........+......
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~------- 251 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------- 251 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC-------
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC-------
Confidence 543211 12233568889999999999999999999999999999999 56666554433322221111100
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
...... . ..+..++..||+.||.+|||+.++++.|+..
T Consensus 252 -----~~~~~~-~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 252 -----LQPEYC-P---DPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp -----CCCTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCccC-C---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 001111 1 2355666779999999999999999998753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=344.95 Aligned_cols=261 Identities=27% Similarity=0.429 Sum_probs=196.4
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecC----ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~----~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++. .......+.+|+.++..++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999986 5799999999975 235567889999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++++|.+++.........+++..++.++.+++.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999987533333468999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
..... .....||+.|+|||++....++.++||||||+++|+|++|+.||......... +..... ........
T Consensus 188 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~----~~~~~~~~- 259 (310)
T 2wqm_A 188 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCKKIE----QCDYPPLP- 259 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH-HHHHHH----TTCSCCCC-
T ss_pred CCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH-HHHHhh----cccCCCCc-
Confidence 43222 22357999999999999899999999999999999999999999765432211 111110 01111110
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
...+ ...+..++..||+.||.+|||+.+|++.|+...
T Consensus 260 ---~~~~----~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 260 ---SDHY----SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp ---TTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cccc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0111 124555667799999999999999999997543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=362.50 Aligned_cols=207 Identities=29% Similarity=0.428 Sum_probs=168.7
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecC--ce
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDN--NL 418 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~--~~ 418 (696)
..++|.+.+.||+|+||.||+|.. .+|+.||||++.. .......+.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999986 5789999999864 3455677889999999997 999999999997644 68
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
|+||||++ ++|..++... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+|+
T Consensus 87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999997 5899998753 47899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCC-------------------CcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCcc
Q 005450 499 WASTSSS-------------------HITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 558 (696)
Q Consensus 499 ~~~~~~~-------------------~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~ 558 (696)
....... ....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 6643111 112234689999999999876 67999999999999999999999999877654
Q ss_pred chh
Q 005450 559 GQE 561 (696)
Q Consensus 559 ~~~ 561 (696)
.+.
T Consensus 238 ~~~ 240 (388)
T 3oz6_A 238 NQL 240 (388)
T ss_dssp HHH
T ss_pred HHH
Confidence 443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=352.68 Aligned_cols=268 Identities=23% Similarity=0.342 Sum_probs=195.1
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHH--HHhcCCcceeEEeeEEEe-----cCceE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEI--ITTLHHKNIISLLGFCFE-----DNNLL 419 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~i--L~~L~HpnIV~l~g~~~~-----~~~~~ 419 (696)
.++|.+.+.||+|+||.||+|.. +++.||||++..... ..+..|.++ +..++||||+++++++.. ...++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch--hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 46899999999999999999976 789999999976443 334444444 556899999999986643 23578
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCC---------ceEeecccccceeeCCCCceE
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ---------RVIHRDVKSSNILLSDDFEPQ 490 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~---------gIIHrDLKpsNILLd~~~~vK 490 (696)
+||||+++|+|.+++.... +++..++.++.||+.||.|||+ . +|+||||||+|||++.++.+|
T Consensus 89 lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred EEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEE
Confidence 9999999999999997543 5889999999999999999999 6 999999999999999999999
Q ss_pred EeecCccccccCCCC------CcccccccccCCCCCcceecc-------CCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Q 005450 491 LSDFGLAKWASTSSS------HITCTDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 491 L~DFGlA~~~~~~~~------~~~~~~~~GT~~YlAPE~l~~-------~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~ 557 (696)
|+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987654321 111223579999999999976 3567789999999999999999877654332
Q ss_pred cchh-hHHh-hhccccccCcc-----ccccCcccCCCC--ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 558 KGQE-SLVM-WAKPILSSGKV-----TQLLDPALGNNY--DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 558 ~~~~-~lv~-~~~~~~~~g~l-----~~llD~~L~~~~--~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
.... .... ..........+ .....+.+.... .......+..++..||+.||.+|||+.++++.|+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 1111 0000 00000000000 000011111111 2234456777888899999999999999999997543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.47 Aligned_cols=254 Identities=23% Similarity=0.358 Sum_probs=199.6
Q ss_pred CceeeeeeeccCceEEEEEEeC-C---CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce-EEE
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-D---GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL-LLV 421 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~---g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~-~LV 421 (696)
.|...+.||+|+||+||+|... + +..+|+|++... ....+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4667799999999999999853 2 237999999753 34567899999999999999999999999876655 999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999997643 357899999999999999999999 899999999999999999999999999998654
Q ss_pred CCC--CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCC-CCCCCccchhhHHhhhccccccCcccc
Q 005450 502 TSS--SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP-ISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 502 ~~~--~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~P-f~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
... .........||+.|+|||.+.+..++.++||||||+++|+|++|..| |...........+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-------- 247 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-------- 247 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC--------
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC--------
Confidence 322 11122335689999999999999999999999999999999995555 4443332222222111100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
...... ...+..++..||+.||.+|||+.++++.|+..
T Consensus 248 ----~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 248 ----PQPEYC----PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp ----CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCccc----hHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001111 13455667779999999999999999998753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=339.86 Aligned_cols=248 Identities=26% Similarity=0.422 Sum_probs=181.9
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35799999999999999999986 579999999997532 2246789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999997543 258999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+ .. . +
T Consensus 164 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~-~------~ 228 (278)
T 3cok_A 164 MPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------VL-A------D 228 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C------CS-S------C
T ss_pred CCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH------hh-c------c
Confidence 43221 12357999999999999889999999999999999999999999765432211100 00 0 0
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..+...+ ...+..++..||+.||.+|||+.++++
T Consensus 229 ~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 YEMPSFL----SIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCCcccc----CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0111111 124456677799999999999999886
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=354.81 Aligned_cols=263 Identities=21% Similarity=0.324 Sum_probs=196.4
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhH--HHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDV--IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~--~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
++|.+.+.||+|+||+||+|... +++.||||+++..... ...+.+|+.++..++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999975 7899999999754322 22456799999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++ +|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CSE-EHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred ccc-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 974 99998876532 58899999999999999999999 899999999999999999999999999998655432
Q ss_pred CCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc-
Q 005450 505 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP- 582 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~- 582 (696)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...........+......
T Consensus 155 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 155 K--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred c--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 2 2233578999999999876 56899999999999999999999999876654433332221111111111111110
Q ss_pred --------ccCCCC----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 583 --------ALGNNY----DYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 583 --------~L~~~~----~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
...... .......+..++..||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 0011234556777899999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=356.88 Aligned_cols=248 Identities=23% Similarity=0.303 Sum_probs=201.7
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~ 419 (696)
..++|.+.+.||+|+||.||++... +|+.||||+++... ...+.+..|..++..+ +||||+++++++.+.+.+|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3468999999999999999999975 57899999997532 3456788999999988 7999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+||||++||+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999999999997543 48999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....
T Consensus 171 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~---------- 238 (353)
T 2i0e_A 171 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---------- 238 (353)
T ss_dssp CCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred cccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC----------
Confidence 433222 22346899999999999999999999999999999999999999987654332222211100
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLK 619 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPS-----m~eVL~ 619 (696)
.+...+ ...+..++..||+.||.+||+ +.++++
T Consensus 239 ---~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 ---AYPKSM----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---CCCTTS----CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---CCCCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 011111 134555667799999999996 466664
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=346.45 Aligned_cols=251 Identities=23% Similarity=0.314 Sum_probs=204.7
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~ 418 (696)
.++|.+.+.||+|+||.||++... +|+.||+|+++... ...+.+.+|+.++..++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456999999999999999999965 68999999987532 1367899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC----ceEEeec
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 494 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~----~vKL~DF 494 (696)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999997543 58999999999999999999999 8999999999999999887 7999999
Q ss_pred CccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC
Q 005450 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 495 GlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
|++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.....
T Consensus 164 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~----- 235 (321)
T 2a2a_A 164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY----- 235 (321)
T ss_dssp TTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC-----
T ss_pred ccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc-----
Confidence 99987665332 2335799999999999989999999999999999999999999976543322211111000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 575 ~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.+++.+....+ ..+..++..||+.||.+|||+.++++.
T Consensus 236 ----~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 236 ----DFDEEFFSHTS----ELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ----CCCHHHHTTCC----HHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ----ccChhhhcccC----HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00111111111 235566777999999999999999973
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=337.90 Aligned_cols=249 Identities=24% Similarity=0.301 Sum_probs=201.4
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
.++|.+.+.||+|+||.||+|... ++..+|+|.+... ....+.+.+|++++..++||||++++++|.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 467999999999999999999865 5778999998753 24467889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee---CCCCceEEeecCcccccc
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL---d~~~~vKL~DFGlA~~~~ 501 (696)
+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999987543 48999999999999999999999 899999999999999 788999999999998765
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
..... ....||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+........ .
T Consensus 161 ~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------~ 228 (277)
T 3f3z_A 161 PGKMM---RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP--------E 228 (277)
T ss_dssp TTSCB---CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------H
T ss_pred Cccch---hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--------c
Confidence 54322 23579999999998864 599999999999999999999999977554322222111110000 0
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
... ... ...+..++..||+.||.+|||+.++++
T Consensus 229 ~~~-~~~----~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KDW-LNV----SPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHH-TTS----CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhh-hcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 001 134556667799999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=349.41 Aligned_cols=259 Identities=24% Similarity=0.394 Sum_probs=203.2
Q ss_pred hcCceeeeeeeccCceEEEEEEe------CCCCEEEEEEecC--ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~------~~g~~vAVK~l~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~ 418 (696)
.++|.+.+.||+|+||.||+|.. .++..||||++.. .......+.+|+.++.+++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46799999999999999999983 3577899999964 345567899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCC---CCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC---CCceEEe
Q 005450 419 LLVYDFLSRGSLEENLHGNKKD---PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLS 492 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~---~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~---~~~vKL~ 492 (696)
++||||+++++|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999999865422 2458999999999999999999999 89999999999999984 4569999
Q ss_pred ecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhcccc
Q 005450 493 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPIL 571 (696)
Q Consensus 493 DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~ 571 (696)
|||++................||+.|+|||++....++.++||||||+++|+|++ |+.||...........+...
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---- 261 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG---- 261 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT----
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC----
Confidence 9999986654433333334568999999999998999999999999999999998 99999765433222111111
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 572 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 572 ~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.. ....... ...+..++..||+.||.+||++.++++.|...
T Consensus 262 ---~~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 262 ---GR-----MDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp ---CC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CC-----CCCCCCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 00 0011111 13455667779999999999999999998743
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=342.85 Aligned_cols=258 Identities=23% Similarity=0.311 Sum_probs=205.2
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~--~~~~~L 420 (696)
.++|.+.+.||+|+||.||++... +|+.||+|++... ....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999864 7899999999753 3556789999999999999999999998854 567999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCc-----eEeecccccceeeCCCCceEEeecC
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-----VIHRDVKSSNILLSDDFEPQLSDFG 495 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~g-----IIHrDLKpsNILLd~~~~vKL~DFG 495 (696)
||||+++++|.+++.........+++..++.++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997644334468999999999999999999999 66 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCc
Q 005450 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 575 (696)
Q Consensus 496 lA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 575 (696)
++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+. .+.
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~-------~~~ 232 (279)
T 2w5a_A 162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-------EGK 232 (279)
T ss_dssp HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HTC
T ss_pred hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh-------hcc
Confidence 9987654322 1223579999999999998899999999999999999999999997654322211111 111
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 576 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 576 l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
.. .+...+ ...+..++..||+.||.+||++.++++.+....
T Consensus 233 ~~-----~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 233 FR-----RIPYRY----SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp CC-----CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred cc-----cCCccc----CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 11 111111 234556667799999999999999998775443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=340.05 Aligned_cols=246 Identities=28% Similarity=0.426 Sum_probs=199.8
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|+||+||+|... ++..||+|++.... .....+.+|+.++..++||||++++++|.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467999999999999999999864 67899999986532 2346788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999997543 48899999999999999999999 899999999999999999999999999986554
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.....
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 224 (279)
T 3fdn_A 161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF------------ 224 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC------------
T ss_pred ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC------------
Confidence 322 2235799999999999988999999999999999999999999986554332222211110
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.+.... ...+..++..||+.||.+|||+.++++.
T Consensus 225 -~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 -TFPDFV----TEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -CCCTTS----CHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -CCCCcC----CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 011111 1234456667999999999999999973
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=353.10 Aligned_cols=249 Identities=20% Similarity=0.329 Sum_probs=196.7
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~L 420 (696)
.++|.+.+.||+|+||.||++... +++.||+|+++.. ....+.+.+|+.++.++ +||||++++++|.+.+.+++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357999999999999999999965 6889999999753 34566788999999988 89999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999999997543 48999999999999999999999 89999999999999999999999999999864
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchh--hHHhhhccccccCcccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE--SLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~--~lv~~~~~~~~~g~l~~ 578 (696)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ............+.
T Consensus 161 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--- 235 (345)
T 3a8x_A 161 LRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--- 235 (345)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC---
T ss_pred cCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC---
Confidence 33221 223468999999999999999999999999999999999999999653211100 00000000000000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQM 614 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm 614 (696)
..+...+ ...+..++..||+.||.+||++
T Consensus 236 ---~~~p~~~----s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 ---IRIPRSL----SVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ---CCCCTTS----CHHHHHHHHHHTCSSTTTSTTC
T ss_pred ---CCCCCCC----CHHHHHHHHHHhcCCHhHCCCC
Confidence 0111111 2334556677999999999995
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=360.13 Aligned_cols=249 Identities=20% Similarity=0.321 Sum_probs=195.2
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~L 420 (696)
.++|.+.+.||+|+||.||++... +++.||+|+++... ...+.+.+|..++.++ +||||++++++|.+.+.+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999865 67889999997532 3345678899999887 89999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++++||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999997643 48999999999999999999999 89999999999999999999999999999853
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchh--hHHhhhccccccCcccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE--SLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~--~lv~~~~~~~~~g~l~~ 578 (696)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ............+.
T Consensus 204 ~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--- 278 (396)
T 4dc2_A 204 LRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--- 278 (396)
T ss_dssp CCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC---
T ss_pred ccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc---
Confidence 33222 233478999999999999999999999999999999999999999643221110 00000000000000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQM 614 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm 614 (696)
..+...+ ...+..++..||+.||.+||++
T Consensus 279 ---~~~p~~~----s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 ---IRIPRSL----SVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ---CCCCTTS----CHHHHHHHHHHTCSCTTTSTTC
T ss_pred ---cCCCCcC----CHHHHHHHHHHhcCCHhHcCCC
Confidence 0111111 2234556677999999999995
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=339.47 Aligned_cols=262 Identities=22% Similarity=0.289 Sum_probs=200.2
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEE-EecCceEEEEe
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC-FEDNNLLLVYD 423 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~-~~~~~~~LV~E 423 (696)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+|+.++..++|++++..+.++ ...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 467899999999999999999986 578999999876533 224578899999999988877766665 56677899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee---CCCCceEEeecCccccc
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL---d~~~~vKL~DFGlA~~~ 500 (696)
|+ +++|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred cc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99 9999999975432 58999999999999999999999 899999999999999 78899999999999877
Q ss_pred cCCCCCc-----ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCc
Q 005450 501 STSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 575 (696)
Q Consensus 501 ~~~~~~~-----~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 575 (696)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.................. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~ 234 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----K 234 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----H
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc----c
Confidence 6543321 123467999999999999999999999999999999999999999875443322211111000 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 576 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 576 l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.... .+.+...++ ..+..++..||+.+|.+|||+.++++.|+..
T Consensus 235 ~~~~-~~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 235 MSTP-IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHSC-HHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred ccch-hhhhhccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 0000 001111111 3455666779999999999999999998743
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.37 Aligned_cols=257 Identities=24% Similarity=0.406 Sum_probs=199.7
Q ss_pred hcCceeeeeeeccCceEEEEEEeCC-----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPD-----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~-----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
.++|...+.||+|+||.||+|.... +..||||+++.. ......+.+|+.++..++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4678899999999999999998642 235999999863 345567899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 123 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999997643 258999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCc-ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 500 ASTSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 500 ~~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+.... ..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~------~~- 269 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------RL- 269 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------CC-
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC------cC-
Confidence 65432211 1122456889999999998999999999999999999999 999997654332211111000 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
.. +......+..++..||+.+|.+||++.++++.|+...
T Consensus 270 -----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 270 -----PT----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp -----CC----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----CC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 1111234556677799999999999999999987543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.55 Aligned_cols=264 Identities=28% Similarity=0.384 Sum_probs=206.7
Q ss_pred HHhhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHh--cCCcceeEEeeEEEecC----c
Q 005450 344 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFEDN----N 417 (696)
Q Consensus 344 ~~~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~--L~HpnIV~l~g~~~~~~----~ 417 (696)
....++|.+.+.||+|+||.||+|.. +|+.||||++.... ...+.+|++++.. ++||||+++++++.... .
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh--HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 44567899999999999999999987 58999999997543 4567889999888 78999999999998876 7
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh--------cCCCCceEeecccccceeeCCCCce
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH--------SGSAQRVIHRDVKSSNILLSDDFEP 489 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH--------~~~~~gIIHrDLKpsNILLd~~~~v 489 (696)
.++||||+++|+|.+++... .+++..++.++.|++.||.||| + .+|+||||||+|||++.++.+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCE
T ss_pred eEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCE
Confidence 99999999999999999753 4899999999999999999999 6 899999999999999999999
Q ss_pred EEeecCccccccCCCCCc--ccccccccCCCCCcceeccC------CCCCcccchhhHHHHHHHHhC----------CCC
Q 005450 490 QLSDFGLAKWASTSSSHI--TCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTG----------RKP 551 (696)
Q Consensus 490 KL~DFGlA~~~~~~~~~~--~~~~~~GT~~YlAPE~l~~~------~~s~ksDVwSLGvvL~ELltG----------~~P 551 (696)
||+|||++.......... ......||+.|+|||++... .++.++|||||||++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998776543221 12345799999999998765 234689999999999999999 778
Q ss_pred CCCCCccchhhHHhhhccccccCccccccCcccCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 552 ISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN-YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 552 f~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~-~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
|........... .+..... ... +.+.+... ...+....+..++..||+.||.+|||+.+|++.|+..
T Consensus 267 ~~~~~~~~~~~~-~~~~~~~-~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 267 YYDLVPSDPSVE-EMRKVVC-EQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTTSCSSCCHH-HHHHHHT-TSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCcCcccHH-HHHHHHH-HHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 865433221110 0000000 011 11111111 1234556777888889999999999999999999753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=341.77 Aligned_cols=262 Identities=21% Similarity=0.317 Sum_probs=207.2
Q ss_pred hcCceeeeeeeccCceEEEEEEe--CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc------eeEEeeEEEecCce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN------IISLLGFCFEDNNL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~--~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hpn------IV~l~g~~~~~~~~ 418 (696)
.++|.+.+.||+|+||.||+|.. .+++.||||+++......+.+.+|+.++..++|++ ++++++++...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 46899999999999999999986 36889999999987777788999999999998765 99999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC-------------
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD------------- 485 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~------------- 485 (696)
++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 9999999 8899999976543 358899999999999999999999 89999999999999987
Q ss_pred ------CCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccc
Q 005450 486 ------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 559 (696)
Q Consensus 486 ------~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~ 559 (696)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 6689999999998654432 23579999999999998899999999999999999999999998765433
Q ss_pred hhhHHhhhccccccC--------c------------------cccccCcccC-CCCChHHHHHHHHHHHHhcccCCCCCC
Q 005450 560 QESLVMWAKPILSSG--------K------------------VTQLLDPALG-NNYDYDQMERMVLASILCIRRDPRARP 612 (696)
Q Consensus 560 ~~~lv~~~~~~~~~g--------~------------------l~~llD~~L~-~~~~~~e~~~l~~la~~Cl~~dP~~RP 612 (696)
....+.......... . ......+... ..........+..++..||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 322221111000000 0 0000000000 011223445677788889999999999
Q ss_pred CHHHHHH
Q 005450 613 QMSLVLK 619 (696)
Q Consensus 613 Sm~eVL~ 619 (696)
|+.++++
T Consensus 322 t~~ell~ 328 (339)
T 1z57_A 322 TLREALK 328 (339)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999885
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.01 Aligned_cols=261 Identities=22% Similarity=0.300 Sum_probs=203.1
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEE-EecCceEEEEe
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC-FEDNNLLLVYD 423 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~-~~~~~~~LV~E 423 (696)
..++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+|+.++..++|++++..+.++ ...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 357899999999999999999996 6789999999875432 24688999999999988877666665 56677899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC---CCCceEEeecCccccc
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKWA 500 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd---~~~~vKL~DFGlA~~~ 500 (696)
|+ +++|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||++ .++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 8999999974432 58999999999999999999999 8999999999999994 8889999999999877
Q ss_pred cCCCCCc-----ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCc
Q 005450 501 STSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 575 (696)
Q Consensus 501 ~~~~~~~-----~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 575 (696)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||................. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----~~ 234 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE----KK 234 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH----HH
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc----cc
Confidence 6543321 12346799999999999999999999999999999999999999987543322111111100 00
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 576 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 576 l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
... ..+.+...++ ..+..++..||+.||.+|||+.++++.|+.
T Consensus 235 ~~~-~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 235 MST-PIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HHS-CHHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred cCC-chHHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 000 0001111112 345566777999999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=364.45 Aligned_cols=262 Identities=22% Similarity=0.236 Sum_probs=197.4
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEec------
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFED------ 415 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~------ 415 (696)
..++|.+.+.||+|+||+||+|.. .+|+.||||++.. .....+.+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999985 4689999999975 345567889999999999999999999999754
Q ss_pred CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecC
Q 005450 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 495 (696)
Q Consensus 416 ~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFG 495 (696)
...|+||||+++ +|.+.+.. .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEE
Confidence 357999999976 56666642 37899999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccc----
Q 005450 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL---- 571 (696)
Q Consensus 496 lA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~---- 571 (696)
+|+....... ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+...+...+.......
T Consensus 210 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 210 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp CC-----CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeeecCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9987654322 234689999999999999999999999999999999999999998766443332221110000
Q ss_pred ------------------ccCccccccCcccCCCCC---hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 572 ------------------SSGKVTQLLDPALGNNYD---YDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 572 ------------------~~g~l~~llD~~L~~~~~---~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
..-.+...+...+..... ......+..++..||+.||.+|||+.|+++.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000011111111100000 0113456677788999999999999999973
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=337.95 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=200.7
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~ 418 (696)
.++|.+.+.||+|+||.||++... +|+.||+|+++... ...+.+.+|+.++.+++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999975 68999999987532 2367899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC----ceEEeec
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 494 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~----~vKL~DF 494 (696)
++||||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEec
Confidence 99999999999999997543 58999999999999999999999 8999999999999998877 7999999
Q ss_pred CccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC
Q 005450 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 495 GlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
|++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.....
T Consensus 157 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----- 228 (283)
T 3bhy_A 157 GIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY----- 228 (283)
T ss_dssp TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-----
T ss_pred ccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc-----
Confidence 99987654332 2235699999999999989999999999999999999999999977543322111111100
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 575 ~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. .++...... ...+..++..||+.||.+||++.++++
T Consensus 229 ~----~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 D----FDEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C----CCHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C----CcchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 000010111 134556677899999999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.91 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=202.8
Q ss_pred hcCceeee-eeeccCceEEEEEEe---CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 347 TSNFLAEN-LIGKGGSSQVYKGCL---PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 347 t~~f~~~~-~LG~G~fG~Vyka~~---~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
.++|.+.+ .||+|+||.||+|.. .+++.||||+++... ...+.+.+|++++..++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45788887 999999999999954 357889999997642 3467899999999999999999999999 667899
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 94 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 9999999999999998643 48899999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCcc-cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 500 ASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 500 ~~~~~~~~~-~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
......... .....||+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+... ..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-------~~- 238 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-------ER- 238 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------CC-
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------CC-
Confidence 755433211 122456789999999998889999999999999999999 99999875543322221111 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
+.+... ....+..++..||+.||.+||++.++++.|+..
T Consensus 239 ----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 239 ----MGCPAG----CPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp ----CCCCTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011111 123455667779999999999999999999753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=349.46 Aligned_cols=266 Identities=23% Similarity=0.326 Sum_probs=202.1
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEe--------
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE-------- 414 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~-------- 414 (696)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.++..++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36799999999999999999997 578999999986532 334577899999999999999999999987
Q ss_pred cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeec
Q 005450 415 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 494 (696)
Q Consensus 415 ~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DF 494 (696)
.+..++||||+++ +|.+.+..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 4468999999986 78777765432 58999999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCC--CcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccc
Q 005450 495 GLAKWASTSSS--HITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 571 (696)
Q Consensus 495 GlA~~~~~~~~--~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~ 571 (696)
|+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99987653222 122234678999999999875 458999999999999999999999998766544333332211111
Q ss_pred ccCccccc-----cCc---ccCCCCCh-HH------HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 572 SSGKVTQL-----LDP---ALGNNYDY-DQ------MERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 572 ~~g~l~~l-----lD~---~L~~~~~~-~e------~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
........ .+. ........ +. ...+..++..||+.||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 11111110 000 00000011 11 123556777899999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=347.17 Aligned_cols=262 Identities=25% Similarity=0.373 Sum_probs=202.1
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecC-ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe----cCceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~----~~~~~L 420 (696)
.++|.+.+.||+|+||.||++.. .+|+.||||++.. .....+.+.+|+.++..++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999996 5789999998864 34566789999999999999999999999973 347899
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++|+|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999997643334468999999999999999999999 89999999999999999999999999998765
Q ss_pred cCCCCCc-------ccccccccCCCCCcceeccCC---CCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccc
Q 005450 501 STSSSHI-------TCTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 570 (696)
Q Consensus 501 ~~~~~~~-------~~~~~~GT~~YlAPE~l~~~~---~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 570 (696)
....... ......||+.|+|||++.... ++.++||||||+++|+|++|+.||.................
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~- 263 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ- 263 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc-
Confidence 4321110 012245799999999987543 78999999999999999999999954211111111100000
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 571 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 571 ~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
. .. + ....+ ...+..++..||+.||.+||++.++++.|+...
T Consensus 264 ~---~~-----~-~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 264 L---SI-----P-QSPRH----SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp -----C-----C-CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred C---CC-----C-ccccC----CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 0 00 0 00111 234566677799999999999999999997654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=366.39 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=194.4
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|+||.||++.. .+|+.||||+++.. ......+.+|+.++..++||||++++++|...+.+++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35799999999999999999985 47899999999742 34456778899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ .++|+||||||+||||+.++.+||+|||+|+...
T Consensus 227 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999997543 48999999999999999999995 1679999999999999999999999999998644
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
.... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||...........+..... .
T Consensus 301 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-----~------ 367 (446)
T 4ejn_A 301 KDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-----R------ 367 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----C------
T ss_pred CCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-----C------
Confidence 3222 22347899999999999999999999999999999999999999977654333222221110 0
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 620 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~~ 620 (696)
+...++ ..+..++..||+.||.+|| ++.++++.
T Consensus 368 --~p~~~~----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 368 --FPRTLG----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp --CCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCccCC----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 111111 2345566679999999999 99999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=354.79 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=189.8
Q ss_pred hcCceee-eeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHh-cCCcceeEEeeEEEe----cCceE
Q 005450 347 TSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITT-LHHKNIISLLGFCFE----DNNLL 419 (696)
Q Consensus 347 t~~f~~~-~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~-L~HpnIV~l~g~~~~----~~~~~ 419 (696)
.++|.+. +.||+|+||+||++... +|+.||||+++.. ..+.+|+.++.+ .+||||++++++|.. ...++
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 3467666 78999999999999864 6899999999754 346678888744 589999999999875 56789
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC---CCceEEeecCc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGL 496 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~---~~~vKL~DFGl 496 (696)
|||||+++|+|.+++..... ..+++..+..|+.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999986432 358999999999999999999999 89999999999999997 78899999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchh----hHHhhhccccc
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE----SLVMWAKPILS 572 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~----~lv~~~~~~~~ 572 (696)
++....... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+......+
T Consensus 211 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~- 286 (400)
T 1nxk_A 211 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF- 286 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC-
T ss_pred ccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC-
Confidence 986654322 23467999999999999999999999999999999999999999765543211 1111110000
Q ss_pred cCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 573 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 573 ~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
..+.. .. ....+..++..||+.||.+|||+.++++.
T Consensus 287 -------~~~~~-~~----~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 287 -------PNPEW-SE----VSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -------CTTTT-TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -------CCccc-cc----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 01 12345566777999999999999999973
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=337.89 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=197.5
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|+||+||+|... +++.||||+++.. ......+.+|+.++..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999975 7999999999753 34567888999999999 899999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC----------------
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---------------- 485 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~---------------- 485 (696)
|||+++++|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997643222358999999999999999999999 89999999999999984
Q ss_pred ---CCceEEeecCccccccCCCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchh
Q 005450 486 ---DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 561 (696)
Q Consensus 486 ---~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~ 561 (696)
...+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+|+.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 4479999999998765432 23599999999999865 566899999999999999999987744321
Q ss_pred hHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 562 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 562 ~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..... .+... .+...++ ..+..++..||+.||.+|||+.++++
T Consensus 237 -~~~~~-----~~~~~-----~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 -WHEIR-----QGRLP-----RIPQVLS----QEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -HHHHH-----TTCCC-----CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHH-----cCCCC-----CCCcccC----HHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11111 11111 1111112 34555666799999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=350.12 Aligned_cols=264 Identities=24% Similarity=0.374 Sum_probs=199.5
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.++..++||||++++++|.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357999999999999999999875 5899999998643 344567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999998876443 48999999999999999999999 8999999999999999999999999999986654
Q ss_pred CCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhh-c------------
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA-K------------ 568 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~-~------------ 568 (696)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+... .
T Consensus 177 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 177 PGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred Cccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 3221 2335799999999999865 7899999999999999999999999876543322211110 0
Q ss_pred -cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 569 -PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 569 -~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+......+..+................+..++..||+.||.+|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000101111111100000000111245666777899999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=348.07 Aligned_cols=267 Identities=25% Similarity=0.302 Sum_probs=198.3
Q ss_pred HhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChh------HHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED------VIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 417 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~------~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~ 417 (696)
...++|.+.+.||+|+||.||+|... +|+.||||+++.... ....+.+|+.++..++||||++++++|...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999974 689999999975321 12467899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA 497 (696)
.++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999986 8988886543 358889999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 498 KWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 498 ~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
+........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+............
T Consensus 160 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 160 KSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp STTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 876543322 2346799999999998754 5899999999999999999999999876543332222111111111110
Q ss_pred c---cccCcccC---CCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 577 T---QLLDPALG---NNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 577 ~---~llD~~L~---~~~~-----~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
. .+.+.... ...+ ......+..++..||+.||.+|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 00000000 0001 1112456667777999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=346.08 Aligned_cols=254 Identities=26% Similarity=0.431 Sum_probs=201.1
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEE--EEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKEL--AVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~v--AVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV 421 (696)
++|.+.+.||+|+||.||+|... +|..+ |+|.++.. ....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57899999999999999999864 56544 99988753 34556789999999999 899999999999999999999
Q ss_pred EeecCCCChhhhhhcCC------------CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCce
Q 005450 422 YDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 489 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~------------~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~v 489 (696)
|||+++|+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999997653 223468999999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhc
Q 005450 490 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 568 (696)
Q Consensus 490 KL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~ 568 (696)
||+|||+++....... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+.
T Consensus 182 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~--- 255 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--- 255 (327)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG---
T ss_pred EEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh---
Confidence 9999999974433221 122457889999999998889999999999999999998 999997654322211111
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 569 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 569 ~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.+ ........ ....+..++..||+.+|.+|||+.++++.|+.
T Consensus 256 ----~~-----~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 256 ----QG-----YRLEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp ----GT-----CCCCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----cC-----CCCCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00 00001111 12345566778999999999999999998864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=353.18 Aligned_cols=264 Identities=17% Similarity=0.213 Sum_probs=197.3
Q ss_pred hcCceeeeeeeccCceEEEEEEeC----CCCEEEEEEecCChh------------HHHHHHHHHHHHHhcCCcceeEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSED------------VIKEFVLEIEIITTLHHKNIISLLG 410 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~----~g~~vAVK~l~~~~~------------~~~~~~~Ei~iL~~L~HpnIV~l~g 410 (696)
.++|.+.+.||+|+||.||+|... ++..+|||++..... ....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999975 578899999876431 1124667889999999999999999
Q ss_pred EEEe----cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC
Q 005450 411 FCFE----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 486 (696)
Q Consensus 411 ~~~~----~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~ 486 (696)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccC
Confidence 9988 67899999999 999999997554 58999999999999999999999 899999999999999887
Q ss_pred C--ceEEeecCccccccCCCCC-----cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccc
Q 005450 487 F--EPQLSDFGLAKWASTSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 559 (696)
Q Consensus 487 ~--~vKL~DFGlA~~~~~~~~~-----~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~ 559 (696)
+ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 9999999999876543211 11234679999999999998899999999999999999999999996533222
Q ss_pred hhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 560 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 560 ~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
........ ... ..+...+........-. ..+..++..||+.||.+||++.+|++.|+..
T Consensus 268 ~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 VAVQTAKT-NLL--DELPQSVLKWAPSGSSC---CEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHH-HHH--HTTTHHHHHHSCTTSCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHHH-hhc--ccccHHHHhhccccccH---HHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 11111100 000 01111111111110112 2455566679999999999999999999754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=351.90 Aligned_cols=262 Identities=19% Similarity=0.283 Sum_probs=204.3
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcC--------CcceeEEeeEEE----
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH--------HKNIISLLGFCF---- 413 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~--------HpnIV~l~g~~~---- 413 (696)
.++|.+.+.||+|+||+||+|.. .+++.||||+++......+.+.+|+.++..++ |+||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 47899999999999999999985 56889999999987777788999999999995 788999999997
Q ss_pred ecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCC-ceEeecccccceeeCCCC-----
Q 005450 414 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDF----- 487 (696)
Q Consensus 414 ~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~-gIIHrDLKpsNILLd~~~----- 487 (696)
.....++||||+ +++|.+.+..... ..+++..++.|+.||+.||.|||+ + +|+||||||+||||+.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhh
Confidence 556899999999 5567666654322 358999999999999999999999 7 899999999999999775
Q ss_pred --------------------------------------------ceEEeecCccccccCCCCCcccccccccCCCCCcce
Q 005450 488 --------------------------------------------EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523 (696)
Q Consensus 488 --------------------------------------------~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~ 523 (696)
.+||+|||++....... ....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccCChh
Confidence 79999999998765432 23579999999999
Q ss_pred eccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhh-------HHhhhcc--------------cc-ccCccccccC
Q 005450 524 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES-------LVMWAKP--------------IL-SSGKVTQLLD 581 (696)
Q Consensus 524 l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~-------lv~~~~~--------------~~-~~g~l~~llD 581 (696)
+.+..++.++|||||||+||||++|+.||.......... +...... .+ ..+.+..+.+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999998654332110 0000000 00 0011111100
Q ss_pred cc-------c--CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 582 PA-------L--GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 582 ~~-------L--~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.. + ...........+..++..||+.||.+|||+.++++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 0 01223455567778888999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=352.62 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=176.0
Q ss_pred eeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEeecCCCCh
Q 005450 353 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSL 430 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL 430 (696)
.+.||+|+||+||++... +|+.||||++... ....+.+|+.++..+. ||||++++++|.+....++||||+++|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 378999999999999874 6899999999753 3467788999999997 99999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC---ceEEeecCccccccCCCCCc
Q 005450 431 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 431 ~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~---~vKL~DFGlA~~~~~~~~~~ 507 (696)
.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++........
T Consensus 94 ~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~- 165 (325)
T 3kn6_A 94 FERIKKKK----HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP- 165 (325)
T ss_dssp HHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-
Confidence 99998653 58999999999999999999999 8999999999999997665 7999999999866543322
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~ 587 (696)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||..................+..+.... ..+..
T Consensus 166 -~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~--- 240 (325)
T 3kn6_A 166 -LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF-EGEAW--- 240 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC-CSHHH---
T ss_pred -ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC-Ccccc---
Confidence 2346789999999999999999999999999999999999999976543211000000000001111100 00000
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 588 YDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 588 ~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
......+..++..||+.||.+|||+.++++
T Consensus 241 --~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 241 --KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp --HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred --cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 011234556677799999999999998874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=350.06 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=204.1
Q ss_pred HHHHhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---------hHHHHHHHHHHHHHhc-CCcceeEEee
Q 005450 342 DLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------DVIKEFVLEIEIITTL-HHKNIISLLG 410 (696)
Q Consensus 342 el~~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~L-~HpnIV~l~g 410 (696)
......++|.+.+.||+|+||.||+|.+. +|+.||||+++... ...+.+.+|+.++.++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 33445678999999999999999999975 79999999987532 2246688999999999 7999999999
Q ss_pred EEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceE
Q 005450 411 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 490 (696)
Q Consensus 411 ~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vK 490 (696)
++...+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+|
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999997543 58999999999999999999999 8999999999999999999999
Q ss_pred EeecCccccccCCCCCcccccccccCCCCCcceecc------CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHH
Q 005450 491 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 564 (696)
Q Consensus 491 L~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~------~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv 564 (696)
|+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+
T Consensus 241 l~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i 317 (365)
T 2y7j_A 241 LSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317 (365)
T ss_dssp ECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999999987765432 234679999999999863 35889999999999999999999999765432221111
Q ss_pred hhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 565 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 565 ~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..... . ...+.. ... ...+..++..||+.||.+|||+.++++
T Consensus 318 ~~~~~-------~-~~~~~~-~~~----~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 318 MEGQY-------Q-FSSPEW-DDR----SSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHTCC-------C-CCHHHH-SSS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhCCC-------C-CCCccc-ccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11100 0 000000 011 123555667799999999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=349.33 Aligned_cols=264 Identities=19% Similarity=0.281 Sum_probs=193.8
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
..++|.+.+.||+|+||+||+|.. .+++.||||+++... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 346799999999999999999985 478999999997543 3345678999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee-----CCCCceEEeecCc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-----SDDFEPQLSDFGL 496 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL-----d~~~~vKL~DFGl 496 (696)
|||+++ +|.+++.... .+++..+..|+.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+
T Consensus 112 ~e~~~~-~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCSE-EHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCCC-CHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999985 9999997654 48999999999999999999999 899999999999999 4555699999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCc
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 575 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 575 (696)
+......... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+...........
T Consensus 184 a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 184 ARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 9876543222 2335789999999999864 489999999999999999999999987654333222211111111000
Q ss_pred cc------cccC--cccCCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 576 VT------QLLD--PALGNN-----YDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 576 l~------~llD--~~L~~~-----~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.. .+.. +..... ........+..++..||+.||.+|||+.++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 0000 000000 00001234556777899999999999999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=365.33 Aligned_cols=246 Identities=24% Similarity=0.389 Sum_probs=203.4
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367999999999999999999965 79999999997532 3356789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999997543 58999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCCCCcceeccCCC-CCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~-s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
.... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+.. +..
T Consensus 168 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-------~~~---- 233 (476)
T 2y94_A 168 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD-------GIF---- 233 (476)
T ss_dssp TTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHT-------TCC----
T ss_pred cccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc-------CCc----
Confidence 5332 234679999999999987765 6799999999999999999999986554322211111 100
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
......+ ..+..++..||+.||.+|||+.++++
T Consensus 234 --~~p~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 --YTPQYLN----PSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --CCCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCCccCC----HHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0011111 23455667799999999999999997
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=337.38 Aligned_cols=247 Identities=28% Similarity=0.458 Sum_probs=204.2
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
+.|.+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++..++||||+++++++......++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4689999999999999999985 47899999999754 34567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999998642 48999999999999999999999 899999999999999999999999999998765433
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+... . .+.+
T Consensus 174 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------~-----~~~~ 239 (303)
T 3a7i_A 174 IK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-------N-----PPTL 239 (303)
T ss_dssp CC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-------C-----CCCC
T ss_pred cc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC-------C-----CCCC
Confidence 22 23467999999999999999999999999999999999999999765433221111110 0 0111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
...++ ..+..++..||+.||.+|||+.++++.
T Consensus 240 ~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNYS----KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSCC----HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccccC----HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11222 235566677999999999999999863
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=355.04 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=192.9
Q ss_pred cCceeeeeeeccCceEEEEEEeC--CC--CEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe-cCceEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP--DG--KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLL 420 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~--~g--~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~-~~~~~L 420 (696)
..|.+.+.||+|+||.||+|... ++ ..||||.++.. ....+.+.+|+.++++++||||++++++|.. ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35778899999999999999853 32 36899998753 3556789999999999999999999998764 567899
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 169 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccc
Confidence 999999999999997543 257899999999999999999999 89999999999999999999999999999866
Q ss_pred cCCCCCc--ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 501 STSSSHI--TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 501 ~~~~~~~--~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |.+||...........+......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~------- 315 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------- 315 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC-------
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 4432211 1223567889999999999999999999999999999999 77788765543332222111100
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.. .... . ..+..++..||+.||.+||++.++++.|+..
T Consensus 316 --~~---p~~~-~---~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 316 --LQ---PEYC-P---DPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp --CC---CTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CC---CCCC-C---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 1111 1 2455666779999999999999999998743
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=356.27 Aligned_cols=270 Identities=20% Similarity=0.301 Sum_probs=208.1
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecC--ceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~--~~~LV 421 (696)
.++|.+.+.||+|+||+||+|... +|+.||||+++... ...+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 457999999999999999999875 58999999997533 34577889999999999999999999998755 78999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee----CCCCceEEeecCcc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLA 497 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL----d~~~~vKL~DFGlA 497 (696)
|||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999975432 2248999999999999999999999 899999999999999 77888999999999
Q ss_pred ccccCCCCCcccccccccCCCCCcceecc--------CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchh-hHHh-h-
Q 005450 498 KWASTSSSHITCTDVAGTFGYLAPEYFMY--------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-SLVM-W- 566 (696)
Q Consensus 498 ~~~~~~~~~~~~~~~~GT~~YlAPE~l~~--------~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~-~lv~-~- 566 (696)
+....... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||......... .... .
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp EECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred eEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 87654322 233679999999999865 56788999999999999999999999754322211 1111 1
Q ss_pred -hcccc--------ccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 567 -AKPIL--------SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 567 -~~~~~--------~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
..+.. ..+.+.-.-+..............+..++..||+.||++||++.++++.+..
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 11100 0000000000011122334555667778888999999999999999987754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=346.31 Aligned_cols=256 Identities=24% Similarity=0.364 Sum_probs=194.5
Q ss_pred hcCceee-eeeeccCceEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEE
Q 005450 347 TSNFLAE-NLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 347 t~~f~~~-~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
.+.|.+. +.||+|+||+||+|.. .+++.||||++.... .....+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 7899999999999985 478999999997543 4467889999999985 7999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc---eEEeecCcccc
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLAKW 499 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~---vKL~DFGlA~~ 499 (696)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 9999999999997643 48899999999999999999999 89999999999999998776 99999999986
Q ss_pred ccCCCC-----CcccccccccCCCCCcceecc-----CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchh--------
Q 005450 500 ASTSSS-----HITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-------- 561 (696)
Q Consensus 500 ~~~~~~-----~~~~~~~~GT~~YlAPE~l~~-----~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~-------- 561 (696)
...... ........||+.|+|||++.. ..++.++|||||||++|+|++|+.||.........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 543211 111123569999999999875 56899999999999999999999999876433210
Q ss_pred ----hHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 562 ----SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 562 ----~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+.... ..+.. .+..... .. ....+..++..||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~i----~~~~~-~~~~~~~-~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESI----QEGKY-EFPDKDW-AH----ISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHH----HHCCC-CCCHHHH-TT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHH----hccCc-ccCchhc-cc----CCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000000 00000 0000000 01 1134556777799999999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.19 Aligned_cols=258 Identities=21% Similarity=0.277 Sum_probs=197.2
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|+.++..++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999965 7889999999753 23457889999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999997543 48999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+. ... ....
T Consensus 186 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~---~~~~--- 255 (309)
T 2h34_A 186 DEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN---QAI---PRPS--- 255 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH---SCC---CCGG---
T ss_pred ccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc---cCC---CCcc---
Confidence 43222 2234579999999999998899999999999999999999999997654321111111 000 0000
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhhCCcc
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARP-QMSLVLKLLRGDAD 626 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RP-Sm~eVL~~L~~~~~ 626 (696)
.+...++ ..+..++..||+.||.+|| ++.++++.|+....
T Consensus 256 -~~~~~~~----~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 256 -TVRPGIP----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp -GTSTTCC----THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred -ccCCCCC----HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 0111111 2344566679999999999 89999999976543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=352.36 Aligned_cols=200 Identities=25% Similarity=0.435 Sum_probs=177.8
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.++|.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|+.++..++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999865 7899999999764 4556789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCC-ceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~-gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
|+++++|.+++.... .+++..+..++.+++.||.|||+ . +|+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999997643 48899999999999999999998 5 799999999999999999999999999976543
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~ 557 (696)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 185 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 185 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp HC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred cc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 21 1235799999999999999999999999999999999999999976544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=350.17 Aligned_cols=271 Identities=25% Similarity=0.346 Sum_probs=204.2
Q ss_pred hcCceeeeeeeccCceEEEEEEe-----CCCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC--ce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-----~~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~--~~ 418 (696)
.++|.+.+.||+|+||.||++.. .+|+.||||++... ....+.+.+|+++++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35689999999999999999983 46889999999764 355678999999999999999999999987644 78
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 99999999999999997653 258999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcc-cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcc-ccccCcc
Q 005450 499 WASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP-ILSSGKV 576 (696)
Q Consensus 499 ~~~~~~~~~~-~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~-~~~~g~l 576 (696)
.......... .....+|..|+|||++.+..++.++||||||+++|+|++|..||......... ....... ......+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR-MIGNDKQGQMIVFHL 272 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHH-HHCTTCCTHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHH-hhccccchhhhHHHH
Confidence 7765433211 12345788899999999888999999999999999999999998642110000 0000000 0000000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.+.+........+......+..++..||+.||.+|||+.++++.|+..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000000000001111123456677779999999999999999998753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=350.72 Aligned_cols=269 Identities=20% Similarity=0.246 Sum_probs=192.2
Q ss_pred HHhhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc-----
Q 005450 344 LSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 417 (696)
Q Consensus 344 ~~~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~----- 417 (696)
....++|.+.+.||+|+||.||+|.. .+|+.||||++.........+.+|++.+..++||||++++++|.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 34567899999999999999999997 468999999987765555677888999999999999999999976544
Q ss_pred --eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh--cCCCCceEeecccccceeeCC-CCceEEe
Q 005450 418 --LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH--SGSAQRVIHRDVKSSNILLSD-DFEPQLS 492 (696)
Q Consensus 418 --~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH--~~~~~gIIHrDLKpsNILLd~-~~~vKL~ 492 (696)
.++||||+++ +|...+.........+++..+..++.|++.||.||| + ++|+||||||+|||++. ++.+||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEe
Confidence 8899999987 555544432222346889999999999999999999 7 89999999999999996 8999999
Q ss_pred ecCccccccCCCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccc
Q 005450 493 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 571 (696)
Q Consensus 493 DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~ 571 (696)
|||+++........ ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.......
T Consensus 175 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 175 DFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp CCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 99999877654332 235789999999998655 48999999999999999999999998765443322221110000
Q ss_pred cc---------CccccccC------cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 572 SS---------GKVTQLLD------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 572 ~~---------g~l~~llD------~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.. .......+ ..............+..++..||+.||.+|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 00000000 00001111123456677778899999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=375.28 Aligned_cols=257 Identities=24% Similarity=0.421 Sum_probs=208.6
Q ss_pred hhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
..++|.+.+.||+|+||.||+|.+.++..||||+++......+.|.+|+++|++++||||+++++++.+ +..+|||||+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 456789999999999999999999888889999998766556789999999999999999999999876 6789999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++|+|.+++..... ..+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 344 ~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 344 SKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp TTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred cCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999974321 248899999999999999999999 8999999999999999999999999999986643211
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
.......+|..|+|||++..+.++.++|||||||+||||++ |+.||...........+.... .+ ..
T Consensus 419 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~------~~------~~ 485 (535)
T 2h8h_A 419 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------RM------PC 485 (535)
T ss_dssp -HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC------CC------CC
T ss_pred -ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------CC------CC
Confidence 11122457789999999999999999999999999999999 999997654432222111100 00 00
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
.... ...+..++..||+.||++|||+.+|++.|+...
T Consensus 486 ~~~~----~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 486 PPEC----PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111 234556677799999999999999999998654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=351.80 Aligned_cols=251 Identities=29% Similarity=0.406 Sum_probs=197.9
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
.++|.+.+.||+|+||.||++... +|+.||||++..... .+.+|++++.++ +||||+++++++.+++..++||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 457999999999999999999865 688999999976542 345688888888 799999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC----CceEEeecCccccc
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAKWA 500 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~----~~vKL~DFGlA~~~ 500 (696)
+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||+..+ +.+||+|||+++..
T Consensus 98 ~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 98 MKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999997543 58999999999999999999999 899999999999998543 34999999999876
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
...... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||..........+..... .+...
T Consensus 171 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~~~~--- 241 (342)
T 2qr7_A 171 RAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG----SGKFS--- 241 (342)
T ss_dssp BCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH----HCCCC---
T ss_pred cCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc----cCCcc---
Confidence 554322 234679999999999988889999999999999999999999998643332222221111 01110
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+...+.......+..++..||+.||.+||++.++++
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000111233455666799999999999999886
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=338.56 Aligned_cols=246 Identities=26% Similarity=0.423 Sum_probs=200.7
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe-----------
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----------- 414 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~----------- 414 (696)
..+|.+.+.||+|+||.||+|... +|+.||+|+++... ..+.+|++++..++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 457999999999999999999975 79999999998654 356789999999999999999998864
Q ss_pred -----cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCce
Q 005450 415 -----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 489 (696)
Q Consensus 415 -----~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~v 489 (696)
....++||||+++++|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCE
Confidence 4458999999999999999975422 358899999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcc
Q 005450 490 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 569 (696)
Q Consensus 490 KL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~ 569 (696)
||+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..|+.... .....
T Consensus 162 kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~~~~--- 230 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----KFFTD--- 230 (284)
T ss_dssp EECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----HHHHH---
T ss_pred EECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----HHHHH---
Confidence 99999999877654322 23569999999999998899999999999999999999998874211 11100
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 570 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 570 ~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
...+. +...++ ..+..++..||+.||.+|||+.++++.|...
T Consensus 231 -~~~~~--------~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 231 -LRDGI--------ISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp -HHTTC--------CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -hhccc--------ccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00111 111122 2345566779999999999999999998643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=349.71 Aligned_cols=245 Identities=28% Similarity=0.414 Sum_probs=198.1
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
+.|...+.||+|+||+||+|.. .+|+.||||++... ....+.+.+|++++.+++||||++++++|...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4589999999999999999985 57899999998643 244567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+. |+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 58888876433 258999999999999999999999 8999999999999999999999999999986643
Q ss_pred CCCCcccccccccCCCCCcceec---cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~---~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
. ....||+.|+|||++. .+.++.++|||||||++|||++|+.||...........+. . +..
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~--~-----~~~--- 270 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA--Q-----NES--- 270 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--H-----SCC---
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--h-----cCC---
Confidence 2 2357999999999984 5679999999999999999999999997654322211111 1 000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
+.+....-. ..+..++..||+.||.+|||+.++++.
T Consensus 271 --~~~~~~~~~---~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 --PALQSGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp --CCCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --CCCCCCCCC---HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111111112 234456667999999999999999863
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=356.91 Aligned_cols=266 Identities=20% Similarity=0.248 Sum_probs=196.9
Q ss_pred HHhhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-------
Q 005450 344 LSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED------- 415 (696)
Q Consensus 344 ~~~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~------- 415 (696)
....++|.+.+.||+|+||+||+|.. .+|+.||||++..... ...+|+.+++.++||||++++++|...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 34578899999999999999999985 5799999999875432 234799999999999999999998543
Q ss_pred -------------------------------CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh
Q 005450 416 -------------------------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464 (696)
Q Consensus 416 -------------------------------~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH 464 (696)
...++||||+++ +|.+.+.........+++..+..++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 348899999985 888777643223346899999999999999999999
Q ss_pred cCCCCceEeecccccceeeC-CCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHH
Q 005450 465 SGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVL 542 (696)
Q Consensus 465 ~~~~~gIIHrDLKpsNILLd-~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL 542 (696)
+ ++|+||||||+|||++ .++.+||+|||+|+........ ....||+.|+|||++.+. .++.++|||||||++
T Consensus 159 ~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 S---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp T---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred H---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9 8999999999999997 6889999999999876554332 235789999999998765 589999999999999
Q ss_pred HHHHhCCCCCCCCCccchhhHHhhhccc------------cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCC
Q 005450 543 LELLTGRKPISNDHPKGQESLVMWAKPI------------LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA 610 (696)
Q Consensus 543 ~ELltG~~Pf~~~~~~~~~~lv~~~~~~------------~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~ 610 (696)
|||++|+.||.+.....+...+...... .....+..+....+...++......+..++..||+.||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999876544332222111000 0000111111110000011111234566777799999999
Q ss_pred CCCHHHHHH
Q 005450 611 RPQMSLVLK 619 (696)
Q Consensus 611 RPSm~eVL~ 619 (696)
|||+.++++
T Consensus 313 R~t~~e~l~ 321 (383)
T 3eb0_A 313 RINPYEAMA 321 (383)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=337.39 Aligned_cols=247 Identities=25% Similarity=0.399 Sum_probs=203.5
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999975 5889999998653 34567788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999887543 58999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+... ..
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------~~----- 232 (294)
T 2rku_A 167 YDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------EY----- 232 (294)
T ss_dssp STTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------CC-----
T ss_pred cCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-------cC-----
Confidence 43222 23367999999999999888999999999999999999999999765433221111110 00
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+....+ ..+..++..||+.||.+|||+.++++
T Consensus 233 -~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 -SIPKHIN----PVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp -CCCTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -CCccccC----HHHHHHHHHHcccChhhCcCHHHHhh
Confidence 0111111 23455667799999999999999886
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.20 Aligned_cols=271 Identities=21% Similarity=0.268 Sum_probs=199.3
Q ss_pred ChHHHHHhhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCC------------hhHHHHHHHHHHHHHhcCCccee
Q 005450 339 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS------------EDVIKEFVLEIEIITTLHHKNII 406 (696)
Q Consensus 339 ~~~el~~~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~------------~~~~~~~~~Ei~iL~~L~HpnIV 406 (696)
...++....++|.+.+.||+|+||.||+|...+|+.||||++... ....+.+.+|++++.+++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 356778889999999999999999999999888999999998642 12347899999999999999999
Q ss_pred EEeeEEEec-----CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccce
Q 005450 407 SLLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 481 (696)
Q Consensus 407 ~l~g~~~~~-----~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNI 481 (696)
++++++... ...++||||+. |+|.+.+.... ..+++..+..++.||+.||.|||+ ++|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHE
Confidence 999998643 35899999998 58888887543 358999999999999999999999 8999999999999
Q ss_pred eeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccch
Q 005450 482 LLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 560 (696)
Q Consensus 482 LLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~ 560 (696)
|++.++.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999985544322 223579999999999876 6799999999999999999999999987654332
Q ss_pred hhHHhhhcccc--------ccCccccccCcccCCCC-------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 561 ESLVMWAKPIL--------SSGKVTQLLDPALGNNY-------DYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 561 ~~lv~~~~~~~--------~~g~l~~llD~~L~~~~-------~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
...+....... ........+...+.... .......+..++..||+.||.+|||+.++++
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 21111000000 00000000000000000 0011234556777899999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=337.81 Aligned_cols=250 Identities=29% Similarity=0.436 Sum_probs=195.8
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-CceEEEEeec
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED-NNLLLVYDFL 425 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~-~~~~LV~Ey~ 425 (696)
.++|.+.+.||+|+||.||++.. +|+.||||+++... ..+.+.+|+.++.+++||||+++++++.+. +..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 46799999999999999999987 58899999998643 457889999999999999999999997654 4789999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++++|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp TTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999999975421 137889999999999999999999 899999999999999999999999999998654422
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+. .+. ....
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-------~~~-----~~~~ 235 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGY-----KMDA 235 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-------TTC-----CCCC
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------cCC-----CCCC
Confidence 12457899999999998999999999999999999998 999997654332221111 010 0111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.... ...+..++..||+.||.+||++.++++.|+..
T Consensus 236 ~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 236 PDGC----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccC----CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 1111 23455566779999999999999999998753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=340.27 Aligned_cols=253 Identities=22% Similarity=0.314 Sum_probs=185.0
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh--h-HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--D-VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~--~-~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
..++|.+.+.||+|+||+||++.. .+|+.||||+++... . ..+.+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 357899999999999999999986 578999999997642 2 233344555568888999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCC-ceEeecccccceeeCCCCceEEeecCccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~-gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
|||+++ +|.+++.........+++..++.++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999975 8888776432223468999999999999999999999 7 8999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCCCCCccee----ccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYF----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l----~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
...... ....||+.|+|||++ ....++.++||||||+++|+|++|+.||......... +...... ..
T Consensus 161 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~-----~~ 231 (290)
T 3fme_A 161 VDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-LKQVVEE-----PS 231 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-HHHHHHS-----CC
T ss_pred cccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-HHHHhcc-----CC
Confidence 553322 224699999999996 5567899999999999999999999999754322211 1111110 00
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+..... .....+..++..||+.||.+|||+.++++
T Consensus 232 -----~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 -----PQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----CCCCTT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCcccc---cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 000000 11234556667799999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=356.95 Aligned_cols=252 Identities=26% Similarity=0.379 Sum_probs=190.9
Q ss_pred HhhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcCCcceeEEeeEEEe
Q 005450 345 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFE 414 (696)
Q Consensus 345 ~~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~ 414 (696)
...++|.+.+.||+|+||+||+|.. .+++.||||++.... .....+.+|+.+|.+++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 3467899999999999999999986 468999999987532 12235789999999999999999999975
Q ss_pred cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC---ceEE
Q 005450 415 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQL 491 (696)
Q Consensus 415 ~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~---~vKL 491 (696)
.+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++ .+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred cCceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEE
Confidence 456899999999999999987543 58999999999999999999999 8999999999999997544 5999
Q ss_pred eecCccccccCCCCCcccccccccCCCCCcceec---cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhh-HHhhh
Q 005450 492 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES-LVMWA 567 (696)
Q Consensus 492 ~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~---~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~-lv~~~ 567 (696)
+|||+++....... .....||+.|+|||++. ...++.++|||||||++|+|++|+.||.......... .+..
T Consensus 284 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~- 359 (419)
T 3i6u_A 284 TDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS- 359 (419)
T ss_dssp CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT-
T ss_pred eecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc-
Confidence 99999987654322 23467999999999985 3578889999999999999999999997654322211 1110
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 568 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 568 ~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
+.... .+..... ....+..++..||+.||.+|||+.++++.
T Consensus 360 ------~~~~~--~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 360 ------GKYNF--IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ------TCCCC--CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------CCCCC--Cchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 10000 0000001 12345566777999999999999999873
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=357.54 Aligned_cols=250 Identities=26% Similarity=0.325 Sum_probs=193.2
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHH-HHhcCCcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEI-ITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~i-L~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
.++|.+.+.||+|+||.||++..+ +++.||||+++... .....+..|..+ ++.++||||++++++|.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357999999999999999999965 68899999997532 334556677776 567899999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||++||+|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999997643 48899999999999999999999 89999999999999999999999999999864
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... + +
T Consensus 190 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~------~---- 256 (373)
T 2r5t_A 190 IEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-P------L---- 256 (373)
T ss_dssp BCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-C------C----
T ss_pred ccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-c------c----
Confidence 43222 223478999999999999999999999999999999999999999765443222211110 0 0
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
.+...++ ..+..++..||+.||.+||++.+.++.+.
T Consensus 257 --~~~~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 257 --QLKPNIT----NSARHLLEGLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp --CCCSSSC----HHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred --CCCCCCC----HHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence 0111111 23455666799999999999865444443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=344.83 Aligned_cols=255 Identities=20% Similarity=0.305 Sum_probs=200.7
Q ss_pred HHhhcCceee-eeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCc
Q 005450 344 LSATSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNN 417 (696)
Q Consensus 344 ~~~t~~f~~~-~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~ 417 (696)
....+.|.+. +.||+|+||.||+|... +|+.||+|+++.. ......+.+|+.++..+. ||||+++++++...+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3445567776 89999999999999865 6899999999753 234678899999999995 6999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC---CCceEEeec
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDF 494 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~---~~~vKL~DF 494 (696)
.++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELA--EMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 9999999999999999865422 358999999999999999999999 89999999999999987 789999999
Q ss_pred CccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC
Q 005450 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 495 GlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
|+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+........
T Consensus 179 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-- 253 (327)
T 3lm5_A 179 GMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS-- 253 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--
T ss_pred ccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC--
Confidence 99987654332 2236799999999999999999999999999999999999999977554332222211110000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 575 ~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. .........+..++..||+.||.+|||+.++++
T Consensus 254 -------~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 254 -------E----ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp -------T----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -------c----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0 000111233555667799999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=363.79 Aligned_cols=250 Identities=26% Similarity=0.363 Sum_probs=200.6
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh--------------hHHHHHHHHHHHHHhcCCcceeEEee
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--------------DVIKEFVLEIEIITTLHHKNIISLLG 410 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~--------------~~~~~~~~Ei~iL~~L~HpnIV~l~g 410 (696)
..++|.+.+.||+|+||+||+|... +++.||||+++... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999964 68899999987532 23567889999999999999999999
Q ss_pred EEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC---
Q 005450 411 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF--- 487 (696)
Q Consensus 411 ~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~--- 487 (696)
+|.+....++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999987543 48999999999999999999999 8999999999999998775
Q ss_pred ceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhh
Q 005450 488 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 567 (696)
Q Consensus 488 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~ 567 (696)
.+||+|||++........ .....||+.|+|||++. +.++.++|||||||++|+|++|+.||...........+...
T Consensus 187 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262 (504)
T ss_dssp SEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred cEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 699999999987765432 23467999999999987 57999999999999999999999999876543332222211
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 568 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 568 ~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..... ....... ...+..++..||+.||.+|||+.++++
T Consensus 263 ~~~~~---------~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 263 KYYFD---------FNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCCCC---------HHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCC---------ccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11000 0000011 123555667799999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=350.99 Aligned_cols=241 Identities=22% Similarity=0.359 Sum_probs=199.3
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecC
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 416 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~ 416 (696)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+|+.++..++||||++++++|.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46799999999999999999985 578899999997642 13346778999999999999999999999999
Q ss_pred ceEEEEeecCCC-ChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecC
Q 005450 417 NLLLVYDFLSRG-SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 495 (696)
Q Consensus 417 ~~~LV~Ey~~gG-sL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFG 495 (696)
..++||||+.+| +|.+++.... .+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999777 9999997654 48999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCCCCcceeccCCC-CCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC
Q 005450 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 496 lA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~-s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
++......... ....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... . ...
T Consensus 176 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~---~~~---- 240 (335)
T 3dls_A 176 SAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----V---EAA---- 240 (335)
T ss_dssp TCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----T---TTC----
T ss_pred cceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----H---hhc----
Confidence 99877654332 23679999999999988776 78999999999999999999999642110 0 000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 575 ~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
..+ ...+ ...+..++..||+.||.+|||+.++++.
T Consensus 241 -----~~~--~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 241 -----IHP--PYLV----SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----CCC--SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----cCC--Cccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0011 1235556677999999999999999984
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.87 Aligned_cols=260 Identities=25% Similarity=0.426 Sum_probs=200.2
Q ss_pred cChHHHHHhhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEe-
Q 005450 338 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE- 414 (696)
Q Consensus 338 f~~~el~~~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~- 414 (696)
+++.++....++|.+.+.||+|+||.||+|.. .+|+.||||++.........+.+|+.++.++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 34444555678999999999999999999996 5789999999987666667889999999999 79999999999987
Q ss_pred -----cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCce
Q 005450 415 -----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 489 (696)
Q Consensus 415 -----~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~v 489 (696)
.+..++||||+++++|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCE
Confidence 4678999999999999999976432 358899999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCcccccccccCCCCCcceec-----cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHH
Q 005450 490 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 564 (696)
Q Consensus 490 KL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~-----~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv 564 (696)
||+|||++......... .....||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+
T Consensus 169 kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 246 (326)
T ss_dssp EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred EEeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence 99999999866543221 22357999999999987 567899999999999999999999999765433221111
Q ss_pred hhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 565 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 565 ~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.. ....... ...+ . ..+..++..||..||.+||++.++++
T Consensus 247 ~~-------~~~~~~~----~~~~-~---~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 247 PR-------NPAPRLK----SKKW-S---KKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HH-------SCCCCCS----CSCS-C---HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hc-------CccccCC----cccc-C---HHHHHHHHHHhccChhhCCCHHHHhh
Confidence 10 0000110 1111 1 24555666799999999999999987
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=363.58 Aligned_cols=193 Identities=23% Similarity=0.369 Sum_probs=155.0
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-----Cc
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 417 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~-----~~ 417 (696)
.++|.+.+.||+|+||+||+|... +|+.||||++... ....+.+.+|+.+|..++||||++++++|... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999864 7899999998652 34567899999999999999999999999543 57
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA 497 (696)
+|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+ .+||||||||+||||+.++.+||+|||+|
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 569999987543 58999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC-------------------------cccccccccCCCCCccee-ccCCCCCcccchhhHHHHHHHHh
Q 005450 498 KWASTSSSH-------------------------ITCTDVAGTFGYLAPEYF-MYGKVNDKIDVYAFGVVLLELLT 547 (696)
Q Consensus 498 ~~~~~~~~~-------------------------~~~~~~~GT~~YlAPE~l-~~~~~s~ksDVwSLGvvL~ELlt 547 (696)
+........ ...+..+||+.|+|||++ ....|+.++||||||||||||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 876532211 122346789999999986 45679999999999999999999
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=373.98 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=199.7
Q ss_pred hcCceeee-eeeccCceEEEEEEeC---CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAEN-LIGKGGSSQVYKGCLP---DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~-~LG~G~fG~Vyka~~~---~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
.+++.+.+ .||+|+||.||+|... ++..||||+++.. ....+.|.+|+++|.+++||||++++++|.. +..++
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 34555555 8999999999999863 5667999999863 3456889999999999999999999999976 57999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++|+|.+++.... ..+++..+..|+.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 413 v~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEECCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEEeCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 999999999999997543 358999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCc-ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 501 STSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 501 ~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
....... ......+|+.|+|||++.++.++.++|||||||+||||++ |+.||...........+.. +...
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-------~~~~- 558 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-------GKRM- 558 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT-------TCCC-
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------CCCC-
Confidence 5433221 1122346789999999999999999999999999999998 9999987654332222211 1100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
..... ....+..++..||+.+|.+||++.+|++.|+.
T Consensus 559 ----~~p~~----~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 559 ----ECPPE----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp ----CCCTT----CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred ----CCCCc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 01111 12345566777999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=358.76 Aligned_cols=202 Identities=27% Similarity=0.372 Sum_probs=178.8
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhc------CCcceeEEeeEEEecCceE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL------HHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L------~HpnIV~l~g~~~~~~~~~ 419 (696)
..+|.+.+.||+|+||+||+|... +++.||||+++........+.+|+.++..+ +|+||+++++++...+..+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 457999999999999999999864 688999999998877778888999999888 5679999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc--eEEeecCcc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--PQLSDFGLA 497 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~--vKL~DFGlA 497 (696)
+||||+. ++|.+++..... ..+++..+..|+.||+.||+|||+ ++|+||||||+||||+.++. +||+|||++
T Consensus 176 lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 9999996 599999876543 248999999999999999999999 89999999999999999887 999999999
Q ss_pred ccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccc
Q 005450 498 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 559 (696)
Q Consensus 498 ~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~ 559 (696)
....... ....||+.|+|||++.+..++.++|||||||+||||++|+.||.......
T Consensus 250 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 306 (429)
T 3kvw_A 250 CYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306 (429)
T ss_dssp EETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred eecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 7654422 23579999999999999999999999999999999999999998765443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=344.65 Aligned_cols=260 Identities=22% Similarity=0.342 Sum_probs=197.7
Q ss_pred ccChHHHHHhhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcC--CcceeEEeeE
Q 005450 337 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLH--HKNIISLLGF 411 (696)
Q Consensus 337 ~f~~~el~~~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~--HpnIV~l~g~ 411 (696)
.+.++.+....++|.+.+.||+|+||.||++...+++.||||++... ....+.+.+|+.++.+++ ||||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 34444455567789999999999999999999988999999999643 455678999999999997 5999999999
Q ss_pred EEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEE
Q 005450 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 491 (696)
Q Consensus 412 ~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL 491 (696)
+...+..++||| +.+++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||+++ +.+||
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEE
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEE
Confidence 999999999999 56889999998653 58899999999999999999999 89999999999999965 79999
Q ss_pred eecCccccccCCCCCcccccccccCCCCCcceecc-----------CCCCCcccchhhHHHHHHHHhCCCCCCCCCccch
Q 005450 492 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 560 (696)
Q Consensus 492 ~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~-----------~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~ 560 (696)
+|||++................||+.|+|||++.. ..++.++||||||+++|+|++|+.||........
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH
Confidence 99999987755433333334679999999999875 4788899999999999999999999976433211
Q ss_pred hhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 561 ESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 561 ~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+..... +.....++......+..++..||+.||.+||++.++++
T Consensus 248 -~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 248 -KLHAIID-------------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp -HHHHHHC-------------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHHHh-------------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 1111111 10000111111234555667799999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=338.31 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=200.9
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
..++|.+.+.||+|+||.||++... +|+.||+|+++... ...+.+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467999999999999999999864 78999999998653 334578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee---CCCCceEEeecCccccc
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL---d~~~~vKL~DFGlA~~~ 500 (696)
|+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999999987543 48899999999999999999999 899999999999999 78899999999999755
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+..... . +
T Consensus 160 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-----~----~ 226 (304)
T 2jam_A 160 QNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY-----E----F 226 (304)
T ss_dssp CCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCC-----C----C
T ss_pred CCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-----C----C
Confidence 4321 2235699999999999999999999999999999999999999976543322111111100 0 0
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
........ ...+..++..||+.||.+|||+.++++
T Consensus 227 ~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 ESPFWDDI----SESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CTTTTTTS----CHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CccccccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111111 234556677799999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=335.36 Aligned_cols=244 Identities=25% Similarity=0.388 Sum_probs=201.7
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||.||+|... +++.||+|++.... .....+.+|++++..++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999865 67889999996532 23467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999997643 48899999999999999999999 8999999999999999999999999999976544
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+... . .
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------~------~ 229 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-------D------L 229 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------C------C
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-------c------c
Confidence 22 12357999999999999989999999999999999999999999765432221111110 0 0
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+...+ ...+..++..||+.||.+||++.++++
T Consensus 230 ~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 KFPPFL----SDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCcC----CHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 111111 134455667799999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=353.30 Aligned_cols=254 Identities=26% Similarity=0.364 Sum_probs=200.8
Q ss_pred hcCceeeeeeeccCceEEEEEEe----CCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhc-CCcceeEEeeEEEecC
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 416 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~ 416 (696)
.++|.+.+.||+|+||.||++.. .+|+.||||+++... ...+.+.+|+.++..+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999986 478999999987532 3345677899999999 6999999999999999
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCc
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGl 496 (696)
..++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999997543 48899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceeccC--CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~--~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
++........ ......||+.|+|||++.++ .++.++|||||||+||||++|+.||...........+.. .....
T Consensus 206 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~~~- 281 (355)
T 1vzo_A 206 SKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--RILKS- 281 (355)
T ss_dssp EEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--HHHHC-
T ss_pred CeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH--HHhcc-
Confidence 9866443222 22346799999999999853 478999999999999999999999976543322111110 00000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 005450 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKLL 621 (696)
Q Consensus 575 ~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~~L 621 (696)
.+.+...+ ...+..++..||+.||.+|| ++.++++..
T Consensus 282 ------~~~~~~~~----~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 ------EPPYPQEM----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ------CCCCCTTS----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ------CCCCCccc----CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 01111111 23345566779999999999 999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=361.93 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=200.7
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
.++|.+.+.||+|+||+||++... +++.||||++... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 456999999999999999999864 7899999998642 234577899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC---CCCceEEeecCcccc
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKW 499 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd---~~~~vKL~DFGlA~~ 499 (696)
||+.+|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999887543 48999999999999999999999 8999999999999995 456799999999987
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+.........
T Consensus 174 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------ 243 (486)
T 3mwu_A 174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL------ 243 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS------
T ss_pred CCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC------
Confidence 654332 234679999999999874 6999999999999999999999999876543322222211110000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
+.. ......+..++..||+.||.+|||+.++++.
T Consensus 244 --~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 --PQW-----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp --GGG-----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred --ccc-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0011234556677999999999999999973
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=359.19 Aligned_cols=242 Identities=13% Similarity=0.190 Sum_probs=188.1
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecC----ChhHHHHHHHHH---HHHHhcCCcceeEEe-------eE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEI---EIITTLHHKNIISLL-------GF 411 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~----~~~~~~~~~~Ei---~iL~~L~HpnIV~l~-------g~ 411 (696)
.++|.+.+.||+|+||+||+|.. .+|+.||||++.. .....+.+.+|+ ++++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999996 5799999999863 335667899999 455556899999998 66
Q ss_pred EEecC-----------------ceEEEEeecCCCChhhhhhcCCCC---CCCCChHHHHHHHHHHHHHHHHHhcCCCCce
Q 005450 412 CFEDN-----------------NLLLVYDFLSRGSLEENLHGNKKD---PAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471 (696)
Q Consensus 412 ~~~~~-----------------~~~LV~Ey~~gGsL~~~L~~~~~~---~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gI 471 (696)
+...+ ..++||||+ +|+|.+++...... ...+++..++.|+.||+.||+|||+ ++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 55443 389999999 67999999754211 1234468889999999999999999 899
Q ss_pred EeecccccceeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccC-----------CCCCcccchhhHH
Q 005450 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----------KVNDKIDVYAFGV 540 (696)
Q Consensus 472 IHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~-----------~~s~ksDVwSLGv 540 (696)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985433 2234568 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 541 VLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 541 vL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+||||++|+.||...........+ ... ...++ ..+..++..||+.||.+|||+.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~---------------~~~--~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWI---------------FRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGG---------------GSS--CCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchhhh---------------hhh--ccCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999765432221111 000 01111 23555667799999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=351.36 Aligned_cols=262 Identities=16% Similarity=0.230 Sum_probs=202.0
Q ss_pred hcCceeeeeeeccCceEEEEEEeCC---------CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeE----------
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPD---------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS---------- 407 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~---------g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~---------- 407 (696)
.++|.+.+.||+|+||.||+|.... ++.||||++... +.+.+|++++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 3689999999999999999998753 789999999865 36788999999999999987
Q ss_pred -----EeeEEEe-cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccce
Q 005450 408 -----LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 481 (696)
Q Consensus 408 -----l~g~~~~-~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNI 481 (696)
+++++.. ++..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NI 190 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENI 190 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHE
Confidence 6777776 67899999999 999999998652 1358999999999999999999999 8999999999999
Q ss_pred eeCCCC--ceEEeecCccccccCCCCCc-----ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCC
Q 005450 482 LLSDDF--EPQLSDFGLAKWASTSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 554 (696)
Q Consensus 482 LLd~~~--~vKL~DFGlA~~~~~~~~~~-----~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~ 554 (696)
|++.++ .+||+|||+++......... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 89999999998765432211 11335799999999999988999999999999999999999999986
Q ss_pred CCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 555 DHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 555 ~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
........ ....... ......+.+.......-. ..+..++..||+.||.+||++.++++.|+..
T Consensus 271 ~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 271 CLPNTEDI-MKQKQKF--VDKPGPFVGPCGHWIRPS---ETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GTTCHHHH-HHHHHHH--HHSCCCEECTTSCEECCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CCcCHHHH-HHHHHhc--cCChhhhhhhccccCCCc---HHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 54222211 1111100 001111111111100112 3455566679999999999999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=368.01 Aligned_cols=249 Identities=25% Similarity=0.369 Sum_probs=202.5
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|...+.||+|+||.||++... +|+.||||++.... .....+.+|+.++..++||||++++++|...+.+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999974 69999999997532 3346788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||++||+|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+||||+.++++||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999998665444579999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccch-hhHHhhhccccccCcccccc
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ-ESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~-~~lv~~~~~~~~~g~l~~ll 580 (696)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+.... .. +.
T Consensus 341 ~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i---~~-~~----- 409 (543)
T 3c4z_A 341 AGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV---LE-QA----- 409 (543)
T ss_dssp TTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH---HH-CC-----
T ss_pred CCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH---hh-cc-----
Confidence 54322 2336899999999999999999999999999999999999999987543221 1111110 00 00
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQM 614 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm 614 (696)
..+...+ ...+..++..||+.||.+||++
T Consensus 410 -~~~p~~~----s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 410 -VTYPDKF----SPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp -CCCCTTS----CHHHHHHHHHHSCSSGGGSCCC
T ss_pred -cCCCccc----CHHHHHHHHHhccCCHhHCCCC
Confidence 0011111 1234456667999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=344.91 Aligned_cols=247 Identities=25% Similarity=0.396 Sum_probs=203.9
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999975 5789999998653 34567889999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999987543 58999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.....
T Consensus 193 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------------ 258 (335)
T 2owb_A 193 YDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY------------ 258 (335)
T ss_dssp STTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC------------
T ss_pred cCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC------------
Confidence 43222 2336799999999999988999999999999999999999999976543222111111100
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+...++ ..+..++..||+.||.+||++.++++
T Consensus 259 -~~~~~~~----~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 -SIPKHIN----PVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -CCCTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -CCCccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111111 23455667799999999999999886
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=363.49 Aligned_cols=249 Identities=25% Similarity=0.370 Sum_probs=203.1
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|+||.||++... +|+.||||++... ......+.+|+.++++++||||++++++|.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457999999999999999999965 7899999998643 34567899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee---CCCCceEEeecCccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAK 498 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL---d~~~~vKL~DFGlA~ 498 (696)
|||+.+|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++.
T Consensus 105 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999997543 48999999999999999999999 899999999999999 567899999999998
Q ss_pred cccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 499 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 499 ~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+.........
T Consensus 178 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----- 248 (484)
T 3nyv_A 178 HFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL----- 248 (484)
T ss_dssp HBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-----
T ss_pred Ecccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC-----
Confidence 7755432 233679999999999875 7999999999999999999999999876543332222211110000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+.. ......+..++..||+.+|.+|||+.++++
T Consensus 249 ---~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 249 ---PQW-----KKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ---GGG-----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---ccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 000 011133555667799999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=349.86 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=195.5
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC------
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 416 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~------ 416 (696)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.. .....+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 56899999999999999999986 5799999999964 3345678899999999999999999999997653
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCc
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGl 496 (696)
..|+||||+ +++|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 88999999753 48899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCc
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 575 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 575 (696)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.....+...+...........
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9876542 233579999999999886 6799999999999999999999999987654433322211110000000
Q ss_pred ---------------cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 576 ---------------VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 576 ---------------l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+.......+.. ........+..++..||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00000000000 00111234555667799999999999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=335.77 Aligned_cols=246 Identities=26% Similarity=0.372 Sum_probs=196.5
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe----cCceE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLL 419 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~----~~~~~ 419 (696)
..|.+.+.||+|+||.||+|.. .++..||+|++... ....+.+.+|+.+++.++||||++++++|.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 3478889999999999999986 46889999998753 4556789999999999999999999999875 35589
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCc--eEeecccccceeeC-CCCceEEeecCc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLS-DDFEPQLSDFGL 496 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~g--IIHrDLKpsNILLd-~~~~vKL~DFGl 496 (696)
+||||+++++|.+++.... .+++..++.++.||+.||.|||+ .+ |+||||||+|||++ .++.+||+|||+
T Consensus 106 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999997643 48899999999999999999999 67 99999999999998 789999999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
+....... .....||+.|+|||++. +.++.++||||||+++|+|++|+.||......... ...... +..
T Consensus 179 ~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~----~~~ 247 (290)
T 1t4h_A 179 ATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRVTS----GVK 247 (290)
T ss_dssp GGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHHHTT----TCC
T ss_pred cccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--HHHHhc----cCC
Confidence 97554432 22357999999999887 56999999999999999999999999764432221 111110 100
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
... +... . ...+..++..||+.||.+|||+.++++
T Consensus 248 ~~~----~~~~-~---~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 PAS----FDKV-A---IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CGG----GGGC-C---CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccc----cCCC-C---CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 011 1111 1 124556677799999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=352.67 Aligned_cols=253 Identities=13% Similarity=0.080 Sum_probs=180.5
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc--CCcceeEEe-------eEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL--HHKNIISLL-------GFC 412 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L--~HpnIV~l~-------g~~ 412 (696)
..+|.+.+.||+|+||.||+|... +|+.||||+++.. ....+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345899999999999999999964 7899999999873 34556777886555555 699988865 444
Q ss_pred Eec-----------------CceEEEEeecCCCChhhhhhcCCCCCCCCChHHH------HHHHHHHHHHHHHHhcCCCC
Q 005450 413 FED-----------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQ 469 (696)
Q Consensus 413 ~~~-----------------~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~------~~Ia~qIa~aL~yLH~~~~~ 469 (696)
... ...++||||++ |+|.+++..... .+.+..+ +.++.||+.||+|||+ +
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~ 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS---K 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH---C
Confidence 332 33899999999 899999975422 3455666 7888999999999999 8
Q ss_pred ceEeecccccceeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceecc--CCCCCcccchhhHHHHHHHHh
Q 005450 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLT 547 (696)
Q Consensus 470 gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~--~~~s~ksDVwSLGvvL~ELlt 547 (696)
+|+||||||+|||++.++.+||+|||+|+...... ....||+.|+|||++.+ ..++.++|||||||+||||++
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 99999999999999999999999999998664321 13467899999999987 679999999999999999999
Q ss_pred CCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 548 GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 548 G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
|+.||....+..... +...............+. .......+..++..||+.||.+|||+.++++
T Consensus 289 g~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKGS---WKRPSLRVPGTDSLAFGS-----CTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTTC---CCBCCTTSCCCCSCCCTT-----SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCcccccc---hhhhhhhhccccccchhh-----ccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999998764432211 111000000000000000 0111234555667799999999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=331.95 Aligned_cols=246 Identities=23% Similarity=0.376 Sum_probs=194.2
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999975 79999999997532 3356788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++++|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999997543 48899999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCCCCcceeccCCC-CCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~-s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
.... .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...........+.....
T Consensus 163 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 228 (276)
T 2h6d_A 163 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF----------- 228 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------
T ss_pred CCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-----------
Confidence 4322 123569999999999987665 6899999999999999999999976543222111110000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+....+ ..+..++..||+.||.+|||+.++++
T Consensus 229 --~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 --YIPEYLN----RSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp --CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --cCchhcC----HHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0111111 23555677799999999999999997
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=362.38 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=197.8
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
.++|.+.+.||+|+||+||+|... ++..||+|+++... .....+.+|+.+++.++||||++++++|.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456999999999999999999965 78999999997532 33567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC---CceEEeecCcccc
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKW 499 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~---~~vKL~DFGlA~~ 499 (696)
||+++|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999887543 48899999999999999999999 899999999999999764 4599999999987
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
...... .....||+.|+|||++. +.++.++|||||||++|+|++|+.||...........+......+.
T Consensus 189 ~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------- 257 (494)
T 3lij_A 189 FENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD------- 257 (494)
T ss_dssp CBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-------
T ss_pred CCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence 765332 23467999999999886 5799999999999999999999999987654433222221111110
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+.. ... ...+..++..||+.||.+|||+.++++
T Consensus 258 -~~~~-~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 -SPEW-KNV----SEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -SGGG-TTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -chhc-ccC----CHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0111 011 123455667799999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=340.03 Aligned_cols=264 Identities=28% Similarity=0.442 Sum_probs=186.4
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
..++|.+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 457899999999999999999986 47899999998754 244567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcC----CCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 423 DFLSRGSLEENLHGN----KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~----~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
||+++++|.+++... ......+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998631 1122358999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC---cccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC
Q 005450 499 WASTSSSH---ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 499 ~~~~~~~~---~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
........ .......||+.|+|||++.. ..++.++||||||+++|+|++|+.||................+ ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~ 246 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP---PS 246 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC---CC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC---Cc
Confidence 66543211 11223579999999999875 5689999999999999999999999987654332211111100 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 575 ~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
......++.....++ ..+..++..||+.||.+||++.++++
T Consensus 247 ~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 247 LETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000111111112222 24555667799999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=333.98 Aligned_cols=250 Identities=23% Similarity=0.320 Sum_probs=198.5
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhcCCcceeEEeeEEE--ecCce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCF--EDNNL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~--~~~~~ 418 (696)
.++|.+.+.||+|+||.||++.. .+++.||+|+++... .....+.+|+.++..++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999996 468999999997532 34578999999999999999999999984 45689
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
++||||++++ |.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999886 7777765432 368999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCCCCCcceeccCC--CCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 499 WASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 499 ~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~--~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
...............||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...........+... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~-------~~ 230 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG-------SY 230 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-------CC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-------CC
Confidence 776543333444567999999999987643 477999999999999999999999865432222111111 00
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+.... ...+..++..||+.||.+|||+.++++
T Consensus 231 ------~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 231 ------AIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp ------CCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------CCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011111 123455667799999999999999997
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=332.91 Aligned_cols=251 Identities=26% Similarity=0.372 Sum_probs=202.3
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----------hHHHHHHHHHHHHHhcC-CcceeEEeeEEE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----------DVIKEFVLEIEIITTLH-HKNIISLLGFCF 413 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----------~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~ 413 (696)
..++|.+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|++++.++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3468999999999999999999974 68999999996532 33567889999999996 999999999999
Q ss_pred ecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEee
Q 005450 414 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 493 (696)
Q Consensus 414 ~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~D 493 (696)
..+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999997543 58999999999999999999999 8999999999999999999999999
Q ss_pred cCccccccCCCCCcccccccccCCCCCcceec------cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhh
Q 005450 494 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFM------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 567 (696)
Q Consensus 494 FGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~------~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~ 567 (696)
||++........ .....||+.|+|||++. ...++.++||||||+++|+|++|+.||...........+...
T Consensus 168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 168 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred ccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 999987654332 22357999999999885 456889999999999999999999999765432222111111
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 568 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 568 ~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.... ..+. .......+..++..||+.||.+|||+.++++
T Consensus 245 ~~~~--------~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 NYQF--------GSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCCC--------CTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Cccc--------Cccc-----ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1000 0000 0111234556677799999999999999886
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=347.60 Aligned_cols=211 Identities=24% Similarity=0.328 Sum_probs=180.8
Q ss_pred hHHHHHhhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcC-Cc-----ceeEEeeEE
Q 005450 340 YQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HK-----NIISLLGFC 412 (696)
Q Consensus 340 ~~el~~~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~-Hp-----nIV~l~g~~ 412 (696)
........++|.+.+.||+|+||+||+|... +++.||||+++........+..|+.++..++ |+ +|+++++++
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 3334445689999999999999999999865 6889999999987777788889999998885 44 599999999
Q ss_pred EecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC--CCCceE
Q 005450 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQ 490 (696)
Q Consensus 413 ~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd--~~~~vK 490 (696)
...+..++||||+.+ +|.+++..... ..+++..+..++.|++.||.|||... .+|+||||||+|||++ .++.+|
T Consensus 126 ~~~~~~~lv~e~~~~-~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 126 MFRNHLCLVFEMLSY-NLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EETTEEEEEEECCCC-BHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEE
T ss_pred ccCCceEEEEecCCC-CHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEE
Confidence 999999999999965 99999976542 24899999999999999999999522 7899999999999995 477899
Q ss_pred EeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccc
Q 005450 491 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 559 (696)
Q Consensus 491 L~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~ 559 (696)
|+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 202 L~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 265 (382)
T 2vx3_A 202 IVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265 (382)
T ss_dssp ECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999998765432 23579999999999999999999999999999999999999998765443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=370.15 Aligned_cols=253 Identities=24% Similarity=0.324 Sum_probs=205.2
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
..++|.+.+.||+|+||.||++... +|+.||||++.... .....+.+|+++|..++||||+++++++.+.+.+++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4567999999999999999999864 79999999997532 234568899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||++||+|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++++||+|||+++..
T Consensus 262 VmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999999976532 348999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhh-HHhhhccccccCccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES-LVMWAKPILSSGKVTQL 579 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~-lv~~~~~~~~~g~l~~l 579 (696)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... +.......
T Consensus 337 ~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--------- 404 (576)
T 2acx_A 337 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--------- 404 (576)
T ss_dssp CTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC---------
T ss_pred ccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc---------
Confidence 55332 233689999999999998899999999999999999999999998754332211 11111000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 620 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~~ 620 (696)
...+...+ ...+..++..||+.||.+|| ++.+++++
T Consensus 405 -~~~~p~~~----s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 -PEEYSERF----SPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -CCCCCTTS----CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -cccCCccC----CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 00111111 13445566679999999999 77888763
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=337.70 Aligned_cols=257 Identities=20% Similarity=0.320 Sum_probs=199.1
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEe--cCceEEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFE--DNNLLLVY 422 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~--~~~~~LV~ 422 (696)
.++|.+.+.||+|+||+||+|.. .+++.||||+++... .+.+.+|+.++..++ ||||+++++++.. ....++||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 46799999999999999999985 578999999998543 467889999999997 9999999999987 66789999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC-ceEEeecCcccccc
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWAS 501 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~-~vKL~DFGlA~~~~ 501 (696)
||+++++|.+++. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++...
T Consensus 113 e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999985 37889999999999999999999 8999999999999999776 89999999998765
Q ss_pred CCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhc------------
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK------------ 568 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~------------ 568 (696)
..... ....||+.|+|||++.. ..++.++|||||||++|+|++|+.||......... +.....
T Consensus 183 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 183 PGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp TTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHH
T ss_pred CCCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHH
Confidence 54332 23579999999999876 67999999999999999999999999654332111 110000
Q ss_pred c--ccccCccccc--------cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 569 P--ILSSGKVTQL--------LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 569 ~--~~~~g~l~~l--------lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. .........+ ................+..++..||+.||.+|||+.++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0000000000 0001111111112345666777899999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=359.05 Aligned_cols=262 Identities=23% Similarity=0.272 Sum_probs=194.1
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC------ceEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------NLLL 420 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~------~~~L 420 (696)
.+|.+.+.||+|+||.||+|... +|+.||||++..... .+.+|+++|+.++||||++++++|.... .+++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 35889999999999999999975 699999999875432 2347999999999999999999986422 3679
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC-CceEEeecCcccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKW 499 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~-~~vKL~DFGlA~~ 499 (696)
||||+++ +|.+.+.........+++..++.++.||+.||.|||+ ++|+||||||+||||+.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999986 6766664322223468999999999999999999999 899999999999999965 5689999999987
Q ss_pred ccCCCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccc------
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS------ 572 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~------ 572 (696)
....... ....||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.....+...+........
T Consensus 207 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 207 LVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp CCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred cccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 6543322 235799999999998764 799999999999999999999999987654333222211100000
Q ss_pred -cCccccccCcccCC-----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 573 -SGKVTQLLDPALGN-----NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 573 -~g~l~~llD~~L~~-----~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
......+.-+.+.. .+.......+..++..||+.||.+||++.++++
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00011110111100 011111245666777899999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=336.79 Aligned_cols=251 Identities=23% Similarity=0.368 Sum_probs=198.7
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
..++|.+.+.||+|+||.||+|... +|+.||+|++.... ..+.+.+|+.++..++||||+++++++...+..++||||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 3567999999999999999999865 58999999997643 346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++.... ..+++..++.++.+++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 106 ~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 106 CGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred CCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999986332 258999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.... ...+..
T Consensus 180 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~--- 247 (314)
T 3com_A 180 AK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP-------PPTFRK--- 247 (314)
T ss_dssp SC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------CCCCSS---
T ss_pred cc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-------CcccCC---
Confidence 21 223579999999999998899999999999999999999999997654322211111000 000000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.......+..++..||+.||.+|||+.++++
T Consensus 248 ----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 ----PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ----GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0111234556677799999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.51 Aligned_cols=260 Identities=22% Similarity=0.252 Sum_probs=193.0
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC------
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 416 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~------ 416 (696)
.++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999864 6889999998752 345677889999999999999999999997654
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCc
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGl 496 (696)
..++||||+++ +|.+.+.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeec
Confidence 68999999975 78888852 37899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhc--------
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-------- 568 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~-------- 568 (696)
++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+....
T Consensus 174 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred ccccccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 986654321 233679999999999999899999999999999999999999998765433221111000
Q ss_pred --------------cccccCccccccCcccCCCCC---hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 569 --------------PILSSGKVTQLLDPALGNNYD---YDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 569 --------------~~~~~g~l~~llD~~L~~~~~---~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+......+..++......... ......+..++..||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000011111111100000 112345667788899999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.22 Aligned_cols=257 Identities=25% Similarity=0.399 Sum_probs=196.2
Q ss_pred hcCceeeeeeeccCceEEEEEEeC--CCC--EEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP--DGK--ELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~--~g~--~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~ 418 (696)
.++|.+.+.||+|+||+||+|... +++ .||||+++.. ....+.+.+|++++..++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357999999999999999999853 333 6899998753 345678999999999999999999999998754 8
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccc
Confidence 99999999999999997542 258899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCc-ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 499 WASTSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 499 ~~~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
......... ......+|+.|+|||++....++.++||||||+++|+|++ |+.||...........+..... .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-----~- 243 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-----R- 243 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC-----C-
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC-----C-
Confidence 776543322 1223567889999999998889999999999999999999 9999976654322111111000 0
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
...... ....+..++..||+.||.+|||+.++++.|+...
T Consensus 244 -----~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 244 -----LPRPED----CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp -----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -----CCCCcC----cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 000111 1234556677799999999999999999987543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=342.15 Aligned_cols=254 Identities=22% Similarity=0.293 Sum_probs=182.6
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC-hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEe--------c
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS-EDVIKEFVLEIEIITTLH-HKNIISLLGFCFE--------D 415 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~--------~ 415 (696)
..+|.+.+.||+|+||.||++.. .+++.||||++... ....+.+.+|+.++.++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 45799999999999999999996 47899999988543 455678899999999996 9999999999953 3
Q ss_pred CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCc--eEeecccccceeeCCCCceEEee
Q 005450 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFEPQLSD 493 (696)
Q Consensus 416 ~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~g--IIHrDLKpsNILLd~~~~vKL~D 493 (696)
...++||||+. |+|.+++..... ...+++..++.++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEec
Confidence 34899999996 699998865221 1258999999999999999999999 77 99999999999999999999999
Q ss_pred cCccccccCCCCCc----------ccccccccCCCCCccee---ccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccch
Q 005450 494 FGLAKWASTSSSHI----------TCTDVAGTFGYLAPEYF---MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 560 (696)
Q Consensus 494 FGlA~~~~~~~~~~----------~~~~~~GT~~YlAPE~l---~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~ 560 (696)
||+++......... ......||+.|+|||++ ....++.++|||||||++|+|++|+.||........
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 99998765532211 11135699999999998 566789999999999999999999999975432111
Q ss_pred hhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 561 ESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 561 ~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.... ... ..... ... .+..++..||+.||.+|||+.++++.|+..
T Consensus 262 ---~~~~--------~~~----~~~~~-~~~---~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 262 ---VNGK--------YSI----PPHDT-QYT---VFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp ---------------CCC----CTTCC-SSG---GGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ---hcCc--------ccC----Ccccc-cch---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000 000 00000 111 244566679999999999999999998644
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=333.68 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=194.0
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe-----------
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----------- 414 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~----------- 414 (696)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++......+.+.+|+.++..++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 46799999999999999999996 479999999998777777889999999999999999999999865
Q ss_pred --cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEe
Q 005450 415 --DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 492 (696)
Q Consensus 415 --~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~ 492 (696)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEe
Confidence 456899999999999999997543 257889999999999999999999 899999999999999999999999
Q ss_pred ecCccccccCCCC------------CcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccc
Q 005450 493 DFGLAKWASTSSS------------HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 559 (696)
Q Consensus 493 DFGlA~~~~~~~~------------~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~ 559 (696)
|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++ ||.....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-- 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-- 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence 9999986643211 1112335799999999998754 78999999999999999998 5543211
Q ss_pred hhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 560 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 560 ~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.......... . ...+...+.......+..++..||+.||.+|||+.++++.
T Consensus 234 ~~~~~~~~~~----~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 RVNILKKLRS----V------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHHS----T------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhccc----c------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111111100 0 0011111222223345566777999999999999999973
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.03 Aligned_cols=265 Identities=22% Similarity=0.330 Sum_probs=202.5
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-----Cc
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 417 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~-----~~ 417 (696)
..++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|++++.+++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3568999999999999999999864 6889999999753 34557889999999999999999999999754 36
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA 497 (696)
.++||||+.+ +|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~iv~e~~~~-~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCSE-EHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccCc-CHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcce
Confidence 8999999975 999998753 48999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCc-ccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCc
Q 005450 498 KWASTSSSHI-TCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 575 (696)
Q Consensus 498 ~~~~~~~~~~-~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 575 (696)
.......... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||...........+...........
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 8765432221 1234689999999998764 4589999999999999999999999987665443322211110000000
Q ss_pred cccccC--------c-ccCCCCCh-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 576 VTQLLD--------P-ALGNNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 576 l~~llD--------~-~L~~~~~~-----~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+..+.+ . ......+. .....+..++..||+.||.+|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 0 00000011 11234566777899999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=338.57 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=195.4
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcCCcceeEEeeEEEec
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFED 415 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~ 415 (696)
..++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|++++..++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999864 68899999987532 2234588999999999999999999998765
Q ss_pred CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc---eEEe
Q 005450 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLS 492 (696)
Q Consensus 416 ~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~---vKL~ 492 (696)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+
T Consensus 88 -~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 -DYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp -SEEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred -ceEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 4899999999999999987543 58999999999999999999999 89999999999999987654 9999
Q ss_pred ecCccccccCCCCCcccccccccCCCCCcceec---cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchh-hHHhhhc
Q 005450 493 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-SLVMWAK 568 (696)
Q Consensus 493 DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~---~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~-~lv~~~~ 568 (696)
|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||......... ..+..
T Consensus 160 Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-- 234 (322)
T 2ycf_A 160 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS-- 234 (322)
T ss_dssp CCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH--
T ss_pred cCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh--
Confidence 999998765421 123357999999999974 567899999999999999999999999765432211 11110
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 569 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 569 ~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
+... ..+...... ...+..++..||+.||.+||++.++++.
T Consensus 235 -----~~~~--~~~~~~~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 235 -----GKYN--FIPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp -----TCCC--CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -----Cccc--cCchhhhhc----CHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 0000 000110111 2345667778999999999999999863
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=350.33 Aligned_cols=199 Identities=25% Similarity=0.363 Sum_probs=168.0
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-----Cc
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 417 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~-----~~ 417 (696)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. ....+.+.+|+.+|+.++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 568999999999999999999864 6889999999753 34567899999999999999999999999776 57
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA 497 (696)
.|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+|
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 999999986 59999997543 58999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC--------------------cccccccccCCCCCccee-ccCCCCCcccchhhHHHHHHHHhCCCCCC
Q 005450 498 KWASTSSSH--------------------ITCTDVAGTFGYLAPEYF-MYGKVNDKIDVYAFGVVLLELLTGRKPIS 553 (696)
Q Consensus 498 ~~~~~~~~~--------------------~~~~~~~GT~~YlAPE~l-~~~~~s~ksDVwSLGvvL~ELltG~~Pf~ 553 (696)
+........ ...+..+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876543221 122457899999999986 45679999999999999999998655543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=354.30 Aligned_cols=264 Identities=20% Similarity=0.261 Sum_probs=194.6
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc------eEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN------LLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~------~~L 420 (696)
..+|.+.+.||+|+||+||+|....+..+|+|.+..... ...+|+++++.++||||++++++|..... +++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 346899999999999999999987777799998865432 22369999999999999999999976543 889
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC-CCCceEEeecCcccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKW 499 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd-~~~~vKL~DFGlA~~ 499 (696)
||||++++.+ ..+.........+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+|+.
T Consensus 116 v~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 116 VLEYVPETVY-RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEECCSEEHH-HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeeccCccHH-HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999987544 3332211122368999999999999999999999 8999999999999999 789999999999987
Q ss_pred ccCCCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhc----------
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK---------- 568 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~---------- 568 (696)
....... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.....+...+....
T Consensus 192 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 192 LIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 6544332 235789999999998754 59999999999999999999999998765443322211110
Q ss_pred --cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 569 --PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 569 --~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
+......+.......+...+.......+..++..||+.||.+|||+.++++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000011111100000000111112355667778999999999999999873
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=372.03 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=196.2
Q ss_pred eeeeeccCceEEEEEEe---CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 353 ENLIGKGGSSQVYKGCL---PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~---~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
.+.||+|+||.||+|.+ ..++.||||+++... ...+++.+|++++.+++||||++++++|. .+..++||||++
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~ 452 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAE 452 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCT
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccC
Confidence 35899999999999964 356789999998632 34678999999999999999999999996 456899999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+|+|.+++.... .+++..++.|+.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 453 ~g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 453 LGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp TEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 999999997543 58999999999999999999999 89999999999999999999999999999877554322
Q ss_pred -cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCccc
Q 005450 507 -ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584 (696)
Q Consensus 507 -~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L 584 (696)
.......||+.|+|||++.+..++.++|||||||+||||++ |+.||...........+.... .. ..
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-------~~-----~~ 593 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-------RM-----GC 593 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------CC-----CC
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------CC-----CC
Confidence 12223457889999999999999999999999999999998 999998765433222222111 00 01
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 585 ~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.... ...+..++..||+.||++||++.+|++.|+.
T Consensus 594 p~~~----~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 594 PAGC----PREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CTTC----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1111 2345566777999999999999999999873
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=335.27 Aligned_cols=262 Identities=19% Similarity=0.258 Sum_probs=203.1
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CC-CEEEEEEecCChhHHHHHHHHHHHHHhcCCcc------eeEEeeEEEecCce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DG-KELAVKILKPSEDVIKEFVLEIEIITTLHHKN------IISLLGFCFEDNNL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g-~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hpn------IV~l~g~~~~~~~~ 418 (696)
.++|.+.+.||+|+||+||+|... ++ +.||+|+++......+.+.+|+.++..++|++ ++.+++++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 468999999999999999999864 44 68999999987777788999999999998776 99999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee---------------
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL--------------- 483 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL--------------- 483 (696)
++||||+ +++|.+.+..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccc
Confidence 9999999 6677777765432 358999999999999999999999 899999999999999
Q ss_pred ----CCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccc
Q 005450 484 ----SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 559 (696)
Q Consensus 484 ----d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~ 559 (696)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 567899999999998654432 23579999999999999999999999999999999999999998765433
Q ss_pred hhhHHhhhccccccC------ccccc--------------------cCcccC-CCCChHHHHHHHHHHHHhcccCCCCCC
Q 005450 560 QESLVMWAKPILSSG------KVTQL--------------------LDPALG-NNYDYDQMERMVLASILCIRRDPRARP 612 (696)
Q Consensus 560 ~~~lv~~~~~~~~~g------~l~~l--------------------lD~~L~-~~~~~~e~~~l~~la~~Cl~~dP~~RP 612 (696)
....+.......... ..... ..+... ..........+..++..||+.||.+||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 222211111000000 00000 000000 011222344667788889999999999
Q ss_pred CHHHHHH
Q 005450 613 QMSLVLK 619 (696)
Q Consensus 613 Sm~eVL~ 619 (696)
|+.++++
T Consensus 327 t~~e~l~ 333 (355)
T 2eu9_A 327 TLAEALL 333 (355)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=337.75 Aligned_cols=264 Identities=22% Similarity=0.340 Sum_probs=199.3
Q ss_pred hhcCceeeeeeeccCceEEEEEEe--CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhc---CCcceeEEeeEEE----
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSE---DVIKEFVLEIEIITTL---HHKNIISLLGFCF---- 413 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~--~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L---~HpnIV~l~g~~~---- 413 (696)
..++|.+.+.||+|+||.||+|.. .+|+.||+|+++... .....+.+|+.+++.+ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 468899999986422 1223566777777766 8999999999987
Q ss_pred -ecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEe
Q 005450 414 -EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 492 (696)
Q Consensus 414 -~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~ 492 (696)
.....++||||+. |+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEe
Confidence 5667999999998 599999976543 248999999999999999999999 899999999999999999999999
Q ss_pred ecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccc
Q 005450 493 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 572 (696)
Q Consensus 493 DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~ 572 (696)
|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+........
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999998664322 22346799999999999989999999999999999999999999987654332221111100000
Q ss_pred cCcccc-------cc----CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 573 SGKVTQ-------LL----DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 573 ~g~l~~-------ll----D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
...... .+ ...+ ..+.......+..++..||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhhcccCcchh-hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 00 0000 0011111234556677799999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=341.06 Aligned_cols=263 Identities=20% Similarity=0.294 Sum_probs=202.8
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChh------------------HHHHHHHHHHHHHhcCCcceeEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED------------------VIKEFVLEIEIITTLHHKNIISL 408 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~------------------~~~~~~~Ei~iL~~L~HpnIV~l 408 (696)
.++|.+.+.||+|+||.||+|.. +|+.||||++..... ..+.+.+|+.++..++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 999999999875321 12789999999999999999999
Q ss_pred eeEEEecCceEEEEeecCCCChhhh------hhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccccee
Q 005450 409 LGFCFEDNNLLLVYDFLSRGSLEEN------LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 482 (696)
Q Consensus 409 ~g~~~~~~~~~LV~Ey~~gGsL~~~------L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNIL 482 (696)
++++.+.+..++||||+++++|.++ +.... ...+++..++.++.|++.||.|||+ .++|+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEE
Confidence 9999999999999999999999998 54321 2468999999999999999999996 267999999999999
Q ss_pred eCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccC-CCCC-cccchhhHHHHHHHHhCCCCCCCCCcc-c
Q 005450 483 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVND-KIDVYAFGVVLLELLTGRKPISNDHPK-G 559 (696)
Q Consensus 483 Ld~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~-ksDVwSLGvvL~ELltG~~Pf~~~~~~-~ 559 (696)
++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|+|++|+.||...... .
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999876543 22346799999999999877 6666 999999999999999999999876542 1
Q ss_pred hhhHHhhhccccccCccccccCcccCC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 560 QESLVMWAKPILSSGKVTQLLDPALGN---NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 560 ~~~lv~~~~~~~~~g~l~~llD~~L~~---~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
....+......... .......+.... .........+..++..||+.||.+|||+.++++
T Consensus 261 ~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 LFNNIRTKNIEYPL-DRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHTSCCCCCCC-SSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhccCcCCcc-chhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111111000000 000001100000 000111234556677799999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.05 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=195.7
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
+|....+||+|+||.||+|.. .+++.||||.+.... ...+.+.+|+.++..++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 345566899999999999995 578899999987643 456788999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC-CCceEEeecCccccccCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~-~~~vKL~DFGlA~~~~~~~~ 505 (696)
+++|.+++..... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999976432 2356788999999999999999999 89999999999999987 89999999999987654322
Q ss_pred CcccccccccCCCCCcceeccCC--CCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~--~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
. .....||+.|+|||++..+. ++.++||||||+++|+|++|+.||......... ...... . ...+.
T Consensus 179 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~-~--------~~~~~ 246 (295)
T 2clq_A 179 C--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MFKVGM-F--------KVHPE 246 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HHHHHH-H--------CCCCC
T ss_pred c--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HHhhcc-c--------ccccc
Confidence 1 22357999999999987653 889999999999999999999999653322111 100000 0 00111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+...+ ...+..++..||+.||++||++.++++
T Consensus 247 ~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 247 IPESM----SAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCTTS----CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccC----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111 234555667799999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=374.81 Aligned_cols=248 Identities=23% Similarity=0.311 Sum_probs=203.1
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~ 419 (696)
..++|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+..|..++..+ +||||+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999964 6889999999753 23456788899999988 6999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
|||||+++|+|.+++.... .+++..+..|+.||+.||+|||+ ++||||||||+||||+.++++||+|||+|+.
T Consensus 419 lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 9999999999999998653 48999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
...... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+.......+.....
T Consensus 492 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------- 559 (674)
T 3pfq_A 492 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---------- 559 (674)
T ss_dssp CCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC----------
T ss_pred cccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC----------
Confidence 443222 23347899999999999999999999999999999999999999987654333222211110
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQM-----SLVLK 619 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm-----~eVL~ 619 (696)
.+...+ ...+..++..||+.||.+||++ .+|++
T Consensus 560 ---~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 ---AYPKSM----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---CCCTTS----CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---CCCccC----CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 011111 2345556667999999999997 66654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=335.64 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=196.7
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++..++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 468999999999999999999975 58999999987543 4567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 98 CPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999987533 258999999999999999999999 899999999999999999999999999976432211
Q ss_pred CCcccccccccCCCCCcceec-----cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~-----~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
. ......||+.|+|||++. ...++.++||||||+++|+|++|+.||.......... ..... .....
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~-----~~~~~ 242 (302)
T 2j7t_A 172 Q--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--KIAKS-----DPPTL 242 (302)
T ss_dssp H--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHHS-----CCCCC
T ss_pred c--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH--HHhcc-----CCccc
Confidence 0 112356999999999983 6678999999999999999999999997654322211 11110 00000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.. +......+..++..||+.||.+|||+.++++
T Consensus 243 ~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 LT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SS-------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CC-------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 0111234556677799999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.95 Aligned_cols=265 Identities=22% Similarity=0.297 Sum_probs=199.3
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-----Cc
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 417 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~-----~~ 417 (696)
..++|.+.+.||+|+||.||+|... +|+.||||++... ......+.+|+.++..++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3578999999999999999999965 6899999999753 34566788999999999999999999998754 67
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA 497 (696)
.++||||+. ++|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999997 5999998753 48999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCc--------ccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhc
Q 005450 498 KWASTSSSHI--------TCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 568 (696)
Q Consensus 498 ~~~~~~~~~~--------~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~ 568 (696)
.......... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||...........+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 8765432111 1223578999999998764 678999999999999999999999998765433222211110
Q ss_pred cccc-cCcc--------ccccCcccC-CCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 569 PILS-SGKV--------TQLLDPALG-NNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 569 ~~~~-~g~l--------~~llD~~L~-~~~~-----~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.... .... .+.+..... .... ......+..++..||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000 0000 000000000 0000 011234556777899999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.72 Aligned_cols=259 Identities=23% Similarity=0.315 Sum_probs=183.7
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec------C
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------N 416 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~------~ 416 (696)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 57899999999999999999985 57899999999753 34567888999999999999999999998654 5
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCc
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGl 496 (696)
..++||||+ +++|.+++... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 689999999 67999988642 48999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccc---
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS--- 572 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~--- 572 (696)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.....+...+........
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9865432 233679999999999876 6799999999999999999999999987665443332221111000
Q ss_pred -----cCccccccCcccC-CCCChH-----HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 573 -----SGKVTQLLDPALG-NNYDYD-----QMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 573 -----~g~l~~llD~~L~-~~~~~~-----e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
......++..... ...... ....+..++..||+.||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000000000000 000111 1134556677799999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.38 Aligned_cols=264 Identities=23% Similarity=0.340 Sum_probs=193.3
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEE-----------
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCF----------- 413 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~----------- 413 (696)
.++|.+.+.||+|+||.||+|... +|+.||+|++... ....+.+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999975 5899999998754 355678999999999999999999999873
Q ss_pred ---ecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC-CCCce
Q 005450 414 ---EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEP 489 (696)
Q Consensus 414 ---~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd-~~~~v 489 (696)
+.+..++||||+. |+|.+++... .+++..++.++.|++.||+|||+ ++|+||||||+|||++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeE
Confidence 3467899999998 5999998642 47899999999999999999999 8999999999999997 56799
Q ss_pred EEeecCccccccCCCCC-cccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhh
Q 005450 490 QLSDFGLAKWASTSSSH-ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 567 (696)
Q Consensus 490 KL~DFGlA~~~~~~~~~-~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~ 567 (696)
||+|||+++........ .......||+.|+|||++.. ..++.++||||||+++|||++|+.||...........+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999876543221 12233568999999998865 67899999999999999999999999876543332222211
Q ss_pred ccccccCcccccc-------CcccC-CCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 568 KPILSSGKVTQLL-------DPALG-NNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 568 ~~~~~~g~l~~ll-------D~~L~-~~~~-----~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+........++. ..... .... ......+..++..||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1111110000000 00000 0000 011234566777899999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=339.42 Aligned_cols=262 Identities=18% Similarity=0.299 Sum_probs=201.7
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-----------CcceeEEeeEEEe
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----------HKNIISLLGFCFE 414 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~-----------HpnIV~l~g~~~~ 414 (696)
.++|.+.+.||+|+||+||+|.. .+++.||||++.........+.+|+.++.+++ ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 36799999999999999999986 57899999999987777788899999999886 8999999999986
Q ss_pred cC----ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCC-ceEeecccccceeeC-----
Q 005450 415 DN----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLS----- 484 (696)
Q Consensus 415 ~~----~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~-gIIHrDLKpsNILLd----- 484 (696)
.+ ..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+ + +|+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCC
Confidence 54 789999999 8899999976433 248899999999999999999999 7 899999999999994
Q ss_pred -CCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccch---
Q 005450 485 -DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ--- 560 (696)
Q Consensus 485 -~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~--- 560 (696)
..+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 44579999999998765432 235799999999999999999999999999999999999999986542211
Q ss_pred -h---hHHhhhccc--------------cccC-ccccccC-------ccc--CCCCChHHHHHHHHHHHHhcccCCCCCC
Q 005450 561 -E---SLVMWAKPI--------------LSSG-KVTQLLD-------PAL--GNNYDYDQMERMVLASILCIRRDPRARP 612 (696)
Q Consensus 561 -~---~lv~~~~~~--------------~~~g-~l~~llD-------~~L--~~~~~~~e~~~l~~la~~Cl~~dP~~RP 612 (696)
. .++...... +... .+..+.. ..+ ...++......+..++..||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 0 011100000 0000 0000000 000 1123445566777888899999999999
Q ss_pred CHHHHHH
Q 005450 613 QMSLVLK 619 (696)
Q Consensus 613 Sm~eVL~ 619 (696)
|+.++++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=356.46 Aligned_cols=260 Identities=23% Similarity=0.314 Sum_probs=204.5
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC-cceeEEeeEEEecCceEEEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~g~~~~~~~~~LV~Ey 424 (696)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+|++++..++| ++|..+..++...+..+|||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 47899999999999999999985 5799999998875332 2457889999999987 5566666777788889999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee---CCCCceEEeecCcccccc
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL---d~~~~vKL~DFGlA~~~~ 501 (696)
+ +++|.+++..... .+++..++.|+.||+.||.|||+ ++|+||||||+|||| +.++.+||+|||+++...
T Consensus 85 ~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp C-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred C-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9 9999999975432 58999999999999999999999 899999999999999 588999999999998776
Q ss_pred CCCCCc-----ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 502 TSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 502 ~~~~~~-----~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...........+...... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----~~ 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----KV 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH----HH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc----cc
Confidence 543321 122467999999999999999999999999999999999999999876554333222211110 01
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
...+.. +...++ ..+..++..||+.+|.+||++.+|+++|+.
T Consensus 234 ~~~~~~-l~~~~p----~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 234 ATSIEA-LCRGYP----TEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp HSCHHH-HHTTSC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred cccHHH-HhcCCc----HHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 111110 111111 345666777999999999999999998865
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=327.85 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=200.3
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
..++|.+.+.||+|+||.||+|... +++.||+|++... ......+.+|++++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3467999999999999999999975 7899999998653 23467889999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC---CceEEeecCccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAK 498 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~---~~vKL~DFGlA~ 498 (696)
|||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999999886543 48999999999999999999999 899999999999999754 469999999998
Q ss_pred cccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 499 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 499 ~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
........ ....||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+... ....
T Consensus 173 ~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------~~~~ 241 (287)
T 2wei_A 173 CFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG-------KYAF 241 (287)
T ss_dssp TBCCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------CCCC
T ss_pred eecCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------CCCC
Confidence 76543322 23468999999998874 5899999999999999999999999775433221111111 1000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.. +.. ..+ ...+..++..||+.||.+|||+.++++
T Consensus 242 ~~-~~~-~~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 DL-PQW-RTI----SDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CS-GGG-TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cc-hhh-hhc----CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 000 111 124556667799999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=343.34 Aligned_cols=258 Identities=22% Similarity=0.323 Sum_probs=195.2
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce----
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL---- 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~---- 418 (696)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+++.++||||++++++|...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 568999999999999999999864 6899999999753 34567889999999999999999999999877655
Q ss_pred --EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCc
Q 005450 419 --LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496 (696)
Q Consensus 419 --~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGl 496 (696)
++||||+. ++|.+.+.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 588887742 38899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCc
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 575 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 575 (696)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...........
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 9865442 223578999999999886 6899999999999999999999999987654332221111000000000
Q ss_pred --------cccccCcccC-CCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 576 --------VTQLLDPALG-NNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 576 --------l~~llD~~L~-~~~~-----~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.......... .... ......+..++..||+.||.+|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000000000 0000 011234566777899999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=336.05 Aligned_cols=257 Identities=22% Similarity=0.316 Sum_probs=195.0
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc-----
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 417 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~----- 417 (696)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+.++..++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46899999999999999999986 46899999999753 3456788999999999999999999999987654
Q ss_pred -eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCc
Q 005450 418 -LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496 (696)
Q Consensus 418 -~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGl 496 (696)
.++||||+. ++|.+++.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 588887742 38899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccc---
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS--- 572 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~--- 572 (696)
+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+........
T Consensus 173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9865432 223578999999999876 6789999999999999999999999987654332211111000000
Q ss_pred -----cC-------ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 573 -----SG-------KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 573 -----~g-------~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.. .+.....+.+. .........+..++..||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 00000000000 011112344556677799999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=336.50 Aligned_cols=257 Identities=21% Similarity=0.346 Sum_probs=197.5
Q ss_pred hhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
..++|.+.+.||+|+||.||+|...+ .+|+|+++.. ....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 45789999999999999999998754 4999998753 233456778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||++.....
T Consensus 109 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp BCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999997543 358899999999999999999999 8999999999999998 67999999999876532
Q ss_pred CCC---CcccccccccCCCCCcceecc---------CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccc
Q 005450 503 SSS---HITCTDVAGTFGYLAPEYFMY---------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 570 (696)
Q Consensus 503 ~~~---~~~~~~~~GT~~YlAPE~l~~---------~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 570 (696)
... ........||+.|+|||++.. ..++.++||||||+++|+|++|+.||...........+..
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---- 257 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT---- 257 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT----
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc----
Confidence 211 112223569999999999864 3578899999999999999999999976543322111110
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCcc
Q 005450 571 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 626 (696)
Q Consensus 571 ~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~~ 626 (696)
+........ ..+ ..+..++..||+.||.+|||+.++++.|+....
T Consensus 258 ---~~~~~~~~~----~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 258 ---GMKPNLSQI----GMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp ---TCCCCCCCS----SCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred ---CCCCCCCcC----CCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 110111100 111 124556667999999999999999999986553
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=335.11 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=171.2
Q ss_pred hcCceee-eeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe----cCceEE
Q 005450 347 TSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLL 420 (696)
Q Consensus 347 t~~f~~~-~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~----~~~~~L 420 (696)
.++|.+. ++||+|+||+||+|... +|+.||||++........++ ...+..+.||||+++++++.. ....++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~---~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEV---DHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHH---HHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHH---HHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 5678885 47999999999999875 79999999998755433332 234566799999999999976 445899
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC---CCceEEeecCcc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLA 497 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~---~~~vKL~DFGlA 497 (696)
||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 104 v~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999986532 358999999999999999999999 89999999999999976 455999999999
Q ss_pred ccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 498 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 498 ~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
....... .....||+.|+|||++....++.++||||||+++|+|++|+.||............. .....+..
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~- 250 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRIRLGQY- 250 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhhhcccc-
Confidence 8665432 223578999999999988899999999999999999999999997654322111000 00000000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+..+. .......+..++..||+.||.+|||+.++++
T Consensus 251 ~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 251 GFPNPE-----WSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CCCTTT-----STTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccCchh-----hccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000 0111234555667799999999999999997
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=346.81 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=188.5
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeecC
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
+.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|+.++.++ +||||+++++++.+.+..++||||+.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 4466778999999999987777789999999987533 45678899999986 89999999999999999999999996
Q ss_pred CCChhhhhhcCCCCCCC---CChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC-------------CceE
Q 005450 427 RGSLEENLHGNKKDPAA---FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-------------FEPQ 490 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~---l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~-------------~~vK 490 (696)
|+|.+++......... ..+..++.++.||+.||+|||+ ++|+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 5999999865432211 2344567899999999999999 899999999999999654 4899
Q ss_pred EeecCccccccCCCCCc--ccccccccCCCCCcceecc-------CCCCCcccchhhHHHHHHHHh-CCCCCCCCCccch
Q 005450 491 LSDFGLAKWASTSSSHI--TCTDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQ 560 (696)
Q Consensus 491 L~DFGlA~~~~~~~~~~--~~~~~~GT~~YlAPE~l~~-------~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~ 560 (696)
|+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 99999999776543221 1234679999999999875 578999999999999999999 999997544322
Q ss_pred hhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 561 ESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 561 ~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..+.. ........ ....+......+..++..||+.||.+|||+.++++
T Consensus 248 ~~i~~---~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 SNIIR---GIFSLDEM--------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHH---TCCCCCCC--------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHhc---CCCCcccc--------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11111 11110011 11112334456677788899999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=342.10 Aligned_cols=203 Identities=26% Similarity=0.411 Sum_probs=155.8
Q ss_pred Ccee-eeeeeccCceEEEEEEeC---CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCceEEEE
Q 005450 349 NFLA-ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVY 422 (696)
Q Consensus 349 ~f~~-~~~LG~G~fG~Vyka~~~---~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~--~~~~~LV~ 422 (696)
.|.+ .++||+|+||+||+|... +++.||||++..... ...+.+|+.+|+.++||||++++++|.. ....++||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 4665 458999999999999964 578999999986432 3467899999999999999999999965 66899999
Q ss_pred eecCCCChhhhhhcCC-----CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee----CCCCceEEee
Q 005450 423 DFLSRGSLEENLHGNK-----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSD 493 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~-----~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL----d~~~~vKL~D 493 (696)
||+.+ +|.+++.... .....+++..++.|+.||+.||.|||+ ++|+||||||+|||| +.++.+||+|
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99975 8888775221 122358999999999999999999999 899999999999999 6778999999
Q ss_pred cCccccccCCCCC-cccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCC
Q 005450 494 FGLAKWASTSSSH-ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDH 556 (696)
Q Consensus 494 FGlA~~~~~~~~~-~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~ 556 (696)
||+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999876543221 222346799999999999864 58999999999999999999999997654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=333.51 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=176.5
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHH-HHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~-iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. ......+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367899999999999999999974 7899999999764 334456666666 677789999999999999999999999
Q ss_pred eecCCCChhhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHhcCCCC-ceEeecccccceeeCCCCceEEeecCccccc
Q 005450 423 DFLSRGSLEENLHGNK-KDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~-~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~-gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||+++ +|.+++.... .....+++..+..++.+++.||.|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99986 8887775311 112358999999999999999999999 7 8999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCCCCCccee----ccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYF----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l----~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
...... ....||+.|+|||++ .+..++.++||||||+++|+|++|+.||........ ...... .+..
T Consensus 177 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~-~~~~ 247 (327)
T 3aln_A 177 VDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVV-KGDP 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCC-CSCC
T ss_pred cccccc---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHh-cCCC
Confidence 543222 234699999999998 456789999999999999999999999976432111 001111 1111
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.. +...........+..++..||+.||.+||++.++++
T Consensus 248 ~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQ-----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CC-----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC-----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11 111111111234566677799999999999999976
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=362.71 Aligned_cols=255 Identities=23% Similarity=0.362 Sum_probs=202.4
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
..++|.+.+.||+|+||.||+|... .+..||||.++.. ....+.+.+|+.++.+++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 4567999999999999999999863 2457999998753 345578999999999999999999999985 56789
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 467 lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999997543 258999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
....... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.....
T Consensus 541 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~--------- 610 (656)
T 2j0j_A 541 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--------- 610 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC---------
T ss_pred cCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 6543322 2223567889999999998999999999999999999997 9999987554332222111110
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
..+.... ...+..++..||+.||.+|||+.++++.|+..
T Consensus 611 ---~~~~~~~----~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 611 ---LPMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ---CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0011111 13455667779999999999999999998754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=323.71 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=176.6
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh--hH-HHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DV-IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~--~~-~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
.++|.+.+.||+|+||.||+|... +|+.||||++.... .. .+.+.++..++..++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467899999999999999999975 78999999997542 22 233445556788889999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCC-ceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~-gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
||+ ++.+..+..... ..+++..++.++.+++.||.|||+ . +|+||||||+|||++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 556655554322 258899999999999999999998 5 89999999999999999999999999997665
Q ss_pred CCCCCcccccccccCCCCCcceec-----cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~-----~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
..... ....||+.|+|||++. ...++.++||||||+++|+|++|+.||......... +...... .
T Consensus 177 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~-----~- 246 (318)
T 2dyl_A 177 DDKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-LTKVLQE-----E- 246 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-HHHHHHS-----C-
T ss_pred CCccc---cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH-HHHHhcc-----C-
Confidence 43222 2356999999999984 557899999999999999999999999764322111 1110000 0
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+.+.... .....+..++..||+.||.+||++.++++
T Consensus 247 ----~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 ----PPLLPGHM--GFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----CCCCCSSS--CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CCCCCccC--CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00111000 01123555667799999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=329.45 Aligned_cols=241 Identities=23% Similarity=0.370 Sum_probs=189.4
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-------hHHHHHHHHHHHHHhc----CCcceeEEeeEEE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTL----HHKNIISLLGFCF 413 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~L----~HpnIV~l~g~~~ 413 (696)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... .....+.+|+.++.++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 457899999999999999999986 578999999997543 1233466799999999 8999999999999
Q ss_pred ecCceEEEEee-cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC-CCCceEE
Q 005450 414 EDNNLLLVYDF-LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQL 491 (696)
Q Consensus 414 ~~~~~~LV~Ey-~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd-~~~~vKL 491 (696)
..+..++|||| +.+++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEE
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEE
Confidence 99999999999 78999999997643 48999999999999999999999 8999999999999999 8899999
Q ss_pred eecCccccccCCCCCcccccccccCCCCCcceeccCCCC-CcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccc
Q 005450 492 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 570 (696)
Q Consensus 492 ~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s-~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 570 (696)
+|||++....... .....||+.|+|||++....+. .++||||||+++|+|++|+.||.... .... ...
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~-~~~- 250 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EILE-AEL- 250 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH-TCC-
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HHhh-hcc-
Confidence 9999998765532 2335699999999999877664 48999999999999999999996421 1111 000
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 571 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 571 ~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.+.... ...+..++..||+.||++|||+.++++.
T Consensus 251 ------------~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 251 ------------HFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ------------CCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------------CCcccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111 1245566677999999999999999973
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=334.86 Aligned_cols=245 Identities=22% Similarity=0.361 Sum_probs=197.5
Q ss_pred HHHHhhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcC--CcceeEEeeE
Q 005450 342 DLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTLH--HKNIISLLGF 411 (696)
Q Consensus 342 el~~~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~L~--HpnIV~l~g~ 411 (696)
+.....++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+|+.++.+++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3334567899999999999999999985 578999999997542 12345778999999996 5999999999
Q ss_pred EEecCceEEEEeecCC-CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC-CCCce
Q 005450 412 CFEDNNLLLVYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEP 489 (696)
Q Consensus 412 ~~~~~~~~LV~Ey~~g-GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd-~~~~v 489 (696)
+...+..++|||++.+ ++|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+|||++ +++.+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCE
Confidence 9999999999999986 89999997643 58899999999999999999999 8999999999999999 78899
Q ss_pred EEeecCccccccCCCCCcccccccccCCCCCcceeccCCC-CCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhc
Q 005450 490 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 568 (696)
Q Consensus 490 KL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~-s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~ 568 (696)
||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... .... ..
T Consensus 190 kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~-~~ 259 (320)
T 3a99_A 190 KLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIR-GQ 259 (320)
T ss_dssp EECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH-CC
T ss_pred EEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hhhc-cc
Confidence 999999998765432 223579999999999987765 678999999999999999999996431 1110 00
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 569 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 569 ~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
. .+...++ ..+..++..||+.||.+|||+.++++.
T Consensus 260 -~------------~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 260 -V------------FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -C------------CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -c------------cccccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0111111 245566677999999999999999873
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=340.20 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=186.6
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeec
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
..+|...+.||+|+||+||.....+|+.||||++..... ..+.+|+.+|+.+ +||||+++++++.+....++||||+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 446889999999999997665667899999999975432 2356899999999 7999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC-----CCceEEeecCccccc
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-----DFEPQLSDFGLAKWA 500 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~-----~~~vKL~DFGlA~~~ 500 (696)
. |+|.+++..... .+.+..+..++.||+.||.|||+ ++|+||||||+|||++. ...+||+|||+++..
T Consensus 101 ~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 101 A-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp S-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred C-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 6 599999976543 34555678899999999999999 89999999999999953 345889999999877
Q ss_pred cCCCCC-cccccccccCCCCCcceec---cCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCc
Q 005450 501 STSSSH-ITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGK 575 (696)
Q Consensus 501 ~~~~~~-~~~~~~~GT~~YlAPE~l~---~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 575 (696)
...... .......||+.|+|||++. ...++.++|||||||++|||++ |..||............ . ...
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~--~-----~~~ 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL--G-----ACS 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT--T-----CCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh--c-----cCC
Confidence 543221 2233467999999999997 4567889999999999999999 99999654322111110 0 000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 576 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 576 l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.. ... ........+..++..||+.||.+|||+.++++
T Consensus 247 ~~-~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 LD-CLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CT-TSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc-ccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00 000 01122333556777899999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=351.89 Aligned_cols=236 Identities=21% Similarity=0.298 Sum_probs=190.2
Q ss_pred hcCceeeeeeeccCceEEEEEEeC--CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc-----
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 417 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~--~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~----- 417 (696)
.++|.+.+.||+|+||.||++.+. +|+.||||++... ......+.+|+.++.+++||||++++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 468999999999999999999975 6899999998753 3456678999999999999999999999988766
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA 497 (696)
.||||||++|++|.+++.. .+++..++.|+.||+.||.|||+ ++||||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999987753 48999999999999999999999 899999999999999986 8999999999
Q ss_pred ccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 498 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 498 ~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
+..... ....||++|+|||++.++ ++.++|||||||+||+|++|..||....... . .
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~------~ 285 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------L------P 285 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------C------C
T ss_pred hhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc----------c------c
Confidence 876543 235799999999998765 4889999999999999999998886421110 0 0
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhh
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLKLLR 622 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPS-m~eVL~~L~ 622 (696)
. ..........+..++..||+.||.+||+ +.++...|.
T Consensus 286 ~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 286 E-------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp T-------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred c-------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 0000111234566777899999999996 555555554
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=348.96 Aligned_cols=258 Identities=24% Similarity=0.328 Sum_probs=198.2
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe------cCce
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------DNNL 418 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~------~~~~ 418 (696)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|++++..++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999986 46899999998753 4556789999999999999999999998765 6778
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc---eEEeecC
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFG 495 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~---vKL~DFG 495 (696)
++||||+++|+|.+++..... ...+++..++.++.+++.||.|||+ .+|+||||||+|||++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 999999999999999986432 2358899999999999999999999 89999999999999997665 8999999
Q ss_pred ccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccccc--
Q 005450 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS-- 573 (696)
Q Consensus 496 lA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~-- 573 (696)
++......... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..|.......
T Consensus 170 ~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC----
T ss_pred ccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccc
Confidence 99877654322 3467999999999999999999999999999999999999999764221 1111111100
Q ss_pred ----------CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005450 574 ----------GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLV 617 (696)
Q Consensus 574 ----------g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eV 617 (696)
+.+...-...............+..++..||+.||.+|||+.++
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 00000000011122333445667778888999999999999763
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=306.61 Aligned_cols=229 Identities=16% Similarity=0.188 Sum_probs=180.7
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.++.+++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999975 5899999999864 34557899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||++|++|.+++... ....++.+|+.|++.||.|||+ ++|+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999999999999532 2455788899999999999999 899999999999999999999998543
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
|++| ++.++|||||||++|||++|+.||........... ...... +.... .
T Consensus 175 ----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~~~~~-~~~~~--~ 225 (286)
T 3uqc_A 175 ----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERDTA-GQPIE--P 225 (286)
T ss_dssp ----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CCBCTT-SCBCC--H
T ss_pred ----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HHHHhc-cCCCC--h
Confidence 3333 68899999999999999999999987654321100 000000 00000 0
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
..+....+ ..+..++..||+.||.+| |+.++++.|+..
T Consensus 226 ~~~~~~~~----~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 226 ADIDRDIP----FQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp HHHCTTSC----HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred hhcccCCC----HHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 00111111 235566677999999999 999999999753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=330.63 Aligned_cols=243 Identities=14% Similarity=0.189 Sum_probs=179.9
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCC-cce--------------
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHH-KNI-------------- 405 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~H-pnI-------------- 405 (696)
.+.+|...+.||+|+||+||+|.+ .+|+.||||+++.. ....+.+.+|+.++..++| +|.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345688899999999999999994 57999999999842 2335778999999999976 211
Q ss_pred -eE------EeeEEEe-----cCceEEEEeecCCCChhhhhhcC---CCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCc
Q 005450 406 -IS------LLGFCFE-----DNNLLLVYDFLSRGSLEENLHGN---KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 470 (696)
Q Consensus 406 -V~------l~g~~~~-----~~~~~LV~Ey~~gGsL~~~L~~~---~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~g 470 (696)
+. ++.++.. ....+++|+++ +++|.+++... ......+++..++.++.||+.||+|||+ ++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YG 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence 11 1111111 22467777765 67999988421 1122357888999999999999999999 89
Q ss_pred eEeecccccceeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCccee----------ccCCCCCcccchhhHH
Q 005450 471 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF----------MYGKVNDKIDVYAFGV 540 (696)
Q Consensus 471 IIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l----------~~~~~s~ksDVwSLGv 540 (696)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999999865543 234568 999999999 5556889999999999
Q ss_pred HHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 541 VLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 541 vL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
++|||++|+.||........... . +... ..++ ..+..++..||+.||.+||++.++++
T Consensus 306 il~elltg~~Pf~~~~~~~~~~~------~---------~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGGSEW------I---------FRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSCSGG------G---------GSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHCCCCCCCcchhhhHHH------H---------Hhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999999976543221111 0 1000 0111 34556666799999999999998875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.11 Aligned_cols=231 Identities=23% Similarity=0.371 Sum_probs=175.6
Q ss_pred hcCceee-eeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHH-HhcCCcceeEEeeEEEe----cCceE
Q 005450 347 TSNFLAE-NLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEII-TTLHHKNIISLLGFCFE----DNNLL 419 (696)
Q Consensus 347 t~~f~~~-~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL-~~L~HpnIV~l~g~~~~----~~~~~ 419 (696)
.++|.+. +.||+|+||.||++.. .+++.||+|+++.. ..+.+|+.++ +.++||||+++++++.. ....+
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 3567766 7899999999999986 57899999999754 3566788887 55689999999999987 67899
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC---CCceEEeecCc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGL 496 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~---~~~vKL~DFGl 496 (696)
+||||+++|+|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999986532 358999999999999999999999 89999999999999998 78899999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
+.... ...++.++|||||||++|+|++|+.||........... .......+..
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~ 219 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQY 219 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC---SCCSSCTTCC
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH---HHHHHhhccc
Confidence 86432 13567899999999999999999999976543211000 0000000000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+..+. ... ....+..++..||+.||.+|||+.++++
T Consensus 220 -~~~~~~-~~~----~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 220 -EFPNPE-WSE----VSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp -SSCHHH-HTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -cCCchh-ccc----CCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000 001 1234556667799999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.04 Aligned_cols=190 Identities=21% Similarity=0.234 Sum_probs=160.3
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcC---------CcceeEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLH---------HKNIISL 408 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~L~---------HpnIV~l 408 (696)
.++|.+.+.||+|+||+||+|.. +|+.||||+++... ...+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688999999999999999987 78999999997532 23477889999999886 6666666
Q ss_pred eeEE-----------------Ee-------------cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHH
Q 005450 409 LGFC-----------------FE-------------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 458 (696)
Q Consensus 409 ~g~~-----------------~~-------------~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~ 458 (696)
.+.+ .+ .+..+|||||+++|++.+.+.. ..+++..+..|+.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 6553 32 6789999999999987777643 24789999999999999
Q ss_pred HHHHHh-cCCCCceEeecccccceeeCCCC--------------------ceEEeecCccccccCCCCCcccccccccCC
Q 005450 459 ALEYLH-SGSAQRVIHRDVKSSNILLSDDF--------------------EPQLSDFGLAKWASTSSSHITCTDVAGTFG 517 (696)
Q Consensus 459 aL~yLH-~~~~~gIIHrDLKpsNILLd~~~--------------------~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~ 517 (696)
||.||| + ++|+||||||+||||+.++ .+||+|||+|+..... ...||+.
T Consensus 173 aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~ 242 (336)
T 2vuw_A 173 SLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV 242 (336)
T ss_dssp HHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred HHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence 999999 8 8999999999999999887 8999999999876542 2479999
Q ss_pred CCCcceeccCCCCCcccchhhHHH-HHHHHhCCCCCC
Q 005450 518 YLAPEYFMYGKVNDKIDVYAFGVV-LLELLTGRKPIS 553 (696)
Q Consensus 518 YlAPE~l~~~~~s~ksDVwSLGvv-L~ELltG~~Pf~ 553 (696)
|+|||++.+.. +.++||||||++ .+++++|..||.
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 99999998655 889999998777 778889999984
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=295.36 Aligned_cols=185 Identities=17% Similarity=0.099 Sum_probs=131.8
Q ss_pred eeeccCceEEEEEE-eCCCCEEEEEEecCC-----------hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEE
Q 005450 355 LIGKGGSSQVYKGC-LPDGKELAVKILKPS-----------EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 355 ~LG~G~fG~Vyka~-~~~g~~vAVK~l~~~-----------~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV 421 (696)
..+.|++|.+..+. .-.|+.|+||++... +...++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777666544 336888999999642 24456799999999999 699999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||++|++|.++|.... .++. .+|+.||+.||+|||+ +|||||||||+||||+.++.+||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~~~----~l~~---~~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE----EIDR---EKILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHTTC----CCCH---HHHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHhCC----CCCH---HHHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 99999999999997654 3444 3589999999999999 999999999999999999999999999998776
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 552 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf 552 (696)
..... ....+||++|+|||++. +.+..++|+||+|+++++|.++..|+
T Consensus 391 ~~~~~--~~t~vGTp~YmAPE~l~-g~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 QDCSW--PTNLVQSFFVFVNELFA-ENKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCcc--ccCceechhhccHHHhC-CCCCCcccccccccchhhhccccchh
Confidence 54332 23478999999999987 46778899999999998887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-27 Score=268.02 Aligned_cols=185 Identities=17% Similarity=0.212 Sum_probs=148.1
Q ss_pred eeeeeeeccCceEEEEEEeCCCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 351 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 351 ~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
...+.||+|+||.||++. ..++.+++|...... ...+++.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 446789999999999994 467889999864321 1245689999999999999999777777788889999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++++|.+++.. +..++.|++.||.|||+ ++|+||||||+|||++. .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999975 35799999999999999 89999999999999999 99999999999775
Q ss_pred CCCCCc-----ccccccccCCCCCcceecc--CCCCCcccchhhHHHHHHHHhCCCCCC
Q 005450 502 TSSSHI-----TCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPIS 553 (696)
Q Consensus 502 ~~~~~~-----~~~~~~GT~~YlAPE~l~~--~~~s~ksDVwSLGvvL~ELltG~~Pf~ 553 (696)
...... ......||+.|+|||++.. ..|+..+|+|+..+-.++.+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 532211 1234689999999999986 568889999999999999998887763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-23 Score=218.61 Aligned_cols=152 Identities=16% Similarity=0.124 Sum_probs=124.5
Q ss_pred hHHHHHhhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCCh-------------------hHHHHHHHHHHHHHhc
Q 005450 340 YQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-------------------DVIKEFVLEIEIITTL 400 (696)
Q Consensus 340 ~~el~~~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~-------------------~~~~~~~~Ei~iL~~L 400 (696)
...+......|.+.+.||+|+||.||+|...+|+.||||+++... .....+.+|+.++..+
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 344555566788889999999999999999789999999997432 1356789999999999
Q ss_pred CCcceeEEeeEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccc
Q 005450 401 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 480 (696)
Q Consensus 401 ~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsN 480 (696)
+ | +++.+++. .+..++||||++|++|.+ +.. .....++.|++.||.|||+ ++|+||||||+|
T Consensus 162 ~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~N 223 (282)
T 1zar_A 162 Q--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYN 223 (282)
T ss_dssp T--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTS
T ss_pred c--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHH
Confidence 9 5 66666554 356799999999999998 421 2345799999999999999 999999999999
Q ss_pred eeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceec
Q 005450 481 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 525 (696)
Q Consensus 481 ILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~ 525 (696)
||++ ++.+||+|||+|+ .+..|.|||++.
T Consensus 224 ILl~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSV---------------EVGEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCE---------------ETTSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCe---------------ECCCCCHHHHHH
Confidence 9999 9999999999986 234578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.1e-19 Score=185.32 Aligned_cols=137 Identities=20% Similarity=0.193 Sum_probs=108.8
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCE--EEEEEecCChh-------------------------HHHHHHHHHHHHHh
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKE--LAVKILKPSED-------------------------VIKEFVLEIEIITT 399 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~--vAVK~l~~~~~-------------------------~~~~~~~Ei~iL~~ 399 (696)
.-|.+.+.||+|+||.||+|.. .+|+. ||||+++.... ....+.+|+.+|..
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999997 78999 99999765321 12367889999999
Q ss_pred cCCcce--eEEeeEEEecCceEEEEeecCC-C----ChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHh-cCCCCce
Q 005450 400 LHHKNI--ISLLGFCFEDNNLLLVYDFLSR-G----SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH-SGSAQRV 471 (696)
Q Consensus 400 L~HpnI--V~l~g~~~~~~~~~LV~Ey~~g-G----sL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH-~~~~~gI 471 (696)
++|+++ ..++.+ +..+|||||+.+ | +|.+.... .++..+..++.|++.||.||| + .+|
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~---~gi 192 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE---AEL 192 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT---SCE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH---CCE
Confidence 988764 334432 367999999942 4 66665432 234567889999999999999 8 899
Q ss_pred EeecccccceeeCCCCceEEeecCccccc
Q 005450 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 472 IHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
+||||||+|||++. .++|+|||+|...
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.5e-16 Score=173.75 Aligned_cols=136 Identities=15% Similarity=0.155 Sum_probs=101.2
Q ss_pred CceeeeeeeccCceEEEEEEeCCCCEEEEEEecCCh---------------hHH--------HHHHHHHHHHHhcCCcce
Q 005450 349 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------------DVI--------KEFVLEIEIITTLHHKNI 405 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~---------------~~~--------~~~~~Ei~iL~~L~HpnI 405 (696)
-|.+.+.||.|+||.||+|...+|+.||||+++... ... -...+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 489999999999999999999999999999986421 000 112346667777755443
Q ss_pred eEEeeEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC
Q 005450 406 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 485 (696)
Q Consensus 406 V~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~ 485 (696)
.-..-+.. +..+|||||++|++|.++... .....++.||+.+|.|||+ .|||||||||.|||+++
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEE
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeC
Confidence 22211111 234799999999888765421 2345688999999999999 89999999999999987
Q ss_pred CC----------ceEEeecCcccc
Q 005450 486 DF----------EPQLSDFGLAKW 499 (696)
Q Consensus 486 ~~----------~vKL~DFGlA~~ 499 (696)
++ .+.|+||+-+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 76 389999997753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.5e-11 Score=125.50 Aligned_cols=142 Identities=18% Similarity=0.118 Sum_probs=112.4
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
...|.+...++.|+.+.||+.... +..+++|+..... .....+.+|+++++.+. +..+.++++++...+..|+||||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 356888888999999999998754 6899999987521 22346888999999985 67788999999888899999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG-------------------------------------- 466 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~-------------------------------------- 466 (696)
++|.+|.+.+.. ......++.+++++|..||+-
T Consensus 92 i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 92 ADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred cCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999876421 122346888999999999981
Q ss_pred ------------------CCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 467 ------------------SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 467 ------------------~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
....++|+|++|.|||++++..+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11458999999999999876556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.23 E-value=1.6e-11 Score=123.97 Aligned_cols=136 Identities=16% Similarity=0.086 Sum_probs=101.1
Q ss_pred CceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc--eeEEeeEEEecCceEEEEeecC
Q 005450 349 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN--IISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hpn--IV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
+|.+..+.+.|..+.||+....+|..+++|+.... ....+..|+.++..+.+.+ +.++++++..++..++||||++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 34444333456669999998877888999998754 2345778999999986544 5568888887778999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--------------------------------------- 467 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~--------------------------------------- 467 (696)
|.+|. ... . ....++.++++.|..||+..
T Consensus 99 G~~l~--~~~-------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 99 GQDLL--SSH-------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SEETT--TSC-------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CcccC--cCc-------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 98884 211 1 12356777888888888632
Q ss_pred ----------------CCceEeecccccceeeCCCCceEEeecCccc
Q 005450 468 ----------------AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 468 ----------------~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
...++|+|++|.|||++++..+.|+|||.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999877666799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.04 E-value=1.1e-09 Score=117.41 Aligned_cols=143 Identities=14% Similarity=0.253 Sum_probs=108.2
Q ss_pred eeeeeeeccCceEEEEEEeCCCCEEEEEEec--CCh--hHHHHHHHHHHHHHhcC--CcceeEEeeEEEec---CceEEE
Q 005450 351 LAENLIGKGGSSQVYKGCLPDGKELAVKILK--PSE--DVIKEFVLEIEIITTLH--HKNIISLLGFCFED---NNLLLV 421 (696)
Q Consensus 351 ~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~--~~~--~~~~~~~~Ei~iL~~L~--HpnIV~l~g~~~~~---~~~~LV 421 (696)
...+.|+.|.++.||+....+ ..+++|+.. ... .....+.+|+.+++.+. +..+.+++.++.+. +..++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 346788999999999988754 678999887 432 22456788999999997 45688889888776 348999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS---------------------------------- 467 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~---------------------------------- 467 (696)
|||++|..+.+... ..++...+..++.++++.|..||...
T Consensus 120 me~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 120 MEFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 99999987754211 13677888899999999999999721
Q ss_pred ---------------------CCceEeecccccceeeCCCCc--eEEeecCccccc
Q 005450 468 ---------------------AQRVIHRDVKSSNILLSDDFE--PQLSDFGLAKWA 500 (696)
Q Consensus 468 ---------------------~~gIIHrDLKpsNILLd~~~~--vKL~DFGlA~~~ 500 (696)
...++|+|+++.|||++.++. +.|+||+.+...
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999997753 689999988643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=6.2e-10 Score=116.53 Aligned_cols=183 Identities=19% Similarity=0.195 Sum_probs=122.9
Q ss_pred eeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-Ccc--eeEEeeEEEecC---ceEEEEeecC
Q 005450 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKN--IISLLGFCFEDN---NLLLVYDFLS 426 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~-Hpn--IV~l~g~~~~~~---~~~LV~Ey~~ 426 (696)
.+.++.|.+..||+.. ..+++|+.... .....+.+|.++|..+. +.. +.+++.+....+ ..|+||++++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999853 56899987643 44567889999998884 322 344554443333 3588999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG---------------------------------------- 466 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~---------------------------------------- 466 (696)
|.+|.+.... .++..++..++.+++..|..||+.
T Consensus 100 G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9888754321 256667777888888888888851
Q ss_pred ---------------CCCceEeecccccceeeCC--CCceEEeecCccccccCCCCCcccccccccCCC---CCcceec-
Q 005450 467 ---------------SAQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY---LAPEYFM- 525 (696)
Q Consensus 467 ---------------~~~gIIHrDLKpsNILLd~--~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y---lAPE~l~- 525 (696)
....++|+|++|.||++++ +..+.|+||+.+....... +......+ ..|+...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhhccccCHHHHHH
Confidence 1135899999999999998 4567899999987543310 01111111 2232211
Q ss_pred ----cCC---------CCCcccchhhHHHHHHHHhCCCCC
Q 005450 526 ----YGK---------VNDKIDVYAFGVVLLELLTGRKPI 552 (696)
Q Consensus 526 ----~~~---------~s~ksDVwSLGvvL~ELltG~~Pf 552 (696)
++. .....+.|++|.++|.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 011 112358899999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.3e-06 Score=91.66 Aligned_cols=137 Identities=20% Similarity=0.196 Sum_probs=95.8
Q ss_pred eeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCc---ceeEEeeEEE-ecCceEEEEeecCCC
Q 005450 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK---NIISLLGFCF-EDNNLLLVYDFLSRG 428 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hp---nIV~l~g~~~-~~~~~~LV~Ey~~gG 428 (696)
.+.++.|....||+. |..+++|+.. .......+.+|.++|..+.+. .+.+++.++. ..+..++||||++|.
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 466889999999987 5778999854 334567889999999999752 3566666664 345678999999998
Q ss_pred ChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 005450 429 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG------------------------------------------ 466 (696)
Q Consensus 429 sL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~------------------------------------------ 466 (696)
+|.+.... .++...+..++.++++.|..||+.
T Consensus 99 ~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 99 ILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88763211 123344444555555555555531
Q ss_pred ---------------CCCceEeecccccceeeCC---CCce-EEeecCccccc
Q 005450 467 ---------------SAQRVIHRDVKSSNILLSD---DFEP-QLSDFGLAKWA 500 (696)
Q Consensus 467 ---------------~~~gIIHrDLKpsNILLd~---~~~v-KL~DFGlA~~~ 500 (696)
....++|+|++|.|||++. ++.+ .|+||+.+...
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2246799999999999987 4554 89999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=6.2e-06 Score=83.93 Aligned_cols=135 Identities=19% Similarity=0.118 Sum_probs=96.9
Q ss_pred eeeccCce-EEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEeecCCCChh
Q 005450 355 LIGKGGSS-QVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSLE 431 (696)
Q Consensus 355 ~LG~G~fG-~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL~ 431 (696)
.+..|..+ .||+.... ++..+++|+-... ....+.+|..+|+.+. +--+.+++.++.+.+..++|||+++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34555554 68987754 5678999987643 3456788999998885 334678889998889999999999998887
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC--------------------------------------------
Q 005450 432 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-------------------------------------------- 467 (696)
Q Consensus 432 ~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~-------------------------------------------- 467 (696)
+..... ......+..+++..|.-||...
T Consensus 109 ~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 109 QVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 755321 1223345556666666666411
Q ss_pred -----------CCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 468 -----------AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 468 -----------~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
...++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999877677999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=2.8e-06 Score=90.37 Aligned_cols=81 Identities=12% Similarity=0.103 Sum_probs=58.1
Q ss_pred eeeee-eccCceEEEEEEeC-------CCCEEEEEEecCChh----HHHHHHHHHHHHHhcCC---cceeEEeeEEEec-
Q 005450 352 AENLI-GKGGSSQVYKGCLP-------DGKELAVKILKPSED----VIKEFVLEIEIITTLHH---KNIISLLGFCFED- 415 (696)
Q Consensus 352 ~~~~L-G~G~fG~Vyka~~~-------~g~~vAVK~l~~~~~----~~~~~~~Ei~iL~~L~H---pnIV~l~g~~~~~- 415 (696)
..+.| +.|....+|+.... ++..+++|+...... ....+.+|+.++..+.. -.+.+++.++.+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34677 88889999988754 267899998765331 12457788888888853 3567788877655
Q ss_pred --CceEEEEeecCCCChhh
Q 005450 416 --NNLLLVYDFLSRGSLEE 432 (696)
Q Consensus 416 --~~~~LV~Ey~~gGsL~~ 432 (696)
+..++||||++|..+.+
T Consensus 104 ~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTSSCEEEEECCCCBCCCB
T ss_pred ccCCceEEEEecCCCChhh
Confidence 35789999999977654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.15 E-value=9e-06 Score=85.12 Aligned_cols=142 Identities=19% Similarity=0.283 Sum_probs=81.7
Q ss_pred eeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC--cceeEEee------EEEecCceEEEEee
Q 005450 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLG------FCFEDNNLLLVYDF 424 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~H--pnIV~l~g------~~~~~~~~~LV~Ey 424 (696)
.+.|+.|..+.||+....+| .+++|+..... ..+..|..++..|.. -.+.+++. +....+..+++|+|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRPE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSCH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCCH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 35566677899999887655 49999998643 233345555555531 12333332 12345678999999
Q ss_pred cCCCChh--------------hhhhcCCC-C--C-------CCCChHHHH------------------------------
Q 005450 425 LSRGSLE--------------ENLHGNKK-D--P-------AAFGWSERY------------------------------ 450 (696)
Q Consensus 425 ~~gGsL~--------------~~L~~~~~-~--~-------~~l~~~~~~------------------------------ 450 (696)
++|..+. ..+|.... . + ....|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9987542 11221110 0 0 011232211
Q ss_pred -HHHHHHHHHHHHHhc----------CCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 451 -KVAMGVAEALEYLHS----------GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 451 -~Ia~qIa~aL~yLH~----------~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
.+...+..++.+|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111123345666653 123789999999999999888889999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=1.4e-05 Score=86.44 Aligned_cols=75 Identities=16% Similarity=0.140 Sum_probs=51.0
Q ss_pred eeeeeeccCceEEEEEEeC-CCCEEEEEEecCChh--------HHHHHHHHHHHHHhcCC--cc-eeEEeeEEEecCceE
Q 005450 352 AENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED--------VIKEFVLEIEIITTLHH--KN-IISLLGFCFEDNNLL 419 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~--------~~~~~~~Ei~iL~~L~H--pn-IV~l~g~~~~~~~~~ 419 (696)
..+.||.|.++.||++... +++.++||...+... ...++..|.++|..+.. |. +.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3568999999999999754 578899998754221 23456779999888742 33 4455543 345678
Q ss_pred EEEeecCCC
Q 005450 420 LVYDFLSRG 428 (696)
Q Consensus 420 LV~Ey~~gG 428 (696)
+||||+++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00024 Score=77.64 Aligned_cols=73 Identities=16% Similarity=0.134 Sum_probs=45.9
Q ss_pred eeeeeeccCceEEEEEEeCCCCEEEEEEecCC-----hh-----HHHHHHHHHHHHH-hcCCcceeEEeeEEEecCceEE
Q 005450 352 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS-----ED-----VIKEFVLEIEIIT-TLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~-----~~-----~~~~~~~Ei~iL~-~L~HpnIV~l~g~~~~~~~~~L 420 (696)
..+.||.|..+.||+... +++.++||...+. .. ....+..|+..+. ......+.+++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 457789999999999864 5678999953321 10 2223333333222 22234566777665 567899
Q ss_pred EEeec-CC
Q 005450 421 VYDFL-SR 427 (696)
Q Consensus 421 V~Ey~-~g 427 (696)
||||+ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 77
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.0002 Score=75.72 Aligned_cols=141 Identities=15% Similarity=0.196 Sum_probs=94.9
Q ss_pred eeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcC---CcceeEEeeEEEecCceEEEEeecCC
Q 005450 351 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 351 ~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~---HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
...+.|+.|....+|+... ++..+++|+.... ....+..|...|+.|. ...+.+++.++...+..++||||+++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 3456799999999999876 5678999987643 3566888999988884 35688888888877889999999999
Q ss_pred CChh-----------hhhhcCCC-CC-----------------CCCChHHHH---HHHH----------------HHHHH
Q 005450 428 GSLE-----------ENLHGNKK-DP-----------------AAFGWSERY---KVAM----------------GVAEA 459 (696)
Q Consensus 428 GsL~-----------~~L~~~~~-~~-----------------~~l~~~~~~---~Ia~----------------qIa~a 459 (696)
..+. ..||.... .. ..-+|...+ ++.. .+++.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 8652 12343221 00 011454332 1111 11111
Q ss_pred -HHHHhc-CCCCceEeecccccceeeCCCCceEEeecC
Q 005450 460 -LEYLHS-GSAQRVIHRDVKSSNILLSDDFEPQLSDFG 495 (696)
Q Consensus 460 -L~yLH~-~~~~gIIHrDLKpsNILLd~~~~vKL~DFG 495 (696)
...|.. .....++|+|+.+.|++++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223421 2236799999999999999887 8899984
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00014 Score=75.66 Aligned_cols=139 Identities=14% Similarity=0.129 Sum_probs=77.4
Q ss_pred eeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcce-eEEeeEEEecCceEEEEeec-CCCCh
Q 005450 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFL-SRGSL 430 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~g~~~~~~~~~LV~Ey~-~gGsL 430 (696)
.+.|+.|....+|+. ..+++|+............+|..++..+...++ .+++.+ ..+.-++|+||+ +|.+|
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 678999999999998 568999887542222223468877777753233 355544 334457899999 66554
Q ss_pred hh------------------hhhcCCCC-CCCCC-hHHHHHHHH--------------HHHHHH----HHHhc-CCCCce
Q 005450 431 EE------------------NLHGNKKD-PAAFG-WSERYKVAM--------------GVAEAL----EYLHS-GSAQRV 471 (696)
Q Consensus 431 ~~------------------~L~~~~~~-~~~l~-~~~~~~Ia~--------------qIa~aL----~yLH~-~~~~gI 471 (696)
.. .+|..... ...+. +.....+.. .+.+.+ ..|.. .....+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 32 11221110 00011 111111100 011111 12211 223568
Q ss_pred EeecccccceeeCCCCceEEeecCcccc
Q 005450 472 IHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 472 IHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+|+|+.+.||+ ..++.+.|+||..+..
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccC
Confidence 99999999999 5566789999988753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0013 Score=68.68 Aligned_cols=143 Identities=17% Similarity=0.238 Sum_probs=83.8
Q ss_pred eeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc--eeEEeeE-----EEecCceEEEEeecC
Q 005450 354 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN--IISLLGF-----CFEDNNLLLVYDFLS 426 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hpn--IV~l~g~-----~~~~~~~~LV~Ey~~ 426 (696)
..|+ |....||+....+|+.+++|+..+.......+..|..++..+.... +++++.. ...++..+++|+|++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 4566 8888999987777888999999754333456677888887775222 3444432 222455688999999
Q ss_pred CCChhh--------------hhhcCCC-----CCCCCChHHH----------------------HHHHHHHHHHHHHHhc
Q 005450 427 RGSLEE--------------NLHGNKK-----DPAAFGWSER----------------------YKVAMGVAEALEYLHS 465 (696)
Q Consensus 427 gGsL~~--------------~L~~~~~-----~~~~l~~~~~----------------------~~Ia~qIa~aL~yLH~ 465 (696)
|..+.. .+|.... ....+.+... ..++..++..+.-+-.
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 864321 1121100 0011222111 0111122222222211
Q ss_pred -CCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 466 -GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 466 -~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
.....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1236789999999999999 4 899999987753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00099 Score=69.38 Aligned_cols=144 Identities=17% Similarity=0.170 Sum_probs=81.2
Q ss_pred eeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc--eeEEeeE------EEecCceEEEEee
Q 005450 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN--IISLLGF------CFEDNNLLLVYDF 424 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hpn--IV~l~g~------~~~~~~~~LV~Ey 424 (696)
.+.|+.|....+|+....+| .+++|+.... .....+..|+.++..+...+ +.+++.. ....+..+++|+|
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 45677888899999887666 6889998762 11234556777777664222 2333321 1234567899999
Q ss_pred cCCCChhh--------------hhhcCCC---CCC--C---CChHHHHH------------HHHHHHHHHHHHhc----C
Q 005450 425 LSRGSLEE--------------NLHGNKK---DPA--A---FGWSERYK------------VAMGVAEALEYLHS----G 466 (696)
Q Consensus 425 ~~gGsL~~--------------~L~~~~~---~~~--~---l~~~~~~~------------Ia~qIa~aL~yLH~----~ 466 (696)
++|..+.. .+|.... .+. . ..|...+. +...+.+.+++|+. .
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99865421 1221110 000 0 11322110 01123444555553 1
Q ss_pred CCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 467 ~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
...+++|+|+.+.|||++++..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23679999999999999887556899998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00032 Score=77.30 Aligned_cols=74 Identities=18% Similarity=0.222 Sum_probs=51.5
Q ss_pred eeeeeeccCceEEEEEEeCC--------CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcce-eEEeeEEEecCceEEEE
Q 005450 352 AENLIGKGGSSQVYKGCLPD--------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~--------g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~g~~~~~~~~~LV~ 422 (696)
..+.|+.|....+|+....+ +..+++|+..... ....+..|..++..+...++ .++++.+.. .+||
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 45678889999999998653 5789999985421 11455679988888854333 566665532 3899
Q ss_pred eecCCCCh
Q 005450 423 DFLSRGSL 430 (696)
Q Consensus 423 Ey~~gGsL 430 (696)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.002 Score=66.25 Aligned_cols=79 Identities=19% Similarity=0.180 Sum_probs=58.2
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCC---cceeEEeeEEEecCceEEEEe
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHH---KNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~H---pnIV~l~g~~~~~~~~~LV~E 423 (696)
......+.+|.|..+.||+....||+.|++|+..... .....|..|...|+.|.. -.+.+++++. .-++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 3566678899999999999999999999999876433 223457789999988852 1244555442 3478999
Q ss_pred ecCCCCh
Q 005450 424 FLSRGSL 430 (696)
Q Consensus 424 y~~gGsL 430 (696)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9988754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0015 Score=68.62 Aligned_cols=144 Identities=15% Similarity=0.124 Sum_probs=75.3
Q ss_pred eeeeeccCceE-EEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC--cceeEEeeEEEecCceEEEEeecCCCC
Q 005450 353 ENLIGKGGSSQ-VYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLVYDFLSRGS 429 (696)
Q Consensus 353 ~~~LG~G~fG~-Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~H--pnIV~l~g~~~~~~~~~LV~Ey~~gGs 429 (696)
.+.|+.|+... +|+....+|..+++|...+... ..+..|+.++..+.. -.+.+++.+.... -+++||++.+..
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~--~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG--GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT--CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC--ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 34566665554 6676654577888887665421 233456666666642 2345566654332 378999998766
Q ss_pred hhhhhhcC---------------------CCC-CCCCChHHHH-------H-H------------HHHHHHHHHHHh---
Q 005450 430 LEENLHGN---------------------KKD-PAAFGWSERY-------K-V------------AMGVAEALEYLH--- 464 (696)
Q Consensus 430 L~~~L~~~---------------------~~~-~~~l~~~~~~-------~-I------------a~qIa~aL~yLH--- 464 (696)
+.+.+... ... ...+...... . + ...+...+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65443221 000 0011111000 0 0 011112222221
Q ss_pred cCCCCceEeecccccceeeCCC----CceEEeecCccccc
Q 005450 465 SGSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAKWA 500 (696)
Q Consensus 465 ~~~~~gIIHrDLKpsNILLd~~----~~vKL~DFGlA~~~ 500 (696)
......++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1223689999999999999874 67899999988643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0011 Score=72.07 Aligned_cols=142 Identities=19% Similarity=0.254 Sum_probs=84.0
Q ss_pred eeeeeccCceEEEEEEeC--------CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc-eeEEeeEEEecCceEEEEe
Q 005450 353 ENLIGKGGSSQVYKGCLP--------DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~--------~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~g~~~~~~~~~LV~E 423 (696)
.+.|..|-...+|+.... +++.+++|+..........+.+|.++++.+..-+ ..++++++.. .+|||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 456777888899998864 3578999997543233456668999998885322 3566666543 29999
Q ss_pred ecCCCChhh-----------------hhhcCCC-CCCCC--ChHHHHHHHHHHHH-------------------HHHHHh
Q 005450 424 FLSRGSLEE-----------------NLHGNKK-DPAAF--GWSERYKVAMGVAE-------------------ALEYLH 464 (696)
Q Consensus 424 y~~gGsL~~-----------------~L~~~~~-~~~~l--~~~~~~~Ia~qIa~-------------------aL~yLH 464 (696)
|++|..|.. .||.... ..... -|.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999876542 1222211 01112 24444444443321 223332
Q ss_pred ----c-CCCCceEeecccccceeeCCC----CceEEeecCccc
Q 005450 465 ----S-GSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAK 498 (696)
Q Consensus 465 ----~-~~~~gIIHrDLKpsNILLd~~----~~vKL~DFGlA~ 498 (696)
. .....++|+|+.+.|||++.+ +.+.|+||..|.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 233579999999999999876 689999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00042 Score=74.14 Aligned_cols=74 Identities=19% Similarity=0.191 Sum_probs=46.5
Q ss_pred eeeeeccCceEEEEEEeCC---------CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc-eeEEeeEEEecCceEEEE
Q 005450 353 ENLIGKGGSSQVYKGCLPD---------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~---------g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~g~~~~~~~~~LV~ 422 (696)
.+.|+.|....+|+....+ +..+++|+.............|..++..+...+ ..++++.+ .-++||
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 4677888889999988654 278999998754332223457888888775333 34565543 237899
Q ss_pred eecCCCCh
Q 005450 423 DFLSRGSL 430 (696)
Q Consensus 423 Ey~~gGsL 430 (696)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998644
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00067 Score=75.47 Aligned_cols=75 Identities=21% Similarity=0.179 Sum_probs=49.5
Q ss_pred eeeeeeccCceEEEEEEeCC-CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcce-eEEeeEEEecCceEEEEeecCCCC
Q 005450 352 AENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFLSRGS 429 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~-g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~g~~~~~~~~~LV~Ey~~gGs 429 (696)
..+.|+.|-...+|+....+ +..+++|+........-...+|..++..|...++ .++++++. + .+||||++|.+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 45678889999999988765 5789999885432111112578889998875444 46666662 2 35999999865
Q ss_pred h
Q 005450 430 L 430 (696)
Q Consensus 430 L 430 (696)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0066 Score=64.38 Aligned_cols=67 Identities=18% Similarity=0.197 Sum_probs=44.3
Q ss_pred ccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC---cceeEEeeE------EEecCceEEEEeecCCC
Q 005450 358 KGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH---KNIISLLGF------CFEDNNLLLVYDFLSRG 428 (696)
Q Consensus 358 ~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~H---pnIV~l~g~------~~~~~~~~LV~Ey~~gG 428 (696)
.|....||+....+| .+++|+...... ..|+.++..|.. |++++++.. ....+..+++|+|++|.
T Consensus 33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 33 ADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp SCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred CccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 333688999987777 899998876442 346666665532 224444432 23356789999999987
Q ss_pred Ch
Q 005450 429 SL 430 (696)
Q Consensus 429 sL 430 (696)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 66
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.42 E-value=0.022 Score=62.59 Aligned_cols=142 Identities=14% Similarity=0.184 Sum_probs=84.9
Q ss_pred eeeeeeccCceEEEEEEeCC--------CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc-eeEEeeEEEecCceEEEE
Q 005450 352 AENLIGKGGSSQVYKGCLPD--------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~--------g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~g~~~~~~~~~LV~ 422 (696)
..+.|..|-...+|+....+ +..+++++........-...+|..+++.+...+ ..++++.+ .-++||
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 35677788889999988653 688999997653322222356888888775322 34555433 237899
Q ss_pred eecCCCChhh-----------------hhhcCCC---------CCCCCChHHHHHHHHHH-------------------H
Q 005450 423 DFLSRGSLEE-----------------NLHGNKK---------DPAAFGWSERYKVAMGV-------------------A 457 (696)
Q Consensus 423 Ey~~gGsL~~-----------------~L~~~~~---------~~~~l~~~~~~~Ia~qI-------------------a 457 (696)
||++|..|.. .||.... ...+..|.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999876431 0111000 11111244443333222 1
Q ss_pred HHHHHHhc---------------------CCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 458 EALEYLHS---------------------GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 458 ~aL~yLH~---------------------~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
..+.+|.. .....++|+|+.+.||+ +.++.+.|+||..|.
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 22333321 12356899999999999 778889999998775
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=94.84 E-value=0.052 Score=49.14 Aligned_cols=84 Identities=17% Similarity=0.138 Sum_probs=59.3
Q ss_pred cEEEEEEecCcchHHHHhHHHHhhcCCCCeEEEEEeeecccccccCC----cchhhhhHHHHHHHHHHHHhcccccce-e
Q 005450 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDG----KSSLLSLVKAFDSVLAVYEGFCNLKQV-D 91 (696)
Q Consensus 17 ~~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~hv~~~~~~~~~~~----~~~~~~~~~~~~~~l~~~~~~c~~kq~-~ 91 (696)
++|||++.....++..|.||+.-..+.|..|..|||........... ....-...+.....|+.+...|.-..+ .
T Consensus 6 ~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~~ 85 (146)
T 3s3t_A 6 TNILVPVDSSDAAQAAFTEAVNIAQRHQANLTALYVVDDSAYHTPALDPVLSELLDAEAAHAKDAMRQRQQFVATTSAPN 85 (146)
T ss_dssp CEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEEECCCCCCGGGHHHHHHHHHHHHHHHHHHHHHHHHHHTTSSCCC
T ss_pred ceEEEEcCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccHHHHHHHHHHHHHHHHHHHHHHHhcCCcc
Confidence 68999999999999999999998888899999999987543211000 000011224555677777777776667 7
Q ss_pred eEEEEecCc
Q 005450 92 LKLKICRGT 100 (696)
Q Consensus 92 l~~~~~~~~ 100 (696)
.+.++..|.
T Consensus 86 ~~~~~~~g~ 94 (146)
T 3s3t_A 86 LKTEISYGI 94 (146)
T ss_dssp CEEEEEEEC
T ss_pred eEEEEecCC
Confidence 777777764
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=94.25 E-value=0.067 Score=47.97 Aligned_cols=84 Identities=10% Similarity=0.084 Sum_probs=59.6
Q ss_pred cEEEEEEecCcchHHHHhHHHHhh-cCCCCeEEEEEeeecccccccCC---cchhhhhH-HHHHHHHHHHHhccccccee
Q 005450 17 RTVVVGVKLDTHSRELLTWALVKV-AQPGDTVIALHVLANNAIVDRDG---KSSLLSLV-KAFDSVLAVYEGFCNLKQVD 91 (696)
Q Consensus 17 ~~~~vg~~~d~~~~~~l~wa~~~~-a~~~d~v~a~hv~~~~~~~~~~~---~~~~~~~~-~~~~~~l~~~~~~c~~kq~~ 91 (696)
++|||++.....++..|.||+.-. .+.|..|..|||..........+ ....-.+. +.....|+.+...|.-..+.
T Consensus 2 ~~ILv~~D~s~~s~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~ 81 (138)
T 3idf_A 2 KKLLFAIDDTEACERAAQYILDMFGKDADCTLTLIHVKPEFMLYGEAVLAAYDEIEMKEEEKAKLLTQKFSTFFTEKGIN 81 (138)
T ss_dssp EEEEEECCSSHHHHHHHHHHHHHHTTCTTEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHhccCCCCEEEEEEEecCCCcccccccCcHHHHHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 589999999999999999999999 89999999999987543210000 00011112 34456677777777767788
Q ss_pred eEEEEecCc
Q 005450 92 LKLKICRGT 100 (696)
Q Consensus 92 l~~~~~~~~ 100 (696)
.+.++..|.
T Consensus 82 ~~~~v~~g~ 90 (138)
T 3idf_A 82 PFVVIKEGE 90 (138)
T ss_dssp CEEEEEESC
T ss_pred eEEEEecCC
Confidence 888887774
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.86 E-value=0.27 Score=49.26 Aligned_cols=99 Identities=18% Similarity=0.140 Sum_probs=65.2
Q ss_pred ChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCcc
Q 005450 429 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 508 (696)
Q Consensus 429 sL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~~ 508 (696)
+|.++|..... +++++++|.++.|.+.+|.-+-... .+ ..+=+-|..|+|..+|.+-+.+ +.+.
T Consensus 34 SL~eIL~~~~~---PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRLYNQ---PINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHHcCC---CcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 78999986653 7999999999999999987762100 11 1333457899999999888774 1110
Q ss_pred cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhC
Q 005450 509 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 548 (696)
Q Consensus 509 ~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG 548 (696)
.....+.|||... ...+.+.=|||||++||.-+-=
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 1122466888764 3556788999999999998863
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=93.71 E-value=0.09 Score=47.47 Aligned_cols=84 Identities=11% Similarity=-0.003 Sum_probs=57.9
Q ss_pred cEEEEEEecCcchHHHHhHHHHhhcCCCCeEEEEEeeecccc-cccC---Ccch----hhhhHHHHHHHHHHHHhccccc
Q 005450 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAI-VDRD---GKSS----LLSLVKAFDSVLAVYEGFCNLK 88 (696)
Q Consensus 17 ~~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~hv~~~~~~-~~~~---~~~~----~~~~~~~~~~~l~~~~~~c~~k 88 (696)
++|||++.....++..|.||+.-..+.|..|..|||...... .... .... .-...+.....|+.+...|.-.
T Consensus 3 ~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 82 (147)
T 3hgm_A 3 NRIMVPVDGSKGAVKALEKGVGLQQLTGAELYILCVFKHHSLLEASLSMARPEQLDIPDDALKDYATEIAVQAKTRATEL 82 (147)
T ss_dssp SEEEEECCSBHHHHHHHHHHHHHHHHHCCEEEEEEEECCHHHHHHTBSSCCCGGGCCCTTHHHHHHHHHHHHHHHHHHHT
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCcccccccccccChhhhhhHHHHHHHHHHHHHHHHHHHHHhc
Confidence 689999999999999999999988889999999999875431 0000 0000 1122245556667777666666
Q ss_pred ceee---EEEEecCc
Q 005450 89 QVDL---KLKICRGT 100 (696)
Q Consensus 89 q~~l---~~~~~~~~ 100 (696)
.+.. +.++..|.
T Consensus 83 g~~~~~~~~~~~~g~ 97 (147)
T 3hgm_A 83 GVPADKVRAFVKGGR 97 (147)
T ss_dssp TCCGGGEEEEEEESC
T ss_pred CCCccceEEEEecCC
Confidence 6666 77777764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.92 E-value=0.32 Score=52.56 Aligned_cols=30 Identities=33% Similarity=0.439 Sum_probs=24.8
Q ss_pred CceEeecccccceee------CCCCceEEeecCccc
Q 005450 469 QRVIHRDVKSSNILL------SDDFEPQLSDFGLAK 498 (696)
Q Consensus 469 ~gIIHrDLKpsNILL------d~~~~vKL~DFGlA~ 498 (696)
..++|+|+.+.|||+ +++..+.++||-+|.
T Consensus 244 ~vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 244 VVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 346799999999999 456679999998774
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=92.72 E-value=0.24 Score=44.48 Aligned_cols=40 Identities=10% Similarity=0.209 Sum_probs=36.4
Q ss_pred cEEEEEEecCcc--hHHHHhHHHHhhcCCCCeEEEEEeeecc
Q 005450 17 RTVVVGVKLDTH--SRELLTWALVKVAQPGDTVIALHVLANN 56 (696)
Q Consensus 17 ~~~~vg~~~d~~--~~~~l~wa~~~~a~~~d~v~a~hv~~~~ 56 (696)
++|||++..... ++..|.||+.-..+.|..|..|||....
T Consensus 2 k~ILv~vD~s~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~ 43 (143)
T 3fdx_A 2 NAILVPIDISDKEFTERIISHVESEARIDDAEVHFLTVIPSL 43 (143)
T ss_dssp CEEEEECCTTCSSCCTTHHHHHHHHHHHHTCEEEEEEEECC-
T ss_pred CEEEEEecCChHhhHHHHHHHHHHHHHhcCCeEEEEEEecCC
Confidence 689999999999 9999999998888899999999998753
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=92.71 E-value=0.19 Score=47.05 Aligned_cols=92 Identities=15% Similarity=0.053 Sum_probs=53.3
Q ss_pred CCcccCCCCcEEEEEEecCcchHHHHhHHHHhhcCCCCeEEEE--Eeeecccc-cc-cCCcchhh-hhHHHHHHHHHHHH
Q 005450 8 GDVISSGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIAL--HVLANNAI-VD-RDGKSSLL-SLVKAFDSVLAVYE 82 (696)
Q Consensus 8 ~~~~~~~~~~~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~--hv~~~~~~-~~-~~~~~~~~-~~~~~~~~~l~~~~ 82 (696)
+.......-++|||++.....|+..|.||+.-.. .|..|..| ||...... .. ..+..... ...+.....|+.+.
T Consensus 9 ~~~~~~~~~~~ILv~vD~s~~s~~al~~A~~lA~-~~a~l~ll~a~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 87 (163)
T 1tq8_A 9 GGHMSLSAYKTVVVGTDGSDSSMRAVDRAAQIAG-ADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAK 87 (163)
T ss_dssp ----CCCCCCEEEEECCSSHHHHHHHHHHHHHHT-TTSEEEEEEECCC--------------------CCTHHHHHHHHH
T ss_pred CCccccccCCEEEEEcCCCHHHHHHHHHHHHHhC-CCCEEEEEEeeeccCcccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 3334455567999999999999999999998888 99999999 88753321 00 00000110 11123344555555
Q ss_pred hccccccee-eEEEEecCc
Q 005450 83 GFCNLKQVD-LKLKICRGT 100 (696)
Q Consensus 83 ~~c~~kq~~-l~~~~~~~~ 100 (696)
..|.-..|. .+..+..|.
T Consensus 88 ~~~~~~gv~~v~~~v~~G~ 106 (163)
T 1tq8_A 88 ERAHNAGAKNVEERPIVGA 106 (163)
T ss_dssp HHHHTTTCCEEEEEEECSS
T ss_pred HHHHHcCCCeEEEEEecCC
Confidence 555555666 777777764
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=92.51 E-value=0.34 Score=44.54 Aligned_cols=84 Identities=15% Similarity=0.085 Sum_probs=55.2
Q ss_pred cEEEEEEecCcchHHHHhHHHHhhcCCCCeEEEEEeeecc-----cc-ccc-CC--c-ch-------hh-hhHHHHHHHH
Q 005450 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANN-----AI-VDR-DG--K-SS-------LL-SLVKAFDSVL 78 (696)
Q Consensus 17 ~~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~hv~~~~-----~~-~~~-~~--~-~~-------~~-~~~~~~~~~l 78 (696)
++|||++.....++..|.||+.-..+.|..|+.|||.... .. ... .+ - .. .. .+.+.....|
T Consensus 6 ~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 85 (162)
T 1mjh_A 6 KKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKNKM 85 (162)
T ss_dssp CEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHHHH
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHHhhcCCeEEEEEEecCccccccccccccccccccccchhhhHHHHHHHHHHHHHHHH
Confidence 6899999999999999999998888889999999998753 10 000 00 0 00 11 1123444566
Q ss_pred HHHHhcccccceeeEEEEecCc
Q 005450 79 AVYEGFCNLKQVDLKLKICRGT 100 (696)
Q Consensus 79 ~~~~~~c~~kq~~l~~~~~~~~ 100 (696)
+.+...|....|..+.++..|.
T Consensus 86 ~~~~~~~~~~g~~~~~~v~~G~ 107 (162)
T 1mjh_A 86 ENIKKELEDVGFKVKDIIVVGI 107 (162)
T ss_dssp HHHHHHHHHTTCEEEEEEEEEC
T ss_pred HHHHHHHHHcCCceEEEEcCCC
Confidence 6666666666677777776653
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=92.26 E-value=0.35 Score=44.96 Aligned_cols=40 Identities=18% Similarity=0.164 Sum_probs=36.7
Q ss_pred cEEEEEEecCcchHHHHhHHHHhhcCCCCeEEEEEeeecc
Q 005450 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANN 56 (696)
Q Consensus 17 ~~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~hv~~~~ 56 (696)
++|||++.....++..|.||+.-..+.|..|+.|||....
T Consensus 6 ~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~ 45 (170)
T 2dum_A 6 RKVLFPTDFSEGAYRAVEVFEKRNKMEVGEVILLHVIDEG 45 (170)
T ss_dssp SEEEEECCSSHHHHHHHHHHHHHCCSCCSEEEEEEEEETT
T ss_pred ceEEEEecCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCc
Confidence 6899999999999999999999888899999999998643
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=90.61 E-value=0.33 Score=44.42 Aligned_cols=86 Identities=19% Similarity=0.167 Sum_probs=54.8
Q ss_pred CCcEEEEEEe--cCcchHHHHhHHHHhhcCCCCeEEEEEeeecccccccCCcc-hh-hhhHHHHHHHHHHHHhcccccce
Q 005450 15 AGRTVVVGVK--LDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKS-SL-LSLVKAFDSVLAVYEGFCNLKQV 90 (696)
Q Consensus 15 ~~~~~~vg~~--~d~~~~~~l~wa~~~~a~~~d~v~a~hv~~~~~~~~~~~~~-~~-~~~~~~~~~~l~~~~~~c~~kq~ 90 (696)
.-++|||++. ....++..|.||+.-..+.|..|..|||..........+-. .. -...+.....|+.+...+.-..+
T Consensus 14 ~~~~ILv~vD~~~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~ 93 (156)
T 3fg9_A 14 VYRRILLTVDEDDNTSSERAFRYATTLAHDYDVPLGICSVLESEDINIFDSLTPSKIQAKRKHVEDVVAEYVQLAEQRGV 93 (156)
T ss_dssp CCC-EEEECCSCCCHHHHHHHHHHHHHHHHHTCCEEEEEEECCCCTTCCCSSHHHHHHHHHHHHHHHHHHHHHHHHHHTC
T ss_pred cCceEEEEECCCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEeCCCccccccCCHHHHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 3479999999 77789999999999888889999999998754321111100 11 11223444556666555554455
Q ss_pred -eeEEEEec-Cc
Q 005450 91 -DLKLKICR-GT 100 (696)
Q Consensus 91 -~l~~~~~~-~~ 100 (696)
..+..+.. |.
T Consensus 94 ~~~~~~v~~~g~ 105 (156)
T 3fg9_A 94 NQVEPLVYEGGD 105 (156)
T ss_dssp SSEEEEEEECSC
T ss_pred CceEEEEEeCCC
Confidence 36666666 54
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=90.45 E-value=0.39 Score=44.40 Aligned_cols=73 Identities=15% Similarity=0.104 Sum_probs=50.0
Q ss_pred CcEEEEEEec-CcchHHHHhHHHHhhcCCCCeEEEEEeeecccccccCCcchhhhhHHHHHHHHHHHHhcccccceeeEE
Q 005450 16 GRTVVVGVKL-DTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL 94 (696)
Q Consensus 16 ~~~~~vg~~~-d~~~~~~l~wa~~~~a~~~d~v~a~hv~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c~~kq~~l~~ 94 (696)
-++|||++.. ...++..|.||+.-..+.|..|+.|||....... . -...+.....|+.+...+.-..++.+.
T Consensus 24 ~~~ILv~vD~~s~~s~~al~~A~~la~~~~a~l~llhV~~~~~~~----~---~~~~~~~~~~l~~~~~~~~~~g~~~~~ 96 (155)
T 3dlo_A 24 YMPIVVAVDKKSDRAERVLRFAAEEARLRGVPVYVVHSLPGGGRT----K---DEDIIEAKETLSWAVSIIRKEGAEGEE 96 (155)
T ss_dssp CCCEEEECCSSSHHHHHHHHHHHHHHHHHTCCEEEEEEECCSTTS----C---HHHHHHHHHHHHHHHHHHHHTTCCEEE
T ss_pred cCeEEEEECCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEcCCCcc----c---HHHHHHHHHHHHHHHHHHHhcCCCceE
Confidence 3689999999 7889999999999888889999999998643221 0 112233444555555555445555554
Q ss_pred E
Q 005450 95 K 95 (696)
Q Consensus 95 ~ 95 (696)
+
T Consensus 97 ~ 97 (155)
T 3dlo_A 97 H 97 (155)
T ss_dssp E
T ss_pred E
Confidence 3
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=89.29 E-value=0.75 Score=42.90 Aligned_cols=86 Identities=19% Similarity=0.200 Sum_probs=52.0
Q ss_pred CCcEEEEEEecCc---------chHHHHhHHHHhhcCC---CCeEEEEEeeecccccc-c-CC---cchhh-h----hHH
Q 005450 15 AGRTVVVGVKLDT---------HSRELLTWALVKVAQP---GDTVIALHVLANNAIVD-R-DG---KSSLL-S----LVK 72 (696)
Q Consensus 15 ~~~~~~vg~~~d~---------~~~~~l~wa~~~~a~~---~d~v~a~hv~~~~~~~~-~-~~---~~~~~-~----~~~ 72 (696)
.-++|||++.... .++..|.||+..+++. |..|+.|||........ . .. ....+ . ..+
T Consensus 4 ~~~~ILv~vD~s~~~~~~~~~~~s~~al~~a~~la~~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (175)
T 2gm3_A 4 EPTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKA 83 (175)
T ss_dssp -CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHH
T ss_pred CccEEEEEECCCcccccccccHHHHHHHHHHHHHhhcccCCCCEEEEEEEeecccccccccccccCCHHHHHHHHHHHHH
Confidence 4479999999999 9999999999988774 78999999975322100 0 00 00001 0 111
Q ss_pred HHHHHHHHHHhcccccceeeEEEEecCc
Q 005450 73 AFDSVLAVYEGFCNLKQVDLKLKICRGT 100 (696)
Q Consensus 73 ~~~~~l~~~~~~c~~kq~~l~~~~~~~~ 100 (696)
.-...|+.+...|.-..|..+.++..|.
T Consensus 84 ~~~~~l~~~~~~~~~~g~~~~~~v~~G~ 111 (175)
T 2gm3_A 84 KGLHLLEFFVNKCHEIGVGCEAWIKTGD 111 (175)
T ss_dssp HHHHHHHHHHHHHHHHTCEEEEEEEESC
T ss_pred HHHHHHHHHHHHHHHCCCceEEEEecCC
Confidence 2334555555555545566676776664
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=88.90 E-value=0.46 Score=42.36 Aligned_cols=38 Identities=18% Similarity=0.214 Sum_probs=35.5
Q ss_pred cEEEEEEecCcchHHHHhHHHHhhcCCCCeEEEEEee-e
Q 005450 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVL-A 54 (696)
Q Consensus 17 ~~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~hv~-~ 54 (696)
++|||++.....++..|.||+.-..+.|..|+.|||. .
T Consensus 5 ~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~ 43 (138)
T 1q77_A 5 KVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLED 43 (138)
T ss_dssp EEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHH
T ss_pred cEEEEEccCCHhHHHHHHHHHHHHHHcCCeEEEEEEecc
Confidence 6899999999999999999999888889999999998 5
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=87.85 E-value=0.64 Score=47.32 Aligned_cols=81 Identities=11% Similarity=0.066 Sum_probs=56.1
Q ss_pred cEEEEEEecCcchHHHHhHHHHhhcCCCCeEEEEEeeeccccccc-CC--cchh-hhhHHHHHHHHHHHHhcccccceee
Q 005450 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDR-DG--KSSL-LSLVKAFDSVLAVYEGFCNLKQVDL 92 (696)
Q Consensus 17 ~~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~hv~~~~~~~~~-~~--~~~~-~~~~~~~~~~l~~~~~~c~~kq~~l 92 (696)
++|||++.....++.+|.||+.-..+-|..|++|||......... .+ .... -...+.-...|+.+...|.-..+..
T Consensus 23 ~~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~~ 102 (294)
T 3loq_A 23 NAMLLPTDLSENSFKVLEYLGDFKKVGVEEIGVLFVINLTKLSTVSGGIDIDHYIDEMSEKAEEVLPEVAQKIEAAGIKA 102 (294)
T ss_dssp CEEEEECCSCTGGGGGGGGHHHHHHTTCCEEEEECCEECTTC-----CCCTTHHHHHHHHHHHHHHHHHHHHHHHTTCEE
T ss_pred ccEEEecCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCcccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHcCCCc
Confidence 699999999999999999999988888999999999875432100 00 1111 1223345566777777776666776
Q ss_pred EE-EEe
Q 005450 93 KL-KIC 97 (696)
Q Consensus 93 ~~-~~~ 97 (696)
+. ++.
T Consensus 103 ~~~~v~ 108 (294)
T 3loq_A 103 EVIKPF 108 (294)
T ss_dssp EECSSC
T ss_pred ceeEee
Confidence 66 555
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=86.92 E-value=0.42 Score=43.26 Aligned_cols=39 Identities=18% Similarity=0.321 Sum_probs=35.9
Q ss_pred cEEEEEEecCcchHHHHhHHHHhhcCCCCeEEEEEeeec
Q 005450 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLAN 55 (696)
Q Consensus 17 ~~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~hv~~~ 55 (696)
++|||++.....++..|.||+.-..+.|..|+.|||...
T Consensus 7 ~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~ 45 (150)
T 3tnj_A 7 HHILLAVDFSSEDSQVVQKVRNLASQIGARLSLIHVLDN 45 (150)
T ss_dssp SEEEEECCCSTTHHHHHHHHHHHHHHHTCEEEEEEEEC-
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEEcC
Confidence 689999999999999999999988888999999999865
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=85.42 E-value=0.64 Score=41.50 Aligned_cols=38 Identities=24% Similarity=0.260 Sum_probs=35.1
Q ss_pred cEEEEEEecCcchHHHHhHHHHhhcCCCCeEEEEEeee
Q 005450 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLA 54 (696)
Q Consensus 17 ~~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~hv~~ 54 (696)
++|||++.....++..|.||+.-..+.|..|+.|||..
T Consensus 3 ~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~ 40 (141)
T 1jmv_A 3 KHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDV 40 (141)
T ss_dssp SEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEE
T ss_pred ceEEEEecCchhhHHHHHHHHHHHHhcCCEEEEEEEec
Confidence 68999999999999999999998888899999999984
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=85.11 E-value=1.3 Score=45.42 Aligned_cols=42 Identities=12% Similarity=0.265 Sum_probs=37.0
Q ss_pred CCCCcEEEEEEecCcchHHHHhHHHHhhcCCCCeEEEEEeee
Q 005450 13 SGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLA 54 (696)
Q Consensus 13 ~~~~~~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~hv~~ 54 (696)
...-++|||++.....++..|.||+.-..+.|..|+.|||..
T Consensus 16 ~~~~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~ 57 (309)
T 3cis_A 16 GNSSLGIIVGIDDSPAAQVAVRWAARDAELRKIPLTLVHAVS 57 (309)
T ss_dssp --CTTEEEEECCSSHHHHHHHHHHHHHHHHHTCCEEEEEECC
T ss_pred cCCCCeEEEEECCCHHHHHHHHHHHHHHHhcCCcEEEEEEec
Confidence 444579999999999999999999998888999999999986
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=84.73 E-value=0.58 Score=41.70 Aligned_cols=39 Identities=18% Similarity=0.295 Sum_probs=35.7
Q ss_pred cEEEEEEecCcchHHHHhHHHHhhcCCCCeEEEEEeeec
Q 005450 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLAN 55 (696)
Q Consensus 17 ~~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~hv~~~ 55 (696)
++|||++.....++..|.||+.-..+.|..|..|||...
T Consensus 3 ~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~ 41 (137)
T 2z08_A 3 KTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEP 41 (137)
T ss_dssp SEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECC
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecC
Confidence 689999999999999999999988888999999999863
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=84.38 E-value=0.99 Score=45.07 Aligned_cols=83 Identities=11% Similarity=-0.001 Sum_probs=55.5
Q ss_pred cEEEEEEecCcchHHHHhHHHHhhcCCCCeEEEEEeeeccccc--ccCCcc----h--------hhhhHHHHHHHHHHHH
Q 005450 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIV--DRDGKS----S--------LLSLVKAFDSVLAVYE 82 (696)
Q Consensus 17 ~~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~hv~~~~~~~--~~~~~~----~--------~~~~~~~~~~~l~~~~ 82 (696)
++|||++.....++..|.||+.-..+.|..|+.|||....... ...+.. . .-...+....+|+.+.
T Consensus 1 k~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 80 (268)
T 3ab8_A 1 MRILLATDGSPQARGAEALAEWLAYKLSAPLTVLFVVDTRLARIPELLDFGALTVPVPVLRTELERALALRGEAVLERVR 80 (268)
T ss_dssp CCEEEECCSCGGGHHHHHHHHHHHHHHTCCEEEEEEEEHHHHTHHHHC-------CHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcEEEEcCCCHHHHHHHHHHHHHHHHhCCcEEEEEEeccCCcccccccCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4799999999999999999999888889999999998643210 000100 0 0112234456677777
Q ss_pred hcccccceeeEEEEecC
Q 005450 83 GFCNLKQVDLKLKICRG 99 (696)
Q Consensus 83 ~~c~~kq~~l~~~~~~~ 99 (696)
..|.-..+..+.++..|
T Consensus 81 ~~~~~~g~~~~~~~~~g 97 (268)
T 3ab8_A 81 QSALAAGVAVEAVLEEG 97 (268)
T ss_dssp HHHHHTTCCEEEEEEEE
T ss_pred HHHHhCCCCeEEEEecC
Confidence 77665666666666554
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.79 E-value=1.9 Score=42.88 Aligned_cols=115 Identities=11% Similarity=0.195 Sum_probs=79.0
Q ss_pred CCcceeEEeeEEEecCceEEEEeecCCC-ChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccc
Q 005450 401 HHKNIISLLGFCFEDNNLLLVYDFLSRG-SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 479 (696)
Q Consensus 401 ~HpnIV~l~g~~~~~~~~~LV~Ey~~gG-sL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKps 479 (696)
.||+++.. .+-.+++.+.+.|+.-+.+ ++.. +. .++...+++++..|+....+++. -+|--|.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 58888866 4556666666766654422 2222 32 36778999999999988877664 488999999
Q ss_pred ceeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCC
Q 005450 480 NILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPIS 553 (696)
Q Consensus 480 NILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~ 553 (696)
||+++.++.+++.-.|+-..+ +|. .++...=.-.+=+++..+++++..|.
T Consensus 109 NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999877754322 221 11111223356788899999998874
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.63 E-value=3.3 Score=41.16 Aligned_cols=115 Identities=14% Similarity=0.146 Sum_probs=77.6
Q ss_pred CCcceeEEeeEEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHH-HHhcCCCCceEeeccccc
Q 005450 401 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE-YLHSGSAQRVIHRDVKSS 479 (696)
Q Consensus 401 ~HpnIV~l~g~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~-yLH~~~~~gIIHrDLKps 479 (696)
.||++ -..+-.+++.+.+.|+.-+++.=...+. .++...+++++..|+.... +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57877 3444466777777777654433233332 3677899999999988766 5554 588899999
Q ss_pred ceeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCC
Q 005450 480 NILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPIS 553 (696)
Q Consensus 480 NILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~ 553 (696)
||+++.++.++|.-.|+-.. ++|.-+ +..-=.-.+=+++..++.++..|.
T Consensus 114 NL~f~~~~~p~i~hRGi~~~-------------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES-------------------LPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTT-------------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCccc-------------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999987775432 233211 111112356778888888888774
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=80.39 E-value=2.2 Score=43.62 Aligned_cols=84 Identities=8% Similarity=0.107 Sum_probs=57.0
Q ss_pred cEEEEEEecCcchHHHHhHHHHhhcCCCCeEEEEEeeecccccccC--Ccchhh----hhHHHHHHHHHHHHhcccccce
Q 005450 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRD--GKSSLL----SLVKAFDSVLAVYEGFCNLKQV 90 (696)
Q Consensus 17 ~~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~hv~~~~~~~~~~--~~~~~~----~~~~~~~~~l~~~~~~c~~kq~ 90 (696)
++|||++.....+...|.||+.-..+-|-.|+.|||.......... +....- ...+.....|+.+...|....|
T Consensus 8 k~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v 87 (319)
T 3olq_A 8 QNLLVVIDPNQDDQPALRRAVYIVQRNGGRIKAFLPVYDLSYDMTTLLSPDERNAMRKGVINQKTAWIKQQARYYLEAGI 87 (319)
T ss_dssp CEEEEECCTTCSCCHHHHHHHHHHHHHCCEEEEEEEECCGGGGCTTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred ceEEEEECCCcccHHHHHHHHHHHHHcCCeEEEEEEecccchhhccccChhhHHHHHHHHHHHHHHHHHHHHHHHhhcCC
Confidence 6899999999999999999999998899999999997532211000 000000 1122334566666666666778
Q ss_pred eeEEEEe-cCc
Q 005450 91 DLKLKIC-RGT 100 (696)
Q Consensus 91 ~l~~~~~-~~~ 100 (696)
..+.++. .|.
T Consensus 88 ~~~~~~~~~g~ 98 (319)
T 3olq_A 88 QIDIKVIWHNR 98 (319)
T ss_dssp CEEEEEEECSC
T ss_pred eEEEEEEecCC
Confidence 8888886 543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 696 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 1e-64
Identities = 74/281 (26%), Positives = 128/281 (45%), Gaps = 26/281 (9%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKN 404
IG G VYKG ++AVK+L P+ ++ F E+ ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
I+ +G+ L +V + SL +LH + F + +A A+ ++YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLH 121
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 524
+ + +IHRD+KS+NI L +D ++ DFGLA S S ++G+ ++APE
Sbjct: 122 A---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 525 MY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581
+ + DVYAFG+VL EL+TG+ P SN + + Q ++ +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD-------L 231
Query: 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
+ +N M+R++ C+++ RP +L +
Sbjct: 232 SKVRSNCP-KAMKRLMAE---CLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-61
Identities = 56/274 (20%), Positives = 114/274 (41%), Gaps = 22/274 (8%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 407
+G G +V+ G ++AVK LK F+ E ++ L H+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 467
L + ++ +++ GSL + L ++ +A +AE + ++
Sbjct: 73 LYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEE-- 127
Query: 468 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 527
+ IHRD++++NIL+SD +++DFGLA+ + + APE YG
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYG 185
Query: 528 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587
K DV++FG++L E++T + + V+ + + +N
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQ--------NLERGYRMVRPDN 234
Query: 588 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621
+++ +++ LC + P RP + +L
Sbjct: 235 CP-EELYQLMR---LCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 6e-61
Identities = 66/279 (23%), Positives = 119/279 (42%), Gaps = 22/279 (7%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 407
S IG G V+ G + ++A+K ++ ++F+ E E++ L H ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 467
L G C E + LV++F+ G L + L F + + V E + YL
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 468 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 527
VIHRD+ + N L+ ++ ++SDFG+ ++ + + +PE F +
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFS 177
Query: 528 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587
+ + K DV++FGV++ E+ + K P S + I + + L P L +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKI-----PYENRSNSEVVEDISTGFR---LYKPRLAST 229
Query: 588 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 626
+ Y M C + P RP S +L+ L A+
Sbjct: 230 HVYQIMNH-------CWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 3e-60
Identities = 59/304 (19%), Positives = 119/304 (39%), Gaps = 40/304 (13%)
Query: 346 ATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHH 402
+F + +G G V+K P G +A K++ + + + E++++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 403 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 462
I+ G + D + + + + GSL++ L + KV++ V + L Y
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTY 119
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
L +++HRDVK SNIL++ E +L DFG++ S + GT Y++PE
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPE 173
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLTGRKPI-SNDHPKGQESLVMWAKPILSSGKVTQLLD 581
+ + D+++ G+ L+E+ GR PI D + + + +
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 582 PALGNNYDYDQMERMVLASIL--------------------------CIRRDPRARPQMS 615
++Y D M + +L C+ ++P R +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 616 LVLK 619
++
Sbjct: 294 QLMV 297
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-59
Identities = 72/292 (24%), Positives = 115/292 (39%), Gaps = 28/292 (9%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 412
+ IGKG +V++G G+E+AVKI E+ EI L H+NI+ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 413 FEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS--- 465
+DN L LV D+ GSL + L+ K+A+ A L +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT-----VEGMIKLALSTASGLAHLHMEIV 121
Query: 466 --GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW--ASTSSSHITCTDVAGTFGYLAP 521
+ HRD+KS NIL+ + ++D GLA ++T + I GT Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 522 EYF------MYGKVNDKIDVYAFGVVLLELLTGRKPISND----HPKGQESLVMWAKPIL 571
E + + + D+YA G+V E+ P + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 572 SSGKVTQLLDPALGNNYDYDQMERMVLASIL-CIRRDPRARPQMSLVLKLLR 622
Q L P + N + + R++ + C + AR + K L
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 6e-58
Identities = 69/277 (24%), Positives = 114/277 (41%), Gaps = 33/277 (11%)
Query: 348 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHH 402
+F +GKG VY LA+K+L + V + E+EI + L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 403 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 462
NI+ L G+ + + L+ ++ G++ L K F +A AL Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
HS +RVIHRD+K N+LL E +++DFG + A +S C GT YL PE
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPE 174
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582
++K+D+++ GV+ E L G+ P + + + + +
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD-----FVTE 229
Query: 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
D + R ++ +P RP + VL+
Sbjct: 230 GA-----RDLISR-------LLKHNPSQRPMLREVLE 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-57
Identities = 60/276 (21%), Positives = 114/276 (41%), Gaps = 24/276 (8%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 407
+ +G G V G ++A+K++K EF+ E +++ L H+ ++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 467
L G C + + ++ ++++ G L L + F + ++ V EA+EYL S
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES-- 118
Query: 468 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 527
++ +HRD+ + N L++D ++SDFGL+++ + + PE MY
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYS 176
Query: 528 KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586
K + K D++AFGV++ E+ + G+ P + L P L +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR---------LYRPHLAS 227
Query: 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
Y M C RP ++L +
Sbjct: 228 EKVYTIMYS-------CWHEKADERPTFKILLSNIL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 2e-57
Identities = 58/274 (21%), Positives = 117/274 (42%), Gaps = 22/274 (8%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 407
+ E +G+G +V+ G +A+K LKP + F+ E +++ L H+ ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 467
L + + +V +++S+GSL + L G + +A +A + Y+
Sbjct: 77 LYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVER-- 131
Query: 468 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 527
+HRD++++NIL+ ++ +++DFGLA+ + + APE +YG
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYG 189
Query: 528 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587
+ K DV++FG++L EL T + + + +V ++
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPG---------------MVNREVLDQVERGYRMP 234
Query: 588 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621
+ E + C R++P RP + L
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-57
Identities = 62/283 (21%), Positives = 106/283 (37%), Gaps = 26/283 (9%)
Query: 345 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTL 400
S ++ IG G + K DGK L K L +E + V E+ ++ L
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 401 HHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 458
H NI+ + + L +V ++ G L + K+ +V +
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 459 ALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 516
AL+ H S V+HRD+K +N+ L +L DFGLA+ + +S GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTP 178
Query: 517 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576
Y++PE N+K D+++ G +L EL P + K + K +
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238
Query: 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
+ L + + R + RP + +L+
Sbjct: 239 SDEL---------NEIITR-------MLNLKDYHRPSVEEILE 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (492), Expect = 4e-57
Identities = 68/304 (22%), Positives = 126/304 (41%), Gaps = 41/304 (13%)
Query: 338 FNYQDLLSATSNFLAE---------NLIGKGGSSQVYKGCLPDGKEL----AVKILKP-- 382
F ++D A F E +IG G +V G L + A+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 383 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 442
+E ++F+ E I+ H N+I L G + ++++ +F+ GSL+ L N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-- 124
Query: 443 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502
F + + G+A ++YL +HRD+ + NIL++ + ++SDFGL+++
Sbjct: 125 -FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 503 SSSHITCTDV---AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPK 558
+S T T + APE Y K DV+++G+V+ E+++ G +P + +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 559 GQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 618
V ++ D + + C ++D RP+ ++
Sbjct: 241 ----------------DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 619 KLLR 622
L
Sbjct: 285 NTLD 288
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 8e-57
Identities = 66/290 (22%), Positives = 121/290 (41%), Gaps = 31/290 (10%)
Query: 341 QDLLSATSNFLAENL-IGKGGSSQVYKGCL---PDGKELAVKILKP--SEDVIKEFVLEI 394
+ L N L ++ +G G V +G ++A+K+LK + +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 395 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 454
+I+ L + I+ L+G C + L+LV + G L + L G +++ S ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLH 116
Query: 455 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VA 513
V+ ++YL + +HRD+ + N+LL + ++SDFGL+K S+ T
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 514 GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILS 572
+ APE + K + + DV+++GV + E L+ G+KP + + K +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 233
Query: 573 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
+ L Y M C RP V + +R
Sbjct: 234 PPECPPEL---------YALMSD-------CWIYKWEDRPDFLTVEQRMR 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 2e-56
Identities = 70/276 (25%), Positives = 120/276 (43%), Gaps = 28/276 (10%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 407
IGKG V G G ++AVK +K ++ + F+ E ++T L H N++
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 408 LLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
LLG E+ L +V +++++GSL + L + G K ++ V EA+EYL
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEG- 121
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 526
+HRD+ + N+L+S+D ++SDFGL K AS+ T + APE
Sbjct: 122 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALRE 174
Query: 527 GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586
K + K DV++FG++L E+ + + P + L +V + +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVP------RVEKGYKMDAPD 223
Query: 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
+ ++ C D RP + + L
Sbjct: 224 GCP-PAVYEVMK---NCWHLDAAMRPSFLQLREQLE 255
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 2e-56
Identities = 66/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 354 NLIGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISL 408
IG G VY + + + +A+K + S + ++ + E+ + L H N I
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 409 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 468
G ++ LV ++ + + K E V G + L YLHS
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLHS--- 133
Query: 469 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM--- 525
+IHRDVK+ NILLS+ +L DFG A + ++S + GT ++APE +
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMD 187
Query: 526 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585
G+ + K+DV++ G+ +EL + P+ N + + + PAL
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------------PALQ 235
Query: 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
+ + + V + C+++ P+ RP ++LK
Sbjct: 236 SGHWSEYFRNFVDS---CLQKIPQDRPTSEVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-55
Identities = 60/275 (21%), Positives = 109/275 (39%), Gaps = 25/275 (9%)
Query: 349 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNI 405
++ +G+G +V + +AVKI+ + D + EI I L+H+N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 406 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 465
+ G E N L ++ S G L + + + + + + + YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHG 121
Query: 466 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 525
+ HRD+K N+LL + ++SDFGLA ++ + GT Y+APE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 526 YGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584
+ + +DV++ G+VL +L G P QE K + + +D A
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN--PWKKIDSAP 236
Query: 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
+ + + +P AR + + K
Sbjct: 237 -----LALLHK-------ILVENPSARITIPDIKK 259
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 5e-55
Identities = 66/280 (23%), Positives = 112/280 (40%), Gaps = 32/280 (11%)
Query: 351 LAENLIGKGGSSQVYKGCLPD---GKELAVKILKP---SEDVIKEFVLEIEIITTLHHKN 404
L + +G G V KG K +AVKILK + E + E ++ L +
Sbjct: 10 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 69
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
I+ ++G C E + +LV + G L + L N+ ++ V+ ++YL
Sbjct: 70 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLE 124
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEY 523
+HRD+ + N+LL ++SDFGL+K ++ + APE
Sbjct: 125 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 524 FMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582
Y K + K DV++FGV++ E + G+KP +++ + + + +
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM-- 239
Query: 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
YD M C D RP + V LR
Sbjct: 240 -------YDLMNL-------CWTYDVENRPGFAAVELRLR 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 5e-55
Identities = 66/273 (24%), Positives = 125/273 (45%), Gaps = 29/273 (10%)
Query: 354 NLIGKGGSSQVYKG-CLPDGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGF 411
+G G +VYK A K++ SE+ ++++++EI+I+ + H NI+ LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
+ +NNL ++ +F + G+++ + ++ S+ V +AL YLH ++
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHD---NKI 131
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 531
IHRD+K+ NIL + D + +L+DFG++ + + GT ++APE M D
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKD 189
Query: 532 -----KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586
K DV++ G+ L+E+ P +P + ++P P L
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP------------PTLAQ 237
Query: 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
+ + L C+ ++ AR S +L+
Sbjct: 238 PSRWSSNFKDFLKK--CLEKNVDARWTTSQLLQ 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 187 bits (475), Expect = 9e-55
Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 22/285 (7%)
Query: 339 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEII 397
NY ++ ++ +G G +VY+G +AVK LK ++EF+ E ++
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 67
Query: 398 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA 457
+ H N++ LLG C + ++ +F++ G+L + L + +A ++
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQIS 125
Query: 458 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 517
A+EYL + IHRD+ + N L+ ++ +++DFGL++ + +
Sbjct: 126 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIK 181
Query: 518 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577
+ APE Y K + K DV+AFGV+L E+ T Q V
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VY 226
Query: 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
+LL+ E++ C + +P RP + + +
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-54
Identities = 60/300 (20%), Positives = 114/300 (38%), Gaps = 40/300 (13%)
Query: 348 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSEDV--IKEFVLEIEIITT 399
+ +G G +V + +AVK+LKPS + + + E+++++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 400 L-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK--------------DPAAF 444
L +H NI++LLG C L++ ++ G L L + D A
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 445 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504
+ + VA+ + +L S + IHRD+ + NILL+ ++ DFGLA+ S
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 564
+++ + ++APE + DV+++G+ L EL + P +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256
Query: 565 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624
+++ M C DP RP +++L+
Sbjct: 257 -----------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-54
Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 33/276 (11%)
Query: 353 ENLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISL 408
+ IG+G VYKG E+A L+ ++ + F E E++ L H NI+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 409 LGFCFE----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
++LV + ++ G+L+ L K + + L++LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLH 129
Query: 465 SGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523
+ + +IHRD+K NI ++ ++ D GLA S + V GT ++APE
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEM 184
Query: 524 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583
+ K ++ +DVYAFG+ +LE+ T P S Q ++ +VT + PA
Sbjct: 185 YE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYR-------RVTSGVKPA 232
Query: 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
+ +++ ++ CIR++ R + +L
Sbjct: 233 SFDKVAIPEVKEIIEG---CIRQNKDERYSIKDLLN 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 7e-54
Identities = 72/282 (25%), Positives = 121/282 (42%), Gaps = 32/282 (11%)
Query: 349 NFLAENLIGKGGSSQVYKGCLPDGK----ELAVKILKPSEDV--IKEFVLEIEIITTLHH 402
+F +IG+G VY G L D AVK L D+ + +F+ E I+ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 403 KNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 461
N++SLLG C + + L+V ++ G L + +P + + VA+ ++
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT---VKDLIGFGLQVAKGMK 144
Query: 462 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS--SHITCTDVAGTFGYL 519
+L S ++ +HRD+ + N +L + F +++DFGLA+ S T ++
Sbjct: 145 FLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 520 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579
A E K K DV++FGV+L EL+T P P + +L + L
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---L 253
Query: 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 621
L P Y D + ++L C RP S ++ +
Sbjct: 254 LQP----EYCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 288
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 8e-54
Identities = 70/268 (26%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 354 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGF 411
IG+G S VY + G+E+A++ + + KE ++ EI ++ + NI++ L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
+ L +V ++L+ GSL + + D + V +ALE+LHS +V
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHS---NQV 137
Query: 472 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 531
IHRD+KS NILL D +L+DFG + S + + GT ++APE
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGP 195
Query: 532 KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 591
K+D+++ G++ +E++ G P N++P L+ P L N
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT------------PELQNPEKLS 243
Query: 592 QMERMVLASILCIRRDPRARPQMSLVLK 619
+ R L C+ D R +L+
Sbjct: 244 AIFRDFLNR--CLDMDVEKRGSAKELLQ 269
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 8e-54
Identities = 59/284 (20%), Positives = 119/284 (41%), Gaps = 29/284 (10%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLPDGKE-----LAVKILKP--SEDVIKEFVLEIEIITTL 400
S + +IG G +VYKG L +A+K LK +E +F+ E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 401 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 460
H NII L G + ++++ +++ G+ ++ F + + G+A +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGA---LDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 461 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI-TCTDVAGTFGYL 519
+YL + +HRD+ + NIL++ + ++SDFGL++ T + +
Sbjct: 124 KYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 520 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579
APE Y K DV++FG+V+ E++T + + + V +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------VMKA 225
Query: 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623
++ D + + C +++ RP+ + ++ +L
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-53
Identities = 60/302 (19%), Positives = 118/302 (39%), Gaps = 45/302 (14%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPSED--VIKEFVLEIEIITT 399
N ++G G +V ++AVK+LK D + + E++++T
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 400 L-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK------------------- 439
L H+NI++LLG C + L++++ G L L ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 440 DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499
D + + A VA+ +E+L + +HRD+ + N+L++ ++ DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 559
+ S+++ + ++APE G K DV+++G++L E+ + P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 560 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
+L+ + + E + + C D R RP +
Sbjct: 274 AN--------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 620 LL 621
L
Sbjct: 320 FL 321
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (462), Expect = 1e-52
Identities = 62/303 (20%), Positives = 126/303 (41%), Gaps = 46/303 (15%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKP--SEDVIKEFVLEIEIITT 399
+N IG+G +V++ P +AVK+LK S D+ +F E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 400 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD------------------- 440
+ NI+ LLG C + L++++++ G L E L
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 441 -PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499
P +E+ +A VA + YL ++ +HRD+ + N L+ ++ +++DFGL++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 559
++ + + A ++ PE Y + + DV+A+GVVL E+ +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-- 247
Query: 560 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
E ++ + + G + + ++ ++ LC + P RP + +
Sbjct: 248 HEEVIYYVR----DGNILACPENCP------LELYNLMR---LCWSKLPADRPSFCSIHR 294
Query: 620 LLR 622
+L+
Sbjct: 295 ILQ 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 6e-52
Identities = 61/269 (22%), Positives = 103/269 (38%), Gaps = 29/269 (10%)
Query: 349 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHK 403
+F ++G+G S V L +E A+KIL+ E+ + E ++++ L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 404 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 463
+ L +D L + G L + + F + + ALEYL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYL 124
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523
H + +IHRD+K NILL++D Q++DFG AK S S GT Y++PE
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 524 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583
D++A G ++ +L+ G P + ++ + P
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK-----FFPK 236
Query: 584 LGNNYDYDQMERMVLASILCIRRDPRARP 612
D +E+ + D R
Sbjct: 237 A-----RDLVEK-------LLVLDATKRL 253
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 4e-51
Identities = 64/293 (21%), Positives = 124/293 (42%), Gaps = 39/293 (13%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLPDGKEL---AVKILKP--SEDVIKEFVLEIEIITTL-H 401
++ +++IG+G QV K + A+K +K S+D ++F E+E++ L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 402 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGN------------KKDPAAFGWSER 449
H NII+LLG C L L ++ G+L + L + + +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 450 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 509
A VA ++YL ++ IHRD+ + NIL+ +++ +++DFGL++
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 510 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 569
++A E Y DV+++GV+L E+++ P + +
Sbjct: 187 R---LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEK 238
Query: 570 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
+ ++ + L+ D++ ++ C R P RP + +L L
Sbjct: 239 LPQGYRLEKPLNCD-------DEVYDLMR---QCWREKPYERPSFAQILVSLN 281
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-50
Identities = 65/341 (19%), Positives = 140/341 (41%), Gaps = 46/341 (13%)
Query: 354 NLIGKGGSSQVYKG-CLPDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 406
++G G VYKG +P+G+++ A+K L+ S KE + E ++ ++ + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
LLG C + + L+ + G L + + +K + G + +A+ + YL
Sbjct: 75 RLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED- 129
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 526
+R++HRD+ + N+L+ +++DFGLAK ++A E ++
Sbjct: 130 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 527 GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586
+ DV+++GV + EL+T + P + ++ +L+
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------------ISSILEKGERL 232
Query: 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK-LLRGDADVTKWARLQVNASEESEMLD 645
+ + + C D +RP+ ++ + D ++ +Q +
Sbjct: 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPT 292
Query: 646 DESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLL 686
D + R+ L+D ED ++ V ++YL+
Sbjct: 293 DSNFYRA---------LMDEED-------MDDVVDADEYLI 317
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 176 bits (447), Expect = 4e-50
Identities = 56/275 (20%), Positives = 103/275 (37%), Gaps = 26/275 (9%)
Query: 349 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL-KPSEDVIKEFVLEIEIITTLHHKNII 406
++ +G G V++ G A K + P E + EI+ ++ L H ++
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
+L +DN ++++Y+F+S G L E + E + V + L ++H
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 524
+H D+K NI+ + + L DFGL S T GT + APE
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 197
Query: 525 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584
V D+++ GV+ LL+G P ++ V + + + +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG- 256
Query: 585 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
D + + + DP R + L+
Sbjct: 257 -----KDFIRK-------LLLADPNTRMTIHQALE 279
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 7e-49
Identities = 66/297 (22%), Positives = 119/297 (40%), Gaps = 39/297 (13%)
Query: 348 SNFLAENLIGKGGSSQVYKGC------LPDGKELAVKILKPS--EDVIKEFVLEIEIIT- 398
+G+G QV + + +AVK+LK + + E++I+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 399 TLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPA------------AFG 445
HH N+++LLG C + L+++ +F G+L L + +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 446 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505
+ VA+ +E+L S ++ IHRD+ + NILLS+ ++ DFGLA+
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 565
++ D ++APE + DV++FGV+L E+ + P +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 244
Query: 566 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
L G + D Y +M + +L C +P RP S +++ L
Sbjct: 245 EFCRRLKEGTRMRAPD------YTTPEMYQTML---DCWHGEPSQRPTFSELVEHLG 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 169 bits (429), Expect = 2e-48
Identities = 65/271 (23%), Positives = 114/271 (42%), Gaps = 30/271 (11%)
Query: 353 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIIS 407
++G GG S+V+ L +++AVK+L+ F E + L+H I++
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 408 LLGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 463
+ + +V +++ +L + +H +V +AL +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFS 127
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT-CTDVAGTFGYLAPE 522
H +IHRDVK +NI++S ++ DFG+A+ + S + +T V GT YL+PE
Sbjct: 128 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582
V+ + DVY+ G VL E+LTG P + D P + PI S + L
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244
Query: 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQ 613
+ + + ++P R Q
Sbjct: 245 L------DAVVLK-------ALAKNPENRYQ 262
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 4e-48
Identities = 63/276 (22%), Positives = 107/276 (38%), Gaps = 30/276 (10%)
Query: 356 IGKGGSSQVYKGCLP----DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIIS 407
+G G V +G +AVK LKP + + +F+ E+ + +L H+N+I
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 467
L G + +V + GSL + L ++ F + A+ VAE + YL S
Sbjct: 76 LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLES-- 129
Query: 468 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEYFMY 526
+R IHRD+ + N+LL+ ++ DFGL + + H + F + APE
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 527 GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586
+ D + FGV L E+ T + P + I G+
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGE-----RLPRPE 238
Query: 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
+ + +++ C P RP + L
Sbjct: 239 DCP-QDIYNVMV---QCWAHKPEDRPTFVALRDFLL 270
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 167 bits (425), Expect = 7e-48
Identities = 68/289 (23%), Positives = 115/289 (39%), Gaps = 41/289 (14%)
Query: 349 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----------EDVIKEFVLEIEII 397
N+ + ++G+G SS V + P KE AVKI+ + +++ + + E++I+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 398 TTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 456
+ H NII L + LV+D + +G L + L E K+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRAL 119
Query: 457 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 516
E + LH ++HRD+K NILL DD +L+DFG + +V GT
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 517 GYLAPEYFM------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 570
YLAPE + ++D+++ GV++ LL G P + ++M
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 571 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
S + D D + R + P+ R L
Sbjct: 234 FGSPEWDDYSDTV------KDLVSR-------FLVVQPQKRYTAEEALA 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 170 bits (431), Expect = 8e-48
Identities = 56/269 (20%), Positives = 99/269 (36%), Gaps = 26/269 (9%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 412
+G G V++ G+ K + + K V EI I+ LHH +I+L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 413 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 472
+ ++L+ +FLS G L + + +E E L+++H ++
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHE---HSIV 149
Query: 473 HRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 530
H D+K NI+ + DFGLA + T T + APE V
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVG 206
Query: 531 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 590
D++A GV+ LL+G P + + V + + A
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA------K 260
Query: 591 DQMERMVLASILCIRRDPRARPQMSLVLK 619
D ++ ++++PR R + L+
Sbjct: 261 DFIKN-------LLQKEPRKRLTVHDALE 282
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-47
Identities = 53/293 (18%), Positives = 118/293 (40%), Gaps = 32/293 (10%)
Query: 348 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKP--SEDVIKEFVLEIEIITT 399
+G+G VY+G +A+K + S EF+ E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 400 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFG------WSERYKVA 453
+ +++ LLG + L++ + ++RG L+ L + A S+ ++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 454 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 513
+A+ + YL++ + +HRD+ + N ++++DF ++ DFG+ + + +
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 514 GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 573
+++PE G DV++FGVVL E+ T + +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQVLRFVME 250
Query: 574 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 626
G + D D + ++ +C + +P+ RP ++ ++ + +
Sbjct: 251 GGLLDKPDNCP------DMLFELMR---MCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-47
Identities = 60/277 (21%), Positives = 113/277 (40%), Gaps = 31/277 (11%)
Query: 353 ENLIGKGGSSQVYKGCLPDGKE----LAVKILKP--SEDVIKEFVLEIEIITTLHHKNII 406
IG+G V++G + +A+K K S+ V ++F+ E + H +I+
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
L+G +N + ++ + + G L + + + A ++ AL YL S
Sbjct: 72 KLIGVI-TENPVWIIMELCTLGEL---RSFLQVRKYSLDLASLILYAYQLSTALAYLES- 126
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 526
+R +HRD+ + N+L+S + +L DFGL+++ S+ + + ++APE +
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINF 183
Query: 527 GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585
+ DV+ FGV + E+L G KP + + + L
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL----- 238
Query: 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
Y M + C DP RP+ + + L
Sbjct: 239 ----YSLMTK-------CWAYDPSRRPRFTELKAQLS 264
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 2e-47
Identities = 51/268 (19%), Positives = 103/268 (38%), Gaps = 25/268 (9%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 413
+G+G V++ K K +K EI I+ H+NI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 414 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 473
L+++++F+S + E ++ + + E V EAL++LHS + H
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 474 RDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 531
D++ NI+ + +FG A+ + Y APE + V+
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVHQHDVVST 182
Query: 532 KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 591
D+++ G ++ LL+G P + + +M A+ ++ A+ D
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM------D 236
Query: 592 QMERMVLASILCIRRDPRARPQMSLVLK 619
++R + ++ ++R S L+
Sbjct: 237 FVDR-------LLVKERKSRMTASEALQ 257
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 4e-47
Identities = 61/277 (22%), Positives = 113/277 (40%), Gaps = 32/277 (11%)
Query: 349 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIIT-TLHH 402
+F+ ++GKG +V+ + A+K LK +D ++ ++E +++ H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 403 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 462
+ + NL V ++L+ G L ++ K F S A + L++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQF 118
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
LHS + +++RD+K NILL D +++DFG+ K GT Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPE 173
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582
+ K N +D ++FGV+L E+L G+ P + + P L+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW-----LEK 228
Query: 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
D + + R+P R + ++
Sbjct: 229 EA-----KDLLVK-------LFVREPEKRLGVRGDIR 253
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 6e-47
Identities = 67/315 (21%), Positives = 123/315 (39%), Gaps = 37/315 (11%)
Query: 353 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLL 409
+++G G S+V K +A+K + E EI ++ + H NI++L
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 410 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
+L L+ +S G L + + + + ++ V +A++YLH
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQVLDAVKYLHD---L 126
Query: 470 RVIHRDVKSSNILLS---DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 526
++HRD+K N+L +D + +SDFGL+K S + GT GY+APE
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQ 183
Query: 527 GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586
+ +D ++ GV+ LL G P +++ ++ A+ S + D A
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA--- 240
Query: 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK--LLRGDADVTKWARLQVNASEESEML 644
D + + +DP R L+ + GD + K V+ +
Sbjct: 241 ---KDFIRH-------LMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNF- 289
Query: 645 DDESCPRSNLQSHLN 659
+S + N
Sbjct: 290 -----AKSKWKQAFN 299
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 166 bits (420), Expect = 4e-46
Identities = 62/273 (22%), Positives = 109/273 (39%), Gaps = 34/273 (12%)
Query: 349 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTL 400
+F +IG+GG +VY GK A+K L E + + + +++T
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 401 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 460
I+ + + L + D ++ G L +L + ++ A + L
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYAAEIILGL 120
Query: 461 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 520
E++H+ + V++RD+K +NILL + ++SD GLA S H + GT GY+A
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMA 173
Query: 521 PEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579
PE G D D ++ G +L +LL G P K + + + ++
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--ELPDS 231
Query: 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARP 612
P L +E ++RD R
Sbjct: 232 FSPEL-----RSLLEG-------LLQRDVNRRL 252
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 7e-46
Identities = 70/304 (23%), Positives = 125/304 (41%), Gaps = 41/304 (13%)
Query: 348 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKP--SEDVIKEFVLEIEII 397
+ +G+G QV ++AVK+LK +E + + + E+E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 398 TTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA------------F 444
+ HKNII+LLG C +D L ++ ++ S+G+L E L +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 445 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504
+ A VA +EYL S ++ IHRD+ + N+L+++D +++DFGLA+
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 505 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 564
+ T+ ++APE + DV++FGV+L E+ T P V
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------V 243
Query: 565 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624
+L G +++ M+ C P RP +++ L
Sbjct: 244 EELFKLLKEGHRMDKPSNCT------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRI 294
Query: 625 ADVT 628
+T
Sbjct: 295 VALT 298
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 6e-45
Identities = 55/279 (19%), Positives = 99/279 (35%), Gaps = 25/279 (8%)
Query: 353 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
IG G +Y G + G+E+A+K+ + +E +I + I + +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 412 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 471
C + + ++ L SLE+ + + F +A + +EY+HS +
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS---KNF 124
Query: 472 IHRDVKSSNILLSD---DFEPQLSDFGLAKWASTSSSHITC-----TDVAGTFGYLAPEY 523
IHRDVK N L+ + DFGLAK + +H ++ GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 524 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583
+ + + + D+ + G VL+ G P + K
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-----KKMSTPIEV 239
Query: 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
L Y + + C +P S + +L R
Sbjct: 240 LCKGYP-SEFATYLNF---CRSLRFDDKPDYSYLRQLFR 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (407), Expect = 8e-45
Identities = 63/271 (23%), Positives = 112/271 (41%), Gaps = 34/271 (12%)
Query: 348 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHH 402
+F +G G +V+ +G+ A+K+LK ++ E +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 403 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 462
II + G + + ++ D++ G L L +++ P A V ALEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP----NPVAKFYAAEVCLALEY 119
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
LHS + +I+RD+K NILL + +++DFG AK+ + GT Y+APE
Sbjct: 120 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPE 171
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582
N ID ++FG+++ E+L G P + + ++ A+ +
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF-----FNE 226
Query: 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQ 613
+ D + R I RD R
Sbjct: 227 DV-----KDLLSR-------LITRDLSQRLG 245
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-44
Identities = 70/285 (24%), Positives = 118/285 (41%), Gaps = 28/285 (9%)
Query: 354 NLIGKGGSSQVYKG-CLPDGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNII 406
+ +G+G + VYK + +A+K +K + + + + EI+++ L H NII
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
LL +N+ LV+DF+ + S + + LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV----LTPSHIKAYMLMTLQGLEYLHQ- 118
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 526
++HRD+K +N+LL ++ +L+DFGLAK S S + T T Y APE
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 527 GKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM----------WAKPILSSGK 575
++ +D++A G +L ELL + D Q + + W
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 576 VTQLLDPALGNNYDYDQMERMVLASIL-CIRRDPRARPQMSLVLK 619
VT P + ++ + +L I +P AR + LK
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 7e-44
Identities = 58/296 (19%), Positives = 107/296 (36%), Gaps = 31/296 (10%)
Query: 347 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHK 403
+ + IG+G V + +A+K + P E + + EI+I+ H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 404 NIISLLGFC----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 459
NII + E + + L L + L +
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQILRG 121
Query: 460 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGY 518
L+Y+HS V+HRD+K SN+LL+ + ++ DFGLA+ T+ T Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 519 LAPEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577
APE + K ID+++ G +L E+L+ R H Q + ++ S +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 578 QLLD-PALGNNYDYDQMERMVLASIL-------------CIRRDPRARPQMSLVLK 619
+++ A ++ + + +P R ++ L
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 155 bits (392), Expect = 4e-43
Identities = 53/282 (18%), Positives = 102/282 (36%), Gaps = 25/282 (8%)
Query: 354 NLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG 410
IG+G VYK G+ A+K ++ E + + EI I+ L H NI+ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 411 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 470
L+LV++ L + + + + + Y H +R
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 471 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 530
V+HRD+K N+L++ + E +++DFGLA+ ++ + K +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHEIVTLWYRAPDVLMGSKKYS 179
Query: 531 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 590
ID+++ G + E++ G Q + +S + + + ++
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK-YDPNF 238
Query: 591 DQMERMVLASIL-------------CIRRDPRARPQMSLVLK 619
E + S L ++ DP R L+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-42
Identities = 59/333 (17%), Positives = 134/333 (40%), Gaps = 28/333 (8%)
Query: 353 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
++G G + +V + ++ A+K+L+ +E L +I+ ++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA---SQCPHIVRIVDV 73
Query: 412 C----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 467
LL+V + L G L + F E ++ + EA++YLHS
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYLHS-- 129
Query: 468 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 527
+ HRDVK N+L + + +A ++SH + T T Y+APE
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188
Query: 528 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 587
K + D+++ GV++ LL G P ++H + + + + ++ Q P +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRMGQYEFPNPEWS 242
Query: 588 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDE 647
++++ ++ ++ +P R ++ + + + ++ S +L ++
Sbjct: 243 EVSEEVKMLIRN---LLKTEPTQRMTITEFMN----HPWIMQSTKVPQTPLHTSRVLKED 295
Query: 648 SCPRSNLQSHLNLAL--LDVEDDSFSMSSIEQS 678
+++ + AL + V+ + + IE +
Sbjct: 296 KERWEDVKEEMTSALATMRVDYEQIKIKKIEDA 328
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 152 bits (385), Expect = 3e-42
Identities = 43/285 (15%), Positives = 95/285 (33%), Gaps = 27/285 (9%)
Query: 349 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 407
++ IG+G +++G L + +++A+K D + E L I
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLAGCTGIP 64
Query: 408 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 467
+ + ++ ++ L SLE+ L + F A + ++ +H
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK---FSVKTVAMAAKQMLARVQSIHE-- 119
Query: 468 AQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKWASTSSSH-----ITCTDVAGTFG 517
+ +++RD+K N L+ + DFG+ K+ + +++GT
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 518 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 577
Y++ + + + + D+ A G V + L G P + S +
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622
+L + + + A P + L
Sbjct: 239 ELCA-------GFPEEFYKYMHY--ARNLAFDATPDYDYLQGLFS 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 4e-42
Identities = 58/277 (20%), Positives = 108/277 (38%), Gaps = 35/277 (12%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTLHHKNII 406
+G G + V K G + A K +K ++ E+ I+ + H N+I
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 407 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 466
+L +++L+ + ++ G L + L + E + + + YLHS
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS- 131
Query: 467 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 522
++ H D+K NI+L D P+ + DFGLA + ++ GT ++APE
Sbjct: 132 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 186
Query: 523 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582
Y + + D+++ GV+ LL+G P D + + V +
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
A D + R + +DP+ R + L+
Sbjct: 247 A------KDFIRR-------LLVKDPKKRMTIQDSLQ 270
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 9e-42
Identities = 66/293 (22%), Positives = 115/293 (39%), Gaps = 35/293 (11%)
Query: 349 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKN 404
NF IG+G VYK G+ +A+K ++ +E V + EI ++ L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
I+ LL +N L LV++FL + + + + L + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFCH 119
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE-Y 523
S RV+HRD+K N+L++ + +L+DFGLA+ T T Y APE
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEIL 174
Query: 524 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583
+ +D+++ G + E++T R D Q + + G +++ P
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-----LFRIFRTLGTPDEVVWPG 229
Query: 584 LGNNYDYD----QMERMVLASIL-------------CIRRDPRARPQMSLVLK 619
+ + DY + R + ++ + DP R L
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 63/302 (20%), Positives = 123/302 (40%), Gaps = 37/302 (12%)
Query: 348 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHK 403
S + IG+G +V+K G+++A+K + E + EI+I+ L H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 404 NIISLLGFCFE--------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 455
N+++L+ C ++ LV+DF + K F SE +V
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQM 125
Query: 456 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS--SSHITCTDVA 513
+ L Y+H +++HRD+K++N+L++ D +L+DFGLA+ S + S T+
Sbjct: 126 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 514 GTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 572
T Y PE + + ID++ G ++ E+ T + + + Q +L+ ++
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 573 SGKVTQLLDPALGNNYDYDQMERMVLASIL---------------CIRRDPRARPQMSLV 617
+ + L + + ++ + L + DP R
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
Query: 618 LK 619
L
Sbjct: 303 LN 304
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-41
Identities = 54/297 (18%), Positives = 107/297 (36%), Gaps = 32/297 (10%)
Query: 346 ATSNFLAENLIGKGGSSQVYKG--CLPDGKELAVKILKPS---EDVIKEFVLEIEIITTL 400
A + IG+G +V+K G+ +A+K ++ E + + E+ ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 401 ---HHKNIISLLGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 452
H N++ L C + L LV++ + + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP---GVPTETIKDM 121
Query: 453 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 512
+ L++LHS RV+HRD+K NIL++ + +L+DFGLA+ S + T V
Sbjct: 122 MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSV 175
Query: 513 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 572
T Y APE + +D+++ G + E+ + Q ++ +
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 573 SGKVTQLLDPALGNNYDYDQMERMVLASIL----------CIRRDPRARPQMSLVLK 619
+ + + + + C+ +P R L
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-41
Identities = 76/352 (21%), Positives = 129/352 (36%), Gaps = 32/352 (9%)
Query: 349 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 407
++ +IG G VY+ G+ +A+K + + E++I+ L H NI+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 77
Query: 408 LLGFCFE------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 461
L F + + L LV D++ H ++ + +L
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPVIYVKLYMYQLFRSLA 136
Query: 462 YLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 520
Y+HS + HRD+K N+LL D +L DFG AK +++ + Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRA 190
Query: 521 PEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579
PE IDV++ G VL ELL G+ D Q LV K + + +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIR 248
Query: 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASE 639
+ + Q++ + R P A +L +LL ARL +
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI---ALCSRLLEYTPT----ARLTPLEAC 301
Query: 640 ESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSR 691
D+ P L + + L +F+ + + L L+ +R
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPAL----FNFTTQELSSNPPLATILIPPHAR 349
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 4e-40
Identities = 51/277 (18%), Positives = 99/277 (35%), Gaps = 45/277 (16%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVKILKPSE-------DVIKEFVLEIEIITTLH--HKN 404
L+G GG VY G + D +A+K ++ +E+ ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 405 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
+I LL + ++ +L+ + + + A V EA+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH 127
Query: 465 SGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523
+ V+HRD+K NIL+ + E +L DFG + TD GT Y PE+
Sbjct: 128 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEW 180
Query: 524 FMYGKVNDK-IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582
Y + + + V++ G++L +++ G P +D ++ + +
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR-----VSS 229
Query: 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619
+ C+ P RP +
Sbjct: 230 EC-----QHLIRW-------CLALRPSDRPTFEEIQN 254
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 5e-39
Identities = 59/283 (20%), Positives = 104/283 (36%), Gaps = 25/283 (8%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG 410
+G G V G ++A+K L SE K E+ ++ + H+N+I LL
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 411 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 470
D L DF G G + + + L Y+H+
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AG 141
Query: 471 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 530
+IHRD+K N+ +++D E ++ DFGLA+ A + + V + + +
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT----GYVVTRWYRAPEVILNWMRYT 197
Query: 531 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL-LDPALGNNYD 589
+D+++ G ++ E++TG+ Q +M + V +L D A
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257
Query: 590 YDQMERMVLASIL-------------CIRRDPRARPQMSLVLK 619
++E+ ASIL + D R L
Sbjct: 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-38
Identities = 63/271 (23%), Positives = 109/271 (40%), Gaps = 31/271 (11%)
Query: 349 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHK 403
+F L+GKG +V G+ A+KIL+ ++D + V E ++ H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 404 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 463
+ +L + L V ++ + G L +L + F + ALEYL
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYL 121
Query: 464 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523
HS + V++RD+K N++L D +++DFGL K + + + GT YLAPE
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 176
Query: 524 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583
+D + GVV+ E++ GR P N + L++ + L P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT-----LSPE 231
Query: 584 LGNNYDYDQMERMVLASILCIRRDPRARPQM 614
+ +++DP+ R
Sbjct: 232 A-----KSLLAG-------LLKKDPKQRLGG 250
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 5e-38
Identities = 57/287 (19%), Positives = 105/287 (36%), Gaps = 33/287 (11%)
Query: 354 NLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 409
IG+G V+K + +A+K ++ E V + EI ++ L HKNI+ L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 410 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
D L LV++F + + N + + L + HS +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----PEIVKSFLFQLLKGLGFCHS---R 120
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 529
V+HRD+K N+L++ + E +L++FGLA+ + V + F
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFGAKLY 179
Query: 530 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 589
+ ID+++ G + EL +P+ G + + G T+ P++ D
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLF----PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 590 YDQMERMVLASIL-----------------CIRRDPRARPQMSLVLK 619
Y + L ++ +P R L+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (358), Expect = 6e-38
Identities = 58/263 (22%), Positives = 99/263 (37%), Gaps = 34/263 (12%)
Query: 356 IGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLG 410
+G G +V G A+KIL I+ + E I+ ++ ++ L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 411 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 470
+++NL +V ++++ G + +L + F A + EYLHS
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 471 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 530
+I+RD+K N+L+ Q++DFG AK + GT LAPE + N
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 531 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 590
+D +A GV++ E+ G P D P ++ K S L
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH-----FSSDL-----K 266
Query: 591 DQMERMVLASILCIRRDPRARPQ 613
D + ++ D R
Sbjct: 267 DLLRN-------LLQVDLTKRFG 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-34
Identities = 64/279 (22%), Positives = 115/279 (41%), Gaps = 33/279 (11%)
Query: 349 NFLAENLIGKGGSSQVYKG----CLPDGKELAVKILKPS-----EDVIKEFVLEIEIITT 399
NF ++G G +V+ GK A+K+LK + + E +++
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 400 L-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 458
+ +++L + L L+ D+++ G L +L ++ F E +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVL 140
Query: 459 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 518
ALE+LH +I+RD+K NILL + L+DFGL+K + GT Y
Sbjct: 141 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEY 196
Query: 519 LAPEYFMYGKVND--KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576
+AP+ G +D ++ GV++ ELLTG P + D K ++ + + + S
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS-RRILKSEPPY 255
Query: 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMS 615
Q + D ++R + +DP+ R
Sbjct: 256 PQEMSALA-----KDLIQR-------LLMKDPKKRLGCG 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 127 bits (320), Expect = 6e-33
Identities = 55/287 (19%), Positives = 120/287 (41%), Gaps = 27/287 (9%)
Query: 349 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNII 406
++ +G+G S+V++ + + +++ VKILKP + K+ EI+I+ L NII
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNII 93
Query: 407 SLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
+L + LV++ ++ ++ + + +AL+Y H
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCH 146
Query: 465 SGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 523
S ++HRDVK N+++ + + +L D+GLA++ + + PE
Sbjct: 147 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPEL 200
Query: 524 FM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582
+ Y + +D+++ G +L ++ ++P + H + LV AK + + +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYIDKY 259
Query: 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMS-----LVLKLLRGD 624
+ + ++ + + +S + KLLR D
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-32
Identities = 58/284 (20%), Positives = 102/284 (35%), Gaps = 25/284 (8%)
Query: 354 NLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 409
+ +G G V G +AVK L S K E+ ++ + H+N+I LL
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 410 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 469
+L D L N + + L+Y+HS
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 140
Query: 470 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 529
+IHRD+K SN+ +++D E ++ DFGLA+ + T + +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT----RWYRAPEIMLNWMHY 196
Query: 530 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 589
N +D+++ G ++ ELLTGR Q L++ + + ++ + N
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 590 -YDQMERMVLASIL-------------CIRRDPRARPQMSLVLK 619
QM +M A++ + D R + L
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (305), Expect = 8e-31
Identities = 54/312 (17%), Positives = 106/312 (33%), Gaps = 47/312 (15%)
Query: 353 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 411
+G G S V+ + + +A+KI++ + + EI+++ ++ +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 412 C----------FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEA 459
F V+ + L ENL K G Y +++ +
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 460 LEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 518
L+Y+H +IH D+K N+L+ D L +A + T+ T Y
Sbjct: 138 LDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 519 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG-----------QESLVMWA 567
+PE + D+++ ++ EL+TG D E L
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255
Query: 568 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--------------------CIRRD 607
+L +GK T+ + G + +++ L +L ++ D
Sbjct: 256 SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315
Query: 608 PRARPQMSLVLK 619
PR R ++
Sbjct: 316 PRKRADAGGLVN 327
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-30
Identities = 57/288 (19%), Positives = 105/288 (36%), Gaps = 31/288 (10%)
Query: 355 LIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG 410
IG G V + +A+K L ++ K E+ ++ ++HKNIISLL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 411 FCF------EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 464
E ++ LV + + + + + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHLH 136
Query: 465 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 524
S +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y APE
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVI 190
Query: 525 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 584
+ + +D+++ G ++ E++ + Q + V+ + +L
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 585 GNNYDYDQMERMVLASILCIRRDPRARPQ--------MSLVLKLLRGD 624
+ + + + P L+ K+L D
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.1 bits (215), Expect = 2e-20
Identities = 23/156 (14%), Positives = 45/156 (28%), Gaps = 22/156 (14%)
Query: 354 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIK-----------EFVLEIEIITTLHH 402
L+G+G S V+ E VK K K F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 403 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 462
+ + L G Y + L E + + + + E +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEV--LDMILEEVAK 118
Query: 463 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498
+ + ++H D+ N+L+ + + DF +
Sbjct: 119 FYH---RGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 696 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.41 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.97 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.62 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.34 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.71 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.69 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 95.39 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 95.07 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 93.23 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 92.83 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 91.42 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 91.08 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=417.28 Aligned_cols=255 Identities=24% Similarity=0.428 Sum_probs=200.3
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
.++|.+.+.||+|+||+||+|.+.+++.||||+++......++|.+|++++++++||||++++++|...+..++||||++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 46899999999999999999999889999999998776667889999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+|+|.+++.... ..++|..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999999987543 358999999999999999999999 89999999999999999999999999999877654332
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhC-CCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG-~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
. .....||+.|+|||++.++.|+.++|||||||+||||+|+ ++||...........+..... ...|
T Consensus 158 ~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~---------~~~p--- 224 (263)
T d1sm2a_ 158 S-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------LYKP--- 224 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC---------CCCC---
T ss_pred e-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC---------CCCc---
Confidence 2 2336799999999999999999999999999999999995 555544332222111111100 0111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.. . ...+..++..||+.||.+||||++|++.|+..
T Consensus 225 ~~-~---~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 225 RL-A---STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp TT-S---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc-c---CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11 1 13455677789999999999999999998753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=418.69 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=202.6
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
++|.+.+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+++|++++||||+++++++.+++..||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5799999999999999999986 479999999987543 3456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999997543 58999999999999999999999 899999999999999999999999999999876544
Q ss_pred CCcccccccccCCCCCcceeccCCC-CCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~~~-s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
........+||+.|+|||++.+..+ +.++|||||||+||||++|+.||.................... .+
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~--------~~- 228 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--------NP- 228 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS--------TT-
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--------Cc-
Confidence 3333455789999999999988776 5689999999999999999999976544332221111111000 00
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
....+ ..+..++..||+.||++|||+.|+++
T Consensus 229 -~~~~s----~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 -WKKID----SAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -GGGSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cccCC----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00011 23445666799999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-50 Score=417.34 Aligned_cols=257 Identities=28% Similarity=0.458 Sum_probs=200.5
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.++|.+.+.||+|+||+||+|..++ .||||+++. .....+.|.+|+.+|.+++|||||++++++.+ +.+++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 4678899999999999999998643 699999974 34567889999999999999999999998754 57899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+++|+|.+++..... .+++..+..|+.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 9999999999975432 58999999999999999999999 89999999999999999999999999999877655
Q ss_pred CCCcccccccccCCCCCcceecc---CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~---~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
..........||+.|+|||++.+ +.|+.++|||||||+||||+||+.||.+.............. .....+..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~-- 233 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG--YLSPDLSK-- 233 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT--SCCCCGGG--
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcC--CCCCcchh--
Confidence 44444455789999999999864 358999999999999999999999998765433322211111 00111111
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
+.... ...+..++..||+.||.+||||.+|++.|+.
T Consensus 234 ---~~~~~----~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 234 ---VRSNC----PKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp ---SCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---ccccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11111 1345566778999999999999999998864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-50 Score=414.14 Aligned_cols=254 Identities=22% Similarity=0.397 Sum_probs=205.6
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
.++|.+.+.||+|+||+||+|.+++++.||||+++......+.|.+|++++++++|||||++++++.+ +..++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 35788999999999999999999888999999998776667889999999999999999999998854 56899999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+|+|.+++..... ..++|..++.|+.||++||.|||+ ++|+||||||+||||++++.+||+|||+|+........
T Consensus 91 ~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 91 NGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999998764332 248999999999999999999999 89999999999999999999999999999987654322
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccCC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 586 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~~ 586 (696)
......||+.|+|||++..+.++.++|||||||+||||+||..|+....... .+...... + ..+....
T Consensus 166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~~~i~~----~-----~~~~~p~ 233 (272)
T d1qpca_ 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLER----G-----YRMVRPD 233 (272)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHT----T-----CCCCCCT
T ss_pred -cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHHHHHHh----c-----CCCCCcc
Confidence 2234679999999999999999999999999999999999655544332211 11111110 1 0111111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 587 ~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
..+ ..+..++..||+.||++||||.+|++.|+
T Consensus 234 ~~~----~~l~~li~~cl~~~P~~Rpt~~ei~~~L~ 265 (272)
T d1qpca_ 234 NCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (272)
T ss_dssp TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCh----HHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 112 24556677899999999999999999886
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-49 Score=417.36 Aligned_cols=254 Identities=26% Similarity=0.441 Sum_probs=195.4
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCC---EEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGK---ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~---~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
++|.+.++||+|+||+||+|.+. +|+ .||||.+... ....+.|.+|+++|++++|||||+++++|.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 56788899999999999999864 332 5899998753 45567899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++|+|.+++..... .++|.+++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+...
T Consensus 106 ~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998875432 58999999999999999999999 899999999999999999999999999999776
Q ss_pred CCCCCcc---cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 502 TSSSHIT---CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 502 ~~~~~~~---~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
....... .....||+.|+|||++..+.++.++|||||||+||||+| |+.||.+.........+.... ...
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~------~~~ 253 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY------RLP 253 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------CCC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------CCC
Confidence 5433222 122468999999999999999999999999999999998 899998765433222221110 000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
. +.+....+..++.+||+.||.+||||.+|++.|+.
T Consensus 254 ------~----~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 254 ------P----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp ------C----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ------C----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 0 11112345567778999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=410.81 Aligned_cols=244 Identities=27% Similarity=0.429 Sum_probs=204.5
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||+||+|... +|+.||+|++... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46999999999999999999974 6899999998743 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999997643 48999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
... ....||+.|+|||++.+..|+.++|||||||+||||++|+.||...........+.....
T Consensus 159 ~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------------- 221 (263)
T d2j4za1 159 SRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF------------- 221 (263)
T ss_dssp CCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-------------
T ss_pred Ccc----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence 322 346799999999999999999999999999999999999999977654332222211110
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+....+ ..+..++..||+.||.+|||+.|+++
T Consensus 222 ~~p~~~s----~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 TFPDFVT----EGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCccCC----HHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1111111 23445666799999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-50 Score=419.87 Aligned_cols=257 Identities=23% Similarity=0.379 Sum_probs=210.9
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++.+....++|.+|+++|++++|||||+++++|.+++..++||||+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 457889999999999999999875 6889999999877667788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++|+|.+++..... ..+++..+..|+.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 96 ~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 96 TYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp TTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred cCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999975432 368999999999999999999999 8999999999999999999999999999997765433
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
. ......||+.|+|||++.++.|+.++|||||||++|||++|..||........ +..... .+. .+...
T Consensus 171 ~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~~i~----~~~-----~~~~~ 238 (287)
T d1opja_ 171 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLE----KDY-----RMERP 238 (287)
T ss_dssp E-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHH----TTC-----CCCCC
T ss_pred e-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHHHHh----cCC-----CCCCC
Confidence 2 23345689999999999999999999999999999999997777654433222 111111 010 01111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
... ...+..++..||+.||++||||.+|++.|+..
T Consensus 239 ~~~----~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 239 EGC----PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 23456677779999999999999999988653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=413.54 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=194.1
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~--~~~~~L 420 (696)
.++|.+.+.||+|+||+||+|.. .+|+.||||++... +...+.+.+|++++++++||||+++++++.+ ++.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 36799999999999999999986 57899999998753 3456778999999999999999999999865 456899
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC--CCceEeecccccceeeCCCCceEEeecCccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~--~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
||||+++|+|.+++.........+++..++.++.||+.||.|||+.+ ..+||||||||+||||+.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998754333346899999999999999999999822 2359999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 499 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 499 ~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
........ .....||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+.. +....
T Consensus 163 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~-------~~~~~ 233 (269)
T d2java1 163 ILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-------GKFRR 233 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------TCCCC
T ss_pred ecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-------CCCCC
Confidence 87654322 2347899999999999999999999999999999999999999986554332222211 11111
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+...++ ..+..++..||+.||.+|||+.|+++
T Consensus 234 -----~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 -----IPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCcccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111122 23555667799999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-49 Score=405.10 Aligned_cols=253 Identities=23% Similarity=0.428 Sum_probs=212.9
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecC
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 426 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~ 426 (696)
.++|.+.+.||+|+||+||+|..++++.||||+++......++|.+|+.++.+++||||++++++|.+.+.+++||||++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 46889999999999999999999889999999998876667889999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+|+|.+++..... .+++..+++++.|+++||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999999765433 58899999999999999999999 89999999999999999999999999999876654333
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
......||+.|+|||++....++.++|||||||++|||+| |+.||...........+..... +..|
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~---------~~~p--- 223 (258)
T d1k2pa_ 157 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR---------LYRP--- 223 (258)
T ss_dssp -CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC---------CCCC---
T ss_pred -eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC---------CCCc---
Confidence 2234679999999999999999999999999999999998 8999987654333222211100 0111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
.. -. ..+..++..||+.||++|||+.++++.|.
T Consensus 224 ~~-~~---~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 224 HL-AS---EKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp TT-CC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred cc-cc---HHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 11 11 34556677799999999999999999885
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=411.01 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=204.8
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
++|.+.+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|++++++++||||++++++|.+.+.+|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999985 579999999987543 34577999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
+||+|.+++... .+++..+..|+.||+.||.|||+ +||+||||||+|||++.++++||+|||+|+.......
T Consensus 100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999988653 48999999999999999999999 8999999999999999999999999999997755433
Q ss_pred CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 506 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
. ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+..... ..+. .
T Consensus 172 ~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-------~~~~---~- 238 (293)
T d1yhwa1 172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-------PELQ---N- 238 (293)
T ss_dssp C--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-------CCCS---S-
T ss_pred c--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-------CCCC---C-
Confidence 2 2346899999999999999999999999999999999999999977654332221111100 0000 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+......+..++..||+.||.+|||+.|+++
T Consensus 239 ---~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 ---PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ---GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111123455666799999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=414.47 Aligned_cols=248 Identities=23% Similarity=0.325 Sum_probs=202.8
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|++++++++||||++++++|.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999986 57999999999743 234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||++||+|.+++.... .+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999987654 58999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
..........+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+.......+... .+
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-------~~------ 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-------EY------ 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-------CC------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC-------CC------
Confidence 54444444578999999999999999999999999999999999999999876543322222111 10
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+...+. ..+..++..||+.||.+|||+.|+++
T Consensus 228 ~~p~~~s----~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 DFPEKFF----PKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCTTCC----HHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCccCC----HHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1111122 23455677799999999999998754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-49 Score=417.07 Aligned_cols=257 Identities=23% Similarity=0.394 Sum_probs=206.9
Q ss_pred cCceeeeeeeccCceEEEEEEeCC-C-----CEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCce
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPD-G-----KELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~-g-----~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~ 418 (696)
++|.+.+.||+|+||+||+|.... + ..||||.+... ......+.+|+.+|.++ +|||||+++++|.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578999999999999999998542 2 36899998653 34456789999999998 899999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCC-------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKK-------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 479 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~-------------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKps 479 (696)
++||||+++|+|.++|+.... ....+++..++.|+.||+.||+|||+ ++||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence 999999999999999976532 12358999999999999999999999 89999999999
Q ss_pred ceeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCcc
Q 005450 480 NILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPK 558 (696)
Q Consensus 480 NILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~ 558 (696)
|||++.++.+||+|||+|+...............||+.|+|||++.++.|+.++|||||||+||||+| |+.||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999998776655555555779999999999999999999999999999999998 89999875543
Q ss_pred chhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 559 GQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 559 ~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
.....+.. .+. .+...... ...+..++..||+.||++|||++||+++|.
T Consensus 274 ~~~~~~~~------~~~-----~~~~p~~~----~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFYKLIQ------NGF-----KMDQPFYA----TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHHH------TTC-----CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHh------cCC-----CCCCCCcC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 32211111 110 00111111 234556677799999999999999999984
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=405.91 Aligned_cols=253 Identities=25% Similarity=0.403 Sum_probs=205.3
Q ss_pred hcCceeeee-eeccCceEEEEEEeC---CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAENL-IGKGGSSQVYKGCLP---DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~-LG~G~fG~Vyka~~~---~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
.++|.+.+. ||+|+||+||+|... ++..||||+++.. ....++|.+|+++|++++|||||+++++|.. +.++|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 456777775 999999999999753 4557999999753 4556789999999999999999999999865 57899
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+..
T Consensus 86 vmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 999999999999986543 258999999999999999999999 89999999999999999999999999999977
Q ss_pred cCCCCCc-ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 501 STSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 501 ~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
....... ......||+.|+|||++..+.++.++|||||||++|||+| |+.||...........+.. +...
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~-------~~~~- 231 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-------GKRM- 231 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-------TCCC-
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------CCCC-
Confidence 6543322 2233568999999999999999999999999999999998 9999987654332222211 1111
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
.+....+ ..+..++..||+.||++|||+.+|++.|+
T Consensus 232 ----~~p~~~~----~~l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 232 ----ECPPECP----PELYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp ----CCCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ----CCCCcCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 1111122 34556677899999999999999999886
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=405.74 Aligned_cols=257 Identities=24% Similarity=0.389 Sum_probs=198.3
Q ss_pred hcCceeeeeeeccCceEEEEEEeCCC-----CEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPDG-----KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~g-----~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
++.|...++||+|+||+||+|.+++. ..||||+++.. .....+|.+|++++.+++|||||+++++|.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 46789999999999999999986532 36999999753 345567999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+||||+.+++|.+.+..... .++|..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999998875542 58999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCc-ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 500 ASTSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 500 ~~~~~~~~-~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
........ ......||+.|+|||++.++.++.++|||||||+||||++|..|+........ +..... .+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~~~i~----~~~--- 230 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAIN----DGF--- 230 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHH----TTC---
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HHHHHh----ccC---
Confidence 75543221 22335689999999999999999999999999999999997666544332221 111111 110
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.+. .+......+..++.+||+.||++||||.+|++.|+..
T Consensus 231 --~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 231 --RLP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp --CCC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --CCC----CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 001 1111223466677889999999999999999988653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=418.78 Aligned_cols=202 Identities=25% Similarity=0.441 Sum_probs=179.7
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
..++|.+.+.||+|+||+||+|.. .+|+.||+|+++.. ....+.+.+|+.+|++++|||||+++++|.+.+.+++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357899999999999999999996 47899999998753 345678999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||++||+|.+++.... .+++..+..++.|++.||.|||+. ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999997653 489999999999999999999961 3799999999999999999999999999997654
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 557 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~ 557 (696)
.. ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.....
T Consensus 158 ~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 158 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp HT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred Cc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 32 2246899999999999999999999999999999999999999987553
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=407.22 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=203.2
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
+.|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+++|++++|||||+++++|.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4689999999999999999986 47899999999753 455678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 92 AGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp TTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 99999999865432 58999999999999999999999 899999999999999999999999999997654321
Q ss_pred CcccccccccCCCCCcceec-----cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 506 HITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 506 ~~~~~~~~GT~~YlAPE~l~-----~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
.......||+.|+|||++. ...|+.++|||||||+||||++|+.||...........+.... ...+.
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~-------~~~~~ 236 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE-------PPTLA 236 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC-------CCCCS
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-------CCCCC
Confidence 1223467999999999984 4568999999999999999999999998765543322221111 00000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. +......+..++..||+.||.+|||+.|+++
T Consensus 237 ~-------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 Q-------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp S-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c-------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0111134455667799999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-48 Score=401.34 Aligned_cols=245 Identities=27% Similarity=0.400 Sum_probs=197.2
Q ss_pred eeeeccCceEEEEEEeC---CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 354 NLIGKGGSSQVYKGCLP---DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 354 ~~LG~G~fG~Vyka~~~---~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
+.||+|+||+||+|.+. .++.||||+++.. ....++|.+|+++|++++|||||+++++|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999854 3568999999753 2446789999999999999999999999864 568999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
|+|.+++.... .+++..+..|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.........
T Consensus 92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999998654 58999999999999999999999 899999999999999999999999999998776543322
Q ss_pred -ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 508 -TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 508 -~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+.........+.. +... .+.
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-------~~~~-----~~p 232 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------GERM-----GCP 232 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-------TCCC-----CCC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc-------CCCC-----CCC
Confidence 2234679999999999999999999999999999999998 8999987654332222221 1100 111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
...+ ..+..++.+||+.||.+|||+++|++.|+
T Consensus 233 ~~~~----~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 233 AGCP----REMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp TTCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred cccC----HHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 1112 34556677899999999999999998886
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-48 Score=407.79 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=189.7
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.+.|.+.+.||+|+||+||+|... +|+.||||++.... .....+.+|+.+|++++||||+++++++.+++.+|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999864 68999999997543 334568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC---CCCceEEeecCccccc
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKWA 500 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd---~~~~vKL~DFGlA~~~ 500 (696)
|++||+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||+. +++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999997543 58999999999999999999999 8999999999999994 5789999999999876
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
...... ...+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.........+.......
T Consensus 161 ~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~--------- 228 (307)
T d1a06a_ 161 DPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF--------- 228 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC---------
T ss_pred cCCCee---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC---------
Confidence 544322 33679999999999999999999999999999999999999998765433222221111100
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
+......+ ...+..++..||+.||.+|||+.|+++.
T Consensus 229 ~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 DSPYWDDI----SDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CTTTTTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCccccCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00011111 1335556677999999999999999983
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=399.02 Aligned_cols=243 Identities=26% Similarity=0.386 Sum_probs=193.8
Q ss_pred eeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe----cCceEEEE
Q 005450 351 LAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLVY 422 (696)
Q Consensus 351 ~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~----~~~~~LV~ 422 (696)
...+.||+|+||+||+|.+. +++.||+|.+... ....+.|.+|+++|++++|||||+++++|.. +..+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56778999999999999864 6889999998653 3456789999999999999999999999875 34589999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCc--eEeecccccceeeC-CCCceEEeecCcccc
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLS-DDFEPQLSDFGLAKW 499 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~g--IIHrDLKpsNILLd-~~~~vKL~DFGlA~~ 499 (696)
||+++|+|.+++.... .+++..++.++.||+.||+|||+ ++ |+||||||+||||+ +++.+||+|||+|+.
T Consensus 92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999999999997653 58999999999999999999998 66 99999999999996 578999999999986
Q ss_pred ccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
..... ....+||+.|+|||++. ++|+.++|||||||+||||++|+.||........ +..... .+....
T Consensus 165 ~~~~~----~~~~~GT~~Y~aPE~~~-~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~~i~----~~~~~~- 232 (270)
T d1t4ha_ 165 KRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVT----SGVKPA- 232 (270)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHT----TTCCCG-
T ss_pred ccCCc----cCCcccCccccCHHHhC-CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHHHHH----cCCCCc-
Confidence 54432 23468999999999987 4699999999999999999999999975443221 111111 111111
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+.... .+ .+..++..||+.||++|||+.|+++
T Consensus 233 ---~~~~~~-~~---~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 ---SFDKVA-IP---EVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---GGGGCC-CH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccCccC-CH---HHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111111 12 3445667799999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.8e-47 Score=408.90 Aligned_cols=251 Identities=22% Similarity=0.279 Sum_probs=206.0
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
++|.+.+.||+|+||+||+|.. .+|+.||||++.... ...+.+.+|+.+|++++|||||+++++|.+++.+||||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999986 578999999997643 45677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC--CCCceEEeecCccccccCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd--~~~~vKL~DFGlA~~~~~~ 503 (696)
+||+|.+++.... ..+++..+..|+.||+.||.|||+ ++||||||||+|||++ .++.+||+|||+|+.....
T Consensus 106 ~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 106 SGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999986443 258999999999999999999999 9999999999999996 4678999999999877654
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
... ....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+...... ... .
T Consensus 180 ~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-----~~~----~ 247 (350)
T d1koaa2 180 QSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN-----MDD----S 247 (350)
T ss_dssp SCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----SCC----G
T ss_pred ccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----CCc----c
Confidence 332 3467999999999999999999999999999999999999999876543332222211110 000 0
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
..... ...+..++..||+.||.+|||+.|+++.
T Consensus 248 ~~~~~----s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 AFSGI----SEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGC----CHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011 1234556677999999999999999984
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=401.83 Aligned_cols=253 Identities=23% Similarity=0.395 Sum_probs=200.9
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeecCC
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 427 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~~g 427 (696)
++|.+.+.||+|+||+||+|.+++++.||||+++......+.|.+|+.++.+++|||||+++++|.+ +..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 5689999999999999999999888899999998776667889999999999999999999999854 568999999999
Q ss_pred CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCCc
Q 005450 428 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 507 (696)
Q Consensus 428 GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~~ 507 (696)
|+|..++..... ..++|..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+........
T Consensus 96 g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~- 169 (285)
T d1fmka3 96 GSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 169 (285)
T ss_dssp CBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred Cchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence 999998875422 258999999999999999999999 89999999999999999999999999999876544332
Q ss_pred ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-chhhHHhhhccccccCccccccCcccCC
Q 005450 508 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK-GQESLVMWAKPILSSGKVTQLLDPALGN 586 (696)
Q Consensus 508 ~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~-~~~~lv~~~~~~~~~g~l~~llD~~L~~ 586 (696)
......||+.|+|||++..+.++.++|||||||+||||++|..|+...... .....+..... +....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~------------~~~~~ 237 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------MPCPP 237 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------------CCCCT
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC------------CCCCc
Confidence 223467999999999999999999999999999999999976665443322 22112211100 01111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 587 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 587 ~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.. ...+..++.+||+.||++||+|.+|+++|+.
T Consensus 238 ~~----~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 238 EC----PESLHDLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred cc----CHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 11 2345667788999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-47 Score=402.80 Aligned_cols=261 Identities=24% Similarity=0.423 Sum_probs=211.4
Q ss_pred hhcCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 417 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~ 417 (696)
..++|.+.+.||+|+||+||+|..+ +++.||||+++.. ....++|.+|+++|++++||||++++++|...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4578999999999999999999853 4578999999753 3456789999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCC--------------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeeccc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKK--------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 477 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~--------------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLK 477 (696)
.++||||+++|+|.++++.... ....+++..++.|+.|++.||+|||+ ++|||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEc
Confidence 9999999999999999965321 12358899999999999999999999 899999999
Q ss_pred ccceeeCCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCC-CCCCCCC
Q 005450 478 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR-KPISNDH 556 (696)
Q Consensus 478 psNILLd~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~-~Pf~~~~ 556 (696)
|+||||+.++.+||+|||+|+...........+...||+.|+|||++.+..|+.++|||||||++|||++|. +||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998776554444445578999999999999999999999999999999999985 5776655
Q ss_pred ccchhhHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 005450 557 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 625 (696)
Q Consensus 557 ~~~~~~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~ 625 (696)
.......+. .+.... .....+ ..+..++..||+.+|.+||||.+|+++|+...
T Consensus 248 ~~e~~~~v~-------~~~~~~-----~p~~~~----~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HEEVIYYVR-------DGNILA-----CPENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHH-------TTCCCC-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHH-------cCCCCC-----CCccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 433322221 111111 111122 34666778899999999999999999998643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7e-47 Score=407.13 Aligned_cols=251 Identities=21% Similarity=0.246 Sum_probs=206.4
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
++|.+.+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+.+|++++|||||+++++|.+++.+||||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999986 579999999987643 44567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC--CCCceEEeecCccccccCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd--~~~~vKL~DFGlA~~~~~~ 503 (696)
+||+|.+.+.... ..+++.+++.|+.||+.||.|||+ +|||||||||+||||+ .++.+||+|||+|+.....
T Consensus 109 ~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999998876443 358999999999999999999999 9999999999999998 6789999999999987654
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
... ....||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.........+......+ ...
T Consensus 183 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~---------~~~ 250 (352)
T d1koba_ 183 EIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF---------DED 250 (352)
T ss_dssp SCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC---------CSS
T ss_pred Cce---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------Ccc
Confidence 332 33679999999999999999999999999999999999999998765433322221111100 000
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
..... ...+..++..||+.||.+|||+.|+++.
T Consensus 251 ~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 251 AFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111 1234556777999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-47 Score=396.74 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=204.9
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC-------hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS-------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 418 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~-------~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~ 418 (696)
.++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+.+|++++|||||+++++|.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999996 57999999998642 12367899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC----ceEEeec
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 494 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~----~vKL~DF 494 (696)
||||||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999997643 58999999999999999999999 8999999999999998776 4999999
Q ss_pred CccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC
Q 005450 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 495 GlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
|+|+........ ....||+.|+|||++.+..++.++|||||||+||||++|+.||.+.........+.....
T Consensus 162 G~a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~----- 233 (293)
T d1jksa_ 162 GLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY----- 233 (293)
T ss_dssp TTCEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-----
T ss_pred hhhhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-----
Confidence 999877554322 336799999999999999999999999999999999999999987654332222211110
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 575 ~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
... +...... ...+..++..||+.||.+|||+.++++
T Consensus 234 ~~~----~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 EFE----DEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCC----HHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCC----chhcCCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000111 123455677799999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-47 Score=402.43 Aligned_cols=243 Identities=26% Similarity=0.390 Sum_probs=199.1
Q ss_pred CceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 349 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
.|...+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+++|++++|||||+++++|.+.+..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 489999999999999999985 57889999998653 2445679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+.+|+|..++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 999999987765443 58999999999999999999999 89999999999999999999999999999866442
Q ss_pred CCCcccccccccCCCCCcceecc---CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccccc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 580 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~---~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 580 (696)
....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||.+.........+.. +....+.
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~-------~~~~~~~ 235 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------NESPALQ 235 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------SCCCCCS
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-------CCCCCCC
Confidence 23579999999999863 4689999999999999999999999976554322111111 0111111
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 581 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 581 D~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+ ..+ . ..+..++..||+.||.+|||+.++++
T Consensus 236 ~----~~~-s---~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 S----GHW-S---EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C----TTS-C---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C----CCC-C---HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 111 1 23455666799999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-47 Score=400.02 Aligned_cols=253 Identities=22% Similarity=0.388 Sum_probs=201.6
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCC----EEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~----~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
++|++.++||+|+||+||+|... +|+ .||+|.++.. ....++|.+|+.++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999854 454 5899988753 34567899999999999999999999999764 6788
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
+|||+.+|+|.+++..... .+++..++.++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 8999999999998876543 68999999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
.............||+.|+|||++.++.|+.++|||||||+||||+| |+.||.+.........+......
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~--------- 232 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--------- 232 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC---------
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 76555444445679999999999999999999999999999999998 88898776544433333221110
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.. +......+..++.+||+.||.+|||+.+|++.|..
T Consensus 233 ---~~----p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 233 ---PQ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp ---CC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CC----CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 00 11112345667778999999999999999998864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=390.09 Aligned_cols=253 Identities=23% Similarity=0.370 Sum_probs=195.1
Q ss_pred hcCceeeeeeeccCceEEEEEEeCC----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~~----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~L 420 (696)
.++|.+.+.||+|+||.||+|.+.. +..||||.++.. ....+.|.+|++++++++||||++++++|. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3679999999999999999998642 356899998753 445678999999999999999999999995 568899
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccc
Q 005450 421 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 500 (696)
Q Consensus 421 V~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~ 500 (696)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+..
T Consensus 85 v~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999998865432 58999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccc
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 579 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 579 (696)
....... .....||+.|+|||++..+.++.++|||||||++|||++ |.+||...........+... ...
T Consensus 159 ~~~~~~~-~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~-------~~~-- 228 (273)
T d1mp8a_ 159 EDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-------ERL-- 228 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-------CCC--
T ss_pred cCCccee-ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------CCC--
Confidence 5543322 234678999999999999999999999999999999998 89999876654332222211 100
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 580 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 580 lD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
.+....+ ..+..++..||+.||.+|||+.+|++.|+.
T Consensus 229 ---~~~~~~~----~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 229 ---PMPPNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ---CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCCCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 0111122 345566778999999999999999998864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-46 Score=398.00 Aligned_cols=244 Identities=26% Similarity=0.361 Sum_probs=204.0
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5699999999999999999996 57999999999753 234577899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||++||+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccccc----cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999987654 47888999999999999999999 8999999999999999999999999999997754
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
.. ...+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+.......+..... .
T Consensus 157 ~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-----~------- 219 (316)
T d1fota_ 157 VT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-----R------- 219 (316)
T ss_dssp CB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-----C-------
T ss_pred cc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----C-------
Confidence 32 246899999999999999999999999999999999999999987654333222221110 0
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 620 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~~ 620 (696)
+....+ ..+..++..||+.||.+|| |+++++++
T Consensus 220 -~p~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 -FPPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111112 2344566679999999996 88998863
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=401.58 Aligned_cols=247 Identities=26% Similarity=0.365 Sum_probs=205.5
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
-++|.+.+.||+|+||.||+|.. .+|+.||||+++.. ....+.+.+|+.+|+.++||||++++++|.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36799999999999999999986 57999999999753 23457788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||++||+|.+++.... .+++..++.++.||+.||+|||+ ++||||||||+||||+.+|.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999998654 48899999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
.... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.......+.....
T Consensus 157 ~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~------------ 222 (337)
T d1o6la_ 157 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------------ 222 (337)
T ss_dssp CTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------
T ss_pred cCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC------------
Confidence 4332 23347899999999999999999999999999999999999999987664332222211110
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLK 619 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPS-----m~eVL~ 619 (696)
.+...+. ..+..++..||+.||.+||+ +.++++
T Consensus 223 -~~p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 -RFPRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCccCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1111222 23445666799999999995 777776
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.4e-46 Score=387.46 Aligned_cols=256 Identities=24% Similarity=0.363 Sum_probs=198.5
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc----
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN---- 417 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~---- 417 (696)
.++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ......+.+|+++++.++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999986 57999999999753 3456689999999999999999999999987553
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA 497 (696)
+||||||++|++|.+++.... .+++.+++.|+.||+.||+|||+ ++|+||||||+|||++.++..+|+|||++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhh
Confidence 899999999999999887654 58999999999999999999999 89999999999999999999999999998
Q ss_pred ccccCCCC-CcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 498 KWASTSSS-HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 498 ~~~~~~~~-~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
........ .......+||+.|+|||++.+..++.++|||||||++|||+||+.||...........+....+. .
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~-----~ 233 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI-----P 233 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-----C
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC-----C
Confidence 86644322 22234468999999999999999999999999999999999999999876543322211111111 0
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhh
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-QMSLVLKLLR 622 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RP-Sm~eVL~~L~ 622 (696)
..... ...+ ..+..++..||+.||.+|| |++++++.|.
T Consensus 234 ~~~~~----~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 234 PSARH----EGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp GGGTS----SSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred Cchhc----cCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 01111 1111 3445566679999999999 7999887664
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=395.13 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=197.9
Q ss_pred hcCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec-C
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-N 416 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~-~ 416 (696)
.++|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|..++.++ +|+||+.+++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 467999999999999999999853 3568999999753 34566788888888877 689999999998764 4
Q ss_pred ceEEEEeecCCCChhhhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 484 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd 484 (696)
.+++||||+++|+|.++++.... ....+++..+..++.||+.||.|||+ ++||||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeEC
Confidence 68999999999999999975432 12358999999999999999999999 8999999999999999
Q ss_pred CCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhC-CCCCCCCCccchhhH
Q 005450 485 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQESL 563 (696)
Q Consensus 485 ~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG-~~Pf~~~~~~~~~~l 563 (696)
.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||++| ..||...........
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999999977665555455567899999999999999999999999999999999996 557765543322111
Q ss_pred HhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 564 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 564 v~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
. . ..+.. +...... ...+..++..||+.||.+|||+.+|+++|+.
T Consensus 249 ~--~----~~~~~-----~~~~~~~----~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 249 R--L----KEGTR-----MRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp H--H----HHTCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H--H----hcCCC-----CCCCccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 0 01110 1111111 1245567778999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=396.14 Aligned_cols=251 Identities=20% Similarity=0.244 Sum_probs=207.1
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeec
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 425 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey~ 425 (696)
.++|.+.+.||+|+||+||+|... +|+.||||+++........+.+|+++|+.++||||++++++|.+++.+||||||+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 467999999999999999999864 6889999999887766677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCC--CceEEeecCccccccCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--FEPQLSDFGLAKWASTS 503 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~--~~vKL~DFGlA~~~~~~ 503 (696)
+||+|.+++.... ..+++.++..|+.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 84 ~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 84 SGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999997543 258999999999999999999999 999999999999999854 57999999999876543
Q ss_pred CCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
.. .....||+.|+|||.+.+..|+.++|||||||++|+|++|+.||...........+......+ +..
T Consensus 158 ~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~---------~~~ 225 (321)
T d1tkia_ 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF---------DEE 225 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC---------CHH
T ss_pred Cc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------Chh
Confidence 32 233679999999999999999999999999999999999999998765433322222111100 000
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
....+ ...+..++..||+.||.+|||+.|+++
T Consensus 226 ~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 AFKEI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011 123456677799999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=394.99 Aligned_cols=270 Identities=26% Similarity=0.325 Sum_probs=201.1
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC----ceEEEEe
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----NLLLVYD 423 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~----~~~LV~E 423 (696)
.+|.+.+.||+|+||+||+|.+ +|+.||||+++........+..|+..+.+++||||++++++|.+.+ .+++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 4688899999999999999986 6889999999765443333334555566789999999999998754 5799999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcC-----CCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG-----SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~-----~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
|+++|+|.++|+.. .++|..+++++.+++.||+|||+. ..++|+||||||+||||+.++.+||+|||+++
T Consensus 82 y~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999864 489999999999999999999973 13699999999999999999999999999999
Q ss_pred cccCCCCC--cccccccccCCCCCcceeccC------CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhh-hcc
Q 005450 499 WASTSSSH--ITCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMW-AKP 569 (696)
Q Consensus 499 ~~~~~~~~--~~~~~~~GT~~YlAPE~l~~~------~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~-~~~ 569 (696)
........ .......||+.|+|||++... .++.++|||||||+||||+||..||.............. ..+
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 77654322 123347899999999998754 267789999999999999999988854332211100000 000
Q ss_pred c---cccCccccccCcccCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 570 I---LSSGKVTQLLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 570 ~---~~~g~l~~llD~~L~~~~-~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
. .........++|.+.... ..+....+..++..||+.||.+|||+.||++.|+.
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 0 000001111222222222 22345667888899999999999999999999863
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-45 Score=385.08 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=203.5
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh----------hHHHHHHHHHHHHHhcC-CcceeEEeeEEEec
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----------DVIKEFVLEIEIITTLH-HKNIISLLGFCFED 415 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~----------~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~ 415 (696)
++|.+.+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999986 578999999986531 23456889999999997 99999999999999
Q ss_pred CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecC
Q 005450 416 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 495 (696)
Q Consensus 416 ~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFG 495 (696)
+..||||||+++|+|.++|.... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999997543 58999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCCCCcceecc------CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcc
Q 005450 496 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 569 (696)
Q Consensus 496 lA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~------~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~ 569 (696)
+++........ ....||+.|+|||++.+ ..++.++||||+||+||||++|+.||.+.........+.....
T Consensus 156 ~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~ 232 (277)
T d1phka_ 156 FSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232 (277)
T ss_dssp TCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred heeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence 99987654322 34679999999999863 3578899999999999999999999987654333222221111
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 570 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 570 ~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.... +. .......+..++..||+.||.+|||+.||++
T Consensus 233 ~~~~--------~~-----~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 233 QFGS--------PE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CCCT--------TT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCC--------cc-----cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000 00 0011134556677899999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=388.19 Aligned_cols=248 Identities=29% Similarity=0.442 Sum_probs=195.1
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe-cCceEEEEeecC
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLS 426 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~-~~~~~LV~Ey~~ 426 (696)
++|.+.+.||+|+||.||+|.. .|+.||||+++.+. ..+.|.+|++++++++||||++++++|.+ .+.+++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 5688999999999999999998 57889999997643 45789999999999999999999999965 456899999999
Q ss_pred CCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCCC
Q 005450 427 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 506 (696)
Q Consensus 427 gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~~ 506 (696)
+|+|.++|..... ..++|..+++|+.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 85 KGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp TEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC--
Confidence 9999999975421 248999999999999999999999 899999999999999999999999999998655432
Q ss_pred cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccccccCcccC
Q 005450 507 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 585 (696)
Q Consensus 507 ~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~L~ 585 (696)
....+|+.|+|||++.++.++.++|||||||++|||+| |+.||...........+. .+.. +.+.
T Consensus 158 ---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-------~~~~-----~~~~ 222 (262)
T d1byga_ 158 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYK-----MDAP 222 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-------TTCC-----CCCC
T ss_pred ---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCCC-----CCCC
Confidence 23468999999999999999999999999999999998 788887654333222211 1111 1111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 586 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 586 ~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
...+ ..+..++.+||+.||.+||||.+++++|+.
T Consensus 223 ~~~~----~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 223 DGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCC----HHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 1112 345566778999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=389.54 Aligned_cols=259 Identities=27% Similarity=0.420 Sum_probs=206.6
Q ss_pred hcCceeeeeeeccCceEEEEEEeC--------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 415 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~--------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~ 415 (696)
.++|.+.+.||+|+||.||+|... ++..||||+++.. .....++.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 357889999999999999999853 2347999999764 34567889999999888 799999999999999
Q ss_pred CceEEEEeecCCCChhhhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee
Q 005450 416 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 483 (696)
Q Consensus 416 ~~~~LV~Ey~~gGsL~~~L~~~~~------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL 483 (696)
+..++||||+++|+|.++|..... ....+++.+++.++.||+.||+|||+ ++||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence 999999999999999999975532 12458999999999999999999999 899999999999999
Q ss_pred CCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhh
Q 005450 484 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 562 (696)
Q Consensus 484 d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~ 562 (696)
+.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |+.||..........
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 9999999999999998876655554555789999999999999999999999999999999998 788887655432222
Q ss_pred HHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 563 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 563 lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.+. .+. .+...... ...+..++.+||+.||.+|||+.+|++.|+..
T Consensus 249 ~i~-------~~~-----~~~~p~~~----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 249 LLK-------EGH-----RMDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HHH-------TTC-----CCCCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH-------cCC-----CCCCCccc----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 211 111 01111111 23456677789999999999999999999643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=393.58 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=210.5
Q ss_pred hcCceeeeeeeccCceEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCc
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 417 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~ 417 (696)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.. ......|.+|+.++.++ +|||||+++++|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 35788999999999999999974 35678999999764 34556799999999999 69999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCC--------------CCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceee
Q 005450 418 LLLVYDFLSRGSLEENLHGNKK--------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 483 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~--------------~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILL 483 (696)
.++||||+++|+|.++++.... ....+++..+..++.||+.||.|||+ ++||||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccc
Confidence 9999999999999999976532 22358999999999999999999999 899999999999999
Q ss_pred CCCCceEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchh-
Q 005450 484 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQE- 561 (696)
Q Consensus 484 d~~~~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~- 561 (696)
+.++.+||+|||+++...............||+.|+|||++..+.++.++|||||||++|||+| |.+||.........
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999998877665555556789999999999999999999999999999999999 55555554433221
Q ss_pred hHHhhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 562 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 562 ~lv~~~~~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
..+....+ +.. +......+..++.+||+.||.+||||.+|+++|+.
T Consensus 259 ~~i~~~~~------------~~~----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 259 KMIKEGFR------------MLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHHHHTCC------------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcCCC------------CCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 12211110 011 11112346667778999999999999999999974
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=387.00 Aligned_cols=254 Identities=25% Similarity=0.416 Sum_probs=195.6
Q ss_pred cCceeeeeeeccCceEEEEEEeC--CC--CEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP--DG--KELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~--~g--~~vAVK~l~~~----~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
++|.+.+.||+|+||.||+|... ++ ..||||+++.. ....++|.+|+++|++++||||++++++|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56999999999999999999853 23 36899998753 3456789999999999999999999999965 5779
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhh
Confidence 9999999999999887543 258999999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCcc-cccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHh-CCCCCCCCCccchhhHHhhhccccccCccc
Q 005450 500 ASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 577 (696)
Q Consensus 500 ~~~~~~~~~-~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 577 (696)
......... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.........+. ..+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~------~~~~~~ 234 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KEGERL 234 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------TSCCCC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHH------hCCCCC
Confidence 765543322 233568889999999999999999999999999999998 899998665433222211 111000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 578 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 578 ~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
......+ ..+..++..||+.||++|||+.+|++.|+.
T Consensus 235 -----~~~~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 235 -----PRPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -----CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCccccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 0111112 235566777999999999999999998863
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-45 Score=397.04 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=198.0
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCCh----hHHHHHH---HHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFV---LEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~----~~~~~~~---~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
++|.+.+.||+|+||.||+|... +|+.||||++.... .....+. .|+.+++.++|||||+++++|.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999864 79999999986422 1122333 4467777788999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 499 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~ 499 (696)
+||||++||+|.++|.... .+++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999997653 47899999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcccc
Q 005450 500 ASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 578 (696)
Q Consensus 500 ~~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 578 (696)
...... ....||+.|+|||++.. ..|+.++|||||||+||||+||+.||..........+.......
T Consensus 157 ~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-------- 224 (364)
T d1omwa3 157 FSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-------- 224 (364)
T ss_dssp CSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC--------
T ss_pred cCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--------
Confidence 765432 23579999999999975 46899999999999999999999999876554433332211110
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005450 579 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLK 619 (696)
Q Consensus 579 llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPS-----m~eVL~ 619 (696)
...+...++ ..+..++..||+.||.+||| ++++++
T Consensus 225 --~~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 --AVELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --CCCCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --CCCCCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 001111122 23455666799999999999 677775
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=386.40 Aligned_cols=259 Identities=25% Similarity=0.283 Sum_probs=196.0
Q ss_pred eeeeeeccCceEEEEEEe-CCCCEEEEEEecCChh------HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 352 AENLIGKGGSSQVYKGCL-PDGKELAVKILKPSED------VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~------~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
.+++||+|+||+||+|.. .+|+.||||+++.... ..+.+.+|+.+|++++|||||+++++|..++..+|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999996 4699999999975321 234688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+.++++..++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9998777666533 258889999999999999999999 899999999999999999999999999998766543
Q ss_pred CCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccc---ccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT---QLL 580 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~---~ll 580 (696)
.. ....+||+.|+|||++..+ .|+.++|||||||++|||++|+.||.......+...+............. ...
T Consensus 155 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 155 RA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred cc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 32 2236799999999998755 57999999999999999999999998766544332221110000000000 000
Q ss_pred Cc-ccC--CCCCh-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 581 DP-ALG--NNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 581 D~-~L~--~~~~~-----~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.. ... ...+. .....+..++..||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00 000 00011 11234666777899999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-45 Score=397.50 Aligned_cols=243 Identities=23% Similarity=0.302 Sum_probs=203.8
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~ 422 (696)
++|.+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+++|+.++||||+++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999986 479999999987432 33567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccC
Q 005450 423 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 502 (696)
Q Consensus 423 Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~ 502 (696)
||+.+|+|..++.... .+++..+..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999997654 48999999999999999999999 8999999999999999999999999999997754
Q ss_pred CCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCc
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 582 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~ 582 (696)
. .....||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.........+.....
T Consensus 194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------------- 255 (350)
T d1rdqe_ 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV------------- 255 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------
T ss_pred c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-------------
Confidence 3 2246799999999999999999999999999999999999999987654332222221111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005450 583 ALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLK 619 (696)
Q Consensus 583 ~L~~~~~~~e~~~l~~la~~Cl~~dP~~RP-----Sm~eVL~ 619 (696)
.....++ ..+..++..||+.||.+|+ |++++++
T Consensus 256 ~~p~~~s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 RFPSHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCTTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCccCC----HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0111112 2345566679999999994 8999886
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=389.61 Aligned_cols=260 Identities=21% Similarity=0.383 Sum_probs=210.7
Q ss_pred cCceeeeeeeccCceEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~ 419 (696)
++|.+.+.||+|+||+||+|.+. +++.||||+++.. ......|.+|++++++++||||++++++|..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 56889999999999999999863 3578999999753 344567899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCC------CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEee
Q 005450 420 LVYDFLSRGSLEENLHGNK------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 493 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~------~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~D 493 (696)
+||||+++|+|.+++.... .....+++..+.+++.|++.||.|||+ ++|+||||||+||||+.++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 9999999999999886432 122357899999999999999999999 8999999999999999999999999
Q ss_pred cCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCC-CCCCCCCccchhhHHhhhccccc
Q 005450 494 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR-KPISNDHPKGQESLVMWAKPILS 572 (696)
Q Consensus 494 FGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~-~Pf~~~~~~~~~~lv~~~~~~~~ 572 (696)
||+|+...............||+.|+|||.+.++.++.++||||||+++|||+||. .||.+.........+.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~------- 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM------- 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-------
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------
Confidence 99999776655444445567999999999999999999999999999999999985 6776544332222221
Q ss_pred cCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCcc
Q 005450 573 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 626 (696)
Q Consensus 573 ~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~~~ 626 (696)
.+..... ....+ ..+..++..||+.+|++||||.+|+++|+...+
T Consensus 250 ~~~~~~~-----p~~~~----~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGGLLDK-----PDNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTCCCCC-----CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCCCCCC-----cccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111111 11111 346667777999999999999999999987543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=389.17 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=200.7
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCC--EEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGK--ELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~--~vAVK~l~~~--~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~~~LV 421 (696)
++|.+.+.||+|+||+||+|.++ +|. .||||.++.. ....+.|.+|+++|.++ +|||||+++++|.+++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57889999999999999999865 444 4778887542 34566899999999998 799999999999999999999
Q ss_pred EeecCCCChhhhhhcCC------------CCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCce
Q 005450 422 YDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 489 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~------------~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~v 489 (696)
|||+++|+|.++|+... .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 99999999999997542 223568999999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCC-CCCCCCccchhhHHhhhc
Q 005450 490 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRK-PISNDHPKGQESLVMWAK 568 (696)
Q Consensus 490 KL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~-Pf~~~~~~~~~~lv~~~~ 568 (696)
||+|||+|+........ ....||+.|+|||.+..+.++.++|||||||++|||++|.. ||........ .....
T Consensus 167 kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~---~~~i~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEKLP 240 (309)
T ss_dssp EECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHGG
T ss_pred EEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH---HHHHH
Confidence 99999999866543322 23569999999999999999999999999999999999764 6765443222 11111
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 569 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 569 ~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
.+. .+.. +......+..++.+||+.||++||||.+|++.|+..
T Consensus 241 ----~~~-----~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 241 ----QGY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp ----GTC-----CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----hcC-----CCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 110 0111 111123455667779999999999999999988643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=391.50 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=196.4
Q ss_pred hcCceee-eeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEe----cCceE
Q 005450 347 TSNFLAE-NLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE----DNNLL 419 (696)
Q Consensus 347 t~~f~~~-~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~----~~~~~ 419 (696)
.++|.+. ++||+|+||+||+|.. .+|+.||||+++... .+.+|+.++.++ +|||||+++++|.+ +..+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH----HHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4578876 4699999999999986 579999999997643 466799887655 89999999999875 46789
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC---CCceEEeecCc
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGL 496 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~---~~~vKL~DFGl 496 (696)
+|||||+||+|.++|..... ..+++.+++.|+.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccce
Confidence 99999999999999975432 368999999999999999999999 99999999999999985 46799999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
|+........ ....||+.|+|||++.+..|+.++|||||||+||+|+||+.||.+.........+. .....+..
T Consensus 161 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~---~~i~~~~~ 234 (335)
T d2ozaa1 161 AKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRIRMGQY 234 (335)
T ss_dssp CEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS
T ss_pred eeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH---HHHhcCCC
Confidence 9877654332 34679999999999999999999999999999999999999997654432211110 00000110
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+...........+..++..||+.||.+|||+.|+++
T Consensus 235 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 235 ------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000000111234566777899999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-45 Score=384.73 Aligned_cols=251 Identities=26% Similarity=0.440 Sum_probs=198.4
Q ss_pred eeeeeccCceEEEEEEeCCC----CEEEEEEecC--ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe-cCceEEEEeec
Q 005450 353 ENLIGKGGSSQVYKGCLPDG----KELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFL 425 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~g----~~vAVK~l~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~-~~~~~LV~Ey~ 425 (696)
.++||+|+||+||+|.+.++ ..||||+++. .....++|.+|+++|++++||||++++++|.+ ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999986432 2589999974 44566889999999999999999999999876 45789999999
Q ss_pred CCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCCC
Q 005450 426 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 505 (696)
Q Consensus 426 ~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~~ 505 (696)
++|+|.+++..... .+++..++.++.|++.||.|||+ .+|+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999875543 57788999999999999999999 8999999999999999999999999999997765433
Q ss_pred Cc--ccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccCcc
Q 005450 506 HI--TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 583 (696)
Q Consensus 506 ~~--~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD~~ 583 (696)
.. ......||+.|+|||++..+.++.++||||||+++|||+||+.||........ +..+.. .+.- ...|
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~i~----~g~~--~~~p- 256 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLL----QGRR--LLQP- 256 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH----TTCC--CCCC-
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHHHHH----cCCC--CCCc-
Confidence 22 22336799999999999999999999999999999999998888765432211 111111 1110 0111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 005450 584 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 624 (696)
Q Consensus 584 L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~~ 624 (696)
. ... ..+..++..||+.||++||+|.||++.|+..
T Consensus 257 --~-~~~---~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 257 --E-YCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp --T-TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --c-cCc---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 112 2355667789999999999999999998644
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=392.22 Aligned_cols=246 Identities=24% Similarity=0.398 Sum_probs=202.3
Q ss_pred cCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHH-hcCCcceeEEeeEEEecCceEEE
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIIT-TLHHKNIISLLGFCFEDNNLLLV 421 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~-~L~HpnIV~l~g~~~~~~~~~LV 421 (696)
++|.+.+.||+|+||+||+|... +|+.||||+++.. ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999864 7899999999753 233456777877765 68999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~ 501 (696)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+...
T Consensus 82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999997654 47899999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCccccccC
Q 005450 502 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 581 (696)
Q Consensus 502 ~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~llD 581 (696)
..... .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+....+
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~------------ 220 (320)
T d1xjda_ 155 LGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP------------ 220 (320)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------
T ss_pred ccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 43332 2346899999999999999999999999999999999999999987655433322222111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 005450 582 PALGNNYDYDQMERMVLASILCIRRDPRARPQMS-LVLK 619 (696)
Q Consensus 582 ~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~-eVL~ 619 (696)
.+....+ ..+..++..||+.||.+||++. ++++
T Consensus 221 -~~p~~~s----~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 -FYPRWLE----KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -CCCTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CCCccCC----HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1111112 2345566679999999999985 6654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=382.20 Aligned_cols=264 Identities=26% Similarity=0.371 Sum_probs=198.5
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
++|.+.+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+++|++++||||++++++|.+.+..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999986 579999999997543 235678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
|+.++ +.+++..... ..+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~-~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCc-hhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99765 4444433222 358999999999999999999999 89999999999999999999999999999877543
Q ss_pred CCCcccccccccCCCCCcceeccCC-CCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC---ccccc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG---KVTQL 579 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~-~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g---~l~~l 579 (696)
.. ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||.+.+.......+.......... .....
T Consensus 156 ~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 VR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp SB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 32 233467999999999877665 5789999999999999999999998765433222111100000000 00000
Q ss_pred cC--cccCC--CCCh-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 580 LD--PALGN--NYDY-----DQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 580 lD--~~L~~--~~~~-----~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
.+ ..+.. ..+. .....+..++.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 00000 0000 11134556677899999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.4e-45 Score=378.04 Aligned_cols=263 Identities=23% Similarity=0.330 Sum_probs=200.1
Q ss_pred cCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 005450 348 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~Ey 424 (696)
++|.+.+.||+|+||+||+|.+++|+.||||+++... ...+.+.+|+.+|++++||||++++++|...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999999999999999997542 3357899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCCC
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 504 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~~ 504 (696)
+.++.+..+..... .+++..+..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|.......
T Consensus 82 ~~~~~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhcC----CcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 98877776665433 58999999999999999999999 899999999999999999999999999998775533
Q ss_pred CCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC---cccccc
Q 005450 505 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG---KVTQLL 580 (696)
Q Consensus 505 ~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g---~l~~ll 580 (696)
.. .....||+.|+|||.+... .++.++|||||||++|||++|+.||.+.........+.......... ......
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 155 RK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence 22 2335699999999998754 57899999999999999999999998765433322211111000000 000000
Q ss_pred --CcccC-------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 581 --DPALG-------NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 581 --D~~L~-------~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+..+. ..........+..++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0001111234556677899999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-45 Score=380.72 Aligned_cols=263 Identities=21% Similarity=0.312 Sum_probs=195.9
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CC-CCEEEEEEecCC---hhHHHHHHHHHHHHHhc---CCcceeEEeeEEEe----
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PD-GKELAVKILKPS---EDVIKEFVLEIEIITTL---HHKNIISLLGFCFE---- 414 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~-g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L---~HpnIV~l~g~~~~---- 414 (696)
.++|.+.+.||+|+||+||+|.+ .+ ++.||||+++.. ......+.+|+.+|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999986 34 567999998642 22233566777777665 79999999999863
Q ss_pred -cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEee
Q 005450 415 -DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 493 (696)
Q Consensus 415 -~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~D 493 (696)
....+++|||+.++.+........ ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecc
Confidence 346899999999887765554332 358999999999999999999999 8999999999999999999999999
Q ss_pred cCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccccc
Q 005450 494 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 573 (696)
Q Consensus 494 FGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 573 (696)
||+++...... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+.........
T Consensus 160 fg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 99988654332 234578999999999999999999999999999999999999999876554433222211100000
Q ss_pred Ccc-----------ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 574 GKV-----------TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 574 g~l-----------~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
... .......+ ..+.......+..++..||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcccccccchhhhhccccccch-hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 00000000 0011111233445667799999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-45 Score=377.21 Aligned_cols=239 Identities=22% Similarity=0.366 Sum_probs=194.0
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcC--CcceeEEeeEEEecC
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTLH--HKNIISLLGFCFEDN 416 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~L~--HpnIV~l~g~~~~~~ 416 (696)
.++|.+.+.||+|+||+||+|.. .+|+.||||+++... ....++.+|+.+|++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 36799999999999999999986 579999999987432 12244678999999997 899999999999999
Q ss_pred ceEEEEeecCC-CChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC-CCceEEeec
Q 005450 417 NLLLVYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDF 494 (696)
Q Consensus 417 ~~~LV~Ey~~g-GsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~-~~~vKL~DF 494 (696)
..++||||+.+ +++.+++.... .+++.+++.++.||+.||+|||+ ++|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcc
Confidence 99999999986 57778776543 58999999999999999999999 99999999999999985 478999999
Q ss_pred CccccccCCCCCcccccccccCCCCCcceeccCCC-CCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccccc
Q 005450 495 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 573 (696)
Q Consensus 495 GlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~-s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 573 (696)
|+|+...... .+...||+.|+|||++.+..+ +.++|||||||+||||++|+.||.... . +......
T Consensus 156 G~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~-i~~~~~~--- 222 (273)
T d1xwsa_ 156 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E-IIRGQVF--- 222 (273)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H-HHHCCCC---
T ss_pred ccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H-HhhcccC---
Confidence 9998765432 234689999999999987765 567899999999999999999996532 1 1111110
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 574 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 574 g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+...++ ..+..++.+||+.||.+|||+.|+++
T Consensus 223 ----------~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 223 ----------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----------CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------CCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111122 23455667799999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=370.81 Aligned_cols=266 Identities=23% Similarity=0.297 Sum_probs=197.2
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--------
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-------- 414 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~-------- 414 (696)
.++|.+.+.||+|+||+||+|.. .+|+.||||++... +...+.+.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 37899999999999999999996 57999999998643 2345678899999999999999999998855
Q ss_pred cCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeec
Q 005450 415 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 494 (696)
Q Consensus 415 ~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DF 494 (696)
.+..++||||+.++.+....... ..++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeec
Confidence 34689999999887766554433 258889999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCC--cccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccc
Q 005450 495 GLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 571 (696)
Q Consensus 495 GlA~~~~~~~~~--~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~ 571 (696)
|+++........ ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.........+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999876543221 122235799999999998755 68999999999999999999999998765544333332221111
Q ss_pred ccCccccccCc--------ccCCCCChH-H------HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 572 SSGKVTQLLDP--------ALGNNYDYD-Q------MERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 572 ~~g~l~~llD~--------~L~~~~~~~-e------~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
........... ......... . ...+..++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 11111110000 000000111 1 123345677899999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-43 Score=375.78 Aligned_cols=261 Identities=24% Similarity=0.272 Sum_probs=192.2
Q ss_pred CceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEec------CceEEE
Q 005450 349 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NNLLLV 421 (696)
Q Consensus 349 ~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~------~~~~LV 421 (696)
+|...++||+|+||+||+|.+. +|+.||||+++.... .+.+|+++|++++||||++++++|... ..++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 4778899999999999999964 799999999976542 234799999999999999999998643 247899
Q ss_pred EeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC-ceEEeecCccccc
Q 005450 422 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWA 500 (696)
Q Consensus 422 ~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~-~vKL~DFGlA~~~ 500 (696)
|||++++.+..+.+. ......+++..+..++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+++..
T Consensus 98 ~Ey~~~~~~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 98 LDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EECCSEEHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EeccCCccHHHHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999987644443321 1222368999999999999999999999 9999999999999999775 8999999999877
Q ss_pred cCCCCCcccccccccCCCCCcceecc-CCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhc-----------
Q 005450 501 STSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK----------- 568 (696)
Q Consensus 501 ~~~~~~~~~~~~~GT~~YlAPE~l~~-~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~----------- 568 (696)
...... ....||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||...........+....
T Consensus 174 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 554332 23679999999998764 478999999999999999999999998765433322221100
Q ss_pred -cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 569 -PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 569 -~~~~~g~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
+......+.......+...........+..++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000111110000000011111234555667799999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=370.34 Aligned_cols=266 Identities=22% Similarity=0.305 Sum_probs=198.0
Q ss_pred hhcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC----ce
Q 005450 346 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----NL 418 (696)
Q Consensus 346 ~t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~----~~ 418 (696)
.+++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+.+|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 356799999999999999999985 58999999999753 345678899999999999999999999997643 23
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 419 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 419 ~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
+++++|+.+|+|.+++... .+++..+..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+
T Consensus 86 ~~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 5555677799999999753 48999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC-cccccccccCCCCCcceec-cCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 499 WASTSSSH-ITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 499 ~~~~~~~~-~~~~~~~GT~~YlAPE~l~-~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
........ ......+||+.|+|||++. ...++.++||||+||++|+|++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 76553322 1223467999999999985 446788999999999999999999999876543333222111111000000
Q ss_pred c--------c-ccCcccCCCCChHH-----HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 577 T--------Q-LLDPALGNNYDYDQ-----MERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 577 ~--------~-llD~~L~~~~~~~e-----~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
. . ..........+... ...+..++..||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0 00000000011110 124566777899999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=370.23 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=193.1
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC------
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 416 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~------ 416 (696)
.++|.+.+.||+|+||+||+|.. .+|+.||||+++. .....+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999996 5799999999975 3345678899999999999999999999997654
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCc
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGl 496 (696)
.+++||||+ +.+|..+++.. .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccc
Confidence 579999999 56788777543 48999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC-
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG- 574 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g- 574 (696)
|+...... +...||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....................
T Consensus 168 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 168 ARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 98765432 346799999999998764 57899999999999999999999998765433222111110000000
Q ss_pred --------------ccccccCcc---cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 575 --------------KVTQLLDPA---LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 575 --------------~l~~llD~~---L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
.+....... +....+ ..+..++..||+.||.+|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s----~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNAS----PLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCC----HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCC----HHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 001111 234456677999999999999999973
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-42 Score=356.88 Aligned_cols=263 Identities=21% Similarity=0.250 Sum_probs=202.2
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 423 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~~~LV~E 423 (696)
++|++.+.||+|+||+||+|.+ .+|+.||||+++.. ......+.+|+.+|+.++||||++++++|......++||+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999996 57899999998643 3456889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCccccccCC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 503 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~~~~~~ 503 (696)
++.+++|..++...+ .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.|+.....
T Consensus 82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988887543 57899999999999999999999 89999999999999999999999999999977654
Q ss_pred CCCcccccccccCCCCCcceeccCC-CCCcccchhhHHHHHHHHhCCCCCCCCCccch-hhHHhhhccccccCc---ccc
Q 005450 504 SSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ-ESLVMWAKPILSSGK---VTQ 578 (696)
Q Consensus 504 ~~~~~~~~~~GT~~YlAPE~l~~~~-~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~-~~lv~~~~~~~~~g~---l~~ 578 (696)
.... ....+++.|+|||++.... ++.++|||||||++|||++|+.||........ ...+........... ...
T Consensus 155 ~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 155 VRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred Cccc--eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 3322 2346788999999987665 68999999999999999999999755433221 111111100000000 000
Q ss_pred ccC---------cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 579 LLD---------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 579 llD---------~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
..+ ..-...........+..++.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00000011111234455667799999999999999876
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-42 Score=360.68 Aligned_cols=259 Identities=22% Similarity=0.269 Sum_probs=194.3
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCccee-EEeeEEEecCceEEEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnIV-~l~g~~~~~~~~~LV~Ey 424 (696)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++..... ..++..|+++++.++|+|++ .+..++.+++..++||||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 35799999999999999999986 5789999999876432 24678899999999877655 555556777888999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeC---CCCceEEeecCcccccc
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKWAS 501 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd---~~~~vKL~DFGlA~~~~ 501 (696)
+ +++|...+.... ..+++..+..++.|++.||+|||+ ++||||||||+|||++ .+..+||+|||+|+...
T Consensus 85 ~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 L-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred c-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9 456766665433 258999999999999999999999 9999999999999875 45579999999999876
Q ss_pred CCCCC-----cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCcc
Q 005450 502 TSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 576 (696)
Q Consensus 502 ~~~~~-----~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 576 (696)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+............
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 54332 1233468999999999999889999999999999999999999999875543332221111000000000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 005450 577 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 622 (696)
Q Consensus 577 ~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~ 622 (696)
+.+...++ ..+..++..||+.+|++||+++++.++|+
T Consensus 238 -----~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 274 (299)
T d1ckia_ 238 -----EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274 (299)
T ss_dssp -----HHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred -----hHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 11111122 23455666799999999999999988876
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.5e-42 Score=358.44 Aligned_cols=260 Identities=18% Similarity=0.212 Sum_probs=203.8
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCC-cceeEEeeEEEecCceEEEEee
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYDF 424 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~g~~~~~~~~~LV~Ey 424 (696)
.++|.+.+.||+|+||+||+|.+. +|+.||||++.... ....+.+|++++..++| +|++.+++++..+...++||||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 468999999999999999999964 78999999986533 23457789999999975 8999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCC-----CCceEEeecCcccc
Q 005450 425 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-----DFEPQLSDFGLAKW 499 (696)
Q Consensus 425 ~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~-----~~~vKL~DFGlA~~ 499 (696)
+ +++|.+++..... .+++.++..++.|++.||+|||+ +|||||||||+|||++. ++.+||+|||+|+.
T Consensus 83 ~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 83 L-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp C-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 8 6899999876543 58999999999999999999999 99999999999999974 57899999999998
Q ss_pred ccCCCCC-----cccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccC
Q 005450 500 ASTSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 574 (696)
Q Consensus 500 ~~~~~~~-----~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 574 (696)
....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 7543222 12234689999999999999999999999999999999999999998765543332221111000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 005450 575 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 623 (696)
Q Consensus 575 ~l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~L~~ 623 (696)
...+ +...++ + .+..++..|+..+|++||+++.+.+.|+.
T Consensus 236 ~~~~-----l~~~~p-~---~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 236 PLRE-----LCAGFP-E---EFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp CHHH-----HTTTSC-H---HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ChHH-----hcCCCC-H---HHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1111 111222 2 34455566999999999999998887753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8e-42 Score=362.22 Aligned_cols=257 Identities=19% Similarity=0.310 Sum_probs=195.8
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEe--cCceEEEEe
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFE--DNNLLLVYD 423 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~--~~~~~LV~E 423 (696)
++|.+.+.||+|+||+||+|.. .+|+.||||+++... .+++.+|+++|..++ ||||++++++|.. ...+++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 5899999999999999999986 578999999998644 467889999999996 9999999999974 456999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCC-ceEEeecCccccccC
Q 005450 424 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWAST 502 (696)
Q Consensus 424 y~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~-~vKL~DFGlA~~~~~ 502 (696)
|+.+++|..+.. .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+|+....
T Consensus 113 ~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 113 HVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred ecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987642 48899999999999999999999 9999999999999998655 699999999987765
Q ss_pred CCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchh-hHHh----------hhc--
Q 005450 503 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-SLVM----------WAK-- 568 (696)
Q Consensus 503 ~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~-~lv~----------~~~-- 568 (696)
.... ....||+.|+|||.+.+. .++.++|||||||++|||++|+.||......... ..+. +..
T Consensus 183 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCcc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 4332 346799999999998765 4799999999999999999999999765442211 1100 000
Q ss_pred cccccCccccccC--------cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 569 PILSSGKVTQLLD--------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 569 ~~~~~g~l~~llD--------~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
............. ..............+..++..||+.||.+|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000000 00111111111234556677899999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-42 Score=363.69 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=199.4
Q ss_pred cCceeeeeeeccCceEEEEEEe----CCCCEEEEEEecCC-----hhHHHHHHHHHHHHHhcCC-cceeEEeeEEEecCc
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPS-----EDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNN 417 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~----~~g~~vAVK~l~~~-----~~~~~~~~~Ei~iL~~L~H-pnIV~l~g~~~~~~~ 417 (696)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999974 25889999998642 2345678899999999976 899999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA 497 (696)
.++||||+.+|+|.+++.... .++...+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999997664 36788899999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCCCCcceeccC--CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhccccccCc
Q 005450 498 KWASTSSSHITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 575 (696)
Q Consensus 498 ~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~--~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 575 (696)
+........ ......||+.|+|||.+... .++.++|||||||+||+|++|+.||...........+...... .
T Consensus 177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~---~- 251 (322)
T d1vzoa_ 177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK---S- 251 (322)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH---C-
T ss_pred hhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc---C-
Confidence 876543332 22346799999999998754 4788999999999999999999999877654433222111100 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005450 576 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLK 619 (696)
Q Consensus 576 l~~llD~~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPS-----m~eVL~ 619 (696)
.+.+.. .....+..++..||+.||.+||| ++|+++
T Consensus 252 -----~~~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 -----EPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----CCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----CCCCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 001111 11234555666799999999994 788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-41 Score=360.48 Aligned_cols=261 Identities=22% Similarity=0.240 Sum_probs=191.0
Q ss_pred hcCceeeeeeeccCceEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe------cC
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------DN 416 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~------~~ 416 (696)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++.. .....++.+|+.+|++++||||++++++|.. .+
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999964 6999999999753 3455678999999999999999999999964 36
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCc
Q 005450 417 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 496 (696)
Q Consensus 417 ~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGl 496 (696)
.+|+||||+.++.+ +.+.. .+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~~------~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEEHH-HHHTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchHHH-Hhhhc------CCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhh
Confidence 78999999976544 44432 47899999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhc--------
Q 005450 497 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-------- 568 (696)
Q Consensus 497 A~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~-------- 568 (696)
++....... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 166 ~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 166 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 886655332 234679999999999999999999999999999999999999998765433222111000
Q ss_pred --------------cccccCccccccCcccCCCC---ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005450 569 --------------PILSSGKVTQLLDPALGNNY---DYDQMERMVLASILCIRRDPRARPQMSLVLKL 620 (696)
Q Consensus 569 --------------~~~~~g~l~~llD~~L~~~~---~~~e~~~l~~la~~Cl~~dP~~RPSm~eVL~~ 620 (696)
+..........+........ .......+..++.+||+.||++|||++|+|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000011111111111111 11234456678888999999999999999863
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=362.81 Aligned_cols=260 Identities=22% Similarity=0.290 Sum_probs=194.3
Q ss_pred hcCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-----Cc
Q 005450 347 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 417 (696)
Q Consensus 347 t~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~-----~~ 417 (696)
+++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+++|+.++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999985 57999999999753 34556789999999999999999999998643 34
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceEEeecCcc
Q 005450 418 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 497 (696)
Q Consensus 418 ~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA 497 (696)
.+++|+|+.+|+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchh
Confidence 56777888999999998643 48999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCCCCcceeccC-CCCCcccchhhHHHHHHHHhCCCCCCCCCccchhhHHhhhcccccc---
Q 005450 498 KWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS--- 573 (696)
Q Consensus 498 ~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~-~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~--- 573 (696)
..... ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.......+.........
T Consensus 169 ~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 169 RHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp -CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 75543 22346799999999987655 4688999999999999999999999876543332222111100000
Q ss_pred -----CccccccCcccC-CCCCh-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005450 574 -----GKVTQLLDPALG-NNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLK 619 (696)
Q Consensus 574 -----g~l~~llD~~L~-~~~~~-----~e~~~l~~la~~Cl~~dP~~RPSm~eVL~ 619 (696)
............ ..... .....+..++..||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000000000000 00000 01123455677899999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.2e-37 Score=326.39 Aligned_cols=264 Identities=18% Similarity=0.231 Sum_probs=191.4
Q ss_pred cCceeeeeeeccCceEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-----------CcceeEEeeEEEec
Q 005450 348 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----------HKNIISLLGFCFED 415 (696)
Q Consensus 348 ~~f~~~~~LG~G~fG~Vyka~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~-----------HpnIV~l~g~~~~~ 415 (696)
++|.+.+.||+|+||+||+|.. .+|+.||||+++......+.+.+|+.+++.++ |+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 3599999999999999999996 57999999999987766778889999998885 47899999988653
Q ss_pred --CceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCc-----
Q 005450 416 --NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE----- 488 (696)
Q Consensus 416 --~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~----- 488 (696)
...+++|+++..+.......... ....+++..+..++.||+.||+|||+ ..||+||||||+||||+.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence 45667777766654433332221 22367889999999999999999996 268999999999999986543
Q ss_pred -eEEeecCccccccCCCCCcccccccccCCCCCcceeccCCCCCcccchhhHHHHHHHHhCCCCCCCCCccchh----hH
Q 005450 489 -PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE----SL 563 (696)
Q Consensus 489 -vKL~DFGlA~~~~~~~~~~~~~~~~GT~~YlAPE~l~~~~~s~ksDVwSLGvvL~ELltG~~Pf~~~~~~~~~----~l 563 (696)
++++|||.+....... ....||+.|+|||++....++.++|||||||++++|++|+.||......... .+
T Consensus 170 ~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 8999999998665432 2357999999999999999999999999999999999999999765432111 00
Q ss_pred Hh--hhcc---------------ccccCccccccCc----------ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005450 564 VM--WAKP---------------ILSSGKVTQLLDP----------ALGNNYDYDQMERMVLASILCIRRDPRARPQMSL 616 (696)
Q Consensus 564 v~--~~~~---------------~~~~g~l~~llD~----------~L~~~~~~~e~~~l~~la~~Cl~~dP~~RPSm~e 616 (696)
.. +... ..........+.. .............+..++..||+.||.+|||+.|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 00 0000 0000000000000 0011233455667777888899999999999999
Q ss_pred HHH
Q 005450 617 VLK 619 (696)
Q Consensus 617 VL~ 619 (696)
+|+
T Consensus 325 ~L~ 327 (362)
T d1q8ya_ 325 LVN 327 (362)
T ss_dssp HHT
T ss_pred Hhc
Confidence 985
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.2e-23 Score=203.03 Aligned_cols=163 Identities=16% Similarity=0.157 Sum_probs=123.1
Q ss_pred ceeeeeeeccCceEEEEEEeCCCCEEEEEEecCCh-------------------hHHHHHHHHHHHHHhcCCcceeEEee
Q 005450 350 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-------------------DVIKEFVLEIEIITTLHHKNIISLLG 410 (696)
Q Consensus 350 f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~-------------------~~~~~~~~Ei~iL~~L~HpnIV~l~g 410 (696)
+.+.+.||+|+||+||+|.+.+|+.||||+++... .....+..|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 35689999999999999999899999999876421 11234556889999999999998876
Q ss_pred EEEecCceEEEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCCCCceEeecccccceeeCCCCceE
Q 005450 411 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 490 (696)
Q Consensus 411 ~~~~~~~~~LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~~~gIIHrDLKpsNILLd~~~~vK 490 (696)
+. ..+++|||+++..+.+ ++......++.|++.+|.|||+ ++|+||||||+|||++++ .++
T Consensus 82 ~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEE
T ss_pred ec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEE
Confidence 63 3479999998865533 3334566899999999999999 899999999999999965 599
Q ss_pred EeecCccccccCCCCCcccccccccCCCCC------cceeccCCCCCcccchhhHHHH
Q 005450 491 LSDFGLAKWASTSSSHITCTDVAGTFGYLA------PEYFMYGKVNDKIDVYAFGVVL 542 (696)
Q Consensus 491 L~DFGlA~~~~~~~~~~~~~~~~GT~~YlA------PE~l~~~~~s~ksDVwSLGvvL 542 (696)
|+|||+|.......... |+. .+.+ ...|+.++|+||..--+
T Consensus 143 liDFG~a~~~~~~~~~~----------~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWRE----------ILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHHH----------HHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcHH----------HHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99999997654322111 111 1222 25688899999976444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.41 E-value=5.4e-07 Score=88.96 Aligned_cols=147 Identities=18% Similarity=0.142 Sum_probs=98.8
Q ss_pred HHHHhhcCceeeeeeeccCceEEEEEEeCCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceE
Q 005450 342 DLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLL 419 (696)
Q Consensus 342 el~~~t~~f~~~~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~~~ 419 (696)
++...-..|+..+..+.++.+.||+... +++.+++|+..... .....+.+|..++..+. +--+.+++.++..++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3344445666666655555678998764 56678888876432 23345677888888774 333667788888888899
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHhcCC--------------------------------
Q 005450 420 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-------------------------------- 467 (696)
Q Consensus 420 LV~Ey~~gGsL~~~L~~~~~~~~~l~~~~~~~Ia~qIa~aL~yLH~~~-------------------------------- 467 (696)
+||++++|.++.+..... .....++.++++.|..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 999999998886544211 112234455555555555411
Q ss_pred ------------------------CCceEeecccccceeeCCCCceEEeecCccc
Q 005450 468 ------------------------AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 468 ------------------------~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987666799998775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.97 E-value=1.1e-05 Score=78.77 Aligned_cols=75 Identities=17% Similarity=0.047 Sum_probs=55.2
Q ss_pred eeeccCc-eEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC--cceeEEeeEEEecCceEEEEeecCCCChh
Q 005450 355 LIGKGGS-SQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLVYDFLSRGSLE 431 (696)
Q Consensus 355 ~LG~G~f-G~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~H--pnIV~l~g~~~~~~~~~LV~Ey~~gGsL~ 431 (696)
.+..|.. +.||+....++..+++|....... ..+..|...++.+.. -.+.+++.++.+++..++||+|++|.++.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT--SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH--hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 3445543 689999888888899998776432 346678888777643 33667788888888899999999987654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.62 E-value=0.00012 Score=77.16 Aligned_cols=76 Identities=17% Similarity=0.148 Sum_probs=50.5
Q ss_pred eeeeeccCceEEEEEEeCC-CCEEEEEEecCC--------hhHHHHHHHHHHHHHhcC-C--cceeEEeeEEEecCceEE
Q 005450 353 ENLIGKGGSSQVYKGCLPD-GKELAVKILKPS--------EDVIKEFVLEIEIITTLH-H--KNIISLLGFCFEDNNLLL 420 (696)
Q Consensus 353 ~~~LG~G~fG~Vyka~~~~-g~~vAVK~l~~~--------~~~~~~~~~Ei~iL~~L~-H--pnIV~l~g~~~~~~~~~L 420 (696)
.+.||.|....||+....+ ++.++||.-.+. .....+...|.+.|..+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999998654 678999976431 112344566888887663 2 345556544 4556789
Q ss_pred EEeecCCCCh
Q 005450 421 VYDFLSRGSL 430 (696)
Q Consensus 421 V~Ey~~gGsL 430 (696)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.34 E-value=0.00028 Score=72.02 Aligned_cols=136 Identities=17% Similarity=0.222 Sum_probs=81.8
Q ss_pred ceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcce--eEEe-----eEEEecCceEEEEeecCCCChhh-
Q 005450 361 SSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI--ISLL-----GFCFEDNNLLLVYDFLSRGSLEE- 432 (696)
Q Consensus 361 fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnI--V~l~-----g~~~~~~~~~LV~Ey~~gGsL~~- 432 (696)
--.||+...++|..|++|+.++.....+++..|+..+..|....+ +..+ ..+..+...+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 468999999999999999999876666778889988888753222 1111 12344567888999998753321
Q ss_pred -------------hhhc----CC-CCCCCCChH-------------------H---HHHHHHHHHHHHHHH-hcCCCCce
Q 005450 433 -------------NLHG----NK-KDPAAFGWS-------------------E---RYKVAMGVAEALEYL-HSGSAQRV 471 (696)
Q Consensus 433 -------------~L~~----~~-~~~~~l~~~-------------------~---~~~Ia~qIa~aL~yL-H~~~~~gI 471 (696)
.+|. .. .....+++. . ...++..+...+.-+ ......++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0111 00 001111111 1 112222232222221 12334689
Q ss_pred EeecccccceeeCCCCceEEeecCccc
Q 005450 472 IHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 472 IHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
||+|+.+.|||++++ ..++||+-+.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ecCCCCcccEEEeCC--ceEEechhcc
Confidence 999999999999754 5689998775
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.71 E-value=0.0016 Score=67.86 Aligned_cols=75 Identities=17% Similarity=0.224 Sum_probs=51.7
Q ss_pred eeeeeeccCceEEEEEEeCC--------CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcce-eEEeeEEEecCceEEEE
Q 005450 352 AENLIGKGGSSQVYKGCLPD--------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVY 422 (696)
Q Consensus 352 ~~~~LG~G~fG~Vyka~~~~--------g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~HpnI-V~l~g~~~~~~~~~LV~ 422 (696)
..+.|+.|-.-.+|+...++ .+.|++++.-..... -...+|..+++.+.-.++ .+++++|.. .+||
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 34678889999999988653 356788877643333 345678889888863344 467777632 6899
Q ss_pred eecCCCChh
Q 005450 423 DFLSRGSLE 431 (696)
Q Consensus 423 Ey~~gGsL~ 431 (696)
||++|..|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999876443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.69 E-value=0.0026 Score=63.68 Aligned_cols=157 Identities=14% Similarity=0.068 Sum_probs=81.9
Q ss_pred hHHHHHhhcCceee-----eeeeccCceEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCc-----ceeEEe
Q 005450 340 YQDLLSATSNFLAE-----NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK-----NIISLL 409 (696)
Q Consensus 340 ~~el~~~t~~f~~~-----~~LG~G~fG~Vyka~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~L~Hp-----nIV~l~ 409 (696)
.+++.....+|.+. +.|..|---+.|+....+|+ +++|+..... ..+++..|++++..|... ..+...
T Consensus 5 ~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~~~ 82 (316)
T d2ppqa1 5 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRK 82 (316)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred HHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccceec
Confidence 34445555555443 33556767889998877665 8999986532 223455566677766432 222111
Q ss_pred -e--EEEecCceEEEEeecCCCChhh--------------hhhcC---CCCCCC--C------------------ChHHH
Q 005450 410 -G--FCFEDNNLLLVYDFLSRGSLEE--------------NLHGN---KKDPAA--F------------------GWSER 449 (696)
Q Consensus 410 -g--~~~~~~~~~LV~Ey~~gGsL~~--------------~L~~~---~~~~~~--l------------------~~~~~ 449 (696)
| +.........++.++.+..... .++.. ...+.. . .....
T Consensus 83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (316)
T d2ppqa1 83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 162 (316)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence 1 1223445666777776643321 01100 000000 0 01111
Q ss_pred HHHHHHHHHHHHHHhc-CCCCceEeecccccceeeCCCCceEEeecCccc
Q 005450 450 YKVAMGVAEALEYLHS-GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 498 (696)
Q Consensus 450 ~~Ia~qIa~aL~yLH~-~~~~gIIHrDLKpsNILLd~~~~vKL~DFGlA~ 498 (696)
...+..+...+.-.+. .-..++||+|+.+.||+++.+...-|.||+.+.
T Consensus 163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 2223333333333332 235789999999999999988767899999764
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=95.39 E-value=0.015 Score=52.73 Aligned_cols=84 Identities=19% Similarity=0.205 Sum_probs=56.8
Q ss_pred cEEEEEEecCc---------chHHHHhHHHHhhcCCCCe---EEEEEeeeccccccc-CC----cc----h-hhhhHHHH
Q 005450 17 RTVVVGVKLDT---------HSRELLTWALVKVAQPGDT---VIALHVLANNAIVDR-DG----KS----S-LLSLVKAF 74 (696)
Q Consensus 17 ~~~~vg~~~d~---------~~~~~l~wa~~~~a~~~d~---v~a~hv~~~~~~~~~-~~----~~----~-~~~~~~~~ 74 (696)
++|||+|.--. .|+..|.||+..+.+.||. |+.+||......... .+ .. . .-...+..
T Consensus 2 ~ki~vavd~s~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (171)
T d2gm3a1 2 TKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKAKG 81 (171)
T ss_dssp EEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHHHH
T ss_pred CEEEEEEcCCcccCCCCCCHHHHHHHHHHHHHHHHCCCCCcEEEEEEeccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 58999987432 6999999999999999995 889998865433111 00 00 1 11123455
Q ss_pred HHHHHHHHhcccccceeeEEEEecCc
Q 005450 75 DSVLAVYEGFCNLKQVDLKLKICRGT 100 (696)
Q Consensus 75 ~~~l~~~~~~c~~kq~~l~~~~~~~~ 100 (696)
..+|+.|...|+-+.+..+..|..|.
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~v~~G~ 107 (171)
T d2gm3a1 82 LHLLEFFVNKCHEIGVGCEAWIKTGD 107 (171)
T ss_dssp HHHHHHHHHHHHHHTCEEEEEEEESC
T ss_pred HHHHHHHHHHHHhcCCceEEEEEeCC
Confidence 67888899999888888888887774
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=95.07 E-value=0.027 Score=50.03 Aligned_cols=84 Identities=15% Similarity=0.135 Sum_probs=61.6
Q ss_pred cEEEEEEecCcchHHHHhHHHHhhcCCCCeEEEEEeeeccccccc------CC---cch----h-----hhhHHHHHHHH
Q 005450 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDR------DG---KSS----L-----LSLVKAFDSVL 78 (696)
Q Consensus 17 ~~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~hv~~~~~~~~~------~~---~~~----~-----~~~~~~~~~~l 78 (696)
++|||++.....|+..|.||+.-+...|..++.|||......... .+ ... . -.+.+.....|
T Consensus 4 ~~ILvavD~s~~s~~al~~a~~la~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 83 (160)
T d1mjha_ 4 KKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKNKM 83 (160)
T ss_dssp CEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEECCCHHHHHHHHHHHHHHHhcCCEEEEEEecccccccccccccccccccccchhHHHHHHHHHHHHHHHHHHHH
Confidence 689999998889999999999999999999999999865332110 00 000 0 01123445678
Q ss_pred HHHHhcccccceeeEEEEecCc
Q 005450 79 AVYEGFCNLKQVDLKLKICRGT 100 (696)
Q Consensus 79 ~~~~~~c~~kq~~l~~~~~~~~ 100 (696)
+.+...|....|..+.++..|.
T Consensus 84 ~~~~~~~~~~gv~~~~~~~~G~ 105 (160)
T d1mjha_ 84 ENIKKELEDVGFKVKDIIVVGI 105 (160)
T ss_dssp HHHHHHHHHTTCEEEEEEEEEC
T ss_pred HHHHHHHHhcCCeEEEEEEecc
Confidence 8888889989899999998884
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=93.23 E-value=0.084 Score=45.20 Aligned_cols=72 Identities=15% Similarity=0.176 Sum_probs=49.2
Q ss_pred cEEEEEEecCcchHHHHhHHHHhhcCCCCeEEEEEeeecccccccCCcch----hhhhHHHHHHHHHHHHhcccccce
Q 005450 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS----LLSLVKAFDSVLAVYEGFCNLKQV 90 (696)
Q Consensus 17 ~~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~hv~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~c~~kq~ 90 (696)
++|||++.....|+.++.||+.-+.+.|..|+.+||...... ..+... .-...+.+...|+.+....+.+.+
T Consensus 2 k~Ilv~~D~s~~s~~a~~~a~~~a~~~~~~l~ll~V~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 77 (135)
T d2z3va1 2 KTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPD--YLGEPFFEEALRRRLERAEGVLEEARALTGVPKE 77 (135)
T ss_dssp CEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECCCCT--TCCTTHHHHHHHHHHHHHHHHHHHHHHHHCCCGG
T ss_pred CEEEEEECCCHHHHHHHHHHHHHHHHcCCEEEEEEEecCCcc--ccccchhHHHHHHHHHHHHHHHHHHHHhcCCCeE
Confidence 689999998889999999999999999999999999864332 111111 111223444555555555555544
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=92.83 E-value=0.041 Score=47.47 Aligned_cols=41 Identities=24% Similarity=0.255 Sum_probs=37.5
Q ss_pred cEEEEEEecCcchHHHHhHHHHhhcCCCCeEEEEEeeeccc
Q 005450 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNA 57 (696)
Q Consensus 17 ~~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~hv~~~~~ 57 (696)
++||||+.....++.+|.||..-+.+.|+.|+.+||.....
T Consensus 3 k~ILv~vD~s~~s~~al~~A~~~a~~~~~~v~~lhv~~~~~ 43 (140)
T d1jmva_ 3 KHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFS 43 (140)
T ss_dssp SEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCG
T ss_pred CeEEEEECCCHHHHHHHHHHHHHHHHcCCeEEEEEEeeecc
Confidence 68999999999999999999999999999999999986544
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=91.42 E-value=0.23 Score=42.07 Aligned_cols=39 Identities=18% Similarity=0.230 Sum_probs=37.0
Q ss_pred cEEEEEEecCcchHHHHhHHHHhhcCCCCeEEEEEeeec
Q 005450 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLAN 55 (696)
Q Consensus 17 ~~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~hv~~~ 55 (696)
++|||++.....|+..|.||+.-..+-|..|..+||...
T Consensus 5 k~ILv~~D~S~~s~~al~~A~~~a~~~~a~l~llhv~~~ 43 (138)
T d1q77a_ 5 KVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLED 43 (138)
T ss_dssp EEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHH
T ss_pred CEEEEEEeCCHHHHHHHHHHHHhhhhccceEEEEEEccC
Confidence 799999999999999999999999999999999999863
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=91.08 E-value=0.15 Score=43.98 Aligned_cols=84 Identities=14% Similarity=0.024 Sum_probs=49.5
Q ss_pred cEEEEEEecCcchHHHHhHHHHhhcCCCCeEEEEEeeecccccc-c---C-CcchhhhhHHHHHHHHHHHHhccccccee
Q 005450 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVD-R---D-GKSSLLSLVKAFDSVLAVYEGFCNLKQVD 91 (696)
Q Consensus 17 ~~~~vg~~~d~~~~~~l~wa~~~~a~~~d~v~a~hv~~~~~~~~-~---~-~~~~~~~~~~~~~~~l~~~~~~c~~kq~~ 91 (696)
++|||++.....++..|.||+.- |++++.++-+|+........ . . .........+.....|+.+..+|.-..+.
T Consensus 6 k~ILv~vD~s~~s~~al~~A~~l-a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 84 (147)
T d1tq8a_ 6 KTVVVGTDGSDSSMRAVDRAAQI-AGADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERAHNAGAK 84 (147)
T ss_dssp CEEEEECCSSHHHHHHHHHHHHH-HTTTSEEEEEEECCC--------------------CCTHHHHHHHHHHHHHTTTCC
T ss_pred CEEEEEECCCHHHHHHHHHHHHH-HhcCCCEEEEEEEecccccccccccchhhhHHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 79999999999999999999965 56666666666544322100 0 0 00011112234556677777777655554
Q ss_pred -eEEEEecCcc
Q 005450 92 -LKLKICRGTE 101 (696)
Q Consensus 92 -l~~~~~~~~~ 101 (696)
.+..+..|.-
T Consensus 85 ~~~~~~~~G~~ 95 (147)
T d1tq8a_ 85 NVEERPIVGAP 95 (147)
T ss_dssp EEEEEEECSSH
T ss_pred cEEEEEEecCh
Confidence 6777777653
|